FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kunimoto, D
   Yoon, YH
   Wykoff, CC
   Chang, A
   Khurana, RN
   Maturi, RK
   Agostini, H
   Souied, E
   Chow, DR
   Lotery, AJ
   Ohji, M
   Bandello, F
   Belfort, R
   Li, XY
   Jiao, J
   Le, G
   Schmidt, W
   Hashad, Y
AF Kunimoto, Derek
   Yoon, Young Hee
   Wykoff, Charles C.
   Chang, Andrew
   Khurana, Rahul N.
   Maturi, Raj K.
   Agostini, Hansjuergen
   Souied, Eric
   Chow, David R.
   Lotery, Andrew J.
   Ohji, Masahito
   Bandello, Francesco
   Belfort, Rubens, Jr.
   Li, Xiao-Yan
   Jiao, Jenny
   Le, Grace
   Schmidt, Werner
   Hashad, Yehia
CA CEDAR Study Grp
   SEQUOIA Study Grp
TI Efficacy and Safety of Abicipar in Neovascular Age-Related Macular
   Degeneration 52-Week Results of Phase 3 Randomized Controlled Study
SO OPHTHALMOLOGY
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; ANKYRIN REPEAT PROTEIN; DISEASE BURDEN;
   VISION LOSS; RANIBIZUMAB; PEGOL; AFLIBERCEPT; MORPHOLOGY; BLINDNESS;
   EXTEND
AB Purpose: To compare the efficacy and safety of abicipar every 8 weeks and quarterly (after initial doses) versus ranibizumab every 4 weeks in treatment-naive patients with neovascular age-related macular degeneration (AMD).
   Design: Two randomized, multicenter, double-masked, parallel-group, active-controlled, phase 3 clinical trials (CEDAR, SEQUOIA) with identical protocols were conducted. Data from both trials were pooled for analysis.
   Participants: Patients with active choroidal neovascularization secondary to AMD and best-corrected visual acuity (BCVA) of 24-73 Early Treatment Diabetic Retinopathy Study letters in the study eye were enrolled.
   Methods: Patients (n = 1888) were randomized in a 1:1:1 ratio to study eye treatment with abicipar 2 mg every 8 weeks after 3 initial doses at baseline and weeks 4 and 8 (Q8), abicipar 2 mg every 12 weeks after 3 initial doses at baseline and weeks 4 and 12 (Q12), or ranibizumab 0.5 mg every 4 weeks (Q4).
   Main Outcome Measures: The primary efficacy end point was proportion of patients with stable vision (defined as <15-letter loss in BCVA from baseline) in the study eye at week 52. Secondary end points included change from baseline in BCVA and central retinal thickness (CRT) at week 52. Safety measures included adverse events (AEs).
   Results: The proportion of patients with stable vision at week 52 was 93.2%, 91.3%, and 95.8% in the abicipar Q8, abicipar Q12, and ranibizumab Q4 groups, respectively, with both abicipar Q8 and Q12 noninferior to ranibizumab Q4. Week 52 mean change from baseline in BCVA was 7.5, 6.4, and 8.4 letters and in CRT was -144, -145, and -144 mu m in the abicipar Q8, abicipar Q12, and ranibizumab Q4 groups, respectively. Incidence of intraocular inflammation (IOI) AEs was 15.4%, 15.3%, and 0.3%, respectively. The IOI AEs were typically mild or moderate in severity and treated with topical corticosteroids; 62 of 192 patients (32.3%) received oral and/or injectable corticosteroids.
   Conclusions: Abicipar Q8 and Q12 were both noninferior to ranibizumab Q4 in the primary end point of stable vision at week 52. Intraocular inflammation was more frequent with abicipar. Quarterly and Q8 abicipar reduce nAMD disease and treatment burden compared with monthly treatment. (C) 2020 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology.
C1 [Kunimoto, Derek] Retinal Consultants Arizona, Phoenix, AZ USA.
   [Yoon, Young Hee] Univ Ulsan, Asan Med Ctr, Seoul, South Korea.
   [Wykoff, Charles C.] Retina Consultants Houston, Houston, TX USA.
   [Chang, Andrew] Sydney Retina Clin, Sydney, NSW, Australia.
   [Chang, Andrew] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia.
   [Khurana, Rahul N.] Northern Calif Retina Vitreous Associates, Mountain View, CA USA.
   [Maturi, Raj K.] Midwest Eye Inst, Indianapolis, IN USA.
   [Maturi, Raj K.] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA.
   [Agostini, Hansjuergen] Univ Freiburg, Fac Med, Eye Ctr, Med Ctr, Freiburg, Germany.
   [Souied, Eric] Ctr Hosp Creteil, Serv Univ Ophthalmol, Creteil, France.
   [Chow, David R.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada.
   [Chow, David R.] Toronto Retina Inst, N York, ON, Canada.
   [Lotery, Andrew J.] Univ Southampton, Southampton, Hants, England.
   [Ohji, Masahito] Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga, Japan.
   [Bandello, Francesco] Univ Vita Salute Sci Inst, Hosp San Raffaele, Milan, Italy.
   [Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.
   [Li, Xiao-Yan; Jiao, Jenny; Le, Grace; Schmidt, Werner; Hashad, Yehia] Allergan Plc, Irvine, CA USA.
RP Kunimoto, D (corresponding author), 2152 S Vineyard,Suite 139 Bldg 12, Phoenix, AZ 85253 USA.
EM derek_kunimoto@yahoo.com
OI Khurana, Rahul/0000-0001-5198-1353
FU Allergan plc (Dublin, Ireland); Allergan plcAllergan
FX Sponsored by Allergan plc (Dublin, Ireland). The sponsor participated in
   the design of the study, data management, data analysis, interpretation
   of the data, and preparation, review, and approval of the manuscript.
   Evidence Scientific Solutions, Inc. (Philadelphia, PA) prepared a draft
   of the manuscript under the direction of the authors and provided
   editorial assistance, funded by Allergan plc. All authors met the
   International Committee of Medical Journal Editors authorship criteria.
   Neither honoraria nor payments were made for authorship. DARPin is a
   registered trademark of Molecular Partners (Zurich, Switzerland).
CR Arnold JJ, 2015, OPHTHALMOLOGY, V122, P1212, DOI 10.1016/j.ophtha.2015.02.009
   Augsburger M, 2019, GRAEF ARCH CLIN EXP, V257, P1889, DOI 10.1007/s00417-019-04404-0
   Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655
   Brown MM, 2016, RETINA-J RET VIT DIS, V36, P285, DOI 10.1097/IAE.0000000000000717
   Busbee BG, 2013, OPHTHALMOLOGY, V120, P1046, DOI 10.1016/j.ophtha.2012.10.014
   Callanan D, 2018, J OCUL PHARMACOL TH, V34, P700, DOI 10.1089/jop.2018.0062
   Campochiaro PA, 2013, AM J OPHTHALMOL, V155, P697, DOI 10.1016/j.ajo.2012.09.032
   Dugel PU, 2020, OPHTHALMOLOGY, V127, P72, DOI 10.1016/j.ophtha.2019.04.017
   Dugel PU, 2017, OPHTHALMOLOGY, V124, P1296, DOI 10.1016/j.ophtha.2017.03.057
   FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640
   Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5
   Golbaz I, 2011, INVEST OPHTH VIS SCI, V52, P1599, DOI 10.1167/iovs.09-5018
   Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006
   Jaffe GJ, 2016, OPHTHALMOLOGY, V123, P1856, DOI 10.1016/j.ophtha.2016.05.016
   Jaffe GJ, 2013, OPHTHALMOLOGY, V120, P1860, DOI 10.1016/j.ophtha.2013.01.073
   Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417
   Kertes PJ, 2019, OPHTHALMOLOGY, V126, P841, DOI 10.1016/j.ophtha.2019.01.013
   Krohne TU, 2012, AM J OPHTHALMOL, V154, P682, DOI 10.1016/j.ajo.2012.03.047
   Kunimoto D, 2019, OSLI RETINA, V50, pE10, DOI 10.3928/23258160-20190129-13
   Pluckthun A, 2015, ANNU REV PHARMACOL, V55, P489, DOI 10.1146/annurev-pharmtox-010611-134654
   Prenner JL, 2015, AM J OPHTHALMOL, V160, P725, DOI 10.1016/j.ajo.2015.06.023
   Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004
   Rodrigues GA, 2018, INVEST OPHTH VIS SCI, V59, P5836, DOI 10.1167/iovs.18-25307
   Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481
   Schmidt-Erfurth U, 2015, OPHTHALMOLOGY, V122, P822, DOI 10.1016/j.ophtha.2014.11.017
   Schmidt-Erfurth U, 2014, BRIT J OPHTHALMOL, V98, P1144, DOI 10.1136/bjophthalmol-2014-305702
   Schmidt-Erfurth U, 2011, OPHTHALMOLOGY, V118, P831, DOI 10.1016/j.ophtha.2010.09.004
   Silva R, 2018, OPHTHALMOLOGY, V125, P57, DOI 10.1016/j.ophtha.2017.07.014
   Souied EH, 2014, AM J OPHTHALMOL, V158, P724, DOI 10.1016/j.ajo.2014.05.037
   Sulzbacher F, 2015, INVEST OPHTH VIS SCI, V56, P1158, DOI 10.1167/iovs.14-14298
   Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1
   Yan X, 2010, STAT BIOPHARM RES, V2, P329, DOI 10.1198/sbr.2009.0049
   Yonekawa Y, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017178
NR 33
TC 4
Z9 4
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD OCT
PY 2020
VL 127
IS 10
BP 1331
EP 1344
DI 10.1016/j.ophtha.2020.03.035
PG 14
WC Ophthalmology
SC Ophthalmology
GA NT0HB
UT WOS:000572632200015
PM 32471729
OA Other Gold
DA 2020-12-01
ER

PT J
AU Marinho, PM
   Nascimento, H
   Marcos, AAA
   Romano, AC
   Belfort, R
AF Marinho, Paula M.
   Nascimento, Heloisa
   Marcos, Allexya A. A.
   Romano, Andre C.
   Belfort, Rubens, Jr.
TI Seeking clarity on retinal findings in patients with COVID-19
SO LANCET
LA English
DT Letter
C1 [Nascimento, Heloisa] Inst Paulista Estudos & Pesquisas Oftalmol, IPEPO, Inst Visao, Dept Ophthalmol, Sao Paulo, Brazil.
   Univ Fed Sao Paulo, Dept Ophthalmol, Hosp Sao Paulo, BR-04023062 Sao Paulo, Brazil.
RP Nascimento, H (corresponding author), Inst Paulista Estudos & Pesquisas Oftalmol, IPEPO, Inst Visao, Dept Ophthalmol, Sao Paulo, Brazil.
EM helomn@gmail.com
CR Danzi GB, 2020, EUR HEART J, V41, P1858, DOI 10.1093/eurheartj/ehaa254
   Iba T, 2020, CRIT CARE MED, DOI 10.1097/
   Marinho PM, 2020, LANCET, V395, P1610, DOI 10.1016/S0140-6736(20)31014-X
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Yin SY, 2020, J THROMB THROMBOLYS, DOI 10.1007/s11239-020-02105-8
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD SEP 19
PY 2020
VL 396
IS 10254
BP E40
EP E40
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA OC4PV
UT WOS:000579141200011
PM 32950102
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Roizenblatt, M
   Marin, VDGB
   Grupenmacher, AT
   Muralha, F
   Faber, J
   Jiramongkolchai, K
   Gehlbach, PL
   Farah, ME
   Belfort, R
   Maia, M
AF Roizenblatt, Marina
   Dias Gomes Barrios Marin, Vitor
   Grupenmacher, Alex Treiger
   Muralha, Felipe
   Faber, Jean
   Jiramongkolchai, Kim
   Gehlbach, Peter Louis
   Farah, Michel Eid
   Belfort, Rubens, Jr.
   Maia, Mauricio
TI Association of Weight-Adjusted Caffeine and beta-Blocker Use With
   Ophthalmology Fellow Performance During Simulated Vitreoretinal
   Microsurgery
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID SURGERY; TREMOR; PROPRANOLOL; IMPROVES; TIMOLOL; STRAIN; RISK
AB This cross-sectional study examines the association of weight-adjusted doses of caffeine alone, a beta-blocker alone, or a beta-blocker and caffeine combination with surgical performance of vitreoretinal ophthalmology fellows during simulated vitreoretinal microsurgery.
   Question Is there an association of weight-adjusted doses of caffeine alone, a beta-blocker (propranolol) alone, or a beta-blocker and caffeine combination with surgical performance by novice vitreoretinal surgeons? Findings In this cross-sectional study of 15 vitreoretinal surgical fellows, propranolol alone was associated with improved surgical performance compared with caffeine alone and the combination of caffeine and propranolol. Meaning The findings suggest that caffeine is negatively associated with surgical performance among novice vitreoretinal surgeons but that addition of propranolol is associated with improved performance.
   Importance Vitreoretinal surgery can be technically challenging and is limited by physiologic characteristics of the surgeon. Factors that improve accuracy and precision of the vitreoretinal surgeon are invaluable to surgical performance. Objectives To establish weight-adjusted cutoffs for caffeine and beta-blocker (propranolol) intake and to determine their interactions in association with the performance of novice vitreoretinal microsurgeons. Design, Settings, and Participants This single-blind cross-sectional study of 15 vitreoretinal surgeons who had less than 2 years of surgical experience was conducted from September 19, 2018, to September 25, 2019, at a dry-laboratory setting. Five simulations were performed daily for 2 days. On day 1, performance was assessed after sequential exposure to placebo, low-dose caffeine (2.5 mg/kg), high-dose caffeine (5.0 mg/kg), and high-dose propranolol (0.6 mg/kg). On day 2, performance was assessed after sequential exposure to placebo, low-dose propranolol (0.2 mg/kg), high-dose propranolol (0.6 mg/kg), and high-dose caffeine (5.0 mg/kg). Interventions Surgical simulation tasks were repeated 30 minutes after masked ingestion of placebo, caffeine, or propranolol pills during the 2 days. Main Outcomes and Measures An Eyesi surgical simulator was used to assess surgical performance, which included surgical score (range, 0 [worst] to 700 [best]), task completion time, intraocular trajectory, and tremor rate (range, 0 [worst] to 100 [best]). The nonparametric Friedman test followed by Dunn-Bonferroni post hoc test was applied for multiple comparisons. Results Of 15 vitreoretinal surgeons, 9 (60%) were male, with a mean (SD) age of 29.6 (1.4) years and mean (SD) body mass index (calculated as weight in kilograms divided by height in meters squared) of 23.15 (2.9). Compared with low-dose propranolol, low-dose caffeine was associated with a worse total surgical score (557.0 vs 617.0; difference, -53.0; 95% CI, -99.3 to -6.7; P = .009), a lower antitremor maneuver score (55.0 vs 75.0; difference, -12.0; 95% CI, -21.2 to -2.8; P = .009), longer intraocular trajectory (2298.6 vs 2080.7 mm; difference, 179.3 mm; 95% CI, 1.2-357.3 mm; P = .048), and increased task completion time (14.9 minutes vs 12.7 minutes; difference, 2.3 minutes; 95% CI, 0.8-3.8 minutes; P = .048). Postcaffeine treatment with propranolol was associated with performance improvement; however, surgical performance remained inferior compared with low-dose propranolol alone for total surgical score (570.0 vs 617.0; difference, -51.0; 95% CI, -77.6 to -24.4; P = .01), tremor-specific score (50.0 vs 75.0; difference, -16.0; 95% CI, -31.8 to -0.2; P = .03), and intraocular trajectory (2265.9 mm vs 2080.7 mm; difference, 166.8 mm; 95% CI, 64.1-269.6 mm; P = .03). Conclusions and Relevance The findings suggest that performance of novice vitreoretinal surgeons was worse after receiving low-dose caffeine alone but improved after receiving low-dose propranolol alone. Their performance after receiving propranolol alone was better than after the combination of propranolol and caffeine. These results may be helpful for novice vitreoretinal surgeons to improve microsurgical performance.
C1 [Roizenblatt, Marina; Dias Gomes Barrios Marin, Vitor; Grupenmacher, Alex Treiger; Muralha, Felipe; Farah, Michel Eid; Belfort, Rubens, Jr.; Maia, Mauricio] Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,First Floor, BR-04023062 Sao Paulo, SP, Brazil.
   [Roizenblatt, Marina; Farah, Michel Eid; Belfort, Rubens, Jr.; Maia, Mauricio] Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.
   [Roizenblatt, Marina; Jiramongkolchai, Kim; Gehlbach, Peter Louis] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.
   [Faber, Jean] Univ Fed Sao Paulo, Dept Neurol & Neurosurg, Neuroengn & Neurocognit Lab, Sao Paulo, Brazil.
RP Roizenblatt, M (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,First Floor, BR-04023062 Sao Paulo, SP, Brazil.; Roizenblatt, M (corresponding author), Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.; Roizenblatt, M (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.
EM maroizenb@gmail.com
FU Lemann Foundation; Coordination for the Improvement of Higher Education
   Personnel; Research to Prevent BlindnessResearch to Prevent Blindness
   (RPB); National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq); Instituto da Visao; Latinofarma
FX Dr Roizenblatt received research funding from Lemann Foundation,
   Instituto da Visao, Latinofarma, and Coordination for the Improvement of
   Higher Education Personnel. Dr Gehlbach received research funding from
   Research to Prevent Blindness and gifts from the J. Willard and Alice S.
   Marriott Foundation, the Gale Trust, Herb Ehlers, Bill Wilbur, and
   Rajandre Shaw, Helen Nassif, Mary Ellen Keck, Don and Maggie Feiner, and
   Ronald Stiff. Drs Belfort Jr and Maia received research funding from the
   National Council for Scientific and Technological Development. This
   funding was not specifically given to the present study.
CR ARNOLD RW, 1993, ANN OPHTHALMOL, V25, P250
   Ayometzi CC, 2012, INVEST OPHTH VIS SCI, V53, P6632
   Caprioli G, 2014, INT J FOOD SCI NUTR, V65, P465, DOI 10.3109/09637486.2013.873890
   Deuchler S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150690
   Elman M J, 1998, Trans Am Ophthalmol Soc, V96, P283
   Fargen KM, 2016, WORLD NEUROSURG, V86, P384, DOI 10.1016/j.wneu.2015.10.098
   FOSTER GE, 1980, BRIT J SURG, V67, P609, DOI 10.1002/bjs.1800670902
   Glicksman JT, 2014, AM J MED, V127, P739, DOI 10.1016/j.amjmed.2014.02.033
   Hanu-Cernat LM, 2008, BRIT J ORAL MAX SURG, V46, P171, DOI 10.1016/j.bjoms.2007.07.210
   Haubenberger D, 2018, NEW ENGL J MED, V378, P1802, DOI 10.1056/NEJMcp1707928
   He XC, 2015, IEEE INT CONF ROBOT, P1764, DOI 10.1109/ICRA.2015.7139426
   Humayun MU, 1997, ARCH OPHTHALMOL-CHIC, V115, P371, DOI 10.1001/archopht.1997.01100150373010
   HUNTER IW, 1995, COMPUT BIOL MED, V25, P173, DOI 10.1016/0010-4825(94)00042-O
   Ida Y, 2012, INT J COMPUT ASS RAD, V7, P27, DOI 10.1007/s11548-011-0602-4
   JACOBSON BH, 1992, PERCEPT MOTOR SKILL, V74, P151, DOI 10.2466/PMS.74.1.151-157
   JACOBSON BH, 1991, PERCEPT MOTOR SKILL, V72, P1175, DOI 10.2466/PMS.72.4.1175-1181
   JAMES IM, 1977, LANCET, V2, P952
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   Le TDB, 2011, CAN J OPHTHALMOL, V46, P56, DOI 10.3129/i10-051
   LEE R, 2020, EYE 0313, DOI DOI 10.1038/S41433-020-0832-1
   Lieberman HR, 2001, NUTR REV, V59, P91, DOI 10.1111/j.1753-4887.2001.tb06995.x
   Lubahn JD, 2002, MICROSURG, V22, P273, DOI 10.1002/micr.10049
   Mahr MA, 2008, J CATARACT REFR SURG, V34, P980, DOI 10.1016/j.jcrs.2008.02.015
   Mansur AP, 1998, BRAZ J MED BIOL RES, V31, P691, DOI 10.1590/S0100-879X1998000500014
   McCannel CA, 2013, OPHTHALMOLOGY, V120, P2456, DOI 10.1016/j.ophtha.2013.05.003
   Mehta S, 2013, RETINA-J RET VIT DIS, V33, P439, DOI 10.1097/IAE.0b013e318276cbca
   Mort JR, 2008, ANN PHARMACOTHER, V42, P105, DOI 10.1345/aph.1K337
   Mukai N., 2002, Systems and Computers in Japan, V33, P11, DOI 10.1002/scj.10076
   Murbe D, 2001, OTOL NEUROTOL, V22, P672
   Pointdujour R, 2011, OPHTHALMOLOGY, V118, P1893, DOI 10.1016/j.ophtha.2011.04.019
   PRICHARD BNC, 1988, CLIN EXP PHARMACOL P, V15, P203, DOI 10.1111/j.1440-1681.1988.tb01063.x
   Quintana LM, 2016, WORLD NEUROSURG, V89, P686, DOI 10.1016/j.wneu.2015.11.005
   Roizenblatt M, 2019, BRIT J OPHTHALMOL, V103, P1195, DOI 10.1136/bjophthalmol-2018-313318
   Roizenblatt Marina, 2018, Robot Surg, V5, P1, DOI 10.2147/RSRR.S122301
   Saleh GM, 2013, EYE, V27, P1269, DOI 10.1038/eye.2013.166
   Schadt CR, 2005, EXPERT OPIN PHARMACO, V6, P419, DOI 10.1517/14656566.6.3.419
   Selvander M, 2013, ACTA OPHTHALMOL, V91, P469, DOI 10.1111/j.1755-3768.2012.02440.x
   Solverson DJ, 2009, SIMUL HEALTHC, V4, P98, DOI 10.1097/SIH.0b013e318195419e
   Thomsen ASS, 2017, OPHTHALMOLOGY, V124, P524, DOI 10.1016/j.ophtha.2016.11.015
   Urso-Baiarda F, 2007, MICROSURG, V27, P84, DOI 10.1002/micr.20311
   Vander Poorten E, 2015, P 5 JOINT WORKSH NEW, P10
   Webster R, 2005, STUD HEALTH TECHNOL, V111, P592
   Wong GWK, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007452.pub2
   World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053
NR 44
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2020
VL 138
IS 8
BP 819
EP 825
DI 10.1001/jamaophthalmol.2020.1971
PG 7
WC Ophthalmology
SC Ophthalmology
GA NE8LE
UT WOS:000562855500002
PM 32525517
DA 2020-12-01
ER

PT J
AU Berezovsky, A
   Karanjia, R
   Sacai, PY
   Moraes, MN
   Fernandes, A
   Botelho, GIS
   Belfort, R
   Carelli, V
   Sadun, AA
   Salomao, SR
AF Berezovsky, Adriana
   Karanjia, Rustum
   Sacai, Paula Y.
   Moraes Filho, Milton Nunes
   Fernandes, Arthur
   Santos Botelho, Gabriel Izan
   Belfort, Rubens, Jr.
   Carelli, Valerio
   Sadun, Alfredo A.
   Salomao, Solange Rios
TI Longitudinal Analysis of Photopic Negative Response in Carriers and
   Affected Members of the 11778 SOA-BR Leber's Hereditary Optic Neuropathy
   Pedigree
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-07, 2020
CL ELECTR NETWORK
SP Assoc Res Vis & Ophthalmol
C1 [Berezovsky, Adriana; Sacai, Paula Y.; Fernandes, Arthur; Santos Botelho, Gabriel Izan; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo, Dept Oftalmol, Sao Paulo, Brazil.
   [Karanjia, Rustum] Univ Ottawa, Ottawa Eye Insitute, Ottawa, ON, Canada.
   [Karanjia, Rustum; Sadun, Alfredo A.] Univ Calif Los Angeles, Ophthalmol, Los Angeles, CA USA.
   [Moraes Filho, Milton Nunes] Inst Olhos Colatina, Colatina, Brazil.
   [Carelli, Valerio] Univ Bologna, Sch Med, Biomed & Neuromotor Sci DIBINEM, Bologna, Italy.
   [Sadun, Alfredo A.] Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA USA.
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/05869-9];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil
   (CAPES)CAPES [001]; IFOND -International Foundation for Optic Nerve
   Disease
FX Support Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP
   grant #2018/05869-9 to AB). This study was financed in part by the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil
   (CAPES) -Finance Code 001. IFOND -International Foundation for Optic
   Nerve Disease.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2020
VL 61
IS 7
MA 5050
PG 3
WC Ophthalmology
SC Ophthalmology
GA MS8MR
UT WOS:000554528304274
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU da Costa, DF
   Pessuti, CL
   Tsering, T
   Graue, PGD
   Commodaro, AG
   Nascimento, H
   Belfort, R
   Burnier, JV
   Burnier, MN
AF da Costa, Deise Fialho
   Pessuti, Carmen Luz
   Tsering, Thupten
   de Alba Graue, Paulina Garcia
   Commodaro, Alessandra G.
   Nascimento, Heloisa
   Belfort, Rubens, Jr.
   Burnier, Julia Valdemarin
   Burnier, Miguel N.
TI Characterization of exosomes in patients with ocular toxoplasmosis
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-07, 2020
CL ELECTR NETWORK
SP Assoc Res Vis & Ophthalmol
C1 [da Costa, Deise Fialho; Tsering, Thupten; de Alba Graue, Paulina Garcia; Burnier, Julia Valdemarin; Burnier, Miguel N.] MUHC McGill Univ, Ocular Pathol & Translat Res Lab, Montreal, PQ, Canada.
   [da Costa, Deise Fialho; Pessuti, Carmen Luz; Commodaro, Alessandra G.; Nascimento, Heloisa; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, IPEPO, Dept Ophthalmol, Sao Paulo, SP, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2020
VL 61
IS 7
MA 3673
PG 3
WC Ophthalmology
SC Ophthalmology
GA MS8MR
UT WOS:000554528301332
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Fiorot, CASPF
   Coblentz, J
   da Costa, DF
   Gondim, LAVAD
   Almeida, MCD
   Belfort, R
   Burnier, MN
AF Fiorot, Clara Amaral Silva Perini Fiorot
   Coblentz, Jacqueline
   da Costa, Deise Fialho
   Gondim, Luis Armando Vitorino Alves de Souza
   Almeida, Milena Cristina da Silva
   Belfort, Rubens, Jr.
   Burnier, Miguel N.
TI Ocular toxoplasmosis Outbreak: what we learned and what we should have
   learned?
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-07, 2020
CL ELECTR NETWORK
SP Assoc Res Vis & Ophthalmol
C1 [Fiorot, Clara Amaral Silva Perini Fiorot; Coblentz, Jacqueline; da Costa, Deise Fialho; Gondim, Luis Armando Vitorino Alves de Souza; Almeida, Milena Cristina da Silva; Belfort, Rubens, Jr.; Burnier, Miguel N.] McGill Univ, MUHC, Ocular Pathol & Translat Res Lab, Montreal, PQ, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2020
VL 61
IS 7
MA 5383
PG 3
WC Ophthalmology
SC Ophthalmology
GA MS8MR
UT WOS:000554528305175
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Pessuti, CL
   Costa, DF
   Ribeiro, KS
   Tsering, T
   Nascimento, H
   Commodaro, AG
   Torrecilhas, AT
   Belfort, R
   Burnier, JV
   Belfort, R
   Burnier, MN
AF Pessuti, Carmen Luz
   Costa, Deise Fialho
   Ribeiro, Kleber Silva
   Tsering, Thupten
   Nascimento, Heloisa
   Commodaro, Alessandra G.
   Torrecilhas, Ana Trocoli
   Belfort, Rubens
   Burnier, Julia Valdemarin
   Belfort, Rubens, Jr.
   Burnier, Miguel N.
TI Characterization of Extracellular Vesicles purified from plasma, aqueous
   humor and vitreous from patients with uveal melanoma
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-07, 2020
CL ELECTR NETWORK
SP Assoc Res Vis & Ophthalmol
C1 [Pessuti, Carmen Luz; Costa, Deise Fialho; Ribeiro, Kleber Silva; Nascimento, Heloisa; Commodaro, Alessandra G.; Belfort, Rubens; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, IPEPO,UNIFESP, Sao Paulo, Brazil.
   [Costa, Deise Fialho; Tsering, Thupten; Burnier, Julia Valdemarin; Burnier, Miguel N.] MUHC McGill Univ, Ocular Pathol & Translat Res Lab, Montreal, PQ, Canada.
   [Torrecilhas, Ana Trocoli] Univ Fed Sao Paulo, Dept Pharmaceut Sci, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2020
VL 61
IS 7
MA 2841
PG 3
WC Ophthalmology
SC Ophthalmology
GA MS8MR
UT WOS:000554528300093
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Roizenblatt, M
   Gomes, VD
   Grupenmacher, AT
   Muralha, F
   Urias, MG
   Faber, J
   Jiramongkolchai, K
   Gehlbach, PL
   Farah, ME
   Belfort, R
   Maia, M
AF Roizenblatt, Marina
   Gomes, Vitor Dias
   Grupenmacher, Alex Treiger
   Muralha, Felipe
   Urias, Muller Goncalves
   Faber, Jean
   Jiramongkolchai, Kim
   Gehlbach, Peter L.
   Farah, Michel Eid
   Belfort, Rubens, Jr.
   Maia, Mauricio
TI Effect of weight-adjusted coffeine and propranolol, alone and combined,
   on simulated surgical skills
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-07, 2020
CL ELECTR NETWORK
SP Assoc Res Vis & Ophthalmol
C1 [Roizenblatt, Marina; Gomes, Vitor Dias; Grupenmacher, Alex Treiger; Muralha, Felipe; Urias, Muller Goncalves; Faber, Jean; Farah, Michel Eid; Belfort, Rubens, Jr.; Maia, Mauricio] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil.
   [Roizenblatt, Marina; Jiramongkolchai, Kim; Gehlbach, Peter L.] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA.
   [Farah, Michel Eid; Belfort, Rubens, Jr.; Maia, Mauricio] IPEPO, Vis Inst, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2020
VL 61
IS 7
MA 3701
PG 3
WC Ophthalmology
SC Ophthalmology
GA MS8MR
UT WOS:000554528301348
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Botelho, GIS
   Salomao, SR
   Tengan, CH
   Rocha, DM
   Silva, PB
   Sacai, PY
   Moura, FV
   Fernandes, A
   Karanjia, R
   Sadun, AA
   Belfort, R
   Berezovsky, A
AF Santos Botelho, Gabriel Izan
   Salomao, Solange Rios
   Tengan, Celia Harumi
   Rocha, Daniel M.
   Silva, Paula B.
   Sacai, Paula Y.
   Moura, Felipo V.
   Fernandes, Arthur
   Karanjia, Rustum
   Sadun, Alfredo A.
   Belfort, Rubens, Jr.
   Berezovsky, Adriana
TI Photopic Negative Response and Retinal Nerve Fiber Layer Measured by OCT
   in Brazilian Families with Leber's Hereditary Optic Neuropathy
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-07, 2020
CL ELECTR NETWORK
SP Assoc Res Vis & Ophthalmol
C1 [Santos Botelho, Gabriel Izan; Salomao, Solange Rios; Rocha, Daniel M.; Silva, Paula B.; Sacai, Paula Y.; Fernandes, Arthur; Belfort, Rubens, Jr.; Berezovsky, Adriana] Univ Fed Sao Paulo, Oftalmol, Sao Paulo, SP, Brazil.
   [Tengan, Celia Harumi; Moura, Felipo V.] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Neurol & Neurocirurg, Sao Paulo, Brazil.
   [Karanjia, Rustum] Ottawa Eye Inst, Ottawa, ON, Canada.
   [Karanjia, Rustum; Sadun, Alfredo A.] Univ Calif Los Angeles, Ophthalmol, Los Angeles, CA USA.
   [Sadun, Alfredo A.] Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA USA.
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/05869-9];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil
   (CAPES)CAPES [001]
FX Support Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP
   grant #2018/05869-9 to AB). This study was financed in part by the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil
   (CAPES) -Finance Code 001.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2020
VL 61
IS 7
MA 5051
PG 3
WC Ophthalmology
SC Ophthalmology
GA MS8MR
UT WOS:000554528304275
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Osaki, MH
   Osaki, TH
   Osaki, T
   Gameiro, GR
   Belfort, R
   Marie, SKN
AF Osaki, Midori H.
   Osaki, Tammy H.
   Osaki, Teissy
   Gameiro, Gustavo R.
   Belfort, Rubens, Jr.
   Marie, Suely K. N.
TI Orbicularis Oculi Morphological Alterations in Affected and Nonaffected
   Sides in Hemifacial Spasm
SO JOURNAL OF NEURO-OPHTHALMOLOGY
LA English
DT Article
ID QUALITY-OF-LIFE; BOTULINUM
AB Background: Although the nonaffected side appears to be clinically normal in hemifacial spasm (HFS), it is not known whether this side can be considered normal regarding histopathological findings. The purpose of this study was to objectively evaluate and compare orbicularis oculi samples of patients with HFS (not previously treated with botulinum toxin) and control patients undergoing cosmetic upper eyelid blepharoplasty. Methods: Orbicularis oculi samples from 22 eyelids were evaluated. There were 7 samples from the affected and 7 samples from the nonaffected sides of patients with HFS who had not been previously treated with botulinum toxin, and 8 samples from normal control patients. Muscle samples were prepared using hematoxylin and eosin staining, and a digital image analysis software was used for objective analyses. Results: When compared with normal controls, endomysial and perimysial connective tissue areas were significantly increased (P = 0.015) on the affected side in HFS, suggesting that this disorder is associated with chronic alterations that lead to muscle degeneration. Cell density was significantly reduced on the affected (P = 0.028) and also on the nonaffected sides in HFS (P = 0.003) compared with normal controls. This was observed, although, clinically, there were no signs or symptoms of increased muscular contraction on the nonaffected sides in any of the patients with HFS studied. Conclusions: Significant morphological differences in the orbicularis oculi muscle in patients with HFS were observed on both the affected and nonaffected sides. Our findings suggest a potential role for muscle homeostasis disturbances on both sides for patients with HFS. Affected sides in patients with HFS did, however, demonstrate muscle degeneration that was not present on the nonaffected sides.
C1 [Osaki, Midori H.; Osaki, Tammy H.; Osaki, Teissy; Belfort, Rubens, Jr.] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med EPM, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Gameiro, Gustavo R.] Univ Sao Paulo, Univ Sao Paulo Med Sch, Sao Paulo, SP, Brazil.
   [Marie, Suely K. N.] Univ Sao Paulo, Dept Neurol, Lab Mol & Cellular Biol, Sao Paulo, SP, Brazil.
RP Osaki, MH (corresponding author), Univ Fed Sao Paulo, Osaki Ophthalmol Clin, Dept Ophthalmol & Visual Sci, Vergueiro St 2045,St 1009, BR-04101000 Sao Paulo, SP, Brazil.
EM midori_osaki@yahoo.com.br
CR BORODIC GE, 1992, J CLIN NEURO-OPHTHAL, V12, P121
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   Cruz AAV, 1998, OPHTHALMOLOGY, V105, P913, DOI 10.1016/S0161-6420(98)95037-0
   Czyz CN, 2013, AM J OPHTHALMOL, V156, P173, DOI 10.1016/j.ajo.2013.02.001
   Girard N, 1997, NEURORADIOLOGY, V39, P46, DOI 10.1007/s002340050366
   HARRIS CP, 1991, ARCH OPHTHALMOL-CHIC, V109, P393, DOI 10.1001/archopht.1991.01080030095046
   Hilker R, 2001, J NEUROL NEUROSUR PS, V71, P193, DOI 10.1136/jnnp.71.2.193
   Jankovic J, 2009, MOVEMENT DISORD, V24, P407, DOI 10.1002/mds.22368
   Kent TL, 2015, OPHTHAL PLAST RECONS, V31, P222, DOI 10.1097/IOP.0000000000000263
   Lim SH, 1999, ANN ACAD MED SINGAP, V28, P169
   Olson RM, 2019, CURR EYE RES, V44, P257, DOI 10.1080/02713683.2018.1543707
   Osaki Midori Hentona, 2004, Arq. Bras. Oftalmol., V67, P43, DOI 10.1590/S0004-27492004000100008
   Peverelli L, 2015, NEUROLOGY, V85, P1886, DOI 10.1212/WNL.0000000000002147
   PORTER JD, 1991, ARCH OPHTHALMOL-CHIC, V109, P396, DOI 10.1001/archopht.1991.01080030098047
   Pottier F, 2008, ARCH FACIAL PLAST S, V10, P346, DOI 10.1001/archfaci.10.5.346
   Ross AH, 2011, SURV OPHTHALMOL, V56, P54, DOI 10.1016/j.survophthal.2010.03.008
   Rudzinska M, 2012, NEUROL NEUROCHIR POL, V46, P121, DOI 10.5114/ninp.2012.28254
NR 17
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1070-8022
EI 1536-5166
J9 J NEURO-OPHTHALMOL
JI J. Neuro-Ophthal.
PD JUN
PY 2020
VL 40
IS 2
BP 193
EP 197
DI 10.1097/WNO.0000000000000823
PG 5
WC Clinical Neurology; Ophthalmology
SC Neurosciences & Neurology; Ophthalmology
GA LW6HJ
UT WOS:000539245000014
PM 31453923
DA 2020-12-01
ER

PT J
AU Marinho, PM
   Marcos, AAA
   Romano, AC
   Nascimento, H
   Belfort, R
AF Marinho, Paula M.
   Marcos, Allexya A. A.
   Romano, Andre C.
   Nascimento, Heloisa
   Belfort, Rubens, Jr.
TI Retinal findings in patients with COVID-19
SO LANCET
LA English
DT Letter
C1 [Nascimento, Heloisa] Inst Paulista Estudos Pesquisas Oftalmol, Sao Paulo, Brazil.
   Univ Fed Sao Paulo, Inst Visao, BR-04023062 Sao Paulo, Brazil.
RP Nascimento, H (corresponding author), Inst Paulista Estudos Pesquisas Oftalmol, Sao Paulo, Brazil.
EM helomn@gmail.com
RI Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317; Marinho,
   Paula/0000-0001-7904-4169
CR Kurup SP, 2014, RETINA-J RET VIT DIS, V34, P2233, DOI 10.1097/IAE.0000000000000218
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   Seah I, 2020, OCUL IMMUNOL INFLAMM, V28, P391, DOI 10.1080/09273948.2020.1738501
   Wang Y, 2000, INVEST OPHTH VIS SCI, V41, P3011
   Wu P, 2020, JAMA OPHTHALMOL, V138, P575, DOI 10.1001/jamaophthalmol.2020.1291
NR 5
TC 55
Z9 55
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 23
PY 2020
VL 395
IS 10237
BP 1610
EP 1610
DI 10.1016/S0140-6736(20)31014-X
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA LZ1JO
UT WOS:000540986100021
PM 32405105
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Goncalves, MB
   Alves, BD
   Moura, R
   Magalhaes, O
   Maia, A
   Belfort, R
   De Avila, MP
   Zas, M
   Saravia, M
   Lousas, M
   Wu, L
   Arevalo, JF
   Pacheco, KD
   Johnson, T
   Farah, ME
   Rodriguez, FJ
   Maia, M
AF Goncalves, Mariana Batista
   Alves, Bruno de Queiroz
   Moura, Raphael
   Magalhaes, Octaviano
   Maia, Andre
   Belfort Jr, Rubens
   De Avila, Marcos Pereira
   Zas, Marcelo
   Saravia, Mario
   Lousas, Marcia
   Wu, Lihteh
   Arevalo, J. Fernando
   Pacheco, Katia Delalibera
   Johnson, Taylor
   Farah, Michel Eid
   Rodriguez, Francisco Jose
   Maia, Mauricio
CA Pan-Amer Collaborative Retina Stud
TI INTRAVITREAL DEXAMETHASONE IMPLANT MIGRATION INTO THE ANTERIOR CHAMBER A
   Multicenter Study From the Pan-American Collaborative Retina Study Group
SO RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
LA English
DT Article
DE anterior chamber; dexamethasone; intravitreal; migration
ID MACULAR EDEMA; SURGICAL-MANAGEMENT
AB Purpose: To establish the prevalence and risk factors for intravitreal dexamethasone implant migration into the anterior chamber in eyes with macular edema. Methods: This was a multicenter, retrospective, observational chart review of data that included patients with macular edema who had been treated with at least one intravitreal dexamethasone injection. Patients with incomplete chart information during the follow-up period were excluded. Results: The prevalence of implant migration in 468 patients, considering the number of injections, was 1.6%, with significant associations between implant migration and cataract surgery (P = 0.043) and intraocular lens status (P = 0.005) and a trend toward statistical significance (P = 0.057) with vitrectomy. A higher rate of implant migration into the anterior chamber was observed in vitrectomized eyes (4.8%) when compared with patients who did not undergo a vitrectomy (1.6%). The implants that migrated were removed with forceps with/without viscoelastic expression or with 20-gauge cannulas connected to the vitreous cutter machine. Conclusion: The risk of implant migration into the anterior chamber was 1.6%. Risk factors were a history of cataract surgery or vitrectomy and aphakia. When anterior migration occurs, rapid removal is advised, especially if corneal edema is present.
C1 [Goncalves, Mariana Batista; Alves, Bruno de Queiroz; Moura, Raphael; Magalhaes, Octaviano; Maia, Andre; Belfort Jr, Rubens; Johnson, Taylor; Farah, Michel Eid; Maia, Mauricio] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Retina Div, 781 Pedro Toledo St,2nd Floor, BR-04039032 Sao Paulo, Brazil.
   [De Avila, Marcos Pereira] Univ Fed Goias, Ophthalmol Dept, Goiania, Go, Brazil.
   [Zas, Marcelo] Univ Buenos Aires, Hosp Clin Jose San Martin, Sch Med, Retina Sect,Ophthalmol Dept, Buenos Aires, DF, Argentina.
   [Saravia, Mario; Lousas, Marcia] Univ Austral, Dept Ophthalmol, Buenos Aires, DF, Argentina.
   [Wu, Lihteh] Inst Cirugia Ocular, Vitreo Retinal Dept, San Jose, Costa Rica.
   [Arevalo, J. Fernando] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Retina Div, Baltimore, MD 21205 USA.
   [Pacheco, Katia Delalibera] Vis Eye Hosp, Brazilian Ctr, Retina Div, Brasilia, DF, Brazil.
   [Rodriguez, Francisco Jose] Univ Rosario, Fdn Oftalmol Colombia Fundonal, Retina Div, Bogota, Colombia.
RP Maia, M (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Retina Div, 781 Pedro Toledo St,2nd Floor, BR-04039032 Sao Paulo, Brazil.
EM mmaia@unifesp.br
OI Johnson, Taylor/0000-0002-8862-6969
CR Allergan, 2014, OZUUDEX FULL PRESCR
   Allergan, 2013, OZURDEX
   Bansal R, 2012, J OPHTHALMIC INFLAMM, V2, P1, DOI 10.1007/s12348-011-0042-x
   Bellocq D, 2015, BRIT J OPHTHALMOL, V99, P979, DOI 10.1136/bjophthalmol-2014-306159
   Boyer DS, 2014, OPHTHALMOLOGY, V121, P1904, DOI 10.1016/j.ophtha.2014.04.024
   Boyer DS, 2011, RETINA-J RET VIT DIS, V31, P915, DOI 10.1097/IAE.0b013e318206d18c
   Eadie James A, 2012, Retin Cases Brief Rep, V6, P269, DOI 10.1097/ICB.0b013e3182258b08
   Guo SQ, 2015, SURV OPHTHALMOL, V60, P123, DOI 10.1016/j.survophthal.2014.08.005
   Haller JA, 2011, OPHTHALMOLOGY, V118, P2453, DOI 10.1016/j.ophtha.2011.05.014
   Haller JA, 2010, OPHTHALMOLOGY, V117, P1134, DOI 10.1016/j.ophtha.2010.03.032
   Kang H, 2017, GRAEF ARCH CLIN EXP, V255, P1819, DOI 10.1007/s00417-017-3705-y
   Khurana RN, 2014, OPHTHALMOLOGY, V121, P67, DOI 10.1016/j.ophtha.2013.06.033
   Kishore SA, 2013, OCUL IMMUNOL INFLAMM, V21, P70, DOI 10.3109/09273948.2012.736589
   Lam WC, 2015, CLIN OPHTHALMOL, V9, P1255, DOI 10.2147/OPTH.S80500
   London NJS, 2013, ADV THER, V30, P644, DOI 10.1007/s12325-013-0035-2
   Lowder C, 2011, ARCH OPHTHALMOL-CHIC, V129, P545, DOI 10.1001/archophthalmol.2010.339
   Madi HA, 2017, AM J OPHTHALMOL CASE, P25
   Novais EA, 2016, J OPHTHALMOL, V2016, P7984576
   Pardo-Lopez D, 2012, GRAEF ARCH CLIN EXP, V250, P1703, DOI 10.1007/s00417-011-1802-x
   Rahimy E, 2015, RETINA-J RET VIT DIS, V35, P2414, DOI 10.1097/IAE.0000000000000753
   Ruiz-Casas Diego, 2016, Retin Cases Brief Rep, V10, P313, DOI 10.1097/ICB.0000000000000335
   Ryder SJ, 2015, CLIN OPHTHALMOL, V9, P1109, DOI 10.2147/OPTH.S84207
   Stelton CR, 2015, OSLI RETINA, V46, P756, DOI 10.3928/23258160-20150730-11
   Wiley HE, 2013, RETINA, P956
NR 24
TC 2
Z9 2
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0275-004X
EI 1539-2864
J9 RETINA-J RET VIT DIS
JI Retin.-J. Retin. Vitr. Dis.
PD MAY
PY 2020
VL 40
IS 5
BP 825
EP 832
DI 10.1097/IAE.0000000000002475
PG 8
WC Ophthalmology
SC Ophthalmology
GA LL2HK
UT WOS:000531376000005
PM 30789460
DA 2020-12-01
ER

PT J
AU Jager, MJ
   Shields, CL
   Cebulla, CM
   Abdel-Rahman, MH
   Grossniklaus, HE
   Stern, MH
   Carvajal, RD
   Belfort, RN
   Jia, RB
   Shields, JA
   Damato, BE
AF Jager, Martine J.
   Shields, Carol L.
   Cebulla, Colleen M.
   Abdel-Rahman, Mohamed H.
   Grossniklaus, Hans E.
   Stern, Marc-Henri
   Carvajal, Richard D.
   Belfort, Rubens N.
   Jia, Renbing
   Shields, Jerry A.
   Damato, Bertil E.
TI Uveal melanoma
SO NATURE REVIEWS DISEASE PRIMERS
LA English
DT Review
ID OPTICAL COHERENCE TOMOGRAPHY; TUMOR-INFILTRATING LYMPHOCYTES;
   PROTON-BEAM IRRADIATION; HLA CLASS-I; PRIMARY TRANSPUPILLARY
   THERMOTHERAPY; AMELANOTIC CHOROIDAL MELANOMA; PATHOGENIC GERMLINE
   VARIANTS; NEEDLE-ASPIRATION BIOPSY; OCULAR MELANOMA; PLAQUE RADIOTHERAPY
AB Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. UMs are usually initiated by a mutation in GNAQ or GNA11, unlike cutaneous melanomas, which usually harbour a BRAF or NRAS mutation. The annual incidence in Europe and the USA is 6 per million population per year. Risk factors include fair skin, light-coloured eyes, congenital ocular melanocytosis, ocular melanocytoma and the BAP1-tumour predisposition syndrome. Ocular treatment aims at preserving the eye and useful vision and, if possible, preventing metastases. Enucleation has largely been superseded by various forms of radiotherapy, phototherapy and local tumour resection, often administered in combination. Ocular outcomes are best with small tumours not extending close to the optic disc and/or fovea. Almost 50% of patients develop metastatic disease, which usually involves the liver, and is usually fatal within 1 year. Although UM metastases are less responsive than cutaneous melanoma to chemotherapy or immune checkpoint inhibitors, encouraging results have been reported with partial hepatectomy for solitary metastases, with percutaneous hepatic perfusion with melphalan or with tebentafusp. Better insight into tumour immunology and metabolism may lead to new treatments.
C1 [Jager, Martine J.] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands.
   [Shields, Carol L.; Shields, Jerry A.] Thomas Jefferson Univ, Wills Eye Hosp, Ocular Oncol Serv, Philadelphia, PA 19107 USA.
   [Cebulla, Colleen M.; Abdel-Rahman, Mohamed H.] Ohio State Univ, Havener Eye Inst, Dept Ophthalmol & Visual Sci, Wexner Med Ctr, Columbus, OH 43210 USA.
   [Abdel-Rahman, Mohamed H.] Ohio State Univ Columbus, Div Human Genet, Dept Internal Med, Columbus, OH USA.
   [Grossniklaus, Hans E.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA.
   [Grossniklaus, Hans E.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
   [Stern, Marc-Henri] PSL Res Univ, INSERM, U830,Inst Curie, DNA Repair & Uveal Melanoma DRUM,Equipe Labellise, Paris, France.
   [Carvajal, Richard D.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA.
   [Belfort, Rubens N.] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
   [Jia, Renbing] Shanghai Jiao Tong Univ, Ninth Peoples Hosp, Dept Ophthalmol, Sch Med, Shanghai, Peoples R China.
   [Damato, Bertil E.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, West Wing, Oxford, England.
RP Jager, MJ (corresponding author), Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands.
EM m.j.jager@lumc.nl
RI Jager, Martine/AAR-3525-2020; Stern, Marc-Henri/A-2728-2011
OI Stern, Marc-Henri/0000-0002-8100-2272
FU Horizon 2020 grant [667787]
FX The Horizon 2020 grant 667787, UM CURE, helped to build international
   collaborations (M.J.J. and M.-H.S.).
CR Abdel-Rahman MH, 2010, FAM CANCER, V9, P431, DOI 10.1007/s10689-010-9328-7
   Abdel-Rahman MH, 2020, OPHTHALMOLOGY, V127, P668, DOI 10.1016/j.ophtha.2019.11.009
   Afshar AR, 2018, OCUL ONCOL PATHOL, V4, P280, DOI 10.1159/000485189
   Akbaba S, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1088-9
   Al-Jamal RT, 2016, OPHTHALMOLOGY, V123, P898, DOI 10.1016/j.ophtha.2015.12.024
   Algazi AP, 2016, CANCER-AM CANCER SOC, V122, P3344, DOI 10.1002/cncr.30258
   Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615
   Ambrosini G, 2015, ONCOTARGET, V6, P33397, DOI 10.18632/oncotarget.5179
   Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388
   Amirouchene-Angelozzi N, 2014, MOL ONCOL, V8, P1508, DOI 10.1016/j.molonc.2014.06.004
   Anastassiou G, 2003, INVEST OPHTH VIS SCI, V44, P2016, DOI 10.1167/iovs.02-0810
   [Anonymous], 2016, OPHTHALMOLOGY, V123, P86, DOI DOI 10.1016/j.ophtha.2015.09.014
   Aoude LG, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12046
   Apt L, 1962, INT OPHTHALMOL CLIN, V2, P403
   Bagger M, 2015, INVEST OPHTH VIS SCI, V56, P438, DOI 10.1167/iovs.14-15571
   Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473
   Baily C, 2019, OCUL ONCOL PATHOL, V5, P195, DOI 10.1159/000492391
   Barker CA, 2018, J NATL COMPR CANC NE, V16, P646, DOI 10.6004/jnccn.2018.0042
   Beahm A., 2018, NO EVIDENCE AUBURN O
   Bechrakis Nikolaos E., 2006, International Ophthalmology Clinics, V46, P95, DOI 10.1097/01.iio.0000195856.31324.00
   Bedikian AY, 2003, MELANOMA RES, V13, P303, DOI 10.1097/00008390-200306000-00013
   Beenakker JWM, 2016, MAGN RESON MATER PHY, V29, P571, DOI 10.1007/s10334-016-0529-4
   Bellerive C, 2017, AM J OPHTHALMOL, V177, P9, DOI 10.1016/j.ajo.2017.01.024
   Bergman L, 2006, INVEST OPHTH VIS SCI, V47, P72, DOI 10.1167/iovs.05-0884
   Betti M, 2018, GENE CHROMOSOME CANC, V57, P573, DOI 10.1002/gcc.22670
   Bhatia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048787
   Bianciotto C, 2011, OPHTHALMOLOGY, V118, P1297, DOI 10.1016/j.ophtha.2010.11.011
   Bindewald-Wittich Almut, 2020, Ophthalmologica, V243, P303, DOI 10.1159/000504715
   Blasi MA, 2016, RETINA-J RET VIT DIS, V36, P2205, DOI 10.1097/IAE.0000000000001048
   Blasi MA, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010017
   Blom DJR, 1997, INVEST OPHTH VIS SCI, V38, P1865
   Bononi A, 2017, NATURE, V546, P549, DOI 10.1038/nature22798
   Bosch JJ, 2007, CANCER RES, V67, P4499, DOI 10.1158/0008-5472.CAN-06-3770
   Braun RD, 2012, INVEST OPHTH VIS SCI, V53, P2693, DOI 10.1167/iovs.11-9265
   Bronkhorst IHG, 2012, INVEST OPHTH VIS SCI, V53, P5370, DOI 10.1167/iovs.11-9280
   Bronkhorst IHG, 2011, INVEST OPHTH VIS SCI, V52, P643, DOI 10.1167/iovs.10-5979
   Brouwer NJ, 2020, RETINA-J RET VIT DIS, V40, P2207, DOI 10.1097/IAE.0000000000002719
   Brouwer NJ, 2019, CANCERS, V11, DOI 10.3390/cancers11070979
   Brovkina A F, 2018, Vestn Oftalmol, V134, P52, DOI 10.17116/oftalma201813404152
   Callender GR, 1931, T AM ACAD OPHTHALMOL, V36, P131
   Camp DA, 2019, CURR OPIN OPHTHALMOL, V30, P71, DOI 10.1097/ICU.0000000000000550
   Campagne A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08255-x
   Campbell WG, 2012, RETINA-J RET VIT DIS, V32, P1356, DOI 10.1097/IAE.10.1097/IAE.0b013e31822c28ec
   Cao JF, 2015, OCUL ONCOL PATHOL, V1, P141, DOI 10.1159/000370152
   Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459
   Carlring J, 2003, IMMUNOLOGY, V109, P41, DOI 10.1046/j.1365-2567.2003.01632.x
   Carvajal RD, 2018, J CLIN ONCOL, V36, P1232, DOI 10.1200/JCO.2017.74.1090
   Carvajal RD, 2014, JAMA-J AM MED ASSOC, V311, P2397, DOI 10.1001/jama.2014.6096
   Cassoux N, 2014, BRIT J OPHTHALMOL, V98, P769, DOI 10.1136/bjophthalmol-2013-303867
   Cassoux N, 2013, RETINA-J RET VIT DIS, V33, P1441, DOI 10.1097/IAE.0b013e31827f65c8
   Chandran SS, 2017, LANCET ONCOL, V18, P792, DOI 10.1016/S1470-2045(17)30251-6
   Chen PW, 2007, EXP EYE RES, V85, P617, DOI 10.1016/j.exer.2007.07.014
   Chua V, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809081
   Coleman DJ, 2004, OPHTHALMOLOGY, V111, P1344, DOI 10.1016/j.ophtha.2003.10.029
   Collaborative Ocular Melanoma Grp, 2006, ARCH OPHTHALMOL-CHIC, V124, P1684
   Collaborative Ocular Melanoma Study Group, 2001, OPHTHALMOLOGY, V108, P348, DOI [10.1016/S0161-6420(00)00526-1, DOI 10.1016/S0161-6420(00)00526-1]
   Colli LM, 2016, CANCER RES, V76, P3767, DOI 10.1158/0008-5472.CAN-16-0170
   Cruz C, 2011, J CLIN ONCOL, V29, pE827, DOI 10.1200/JCO.2011.37.8828
   Damato B, 2005, INT J RADIAT ONCOL, V63, P109, DOI 10.1016/j.ijrobp.2005.01.050
   Damato B, 2012, EYE, V26, P1157, DOI 10.1038/eye.2012.126
   Damato B., 2007, RETINAL VASCULAR DIS, P582
   DAMATO BE, 1992, EYE, V6, P587, DOI 10.1038/eye.1992.127
   DAMATO BE, 1990, EYE, V4, P382, DOI 10.1038/eye.1990.51
   Damato BE, 2013, RETINA, V3, P2298
   Damato Bertil, 2006, International Ophthalmology Clinics, V46, P81, DOI 10.1097/01.iio.0000195862.71558.c8
   Damato B, 2007, OPHTHALMOLOGY, V114, P1925, DOI 10.1016/j.ophtha.2007.06.012
   Damato B, 2019, OCUL ONCOL PATHOL, V5, P402, DOI 10.1159/000496927
   Damato B, 2018, PROG RETIN EYE RES, V66, P187, DOI 10.1016/j.preteyeres.2018.03.004
   Damato B, 2018, AM J OPHTHALMOL, V193, P230, DOI 10.1016/j.ajo.2018.03.015
   Damato B, 2011, PROG RETIN EYE RES, V30, P285, DOI 10.1016/j.preteyeres.2011.05.003
   Damato BE, 2019, CANCERS, V11, DOI 10.3390/cancers11070971
   Damato BE, 2014, JAMA OPHTHALMOL, V132, P605, DOI 10.1001/jamaophthalmol.2014.77
   Damato EM, 2012, OPHTHALMOLOGY, V119, P1582, DOI 10.1016/j.ophtha.2012.01.048
   Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053
   DAVIDORF FH, 1977, T OPHTHAL SOC UK, V97, P394
   DAVIDORF FH, 1981, SURV OPHTHALMOL, V25, P373, DOI 10.1016/0039-6257(81)90073-4
   de Lange MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138002
   de Vries TJ, 1998, BRIT J CANCER, V78, P1156, DOI 10.1038/bjc.1998.646
   DELACRUZ PO, 1990, CANCER-AM CANCER SOC, V65, P112
   DeParis SW, 2016, INVEST OPHTH VIS SCI, V57, P6116, DOI 10.1167/iovs.16-19654
   Desjardins L, 1998, OPHTALMOLOGIE, V12, P168
   Desjardins L, 2011, ACTA OPHTHALMOL, DOI [10.1111/j.1755-3768.2011.4362.x, DOI 10.1111/J.1755-3768.2011.4362.X]
   DEWAARDSIEBINGA I, 1995, BRIT J OPHTHALMOL, V79, P847, DOI 10.1136/bjo.79.9.847
   deWaardSiebinga I, 1996, GRAEF ARCH CLIN EXP, V234, P34, DOI 10.1007/BF00186516
   Diaz CE, 1999, CURR EYE RES, V18, P125, DOI 10.1076/ceyr.18.2.125.5380
   Diener-West M, 2005, ARCH OPHTHALMOL-CHIC, V123, P1639
   Diener-West M, 2001, ARCH OPHTHALMOL-CHIC, V119, P969
   Dithmar S, 2002, OPHTHALMOLOGE, V99, P625, DOI 10.1007/s00347-001-0596-3
   Dithmar S, 1999, CURR EYE RES, V19, P426, DOI 10.1076/ceyr.19.5.426.5294
   Dogrusoz M, 2019, CANCERS, V11, DOI 10.3390/cancers11081104
   Dogrusoz M, 2018, ACTA OPHTHALMOL, V96, P331, DOI 10.1111/aos.13580
   Dogrusoz M, 2017, ASIA-PAC J OPHTHALMO, V6, P186, DOI 10.22608/APO.201734
   Dogrusoz M, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20212
   Doherty RE, 2019, CANCERS, V11, DOI 10.3390/cancers11091278
   Dong L, 2019, CLIN CANCER RES, V25, P2206, DOI 10.1158/1078-0432.CCR-18-1368
   Durante MA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14256-1
   Eefsen RL, 2012, J ONCOL, V2012, DOI 10.1155/2012/907971
   Eide N, 2013, ACTA OPHTHALMOL, V91, P343, DOI 10.1111/j.1755-3768.2012.02449.x
   Eide N, 2009, ACTA OPHTHALMOL, V87, P830, DOI 10.1111/j.1755-3768.2008.01378.x
   Eleuteri A, 2012, INT J BIOMED ENG TEC, V8, P18, DOI 10.1504/IJBET.2012.045355
   Ericsson C, 2001, INVEST OPHTH VIS SCI, V42, P2153
   Fabian ID, 2018, BRIT J OPHTHALMOL, V102, P1705, DOI 10.1136/bjophthalmol-2017-311747
   FELBERG NT, 1980, OPHTHALMOLOGY, V87, P529
   Feng XD, 2019, CANCER CELL, V35, P457, DOI 10.1016/j.ccell.2019.01.009
   Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016
   Ferguson R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31191
   Fernandes Bruno F, 2007, J Carcinog, V6, P6, DOI 10.1186/1477-3163-6-6
   Ferreira TA, 2019, CANCERS, V11, DOI 10.3390/cancers11030377
   Field MG, 2019, CLIN CANCER RES, V25, P5663, DOI 10.1158/1078-0432.CCR-19-0366
   Field MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02428-w
   Field MG, 2016, CLIN CANCER RES, V22, P1234, DOI 10.1158/1078-0432.CCR-15-2071
   Figueiredo CR, 2020, J PATHOL, V250, P420, DOI 10.1002/path.5384
   Finger PT, 2015, JAMA OPHTHALMOL, V133, P376, DOI 10.1001/jamaophthalmol.2014.5395
   FOLBERG R, 1993, OPHTHALMOLOGY, V100, P1389
   Folberg R, 2007, INVEST OPHTH VIS SCI, V48, P2967, DOI 10.1167/iovs.06-1522
   Fontcuberta IC, 2011, OPHTHALMIC GENET, V32, P143, DOI 10.3109/13816810.2010.544367
   Foster Anthony D, 2011, Aging health, V7, P707
   FULLER BB, 1988, J CELL PHYSIOL, V134, P149, DOI 10.1002/jcp.1041340119
   Furdova A, 2017, MELANOMA RES, V27, P463, DOI 10.1097/CMR.0000000000000364
   Furney SJ, 2013, CANCER DISCOV, V3, P1122, DOI 10.1158/2159-8290.CD-13-0330
   Gao M, 2018, INVEST OPHTH VIS SCI, V59, P1251, DOI 10.1167/iovs.17-22197
   Garrido F, 2001, ADV CANCER RES, V83, P117, DOI 10.1016/S0065-230X(01)83005-0
   Gezgin G, 2017, CANCER IMMUNOL IMMUN, V66, P903, DOI 10.1007/s00262-017-1991-1
   Gezgin G, 2017, JAMA OPHTHALMOL, V135, P541, DOI 10.1001/jamaophthalmol.2017.0729
   Gokhale R, 2015, ASIA-PAC J OPHTHALMO, V4, P89, DOI 10.1097/APO.0000000000000083
   Goslings WRO, 1996, INVEST OPHTH VIS SCI, V37, P1884
   GRAGOUDAS ES, 1980, OPHTHALMOLOGY, V87, P571
   Gragoudas ES, 2006, INVEST OPHTH VIS SCI, V47, P4666, DOI 10.1167/iovs.06-0659
   Gragoudas Evangelos S, 2002, Trans Am Ophthalmol Soc, V100, P43
   Grossniklaus HE, 2019, OPHTHALMOLOGY, V126, P483, DOI 10.1016/j.ophtha.2018.09.031
   Grossniklaus HE, 2016, HUM PATHOL, V57, P165, DOI 10.1016/j.humpath.2016.07.012
   Grossniklaus HE, 2013, JAMA OPHTHALMOL, V131, P462, DOI 10.1001/jamaophthalmol.2013.2547
   Gunduz K, 1999, AM J OPHTHALMOL, V127, P579, DOI 10.1016/S0002-9394(98)00445-0
   Gunduz K, 2000, AM J OPHTHALMOL, V130, P97, DOI 10.1016/S0002-9394(00)00385-8
   Gupta MP, 2015, JAMA OPHTHALMOL, V133, P881, DOI 10.1001/jamaophthalmol.2015.1119
   Hallermalm K, 2008, J IMMUNOL, V180, P3766, DOI 10.4049/jimmunol.180.6.3766
   Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523
   Harbour JW, 2013, OPHTHALMOLOGY, V120, P213, DOI 10.1016/j.ophtha.2012.08.016
   Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472
   Hawkins BS, 2004, AM J OPHTHALMOL, V138, P936, DOI DOI 10.1016/J.AJ0.2004.07.006
   Hemminki K, 2001, INT J CANCER, V94, P907, DOI 10.1002/ijc.1542
   Hendrix MJC, 1998, AM J PATHOL, V152, P855
   Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001
   Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P241, DOI 10.1111/j.1755-148X.2010.00783.x
   Holly EA, 1996, EPIDEMIOLOGY, V7, P55, DOI 10.1097/00001648-199601000-00010
   Homsi J, 2010, MELANOMA RES, V20, P507, DOI 10.1097/CMR.0b013e3283403ce9
   Horgan N, 2008, RETINA-J RET VIT DIS, V28, P987, DOI 10.1097/IAE.0b013e31816b3192
   Horgan N, 2009, OPHTHALMOLOGY, V116, P1383, DOI 10.1016/j.ophtha.2009.01.051
   HORSMAN DE, 1990, CANCER GENET CYTOGEN, V45, P249, DOI 10.1016/0165-4608(90)90090-W
   Huang JLY, 2015, CANCER RES, V75, P3384, DOI 10.1158/0008-5472.CAN-14-3229
   Huang KL, 2018, CELL, V173, P355, DOI 10.1016/j.cell.2018.03.039
   Hughes MS, 2016, ANN SURG ONCOL, V23, P1309, DOI 10.1245/s10434-015-4968-3
   Inoue D, 2019, NATURE, V574, P432, DOI 10.1038/s41586-019-1646-9
   Iscovich J, 2002, INT J CANCER, V98, P42, DOI 10.1002/ijc.10155
   Jager MJ, 2018, OPHTHALMOLOGY, V125, P1139, DOI 10.1016/j.ophtha.2018.03.011
   Jager Martine J, 2016, Trans Am Ophthalmol Soc, V114, pT5
   Jager MJ, 2002, HUM IMMUNOL, V63, P444, DOI 10.1016/S0198-8859(02)00389-0
   James MA, 2014, CANCER RES, V74, P1116, DOI 10.1158/0008-5472.CAN-13-1617
   JENSEN OA, 1982, ACTA OPHTHALMOL, V60, P161
   JIANG LQ, 1993, INVEST OPHTH VIS SCI, V34, P3347
   Johansson P, 2016, ONCOTARGET, V7, P4624, DOI 10.18632/oncotarget.6614
   Johansson PA, 2019, IMMUNOGENETICS, V71, P433, DOI 10.1007/s00251-019-01108-x
   Johnson CP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178189
   Jones NM, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5712-3
   Joshua AM, 2015, MELANOMA RES, V25, P342, DOI 10.1097/CMR.0000000000000175
   Kaliki S., 2015, FOCAL POINTS 2015 MO
   KANMITCHELL J, 1991, CANCER IMMUNOL IMMUN, V33, P333, DOI 10.1007/BF01756599
   Kapiteijn E, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-CT068
   Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028
   Kines RC, 2018, MOL CANCER THER, V17, P565, DOI 10.1158/1535-7163.MCT-17-0953
   Kivela T, 2003, OPHTHALMOLOGY, V110, P2235, DOI 10.1016/S0161-6420(03)01016-9
   Kivela T, 2003, EUR J CANCER, V39, P1115, DOI 10.1016/S0959-8049(03)00132-1
   Kivela T, 2012, DEV OPHTHALMOL, V49, P1, DOI 10.1159/000330613
   Kivela T, 2009, BRIT J OPHTHALMOL, V93, P1129, DOI 10.1136/bjo.2008.150292
   KNISELY TL, 1987, J IMMUNOL, V138, P4515
   Konstantinidis L, 2014, BRIT J OPHTHALMOL, V98, P82, DOI 10.1136/bjophthalmol-2013-304022
   Koopmans AE, 2014, MODERN PATHOL, V27, P1321, DOI 10.1038/modpathol.2014.43
   Krishna Y, 2017, HUM PATHOL, V66, P159, DOI 10.1016/j.humpath.2017.06.005
   Krishna Y, 2016, BRIT J OPHTHALMOL, V100, P1012, DOI 10.1136/bjophthalmol-2015-308301
   Ksander BR, 1998, CURR EYE RES, V17, P165, DOI 10.1076/ceyr.17.2.165.5607
   KSANDER BR, 1991, INVEST OPHTH VIS SCI, V32, P3198
   Kujala E, 2003, INVEST OPHTH VIS SCI, V44, P4651, DOI 10.1167/iovs.03-0538
   Lagouros Evan, 2009, Trans Am Ophthalmol Soc, V107, P223
   Lane AM, 2009, OPHTHALMOLOGY, V116, P2206, DOI 10.1016/j.ophtha.2009.04.044
   Lapadula D, 2019, MOL CANCER RES, V17, P963, DOI 10.1158/1541-7786.MCR-18-0574
   Lee Y, 2004, J HARD TISSUE BIOL, V13, P87, DOI [10.2485/jhtb.13.87, DOI 10.2485/JHTB.13.87]
   Leyvraz S, 2014, ANN ONCOL, V25, P742, DOI 10.1093/annonc/mdt585
   Li HC, 2008, INVEST OPHTH VIS SCI, V49, P636, DOI 10.1167/iovs.07-1035
   Li HC, 2009, INVEST OPHTH VIS SCI, V50, P5522, DOI 10.1167/iovs.09-3804
   Li WJ, 2000, CANCER RES, V60, P3757
   Liao A, 2018, OPHTHALMOLOGY, V125, P597, DOI 10.1016/j.ophtha.2017.09.029
   Liepelt A, 2016, AM J PHYSIOL-GASTR L, V311, pG203, DOI 10.1152/ajpgi.00193.2016
   Lobo J, 2017, VIRCHOWS ARCH, V470, P347, DOI 10.1007/s00428-016-2052-4
   Lois N, 1998, OPHTHALMOLOGY, V105, P1091, DOI 10.1016/S0161-6420(98)96013-4
   Lommatzsch P, 1966, Klin Monbl Augenheilkd, V148, P682
   MA D, 1995, INVEST OPHTH VIS SCI, V36, P435
   Maat W, 2008, INVEST OPHTH VIS SCI, V49, P505, DOI 10.1167/iovs.07-0786
   Makitie T, 1999, INVEST OPHTH VIS SCI, V40, P2471
   Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P1414
   MANSCHOT WA, 1987, BRIT J OPHTHALMOL, V71, P348, DOI 10.1136/bjo.71.5.348
   Marinkovic M, 2016, EUR J CANCER, V68, P106, DOI 10.1016/j.ejca.2016.09.009
   Marous Charlotte L, 2019, Retin Cases Brief Rep, V13, P202, DOI 10.1097/ICB.0000000000000595
   Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674
   Mashayekhi A, 2015, OPHTHALMOLOGY, V122, P600, DOI 10.1016/j.ophtha.2014.09.029
   Materin MA, 2012, RETINA-J RET VIT DIS, V32, P1601, DOI 10.1097/IAE.0b013e3182437e70
   Mazloumi M, 2020, JAMA OPHTHALMOL, V138, P260, DOI 10.1001/jamaophthalmol.2019.5710
   McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490
   McKenna KC, 2009, INVEST OPHTH VIS SCI, V50, P4295, DOI 10.1167/iovs.08-3012
   MCLEAN IW, 1983, AM J OPHTHALMOL, V96, P502, DOI 10.1016/S0002-9394(14)77914-0
   MCLEAN IW, 1977, ARCH OPHTHALMOL-CHIC, V95, P48
   MCLEAN IW, 1990, AM J OPHTHALMOL, V110, P522, DOI 10.1016/S0002-9394(14)77876-6
   Meijer TS, 2019, CARDIOVASC INTER RAD, V42, P841, DOI 10.1007/s00270-019-02177-x
   Metzelaar-Blok JAW, 2001, INVEST OPHTH VIS SCI, V42, P1951
   Michalova K, 2001, BRIT J OPHTHALMOL, V85, P4, DOI 10.1136/bjo.85.1.4
   Midena E, 2006, EUR J OPHTHALMOL, V16, P422
   Mobuchon L, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0008-5
   Moore AR, 2018, CELL REP, V22, P2455, DOI 10.1016/j.celrep.2018.01.081
   Moore AR, 2016, NAT GENET, V48, P675, DOI 10.1038/ng.3549
   Mouriaux F, 2003, MELANOMA RES, V13, P161, DOI 10.1097/00008390-200304000-00008
   Mulcahy KA, 1996, INT J CANCER, V66, P738, DOI 10.1002/(SICI)1097-0215(19960611)66:6<738::AID-IJC5>3.0.CO;2-0
   Muscat S, 2004, BRIT J OPHTHALMOL, V88, P120, DOI 10.1136/bjo.88.1.120
   Napolitano A, 2016, ONCOGENE, V35, P1996, DOI 10.1038/onc.2015.243
   Nathan P, 2015, EUR J CANCER, V51, P2404, DOI 10.1016/j.ejca.2015.07.013
   Nayman T, 2017, CURR EYE RES, V42, P1085, DOI 10.1080/02713683.2017.1297997
   Ni-Komatsu L, 2006, EXP EYE RES, V82, P519, DOI 10.1016/j.exer.2005.08.013
   NIEDERKORN J, 1981, INVEST OPHTH VIS SCI, V20, P355
   Niederkorn JY, 2009, PROG RETIN EYE RES, V28, P329, DOI 10.1016/j.preteyeres.2009.06.002
   Nordlund JR, 2003, ARCH OPHTHALMOL-CHIC, V121, P725, DOI 10.1001/archopht.121.5.725
   North Carolina Department of Health and Human Services Division of Public Health, 2015, OC MEL INV MECKL COU
   Nwani NG, 2016, CANCER RES, V76, P2265, DOI 10.1158/0008-5472.CAN-15-2468
   O'Neill PA, 2006, MELANOMA RES, V16, P245, DOI 10.1097/01.cmr.0000205017.38859.07
   O'Reilly FM, 2001, J AM ACAD DERMATOL, V45, P414, DOI 10.1067/mjd.2001.117526
   Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750
   Onken MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6852
   Onken MD, 2012, OPHTHALMOLOGY, V119, P1596, DOI 10.1016/j.ophtha.2012.02.017
   Oosterhuis JA, 1998, ARCH OPHTHALMOL-CHIC, V116, P157
   Ozaki S, 2016, AM J PATHOL, V186, P43, DOI 10.1016/j.ajpath.2015.09.011
   Papakostas TD, 2017, JAMA OPHTHALMOL, V135, P1191, DOI 10.1001/jamaophthalmol.2017.3805
   Park SJ, 2015, INVEST OPHTH VIS SCI, V56, P4719, DOI 10.1167/iovs.15-16532
   Pellosi MC, 2014, ARCH BIOCHEM BIOPHYS, V557, P55, DOI 10.1016/j.abb.2014.05.024
   Perez DE, 2018, PIGM CELL MELANOMA R, V31, P604, DOI 10.1111/pcmr.12700
   Petousis V, 2011, AM J OPHTHALMOL, V152, P771, DOI 10.1016/j.ajo.2011.04.032
   Piaggio F, 2019, CANCERS, V11, DOI 10.3390/cancers11111688
   Piperno-Neumann S, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.9030
   Piulats JM, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9533
   Popovic M, 2017, SURV OPHTHALMOL, V62, P302, DOI 10.1016/j.survophthal.2016.12.012
   PRESCHER G, 1992, LANCET, V339, P691, DOI 10.1016/0140-6736(92)90861-V
   Qiu M, 2015, OPHTHALMOLOGY, V122, P2071, DOI 10.1016/j.ophtha.2015.06.008
   RAHI AHS, 1971, BRIT J OPHTHALMOL, V55, P793, DOI 10.1136/bjo.55.12.793
   Rai K, 2017, GENE CHROMOSOME CANC, V56, P168, DOI 10.1002/gcc.22424
   Rice JC, 2014, BRIT J OPHTHALMOL, V98, P86, DOI 10.1136/bjophthalmol-2013-304006
   Richtig E, 2006, OPHTHALMOLOGE, V103, P506, DOI 10.1007/s00347-006-1350-7
   Richtig E, 2004, OPHTHALMOLOGICA, V218, P111, DOI 10.1159/000076146
   Ritsma L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004394
   Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003
   Rodrigues M, 2019, CANCERS, V11, DOI 10.3390/cancers11071032
   Rodrigues M, 2019, CLIN CANCER RES, V25, P5513, DOI 10.1158/1078-0432.CCR-19-1215
   Rodrigues M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04322-5
   Rogers MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035237
   Rothermel LD, 2016, CLIN CANCER RES, V22, P2237, DOI 10.1158/1078-0432.CCR-15-2294
   Royer-Bertrand B, 2016, AM J HUM GENET, V99, P1190, DOI 10.1016/j.ajhg.2016.09.008
   Rundle P, 2014, BRIT J OPHTHALMOL, V98, P494, DOI 10.1136/bjophthalmol-2013-304432
   Sadegh L, 2015, INT J CANCER, V137, P1085, DOI 10.1002/ijc.29480
   Sagoo MS, 2011, OPHTHALMOLOGY, V118, P402, DOI 10.1016/j.ophtha.2010.06.007
   Sandinha T, 2012, EYE, V26, P937, DOI 10.1038/eye.2012.62
   Scelo G, 2007, INT J CANCER, V120, P152, DOI 10.1002/ijc.22159
   Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966
   Schmidt-Hieber M, 2004, MELANOMA RES, V14, P439, DOI 10.1097/00008390-200412000-00001
   Schmidt-Pokrzywniak A, 2009, OPHTHALMOLOGY, V116, P340, DOI 10.1016/j.ophtha.2008.09.040
   Schmittel A, 2005, MELANOMA RES, V15, P447, DOI 10.1097/00008390-200510000-00014
   Schmittel A, 2005, MELANOMA RES, V15, P205, DOI 10.1097/00008390-200506000-00010
   Scholes AGM, 2003, INVEST OPHTH VIS SCI, V44, P1008, DOI 10.1167/iovs.02-0159
   Scholz SL, 2017, INVEST OPHTH VIS SCI, V58, P3464, DOI 10.1167/iovs.17-21838
   Schurmans LRHM, 1999, CANCER RES, V59, P5250
   Shah SU, 2014, OPHTHALMOLOGY, V121, P269, DOI 10.1016/j.ophtha.2013.08.039
   Shah SU, 2012, OPHTHALMOLOGY, V119, P1066, DOI 10.1016/j.ophtha.2011.11.001
   Shain AH, 2019, NAT GENET, V51, P1123, DOI 10.1038/s41588-019-0440-9
   Shields CL, 2008, BRIT J OPHTHALMOL, V92, P617, DOI 10.1136/bjo.2007.130286
   Shields CL, 2008, RETINA-J RET VIT DIS, V28, P1035, DOI 10.1097/IAE.0b013e318181b94b
   Shields CL, 2019, CURR OPIN OPHTHALMOL, V30, P206, DOI 10.1097/ICU.0000000000000560
   Shields CL, 2019, RETINA-J RET VIT DIS, V39, P1840, DOI 10.1097/IAE.0000000000002440
   Shields CL, 2018, JAMA OPHTHALMOL, V136, P1325, DOI 10.1001/jamaophthalmol.2018.3881
   Shields CL, 2018, OPHTHALMOLOGY, V125, P913, DOI 10.1016/j.ophtha.2017.11.040
   Shields CL, 2018, RETINA-J RET VIT DIS, V38, P2010, DOI 10.1097/IAE.0000000000002144
   Shields CL, 2017, OPHTHALMOLOGY, V124, P1523, DOI 10.1016/j.ophtha.2017.04.003
   Shields CL, 2017, OPHTHALMOLOGY, V124, P609, DOI 10.1016/j.ophtha.2016.12.026
   Shields CL, 2016, RETINA-J RET VIT DIS, V36, P1493, DOI 10.1097/IAE.0000000000001021
   Shields CL, 2015, INDIAN J OPHTHALMOL, V63, P117, DOI 10.4103/0301-4738.154377
   Shields CL, 2014, RETINA-J RET VIT DIS, V34, P1495, DOI 10.1097/IAE.0000000000000288
   Shields CL, 2014, CURR OPIN OPHTHALMOL, V25, P177, DOI 10.1097/ICU.0000000000000041
   Shields CL, 2013, OPHTHALMOLOGY, V120, P766, DOI 10.1016/j.ophtha.2012.09.042
   Shields CL, 2013, OPHTHALMOLOGY, V120, P55, DOI 10.1016/j.ophtha.2012.06.053
   Shields CL, 2012, RETINA-J RET VIT DIS, V32, P1363, DOI 10.1097/IAE.0b013e31824d09a8
   Shields CL, 2012, J AAPOS, V16, P10, DOI 10.1016/j.jaapos.2011.10.012
   Shields CL, 2012, OPHTHALMOLOGY, V119, P407, DOI 10.1016/j.ophtha.2011.07.059
   Shields CL, 2011, OPHTHALMOLOGY, V118, P396, DOI 10.1016/j.ophtha.2010.05.023
   Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P989, DOI 10.1001/archophthalmol.2009.208
   SHIELDS CL, 1995, BRIT J OPHTHALMOL, V79, P237, DOI 10.1136/bjo.79.3.237
   SHIELDS CL, 1991, OPHTHALMOLOGY, V98, P1662
   Shields CL, 2002, OPHTHALMOLOGY, V109, P225, DOI 10.1016/S0161-6420(01)00902-2
   Shields CL, 2000, ARCH OPHTHALMOL-CHIC, V118, P1219
   Shields CL, 1998, OPHTHALMIC SURG LAS, V29, P397
   Shields CL, 2008, INVEST OPHTH VIS SCI, V49, P5689
   Shields J. A., 2015, INTRAOCULAR TUMORS A
   SHIELDS JA, 1991, OPHTHALMOLOGY, V98, P971
   SHIELDS JA, 1993, OPHTHALMOLOGY, V100, P1677
   Shields JA, 2015, OPHTHALMOLOGY, V122, P414, DOI 10.1016/j.ophtha.2014.08.046
   Siedlecki J, 2017, ACTA OPHTHALMOL, V95, pe734, DOI 10.1111/aos.13418
   Singh AD, 2005, OPHTHALMOLOGY, V112, P1784, DOI 10.1016/j.ophtha.2005.06.011
   Singh AD, 2004, SURV OPHTHALMOL, V49, P419, DOI 10.1016/j.survophthal.2004.04.009
   Singh AD, 2004, BRIT J OPHTHALMOL, V88, P962, DOI 10.1136/bjo.2003.029058
   Singh AD, 1996, ARCH OPHTHALMOL-CHIC, V114, P392, DOI 10.1001/archopht.1996.01100130388005
   Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040
   Singh AD, 2010, BRIT J OPHTHALMOL, V94, P474, DOI 10.1136/bjo.2009.162636
   Sinilnikova OM, 1999, INT J CANCER, V82, P325
   Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069
   Sisley K, 1997, GENE CHROMOSOME CANC, V19, P22, DOI 10.1002/(SICI)1098-2264(199705)19:1<22::AID-GCC4>3.0.CO;2-2
   Sliney DH, 2002, INT J TOXICOL, V21, P501, DOI 10.1080/10915810290169927
   Smith JR, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.1.9
   Souri Z, 2019, CANCERS, V11, DOI 10.3390/cancers11081132
   Stang A, 2009, J NATL CANCER I, V101, P120, DOI 10.1093/jnci/djn441
   Strande NT, 2017, AM J HUM GENET, V100, P895, DOI 10.1016/j.ajhg.2017.04.015
   STREILEIN JW, 1981, J EXP MED, V153, P1058, DOI 10.1084/jem.153.5.1058
   Szalai E, 2018, JAMA OPHTHALMOL, V136, P1115, DOI 10.1001/jamaophthalmol.2018.2986
   Szalai E, 2018, OPHTHALMOLOGY, V125, P203, DOI 10.1016/j.ophtha.2017.07.018
   Tartaglione T, 2014, RADIOL MED, V119, P775, DOI 10.1007/s11547-014-0388-x
   Thariat J, 2018, OPHTHALMOLOGY, V125, P606, DOI 10.1016/j.ophtha.2017.10.009
   Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023
   TOBAL K, 1993, MELANOMA RES, V3, P63, DOI 10.1097/00008390-199304000-00009
   Tomizuka T, 2017, MELANOMA RES, V27, P492, DOI [10.1097/CMR.0000000000000375, 10.1097/cmr.0000000000000375]
   Toyofuku K, 2002, PIGM CELL RES, V15, P217, DOI 10.1034/j.1600-0749.2002.02007.x
   Tschentscher F, 2003, CANCER RES, V63, P2578
   Turkoglu EB, 2019, RETINA-J RET VIT DIS, V39, P1319, DOI 10.1097/IAE.0000000000002169
   Vader MJC, 2017, BRIT J CANCER, V117, P884, DOI 10.1038/bjc.2017.259
   Vajdic CM, 2003, INT J CANCER, V105, P117, DOI 10.1002/ijc.11057
   Valsecchi ME, 2018, OPHTHALMOLOGY, V125, P210, DOI 10.1016/j.ophtha.2017.08.017
   Valverde-Megias A, 2017, RETINA-J RET VIT DIS, V37, P731, DOI 10.1097/IAE.0000000000001233
   van der Ent W, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-15202
   van Essen TH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164292
   van Essen TH, 2014, BRIT J OPHTHALMOL, V98, P1738, DOI 10.1136/bjophthalmol-2014-305047
   van Hees CLM, 1998, MELANOMA RES, V8, P175, DOI 10.1097/00008390-199804000-00013
   van Poppelen NM, 2018, OPHTHALMOLOGY, V125, P904, DOI 10.1016/j.ophtha.2017.12.022
   Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584
   Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586
   VANDERPOL JP, 1987, CURR EYE RES, V6, P757, DOI 10.3109/02713688709034842
   VANHEES CLM, 1994, J INVEST DERMATOL, V103, P202, DOI 10.1111/1523-1747.ep12392754
   Vaquero-Garcia J, 2017, INVEST OPHTH VIS SCI, V58, P4096, DOI 10.1167/iovs.17-22255
   Verbik DJ, 1997, INT J CANCER, V73, P470, DOI 10.1002/(SICI)1097-0215(19971114)73:4<470::AID-IJC3>3.0.CO;2-X
   Vidoris Andre A C, 2017, Int J Retina Vitreous, V3, P42, DOI 10.1186/s40942-017-0096-5
   Virgili G, 2007, OPHTHALMOLOGY, V114, P2309, DOI 10.1016/j.ophtha.2007.01.032
   Vivet-Noguer R, 2019, CANCERS, V11, DOI 10.3390/cancers11071019
   Wackernagel W, 2014, BRIT J OPHTHALMOL, V98, P218, DOI 10.1136/bjophthalmol-2013-304031
   Wakamatsu K, 2008, PIGM CELL MELANOMA R, V21, P97, DOI 10.1111/j.1755-148X.2007.00415.x
   Wakamatsu K, 2007, PIGM CELL RES, V20, P222, DOI 10.1111/j.1600-0749.2007.00370.x
   Walpole S, 2018, JNCI-J NATL CANCER I, V110, P1328, DOI 10.1093/jnci/djy171
   Wang L, 2018, NAT MED, V24, P758, DOI 10.1038/s41591-018-0034-6
   Weis E, 2006, ARCH OPHTHALMOL-CHIC, V124, P54, DOI 10.1001/archopht.124.1.54
   White VA, 1998, CANCER, V83, P354, DOI 10.1002/(SICI)1097-0142(19980715)83:2<354::AID-CNCR20>3.0.CO;2-R
   Wierenga Annemijn P A, 2019, Int Ophthalmol Clin, V59, P53, DOI 10.1097/IIO.0000000000000263
   Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910
   Wisely CE, 2016, BRACHYTHERAPY, V15, P12, DOI 10.1016/j.brachy.2015.09.013
   Yang WH, 2009, INVEST OPHTH VIS SCI, V50, P273, DOI 10.1167/iovs.08-2397
   Yasui F, 2008, BRIT J PHARMACOL, V154, P890, DOI 10.1038/bjp.2008.140
   Yavuzyigitoglu S, 2016, OPHTHALMOLOGY, V123, P1118, DOI 10.1016/j.ophtha.2016.01.023
   Yoo JH, 2016, CANCER CELL, V29, P889, DOI 10.1016/j.ccell.2016.04.015
   Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017
   Yu GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073312
   Zhang BJ, 2020, BIOCHEM BIOPH RES CO, V522, P639, DOI 10.1016/j.bbrc.2019.11.133
   Zhu AZ, 2010, J MED CHEM, V53, P8556, DOI 10.1021/jm100786g
   Zimmer L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118564
   ZIMMERMAN LE, 1978, BRIT J OPHTHALMOL, V62, P420, DOI 10.1136/bjo.62.6.420
NR 371
TC 15
Z9 15
U1 3
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2056-676X
J9 NAT REV DIS PRIMERS
JI Nat. Rev. Dis. Primers
PD APR 9
PY 2020
VL 6
IS 1
AR 24
DI 10.1038/s41572-020-0158-0
PG 25
WC Medicine, General & Internal
SC General & Internal Medicine
GA LF9OB
UT WOS:000527741200001
PM 32273508
DA 2020-12-01
ER

PT J
AU Osaki, TH
   Osaki, MH
   Garcia, DM
   Osaki, T
   Ohkawara, L
   Belfort, R
   Cruz, AAV
AF Osaki, Tammy H.
   Osaki, Midori H.
   Garcia, Denny M.
   Osaki, Teissy
   Ohkawara, Lilian
   Belfort, Rubens, Jr.
   Cruz, Antonio Augusto V.
TI Evaluation of botulinum toxin effects in hemifacial spasm patients:
   correlation between clinical rating scales and high-speed video system
   measurements
SO JOURNAL OF NEURAL TRANSMISSION
LA English
DT Article
DE Hemifacial spasm; Eyelid movements; Eyelid spasms; Botulinum toxin;
   Jankovic rating scale; Hemifacial spasm grading system
AB The purpose of this study was to compare the scores of two clinical rating scales and high-speed video system measurements obtained during spontaneous eyelid movements in hemifacial spasm (HFS) patients before and after treatment. Patients were evaluated before and 30 days after receiving treatment with onabotulinumtoxinA injections. Using a high-speed video system, the eyelid movements were recorded bilaterally for 3 min and the energy power generated by the upper eyelid during spontaneous eyelid movements was assessed before and after treatment. The scores of the Jankovic rating scale (JRS) and Hemifacial Spasm Grading System (HSGS) were also assessed before and after treatment. The authors studied 22 patients. Significant reduction in JRS and HSGS scores and in the energy generated by the upper eyelid was observed after treatment. A power spectrum of less than 23,000 was associated with JRS and HSGS scores less than 4 and 6.25, respectively and a power spectrum greater than or equal to 23,000 was associated with JRS and HSGS scores greater than or equal to 4 and 6.25, respectively (p < 0.0001 and p = 0.0025). Rating systems are easy to use, but they may exhibit limitations in sensitivity to assess differences between distinct disease patterns and between subtle differences in treatment responses. The high-speed video system permits a greater degree of accuracy, which allows for the assessment of differences in eyelid movement patterns and would permit better tailoring of treatment to patients. However, simpler devices employing this system would need to be developed, so that it could be used in clinical practice.
C1 [Osaki, Tammy H.; Osaki, Midori H.; Osaki, Teissy; Ohkawara, Lilian; Belfort, Rubens, Jr.] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Osaki, Tammy H.] Univ Santo Amaro, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Osaki, Tammy H.; Osaki, Midori H.; Osaki, Teissy] Osaki Clin, R Vergueiro,2045 Cj 1009, BR-04101000 Sao Paulo, SP, Brazil.
   [Garcia, Denny M.; Cruz, Antonio Augusto V.] Univ S Paulo Ribeirao Preto, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Ribeirao Preto, SP, Brazil.
RP Osaki, MH (corresponding author), Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.; Osaki, MH (corresponding author), Osaki Clin, R Vergueiro,2045 Cj 1009, BR-04101000 Sao Paulo, SP, Brazil.
EM midori_osaki@yahoo.com.br
OI Osaki, Midori/0000-0001-8574-2879
CR Abbruzzese Giovanni, 2011, Handb Clin Neurol, V100, P675, DOI 10.1016/B978-0-444-52014-2.00048-3
   Bilyk JR, 2018, OPHTHALMOLOGY, V125, P1459, DOI 10.1016/j.ophtha.2018.03.013
   Di Stadio A, 2019, AM J OTOLARYNG, V40, DOI 10.1016/j.amjoto.2019.102278
   Green KE, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0475-0
   JANKOVIC J, 1987, NEUROLOGY, V37, P616, DOI 10.1212/WNL.37.4.616
   Kenney C, 2008, J NEURAL TRANSM, V115, P585, DOI 10.1007/s00702-007-0768-7
   Kollewe K, 2010, J NEURAL TRANSM, V117, P759, DOI 10.1007/s00702-010-0409-4
   Osaki MH, 2020, GRAEF ARCH CLIN EXP, V258, P669, DOI 10.1007/s00417-019-04567-w
   Osaki T, 2016, BRIT J OPHTHALMOL, V100, P963, DOI 10.1136/bjophthalmol-2015-307272
   Ross AH, 2011, SURV OPHTHALMOL, V56, P54, DOI 10.1016/j.survophthal.2010.03.008
   Tambasco N, 2019, NEUROL SCI, V40, P1887, DOI 10.1007/s10072-019-03921-4
   Tan EK, 2004, J NEUROL SCI, V219, P151, DOI 10.1016/j.jns.2004.01.010
   Tan EK, 2008, CLIN NEUROL NEUROSUR, V110, P813, DOI 10.1016/j.clineuro.2008.05.010
   Wabbels B, 2012, J NEURAL TRANSM, V119, P963, DOI 10.1007/s00702-011-0762-y
   Wabbels B, 2011, J NEURAL TRANSM, V118, P925, DOI 10.1007/s00702-010-0546-9
   Wambier SPF, 2014, OPHTHAL PLAST RECONS, V30, P146, DOI 10.1097/IOP.0000000000000031
   YOSHIMURA DM, 1992, MUSCLE NERVE, V15, P1045, DOI 10.1002/mus.880150909
NR 17
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0300-9564
EI 1435-1463
J9 J NEURAL TRANSM
JI J. Neural Transm.
PD JUL
PY 2020
VL 127
IS 7
BP 1041
EP 1046
DI 10.1007/s00702-020-02183-1
EA MAR 2020
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA LX9JP
UT WOS:000522589800001
PM 32232566
DA 2020-12-01
ER

PT J
AU Casoy, J
   Nascimento, H
   Silva, LMP
   Fernandez-Zamora, Y
   Muccioli, C
   Dias, JRD
   Nobrega, MJ
   Nobrega, HAJ
   Zummo, J
   Belfort, R
AF Casoy, Julio
   Nascimento, Heloisa
   Silva, Luci Meire P.
   Fernandez-Zamora, Yuslay
   Muccioli, Cristina
   Dias, Joao Rafael de Oliveira
   Nobrega, Mario Junqueira
   Nobrega, Heloisa Amaral Junqueira
   Zummo, Jacqueline
   Belfort, Rubens
TI Effectiveness of Treatments for Ocular Toxoplasmosis
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Article
DE Ocular toxoplasmosis; pyrimethamine; real-world data; TMP-SMX
ID INTERMITTENT TRIMETHOPRIM/SULFAMETHOXAZOLE TREATMENT; THERAPY;
   RECURRENCES; UVEITIS
AB Purpose: To evaluate the effectiveness of treatments for ocular toxoplasmosis (OT). Methods: A review of charts was conducted from patients who experienced an active episode of OT treated at the Federal University of Sao Paulo and associated sites. OT charts were reviewed to determine treatment effectiveness based on clinical judgment, taking clinical course and outcome into consideration in addition to change in best-corrected visual acuity. Treatment emergent adverse events (TEAEs) were used to assess safety. Results: Overall, 451/1200 patient charts met the inclusion criteria. The most commonly prescribed treatment was trimethoprim + sulfamethoxazole (52.3%) followed by pyrimethamine + sulfadiazine (28%). Treatment was successful in 96.9% of patients. Irrespective of the treatment, active lesions were resolved in 63.9% of patients within 6 weeks. Vision improved in 56.3% of patients. The incidence of TEAEs was low (10%). Conclusions: All treatments were effective for active episodes of OT, with few side effects.
C1 [Casoy, Julio] R&D Dept, Inclinica, Wayne, PA USA.
   [Nascimento, Heloisa; Silva, Luci Meire P.; Fernandez-Zamora, Yuslay; Muccioli, Cristina; Dias, Joao Rafael de Oliveira; Belfort, Rubens] Univ Fed Sao Paulo, Dept Ophthalmol Visual Sci, Sao Paulo, Brazil.
   [Nascimento, Heloisa; Belfort, Rubens] Inst Visao, Sao Paulo, Brazil.
   [Nobrega, Mario Junqueira] Sadalla Amin Ghanem Eye Hosp, Joinville, SC, Brazil.
   [Nobrega, Mario Junqueira] Univ Joinville, Ophthalmol Dept, Santa Catarina, Brazil.
   [Nobrega, Heloisa Amaral Junqueira] Hans Dieter Schmidt Hosp, Ophthalmol Dept, Joinville, SC, Brazil.
   [Zummo, Jacqueline] Nova SE Univ, Dept Hlth Sci, Ft Lauderdale, FL USA.
   [Casoy, Julio] Inclinica, 3726 Liseter Gardens, Newtown Sq, PA USA.
RP Casoy, J (corresponding author), R&D Dept, Inclinica, Wayne, PA USA.; Casoy, J (corresponding author), Inclinica, 3726 Liseter Gardens, Newtown Sq, PA USA.
EM juliocasoy@mac.com
RI Silva, Luci/K-1454-2014; Nascimento, Heloisa/P-8869-2017
OI Silva, Luci/0000-0002-9899-6461; Nascimento,
   Heloisa/0000-0003-0315-1317; Fernandez-Zamora,
   Yuslay/0000-0003-3294-2871; Casoy, Julio/0000-0002-5328-8007
CR Burnett AJ, 1998, OPHTHALMOLOGY, V105, P1032, DOI 10.1016/S0161-6420(98)96004-3
   Centers for Disease Control and Prevention, 2017, PAR TOX TOX INF TREA
   Lima GSC, 2015, J OCUL PHARMACOL TH, V31, P511, DOI 10.1089/jop.2015.0059
   Commodaro AG, 2009, MEM I OSWALDO CRUZ, V104, P345, DOI 10.1590/S0074-02762009000200030
   Dunay IR, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00057-17
   Fernandez DG, 2017, OCUL IMMUNOL INFLAMM, V25, P382, DOI 10.3109/09273948.2015.1132741
   Garweg JG, 2013, OCUL IMMUNOL INFLAMM, V21, P300, DOI 10.3109/09273948.2013.779724
   Kim SJ, 2013, OPHTHALMOLOGY, V120, P371, DOI 10.1016/j.ophtha.2012.07.061
   Novais EA, 2014, BRIT J OPHTHALMOL, V98, P937, DOI 10.1136/bjophthalmol-2013-304184
   Park YH, 2013, KOREAN J PARASITOL, V51, P393, DOI 10.3347/kjp.2013.51.4.393
   PERKINS E S, 1956, Br J Ophthalmol, V40, P577, DOI 10.1136/bjo.40.10.577
   Pradhan E, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002218.pub2
   ROTHOVA A, 1989, INT OPHTHALMOL, V13, P415, DOI 10.1007/BF02306491
   Silveira C, 2002, AM J OPHTHALMOL, V134, P41, DOI 10.1016/S0002-9394(02)01527-1
   Silveira C, 2015, OCUL IMMUNOL INFLAMM, V23, P246, DOI 10.3109/09273948.2014.964422
   Slatore CG, 2004, IMMUNOL ALLERGY CLIN, V24, P477, DOI 10.1016/j.iac.2004.03.011
   Soheilian M, 2005, OPHTHALMOLOGY, V112, P1876, DOI 10.1016/j.ophtha.2005.05.025
   Soheilian M, 2004, OCUL IMMUNOL INFLAMM, V12, P297, DOI 10.1080/092739490500174
   Soheilian M, 2011, OPHTHALMOLOGY, V118, P134, DOI 10.1016/j.ophtha.2010.04.020
   Wakefield D, 2011, OCUL IMMUNOL INFLAMM, V19, P2, DOI 10.3109/09273948.2011.547157
NR 20
TC 1
Z9 1
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PD FEB 17
PY 2020
VL 28
IS 2
BP 249
EP 255
DI 10.1080/09273948.2019.1569242
PG 7
WC Ophthalmology
SC Ophthalmology
GA KQ2JQ
UT WOS:000516755400010
PM 30806556
DA 2020-12-01
ER

PT J
AU Melo, GB
   Emerson, GG
   Dias, CS
   Morais, FB
   Lima, AD
   Ota, S
   Farah, ME
   Rodrigues, EB
   Maia, M
   Belfort, R
AF Melo, Gustavo Barreto
   Emerson, Geoffrey Guy
   Dias, Celso Souza, Jr.
   Morais, Fabio Barreto
   Lima Filho, Acacio de Souza
   Ota, Shoko
   Farah, Michel Eid
   Rodrigues, Eduardo Buchele
   Maia, Mauricio
   Belfort, Rubens, Jr.
TI Release of silicone oil and the off-label use of syringes in
   ophthalmology
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID PARTICLE FORMATION; AGGREGATION; INJECTION; DROPLETS; GLASS
AB Background/aims To assess silicone oil (SO) release by different brands of syringes used for intravitreal injection under different handling conditions.
   Methods Eight syringes were analysed: from the USA, Terumo 0.5 mL, Becton-Dickinson (BD) Tuberculin 1 mL, BD Luer-lok 1 mL, BD Ultra-Fine 0.3 mL and Exel Insulin 0.3 mL; from Germany, Braun Omnifix-F 1 mL and Braun Injekt-F 1 mL and from Spain, BD Plastipak 1 mL. The impact of air, priming the plunger, agitation by flicking and fluid temperature on SO release were assessed by light microscopy. Fourier transform infrared spectroscopy (FTIR) was performed to identify the molecular compound in each syringe.
   Results Five hundred and sixty syringes were analysed. Terumo 0.5 mL and BD Ultra-Fine 0.3 mL released more SO than all others. BD Luer-lok 1 mL, BD Plastipak and Braun Omnifix-F 1 mL released little SO; BD Tuberculin 1 mL, Exel 0.3 mL and Braun Injekt-F 1 mL released the least SO. Priming the syringe and different temperatures did not significantly affect SO release. Agitation by flicking caused a significantly higher proportion of samples to have SO droplets and an increased number of oil droplets. Air had an additive effect on the release of oil in the agitation groups. FTIR identified polysiloxane in all syringes but Injekt-F.
   Conclusion Syringes commonly used for intravitreal injections frequently release SO droplets, especially when agitated by flicking. To avoid unnecessary ocular risks, syringes should not be agitated before intravitreal injection. It is desirable that syringes be manufactured specifically for ophthalmic use.
C1 [Melo, Gustavo Barreto; Dias, Celso Souza, Jr.; Morais, Fabio Barreto] Hosp Olhos Sergipe, BR-49020380 Aracaju, Brazil.
   [Melo, Gustavo Barreto; Morais, Fabio Barreto; Lima Filho, Acacio de Souza; Farah, Michel Eid; Rodrigues, Eduardo Buchele; Maia, Mauricio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
   [Emerson, Geoffrey Guy] Retina Ctr Minnesota, Minneapolis, MN USA.
   [Lima Filho, Acacio de Souza; Farah, Michel Eid; Rodrigues, Eduardo Buchele; Maia, Mauricio; Belfort, Rubens, Jr.] IPEPO, Vis Inst, Sao Paulo, Brazil.
   [Ota, Shoko] Inst Technol Res, Chem Anal Lab, Ctr Chem & Manufactured Goods, Sao Paulo, Brazil.
RP Melo, GB (corresponding author), Hosp Olhos Sergipe, BR-49020380 Aracaju, Brazil.
EM gustavobmelo@yahoo.com.br
OI Melo, Gustavo/0000-0001-5765-2008; Alves de Souza Lima Filho,
   Acacio/0000-0003-1802-9592; Ota, Shoko/0000-0002-5847-5717
FU EyePharma (Sao Paulo, Brazil); FAPESP (Sao Paulo, Brazil)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CNPq (Brasilia,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Pan-American Association of Ophthalmology/Pan-American
   Ophthalmological Foundation; Paul Kayser/Retina Research Foundation
   Global Award (Pan-American Association of Ophthalmology/Pan-American
   Ophthalmological Foundation, Arlington, Texas, USA)
FX This study was supported by EyePharma (Sao Paulo, Brazil), FAPESP (Sao
   Paulo, Brazil), CNPq (Brasilia, Brazil) and Pan-American Association of
   Ophthalmology/Pan-American Ophthalmological Foundation, Paul
   Kayser/Retina Research Foundation Global Award (Pan-American Association
   of Ophthalmology/Pan-American Ophthalmological Foundation, Arlington,
   Texas, USA). None of the funders/sponsors had any role in design and
   conduct of the study; collection, management, analysis and
   interpretation of the data; preparation, review or approval of the
   manuscript and decision to submit the manuscript for publication.
CR Avery RL, 2017, RETIN CASES BRIEF RE
   Bakri SJ, 2008, RETINA-J RET VIT DIS, V28, P996, DOI 10.1097/IAE.0b013e31816c6868
   Chamerski K, 2016, SPECTROCHIM ACTA A, V167, P96, DOI 10.1016/j.saa.2016.05.036
   Chisholm CF, 2015, J PHARM SCI-US, V104, P3681, DOI 10.1002/jps.24573
   FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206
   Funke S, 2015, EUR J PHARM BIOPHARM, V96, P304, DOI 10.1016/j.ejpb.2015.08.009
   Gerhardt A, 2014, J PHARM SCI-US, V103, P1601, DOI 10.1002/jps.23973
   Grzybowski A, 2018, OPHTHALMOLOGICA, V239, P181, DOI 10.1159/000486145
   Hahn P, 2013, OPHTHALMOLOGY, V120, P1100, DOI 10.1016/j.ophtha.2012.11.018
   Khurana RN, 2017, JAMA OPHTHALMOL, V135, P800, DOI 10.1001/jamaophthalmol.2017.1815
   Krayukhina E, 2015, J PHARM SCI-US, V104, P527, DOI 10.1002/jps.24184
   Melo GB, 2019, INT J RETINA VITREOU, V5
   Melo GB, 2019, OPHTHALMIC SURG LASE
   Melo GB, 2019, EYE, V33, P1025, DOI 10.1038/s41433-019-0365-7
   Sacha GA, 2010, PHARM DEV TECHNOL, V15, P6, DOI 10.3109/10837450903511178
   Teska BM, 2016, J PHARM SCI-US, V105, P2053, DOI 10.1016/j.xphs.2016.04.015
   Thompson JT, 2011, SURV OPHTHALMOL, V56, P162, DOI 10.1016/j.survophthal.2010.08.003
   Wambier CG, 2018, INT J DERMATOL, V57, P122, DOI 10.1111/ijd.13825
   Williams PD, 2016, RETINA-J RET VIT DIS, V36, P909, DOI 10.1097/IAE.0000000000000801
   Yu Jea H, 2018, Am J Ophthalmol Case Rep, V10, P142, DOI 10.1016/j.ajoc.2017.07.009
NR 20
TC 7
Z9 7
U1 1
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
EI 1468-2079
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD FEB
PY 2020
VL 104
IS 2
BP 291
EP 296
DI 10.1136/bjophthalmol-2019-313823
PG 6
WC Ophthalmology
SC Ophthalmology
GA KU8KG
UT WOS:000519960400026
PM 30910872
DA 2020-12-01
ER

PT J
AU Lima, LH
   Melo, GB
   Zett, C
   Morais, FB
   Leal, BC
   Farah, ME
   Belfort, R
AF Lima, Luiz H.
   Melo, Gustavo B.
   Zett, Claudio
   Morais, Fabio B.
   Leal, Bruno C.
   Farah, Michel E.
   Belfort, Rubens, Jr.
TI Optical Coherence Tomography Angiography Findings in Diffuse Unilateral
   Subacute Neuroretinitis
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID CLINICAL-FEATURES; VASCULAR LAYERS; NEMATODES
AB BACKGROUND AND OBJECTIVE: To report a unique case series of diffuse unilateral subacute neuroretinitis (DLJSN) patients imaged with optical coherence tomography angiography (OCTA).
   PATIENTS AND METHODS: In this retrospective case series, multimodal imaging was performed in four patients with DUSN at the time of patient visit. The study patients underwent standard clinical treatment for DUSN.
   RESULTS: The clinical findings were consistent with the diagnosis of DUSN. Cross-sectional OCT showed disruption of outer retinal layers in the foveal area and an irregular structure of the outer plexiform layer. En face OCT revealed hyperreflecfive spots and a large hyperreflective lesion in the foveal area correspondent to the outer retina disruption seen on cross-sectional OCT. OCTA demonstrated decreased vascular perfusion in both the superficial and deep retinal capillary plexuses along with choriocapillaris preservation.
   CONCLUSION: OCTA may provide a more detailed assessment of the retinal microvascular changes, allowing a more precise anatomical-functional correlation in DUSN.
C1 [Lima, Luiz H.; Melo, Gustavo B.; Zett, Claudio; Morais, Fabio B.; Farah, Michel E.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Melo, Gustavo B.; Morais, Fabio B.] Hosp Olhos Sergipe, Aracaju, Brazil.
   [Zett, Claudio] Pontificia Univ Catolica Valparaiso, Valparaiso, Chile.
   [Leal, Bruno C.] Univ Tiradentes, Sergipe, Brazil.
RP Melo, GB (corresponding author), Rua Campo Brito,995 Sao Jose, BR-49020380 Aracaju, SE, Brazil.
EM gustavobmelo@yahoo.com.br
CR Casella AMB, 2010, ARQ BRAS OFTALMOL, V73, P182, DOI 10.1590/S0004-27492010000200017
   Berbel RF, 2014, CLIN OPHTHALMOL, V8, P1081, DOI 10.2147/OPTH.S60302
   Garcia Filho CAD, 2012, AM J OPHTHALMOL, V153, P743, DOI 10.1016/j.ajo.2011.09.015
   de Souza EC, 1999, ARCH OPHTHALMOL-CHIC, V117, P1349, DOI 10.1001/archopht.117.10.1349
   Garcia CAD, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/285296
   GASS JDM, 1978, J ROY SOC MED, V71, P95
   GASS JDM, 1983, ARCH OPHTHALMOL-CHIC, V101, P1689
   Gass JDM, 1987, STEREOSCOPIC ATLAS M, V2, P622
   Kalevar Ananda, 2017, Am J Ophthalmol Case Rep, V7, P91, DOI 10.1016/j.ajoc.2017.06.015
   Koustenis A, 2017, BRIT J OPHTHALMOL, V101, P16, DOI 10.1136/bjophthalmol-2016-309389
   Moraes LR, 2002, ARCH OPHTHALMOL-CHIC, V120, P135, DOI 10.1001/archopht.120.2.135
   OLIVEIRA AA, 1991, REV BRAS OFTALMOL, V51, P51, DOI DOI 10.1590/S1517-86922006000100010
   Padhi TR, 2017, SURV OPHTHALMOL, V62, P161, DOI 10.1016/j.survophthal.2016.09.005
   Pichi F, 2017, PROG RETIN EYE RES, V59, P178, DOI 10.1016/j.preteyeres.2017.04.005
   Souza EC, 2005, AM J OPHTHALMOL, V140, P437, DOI 10.1016/j.ajo.2005.03.065
   Souza EC, 1992, ARQ BRAS OFTALMOL, V55, P251, DOI [10.5935/0004-2749.19920002, DOI 10.5935/0004-2749.19920002]
   Spaide RF, 2017, JAMA OPHTHALMOL, V135, P259, DOI 10.1001/jamaophthalmol.2016.5327
   Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616
   Vezzola D, 2014, RETINA-J RET VIT DIS, V34, P1675, DOI 10.1097/IAE.0000000000000114
NR 19
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD FEB
PY 2020
VL 51
IS 2
BP 76
EP 83
DI 10.3928/23258160-20200129-02
PG 8
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA KQ3EI
UT WOS:000516809400002
PM 32084279
DA 2020-12-01
ER

PT J
AU Osaki, MH
   Osaki, TH
   Garcia, DM
   Osaki, T
   Gameiro, GR
   Belfort , R
   Cruz, AAV
AF Osaki, Midori H.
   Osaki, Tammy H.
   Garcia, Denny M.
   Osaki, Teissy
   Gameiro, Gustavo R.
   Belfort Jr, Rubens
   Cruz, Antonio Augusto, V
TI Analysis of blink activity and anomalous eyelid movements in patients
   with hemifacial spasm
SO GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article
DE Hemifacial spasm; Spontaneous blinking; Eyelid movements; Eyelid spasms;
   High-speed video
ID LEVATOR PALPEBRAE SUPERIORIS; KINEMATICS; MOTION
AB To assess spontaneous blinking and anomalous eyelid movements in patients with hemifacial spasm with an emphasis on interocular differences. Spontaneous eyelid movements were registered bilaterally for 3 min using a high-speed video camera in 28 patients with hemifacial spasm (HFS) who had not been treated with botulinum toxin injections for at least 5 months. The degree of blink conjugacy, maximum velocity, and amplitude of the closing phase of the blinks were determined for the affected and non-affected sides. Out of the 28 subjects, 23 (82%) presented with abnormal nonconjugate spasms that were similar to blinks, and in 17 (61%), high-frequency eyelid twitches were detected between blinks on the affected eye. The rate of nonconjugate blink-like spasms ranged from 0.3 to 24.7 movements/min. With regard for conjugate blinks, there was no significant interocular difference in amplitudes or eyelid closure velocities. The amplitude and velocity were significantly lower for nonconjugate movements than for spontaneous blinks. HFS is a unique condition in which complex patterns of eyelid movements, including both conjugate and nonconjugate movements, are present. Conjugate movements correspond to spontaneous blinking, and the same metrics were observed in affected and non-affected eyes. Nonconjugate movements correspond to anomalous nonconjugate blink-like spasms and high-frequency eyelid twitches in the affected eye, both of which were characterized by lower amplitudes and velocities than were observed in conjugate movements.
C1 [Osaki, Midori H.; Osaki, Tammy H.; Osaki, Teissy; Belfort Jr, Rubens] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Osaki, Midori H.; Osaki, Tammy H.; Osaki, Teissy] Osaki Ophthalmol Clin, Sao Paulo, SP, Brazil.
   [Garcia, Denny M.; Cruz, Antonio Augusto, V] Univ Sao Paulo Ribeirao Preto, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Sao Paulo, SP, Brazil.
   [Gameiro, Gustavo R.] Univ Sao Paulo, Med Sch, Sao Paulo, SP, Brazil.
RP Osaki, MH (corresponding author), Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.; Osaki, MH (corresponding author), Osaki Ophthalmol Clin, Sao Paulo, SP, Brazil.
EM midori_osaki@yahoo.com.br
OI Osaki, Midori/0000-0001-8574-2879
FU CAPES Foundation, BrazilCAPES [N/A] Funding Source: Medline
CR Abbruzzese Giovanni, 2011, Handb Clin Neurol, V100, P675, DOI 10.1016/B978-0-444-52014-2.00048-3
   ARAMIDEH M, 1994, BRAIN, V117, P27, DOI 10.1093/brain/117.1.27
   Baccega A, 2017, CURR EYE RES, V42, P1248, DOI 10.1080/02713683.2017.1307417
   Bentivoglio AR, 2006, MOVEMENT DISORD, V21, P1225, DOI 10.1002/mds.20889
   Chaudhry N, 2015, J NEUROL SCI, V356, P27, DOI 10.1016/j.jns.2015.06.032
   Cruz AAV, 2011, OCUL SURF, V9, P29, DOI 10.1016/S1542-0124(11)70007-6
   DOANE MG, 1980, AM J OPHTHALMOL, V89, P507, DOI 10.1016/0002-9394(80)90058-6
   EVINGER C, 1991, INVEST OPHTH VIS SCI, V32, P387
   Ferrazzano G, 2019, J NEUROL, V266, P1136, DOI 10.1007/s00415-019-09243-x
   Frigerio A, 2014, JAMA FACIAL PLAST SU, V16, P211, DOI 10.1001/jamafacial.2014.1
   Garcia DM, 2013, INVEST OPHTH VIS SCI, V54, P1434, DOI 10.1167/iovs.12-11452
   Hanuka A, 2017, GRAEF ARCH CLIN EXP, V255, P1811, DOI 10.1007/s00417-017-3712-z
   Hasan SA, 1997, ARCH OPHTHALMOL-CHIC, V115, P631, DOI 10.1001/archopht.1997.01100150633010
   Hershman R, 2018, BEHAV RES METHODS, V50, P107, DOI 10.3758/s13428-017-1008-1
   Huffman MD, 1996, NEUROLOGY, V46, P1079, DOI 10.1212/WNL.46.4.1079
   Jankovic J, 2009, MOVEMENT DISORD, V24, P407, DOI 10.1002/mds.22368
   Kimura N, 2017, J NEUROL SCI, V380, P200, DOI 10.1016/j.jns.2017.07.035
   Kwon KA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0227
   Lee WH, 2017, P ANN INT IEEE EMBS, P1509, DOI 10.1109/EMBC.2017.8037122
   Malbouisson JMC, 2010, J NEUROSCI METH, V191, P119, DOI 10.1016/j.jneumeth.2010.06.006
   MANNING KA, 1990, ANN NEUROL, V28, P653, DOI 10.1002/ana.410280509
   Osaki MH, 2020, J NEURO-OPHTHALMOL, V40, P193, DOI 10.1097/WNO.0000000000000823
   Palakuru JR, 2007, INVEST OPHTH VIS SCI, V48, P3032, DOI 10.1167/iovs.06-1507
   PORTER JD, 1989, J COMP NEUROL, V287, P64, DOI 10.1002/cne.902870106
   Ross AH, 2011, SURV OPHTHALMOL, V56, P54, DOI 10.1016/j.survophthal.2010.03.008
   Sforza C, 2008, OPHTHAL PHYSL OPT, V28, P345, DOI 10.1111/j.1475-1313.2008.00577.x
   STAVA MW, 1994, INVEST OPHTH VIS SCI, V35, P3966
   Wambier SPF, 2016, CURR EYE RES, V41, P433, DOI 10.3109/02713683.2015.1031252
   Wambier SPF, 2014, OPHTHAL PLAST RECONS, V30, P146, DOI 10.1097/IOP.0000000000000031
   Wang AC, 1998, MUSCLE NERVE, V21, P1740, DOI 10.1002/(SICI)1097-4598(199812)21:12<1740::AID-MUS17>3.0.CO;2-V
NR 30
TC 2
Z9 3
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0721-832X
EI 1435-702X
J9 GRAEF ARCH CLIN EXP
JI Graefes Arch. Clin. Exp. Ophthalmol.
PD MAR
PY 2020
VL 258
IS 3
BP 669
EP 674
DI 10.1007/s00417-019-04567-w
EA DEC 2019
PG 6
WC Ophthalmology
SC Ophthalmology
GA KN4JG
UT WOS:000503685600002
PM 31863396
DA 2020-12-01
ER

PT J
AU Agrawal, R
   Agarwal, A
   Jabs, DA
   Kee, A
   Testi, I
   Mahajan, S
   McCluskey, PJ
   Gupta, A
   Palestine, A
   Denniston, A
   Banker, A
   Invernizzi, A
   Fonollosa, A
   Sharma, A
   Kumar, A
   Curi, A
   Okada, A
   Schlaen, A
   Heiligenhaus, A
   Kumar, A
   Gurbaxani, A
   Bodaghi, B
   Shah, BI
   Lowder, C
   Tappeiner, C
   Muccioli, C
   Vasconcelos-Santos, DV
   Goldstein, D
   Behra, D
   Das, D
   Makhoul, D
   Baglivo, E
   Denisova, E
   Miserocchi, E
   Carreno, E
   Asyari, F
   Pichi, F
   Sen, HN
   Uy, H
   Nascimento, H
   Tugal-Tutkun, I
   Arevalo, JF
   Davis, J
   Thorne, J
   Yamamoto, JH
   Smith, J
   Garweg, JG
   Biswas, J
   Babu, K
   Aggarwal, K
   Cimino, L
   Kuffova, L
   Agarwal, M
   Zierhut, M
   Agarwal, M
   De Smet, M
   Tognon, MS
   Errera, MH
   Munk, M
   Westcott, M
   Soheilian, M
   Accorinti, M
   Khairallah, M
   Nguyen, M
   Kon, OM
   Mahendradas, P
   Yang, PZ
   Neri, P
   Ozdal, P
   Amer, R
   Lee, R
   Nora, RL
   Chhabra, R
   Belfort, R
   Mehta, S
   Shoughy, S
   Luthra, S
   Mohamed, SO
   Chee, SP
   Basu, S
   Teoh, S
   Ganesh, S
   Barisani-Asenbauer, T
   Guex-Crosier, Y
   Ozyazgan, Y
   Akova, Y
   Habot-Wilner, Z
   Kempen, J
   Nguyen, QD
   Pavesio, C
   Gupta, V
AF Agrawal, Rupesh
   Agarwal, Aniruddha
   Jabs, Douglas A.
   Kee, Aera
   Testi, Ilaria
   Mahajan, Sarakshi
   McCluskey, Peter J.
   Gupta, Amod
   Palestine, Alan
   Denniston, Alastair
   Banker, Alay
   Invernizzi, Alessandro
   Fonollosa, Alex
   Sharma, Aman
   Kumar, Amitabh
   Curi, Andre
   Okada, Annabelle
   Schlaen, Ariel
   Heiligenhaus, Arnd
   Kumar, Atul
   Gurbaxani, Avinash
   Bodaghi, Bahram
   Shah, Bulbul Islam
   Lowder, Careen
   Tappeiner, Christoph
   Muccioli, Cristina
   Vasconcelos-Santos, Daniel Vitor
   Goldstein, Debra
   Behra, Digambar
   Das, Dipankar
   Makhoul, Dorine
   Baglivo, Edoardo
   Denisova, Ekaterina
   Miserocchi, Elisabetta
   Carreno, Ester
   Asyari, Fatma
   Pichi, Francesco
   Sen, H. Nida
   Uy, Harvey
   Nascimento, Heloisa
   Tugal-Tutkun, Ilknur
   Arevalo, J. Fernando
   Davis, Janet
   Thorne, Jennifer
   Yamamoto, Joyce Hisae
   Smith, Justine
   Garweg, Justus G.
   Biswas, Jyotirmay
   Babu, Kalpana
   Aggarwal, Kanika
   Cimino, Luca
   Kuffova, Lucia
   Agarwal, Mamta
   Zierhut, Manfred
   Agarwal, Manisha
   De Smet, Marc
   Tognon, Maria Sofia
   Errera, Marie-Helene
   Munk, Marion
   Westcott, Mark
   Soheilian, Masoud
   Accorinti, Massimo
   Khairallah, Moncef
   Myhanh Nguyen
   Kon, Onn Minn
   Mahendradas, Padmamalini
   Yang, Peizeng
   Neri, Piergiorgio
   Ozdal, Pinar
   Amer, Radgonde
   Lee, Richard
   Nora, Rina La Distia
   Chhabra, Romi
   Belfort, Rubens
   Mehta, Salil
   Shoughy, Samir
   Luthra, Saurabh
   Mohamed, Shelina Oli
   Chee, Soon-Phaik
   Basu, Soumyava
   Teoh, Stephen
   Ganesh, Sudha
   Barisani-Asenbauer, Talin
   Guex-Crosier, Yan
   Ozyazgan, Yilmaz
   Akova, Yonca
   Habot-Wilner, Zohar
   Kempen, John
   Quan Dong Nguyen
   Pavesio, Carlos
   Gupta, Vishali
CA Collaborative Ocular TB Study COTS
TI Standardization of Nomenclature for Ocular Tuberculosis - Results of
   Collaborative Ocular Tuberculosis Study (COTS) Workshop
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Article; Early Access
DE Antitubercular therapy; Ocular tuberculosis; remission; tubercular
   uveitis; tuberculous; uveitis
ID SERPIGINOUS-LIKE CHOROIDITIS; REPORTING CLINICAL-DATA; UVEITIS
   NOMENCLATURE; INITIATION; DIAGNOSIS; TUBERCLES; FEATURES; ANGIOGRAPHY
AB Purpose: To standardize a nomenclature system for defining clinical phenotypes, and outcome measures for reporting clinical and research data in patients with ocular tuberculosis (OTB). Methods: Uveitis experts initially administered and further deliberated the survey in an open meeting to determine and propose the preferred nomenclature for terms related to the OTB, terms describing the clinical phenotypes and treatment and reporting outcomes. Results: The group of experts reached a consensus on terming uveitis attributable to tuberculosis (TB) as tubercular uveitis. The working group introduced a SUN-compatible nomenclature that also defines disease "remission" and "cure", both of which are relevant for reporting treatment outcomes. Conclusion: A consensus nomenclature system has been adopted by a large group of international uveitis experts for OTB. The working group recommends the use of standardized nomenclature to prevent ambiguity in communication and to achieve the goal of spreading awareness of this blinding uveitis entity.
C1 [Agrawal, Rupesh; Kee, Aera; Teoh, Stephen] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore, Singapore.
   [Agrawal, Rupesh; Testi, Ilaria; Gurbaxani, Avinash; Westcott, Mark; Lee, Richard; Pavesio, Carlos] NHS Fdn Trust, Moorfields Eye Hosp, Dept Ophthamol, London, England.
   [Agrawal, Rupesh] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore.
   [Agarwal, Aniruddha; Gupta, Amod; Aggarwal, Kanika; Gupta, Vishali] Post Grad Inst Med Educ & Res, Adv Eye Ctr, Dept Ophthamol, Chandigarh, India.
   [Jabs, Douglas A.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Jabs, Douglas A.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21205 USA.
   [Mahajan, Sarakshi; Quan Dong Nguyen] Stanford Univ, Byers Eye Inst, Dept Ophthamol, Palo Alto, CA 94304 USA.
   [McCluskey, Peter J.] Univ Sydney, Fac Med & Hlth, Save Sight Inst, Discipline Ophthalmol, Sydney, NSW, Australia.
   [Palestine, Alan] Univ Colorado, Denver, CO 80202 USA.
   [Denniston, Alastair] Univ Hosp Birmingham NHS Fdn Trust, Dept Ophthalmol, Birmingham, W Midlands, England.
   [Denniston, Alastair] NHS Fdn Trust, Moorfields Eye Hosp, London, England.
   [Banker, Alay] 5 Subhash Soc, Bankers Retina Clin & Laser Ctr, Ahmadabad, Gujarat, India.
   [Invernizzi, Alessandro] Univ Milan, Luigi Sacco Hosp, Dept Biomed & Clin Sci L Sacco, Eye Clin, Milan, Italy.
   [Fonollosa, Alex] Hosp Univ Cruces, Bilbao, Vizcaya, Spain.
   [Sharma, Aman] PGIMER, Dept Rheumatol, Chandigarh, India.
   [Kumar, Amitabh] Aditya Birla Sankara Nethralaya, Dept Uvea, Kolkata, India.
   [Curi, Andre] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Okada, Annabelle] Kyorin Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan.
   [Schlaen, Ariel] Univ Buenos Aires, Hosp Univ Austral, Hosp Clin Jose de San Martin, Buenos Aires, DF, Argentina.
   [Heiligenhaus, Arnd] St Franziskus Hosp, Augenabt, Munster, Germany.
   [Heiligenhaus, Arnd] St Franziskus Hosp, Ophtha Lab, Munster, Germany.
   [Kumar, Atul] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.
   [Bodaghi, Bahram] Sorbonne Univ, Dept Ophthalmol, Paris, France.
   [Shah, Bulbul Islam] Ibn Sina Hosp, Dhaka, Bangladesh.
   [Lowder, Careen] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA.
   [Tappeiner, Christoph; Munk, Marion] Univ Bern, Bern Univ Hosp, Dept Ophthalmol, Inselspital, Bern, Switzerland.
   [Muccioli, Cristina; Nascimento, Heloisa; Belfort, Rubens] Univ Fed Sao Paulo, Hosp Sao Paulo, Inst Visao, Sao Paulo, SP, Brazil.
   [Vasconcelos-Santos, Daniel Vitor] Univ Fed Minas Gerais, Hosp Clin, Hosp Sao Geraldo, Uveitis Unit, Belo Horizonte, MG, Brazil.
   [Goldstein, Debra] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Behra, Digambar] Postgrad Inst Med Educ & Res, Adv Eye Ctr, Dept Pulm Med, Chandigarh, India.
   [Das, Dipankar] Sankaradeva Nethralaya, Dept Ocular Pathol, Uveitis & Neuroophthalmol Serv, Gauhati, India.
   [Makhoul, Dorine] Univ Libre Bruxelles, Dept Ophthalmol, CHU St Pierre, Brussels, Belgium.
   [Baglivo, Edoardo] Clin Oeil, Dept Ophthalmol, Geneva, Switzerland.
   [Denisova, Ekaterina] Helmholtz Res Inst Eye Dis, Moscow, Russia.
   [Miserocchi, Elisabetta] Univ Vita Salute San Raffaele, San Raffaele Hosp, Ophthalmol Dept, Milan, Italy.
   [Carreno, Ester] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain.
   [Asyari, Fatma; Nora, Rina La Distia] Univ Indonesia, INOIIS, Dept Ophthalmol, Depok, Indonesia.
   [Pichi, Francesco; Neri, Piergiorgio] Cleveland Clin Abu Dhabi, Eye Inst, Abu Dhabi, U Arab Emirates.
   [Sen, H. Nida] NEI, Immunol Lab, Bldg 10, Bethesda, MD 20892 USA.
   [Uy, Harvey] Asian Eye Inst, Ocular Immunol & Uveitis Serv, Makati, Philippines.
   [Tugal-Tutkun, Ilknur; Ozyazgan, Yilmaz] Istanbul Univ, Istanbul Fac Med, Dept Ophthalmol, Istanbul, Turkey.
   [Arevalo, J. Fernando] King Khalid Eye Specialist Hosp, Vitreoretinal Div, Riyadh, Saudi Arabia.
   [Arevalo, J. Fernando] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Retina Div, Baltimore, MD 21205 USA.
   [Davis, Janet] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.
   [Thorne, Jennifer] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.
   [Yamamoto, Joyce Hisae] Univ Sao Paulo, Fac Med, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Smith, Justine] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia.
   [Garweg, Justus G.] Swiss Eye Inst, Bern, Switzerland.
   [Garweg, Justus G.] Berner Augenklin Lindenhofspital, Bern, Switzerland.
   [Garweg, Justus G.] Univ Bern, Bern, Switzerland.
   [Biswas, Jyotirmay; Agarwal, Mamta; Ganesh, Sudha] Sankara Nethralaya, Chennai, Tamil Nadu, India.
   [Babu, Kalpana] Vittala Int Inst Ophthalmol, Bangalore, Karnataka, India.
   [Cimino, Luca] Azienda USL IRCCS, Ocular Immunol Unit, Reggio Emilia, Italy.
   [Kuffova, Lucia] Univ Aberdeen, Sch Med & Dent, Div Appl Med, Sect Immun Infect & Inflammat, Aberdeen, Scotland.
   [Zierhut, Manfred] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany.
   [Agarwal, Manisha] Dr Shroffs Char Eye Hosp Daryaganj, New Delhi, India.
   [De Smet, Marc] ZNA Middelhe, Dept Ophthalmol, Antwerp, Belgium.
   [Tognon, Maria Sofia] S Antonio Hosp, Dept Ophthalmol, Ocular Immunol Unit, Padua, Italy.
   [Errera, Marie-Helene] Sorbonne Univ, Ctr Natl Ophtalmol 15 20, Paris 6, France.
   [Soheilian, Masoud] Shahid Beheshti Univ Med Sci, Tehran, Iran.
   [Accorinti, Massimo] Sapienza Univ Rome, Dept Ophthalmol, Rome, Italy.
   [Khairallah, Moncef] Univ Monastir, Fattouma Bourguiba Univ Hosp, Fac Med, Dept Ophthalmol, Monastir, Tunisia.
   [Myhanh Nguyen] Cao Thang Eye Hosp, Ho Chi Minh City, Vietnam.
   [Kon, Onn Minn] Imperial Coll Heathcare Serv Trust, St Marys Hosp, Chest & Allergy Clin, London, England.
   [Mahendradas, Padmamalini] Narayana Nethralaya, Dept Uveitis & Ocular Immunol, Bangalore, Karnataka, India.
   [Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.
   [Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing, Peoples R China.
   [Ozdal, Pinar] Univ Hlth Sci, Ulucanlar Eye Educ & Res Hosp, Dept Ophthalmol, Ankara, Turkey.
   [Amer, Radgonde] Hadassah Med Ctr, Dept Ophthalmol, Jerusalem, Israel.
   [Chhabra, Romi] Univ Manchester, Dept Ophthalmol, Manchester, Lancs, England.
   [Mehta, Salil] Lilavati Hosp & Res Ctr, Dept Ophthalmol, Mumbai, Maharashtra, India.
   [Shoughy, Samir] Eye Ctr & Eye Fdn Res Ophthalmol, Riyadh, Saudi Arabia.
   [Luthra, Saurabh] Drishti Eye Ctr, Dehra Dun, Uttranchal, India.
   [Mohamed, Shelina Oli] Hosp Shah Alam, Shah Alam, Selangor, Malaysia.
   [Chee, Soon-Phaik] Singapore Eye Res Inst, Singapore, Singapore.
   [Chee, Soon-Phaik] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Basu, Soumyava] LV Prasad Eye Inst, Bhubaneswar, India.
   Eagle Eye Ctr, Singapore, Singapore.
   [Barisani-Asenbauer, Talin] Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Ctr Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.
   [Guex-Crosier, Yan] Univ Lausanne, Jules Gonin Eye Hosp, FAA, Lausanne, Switzerland.
   [Akova, Yonca] Bayindir Kavaklidere Hosp, Dept Ophthalmol, Ankara, Turkey.
   [Habot-Wilner, Zohar] Tel Aviv Med Ctr & Sch Med, Ophthalmol Div, Tel Aviv, Israel.
   [Habot-Wilner, Zohar] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
   [Kempen, John] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA.
RP Gupta, V (corresponding author), Postgrad Inst Med Educ & Res, Adv Eye Ctr, Chandigarh 160012, India.
EM vishalisara@yahoo.co.in
RI Denniston, Alastair/ABD-1238-2020; Soheilian, Masoud/AAW-4743-2020;
   Agrawal, Rupesh/AAR-3910-2020; Shoughy, Samir/J-2882-2019; OZDAL,
   PINAR/ABD-9667-2020; Vasconcelos-Santos, Daniel V/D-3576-2013; Carreno,
   Ester/AAD-6863-2020; Nascimento, Heloisa/P-8869-2017; Akova,
   Yonca/AAD-1036-2020; Piergiorgio Neri, BMedSc/K-5600-2019; Errera,
   Marie-Helene/J-3363-2018; Babu, Kalpana/AAF-2922-2020; Gupta,
   Amod/V-7633-2017
OI Denniston, Alastair/0000-0001-7849-0087; Agrawal,
   Rupesh/0000-0002-6662-5850; Shoughy, Samir/0000-0002-9655-0669;
   Vasconcelos-Santos, Daniel V/0000-0002-6747-2024; Carreno,
   Ester/0000-0002-0055-9547; Nascimento, Heloisa/0000-0003-0315-1317;
   Piergiorgio Neri, BMedSc/0000-0002-7673-4276; Agarwal,
   Aniruddha/0000-0003-4985-9855; Kempen, John/0000-0002-2967-4792; Gupta,
   Amod/0000-0001-8427-5738; Soheilian, Masoud/0000-0001-7508-426X; Teoh,
   Stephen/0000-0002-9359-9694
FU Chief Scientist Office [ETM/351] Funding Source: Medline
CR Agarwal A, 2018, CLIN EXP OPHTHALMOL, V46, P62, DOI 10.1111/ceo.12997
   Agarwal A, 2016, OCUL IMMUNOL INFLAMM, V24, P621, DOI 10.1080/09273948.2016.1207785
   Aggarwal K, 2019, OCUL IMMUNOL INFLAMM, V27, P365, DOI 10.1080/09273948.2017.1373829
   Agrawal R, 2018, INVEST OPHTH VIS SCI, V59, P4162, DOI 10.1167/iovs.18-24102
   Agrawal R, 2017, JAMA OPHTHALMOL, V135, P1318, DOI 10.1001/jamaophthalmol.2017.4485
   Agrawal R, 2017, OCUL IMMUNOL INFLAMM, V25, P97, DOI 10.3109/09273948.2015.1087577
   Agrawal R, 2017, RETINA-J RET VIT DIS, V37, P112, DOI 10.1097/IAE.0000000000001239
   Ang M, 2018, OCUL IMMUNOL INFLAMM, V26, P208, DOI 10.1080/09273948.2016.1178304
   Ang M, 2017, BRIT J OPHTHALMOL, V101, P6, DOI 10.1136/bjophthalmol-2016-309531
   Bansal R, 2012, OPHTHALMOLOGY, V119, P2334, DOI 10.1016/j.ophtha.2012.05.034
   Biswas J, 2002, OCUL IMMUNOL INFLAMM, V10, P293, DOI 10.1076/ocii.10.4.293.15590
   Biswas J, 2018, OCUL IMMUNOL INFLAMM, V26, P870, DOI 10.1080/09273948.2017.1298817
   Biswas J, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-11
   Bukhary ZA, 2007, ANN SAUDI MED, V27, P171, DOI 10.4103/0256-4947.51509
   Campbell IA, 2006, BRIT MED J, V332, P1194, DOI 10.1136/bmj.332.7551.1194
   Cheung CMG, 2009, EYE, V23, P1472, DOI 10.1038/eye.2008.204
   Esen E, 2016, TURK OFTALMOL DERG, V46, P186, DOI 10.4274/tjo.94809
   Figueira L, 2017, REV PORT PNEUMOL, V23, P31, DOI 10.1016/j.rppnen.2016.10.004
   Ganesh SK, 2017, INDIAN J OPHTHALMOL, V65, P761, DOI 10.4103/ijo.IJO_184_17
   Gunasekeran DV, 2019, RETINA-J RET VIT DIS, V39, P1623, DOI 10.1097/IAE.0000000000002194
   Gupta V, 2007, SURV OPHTHALMOL, V52, P561, DOI 10.1016/j.survophthal.2007.08.015
   Gupta V, 2015, OCUL IMMUNOL INFLAMM, V23, P14, DOI 10.3109/09273948.2014.986582
   Gupta V, 2011, AM J OPHTHALMOL, V152, P857, DOI 10.1016/j.ajo.2011.05.004
   Invernizzi A, 2017, RETINA-J RET VIT DIS, V37, P144, DOI 10.1097/IAE.0000000000001128
   Invernizzi A, 2015, RETINA-J RET VIT DIS, V35, P525, DOI 10.1097/IAE.0000000000000312
   Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057
   Jabs DA, 2018, AM J OPHTHALMOL, V186, P19, DOI 10.1016/j.ajo.2017.10.028
   Kawali A, 2018, JAMA OPHTHALMOL, V136, P219, DOI 10.1001/jamaophthalmol.2017.5791
   Khanamiri HN, 2013, SURV OPHTHALMOL, V58, P203, DOI 10.1016/j.survophthal.2012.08.008
   Lee C, 2016, OCUL IMMUNOL INFLAMM, V24, P237, DOI 10.3109/09273948.2014.985387
   Lou SM, 2015, OCUL IMMUNOL INFLAMM, V23, P25, DOI 10.3109/09273948.2014.926936
   Mehta S, 2012, J OPHTHALMIC INFLAMM, V2, P95, DOI 10.1007/s12348-011-0040-z
   Mehta Salil, 2006, Indian Journal of Ophthalmology, V54, P273
   Okada AA, 2013, JAMA OPHTHALMOL, V131, P787, DOI 10.1001/jamaophthalmol.2013.1596
   Oliver GF, 2017, OPHTHALMOLOGY, V124, P1084, DOI 10.1016/j.ophtha.2017.03.009
   Rajpal, 2015, INDIAN J MED MICROBI, V33, pS43, DOI 10.4103/0255-0857.148829
   Rosenbaum JT, 2016, CURR OPIN RHEUMATOL, V28, P228, DOI 10.1097/BOR.0000000000000271
   Verma A, 2016, INT OPHTHALMOL, V36, P413, DOI 10.1007/s10792-015-0144-9
   World Health Organization, TREATM TUB 2017 UPD
NR 39
TC 4
Z9 4
U1 3
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
DI 10.1080/09273948.2019.1653933
EA DEC 2019
PG 11
WC Ophthalmology
SC Ophthalmology
GA JU8ML
UT WOS:000501924100001
PM 31821096
DA 2020-12-01
ER

PT J
AU Watanabe, SES
   Berezovsky, A
   Furtado, JM
   Mitsuhiro, MRKH
   Cypel, M
   Cohen, MJ
   Cohen, JM
   Cunha, CC
   Sacai, PY
   Ferraz, NN
   Vasconcelos, GC
   Morales, PH
   Campos, M
   Fernandes, AG
   Munoz, S
   Belfort, R
   Salomao, SR
AF Song Watanabe, Sung Eun
   Berezovsky, Adriana
   Furtado, Joao Marcello
   Kimie Higashi Mitsuhiro, Marcia Regina
   Cypel, Marcela
   Cohen, Marcos Jacob
   Cohen, Jacob Moyses
   Cunha, Cristina Coimbra
   Sacai, Paula Yuri
   Ferraz, Nivea Nunes
   Vasconcelos, Galton Carvalho
   Morales, Paulo Henrique
   Campos, Mauro
   Fernandes, Arthur Gustavo
   Munoz, Sergio
   Belfort, Rubens, Jr.
   Salomao, Solange Rios
TI Population-Based Cataract Surgery Complications and Their Impact on
   Visual Status in the Brazilian Amazon Region
SO AMERICAN JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID OLDER-ADULTS; EYE SURVEY; BLINDNESS; OUTCOMES; IMPAIRMENT; PREVALENCE;
   DISTRICT; INDIA
AB PURPOSE: To investigate cataract surgery prevalence, complications, visual outcomes, and coverage in a population of older adults from the Brazilian Amazon region.
   DESIGN: Population-based cross-sectional study.
   METHODS: Individuals 245 years of age from urban and rural areas of Parintins City, Brazil, were identified by cluster random sampling. Participants underwent ophthalmic examination, including uncorrected visual acuity, acuity with presenting correction (APC), and best-corrected visual acuity (BCVA) from each eye. In those with previous cataract surgery, surgical technique and complications including its contribution to vision impairment were noted. The association of surgical complications and surgical coverage with sociodemographic variables was assessed by multiple logistic regression.
   RESULTS: A total of 2,384 persons were determined to be eligible, and 2,041 (85.6%) were examined. Overall, prevalence of cataract surgery was 8.6%, with 11.3% urban and 5.0% rural. Surgical complications were associated with males, older age, and urban residency and were found in 60.4%, with posterior capsule opacification in 29.6% and posterior capsule rupture in 16.3%. Among the 270 eyes having cataract surgery, APC 20/32 was found in 44.4%, APC 20/40 to 20/63 in 20.8%, APC < 20/63 to 20/200 in 14.4%, APC < 20/200 to 20/400 in 2.6%, and APC < 20/400 in 17.8%. Low surgical coverage was found with 57.9% of those with visual impairment due to cataract not being treated surgically.
   CONCLUSIONS: Although a reasonable prevalence of cataract surgery was found, a high complication rate, poor visual outcomes, and low cataract surgery coverage indicated that actions to improve quality and appropriate postsurgical management should be planned and implemented by public health authorities. ((C) 2019 Elsevier Inc. All rights reserved.)
C1 [Song Watanabe, Sung Eun; Berezovsky, Adriana; Furtado, Joao Marcello; Kimie Higashi Mitsuhiro, Marcia Regina; Cypel, Marcela; Cunha, Cristina Coimbra; Sacai, Paula Yuri; Ferraz, Nivea Nunes; Vasconcelos, Galton Carvalho; Morales, Paulo Henrique; Campos, Mauro; Fernandes, Arthur Gustavo; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Rua Botucatu 816, BR-04023062 Sao Paulo, SP, Brazil.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Univ Fed Amazonas, Fac Med, Dept Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
   [Furtado, Joao Marcello] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Ribeirao Preto, SP, Brazil.
   [Vasconcelos, Galton Carvalho] Univ Fed Minas Gerais, Dept Oftalmol & Otorrinolaringol, Fac Med, Belo Horizonte, MG, Brazil.
RP Salomao, SR (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Rua Botucatu 816, BR-04023062 Sao Paulo, SP, Brazil.
EM ssalomao@unifesp.br
RI Berezovsky, Adriana/F-2341-2013; Sacai, Paula Y/B-6525-2014; Ferraz,
   Nivea/AAC-2439-2020; de Queiroz Campos, Mauro Silveira/H-7609-2017
OI Berezovsky, Adriana/0000-0001-6350-8221; Ferraz,
   Nivea/0000-0001-7568-6199; de Queiroz Campos, Mauro
   Silveira/0000-0002-9448-8742; Furtado, Joao M./0000-0003-2490-5747;
   Fernandes, Arthur Gustavo/0000-0002-7525-1838
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq,
   BrasiliaNational Council for Scientific and Technological Development
   (CNPq); Programa Ciencia sem Fronteiras [402120/2012-4]; Fundacao de
   Amparo Pesquisa do Estado de Sao Paulo, Sao Paulo, Brasil
   [2013/16397-7]; SightFirst Program, Lions Club International Foundation
   [1758]; Institute da Visao-IPEPO, Sao Paulo, Sao Paulo, Brasil; Fundacao
   Piedade Cohen, Manaus, Amazonas, Brasil; Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior-BrasilCAPES [001]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico-CNPq, Brasilia; Programa Ciencia sem Fronteiras
   grant 402120/2012-4 to S.R.S., S.M. and J.M.F.; Research Scholarships to
   S.R.S. and R.B.J.; Fundacao de Amparo Pesquisa do Estado de Sao Paulo,
   Sao Paulo, Brasil grant 2013/16397-7 to S.R.S.; SightFirst Program,
   Lions Club International Foundation grant 1758 to S.R.S.; and Institute
   da Visao-IPEPO, Sao Paulo, Sao Paulo, Brasil; Fundacao Piedade Cohen,
   Manaus, Amazonas, Brasil. This study was also supported in part by the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil
   finance code 001 (postdoctoral scholarship to S.E.S.W.; and predoctoral
   scholarship to A.O.F.).
CR [Anonymous], 2007, GLOB IN EL AV BLINDN
   [Anonymous], 2010, CANS DEM, P1
   Baranano AE, 2008, OPHTHALMOLOGY, V115, P815, DOI 10.1016/j.ophtha.2007.05.052
   Bourne R, 2007, BRIT J OPHTHALMOL, V91, P420, DOI 10.1136/bjo.2006.106724
   Crispim J, 2015, EXPERT REV OPHTHALMO, V10, P13, DOI 10.1586/17469899.2015.982097
   de Oliveira DF, 2008, CAD SAUDE PUBLICA, V24, P2440, DOI 10.1590/S0102-311X2008001000024
   Erie JC, 2007, J CATARACT REFR SURG, V33, P1273, DOI 10.1016/j.jcrs.2007.03.053
   Finger RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044268
   Batlle JF, 2014, AM J OPHTHALMOL, V158, P242, DOI 10.1016/j.ajo.2014.04.019
   Franzco EC, 2010, CLIN EXP OPTOM, P93379
   Furtado JM, 2019, OPHTHAL EPIDEMIOL, V26, P345, DOI 10.1080/09286586.2019.1624783
   Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002
   Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075584
   Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382
   Katsuki Y, 2019, J CATARACT REFR SURG, V45, P1007, DOI 10.1016/j.jcrs.2018.12.022
   Lansingh VC, 2010, OPHTHAL EPIDEMIOL, V17, P75, DOI 10.3109/09286581003624962
   Lewallen S, 2012, ARCH OPHTHALMOL-CHIC, V130, P1575, DOI 10.1001/archophthalmol.2012.2147
   Li EY, 2013, OPHTHALMOLOGY, V120, P2176, DOI 10.1016/j.ophtha.2013.04.003
   Liu B, 2009, OPHTHALMOLOGY, V116, P1322, DOI 10.1016/j.ophtha.2009.01.030
   Lundstrom M, 2013, OPTOMETRY VISION SCI, V90, P754, DOI 10.1097/OPX.0b013e3182956c32
   Murthy GVS, 2010, OPHTHAL EPIDEMIOL, V17, P185, DOI 10.3109/09286586.2010.483751
   Nirmalan PK, 2002, BRIT J OPHTHALMOL, V86, P505, DOI 10.1136/bjo.86.5.505
   Rabiu MM, 2013, OPHTHAL EPIDEMIOL, V20, P26, DOI 10.3109/09286586.2012.746994
   Salomao SR, 2017, OPHTHAL EPIDEMIOL, V24, P257, DOI 10.1080/09286586.2016.1276199
   Salomao SR, 2009, AM J OPHTHALMOL, V148, P199, DOI 10.1016/j.ajo.2009.02.019
   Sherchan A, 2010, BRIT J OPHTHALMOL, V94, P161, DOI 10.1136/bjo.2008.155408
   Sparrow JM, 2012, EYE, V26, P821, DOI 10.1038/eye.2012.51
   Tang YT, 2016, INVEST OPHTH VIS SCI, V57, P1193, DOI 10.1167/iovs.15-18380
   Thapa SS, 2011, CLIN EXP OPHTHALMOL, V39, P851, DOI 10.1111/j.1442-9071.2011.02576.x
   *WHO, 1998, WHOPBL9868
   Yap EY, 1997, INT OPHTHALMOL, V20, P187
   Zhao JL, 2010, OPHTHALMOLOGY, V117, P2120, DOI 10.1016/j.ophtha.2010.03.005
NR 32
TC 1
Z9 1
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9394
EI 1879-1891
J9 AM J OPHTHALMOL
JI Am. J. Ophthalmol.
PD DEC
PY 2019
VL 208
BP 295
EP 304
DI 10.1016/j.ajo.2019.07.017
PG 10
WC Ophthalmology
SC Ophthalmology
GA JZ0OI
UT WOS:000504803400033
PM 31377288
DA 2020-12-01
ER

PT J
AU Ventura, CV
   Gois, AL
   Freire, BO
   de Almeida, DC
   MacKeen, LD
   Ventura, MC
   Berrocal, AM
   Chan, RVP
   Belfort, R
   Maia, M
   Ventura, LO
AF Ventura, Camila V.
   Gois, Adriana L.
   Freire, Barbara O.
   de Almeida, Danielle C.
   MacKeen, Leslie D.
   Ventura Filho, Marcelo C.
   Berrocal, Audina M.
   Chan, R. V. Paul
   Belfort, Rubens
   Maia, Mauricio
   Ventura, Liana O.
TI Fluorescein Angiography Findings in Children With Congenital Zika
   Syndrome
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID OPHTHALMIC MANIFESTATIONS; VIRUS; INFANTS
AB BACKGROUND AND OBJECTIVE: To evaluate the retinal and vasculature changes in infants with congenital Zika syndrome (CZS) using fluorescein angiography (FA).
   PATIENTS AND METHODS: This consecutive case series included six infants with CZS. FA and color fundus imaging were performed under general anesthesia in both eyes of all infants using a contact widefield digital imaging system. All color fundus images were obtained using a 130 degrees field of view lens, and the FA images were captured using either a 130 degrees or 80 degrees field of view lens. The immunoglobulin M antibody capture enzyme-linked immunosorbent assay was positive for Zika virus in the cerebrospinal fluid samples of all infants. Other congenital infections were ruled out.
   RESULTS: The mean +/- standard deviation age of the infants at the time of examination was 1.4 years +/- 0.1 years (range: 1.3 years to 1.5 years). Contact fundus photographs showed macular abnormalities in seven eyes (58%) and retinal vasculature changes in two eyes (17%). FA detected macular abnormalities in all 12 eyes (100%) and retinal vasculature changes in five eyes (42%). The main retinal vasculature changes were peripheral avascularity in five eyes (42%) and microvasculature abnormalities in three eyes (25%).
   CONCLUSION: FA may be an important tool for detecting subtle macular and retinal vasculature changes in CZS.
C1 [Ventura, Camila V.; Gois, Adriana L.; Freire, Barbara O.; de Almeida, Danielle C.; Ventura Filho, Marcelo C.; Ventura, Liana O.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Gois, Adriana L.; Ventura, Liana O.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Belfort, Rubens; Maia, Mauricio] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [MacKeen, Leslie D.] Hosp Sick Children, Dept Ophthalmol & Visual Sci, Toronto, ON, Canada.
   [Berrocal, Audina M.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Coral Gables, FL 33124 USA.
   [Chan, R. V. Paul] Univ Illinois, Dept Ophthalmol & Visual Sci, Illinois Eye & Ear Infirm, Chicago, IL USA.
RP Ventura, CV (corresponding author), Fundacao Altino Ventura, Rua Soledade 170, BR-50070040 Recife, PE, Brazil.
EM camilaventuramd@gmail.com
OI Gois, Adriana/0000-0001-5542-1097
FU National Institute of Health, Bethesda, MarylandUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30
   EY001792]; Research to Prevent Blindness, New York, NYResearch to
   Prevent Blindness (RPB); Blind Children's Center Research Grant;
   NATIONAL EYE INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [P30EY001792, P30EY001792, P30EY001792, P30EY001792,
   P30EY001792, P30EY001792, P30EY001792, P30EY001792, P30EY001792,
   P30EY001792, P30EY001792, P30EY001792, P30EY001792, P30EY001792,
   P30EY001792, P30EY001792, P30EY001792, P30EY001792, P30EY001792,
   P30EY001792, P30EY001792, P30EY001792, P30EY001792, P30EY001792,
   P30EY001792] Funding Source: NIH RePORTER
FX Supported by P30 EY001792 from the National Institute of Health,
   Bethesda, Maryland (RVPC), an Unrestricted Departmental Grant from
   Research to Prevent Blindness, New York, NY (RVPC), and a Blind
   Children's Center Research Grant.
CR Blair MP, 2012, J AAPOS, V16, P234, DOI 10.1016/j.jaapos.2011.12.157
   Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03497-1
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   John VJ, 2016, OSLI RETINA, V47, P14, DOI 10.3928/23258160-20151214-02
   KENO DD, 1978, ARCH OPHTHALMOL-CHIC, V96, P854
   Lepore D, 2011, OPHTHALMOLOGY, V118, P168, DOI 10.1016/j.ophtha.2010.04.021
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   PAHO, 2017, ZIK EP UPD SIT SUMM
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Roos RP, 2016, JAMA NEUROL, V73, P1395, DOI 10.1001/jamaneurol.2016.3677
   Shane Thomas S, 2011, Ophthalmic Surg Lasers Imaging, V42 Online, pe15, DOI 10.3928/15428877-20110203-03
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Tzu JH, 2013, OPHTHAL SURG LAS IM, V44, P91, DOI 10.3928/23258160-20121221-20
   Velia P, 2012, J MATERN-FETAL NEO M, V25, P53, DOI 10.3109/14767058.2012.712313
   Ventura CV, 2018, OSLI RETINA, V49, pE93, DOI 10.3928/23258160-20180907-14
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   World Health Organization (WHO), EP AL NEUR SYNDR CON
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 28
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD NOV
PY 2019
VL 50
IS 11
BP 702
EP +
DI 10.3928/23258160-20191031-05
PG 9
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA JQ3VF
UT WOS:000498876000015
PM 31755969
DA 2020-12-01
ER

PT J
AU Yoon, YH
   Boyer, DS
   Maturi, RK
   Bandello, F
   Belfort, R
   Augustin, AJ
   Li, XY
   Bai, ZY
   Hashad, Y
   Abujamra, S
   Acton, J
   Ali, F
   Antoszyk, A
   Augustin, AJ
   Awh, CC
   Barak, A
   Bartz-Schmidt, KU
   Baumal, CR
   Belfort, R
   Bhende, M
   Boyer, DS
   Bridges, WZ
   Brown, DM
   Carmichael, T
   Carnevale, K
   Casella, AM
   Chang, T
   Chechik, D
   Chen, SN
   Chong, LP
   Chong, V
   Corwin, J
   Creuzot-Garcher, C
   Cruess, A
   Daniell, M
   de Avila, MP
   de Moraes, HV
   Devenyi, RG
   Doft, BH
   Donaldson, M
   Dreyer, R
   Eliott, D
   Engel, HM
   Ernest, J
   Essman, TF
   Falcone, PM
   Fekrat, S
   Ferencz, JR
   Ferreira, JL
   Figueira, J
   Fiser, I
   Foster, B
   Fox, GM
   Freeman, WR
   Garg, SP
   Gillies, M
   Glaser, D
   Goldstein, BG
   Gomes, AMV
   Gonder, JR
   Gopal, L
   Gous, P
   Gupta, A
   Gupta, A
   Halperin, L
   Han, D
   Hariprasad, SM
   Holz, FG
   Kaiser, P
   Kalvodova, B
   Katz, B
   Katz, RS
   Kecik, D
   Kellaway, J
   Klemperer, I
   Kuppermann, B
   Lanzetta, P
   Lattanzio, R
   Lee, WK
   Lehr, J
   Leys, M
   Loose, I
   Lotery, A
   Lu, DW
   McCartney, P
   Majji, AB
   Martinez, JA
   Massin, P
   Maturi, RK
   Menchini, U
   Menon, G
   Michels, M
   Midena, E
   Miller, J
   Mitchell, P
   Moisseiev, J
   Morse, L
   Navarro, R
   Nemeth, J
   Newland, H
   Newsom, R
   Nichols, J
   Orellana, J
   Orzalesi, N
   Paranhos, A
   Park, R
   Park, S
   Parodi, MB
   Pavan, PR
   Peace, J
   Perez-Ortiz, DJ
   Pollack, A
   Ramaswamy, K
   Ratnakaram, R
   Ravalico, G
   Rehak, J
   Rezaei, K
   Rizzo, S
   Rodriguez-Alvira, FJ
   Romanet, JP
   Rose, S
   Rosen, RB
   Rossetti, L
   Ruiz-Moreno, JM
   Sadda, S
   Sall, K
   Sandner, D
   Sanz, AFV
   Sartani, G
   Schmickler, S
   Schwartz, SD
   Sharma, YR
   Sheu, SJ
   Singer, M
   Sivaprasad, S
   Soubrane, G
   Soucek, P
   Souied, EH
   Staurenghi, G
   Studnicka, J
   Suarez-Figueroa, M
   Takahashi, WY
   Tognetto, D
   Tsai, PL
   Ulanski, LJ
   Uy, HS
   Varano, M
   Veith, M
   Vicha, I
   Viola, F
   Visser, L
   Weinberger, D
   Wing, GL
   Wong, E
   Wong, TY
   Wylegala, E
   Yan, J
   Yoon, YH
   Young, LH
   Yu, HG
   Zimmer-Galler, IE
AF Yoon, Young Hee
   Boyer, David S.
   Maturi, Raj K.
   Bandello, Francesco
   Belfort, Rubens
   Augustin, Albert J.
   Li, Xiao-Yan
   Bai, Zhanying
   Hashad, Yehia
   Abujamra, Suel
   Acton, James
   Ali, Fareed
   Antoszyk, Andrew
   Augustin, Albert J.
   Awh, Carl C.
   Barak, Adiel
   Bartz-Schmidt, Karl Ulrich
   Baumal, Caroline R.
   Belfort, Rubens, Jr.
   Bhende, Muna
   Boyer, David S.
   Bridges, William Z., Jr.
   Brown, David M.
   Carmichael, Trevor
   Carnevale, Ken
   Casella, Antonio M.
   Chang, Tom
   Chechik, Daniel
   Chen, San-Ni
   Chong, Lawrence P.
   Chong, Victor
   Corwin, Joel
   Creuzot-Garcher, Catherine
   Cruess, Alan
   Daniell, Mark
   de Avila, Marcos P.
   de Moraes, Haroldo Vieira, Jr.
   Devenyi, Robert G.
   Doft, Bernard H.
   Donaldson, Mark
   Dreyer, Richard
   Eliott, Dean
   Engel, Harry M.
   Ernest, Jan
   Essman, Thomas F.
   Falcone, Philip M.
   Fekrat, Sharon
   Ferencz, Joseph R.
   Ferreira, Joao L.
   Figueira, Joao
   Fiser, Ivan
   Foster, Bradley
   Fox, Gregory M.
   Freeman, William R.
   Garg, S. P.
   Gillies, Mark
   Glaser, David
   Goldstein, Burton G.
   Gomes, Andre M. V.
   Gonder, John R.
   Gopal, Lingam
   Gous, Petrus
   Gupta, Amod
   Gupta, Anurag
   Halperin, Lawrence
   Han, Dennis
   Hariprasad, Seenu M.
   Holz, Frank G.
   Kaiser, Peter
   Kalvodova, Bohdana
   Katz, Barrett
   Katz, Randy S.
   Kecik, Dariusz
   Kellaway, Judianne
   Klemperer, Itamar
   Kuppermann, Baruch
   Lanzetta, Paolo
   Lattanzio, Rosangela
   Lee, Won-Ki
   Lehr, John
   Leys, Monique
   Loose, Isaac
   Lotery, Andrew
   Lu, Da-Wen
   McCartney, Paul
   Majji, Ajit B.
   Martinez, Jose A.
   Massin, Pascale
   Maturi, Raj K.
   Menchini, Ugo
   Menon, Geeta
   Michels, Mark
   Midena, Edoardo
   Miller, James, Jr.
   Mitchell, Paul
   Moisseiev, Joseph
   Morse, Lawrence
   Navarro, Rafael
   Nemeth, Janos
   Newland, Henry
   Newsom, Richard
   Nichols, John
   Orellana, Juan
   Orzalesi, Nicola
   Paranhos, Augusto, Jr.
   Park, Robert
   Park, Susanna
   Parodi, Maurizio Battaglia
   Pavan, Peter R.
   Peace, James
   Perez-Ortiz, Don J.
   Pollack, Ayala
   Ramaswamy, Kim
   Ratnakaram, Ramakrishna
   Ravalico, Giuseppe
   Rehak, Jiri
   Rezaei, Kourous
   Rizzo, Stanislao
   Rodriguez-Alvira, Francisco J.
   Romanet, Jean-Paul
   Rose, Steven
   Rosen, Richard B.
   Rossetti, Luca
   Maria Ruiz-Moreno, Jose
   Sadda, SriniVas
   Sall, Kenneth
   Sandner, Dirk
   Fernandez-Vega Sanz, Alvaro
   Sartani, Gil
   Schmickler, Stefanie
   Schwartz, Steven D.
   Sharma, Y. R.
   Sheu, Shwu-Jiuan
   Singer, Michael
   Sivaprasad, Sobha
   Soubrane, Gisele
   Soucek, Petr
   Souied, Eric H.
   Staurenghi, Giovanni
   Studnicka, Jan
   Suarez-Figueroa, Marta
   Takahashi, Walter Y.
   Tognetto, Daniele
   Tsai, Patrick L.
   Ulanski, Lawrence J., II
   Uy, Harvey S.
   Varano, Monica
   Veith, Miroslav
   Vicha, Igor
   Viola, Francesco
   Visser, Linda
   Weinberger, Dov
   Wing, Glenn L.
   Wong, Edmund
   Wong, Tien Y.
   Wylegala, Edward
   Yan, Jiong
   Yoon, Young Hee
   Young, Lucy H.
   Yu, Hyeong G.
   Zimmer-Galler, Ingrid E.
CA Ozurdex MEAD Study Grp
TI Natural history of diabetic macular edema and factors predicting
   outcomes in sham-treated patients (MEAD study)
SO GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article
DE Diabetic macular edema; Natural history; Prognosis; Risk factors; Visual
   acuity
ID DEXAMETHASONE INTRAVITREAL IMPLANT; SYSTEMIC FACTORS; RISK-FACTORS;
   ANATOMIC OUTCOMES; CLINICAL-RESPONSE; GLYCEMIC CONTROL; SERUM-LIPIDS;
   RANIBIZUMAB; ASSOCIATION; 3-YEAR
AB Purpose To describe the natural history of diabetic macular edema (DME) with respect to best-corrected visual acuity (BCVA) and central retinal thickness (CRT) outcomes and to identify baseline patient characteristics and systemic factors associated with improvement or worsening of outcomes in sham-treated patients. Methods The study population was sham-treated patients (n = 350) in the 3-year MEAD registration study of dexamethasone intravitreal implant for treatment of DME. Patients had center-involved DME and received sham intravitreal injections in the study eye at >= 6-month intervals. Potential prognostic factors for outcomes were evaluated using multiple linear regression analysis. Results Visual and anatomic outcomes were poorer in patients who left the study early (n = 198) than in study completers (n = 152). Mean change in BCVA from baseline at the last visit with available data was + 0.9 letters; 37.5% of patients had no change in BCVA, 23.2% had gained > 10 letters, and 16.0% had lost > 10 letters. Older age and baseline diabetic retinopathy score > 6 were associated with worse BCVA outcomes; thicker baseline CRT and larger number of hypertension medications used were associated with larger reductions in CRT during the study. Conclusions BCVA and CRT outcomes were variable in this population of DME patients with generally good glycemic control. In DME patients without active treatment, older age and baseline diabetic retinopathy score > 6 were associated with less improvement in BCVA; thicker baseline CRT and a larger number of antihypertensive medications used predicted better improvement in CRT.
C1 [Yoon, Young Hee] Asan Med Ctr, Dept Ophthalmol, 88 Olymp Ro 43 Gil, Seoul, South Korea.
   [Boyer, David S.] Retina Vitreous Associates Med Grp, Los Angeles, CA USA.
   [Maturi, Raj K.] Midwest Eye Inst, Indianapolis, IN USA.
   [Maturi, Raj K.] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA.
   [Bandello, Francesco] Univ Vita Salute, Hosp San Raffaele, Milan, Italy.
   [Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.
   [Augustin, Albert J.] Staedt Klinikum Karlsruhe, Dept Ophthalmol, Karlsruhe, Germany.
   [Li, Xiao-Yan; Hashad, Yehia] Allergan Plc, Irvine, CA USA.
   [Bai, Zhanying] Allergan Plc, Bridgewater, NJ USA.
   [Abujamra, Suel] Eye Clin Doctor Suel Abujamra, Sao Paulo, Brazil.
   [Acton, James] Dr J Acton, Cape Town, South Africa.
   [Ali, Fareed] Canadian Ctr Adv Eye Therapeut, Mississauga, ON, Canada.
   [Antoszyk, Andrew] Charlotte Eye Ear Nose & Throat Associates, Charlotte, NC USA.
   [Augustin, Albert J.] Stadt Klinikum Karlsruhe, Karlsruhe, Germany.
   [Awh, Carl C.] Tennessee Retina, Nashville, TN USA.
   [Barak, Adiel] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel.
   [Bartz-Schmidt, Karl Ulrich] Univ Eye Hosp Tubingen, Tubingen, Germany.
   [Baumal, Caroline R.] Tufts Med Ctr, Boston, MA 02111 USA.
   [Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Bhende, Muna] Sankara Nethralaya, Chennai, Tamil Nadu, India.
   [Bridges, William Z., Jr.] Western Carolina Retinal Associates, Asheville, NC USA.
   [Brown, David M.] Vitreoretinal Consultants, Houston, TX USA.
   [Carmichael, Trevor] Wits Donald Gordon Med Ctr, Johannesburg, South Africa.
   [Carnevale, Ken] Ophthalm Consultants Long Isl, Lynbrook, NY USA.
   [Casella, Antonio M.] Fed Univ Londrina, Londrina, Parana, Brazil.
   [Chang, Tom; Chong, Lawrence P.; Eliott, Dean] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA.
   [Chechik, Daniel; Engel, Harry M.; Katz, Barrett] Henkind Eye Inst, Bronx, NY USA.
   [Chen, San-Ni] Changhua Christian Hosp, Changhua, Taiwan.
   [Chong, Victor] Kings Coll Hosp London, London, England.
   [Corwin, Joel] Miramar Eye Specialists Med Grp, Ventura, CA USA.
   [Creuzot-Garcher, Catherine] Hop Dijon, Dijon, France.
   [Cruess, Alan] Capital Hlth, Halifax, NS, Canada.
   [Daniell, Mark] Royal Melbourne Hosp, Parkville, Vic, Australia.
   [de Avila, Marcos P.] Brazilian Ctr Eye Surg, Goiania, Go, Brazil.
   [de Moraes, Haroldo Vieira, Jr.] Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.
   [Devenyi, Robert G.] Toronto Western Hosp, Toronto, ON, Canada.
   [Doft, Bernard H.] Retina Vitreous Consultants, Pittsburgh, PA USA.
   [Donaldson, Mark] Greenlane Clin Ctr, Auckland, New Zealand.
   [Dreyer, Richard] Retina Northwest PC, Portland, OR USA.
   [Ernest, Jan] Cent Mil Hosp, Prague, Czech Republic.
   [Essman, Thomas F.] Mercy Clin Eye Specialists, Springfield, MO USA.
   [Falcone, Philip M.] Connecticut Retina Consultants, Bridgeport, CT USA.
   [Fekrat, Sharon] Duke Univ, Ctr Eye, Durham, NC USA.
   [Ferencz, Joseph R.] Meir Med Ctr, Kefar Sava, Israel.
   [Ferreira, Joao L.] Vista Med Olhos, Florianopolis, SC, Brazil.
   [Figueira, Joao] Assoc Innovat & Biomed Res Light & Image, Coimbra, Portugal.
   [Fiser, Ivan] Cornea Lexum Eye Clin, Prague, Czech Republic.
   [Foster, Bradley] New England Retina Consultants, Springfield, MA USA.
   [Fox, Gregory M.] Retina Associates PA, Shawnee Mission, KS USA.
   [Freeman, William R.] Univ Calif San Diego, Jacobs Retina Ctr, La Jolla, CA USA.
   [Garg, S. P.] Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.
   [Gillies, Mark] Sydney Eye Hosp, Sydney, NSW, Australia.
   [Glaser, David] Retina Associates St Louis, Florissant, MO USA.
   [Goldstein, Burton G.] Univ S Florida, Dept Ophthalmol, Tampa, FL USA.
   [Gomes, Andre M. V.] Eye Clin Doctor Suel Abujamra, Sao Paulo, Brazil.
   [Gonder, John R.] Ivey Eye Inst, London, ON, Canada.
   [Gopal, Lingam] Sankara Nethralaya, Chennai, Tamil Nadu, India.
   [Gous, Petrus] Pretoria Eye Inst, Pretoria, South Africa.
   [Gupta, Amod] Adv Eye Care Ctr, Chandigarh, India.
   [Gupta, Anurag] Doris Stein Eye Res Ctr, Los Angeles, CA USA.
   [Halperin, Lawrence] Retina Grp Florida, Ft Lauderdale, FL USA.
   [Han, Dennis] Med Coll Wisconsin, Inst Eye, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.
   [Hariprasad, Seenu M.] Univ Chicago, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA.
   [Holz, Frank G.] Univ Bonn, Bonn, Germany.
   [Kaiser, Peter] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.
   [Kalvodova, Bohdana] Gen Teaching Hosp, Ophthalmol Clin, Prague, Czech Republic.
   [Katz, Randy S.] Florida Eye Microsurg Inst, Boynton Beach, FL USA.
   [Kecik, Dariusz] Med Univ Warsaw, Warsaw, Poland.
   [Kellaway, Judianne] Texas Med Ctr, Houston, TX USA.
   [Klemperer, Itamar] Soroka Univ Med Ctr, Beer Sheva, Israel.
   [Kuppermann, Baruch] Univ Calif Irvine, Med Ctr, Orange, CA USA.
   [Lanzetta, Paolo] Univ Hosp Univ Udine, Udine, Italy.
   [Lattanzio, Rosangela] San Raffaele Fdn Monte Tabor, Milan, Italy.
   [Lee, Won-Ki] Catholic Univ Korea, St Marys Hosp, Seoul, South Korea.
   [Lehr, John] Magruder Eye Inst, Orlando, FL USA.
   [Leys, Monique] West Virginia Univ, Inst Eye, Morgantown, WV 26506 USA.
   [Loose, Isaac] Retina Res Ctr, Austin, TX USA.
   [Lotery, Andrew; Newsom, Richard] Southampton Gen Hosp, Southampton, Hants, England.
   [Lu, Da-Wen] Triserv Gen Hosp, Taipei, Taiwan.
   [McCartney, Paul] Hobart Eye Surg, Hobart, Tas, Australia.
   [Majji, Ajit B.] LV Prasad Eye Inst, Hyderabad, Andhra Pradesh, India.
   [Martinez, Jose A.] Austin Retina Associates, Austin, TX USA.
   [Massin, Pascale] Natl Hosp Ophthalmol CHNO Quinze Vingts, Paris, France.
   [Menchini, Ugo] Careggi Univ Hosp, Florence, Italy.
   [Menon, Geeta] Frimley Pk Hosp, Camberley, Surrey, England.
   [Michels, Mark] Retina Care Specialists, Palm Beach Gardens, FL USA.
   [Midena, Edoardo] Padova Univ Hosp, Padua, Italy.
   [Miller, James, Jr.] Southeastern Retina Associates, Knoxville, TN USA.
   [Mitchell, Paul] Westmead Hosp, Westmead Eye Clin, Westmead, NSW, Australia.
   [Moisseiev, Joseph] Goldschleger Eye Inst Sheba Med Ctr, Tel Hashomer, Israel.
   [Morse, Lawrence; Park, Susanna] Univ Calif Davis, Med Ctr, Sacramento, CA USA.
   [Navarro, Rafael] Inst Microcirugia Ocular, Barcelona, Spain.
   [Nemeth, Janos] Semmelweis Univ, Budapest, Hungary.
   [Newland, Henry] Royal Adelaide Hosp, Adelaide, SA, Australia.
   [Nichols, John; Park, Robert] Univ Arizona, Tucson, AZ USA.
   [Orellana, Juan] Virginia Commonwealth Univ, Richmond, VA USA.
   [Orzalesi, Nicola] San Paolo Hosp, Milan, Italy.
   [Paranhos, Augusto, Jr.] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
   [Parodi, Maurizio Battaglia; Ravalico, Giuseppe] Univ Trieste, Eye Clin, Trieste, Italy.
   [Pavan, Peter R.] Univ S Florida, Dept Ophthalmol, Tampa, FL USA.
   [Peace, James] United Med Res Inst, Inglewood, CA USA.
   [Perez-Ortiz, Don J.] Perez Eye Ctr, Tampa, FL USA.
   [Pollack, Ayala] Kaplan Med Ctr, Rehovot, Israel.
   [Ramaswamy, Kim] Aravind Eye Hosp, Chennai, Tamil Nadu, India.
   [Ratnakaram, Ramakrishna] Univ Florida, Gainesville, FL USA.
   [Rehak, Jiri] Univ Hosp Olomouc, Olomouc, Czech Republic.
   [Rezaei, Kourous] Univ Chicago, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA.
   [Rizzo, Stanislao] Pisana Univ Hosp, Pisa, Italy.
   [Rodriguez-Alvira, Francisco J.] Fdn Oftalmol Nacl, Bogota, Colombia.
   [Romanet, Jean-Paul] Grenoble Univ Hosp Ctr, Grenoble, France.
   [Rose, Steven] Rochester Ophthalmol Grp, Rochester, NY USA.
   [Rosen, Richard B.] New York Eye & Ear Infirm, New York, NY 10003 USA.
   [Rossetti, Luca] San Paolo Hosp, Milan, Italy.
   [Maria Ruiz-Moreno, Jose] VISSUM Ophthalmol Inst Alicante, Alicante, Spain.
   [Sadda, SriniVas] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA.
   [Sall, Kenneth] Sall Res Med Ctr, Artesia, CA USA.
   [Sandner, Dirk] Univ Eye Clin Dresden, Dresden, Germany.
   [Fernandez-Vega Sanz, Alvaro] Inst Oftalmol Alicante Vissum, Alicante, Spain.
   [Sartani, Gil] HaEmek Med Ctr, Afula, Israel.
   [Schmickler, Stefanie] Augenarzte Gemeinschaftspraxis, Ahaus, Germany.
   [Schwartz, Steven D.] Doris Stein Eye Res Ctr, Los Angeles, CA USA.
   [Sharma, Y. R.] Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.
   [Sheu, Shwu-Jiuan] Vet Gen Hosp Kaohsiung, Kaohsiung, Taiwan.
   [Singer, Michael] Med Ctr Ophthalmol Associates, San Antonio, TX USA.
   [Sivaprasad, Sobha] Kings Coll Hosp London, London, England.
   [Soubrane, Gisele; Souied, Eric H.] Ctr Hosp Intercommunal Creteil, Creteil, France.
   [Soucek, Petr] Univ Hosp Kralovske, Prague, Czech Republic.
   [Staurenghi, Giovanni] Luigi Sacco Hosp, Milan, Italy.
   [Studnicka, Jan] Univ Hosp Hradec Kralove, Eye Clin, Hradec Kralove, Czech Republic.
   [Suarez-Figueroa, Marta] Hosp Oftalmol Madrid Vissum, Madrid, Spain.
   [Takahashi, Walter Y.] Univ Sao Paulo, Fac Med, Clin Hosp, Sao Paulo, Brazil.
   [Tognetto, Daniele] Univ Trieste, Eye Clin, Trieste, Italy.
   [Tsai, Patrick L.] Univ Arizona, Tucson, AZ USA.
   [Ulanski, Lawrence J., II] Univ Illinois, Chicago, IL USA.
   [Uy, Harvey S.] Asian Eye Inst, Makati, Philippines.
   [Varano, Monica] GB Bietti Fdn Study & Res Ophthalmol, Rome, Italy.
   [Veith, Miroslav] Univ Hosp Kralovske, Prague, Czech Republic.
   [Vicha, Igor] Fac Hosp Brno, Ophthalmol Clin, Brno, Czech Republic.
   [Viola, Francesco] Osped Maggiore Policlin Mangiagalli & Regina Elen, Milan, Italy.
   [Visser, Linda] Univ KwaZulu Natal, Durban, South Africa.
   [Weinberger, Dov] Rabin Med Ctr, Petah Tiqwa, Israel.
   [Wing, Glenn L.] Natl Ophthalm Res Inst, Ft Myers, FL USA.
   [Wong, Edmund] Singapore Natl Eye Ctr, Singapore, Singapore.
   [Wong, Tien Y.] Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia.
   [Wylegala, Edward] Dist Railway Hosp Katowice, Katowice, Poland.
   [Yan, Jiong] Emory Univ, Ctr Eye, Atlanta, GA 30322 USA.
   [Yoon, Young Hee] Asan Med Ctr, Seoul, South Korea.
   [Young, Lucy H.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA.
   [Yu, Hyeong G.] Seoul Natl Univ Hosp, Seoul, South Korea.
   [Zimmer-Galler, Ingrid E.] Johns Hopkins Wilmer Eye Inst, Baltimore, MD USA.
RP Yoon, YH (corresponding author), Asan Med Ctr, Dept Ophthalmol, 88 Olymp Ro 43 Gil, Seoul, South Korea.
EM yhyoon@amc.seoul.kr
RI Midena, Edoardo/AAB-6010-2020; Daniell, Mark/AAS-1363-2020; Wong, Tien
   Y/AAC-9724-2020; Varano, Monica/K-8573-2016; viola,
   francesco/AAK-5583-2020; bandello, francesco/AAH-2405-2019
OI Daniell, Mark/0000-0001-9528-7005; Wong, Tien Y/0000-0002-8448-1264;
   viola, francesco/0000-0003-1208-913X; bandello,
   francesco/0000-0003-3238-9682
FU Allergan plc, Dublin, Ireland; AllerganAllergan
FX This study was sponsored by Allergan plc, Dublin, Ireland. Y.H. Yoon,
   D.S. Boyer, R.K. Maturi, F. Bandello, and R. Belfort Jr. are consultants
   to Allergan. A.J. Augustin has received research support and speaker
   fees from Allergan. X.-Y. Li, Z. Bai, and Y. Hashad are employees of
   Allergan. The authors have full control of all primary data and they
   agree to allow Graefe's Archive for Clinical and Experimental
   Ophthalmology to review their data upon request.
CR Ajoy MVK, 2011, INDIAN J OPHTHALMOL, V59, P207, DOI 10.4103/0301-4738.81029
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   American Academy of Ophthalmology, 2017, DIAB RET PREF PRACT
   [Anonymous], 1991, Ophthalmology, V98, P823
   Augustin AJ, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0148-2
   Bansal AS, 2015, OPHTHALMOLOGY, V122, P1573, DOI 10.1016/j.ophtha.2015.04.029
   Boyer DS, 2014, OPHTHALMOLOGY, V121, P1904, DOI 10.1016/j.ophtha.2014.04.024
   Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034
   Danis RP, 2016, BRIT J OPHTHALMOL, V100, P796, DOI 10.1136/bjophthalmol-2015-306823
   Diep TM, 2013, DIABETES RES CLIN PR, V100, P298, DOI 10.1016/j.diabres.2013.01.011
   Do DV, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006127.pub2
   Fong DS, 2009, AM J OPHTHALMOL, V147, P583, DOI 10.1016/j.ajo.2008.10.016
   Gower EW, 2018, AM J OPHTHALMOL, V187, P138, DOI 10.1016/j.ajo.2017.12.007
   Kawasaki R, 2018, DIABETES OBES METAB, V20, P2351, DOI 10.1111/dom.13372
   Khan HA, 2007, CLIN EXP MED, V7, P24, DOI 10.1007/s10238-007-0121-3
   Macky TA, 2013, EUR J OPHTHALMOL, V23, P94, DOI 10.5301/ejo.5000179
   Matsuda S, 2014, J DIABETES COMPLICAT, V28, P166, DOI 10.1016/j.jdiacomp.2013.11.009
   Maturi RK, 2016, RETINA-J RET VIT DIS, V36, P1143, DOI 10.1097/IAE.0000000000001004
   Miljanovic B, 2004, DIABETES, V53, P2883, DOI 10.2337/diabetes.53.11.2883
   Ou WC, 2017, AM J OPHTHALMOL, V180, P8, DOI 10.1016/j.ajo.2017.05.014
   PERKOVICH BT, 1988, AM J OPHTHALMOL, V105, P211, DOI 10.1016/0002-9394(88)90190-0
   Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039
   Romero-Aroca P, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2156273
   Ryan EH, 2006, RETINA-J RET VIT DIS, V26, P562, DOI 10.1097/00006982-200605000-00011
   Shi R, 2018, INT J OPHTHALMOL-CHI, V11, P287, DOI 10.18240/ijo.2018.02.18
   Singh RP, 2016, OPHTHALMOLOGY, V123, P1581, DOI 10.1016/j.ophtha.2016.03.038
   Sophie R, 2015, OPHTHALMOLOGY, V122, P1395, DOI 10.1016/j.ophtha.2015.02.036
   Wong TY, 2018, OPHTHALMOLOGY, V125, P1608, DOI 10.1016/j.ophtha.2018.04.007
   Yamada Y, 2013, CURR EYE RES, V38, P1261, DOI 10.3109/02713683.2013.820327
   Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909
   Zhang X, 2017, AM J MED SCI, V354, P355, DOI 10.1016/j.amjms.2017.07.003
NR 31
TC 0
Z9 0
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0721-832X
EI 1435-702X
J9 GRAEF ARCH CLIN EXP
JI Graefes Arch. Clin. Exp. Ophthalmol.
PD DEC
PY 2019
VL 257
IS 12
BP 2639
EP 2653
DI 10.1007/s00417-019-04464-2
EA OCT 2019
PG 15
WC Ophthalmology
SC Ophthalmology
GA JO0HP
UT WOS:000492583600002
PM 31654188
OA Other Gold
DA 2020-12-01
ER

PT J
AU Senter, G
   Do Nascimento, HM
   Belfort, R
AF Senter, Gabrielle
   Do Nascimento, Heloisa Moraes
   Belfort Junior, Rubens
TI Acute Retinal Necrosis: Is The Current Valacyclovir Regimen Adequate?
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Letter
DE Acute retinal necrosis syndrome; antiviral agents; posterior uveitis;
   retinal detachment; valacyclovir
ID VALACICLOVIR
AB Acute Retinal Necrosis (ARN) is a potentially devastating form of Uveitis. Antivirals are the mainstay treatment for this syndrome. In this letter, we question the current oral Valacyclovir dosage, based on the experience we had with a recent unresponsive ARN case.
C1 [Senter, Gabrielle; Do Nascimento, Heloisa Moraes; Belfort Junior, Rubens] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
RP Senter, G (corresponding author), Rua Botucatu 821, BR-04023062 Sao Paulo, Brazil.
EM gabismed@gmail.com
RI Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317
CR Baltinas J, 2018, AM J OPHTHALMOL, V188, P173, DOI 10.1016/j.ajo.2018.02.001
   Guex-Crosier Y, 2006, EYE, V20, P247, DOI 10.1038/sj.eye.6701821
   Lee JH, 2017, SURV OPHTHALMOL, V62, P404, DOI 10.1016/j.survophthal.2016.12.008
   Schoenberger SD, 2017, OPHTHALMOLOGY, V124, P382, DOI 10.1016/j.ophtha.2016.11.007
   WELLER S, 1993, CLIN PHARMACOL THER, V54, P595, DOI 10.1038/clpt.1993.196
NR 5
TC 0
Z9 0
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PY 2020
VL 28
IS 4
BP 665
EP 666
DI 10.1080/09273948.2019.1616771
EA AUG 2019
PG 2
WC Ophthalmology
SC Ophthalmology
GA MV9EF
UT WOS:000481115700001
PM 31401907
DA 2020-12-01
ER

PT J
AU Berezovsky, A
   Bueno, TN
   Ferraz, NN
   Sacai, PY
   Botelho, GI
   Fernandes, A
   Coupland, S
   Belfort, R
   Sadun, AA
   Karanjia, R
   Salomao, SR
AF Berezovsky, Adriana
   Bueno, Tatiane N.
   Ferraz, Nivea Nunes
   Sacai, Paula Y.
   Botelho, Gabriel I.
   Fernandes, Arthur
   Coupland, Stuart
   Belfort, Rubens, Jr.
   Sadun, Alfredo A.
   Karanjia, Rustum
   Salomao, Solange Rios
TI Photopic Negative Response in Healthy Adults: Normative Values and
   Test-Retest Reliability
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY APR 28-MAY 02, 2019
CL Vancouver, CANADA
SP Assoc Res Vis & Ophthalmol
C1 [Berezovsky, Adriana; Bueno, Tatiane N.; Ferraz, Nivea Nunes; Sacai, Paula Y.; Botelho, Gabriel I.; Fernandes, Arthur; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo, Dept Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Coupland, Stuart; Karanjia, Rustum] Univ Ottawa, Ottawa Eye Inst, Ottawa, ON, Canada.
   [Coupland, Stuart; Karanjia, Rustum] Ottawa Hosp Res Inst, Ottawa, ON, Canada.
   [Sadun, Alfredo A.] Univ Calif Los Angeles, David Geffen Sch Med, Ophthalmol, Los Angeles, CA 90095 USA.
   [Sadun, Alfredo A.] Doheny Eye Inst, Los Angeles, CA 90033 USA.
RI Sacai, Paula Y/B-6525-2014; Ferraz, Nivea/AAC-2439-2020; Berezovsky,
   Adriana/F-2341-2013
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/05869-9];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]
FX Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant
   #2018/05869-9 to AB). This study was financed in part by the Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) -
   Finance Code 001.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2019
VL 60
IS 9
MA 2499
PG 3
WC Ophthalmology
SC Ophthalmology
GA JB5TF
UT WOS:000488628106049
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU de Oliveira, DR
   Ventura, CV
   Esporcatte, BLB
   Gracitelli, CPB
   Dias, NDC
   Ventura, LO
   Belfort, R
   Rolim-de-Moura, C
AF de Oliveira, Daniela R.
   Ventura, Camila V.
   Esporcatte, Bruno L. B.
   Gracitelli, Carolina P. B.
   Dias, Natalia D. C.
   Ventura, Liana O.
   Belfort, Rubens, Jr.
   Rolim-de-Moura, Christiane
TI Glaucoma Workup in Congenital Zika Syndrome
SO JOURNAL OF GLAUCOMA
LA English
DT Letter
ID OPHTHALMIC MANIFESTATIONS; INFANTS
C1 [de Oliveira, Daniela R.; Esporcatte, Bruno L. B.; Gracitelli, Carolina P. B.; Belfort, Rubens, Jr.; Rolim-de-Moura, Christiane] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
   [Ventura, Camila V.; Dias, Natalia D. C.; Ventura, Liana O.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
RP de Oliveira, DR (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
OI de Oliveira, Daniela/0000-0002-9951-644X
CR Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Rossi AD, 2019, J INTERN MED, V285, P215, DOI 10.1111/joim.12829
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 7
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1057-0829
EI 1536-481X
J9 J GLAUCOMA
JI J. Glaucoma
PD JUL
PY 2019
VL 28
IS 7
BP E131
EP E131
DI 10.1097/IJG.0000000000001253
PG 1
WC Ophthalmology
SC Ophthalmology
GA IJ5IM
UT WOS:000475936400026
PM 30921276
DA 2020-12-01
ER

PT J
AU Furtado, JM
   Berezovsky, A
   Ferraz, NN
   Munoz, S
   Fernandes, AG
   Watanabe, SS
   Cunha, CC
   Vasconcelos, GC
   Sacai, PY
   Cypel, M
   Mitsuhiro, MH
   Morales, PH
   Cohen, MJ
   Campos, M
   Cohen, JM
   Belfort, R
   Salomao, SR
AF Furtado, Joao M.
   Berezovsky, Adriana
   Ferraz, Nivea N.
   Munoz, Sergio
   Fernandes, Arthur G.
   Watanabe, Sung S.
   Cunha, Cristina C.
   Vasconcelos, Galton C.
   Sacai, Paula Y.
   Cypel, Marcela
   Mitsuhiro, Marcia H.
   Morales, Paulo H.
   Cohen, Marcos J.
   Campos, Mauro
   Cohen, Jacob M.
   Belfort Jr, Rubens
   Salomao, Solange R.
TI Prevalence and Causes of Visual Impairment and Blindness in Adults Aged
   45 Years and Older from Parintins: The Brazilian Amazon Region Eye
   Survey
SO OPHTHALMIC EPIDEMIOLOGY
LA English
DT Article
DE visual impairment; blindness; prevalence; cataract; refractive error
ID CATARACT-SURGERY; VISION IMPAIRMENT; HEALTH; OPHTHALMOLOGISTS;
   MORTALITY; DISTANCE; COST
AB Purpose: To determine the prevalence and causes of visual impairment and blindness in adults aged 45 years and older from Parintins, Brazilian Amazon Region. Methods: A random cluster sampling method was used to identify subjects 45 years of age and older from urban and rural census sectors of Parintins city, Amazonas State, from March 2014 to May 2015. Participants underwent a detailed ocular examination, including presenting (PVA) and best corrected visual acuity (BCVA). The main cause of PVAResults: A total of 2384 subjects were enumerated and 2041 (85.6%) examined. The prevalence of presenting mild visual impairment - MiVI (<20/32 - >= 20/63) in the better-seeing eye was 17.0% [95% CI: 15.3-18.7%], and 8.5% [95% CI: 7.3-9.7%] with best correction. The prevalence of presenting moderate visual impairment - MVI (<20/63 - >= 20/200) was 18.4% [95% CI: 16.2-20.6%], and 6.9% [95% CI: 5.8-8.0%] with best correction. The prevalence of presenting bilateral VA <20/200 was 4.3% [95% CI: 3.6-5.0%], and 3.3% [95% CI: 2.5-4.0%] with best correction and increased with older age. Cataract (47.8%) and glaucoma (7.5%) were its main causes. In less severely affected eyes, uncorrected refractive errors (MVI: 42.6%; MiVI: 79.0%), cataract (MVI: 40.6%; MiVI: 13.7%) and pterygium (MVI: 7.6%; MiVI: 2.7%) were the main causes. Conclusions: Most cases of visual impairment in Parintins are either preventable or treatable, and public health initiatives should target cataract surgical services and refraction with spectacle provision.
C1 [Furtado, Joao M.; Berezovsky, Adriana; Ferraz, Nivea N.; Fernandes, Arthur G.; Watanabe, Sung S.; Cunha, Cristina C.; Vasconcelos, Galton C.; Sacai, Paula Y.; Cypel, Marcela; Mitsuhiro, Marcia H.; Morales, Paulo H.; Campos, Mauro; Belfort Jr, Rubens; Salomao, Solange R.] Univ Fed Sao Paulo, UNIFESP, Escola Paulista Med, Dept Oftalmol & Ciencias Visuals, Sao Paulo, SP, Brazil.
   [Furtado, Joao M.] Univ Sao Paulo, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
   [Cunha, Cristina C.] Univ Fed Para UFPA, Fac Med, Belem, Para, Brazil.
   [Vasconcelos, Galton C.] Univ Fed Minas Gerais, Dept Oftalmol & Otorrinolaringol, Fac Med, Belo Horizonte, MG, Brazil.
   [Cohen, Marcos J.; Cohen, Jacob M.] Univ Fed Amazonas UFAM, Div Oftalmol, Dept Cirurgia, Fac Med, Manaus, Amazonas, Brazil.
RP Salomao, SR (corresponding author), Univ Fed Sao Paulo, Dept Oftalmol & Ciencias Visuais, Escola Paulista Med, Rua Botucatu 822, BR-04023062 Sao Paulo, Brazil.
EM ssalomao@unifesp.br
RI Berezovsky, Adriana/F-2341-2013; de Queiroz Campos, Mauro
   Silveira/H-7609-2017; Ferraz, Nivea/AAC-2439-2020; Sacai, Paula
   Y/B-6525-2014
OI Berezovsky, Adriana/0000-0001-6350-8221; de Queiroz Campos, Mauro
   Silveira/0000-0002-9448-8742; Ferraz, Nivea/0000-0001-7568-6199; Sacai,
   Paula Yuri/0000-0001-9224-857X; Watanabe, Sung/0000-0001-6553-8117;
   Furtado, Joao M./0000-0003-2490-5747; Fernandes, Arthur
   Gustavo/0000-0002-7525-1838; Munoz, Sergio/0000-0001-8383-6599; Cunha,
   Cristina/0000-0001-7508-5641
FU Instituto da Visao - IPEPO, Sao Paulo, SP; Fundacao Piedade Cohen,
   Manaus, AM; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - CNPq, Brasilia, Brasil, Programa Ciencia sem Fronteiras
   [402120/2012-4]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo,
   FAPESP, Sao Paulo, BrasilFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2013/16397-7]; SightFirst Program - Lions Club
   International Foundation [1758]
FX This paper was funded by Instituto da Visao - IPEPO, Sao Paulo, SP;
   Fundacao Piedade Cohen, Manaus, AM; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico - CNPq, Brasilia, Brasil, Programa Ciencia sem
   Fronteiras (Grant #402120/2012-4 to SRS, SM and JMF; Research
   Scholarships to SRS and RBJ); Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo, FAPESP, Sao Paulo, Brasil (Grant #2013/16397-7 to SRS);
   SightFirst Program - Lions Club International Foundation (Grant #1758 to
   SRS). The sponsor or funding organization had no role in the design or
   conduct of this research.
CR Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0
   Brown GC, 2013, OPHTHALMOLOGY, V120, P2367, DOI 10.1016/j.ophtha.2013.04.030
   Carvalho RD, 2012, ARQ BRAS OFTALMOL, V75, P407, DOI 10.1590/S0004-27492012000600007
   Conselho Brasileiro de Oftalmologia, 2014, CENS CBO 2014
   Conselho Brasileiro de Oftalmologia, 2015, MAIS AC SAUD OC
   Conselho Federal de Medicina, 2018, RAD ESC MED BRAS
   COOK CD, 1993, S AFR MED J, V83, P590
   Danquah L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094140
   Duvivier RJ, 2014, MED EDUC, V48, P860, DOI 10.1111/medu.12499
   Eckert KA, 2015, OPHTHAL EPIDEMIOL, V22, P349, DOI 10.3109/09286586.2015.1066394
   Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5
   Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002
   Gan SH, 2018, OPHTHAL EPIDEMIOL, V25, P331, DOI 10.1080/09286586.2018.1476557
   Hong H, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012819
   Instituto Brasileiro de Geografia e Estatistica, 2010, CAR POP DOM RES U
   Kuper Hannah, 2006, Community Eye Health, V19, P68
   Arieta CEL, 2009, OPHTHAL EPIDEMIOL, V16, P58, DOI 10.1080/09286580802575032
   Murthy G, 2012, EPIDEMIOLOGY EYE DIS, P3
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539
   Paula JS, 2006, EYE, V20, P533, DOI 10.1038/sj.eye.6701917
   Polack S, 2012, OPHTHALMOLOGY, V119, P1033, DOI 10.1016/j.ophtha.2011.11.002
   Polack S, 2010, OPHTHAL EPIDEMIOL, V17, P387, DOI 10.3109/09286586.2010.528136
   Ramke J, 2018, OPHTHAL EPIDEMIOL, V25, P379, DOI 10.1080/09286586.2018.1500613
   Rao GN, 2015, EYE, V29, P30, DOI 10.1038/eye.2014.239
   Resnikoff S, 2012, BRIT J OPHTHALMOL, V96, P783, DOI 10.1136/bjophthalmol-2011-301378
   Salomao SR, 2008, OPHTHAL EPIDEMIOL, V15, P167, DOI 10.1080/09286580701843812
   Salomao SR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19338-6
   Salomao SR, 2017, OPHTHAL EPIDEMIOL, V24, P257, DOI 10.1080/09286586.2016.1276199
   Schellini SA, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-8
   Stata Corporation, 2015, STATE SE STAT SOFTW
   Taylor HR, 2007, AM J OPHTHALMOL, V143, P561, DOI 10.1016/j.ajo.2006.10.055
   Tseng VL, 2018, JAMA OPHTHALMOL, V136, P3, DOI 10.1001/jamaophthalmol.2017.4512
   Tseng VL, 2016, OPHTHALMOLOGY, V123, P1019, DOI 10.1016/j.ophtha.2015.12.033
   United Nations Development Programme, 2010, RANK IDHM MUN 2010
NR 35
TC 5
Z9 5
U1 1
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0928-6586
EI 1744-5086
J9 OPHTHAL EPIDEMIOL
JI Ophthalmic Epidemiol.
PD SEP 3
PY 2019
VL 26
IS 5
BP 345
EP 354
DI 10.1080/09286586.2019.1624783
EA JUN 2019
PG 10
WC Ophthalmology
SC Ophthalmology
GA JC4FV
UT WOS:000471376300001
PM 31161839
DA 2020-12-01
ER

PT J
AU de Oliveira, DR
   Ventura, CV
   Esporcatte, BLB
   Gracitelli, CPB
   Dias, ND
   Ventura, LO
   Belfort, R
   Rolim-de-Moura, C
AF de Oliveira, Daniela R.
   Ventura, Camila V.
   Esporcatte, Bruno L. B.
   Gracitelli, Carolina P. B.
   Dias, Natalia de Carvalho
   Ventura, Liana O.
   Belfort, Rubens, Jr.
   Rolim-de-Moura, Christiane
TI Glaucoma Workup in Congenital Zika Syndrome
SO JOURNAL OF GLAUCOMA
LA English
DT Article
DE congenital glaucoma; Zika virus; ocular manifestations; microcephaly;
   congenital Zika syndrome
ID INTRAOCULAR-PRESSURE; OPHTHALMIC MANIFESTATIONS; SPECTRAL-DOMAIN; VIRUS;
   INFANTS; DISC
AB Purpose: The main aim of this study was to perform a glaucoma workup in infants with congenital Zika syndrome (CZS). Patient and Methods: This cross-sectional study included 188 eyes of 107 children (1.1 +/- 0.3 y; range, 0.3 to 1.8 y) with CZS. The confirmation of the syndrome was possible in 77 of 107 (72.0%) of the enrolled infants based on positive immunoglobulin M antibody capture enzyme-linked immunosorbent assay for Zika virus in the cerebrospinal fluid. All infants underwent a complete ophthalmic examination and bilateral fundus imaging was captured using a wide-angle digital fundus camera (RetCam). Results: Five eyes (2.6%) presented 2 criteria for glaucoma diagnosis: 1 eye (0.5%) presented increased intraocular pressure and increased vertical cup-to-disc ratio (CDR); 3 eyes (1.6%) presented increased horizontal corneal diameter and increased vertical, and 1 eye (0.5%) presented myopia related to increased axial length and increased vertical CDR. When excluding the CDR criterion, there was no case of glaucoma in this sample. A significant correlation was observed between high vertical CDR and small cephalic perimeter at birth (P=0.002) and the presence of clinical macular lesions (P=0.031). Conclusion and Relevance: Although childhood glaucoma was not detected in this sample, increased vertical CDR is present in children with CZS, associated with microcephaly and clinical macular lesions at birth. This finding may lead to a misdiagnosis of glaucoma.
C1 [de Oliveira, Daniela R.; Esporcatte, Bruno L. B.; Gracitelli, Carolina P. B.; Belfort, Rubens, Jr.; Rolim-de-Moura, Christiane] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Rua Botucatu 821 Vila Clementino, BR-04023062 Sao Paulo, SP, Brazil.
   [Ventura, Camila V.; Dias, Natalia de Carvalho; Ventura, Liana O.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] Hope Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
RP de Oliveira, DR (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Rua Botucatu 821 Vila Clementino, BR-04023062 Sao Paulo, SP, Brazil.
EM dani_raposo@hotmail.com
RI de Moura, Christiane R Rolim/P-2489-2015; Ventura, Camila V/N-2654-2018;
   Ventura, Liana Vieira O/N-6151-2018
OI de Moura, Christiane R Rolim/0000-0002-0636-8100; Ventura, Camila
   V/0000-0002-2927-4684; Ventura, Liana Vieira O/0000-0001-6529-6883; de
   Oliveira, Daniela/0000-0002-9951-644X
CR Aboobakar IF, 2016, J NEURO-OPHTHALMOL, V36, P402, DOI 10.1097/WNO.0000000000000436
   Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Chan WH, 2015, ASIA-PAC J OPHTHALMO, V4, P357, DOI 10.1097/APO.0000000000000138
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Flemmons MS, 2011, J AAPOS, V15, P153, DOI 10.1016/j.jaapos.2010.11.022
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Ghate D, 2016, J NEUROL SCI, V368, P25, DOI 10.1016/j.jns.2016.06.029
   Herrerias BTF, 2011, MEASUREMENT CORNEAL
   Kim J, 2015, EYE, V29, P1167, DOI 10.1038/eye.2015.99
   Koch EC, 2017, KLIN MONBL AUGENHEIL
   Lee KM, 2014, GRAEF ARCH CLIN EXP, V252, P1853, DOI 10.1007/s00417-014-2680-9
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Murdoch IE, 1998, BRIT J OPHTHALMOL, V82, P971, DOI 10.1136/bjo.82.8.971
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Olatunji VA, 2016, SAUDI J OPHTHALMOL, V30, P185, DOI 10.1016/j.sjopt.2016.07.001
   PENSIERO S, 1992, J PEDIATR OPHTHALMOL, V29, P79, DOI 10.3928/0191-3913-19920301-05
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   RICHARDS.KT, 1968, INVEST OPHTH VISUAL, V7, P137
   RICHARDSON KT, 1966, AM J OPHTHALMOL, V62, P507, DOI 10.1016/0002-9394(66)91331-6
   SAMPAOLESI R, 1982, ARCH OPHTHALMOL-CHIC, V100, P574
   Shaffer R N, 1969, Trans Am Acad Ophthalmol Otolaryngol, V73, P923
   Sihota R, 2006, J PEDIAT OPHTH STRAB, V43, P14, DOI 10.3928/01913913-20060101-01
   Sihota R, 2006, J PEDIATR OPHTHALMOL, V43, P36
   Tamcelik N, 2014, INDIAN J OPHTHALMOL, V62, P565, DOI 10.4103/0301-4738.126988
   Uva MG, 2011, J AAPOS, V15, P367, DOI 10.1016/j.jaapos.2011.04.004
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weinreb RN, 2013, CHILDHOOD GLAUCOMA, V9
   World Health Organization, 2017, EP AL NEUR SYNDR CON
   World Health Organization, 2017, ZIK SIT REP ZIK VIR
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 35
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1057-0829
EI 1536-481X
J9 J GLAUCOMA
JI J. Glaucoma
PD APR
PY 2019
VL 28
IS 4
BP 313
EP 317
DI 10.1097/IJG.0000000000001150
PG 5
WC Ophthalmology
SC Ophthalmology
GA HU5PH
UT WOS:000465330300016
PM 30531188
DA 2020-12-01
ER

PT J
AU Marquezan, MC
   Nascimento, H
   Dalbem, D
   Muccioli, C
   Belfort, R
AF Marquezan, Maria Carolina
   Nascimento, Heloisa
   Dalbem, Daniele
   Muccioli, Cristina
   Belfort, Rubens
TI Vogt-Koyanagi-Harada Syndrome in Brazilian Children
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Article
DE Band keratopathy; children; nummular chorioretinal depigmented lesions;
   uveitis; Vogt-Koyanagi-Harada syndrome
ID REVISED DIAGNOSTIC-CRITERIA; RETINAL-DETACHMENT; VISION LOSS; DISEASE;
   UVEITIS; MANAGEMENT; EMERGENCY
AB Purpose To evaluate the characteristics of Vogt-Koyanagi-Harada (VKH) syndrome in Brazilian children. Methods Clinical data were obtained from the medical records of six children with VKH disease from March 2014 to June 2018 at the Federal University of Sao Paulo, Brazil. Results Six patients met the diagnostic criteria for VKH. The patients, who ranged in age from 5 to 8 years, all presented with chronic disease. The most common ocular finding was abnormal fundus pigmentation in five patients followed by band keratopathy in four. Two patients had glaucoma, cataract, and subretinal neovascularization. The final visual acuity was less than 20/40 in 50% of the eyes. Conclusion Visual outcomes were favorable in half of patients depending on the long-term sequelae. VKH is rarely reported in children and it may be sight-threatening, and requires careful attention, being an important differential diagnosis.
C1 [Marquezan, Maria Carolina; Nascimento, Heloisa; Dalbem, Daniele; Muccioli, Cristina; Belfort, Rubens] Univ Fed Sao Paulo, UNIFESP, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Sao Paulo, Brazil.
RP Nascimento, H (corresponding author), Univ Fed Sao Paulo, Paulista Sch Med, Sao Paulo Hosp, Dept Ophthalmol, R Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
EM helomn@gmail.com
RI Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317
CR Abu El-Asrar AM, 2008, EYE, V22, P1124, DOI 10.1038/sj.eye.6702859
   Abu El-Asrar AM, 2013, ACTA OPHTHALMOL, V91, pe486, DOI 10.1111/aos.12127
   Al Hemidan AI, 2006, EUR J OPHTHALMOL, V16, P173
   Arellanes Garcia Lourdes, 2008, Int Ophthalmol Clin, V48, P107, DOI 10.1097/IIO.0b013e31817d9b70
   Berker N, 2007, OCUL IMMUNOL INFLAMM, V15, P351, DOI 10.1080/09273940701459453
   Budmann Gustavo A, 2018, Am J Ophthalmol Case Rep, V11, P139, DOI 10.1016/j.ajoc.2018.06.022
   Cardoso IH, 2008, ARQ BRAS OFTALMOL, V71, P67, DOI 10.1590/S0004-27492008000100014
   Cunningham ET, 2000, OCUL IMMUNOL INFLAMM, V8, P251
   CUNNINGHAM ET, 1995, AM J OPHTHALMOL, V120, P675, DOI 10.1016/S0002-9394(14)72219-6
   Farah ME, 2002, AM J OPHTHALMOL, V134, P137, DOI 10.1016/S0002-9394(02)01456-3
   Fernandez DG, 2017, OCUL IMMUNOL INFLAMM, V25, P382, DOI 10.3109/09273948.2015.1132741
   Ghosh Asim Kumar, 2007, J Indian Med Assoc, V105, P212
   GRUICH MJ, 1995, PEDIATR NEUROL, V13, P50, DOI 10.1016/0887-8994(95)00112-S
   Hamade IH, 2009, BRIT J OPHTHALMOL, V93, P569, DOI 10.1136/bjo.2008.148015
   Ikeda N, 1999, OPHTHALMOLOGICA, V213, P197, DOI 10.1159/000027419
   KANSKI JJ, 1984, OPHTHALMOLOGY, V91, P1247
   Khan F, 2017, J PAK MED ASSOC, V67, P1759
   Kohnen EM, 2004, OPHTHALMOLOGE, V101, P390, DOI 10.1007/s00347-003-0792-4
   Krasny J, 1995, Cesk Slov Oftalmol, V51, P156
   Kuo IC, 2000, OPHTHALMOLOGY, V107, P1721, DOI 10.1016/S0161-6420(00)00244-X
   Lucena Daniel Rocha, 2007, Arq. Bras. Oftalmol., V70, P340, DOI 10.1590/S0004-27492007000200027
   Martin TD, 2010, RETINA-J RET VIT DIS, V30, P1113, DOI 10.1097/IAE.0b013e3181c96a87
   Murakami Shigeki, 1994, Nippon Ganka Gakkai Zasshi, V98, P389
   Nascimento H, 2015, J OPHTHALMIC INFLAMM, V5, DOI 10.1186/s12348-015-0062-z
   Paiva R, 2015, ARQ BRAS OFTALMOL, V78, P326, DOI 10.5935/0004-2749.20150086
   Perente Irfan, 2009, International Ophthalmology, V29, P33, DOI 10.1007/s10792-007-9159-1
   PERKINS ES, 1966, BRIT J OPHTHALMOL, V50, P169, DOI 10.1136/bjo.50.4.169
   Rao NA, 1997, EYE, V11, P213, DOI 10.1038/eye.1997.54
   Rathinam SR, 1998, OCUL IMMUNOL INFLAMM, V6, P155, DOI 10.1076/ocii.6.3.155.4041
   Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4
   RUTZEN AR, 1995, AM J OPHTHALMOL, V119, P239, DOI 10.1016/S0002-9394(14)73884-X
   Setiabudiawan B, 2011, ASIA PAC ALLERGY, V1, P98, DOI 10.5415/apallergy.2011.1.2.98
   Soheilian M, 2006, OCUL IMMUNOL INFLAMM, V14, P91, DOI 10.1080/09273940600557001
   Swiech-Zubilewicz Anna, 2005, Klin Oczna, V107, P511
   Tabbara KF, 1998, ACTA OPHTHALMOL SCAN, V76, P723, DOI 10.1034/j.1600-0420.1998.760619.x
   Tabbara KF, 2012, ARCH OPHTHALMOL-CHIC, V130, P394, DOI 10.1001/archopthalmol.2011.1520
   Takada S, 2015, CLIN EXP OPHTHALMOL, V43, P593, DOI 10.1111/ceo.12512
   Tian'en Z, 2003, J DERMATOL, V30, P570, DOI 10.1111/j.1346-8138.2003.tb00436.x
   TugalTutkun I, 1996, OPHTHALMOLOGY, V103, P375
   Umran RMR, 2018, MOD RHEUMATOL, V28, P197, DOI 10.3109/14397595.2015.1071234
   VALDERRAMA V, 2014, INVEST OPHTH VIS SCI, V55
   Venaille A, 2011, ARCH PEDIATRIE, V18, P33, DOI 10.1016/j.arcped.2010.09.013
   Yeh JP, 2016, PEDIATR EMERG CARE, V32, P639, DOI 10.1097/PEC.0000000000000626
   Yoshida A, 2016, CASE REP OPHTHALMOL, DOI 10.1155/2016/7936729
NR 44
TC 1
Z9 1
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PD APR 2
PY 2020
VL 28
IS 3
BP 402
EP 408
DI 10.1080/09273948.2019.1588982
EA MAR 2019
PG 7
WC Ophthalmology
SC Ophthalmology
GA LE0VT
UT WOS:000469584300001
PM 31120768
DA 2020-12-01
ER

PT J
AU Vianello, S
   de Souza, GS
   Maia, M
   Belfort, R
   Dias, JRD
AF Vianello, Silvana
   de Souza, Glaucio Silva
   Maia, Mauricio
   Belfort, Rubens, Jr.
   de Oliveira Dias, Joao Rafael
TI Ocular Findings in Yellow Fever Infection
SO JAMA OPHTHALMOLOGY
LA English
DT Article
AB IMPORTANCE Yellow fever virus (YFV) is a reemerging, potentially lethal arboviral disease that has been occurring recently in Africa and South America. Poor levels of immunization have facilitated the viral spread in southeastern Brazil, leading to an unprecedented outbreak that started in late 2016. Although human cases have been linked to sylvatic mosquitoes, the concern is that YFV may spread to urban centers infested with Aedes aegypti and Aedes albopictus mosquitoes and start a true urban cycle.
   OBJECTiVE To describe the ocular findings in patients with acute YFV infection.
   DESIGN, SETTING, PARTICIPANTS Two adults with an acute YFV infection in southeastern Brazil underwent an ophthalmologic and ocular ultrasonographic examination in early 2018.
   MAIN OUTCOMES AND MEASURES Ocular findings in patients with acute YFV infection.
   RESULTS Both patients presented with increased choroidal thickness bilaterally seen on ocular ultrasonography. A man in his late 50s who had not been vaccinated previously also presented with bilateral, midperipheral, 360 degrees choroidal detachment and yellowish subretinal lesions. After clinical deterioration and liver transplant, the man died. A woman in her early 30s who had been vaccinated previously for YFV presented with increased retinal venous congestion bilaterally. She was discharged with mild conjunctival chemosis and icterus.
   CONCLUSIONS AND RELEVANCE These reports describe different patterns of ocular findings associated with YFV acute infection. However, the exact mechanism involved in the retinal and choroidal findings remains unclear.
C1 [Vianello, Silvana] Ctr Estudo Visao, Juiz De Fora, MG, Brazil.
   [Vianello, Silvana; Maia, Mauricio; Belfort, Rubens, Jr.; de Oliveira Dias, Joao Rafael] Univ Fed Sao Paulo, Dept Ophthalmol, Vis Inst, Paulista Med Sch, Pedro Toledo St 781,Second Floor, BR-04023062 Sao Paulo, SP, Brazil.
   [de Souza, Glaucio Silva] Santa Casa Misericordia Juiz de Fora, Dept Gen Surg, Juiz De Fora, MG, Brazil.
   [Maia, Mauricio] Brazilian Inst Fight Blindness Assis & Presidente, Sao Paulo, Brazil.
RP Dias, JRD (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Vis Inst, Paulista Med Sch, Pedro Toledo St 781,Second Floor, BR-04023062 Sao Paulo, SP, Brazil.
EM dias_joaor@yahoo.com.br
RI Maia, Mauricio/I-5892-2015
OI Maia, Mauricio/0000-0002-7034-8091
CR Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Biancardi AL, 2019, OCUL IMMUNOL INFLAMM, V27, P521, DOI 10.1080/09273948.2018.1510529
   Brazilian Ministry of Health, FEBR AM MIN SAUD AT
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Evandro Chagas Institute, I EV CHAG DET VIR FE
   Klitting R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060291
   Lucey D, 2016, JAMA-J AM MED ASSOC, V315, P2661, DOI 10.1001/jama.2016.6606
   Maggio E, 2016, GRAEF ARCH CLIN EXP, V254, P545, DOI 10.1007/s00417-015-3176-y
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Norrby E, 2007, J EXP MED, V204, P2779, DOI 10.1084/jem.20072290
   Pan American Health Organization, 2017, BRAZ WORKS CONTR YEL
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Romano AP, 2014, PLOS NEGLECT TROP D, V8, pe2740, DOI [10.1371/journal.pntd.OOO2740, DOI 10.1371/J0URNAL.PNTD.0002]
   ROSS RW, 1950, ANN TROP MED PARASIT, V44, P351, DOI 10.1080/00034983.1950.11685460
NR 14
TC 1
Z9 1
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD MAR
PY 2019
VL 137
IS 3
BP 300
EP 304
DI 10.1001/jamaophthalmol.2018.6408
PG 5
WC Ophthalmology
SC Ophthalmology
GA HO8LL
UT WOS:000461203100019
PM 30629101
OA Green Published
DA 2020-12-01
ER

PT J
AU Silva, LMP
   Arantes, TE
   Casaroli-Marano, R
   Vaz, T
   Belfort, R
   Muccioli, C
AF Silva, Luci Meire P.
   Arantes, Tiago Eugenio
   Casaroli-Marano, Ricardo
   Vaz, Tatiana
   Belfort, Rubens, Jr.
   Muccioli, Cristina
TI Quality of Life and Psychological Aspects in Patients with Visual
   Impairment Secondary to Uveitis: A Clinical Study in a Tertiary Care
   Hospital in Brazil
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Article
DE Anxiety; depression; quality of life; uveitis; visual impairment
ID LOW-VISION; DEPRESSION; PREVENTION; BLINDNESS; REHABILITATION;
   DISORDERS; SYMPTOMS; DISTRESS; ANXIETY; IMPACT
AB Purpose: To evaluate the quality of life in individuals with bilateral visual impairment secondary to uveitis and its association with sociodemographic, clinical and psychosocial aspects. Methods: Data were collected through a structured interviews, using four forms; the SF-12v2, HADS, NEI-VFQ-25 and a specific form developed to collect clinical and sociodemographic data. Results: 80 patients were included with a mean age of 42.8 years; 63.8% female; 57.5% with permanent reduction of familiar income. The average number of medical visits was 15.2 +/- 10.7/year. In terms of health-related quality of life (HRQol), the mean of VFQ-25 score was 36.6 +/- 15.1 and the mean of SF-12 physical and mental components scores were 43.3 +/- 9.9 and 44.9 +/- 12.2. Anxiety and depression symptoms were found in 65.1% and 32.5% of patients, respectively. Conclusions: Visual impairment has impact on several scales of HRQoL leading to productivity loss and consumption of health resources.
C1 [Silva, Luci Meire P.; Arantes, Tiago Eugenio; Vaz, Tatiana; Belfort, Rubens, Jr.; Muccioli, Cristina] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Casaroli-Marano, Ricardo] Hosp Clin Barcelona, Inst Clin Oftalmol, Barcelona, Spain.
RP Silva, LMP (corresponding author), Univ Fed Sao Paulo, Ophthalmol, Rua Botucatu 822 1 Andar, BR-04023062 Sao Paulo, Brazil.
EM luci.pesquisa@gmail.com
RI Arantes, Tiago EF/I-3093-2013; Silva, Luci/K-1454-2014; Casaroli-Marano,
   Ricardo Pedro/D-4535-2014
OI Arantes, Tiago EF/0000-0002-8122-3446; Silva, Luci/0000-0002-9899-6461;
   Casaroli-Marano, Ricardo Pedro/0000-0003-1812-9323
CR Adigun K, 2014, J MULTIDISCIP HEALTH, V7, P173, DOI 10.2147/JMDH.S51359
   Andrade Thamine Lessa, 2007, J. bras. pneumol., V33, P414, DOI 10.1590/S1806-37132007000400010
   Araujo A, 2008, ARQ BRAS OFTALMOL, V71, P246, DOI 10.1590/S0004-27492008000200021
   As Z, 1983, ACTA PSYCHIAT SCAND, V7, P361
   Botega NJ, 1995, REV SAUDE PUBL, V29, P355, DOI 10.1590/S0034-89101995000500004
   Cruz LN, 2013, CIENC SAUDE COLETIVA, V18, P1911, DOI 10.1590/S1413-81232013000700006
   Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-7
   Mello PRADP, 2008, ARQ BRAS OFTALMOL, V71, P847, DOI 10.1590/S0004-27492008000600016
   Deschenes J, 2008, OCUL IMMUNOL INFLAMM, V16, P1, DOI 10.1080/09273940801899822
   Durrani OM, 2004, OPHTHALMOLOGICA, V218, P223, DOI 10.1159/000078612
   Esteban JJN, 2008, QUAL LIFE RES, V17, P37, DOI 10.1007/s11136-007-9280-7
   Fernandez DG, 2016, OCUL IMMUNOL INFLAMM, P1, DOI DOI 10.3109/09273948.2015.1132741
   Frick KD, 2012, INVEST OPHTH VIS SCI, V53, P1169, DOI 10.1167/iovs.11-8259
   Globe DR, 2002, OPHTHALMOLOGY, V109, P1793, DOI 10.1016/S0161-6420(02)01124-7
   Ho VH, 2001, BRIT J OPHTHALMOL, V85, P653, DOI 10.1136/bjo.85.6.653
   Hoeksema L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085224
   Horowitz A, 2005, AGING MENT HEALTH, V9, P563, DOI 10.1080/13607860500193500
   Hui MM, 2017, OCUL IMMUNOL INFLAMM, V25, P486, DOI 10.3109/09273948.2016.1139734
   IBGE (INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA), 2010, CENS DEM 2010
   Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057
   Javitt JC, 2007, OPHTHALMOLOGY, V114, P238, DOI 10.1016/j.ophtha.2006.07.054
   Johnson T, 2014, SEMIN OPHTHALMOL, V29, P202, DOI 10.3109/08820538.2013.821500
   Kempen GIJM, 2012, QUAL LIFE RES, V21, P1405, DOI 10.1007/s11136-011-0061-y
   Maca SM, 2011, BRIT J OPHTHALMOL, V95, P699, DOI 10.1136/bjo.2009.174839
   Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050
   Mangione CM, NEI VFQ 25 SCORING A
   MAYER H, 1994, INT CONGR SER, V1068, P349
   Miserocchi E, 2010, OCUL IMMUNOL INFLAMM, V18, P297, DOI 10.3109/09273941003637510
   Muccioli C, 2001, UVEITES CONSELHO BRA
   Murphy CC, 2005, BRIT J OPHTHALMOL, V89, P1161, DOI 10.1136/bjo.2005.067421
   Orefice F, 1987, UVEITES
   da Silva LMP, 2013, ARQ BRAS OFTALMOL, V76, P366, DOI 10.1590/S0004-27492013000600010
   Qian Y, 2012, AM J OPHTHALMOL, V153, P370, DOI 10.1016/j.ajo.2011.06.028
   Rees G, 2013, INVEST OPHTH VIS SCI, V54, P7431, DOI 10.1167/iovs.13-12153
   Reese JP, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-162
   Renieri G, 2013, INT J REHABIL RES, V36, P48, DOI 10.1097/MRR.0b013e328357885b
   Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332
   Rovner BW, 2014, OPHTHALMOLOGY, V121, P2204, DOI 10.1016/j.ophtha.2014.05.002
   Saligan LN, 2010, OPHTHAL EPIDEMIOL, V17, P217, DOI 10.3109/09286586.2010.483754
   SCHIESSER AW, 2008, PAIN RES PROGR MIGRA, P151
   Schiffman RM, 2001, ARCH OPHTHALMOL-CHIC, V119, P841
   Siegrist J, 2008, EUR ARCH PSY CLIN N, V258, P115, DOI 10.1007/s00406-008-5024-0
   Simao LM, 2008, ARQ BRAS OFTALMOL, V71, P540, DOI 10.1590/S0004-27492008000400014
   Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306
   Ware J.E., 2001, SF 36 PHYS MENTAL HL
   Ware JE, 2002, SCORE VERSION 2 SF 1
   West S, 2001, B WORLD HEALTH ORGAN, V79, P244
   World Health Organisation, VIS IMP BLINDN
NR 48
TC 5
Z9 5
U1 3
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PD JAN 2
PY 2019
VL 27
IS 1
BP 99
EP 107
DI 10.1080/09273948.2017.1370551
PG 9
WC Ophthalmology
SC Ophthalmology
GA HW1GM
UT WOS:000466431300015
PM 29020477
DA 2020-12-01
ER

PT J
AU Sturzeneker, G
   Maia, A
   Morales, M
   Belfort, RN
AF Sturzeneker, Guilherme
   Maia, Andre
   Morales, Melina
   Belfort, Rubens N.
TI Vitreoretinal Surgery and Panretinal Photocoagulation in a Patient with
   Multiple Large Retinal Capillary Hemangiomas (von Hippel-Lindau
   Disease): A Novel Approach
SO CASE REPORTS IN OPHTHALMOLOGY
LA English
DT Article
DE Retinal capillary hemangioma; Von Hippel-Lindau disease; Laser
   photocoagulation; Vitreoretinal surgery
ID THERAPY
AB The authors present a novel surgical approach for the treatment of retinal capillary hemangiomas (RCHs) secondary to von Hippel-Lindau (VHL) disease. This is a case report of a 23-year-old male patient with VHL that presented with multiple large RCHs and a thick epiretinal membrane (ERM) in his left eye, with best-corrected visual acuity (BCVA) of 20/80. This condition was surgically addressed with 23-gauge pars plana vitrectomy, ERM and internal limiting membrane peeling, and panretinal photocoagulation. Three monthly intravitreal injections of bevacizumab were administered after surgery. In a 14-month follow-up period, hemangiomas have regressed after laser therapy, macular anatomy has improved, retina remained completely attached, and there has been no development of new tumors or proliferative vitreoretinopathy. The patient achieved a BCVA of 20/40 in the treated eye. Panretinal photocoagulation combined with pars plana vitrectomy may be useful to reduce development of new capillary hemangiomas and reduce overall occurrence of complications in patients with VHL disease. Postoperative intravitreal injections of bevacizumab may have a role in this positive outcome.
C1 [Sturzeneker, Guilherme; Morales, Melina; Belfort, Rubens N.] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Ocular Oncol Serv, 822 Botucatu St, BR-04039032 Sao Paulo, Brazil.
   [Sturzeneker, Guilherme; Maia, Andre] Retina Clin, Retina Dept, Sao Paulo, Brazil.
   [Maia, Andre] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Retina Serv, Sao Paulo, Brazil.
RP Sturzeneker, G (corresponding author), Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Ocular Oncol Serv, 822 Botucatu St, BR-04039032 Sao Paulo, Brazil.
EM guilherme.sturzeneker@retina.com.br
CR Chan CC, 2007, RETINA-J RET VIT DIS, V27, P1, DOI 10.1097/01.iae.0000244659.62202.ee
   Dalvin LA, 2020, BRIT J OPHTHALMOL, V104, P167, DOI 10.1136/bjophthalmol-2019-314021
   Deak Gabor Gy, 2019, Retin Cases Brief Rep, DOI 10.1097/ICB.0000000000000868
   Elborgy E, 2017, ASIA-PAC J OPHTHALMO, V6, P256, DOI 10.22608/APO.2016205
   Farah ME, 2001, EUR J OPHTHALMOL, V11, P386
   Gagnier Joel J, 2013, Glob Adv Health Med, V2, P38, DOI 10.7453/gahmj.2013.008
   Gaudric A, 2011, OPHTHALMOLOGY, V118, P142, DOI 10.1016/j.ophtha.2010.04.031
   Kreusel KM, 1998, OPHTHALMOLOGY, V105, P1386, DOI 10.1016/S0161-6420(98)98017-4
   Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4
   MAHER ER, 1994, EUR J CANCER, V30A, P1987, DOI 10.1016/0959-8049(94)00391-H
   MAHER ER, 1990, Q J MED, V77, P1151, DOI 10.1093/qjmed/77.2.1151
   Miyazawa A, 2009, JPN J OPHTHALMOL, V53, P501, DOI 10.1007/s10384-009-0699-y
   MOORE A T, 1991, Eye (London), V5, P723
   Schmidt D, 2000, Eur J Med Res, V5, P47
   Schmidt-Erfurth UM, 2002, OPHTHALMOLOGY, V109, P1256, DOI 10.1016/S0161-6420(02)01059-X
   Singh AD, 2002, OPHTHALMOLOGY, V109, P1799, DOI 10.1016/S0161-6420(02)01177-6
   Singh AD, 2001, SURV OPHTHALMOL, V46, P117, DOI 10.1016/S0039-6257(01)00245-4
   Wong WT, 2008, OPHTHALMOLOGY, V115, P1957, DOI 10.1016/j.ophtha.2008.04.033
NR 18
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1663-2699
J9 CASE REP OPHTHALM
JI Case Rep. Ophthalmol.
PY 2019
VL 10
IS 3
BP 327
EP 333
DI 10.1159/000502970
PG 7
WC Ophthalmology
SC Ophthalmology
GA KC7BQ
UT WOS:000507329000004
PM 31762763
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Fernandes, RAB
   Silva, LMP
   Dias, DT
   Pereira, RH
   Belfort , R
   Prata, TS
AF Brant Fernandes, Rodrigo A.
   Silva, Luci Meire P.
   Dias, Diego Torres
   Pereira, Rafael Henrique
   Belfort Jr, Rubens
   Prata, Tiago Santos
TI Comparison of clinical effects of two latanoprost 0.005% solutions
   (Xalatan (R) and Arulatan (R)) in primary open-angle glaucoma or ocular
   hypertensive patients: a randomized clinical trial
SO CLINICAL OPHTHALMOLOGY
LA English
DT Article
DE glaucoma; latanoprost; IOP reduction
ID GENERIC LATANOPROST; EFFICACY; DYNAMICS; TIMOLOL; PHXA41; ANALOG
AB Purpose: To evaluate the therapeutic non-inferiority between two ophthalmic latanoprost 0.005% solutions (Arulatan (R) [ALT] versus the reference drug Xalatan (R) [XLT]) in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH).
   Patients and methods: This was a 12-week Phase IV, experimental, randomized, parallel-group, double-masked clinical trial. Consecutive patients with POAG or OH from the Glaucoma Service of Instituto Paulista de Estudos e Pesquisas em Oftalmologia (Sao Paulo, Brazil) were enrolled between July and December 2017. The primary outcome of the study was an analysis of therapeutic non-inferiority between ALT versus XLT at 12 weeks, while secondary outcomes were mean intraocular pressure (IOP) change from baseline at 2, 6 and 12 weeks, mean IOP at 2, 6 and 12 weeks, and topical and systemic side effects. Statistical significance was set at P<0.05. Computerized analysis was performed using the R software, version 3.4.4.
   Results: A total of 45 patients were randomized to the two treatment groups: ALT (22) and XLT (23). A statistically significant reduction in IOP from baseline was observed in both treatment groups at all timepoints, while no statistically significant difference between groups was detected. By week 12, observed IOP reduction was -7.95 and -7.89 mmHg in the ALT and in the XLT groups, respectively (P=0.60). Treatment difference between the ALT and the XLT groups was -0.06 mm Hg (95% CI: -0.97, 0.85) and fell within the interval set for therapeutic non-inferiority. There was no statistically significant difference between the two groups in terms of safety profiles. The most commonly reported side effect was mild conjunctival/palpebral hyperemia.
   Conclusion: ALT was considered non-inferior to XLT in achieving a statistically significant reduction in IOP at 12 weeks in POAG and OH patients. No significant difference in the occurrence of side effects was found between both groups.
C1 [Brant Fernandes, Rodrigo A.; Silva, Luci Meire P.; Dias, Diego Torres; Belfort Jr, Rubens; Prata, Tiago Santos] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Rua Dr Jose Rodrigues Alves Sobrinho 125, BR-05466040 Sao Paulo, SP, Brazil.
   [Pereira, Rafael Henrique; Belfort Jr, Rubens; Prata, Tiago Santos] IPEPO Vis Inst SP, Sao Paulo, SP, Brazil.
   [Prata, Tiago Santos] Mayo Clin, Dept Ophthalmol, Jacksonville, FL 32224 USA.
RP Prata, TS (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Rua Dr Jose Rodrigues Alves Sobrinho 125, BR-05466040 Sao Paulo, SP, Brazil.
EM t.prata0807@gmail.com
RI Silva, Luci/K-1454-2014; Prata, Tiago/AAV-6676-2020
OI Silva, Luci/0000-0002-9899-6461; Prata, Tiago/0000-0003-1830-3766;
   Brant, Rodrigo/0000-0002-0274-0315
CR Allaire C, 2012, EUR J OPHTHALMOL, V22, P19, DOI 10.5301/ejo.5000041
   Angmo D, 2017, INT OPHTHALMOL, V37, P423, DOI 10.1007/s10792-016-0280-x
   Aptel F, 2008, J GLAUCOMA, V17, P667, DOI 10.1097/IJG.0b013e3181666557
   Camras CB, 1996, OPHTHALMOLOGY, V103, P138, DOI 10.1016/S0161-6420(96)30749-5
   Cantor LB, 1997, J GLAUCOMA, V6, P344, DOI 10.1097/00061198-199710000-00011
   Chambers WA, 2012, OPHTHALMOLOGY, V119, P1095, DOI 10.1016/j.ophtha.2012.03.033
   Diagourtas A, 2018, EUR J OPHTHALMOL, V28, P378, DOI 10.1177/1120672117747030
   Digiuni M, 2013, J GLAUCOMA, V22, P707, DOI 10.1097/IJG.0b013e318259b47c
   Golan S, 2015, CLIN EXP PHARMACOL P, V42, P220, DOI 10.1111/1440-1681.12329
   Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887
   Narayanaswamy Arun, 2007, Indian Journal of Ophthalmology, V55, P127
   Orzalesi N, 2006, OPHTHALMOLOGY, V113, P239, DOI 10.1016/j.ophtha.2005.10.045
   Orzalesi N, 2000, INVEST OPHTH VIS SCI, V41, P2566
   Prum Bruce E Jr, 2016, Ophthalmology, V123, pP41, DOI 10.1016/j.ophtha.2015.10.053
   Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013
   TORIS CB, 1993, OPHTHALMOLOGY, V100, P1297
   van der Valk R, 2005, J GLAUCOMA, V14, P239, DOI 10.1097/01.ijg.0000159121.11371.5f
   Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0
   Whitson JT, 2007, EXPERT OPIN PHARMACO, V8, P3237, DOI 10.1517/14656566.8.18.3237
   ZIAI N, 1993, ARCH OPHTHALMOL-CHIC, V111, P1351, DOI 10.1001/archopht.1993.01090100059027
   Zore M, 2013, BRIT J OPHTHALMOL, V97, P253, DOI 10.1136/bjophthalmol-2012-302245
NR 21
TC 0
Z9 0
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1177-5483
J9 CLIN OPHTHALMOL
JI Clin. Ophthalmol.
PY 2019
VL 13
BP 679
EP 684
DI 10.2147/OPTH.S198229
PG 6
WC Ophthalmology
SC Ophthalmology
GA HU9DY
UT WOS:000465595100001
PM 31118553
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Zin, AA
   Tsui, I
   Rossetto, JD
   Gaw, SL
   Neves, LM
   Zin, OA
   Haefeli, L
   Silveira, JCB
   Adachi, K
   Pone, MVD
   Pone, SM
   Molleri, N
   Pereira, JP
   Belfort, R
   Arumugaswami, V
   Vasconcelos, Z
   Brasil, P
   Nielsen-Saines, K
   Moreira, MEL
AF Zin, Andrea A.
   Tsui, Irena
   Rossetto, Julia D.
   Gaw, Stephanie L.
   Neves, Luiza M.
   Zin, Olivia A.
   Haefeli, Lorena
   Barros Silveira Filho, Joel Carlos
   Adachi, Kristina
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Molleri, Natalia
   Pereira, Jose Paulo, Jr.
   Belfort, Rubens
   Arumugaswami, Vaithilingaraja
   Vasconcelos, Zilton
   Brasil, Patricia
   Nielsen-Saines, Karin
   Lopes Moreira, Maria Elisabeth
TI Visual function in infants with antenatal Zika virus exposure
SO JOURNAL OF AAPOS
LA English
DT Article
ID OPHTHALMIC MANIFESTATIONS; MACULAR ATROPHY; BIRTH; IMPAIRMENT;
   PREGNANCY; CHILDREN; IMPACT
AB PURPOSE To report the findings of a cross-sectional study of visual function in infants with confirmed or suspected antenatal Zika virus (ZIKV) infection seen at a single referral center in Rio de Janeiro.
   METHODS Infants were examined following the ZIKV outbreak period at Instituto Fernandes Figueira/FIOCRUZ. Visual function was considered abnormal if an infant could not fix and follow a standardized high-contrast target (10 cm) by 3-6 months of age. Visual function and associations with structural eye abnormalities, central nervous system (CNS) abnormalities, microcephaly, and nystagmus were assessed. Sensitivity and specificity of screening criteria for structural eye abnormalities was assessed.
   RESULTS A total of 173 infants met inclusion criteria. Abnormal visual function was found in 52 infants (30.0%) and was significantly associated with eye abnormalities (40/52; OR = 44.2; 95% CI, 16.6-117.6), CNS abnormalities (50/52; OR = 64.0; 95% CI, 14.7-277.6), microcephaly (44/52; OR = 31.5; 95% CI, 12.7-77.8), and nystagmus (26/52; OR = 120.0; 95% CI, 15.6-924.5). Using microcephaly as screening criteria for the detection of eye abnormalities provided a sensitivity of 88.9% (95% CI, 76.0-96.3) and specificity of 82.8% (95% CI, 75.1-88.9). Using both abnormal visual function and microcephaly increased sensitivity to 100% (95% CI, 92.1-100.0) and decreased specificity to 80.5% (95% CI, 72.5-86.9).
   CONCLUSIONS Infants with suspected antenatal ZIKV infection and reduced visual function should be referred to an ophthalmologist. Visual function assessments are helpful in screening for antenatal ZIKV exposure in resource-limited settings and can identify infants who may benefit from visual habilitation.
C1 [Zin, Andrea A.; Rossetto, Julia D.; Neves, Luiza M.; Haefeli, Lorena; da Silva Pone, Marcos Vinicius; Pone, Sheila Moura; Molleri, Natalia; Pereira, Jose Paulo, Jr.; Vasconcelos, Zilton; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Tsui, Irena; Adachi, Kristina; Arumugaswami, Vaithilingaraja; Nielsen-Saines, Karin] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Neves, Luiza M.; Zin, Olivia A.] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Rio De Janeiro, Brazil.
   [Belfort, Rubens] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Dept Pesquisa Clin, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM andreazin@iff.fiocruz.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019; Vasconcelos,
   Zilton/AAD-5784-2019; Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Vasconcelos, Zilton/0000-0002-2193-2224; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Moura Pone, Sheila/0000-0002-6246-8915; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Eye InstituteUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318-01, R01AI1121207]; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI129534-02]; Research to Prevent BlindnessResearch to Prevent
   Blindness (RPB); Queenan Fellowship in Global Health from the Foundation
   for the Society of Maternal Fetal Medicine; UCSF National Center of
   Excellence in Women's Health; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R21EY028318, R21EY028318] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI129534, R21AI129534, R01AI140718,
   R01AI140718] Funding Source: NIH RePORTER
FX Brazilian National Council for Scientific and Technological Development
   (441098/2016-9), National Eye Institute [R21EY028318-01 and
   R01AI1121207], and National Institute of Allergy and Infectious Diseases
   (R21AI129534-02). Dr. Tsui was supported in part by an unrestricted
   Research to Prevent Blindness grant given to the Stein Eye Institute.
   Dr. Gaw was supported in part by the Queenan Fellowship in Global Health
   from the Foundation for the Society of Maternal Fetal Medicine, and the
   UCSF National Center of Excellence in Women's Health. Funding sources
   had no involvement in design, data collection/interpretation, or
   manuscript preparation.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   Dias JRD, 2018, PROG RETIN EYE RES, V66, P85, DOI 10.1016/j.preteyeres.2018.04.004
   Diretrizes de Atencao a Sande Ocular na Infancia, 2013, DIRETRIZES ATENCAO S
   Donahue SP, 2016, PEDIATRICS, V137
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Freitas B de Paula, 2016, JAMA OPHTHALMOL
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Harvey EM, 1999, INVEST OPHTH VIS SCI, V40, P1565
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Luke B, 2017, AM J OBSTET GYNECOL, V217, P270, DOI 10.1016/j.ajog.2017.03.012
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Pan American Health Organization, 2017, REG ZIK EP UPD AM
   Sherrell H, 2018, EUR J OBSTET GYN R B, V225, P26, DOI 10.1016/j.ejogrb.2018.03.059
   Sonksen PM, 2002, DEV MED CHILD NEUROL, V44, P782
   Sonnander K, 2000, ACTA PAEDIATR, V89, P17, DOI 10.1080/080352500750027358
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 31
TC 2
Z9 3
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD DEC
PY 2018
VL 22
IS 6
BP 452
EP 456
DI 10.1016/j.jaapos.2018.07.352
PG 5
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA HE7RQ
UT WOS:000453638000012
PM 30359768
OA Other Gold, Green Accepted
DA 2020-12-01
ER

PT J
AU Cunha, CC
   Berezovsky, A
   Furtado, JM
   Ferraz, NN
   Fernandes, AG
   Munoz, S
   Watanabe, SS
   Sacai, PY
   Cypel, M
   Mitsuhiro, MH
   Morales, PH
   Vasconcelos, GC
   Cohen, MJ
   Campos, M
   Cohen, JM
   Belfort, R
   Salomao, SR
AF Cunha, Cristina Coimbra
   Berezovsky, Adriana
   Furtado, Joao Marcello
   Ferraz, Nivea Nunes
   Fernandes, Arthur Gustavo
   Munoz, Sergio
   Watanabe, Sung Song
   Sacai, Paula Yuri
   Cypel, Marcela
   Mitsuhiro, Marcia Higashi
   Morales, Paulo Henrique
   Vasconcelos, Galton Carvalho
   Cohen, Marcos Jacob
   Campos, Mauro
   Cohen, Jacob Moyses
   Belfort, Rubens, Jr.
   Salomao, Solange Rios
TI Presbyopia and Ocular Conditions Causing Near Vision Impairment in Older
   Adults From the Brazilian Amazon Region
SO AMERICAN JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID PREVALENCE; BLINDNESS
AB PURPOSE: To investigate the prevalence and causes of near vision impairment (NVI) in a population of older adults from the Brazilian Amazon Region.
   DESIGN: Population-based cross-sectional study.
   METHODS: Cluster sampling was used in randomly selecting subjects 45 years of age and older from urban and rural areas of Parintins city, Brazil. Participants underwent ophthalmic examination, including uncorrected (UCNVA), presenting (PNVA), and best-corrected near visual acuity (BCNVA) from each eye; biomicroscopy; funduscopy; and subjective refraction, including testing with additional lenses for near vision optical correction. A principal cause for NVI was assigned by the ophthalmologist and presbyopia was defined as UCNVA <= 20/40 changing to > 20/40 with BCNVA. Free-of-charge glasses were provided for those in need.
   RESULTS: A total of 2384 subjects were enumerated and 2025 had reliable NVA measurements from both eyes. The prevalence of NVI in the better-seeing eye was 96.5% with UCNVA, decreasing to 81.1% with PNVA and to 20.5% with BCNVA. Presbyopia was the principal cause of NVI in 71.8%, followed by cataract (16.5%) and pterygium (2.5%), and was associated with younger age and high schooling. Glasses for near vision were prescribed and provided to 1414 (69.8%) participants.
   CONCLUSIONS: A high prevalence of NVI was detected even in those wearing glasses for near. Prescription and provision of low-cost reading glasses should be considered by Brazilian health authorities to address this easily and promptly correctable form of vision impairment. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Cunha, Cristina Coimbra; Berezovsky, Adriana; Furtado, Joao Marcello; Ferraz, Nivea Nunes; Fernandes, Arthur Gustavo; Watanabe, Sung Song; Sacai, Paula Yuri; Cypel, Marcela; Mitsuhiro, Marcia Higashi; Morales, Paulo Henrique; Vasconcelos, Galton Carvalho; Campos, Mauro; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Rua Botucatu 816, BR-04023062 Sao Paulo, SP, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Univ Fed Amazonas UFAM, Fac Med, Dept Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
   [Furtado, Joao Marcello] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Ribeirao Preto, Brazil.
   [Vasconcelos, Galton Carvalho] Univ Fed Minas Gerais, Fac Med, Dept Oftalmol & Otorrinolaringol, Belo Horizonte, MG, Brazil.
RP Salomao, SR (corresponding author), Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Rua Botucatu 816, BR-04023062 Sao Paulo, SP, Brazil.
EM ssalomao@unifesp.br
RI de Queiroz Campos, Mauro Silveira/H-7609-2017; Berezovsky,
   Adriana/F-2341-2013; Sacai, Paula Y/B-6525-2014; Ferraz,
   Nivea/AAC-2439-2020
OI de Queiroz Campos, Mauro Silveira/0000-0002-9448-8742; Berezovsky,
   Adriana/0000-0001-6350-8221; Ferraz, Nivea/0000-0001-7568-6199;
   Fernandes, Arthur Gustavo/0000-0002-7525-1838; Furtado, Joao
   M./0000-0003-2490-5747
FU CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO - CNPQ,
   BRASILIA, BRAZILNational Council for Scientific and Technological
   Development (CNPq); Programa Ciencia sem Fronteiras [402120/2012-4];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/16397-7]; SightFirst Program-Lions Club International Foundation
   [1758]; Instituto da Visao, Sao Paulo, SP, Brazil; Fundacao Piedade
   Cohen (FUNDAPI), Manaus, AM, Brazil
FX CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO - CNPQ,
   BRASILIA, BRAZIL, Programa Ciencia sem Fronteiras (Grant # 402120/2012-4
   to S.R.S., S.M., and J.M.F.; Research Scholarships to S.R.S. and
   R.B.J.); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP,
   Sao Paulo, Brazil (Grant # 2013/16397-7 to S.R.S.); SightFirst
   Program-Lions Club International Foundation (Grant #1758 to S.R.S.),
   Instituto da Visao, Sao Paulo, SP, Brazil; Fundacao Piedade Cohen
   (FUNDAPI), Manaus, AM, Brazil.
CR Behar-Cohen F, 2014, CLIN OPHTHALMOL, V8, P87, DOI 10.2147/OPTH.S46189
   Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0
   Duarte Wladimir Ribeiro, 2003, Cad. Saúde Pública, V19, P551, DOI 10.1590/S0102-311X2003000200022
   Han X, 2018, BR J OPHTHALMOL, DOI [10.1136/bjophthalmo1-2017-311073.2018.01.24, DOI 10.1136/BJOPHTHALMO1-2017-311073.2018.01.24]
   He MG, 2012, AM J OPHTHALMOL, V154, P107, DOI 10.1016/j.ajo.2012.01.026
   Holden BA, 2015, B WORLD HEALTH ORGAN, V93, P667, DOI 10.2471/BLT.15.156844
   Hookway LA, 2016, CLIN EXP OPTOM, V99, P559, DOI 10.1111/cxo.12402
   Lu Q, 2011, INVEST OPHTH VIS SCI, V52, P2300, DOI 10.1167/iovs.10-6569
   Marmamula S, 2013, OPHTHAL PHYSL OPT, V33, P597, DOI 10.1111/opo.12079
   Salomao SR, 2008, OPHTHAL EPIDEMIOL, V15, P167, DOI 10.1080/09286580701843812
   Salomao SR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19338-6
   Salomao SR, 2017, OPHTHAL EPIDEMIOL, V24, P257, DOI 10.1080/09286586.2016.1276199
   Tang YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135870
   World Health Organization, CONS DEV STAND CHAR
   Zebardast N, 2017, AM J OPHTHALMOL, V174, P134, DOI 10.1016/j.ajo.2016.11.004
NR 15
TC 4
Z9 5
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9394
EI 1879-1891
J9 AM J OPHTHALMOL
JI Am. J. Ophthalmol.
PD DEC
PY 2018
VL 196
BP 72
EP 81
DI 10.1016/j.ajo.2018.08.012
PG 10
WC Ophthalmology
SC Ophthalmology
GA HD8MZ
UT WOS:000452812500015
PM 30118685
DA 2020-12-01
ER

PT J
AU Mangeon, M
   Zett, C
   Amaral, C
   Novais, E
   Muccioli, C
   Andrade, G
   Nascimento, H
   Belfort, R
AF Mangeon, Monique
   Zett, Claudio
   Amaral, Camila
   Novais, Eduardo
   Muccioli, Cristina
   Andrade, Gabriel
   Nascimento, Heloisa
   Belfort, Rubens, Jr.
TI Multimodal Evaluation of Patients with Acute Posterior Multifocal
   Placoid Pigment Epitheliopathy and Serpiginous Choroiditis
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Article
DE Acute posterior multifocal placoid pigment epitheliopathy; fluorescein
   angiography; fundus autofluorescence; optical coherence tomography
   angiography; serpiginous choroiditis
ID OPTICAL COHERENCE TOMOGRAPHY; ANGIOGRAPHY; NEOVASCULARIZATION
AB Purpose: To evaluate retinal and choroidal changes in patients with non-granulomatous choroiditis using the multimodality imaging (MMI). Methods: Eight eyes of four patients were analyzed. Three patients (six eyes) were diagnosed with serpiginous choroiditis (SC) and one patient (two eyes) with acute posterior multifocal placoid pigment epitheliopathy (APMPPE). The patients were imaged on the same day using the RTVue Avanti XR instrument OCT/OCTA (Optovue Inc, Fremont, CA), Heidelberg Retina Angiograph 2 FAF and FA (Heidelberg Engineering, Germany), and TRC50DXi Topcon FP (Topcon Medical Systems, Oakland, NJ). Results: OCT angiography (OCTA) showed hypoperfusion in all the cases, reperfusion in choriocapillaris in two eyes after treatment and identified a choroidal neovascularization (CNV), which was not detected on the fluorescein angiography (FA). Conclusions: OCTA may be an effective noninvasive image modality to follow up these patients and may provide further information to help us to understand the pathophysiology and complications of these diseases.
C1 [Mangeon, Monique; Zett, Claudio; Amaral, Camila; Novais, Eduardo; Muccioli, Cristina; Andrade, Gabriel; Nascimento, Heloisa; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
   [Zett, Claudio; Novais, Eduardo; Andrade, Gabriel; Nascimento, Heloisa; Belfort, Rubens, Jr.] Inst Visao IPEPO, Sao Paulo, Brazil.
   [Zett, Claudio] Pontificia Univ Catolica Valparaiso, Fac Ciencias, Valparaiso, Chile.
RP Mangeon, M (corresponding author), Rua Doutor Diogo de Faria 1201,Apartamento 71, BR-04037004 Sao Paulo, Brazil.
EM moniquemangeon@gmail.com
RI Nascimento, Heloisa/P-8869-2017; Andrade, Gabriel/AAV-3155-2020
OI Nascimento, Heloisa/0000-0003-0315-1317; Andrade,
   Gabriel/0000-0002-5881-8126
FU ophthalmology department of the Federal University of Sao Paulo
   (UNIFESP); Instituto da Visao - IPEPO, Sao Paulo, Brazil
FX This study was supported by the ophthalmology department of the Federal
   University of Sao Paulo (UNIFESP) and by the Instituto da Visao - IPEPO,
   Sao Paulo, Brazil.
CR Agarwal A, 2016, OCUL IMMUNOL INFLAMM, V24, P621, DOI 10.1080/09273948.2016.1207785
   Bansal Reema, 2012, Int Ophthalmol Clin, V52, P229, DOI 10.1097/IIO.0b013e318265d474
   Baumal CR, 2015, JAMA OPHTHALMOL, V133, P1087, DOI 10.1001/jamaophthalmol.2015.1946
   Combillet F, 2013, J FR OPHTALMOL, V36, P652, DOI 10.1016/j.jfo.2012.08.012
   Crawford Courtney M, 2013, ISRN Inflamm, V2013, P783190, DOI 10.1155/2013/783190
   de Carlo TE, 2015, OPHTHALMOLOGY, V122, P1228, DOI 10.1016/j.ophtha.2015.01.029
   Gupta Aditi, 2014, Oman J Ophthalmol, V7, P100, DOI 10.4103/0974-620X.137175
   Ha SO, 2014, INTERN EMERG MED, V9, P325, DOI 10.1007/s11739-013-1019-6
   Herbort Carl P, 2012, Int Ophthalmol Clin, V52, P13, DOI 10.1097/IIO.0b013e318265d48b
   Kuehlewein L, 2015, AM J OPHTHALMOL, V160, P739, DOI 10.1016/j.ajo.2015.06.030
   Liang MC, 2016, RETINA-J RET VIT DIS, V36, P2265, DOI 10.1097/IAE.0000000000001102
   Malamos P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/247469
   Mandal S. M., 2016, RECENT TRENDS ANTIFU, P1
   Mrejen S, 2016, OSLI RETINA, V47, P20, DOI 10.3928/23258160-20151214-03
   Novais EA, 2016, OSLI RETINA, V47, P201, DOI 10.3928/23258160-20160229-01
   Spaide RF, 2013, RETINA-J RET VIT DIS, V33, P1315, DOI 10.1097/IAE.0b013e318286cc77
   Yu SS, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0277-2
NR 17
TC 5
Z9 5
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PD NOV 17
PY 2018
VL 26
IS 8
BP 1212
EP 1218
DI 10.1080/09273948.2017.1335757
PG 7
WC Ophthalmology
SC Ophthalmology
GA HA9QW
UT WOS:000450641500013
PM 28960121
DA 2020-12-01
ER

PT J
AU Zett, C
   Lima, LH
   Vianello, S
   Ferreira, A
   de Andrade, GC
   Farah, ME
   Belfort, R
AF Zett, Claudio
   Lima, Luiz H.
   Vianello, Silvana
   Ferreira, Adriano
   de Andrade, Gabriel Costa
   Farah, Michel E.
   Belfort, Rubens, Jr.
TI En-Face Optical Coherence Tomography of Acute Syphilitic Posterior
   Placoid Chorioretinopathy
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Article
DE Acute syphilitic posterior placoid chorioretinitis; cross-sectional
   optical coherence tomography; en-face optical coherence tomography;
   outer retinal abnormalities; syphilis
AB Purpose: To report a unique case series of acute syphilitic posterior placoid chorioretinopathy (ASPPC) correlating en-face optical coherence tomography (OCT) with standard imaging modalities. Methods: In this retrospective case series, multimodal imaging was performed in three ASPPC patients at the time of disease presentation. Results: Clinical and laboratory findings were consistent with the diagnosis of ASPPC. In all the study patients, multiple hyperreflective dot-like lesions distributed in the macular area and observed with en-face OCT at the level of retinal pigment epithelium (RPE) corresponded to the nodular RPE elevations on cross-sectional OCT and to the hyperautofluorescent spots on fundus autofluorescence. In addition, the cross-sectional OCT scans showed disorganization of the outer retinal bands and punctate choroidal hyperreflectivity. Conclusion: By combining en-face OCT with multimodal imaging analysis, we propose that a primary inflammation at the level of the choroid may be the pathogenic mechanism for the occurrence of outer retinal band abnormalities.
C1 [Zett, Claudio; Lima, Luiz H.; Vianello, Silvana; Ferreira, Adriano; de Andrade, Gabriel Costa; Farah, Michel E.] Fed Univ Sao Paulo UNIFESP, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Sao Paulo, Brazil.
   [Zett, Claudio] Pontificia Univ Catolica Valparaiso, Dept Ophthalmol, Valparaiso, Chile.
   [de Andrade, Gabriel Costa; Farah, Michel E.] Inst Visao IPEPO, Dept Ophthalmol, Sao Paulo, Brazil.
RP Lima, LH (corresponding author), Fed Univ Sao Paulo UNIFESP, Rua Botucatu 821, Sao Paulo, SP, Brazil.
EM luizlima9@gmail.com
RI Lima, Luiz H/V-4940-2017; Farah, Michel Eid E/F-3285-2012; Andrade,
   Gabriel/AAV-3155-2020
OI Lima, Luiz H/0000-0001-7304-909X; Farah, Michel Eid
   E/0000-0001-5951-0193; Andrade, Gabriel/0000-0002-5881-8126
CR Armstrong BK, 2014, OSLI RETINA, V45, P606, DOI 10.3928/23258160-20141008-02
   Bellmann C, 1999, OPHTHALMOLOGE, V96, P522, DOI 10.1007/s003470050448
   Benhamou N, 2003, AM J OPHTHALMOL, V135, P362, DOI 10.1016/S0002-9394(02)01946-3
   Brito P, 2011, CASE REP OPHTHALM, V2, P39, DOI 10.1159/000324086
   Burkholder BM, 2014, J OPHTHALMIC INFLAMM, V4, DOI 10.1186/1869-5760-4-2
   Centers for Disease Control and Prevention, 2010, SEX TRANSM DIS SYPH
   Chao JR, 2006, OPHTHALMOLOGY, V113, P2074, DOI 10.1016/j.ophtha.2006.05.048
   DESOUZA EC, 1988, AM J OPHTHALMOL, V105, P271, DOI 10.1016/0002-9394(88)90009-8
   Eandi CM, 2012, RETINA-J RET VIT DIS, V32, P1915, DOI 10.1097/IAE.0b013e31825f3851
   Fenton KA, 2004, SEX TRANSM INFECT, V80, P255, DOI 10.1136/sti.2004.009415
   GASS JDM, 1990, OPHTHALMOLOGY, V97, P1288
   Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173
   Joseph A, 2007, EYE, V21, P1114, DOI 10.1038/sj.eye.6702504
   Kiss Szilard, 2005, Semin Ophthalmol, V20, P161, DOI 10.1080/08820530500232092
   Lima LH, 2017, J OPHTHALMIC INFLAMM, V7, DOI 10.1186/s12348-016-0119-7
   Matsumoto Yoko, 2007, Retin Cases Brief Rep, V1, P123, DOI 10.1097/01.iae.0000242759.80833.39
   Meira-Freitas D, 2009, ARQ BRAS OFTALMOL, V72, P832, DOI 10.1590/S0004-27492009000600019
   MORGAN CM, 1984, RETINA-J RET VIT DIS, V4, P225, DOI 10.1097/00006982-198400440-00003
   Parc CE, 2007, SEX TRANSM DIS, V34, P553, DOI 10.1097/01.olq.0000253385.49373.1a
   Pichi F, 2014, RETINA-J RET VIT DIS, V34, P373, DOI 10.1097/IAE.0b013e3182993f11
   Sridhar J, 2016, OPHTHALMOLOGY, V123, P557, DOI 10.1016/j.ophtha.2016.01.001
   World Health Organization Department of Reproductive Health and Research, 2011, METH RES US WHO GEN
   YOUNG H, 1979, BRIT J HOSP MED, V22, P292
   Zamani M, 2003, AM J OPHTHALMOL, V135, P891, DOI 10.1016/S0002-9394(02)02160-8
NR 24
TC 2
Z9 2
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PD NOV 17
PY 2018
VL 26
IS 8
BP 1264
EP 1270
DI 10.1080/09273948.2017.1347265
PG 7
WC Ophthalmology
SC Ophthalmology
GA HA9QW
UT WOS:000450641500022
PM 28976235
DA 2020-12-01
ER

PT J
AU Costa, DF
   Fowler, F
   Silveira, C
   Nobrega, MJ
   Nobrega, HAJ
   Nascimento, H
   Rizzo, LV
   Commodaro, AG
   Belfort, R
AF Costa, Deise F.
   Fowler, Flavio
   Silveira, Claudio
   Nobrega, Mario Junqueira
   Junqueira Nobrega, Heloisa Amaral
   Nascimento, Heloisa
   Rizzo, Luiz Vicente
   Commodaro, Alessandra G.
   Belfort, Rubens, Jr.
TI Prevalence of Toxoplasma gondii DNA in Processed Pork Meat
SO FOODBORNE PATHOGENS AND DISEASE
LA English
DT Article
DE Toxoplasma gondii; real-time PCR; fresh sausage; cured salami
ID INFECTION; SAMPLES
AB Toxoplasma gondii infection may be attributed to the ingestion of pork meat and contaminated water. In southern Brazil, the prevalence of blindness caused by T. gondii is the highest in the world. Our purpose is to determine the frequency of T. gondii DNA in commercial fresh sausage and cured salami samples from Rio Grande do Sul state, south of Brazil. A total of 118 samples (sausage and salami) from 8 different producers were collected and DNA was extracted. Real-time polymerase chain reaction (qPCR) technique was performed to detect T. gondii DNA using B1 marker. The frequency of T. gondii DNA among the total number of samples (sausage and salami) was 39% (46/118). Among these, a higher frequency of positivity was observed in the sausage samples (47.5%) when compared with the salami samples (17%). However, the mean parasite concentration was significantly higher in the salami samples. The prevalence of T. gondii DNA in fresh sausage and cured salami may indicate that infected pigs may be an important source of infections and a public health hazard to be considered.
C1 [Costa, Deise F.; Fowler, Flavio; Nascimento, Heloisa; Commodaro, Alessandra G.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Botucatu St 821,1st Floor, BR-04023062 Sao Paulo, Brazil.
   [Silveira, Claudio] Clin Silveira, Porto Alegre, RS, Brazil.
   [Nobrega, Mario Junqueira; Junqueira Nobrega, Heloisa Amaral] Univ Joinville, Dept Ophathalmol, Joinville, SC, Brazil.
   [Rizzo, Luiz Vicente] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Botucatu St 821,1st Floor, BR-04023062 Sao Paulo, Brazil.
EM prof.belfort@clinicabelfort.com.br
RI Rizzo, Luiz Vicente/B-4458-2009; Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317; Commodaro,
   Alessandra/0000-0002-7816-6508; Fialho da Costa,
   Deise/0000-0002-1974-4451
FU CNPq (AGC) [400040/2014-0]; FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); CAPESCAPES
FX We thank Ana Carolina Cintra Nunes Mafra for statistical analysis. This
   work was supported by CNPq (AGC-grant 400040/2014-0), FAPESP, and CAPES.
   R.B. and L.V.R. are researchers for CNPq-Brazil.
CR Belfort-Neto R, 2007, AN ACAD BRAS CIENC, V79, P111, DOI 10.1590/S0001-37652007000100013
   Condoleo R, 2018, RISK ANAL, V38, P1202, DOI 10.1111/risa.12934
   Dias Rafael André Ferreira, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P185, DOI 10.1590/S0036-46652005000400002
   Dubey J.P., 2010, TOXOPLASMOSIS ANIMAL
   Gomez-Samblas M, 2015, FOOD MICROBIOL, V46, P107, DOI 10.1016/j.fm.2014.07.003
   Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02
   Ibrahim HM, 2017, ASIAN PAC J TROP MED, V10, P996, DOI 10.1016/j.apjtm.2017.09.012
   Mie T, 2008, J FOOD PROTECT, V71, P1442, DOI 10.4315/0362-028X-71.7.1442
   Opsteegh M, 2010, INT J FOOD MICROBIOL, V139, P193, DOI 10.1016/j.ijfoodmicro.2010.02.027
   Silveira C, 2001, AM J OPHTHALMOL, V131, P351, DOI 10.1016/S0002-9394(00)00830-8
NR 10
TC 3
Z9 3
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1535-3141
EI 1556-7125
J9 FOODBORNE PATHOG DIS
JI Foodborne Pathog. Dis.
PD NOV
PY 2018
VL 15
IS 11
BP 734
EP 736
DI 10.1089/fpd.2018.2438
PG 3
WC Food Science & Technology
SC Food Science & Technology
GA HA6TL
UT WOS:000450412700009
PM 30183346
DA 2020-12-01
ER

PT J
AU Pereira, F
   Lima, LH
   de Azevedo, AGB
   Zett, C
   Farah, ME
   Belfort, R
AF Pereira, Felipe
   Lima, Luiz H.
   de Azevedo, Alexandre Gomes B.
   Zett, Claudio
   Farah, Michel E.
   Belfort, Rubens, Jr.
TI Swept-source OCT in patients with multiple evanescent white dot syndrome
SO JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION
LA English
DT Article
DE Choriocapillaris; MEWDS; Outer retina; Swept-source OCT
ID OPTICAL COHERENCE TOMOGRAPHY; FUNDUS AUTOFLUORESCENCE; ANGIOGRAPHY
AB BackgroundSwept-source optical coherence tomography (SS-OCT) has a higher scanning rate and longer wavelength in comparison with spectral-domain OCT (SD-OCT), allowing an improved imaging of retinal vascular plexuses and choriocapillaris. The present two patients diagnosed with multiple evanescent white dot syndrome (MEWDS) underwent fundus autofluorescence (FAF), en-face SS-OCT, and SS-OCT angiography (OCTA) imaging, and its features were described and correlated.ResultsThe clinical and imaging findings of both cases were consistent with the diagnosis of MEWDS. Color fundus photograph revealed subtle deep retinal white spots in the posterior pole and around the optic disk. FAF showed several hyperautofluorescent lesions corresponding topographically to the subtle deep retinal white lesions observed on color fundus photographs. Cross-sectional SS-OCT showed disruption of the ellipsoid zone (EZ) within the macular area in all study patients. En-face SS-OCT at the level of the outer retina showed lower reflectivity correspondent to the diffuse attenuation due to the EZ disruption on cross-sectional OCT. SS-OCTA demonstrated flow preservation within the retinal vasculature and choriocapillaris.ConclusionsSS-OCT imaging allows a better visualization of the choriocapillaris, and its normal appearance in MEWDS may suggest that the outer retina and photoreceptors represent the primary site of inflammation.
C1 [Pereira, Felipe; Lima, Luiz H.; de Azevedo, Alexandre Gomes B.; Zett, Claudio; Farah, Michel E.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
   [Farah, Michel E.; Belfort, Rubens, Jr.] Vis Inst, Sao Paulo, Brazil.
   [Zett, Claudio] Pontificia Univ Catolica Valparaiso, Valparaiso, Chile.
RP Lima, LH (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
EM luizlima9@gmail.com
RI Farah, Michel Eid E/F-3285-2012
OI Farah, Michel Eid E/0000-0001-5951-0193
CR Aoyagi R, 2012, CLIN EXP OPTOM, V95, P212, DOI 10.1111/j.1444-0938.2011.00668.x
   Barteselli G, 2016, RETINA-J RET VIT DIS, V36, P1153, DOI 10.1097/IAE.0000000000000842
   Cahuzac A, 2017, BRIT J OPHTHALMOL, V101, P1381, DOI 10.1136/bjophthalmol-2016-309175
   De Bats F, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/928028
   Dell'Omo R, 2010, BRIT J OPHTHALMOL, V94, P59, DOI 10.1136/bjo.2009.163550
   Fiore T, 2016, OCUL IMMUNOL INFLAMM, V11, P1
   Freund KB, 2013, JAMA OPHTHALMOL, V131, P1645, DOI 10.1001/jamaophthalmol.2013.5030
   Gal-Or O, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/7535320
   Hashimoto H, 2015, AM J OPHTHALMOL, V159, P698, DOI 10.1016/j.ajo.2015.01.015
   Huang YP, 2014, OSLI RETINA, V45, P382, DOI 10.3928/23258160-20140909-08
   JAMPOL LM, 1984, ARCH OPHTHALMOL-CHIC, V102, P671, DOI 10.1001/archopht.1984.01040030527008
   Labriola Leanne T, 2016, Retin Cases Brief Rep, V10, P302, DOI 10.1097/ICB.0000000000000271
   Marsiglia M, 2016, RETINA-J RET VIT DIS, V36, P64, DOI 10.1097/IAE.0000000000000685
   Nozaki M, 2016, OSLI RETINA, V47, P580, DOI 10.3928/23258160-20160601-11
   Obana A, 1996, RETINA-J RET VIT DIS, V16, P97, DOI 10.1097/00006982-199616020-00002
   Pichi F, 2016, RETINA-J RET VIT DIS, V36, pS178, DOI 10.1097/IAE.0000000000001255
   Tavallali Ali, 2017, J Ophthalmic Vis Res, V12, P132, DOI 10.4103/jovr.jovr_241_16
   Thomas BJ, 2013, OSLI RETINA, V44, P584, DOI 10.3928/23258160-20131015-03
   Yannuzzi NA, 2017, OSLI RETINA, V48, P69, DOI 10.3928/23258160-20161219-10
NR 19
TC 2
Z9 2
U1 0
U2 2
PU SPRINGEROPEN
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1869-5760
J9 J OPHTHALMIC INFLAMM
JI J. Ophthalmic Inflamm. Infect.
PD OCT 13
PY 2018
VL 8
AR 16
DI 10.1186/s12348-018-0159-2
PG 5
WC Ophthalmology
SC Ophthalmology
GA GY4BW
UT WOS:000448504600001
PM 30317398
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Tsui, I
   Moreira, MEL
   Rossetto, JD
   Vasconcelos, Z
   Gaw, SL
   Neves, LM
   Zin, OA
   Haefeli, L
   Silveira, JCB
   Gomes, SC
   Adachi, K
   Pone, MVD
   Pone, SM
   Pereira, JP
   Belfort, R
   Arumugaswami, V
   Brasil, P
   Nielsen-Saines, K
   Zin, AA
AF Tsui, Irena
   Lopes Moreira, Maria Elisabeth
   Rossetto, Julia D.
   Vasconcelos, Zilton
   Gaw, Stephanie L.
   Neves, Luiza M.
   Zin, Olivia A.
   Haefeli, Lorena
   Barros Silveira Filho, Joel Carlos
   Gomes, Saint Clair, Jr.
   Adachi, Kristina
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Pereira, Jose Paulo, Jr.
   Belfort, Rubens
   Arumugaswami, Vaithilingaraja
   Brasil, Patricia
   Nielsen-Saines, Karin
   Zin, Andrea A.
TI Eye Findings in Infants With Suspected or Confirmed Antenatal Zika Virus
   Exposure
SO PEDIATRICS
LA English
DT Article
ID OPTICAL COHERENCE TOMOGRAPHY; OPHTHALMIC MANIFESTATIONS; MACULAR
   ATROPHY; INFECTION; STATES
AB OBJECTIVES:To characterize ophthalmic manifestations of confirmed or suspected antenatal Zika virus (ZIKV) exposure.METHODS:Infants with antenatal ZIKV exposure were referred for evaluation during the 2015-2016 Rio de Janeiro outbreak. Mothers with symptomatic ZIKV infection during pregnancy and/or infants with microcephaly or other findings that were suggestive of suspected antenatal exposure were tested with reverse transcriptase polymerase chain reaction (RT-PCR). Complete eye examinations were performed by pediatric ophthalmologists between January 2016 and February 2017. The main outcome measure was eye abnormalities in RT-PCR-positive and suspected (ie, not tested or RT-PCR-negative) antenatal ZIKV cases.RESULTS:Of 224 infants, 189 had RT-PCR testing performed. Of 189 patients, 156 had positive RT-PCR results in their blood, urine, and/or placenta. Of 224 infants, 90 had central nervous system (CNS) abnormalities, including microcephaly (62 infants). Eye abnormalities were present in 57 of 224 (25.4%) infants. Optic nerve (44 of 57; 77.2%) and retina abnormalities (37 of 57; 64.9%) were the most common. The group with suspected ZIKV infection (68 infants) had proportionally more eye (36.8% vs 20.5%; P = .022) and CNS abnormalities (68.3% vs 28.1%; P = .008), likely because of referral patterns. Eye abnormalities consistent with ZIKV infection were clinically comparable in both RT-PCR-positive and unconfirmed groups, including 4 RT-PCR-positive infants of 5 without any CNS abnormalities.CONCLUSIONS:Similar eye manifestations were identified regardless of laboratory confirmation. Well-appearing infants were also found to have eye abnormalities. Therefore, all infants born after ZIKV outbreaks should be universally screened for eye abnormalities.
C1 [Tsui, Irena; Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, Dept Opthalmol, Retina Div, Los Angeles, CA USA.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA.
   [Lopes Moreira, Maria Elisabeth; Rossetto, Julia D.; Vasconcelos, Zilton; Neves, Luiza M.; Haefeli, Lorena; Gomes, Saint Clair, Jr.; da Silva Pone, Marcos Vinicius; Zin, Andrea A.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Pone, Sheila Moura; Pereira, Jose Paulo, Jr.; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Neves, Luiza M.; Zin, Olivia A.] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Dept Ophthalmol, Rio De Janeiro, Brazil.
   [Belfort, Rubens] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM andreazin@iff.fiocruz.br
RI Junior, Clair Gomes/F-7579-2012; Vasconcelos, Zilton/AAD-5784-2019;
   Moreira, Maria Elisabeth Lopes/AAA-3775-2020; da Silva Pone, Marcos
   Vinicius/N-1285-2019
OI Junior, Clair Gomes/0000-0002-1554-943X; Vasconcelos,
   Zilton/0000-0002-2193-2224; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Moura Pone, Sheila/0000-0002-6246-8915; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI AI128697]; National Eye InstituteUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318-01];
   Research to Prevent BlindnessResearch to Prevent Blindness (RPB);
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY
   SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [K12HD000849, K12HD000849,
   K12HD000849] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318,
   R21EY028318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21AI129534, R21AI129534]
   Funding Source: NIH RePORTER
FX Supported by the Brazilian National Council for Scientific and
   Technological Development (grant 441098/2016-9), the National Institute
   of Allergy and Infectious Diseases (grant AI AI128697), and the National
   Eye Institute (grant R21EY028318-01). Dr Tsui was supported in part by a
   Research to Prevent Blindness unrestricted grant given to the Jules
   Stein Eye Institute. Funded by the National Institutes of Health (NIH).
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Ministry of Health, PREV COMB DENG CHIUN
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Fontaine A, 2018, CLIN INFECT DIS, V67, P1143, DOI 10.1093/cid/ciy261
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Rifkin LM, 2016, JAMA OPHTHALMOL, V134, P1427, DOI 10.1001/jamaophthalmol.2016.4299
   Secretaria Municipal de Saude, PREF RIO DE JAN
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1219, DOI 10.1001/jamaophthalmol.2016.3623
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Watts P, 2013, J AAPOS, V17, P70, DOI 10.1016/j.jaapos.2012.07.012
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 35
TC 7
Z9 7
U1 0
U2 0
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD OCT
PY 2018
VL 142
IS 4
AR e20181104
DI 10.1542/peds.2018-1104
PG 8
WC Pediatrics
SC Pediatrics
GA GZ0EU
UT WOS:000449034300029
PM 30213843
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Dias, JRD
   Ventura, CV
   Freitas, BD
   Prazeres, J
   Ventura, LO
   Bravo, V
   Aleman, T
   Ko, AI
   Zin, A
   Belfort, R
   Maia, M
AF de Oliveira Dias, Joao Rafael
   Ventura, Camila V.
   Freitas, Bruno de Paula
   Prazeres, Juliana
   Ventura, Liana O.
   Bravo-Filho, Vasco
   Aleman, Tomas
   Ko, Albert Icksang
   Zin, Andrea
   Belfort, Rubens, Jr.
   Maia, Mauricio
CA Zika Virus Study Grp
TI Zika and the Eye: Pieces of a Puzzle
SO PROGRESS IN RETINAL AND EYE RESEARCH
LA English
DT Review
ID WEST-NILE-VIRUS; OPTICAL COHERENCE TOMOGRAPHY; ASYMPTOMATIC
   BLOOD-DONORS; SEXUAL TRANSMISSION; YELLOW-FEVER; OPHTHALMIC
   MANIFESTATIONS; NEUTRALIZING ANTIBODIES; INVASIVE MOSQUITOS; INTERIM
   GUIDANCE; FRENCH-POLYNESIA
AB Zika virus (ZIKV) is an arbovirus mainly transmitted to humans by mosquitoes from Aedes genus. Other ways of transmission include the perinatal and sexual routes, blood transfusion, and laboratory exposure. Although the first human cases were registered in 1952 in African countries, outbreaks were only reported since 2007, when entire Pacific islands were affected. In March 2015, the first cases of ZIKV acute infection were notified in Brazil and, to date, 48 countries and territories in the Americas have confirmed local mosquito-borne transmission of ZIKV. Until 2015, ZIKV infection was thought to only cause asymptomatic or mild exanthematous febrile infections. However, after explosive ZIKV outbreaks in Polynesia and Latin American countries, it was confirmed that ZIKV could also lead to Guillain-Barre syndrome and congenital birth abnormalities. These abnormalities, which can include neurologic, ophthalmologic, audiologic, and skeletal findings, are now considered congenital Zika syndrome (CZS). Brain abnormalities in CZS include cerebral calcifications, malformations of cortical development, ventriculomegaly, lissencephaly, hypoplasia of the cerebellum and brainstem. The ocular findings, which are present in up to 70% of infants with CZS, include iris coloboma, lens subluxation, cataract, congenital glaucoma, and especially posterior segment findings. Loss of retinal pigment epithelium, the presence of a thin choroid, a perivascular choroidal inflammatory infiltrate, and atrophic changes within the optic nerve were seen in histologic analyses of eyes from deceased fetuses. To date, there is no ZIKV licensed vaccines or antiviral therapies are available for treatment. Preventive measures include individual protection from mosquito bites, control of mosquito populations and the use of barriers measures such as condoms during sexual intercourse or sexual abstinence for couples either at risk or after confirmed infection. A literature review based on studies that analyzed ocular findings in mothers and infants with CZS, with or without microcephaly, was conducted and a theoretical pathophysiologic explanation for ZIKV-ocular abnormalities was formulated.
C1 [de Oliveira Dias, Joao Rafael; Ventura, Camila V.; Freitas, Bruno de Paula; Prazeres, Juliana; Ventura, Liana O.; Belfort, Rubens, Jr.; Maia, Mauricio] Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Sao Paulo, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.; Bravo-Filho, Vasco] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.; Bravo-Filho, Vasco] HOPE Eye Hosp, Recife, PE, Brazil.
   [Freitas, Bruno de Paula] Roberto Santos Gen Hosp, Dept Ophthalmol, Salvador, BA, Brazil.
   [Aleman, Tomas] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Ctr Adv Med,Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Ko, Albert Icksang] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert Icksang] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Zin, Andrea] Fundacao Oswaldo Cruz, Clin Res Unit, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Maia, Mauricio] Brazilian Inst Fight Blindness Assts & Presidente, Sao Paulo, Brazil.
RP Maia, M (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Pedro de Toledo St 781,2nd Floor, BR-04023062 Sao Paulo, SP, Brazil.
EM mmaia@unifesp.br
RI Maia, Mauricio/I-5892-2015; Ventura, Liana Vieira O/N-6151-2018; Ko,
   Albert Icksang/P-2343-2015; Ventura, Camila V/N-2654-2018; Bravo-Filho,
   Vasco/N-6993-2018
OI Maia, Mauricio/0000-0002-7034-8091; Ventura, Liana Vieira
   O/0000-0001-6529-6883; Ko, Albert Icksang/0000-0001-9023-2339; Ventura,
   Camila V/0000-0002-2927-4684; Bravo-Filho, Vasco/0000-0003-4460-3236
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Alpuche-Lazcano SP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020053
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2016, EURO SURVEILL, V21
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bonafede L, 2015, INVEST OPHTH VIS SCI, V56, P7875, DOI 10.1167/iovs.15-17857
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Diasease Control and Prevention, 2017, MORB MORT WEEK REP M
   Centers for Disease Control and Prevention, 2014, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention, 2016, CFDCAP ZIK VIR
   Centers for Disease Control and Prevention, 2018, ZIK CAS US
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   de Paula Freitas B., 2017, OPHTHALMOLOGY
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   European Centre for Disease Prevention and Control (ECDC), 2017, ZIK TRANSM
   European Centre for Disease Prevention and Control (ECDC), 2017, ZIK VIR TRANSM LIST
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Favoretto S., 2016, 1 DETECTION ZIKA VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez M. P., 2017, JAMA OPHTHALMOLOGY
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917
   Freitas B de Paula, 2016, JAMA OPHTHALMOL
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   FUNG JC, 1985, ANN CLIN LAB SCI, V15, P204
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Garg S, 2009, RETINA-J RET VIT DIS, V29, P631, DOI 10.1097/IAE.0b013e318198d8de
   Gasperi G., 2014, PLOS NEGLECTED TROP, V6, pe1836
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Goldenberg D, 2013, GRAEF ARCH CLIN EXP, V251, P2037, DOI 10.1007/s00417-013-2334-3
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Intergrowth-21st Fetal, 2017, PRETERM NEWBORN APPL
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Lindsey NP, 2015, MMWR-MORBID MORTAL W, V64, P929, DOI 10.15585/mmwr.mm6434a1
   MacNamara F., 1952, ANN REPORT, P1951
   Mani RS, 2016, NATL MED J INDIA, V29, P339
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P41, DOI 10.1007/s11604-016-0599-2
   Mehrjardi MZ, 2017, VIROLOGY AUCKL, V8
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Ministerio da Saude do Brasil, 2016, MIN SAUD BRAS B
   Ministerio da Saude do Brasil, 2017, MIN SAUD BRAS B EP, V48
   Ministerio da Saude do Brasil, 2016, NFORM EP 47 SEMANA E
   Mladinich M. C., 2017, ZIKA VIRUS PERSISTEN
   Mlalcar J., 2016, ENGL J MED, V374, P951
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/msphere.00523-17, 10.1128/mSphere.00523-17]
   Morris G., 2017, MOL NEUROBIOL
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pan American Health Organization/World Health Organization, 2016, ZIK VIR INF STEP STE
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reuters, 2016, BRAZ REP ZIK INF BLO
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robin Y, 1978, B SOC PATHOL EXOT, V68, P249
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Roth A., 2014, EURO SURVEILL, V16
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Secretaria de Estado de Saude do Estado de Sao Paulo, 2016, DISTR CAS NOT CONF F
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009
   Sun Lisa L, 2012, Digit J Ophthalmol, V18, P1, DOI 10.5693/djo.02.2012.04.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tognarelli J., 2015, ARCH VIROL, P665
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura CV, 2014, ARQ BRAS OFTALMOL, V77, P300, DOI 10.5935/0004-2749.20140076
   Ventura L. O., 2017, J AAPOS
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   WHO, 2016, INT GUID
   WHO, 2016, WHO STAT 1 M INT HLT
   WHO/Institut Pasteur/ISARIC/CONSISE, 2017, STAND PROT CROSS SEC
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 2018, HIST ZIK VIR
   World Health Organization, 2017, ZIK SIT REP
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization, 2017, INF TRAV VIS ZIK AFF
   World Health Organization (WHO), 2016, ZIK VIR VECT RISK SP
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 195
TC 9
Z9 9
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1350-9462
EI 1873-1635
J9 PROG RETIN EYE RES
JI Prog. Retin. Eye Res.
PD SEP
PY 2018
VL 66
BP 85
EP 106
DI 10.1016/j.preteyeres.2018.04.004
PG 22
WC Ophthalmology
SC Ophthalmology
GA GW6ZN
UT WOS:000447113700004
PM 29698814
DA 2020-12-01
ER

PT J
AU Frousiakis, S
   Tran, J
   Karanjia, R
   Asanad, S
   Gale, J
   Tian, J
   Pouw, AE
   Conrad, G
   Moraes, M
   Salomao, S
   Belfort, R
   Quiros, PA
   Christianakis, S
   Carelli, V
   Sadun, AA
AF Frousiakis, Starleen
   Tran, Jeffrey
   Karanjia, Rustum
   Asanad, Samuel
   Gale, Jesse
   Tian, Jack
   Pouw, Andrew E.
   Conrad, Gary
   Moraes Filho, Milton
   Salomao, Solange
   Belfort, Rubens, Jr.
   Quiros, Peter A.
   Christianakis, Stratos
   Carelli, Valerio
   Sadun, Alfredo A.
TI Cardiovascular comorbidity in Leber's hereditary optic neuropathy mtDNA
   11778
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY APR 29-MAY 03, 2018
CL Honolulu, HI
SP Assoc Res Vis & Ophthalmol
C1 [Frousiakis, Starleen; Conrad, Gary; Christianakis, Stratos] Huntington Mem Hosp, Internal Med, Pasadena, CA USA.
   [Frousiakis, Starleen; Tran, Jeffrey; Karanjia, Rustum; Asanad, Samuel; Gale, Jesse; Tian, Jack; Quiros, Peter A.; Sadun, Alfredo A.] Doheny Eye Inst, Ophthalmol, 1355 San Pablo St, Los Angeles, CA 90033 USA.
   [Karanjia, Rustum] Univ Ottawa, Ophthalmol, Ottawa, ON, Canada.
   [Gale, Jesse] Univ Otago, Surg & Anaesthesia, Wellington, New Zealand.
   [Pouw, Andrew E.] Yale Univ, Ophthalmol & Visual Sci, New Haven, CT USA.
   [Moraes Filho, Milton] Inst Olhos Colatina, Colatina, Colatina, ES, Brazil.
   [Salomao, Solange; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
   [Quiros, Peter A.; Sadun, Alfredo A.] Univ Calif Los Angeles, Doheny Eye Ctr, Ophthalmol, Los Angeles, CA USA.
   [Carelli, Valerio] Univ Bologna, Sci Neurol, Bologna, Italy.
RI Gale, Jesse/AAB-7406-2019
OI Gale, Jesse/0000-0002-6616-445X
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2018
VL 59
IS 9
MA 3366
PG 3
WC Ophthalmology
SC Ophthalmology
GA GR8CB
UT WOS:000442932800236
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Karanjia, R
   Liu, H
   La Morgia, C
   Nazarali, S
   Moraes, M
   Carbonelli, M
   Berezovsky, A
   Di Vito, L
   De Negri, AM
   Ramos, C
   Liam, A
   Belfort, R
   Salomao, S
   Yu-Wai-Man, P
   Sadun, AA
   Carelli, V
AF Karanjia, Rustum
   Liu, Henry
   La Morgia, Chiara
   Nazarali, Samir
   Moraes Filho, Milton
   Carbonelli, Michele
   Berezovsky, Adriana
   Di Vito, Lidia
   De Negri, Anna Maria
   Ramos, Carolina
   Liam, Alexander
   Belfort, Rubens, Jr.
   Salomao, Solange
   Yu-Wai-Man, Patrick
   Sadun, Alfredo A.
   Carelli, Valerio
TI Understanding the onset of Leber's Hereditary Optic Neuropathy
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY APR 29-MAY 03, 2018
CL Honolulu, HI
SP Assoc Res Vis & Ophthalmol
C1 [Karanjia, Rustum; Liu, Henry; Nazarali, Samir; Liam, Alexander] Univ Ottawa, Ophthalmol, Ottawa, ON, Canada.
   [Karanjia, Rustum; Sadun, Alfredo A.] Univ Calif Los Angeles, Ophthalmol, Los Angeles, CA USA.
   [La Morgia, Chiara; Carbonelli, Michele; Di Vito, Lidia; Carelli, Valerio] IRCCS Inst Neurol Sci Bologna, Bologna, Italy.
   [Moraes Filho, Milton] Inst Olhos Colatina, Colatina, Brazil.
   [Berezovsky, Adriana; Belfort, Rubens, Jr.; Salomao, Solange] Univ Fed Sao Paulo UNIFESP, Dept Oftalmol & Ciencias Visuais, Escola Paulista Med, Sao Paulo, Brazil.
   [De Negri, Anna Maria] S Camillo Forlanini Hosp, Rome, Italy.
   [Ramos, Carolina] Hosp Fed Lagoa, Rio De Janeiro, Brazil.
   [Yu-Wai-Man, Patrick] Univ Cambridge, Cambridge, England.
RI Berezovsky, Adriana/F-2341-2013
OI Berezovsky, Adriana/0000-0001-6350-8221
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2018
VL 59
IS 9
MA 3356
PG 3
WC Ophthalmology
SC Ophthalmology
GA GR8CB
UT WOS:000442932800229
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Goncalves, MB
   Alves, BQ
   Moura, R
   Magalhaes, O
   Maia, A
   Belfort, R
   Avila, M
   Zas, M
   Saravia, MJ
   Lousas, M
   Wu, L
   Arevalo, JF
   Pacheco, KD
   Farah, ME
   Rodriguez, FJ
   Maia, M
AF Goncalves, Mariana Batista
   Alves, Bruno Queiroz
   Moura, Raphael
   Magalhaes Junior, Octaviano
   Maia, Andre
   Belfort, Rubens, Jr.
   Avila, Marcos
   Zas, Marcelo
   Saravia, Mario J.
   Lousas, Marcia
   Wu, Lihteh
   Arevalo, J. Fernando
   Pacheco, Katia Delalibera
   Farah, Michel Eid
   Rodriguez, Francisco J.
   Maia, Mauricio
TI Intravitreal Dexamethasone Implant Migration into the Anterior Chamber:
   A Multicenter Study from the Pan-American Collaborative Retina Study
   Group
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY APR 29-MAY 03, 2018
CL Honolulu, HI
SP Assoc Res Vis & Ophthalmol
C1 [Goncalves, Mariana Batista; Alves, Bruno Queiroz; Moura, Raphael; Magalhaes Junior, Octaviano; Maia, Andre; Belfort, Rubens, Jr.; Farah, Michel Eid; Maia, Mauricio] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, SP, Brazil.
   [Avila, Marcos] Univ Fed Goias, Goiania, Go, Brazil.
   [Zas, Marcelo] Univ Buenos Aires, Buenos Aires, DF, Argentina.
   [Saravia, Mario J.; Lousas, Marcia] Univ Austral, Buenos Aires, DF, Argentina.
   [Wu, Lihteh] Inst Cirugia Ocular, San Jose, Costa Rica.
   [Arevalo, J. Fernando] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA.
   [Pacheco, Katia Delalibera] Vis Eye Hosp, Brazilian Ctr, Brasilia, DF, Brazil.
   [Rodriguez, Francisco J.] Fdn Oftalmol Nacl, Bogota, Colombia.
RI Farah, Michel Eid E/F-3285-2012; Zas, Marcelo/AAF-2679-2020; Maia,
   Mauricio/I-5892-2015
OI Farah, Michel Eid E/0000-0001-5951-0193; Maia,
   Mauricio/0000-0002-7034-8091
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2018
VL 59
IS 9
MA 390
PG 7
WC Ophthalmology
SC Ophthalmology
GA GR7XS
UT WOS:000442912501030
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Dick, AD
   Rosenbaum, JT
   Al-Dhibi, HA
   Belfort, R
   Brezin, AP
   Chee, SP
   Davis, JL
   Ramanan, AV
   Sonoda, KH
   Carreno, E
   Nascimento, H
   Salah, S
   Salek, S
   Siak, J
   Steeples, L
AF Dick, Andrew D.
   Rosenbaum, James T.
   Al-Dhibi, Hassan A.
   Belfort, Rubens, Jr.
   Brezin, Antoine P.
   Chee, Soon Phaik
   Davis, Janet L.
   Ramanan, Athimalaipet V.
   Sonoda, Koh-Hei
   Carreno, Ester
   Nascimento, Heloisa
   Salah, Sawsen
   Salek, Sherveen
   Siak, Jay
   Steeples, Laura
CA Fundamentals Care Uveitis Int Cons
TI Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in
   Noninfectious Uveitis Fundamentals Of Care for UveitiS (FOCUS)
   Initiative
SO OPHTHALMOLOGY
LA English
DT Review
ID JUVENILE IDIOPATHIC ARTHRITIS; LONG-TERM EFFICACY; CHILDHOOD CHRONIC
   UVEITIS; INTERFERON-ALPHA TREATMENT; PULSED INTRAVENOUS
   CYCLOPHOSPHAMIDE; CORTICOSTEROID-SPARING THERAPY; MYCOPHENOLATE-MOFETIL
   THERAPY; SIGHT-THREATENING UVEITIS; RANDOMIZED CLINICAL-TRIAL; SHARED
   DECISION-MAKING
AB Topic: An international, expert-led consensus initiative to develop systematic, evidence-based recommendations for the treatment of noninfectious uveitis in the era of biologics.
   Clinical Relevance: The availability of biologic agents for the treatment of human eye disease has altered practice patterns for the management of noninfectious uveitis. Current guidelines are insufficient to assure optimal use of noncorticosteroid systemic immunomodulatory agents.
   Methods: An international expert steering committee comprising 9 uveitis specialists (including both ophthalmologists and rheumatologists) identified clinical questions and, together with 6 bibliographic fellows trained in uveitis, conducted a Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocol systematic review of the literature (English language studies from January 1996 through June 2016; Medline [OVID], the Central Cochrane library, EMBASE, CINAHL, SCOPUS, BIOSIS, and Web of Science). Publications included randomized controlled trials, prospective and retrospective studies with sufficient follow-up, case series with 15 cases or more, peer-reviewed articles, and hand-searched conference abstracts from key conferences. The proposed statements were circulated among 130 international uveitis experts for review. A total of 44 globally representative group members met in late 2016 to refine these guidelines using a modified Delphi technique and assigned Oxford levels of evidence.
   Results: In total, 10 questions were addressed resulting in 21 evidence-based guidance statements covering the following topics: when to start noncorticosteroid immunomodulatory therapy, including both biologic and nonbiologic agents; what data to collect before treatment; when to modify or withdraw treatment; how to select agents based on individual efficacy and safety profiles; and evidence in specific uveitic conditions. Shared decision-making, communication among providers and safety monitoring also were addressed as part of the recommendations. Pharmacoeconomic considerations were not addressed.
   Conclusions: Consensus guidelines were developed based on published literature, expert opinion, and practical experience to bridge the gap between clinical needs and medical evidence to support the treatment of patients with noninfectious uveitis with noncorticosteroid immunomodulatory agents. (C) 2018 by the American Academy of Ophthalmology.
C1 [Dick, Andrew D.; Ramanan, Athimalaipet V.] Univ Bristol, Sch Clin Sci, Ophthalmol, Bristol, Avon, England.
   [Dick, Andrew D.] UCL, Inst Ophthalmol, London, England.
   [Dick, Andrew D.] UCL, Moorfields Eye Hosp, Biomed Res Ctr, NIHR, London, England.
   [Dick, Andrew D.] UCL, Inst Ophthalmol, London, England.
   [Rosenbaum, James T.] Legacy Devers Eye Inst, Portland, OR USA.
   [Rosenbaum, James T.; Salek, Sherveen] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA.
   [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA.
   [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Cell Biol, Portland, OR 97201 USA.
   [Al-Dhibi, Hassan A.] King Khalid Eye Specialist Hosp, Div Vitreoretinal Surg & Uveitis, Riyadh, Saudi Arabia.
   [Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
   [Belfort, Rubens, Jr.] Vis Inst, Sao Paulo, Brazil.
   [Brezin, Antoine P.; Salah, Sawsen] Univ Paris 05, Hop Cochin, Serv Ophtalmol, Paris, France.
   [Chee, Soon Phaik; Siak, Jay] Singapore Natl Eye Ctr, Ocular Inflammat & Immunol Serv, Singapore, Singapore.
   [Chee, Soon Phaik; Siak, Jay] Singapore Eye Res Inst, Singapore, Singapore.
   [Chee, Soon Phaik; Siak, Jay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore.
   [Chee, Soon Phaik; Siak, Jay] Duke Natl Univ, Singapore Med Sch, Ophthalmol & Visual Sci Acad Clin Program, Singapore, Singapore.
   [Davis, Janet L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.
   [Ramanan, Athimalaipet V.] Univ Hosp Bristol NHS Fdn Trust, Pediat Rheumatol, Bristol, Avon, England.
   [Sonoda, Koh-Hei] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan.
   [Carreno, Ester; Steeples, Laura] Univ Hosp Bristol NHS Fdn Trust, Bristol Eye Hosp, Ophthalmol, Bristol, Avon, England.
   [Nascimento, Heloisa] Univ Fed Sao Paulo, Uveitis Serv, Sao Paulo, Brazil.
   [Salek, Sherveen] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.
   [Steeples, Laura] Cent Manchester Univ Hosp, Manchester Royal Eye Hosp, Manchester, Lancs, England.
   [Steeples, Laura] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.
RP Dick, AD (corresponding author), Univ Bristol, Bristol Eye Hosp, Sch Clin Sci, Lower Maudlin St, Bristol BS1 2LX, Avon, England.
EM opadd@bristol.ac.uk
RI Cuevas, Miguel/L-2687-2019; Yamamoto, Joyce H/B-6192-2015; Nascimento,
   Heloisa/P-8869-2017; Valentincic, Natasa/AAA-2346-2020; Porto, Fernanda
   Belga Ottoni/AAR-3562-2020; Proenca, Rui DMB/F-4932-2017; Carreno,
   Ester/AAD-6863-2020; blanco, ricardo/AAA-1248-2020; de-la-Torre,
   Alejandra/G-6436-2016; Piergiorgio Neri, BMedSc/K-5600-2019; Akkoc,
   Nurullah/D-9870-2011; McCluskey, Peter/H-7607-2013
OI Nascimento, Heloisa/0000-0003-0315-1317; Porto, Fernanda Belga
   Ottoni/0000-0002-4308-1766; Proenca, Rui DMB/0000-0003-3459-8664;
   Carreno, Ester/0000-0002-0055-9547; blanco, ricardo/0000-0003-2344-2285;
   de-la-Torre, Alejandra/0000-0003-0684-1989; Piergiorgio Neri,
   BMedSc/0000-0002-7673-4276; Akkoc, Nurullah/0000-0002-3718-171X;
   Chandran, Vinod/0000-0002-8297-0275; Vidovic Valentincic,
   Natasa/0000-0003-4136-8242; Murphy, Conor/0000-0003-2171-0418; Yamamoto,
   Joyce/0000-0001-6869-2988; SALAH, Sawsen/0000-0003-2078-0430; Lim,
   Lyndell/0000-0003-2491-685X; Beare, Nicholas/0000-0001-8086-990X;
   McCluskey, Peter/0000-0002-8177-1637; Barisani-Asenbauer,
   Talin/0000-0002-8661-9183
FU AbbVie, Inc.; Fundamentals of Care for Uveitis Initiative National
   Faculty; AbbVie; Chief Scientist Office [ETM/351] Funding Source:
   researchfish; ReumaFonds [LLP-10] Funding Source: researchfish
FX Supported by AbbVie, Inc., and the Fundamentals of Care for Uveitis
   Initiative National Faculty. This manuscript was developed subsequent to
   an AbbVie-sponsored literature review of noninfectious, nonanterior
   uveitis. The meeting was conducted to understand the available
   literature regarding the management of patients with noninfectious,
   nonanterior uveitis. The program involved a total of 139 experts from 28
   countries, who were selected for participation by AbbVie. However,
   AbbVie was not involved in the development of the manuscript. The
   authors maintained complete control over the content and this manuscript
   reflects the opinions of the authors. AbbVie selected the discussion
   participants and reviewed the final manuscript draft for scientific
   accuracy, but the authors determined the final content. All authors made
   substantial contributions to the article or critically revised it for
   important intellectual content and approved the final manuscript. AbbVie
   provided funding to invited participants, including honoraria for their
   attendance at the meetings. Travel to and from the meetings was
   reimbursed. No payments were made to the authors for the development of
   this manuscript. Dhinakaran Sambandan, PhD, and Shula Sarner, PhD, of
   Lucid Partners, Burleighfield House, Buckinghamshire, United Kingdom,
   provided medical writing and editorial support to the authors in the
   development of this manuscript; financial support for these services was
   provided by AbbVie. AbbVie reviewed the manuscript, but was not involved
   in the methodology, data collection and analysis, or completion of this
   manuscript.
CR Abasolo L, 2016, AM J OPHTHALMOL, V169, P1, DOI 10.1016/j.ajo.2016.06.007
   AbbVie International, 2017, PRESCR INF HUM
   AbbVie Limited, 2017, HUM 40 MG 0 4 ML PRE
   Abu El-Asrar AM, 2012, ACTA OPHTHALMOL, V90, pe603, DOI 10.1111/j.1755-3768.2012.02498.x
   Al Rashidi S, 2013, OCUL IMMUNOL INFLAMM, V21, P468, DOI 10.3109/09273948.2013.779727
   Al-Rayes H, 2008, RHEUMATOL INT, V29, P53, DOI 10.1007/s00296-008-0606-8
   Alpsoy E, 2002, ARCH DERMATOL, V138, P467, DOI 10.1001/archderm.138.4.467
   Ambresin A, 2002, OCUL IMMUNOL INFLAMM, V10, P53, DOI 10.1076/ocii.10.1.53.10326
   [Anonymous], 2017, JAMA-J AM MED ASSOC, V317, P1993
   Cervantes-Castaneda RA, 2013, BRIT J OPHTHALMOL, V97, P637, DOI 10.1136/bjophthalmol-2012-302123
   Arriola-Villalobos P, 2017, OCUL IMMUNOL INFLAMM, P1
   Bagnis CI, 2002, J AM SOC NEPHROL, V13, P2962, DOI 10.1097/01.ASN.0000034945.61533.26
   Baker KB, 2006, BRIT J OPHTHALMOL, V90, P1481, DOI 10.1136/bjo.2006.097998
   Barisani-Asenbauer T, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-57
   Barone SB, 2005, INVEST OPHTH VIS SCI, V46, P2847
   Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283
   Barton JL, 2016, ARTHRIT CARE RES, V68, P889, DOI 10.1002/acr.22801
   Baszis K, 2011, ARTHRITIS RHEUM-US, V63, P3163, DOI 10.1002/art.30502
   Baughman RP, 2005, CHEST, V128, P1062, DOI 10.1378/chest.128.2.1062
   Becker MD, 2005, DRUGS, V65, P497, DOI 10.2165/00003495-200565040-00005
   Biester S, 2007, BRIT J OPHTHALMOL, V91, P319, DOI 10.1136/bjo.2006.103721
   Bodaghi B, 2007, BRIT J OPHTHALMOL, V91, P335, DOI 10.1136/bjo.2006.101550
   BOSKOVICH SA, 1993, CLEV CLIN J MED, V60, P460, DOI 10.3949/ccjm.60.6.460
   Breitbach M, 2017, GRAEF ARCH CLIN EXP, V255, P171, DOI 10.1007/s00417-016-3497-5
   Calguneri M, 2003, ANN RHEUM DIS, V62, P492, DOI 10.1136/ard.62.5.492
   Canete JD, 2014, ACTAS DERMO-SIFILOGR, V105, P216, DOI [10.1016/j.adengl.2013.07.003, 10.1016/j.ad.2013.07.001]
   Centre for Evidence-Based Medicine (CEBM), 2009, OXF CTR EV BAS MED L
   Cervantes-Castaneda RA, 2009, EUR J OPHTHALMOL, V19, P118
   Chang JHM, 2002, OCUL IMMUNOL INFLAMM, V10, P263, DOI 10.1076/ocii.10.4.263.15592
   Chia A, 2003, AM J OPHTHALMOL, V135, P757, DOI 10.1016/S0002-9394(03)00225-3
   Coates LC, 2016, ARTHRITIS RHEUMATOL, V68, P1060, DOI 10.1002/art.39573
   CUMMINS RO, 1980, JAMA-J AM MED ASSOC, V243, P1650, DOI 10.1001/jama.243.16.1650
   D'Angelo S, 2015, ANN RHEUM DIS, V74, P516, DOI 10.1136/annrheumdis-2015-eular.3751
   Dana MR, 1997, OPHTHALMOLOGY, V104, P236, DOI 10.1016/S0161-6420(97)30329-7
   Davatchi F, 2010, INT J RHEUM DIS, V13, P246, DOI 10.1111/j.1756-185X.2010.01546.x
   de Boer J, 2003, BRIT J OPHTHALMOL, V87, P879, DOI 10.1136/bjo.87.7.879
   de Smet M, 2005, INVEST OPHTH VIS SCI, V46, P1139
   Deuter CME, 2009, BRIT J OPHTHALMOL, V93, P906, DOI 10.1136/bjo.2008.153874
   Deuter CME, 2010, ARTHRITIS RHEUM-US, V62, P2796, DOI 10.1002/art.27581
   Diaz-Llopis M, 2008, J OCUL PHARMACOL TH, V24, P351, DOI 10.1089/jop.2007.0104
   Diaz-Llopis M, 2012, OPHTHALMOLOGY, V119, P1575, DOI 10.1016/j.ophtha.2012.02.018
   DICK AD, 1994, BRIT J OPHTHALMOL, V78, P1, DOI 10.1136/bjo.78.1.1
   Dick AD, 2016, OPHTHALMOLOGY, V123, P655, DOI 10.1016/j.ophtha.2015.10.028
   Dick AD, 2013, OPHTHALMOLOGY, V120, P777, DOI 10.1016/j.ophtha.2012.09.040
   Ding T, 2010, RHEUMATOLOGY, V49, P2217, DOI 10.1093/rheumatology/keq249a
   Diwo E, 2017, OCUL IMMUNOL INFLAMM, V25, P76, DOI 10.1080/09273948.2016.1206204
   Doycheva D, 2015, BRIT J OPHTHALMOL, V99, P87, DOI 10.1136/bjophthalmol-2014-305535
   Doycheva D, 2011, GRAEF ARCH CLIN EXP, V249, P1235, DOI 10.1007/s00417-011-1731-8
   Edelsten C, 2003, AM J OPHTHALMOL, V135, P676, DOI 10.1016/S0002-9394(02)02148-7
   Engelhard SB, 2015, CLIN OPHTHALMOL, V9, P1549, DOI [10.2147/OPTH.S89428, 10.2147/OPTH.889428]
   Erckens RJ, 2012, GRAEF ARCH CLIN EXP, V250, P713, DOI 10.1007/s00417-011-1844-0
   Fabiani C, 2016, CLIN RHEUMATOL, V35, P2631, DOI 10.1007/s10067-016-3426-3
   FORRESTER JV, 1990, BRIT J OPHTHALMOL, V74, P620, DOI 10.1136/bjo.74.10.620
   Foster CS, 2016, SURV OPHTHALMOL, V61, P1, DOI 10.1016/j.survophthal.2015.07.001
   Foster CS, 2003, ARCH OPHTHALMOL-CHIC, V121, P437, DOI 10.1001/archopht.121.4.437
   Friedman DS, 2013, OPHTHALMOLOGY, V120, P1571, DOI 10.1016/j.ophtha.2013.01.025
   Galor A, 2008, OPHTHALMOLOGY, V115, P1826, DOI 10.1016/j.ophtha.2008.04.026
   Gandhi TK, 2000, J GEN INTERN MED, V15, P626, DOI 10.1046/j.1525-1497.2000.91119.x
   Gangaputra S, 2009, OPHTHALMOLOGY, V116, P2188, DOI 10.1016/j.ophtha.2009.04.020
   GENDRON G, 2003, INVEST OPHTH VIS S1, V44
   Gendron G, 2005, INVEST OPHTH VIS SCI, V46, P2384
   Georgiou S, 1998, J INTERN MED, V243, P367
   Giardina A, 2011, RHEUMATOL INT, V31, P33, DOI 10.1007/s00296-009-1213-z
   Gossec L, 2016, ANN RHEUM DIS, V75, P499, DOI 10.1136/annrheumdis-2015-208337
   Grange LK, 2014, AM J OPHTHALMOL, V157, P526, DOI 10.1016/j.ajo.2013.11.002
   Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014
   Gueudry J, 2008, AM J OPHTHALMOL, V146, P837, DOI 10.1016/j.ajo.2008.08.038
   Guignard S, 2006, ANN RHEUM DIS, V65, P1631, DOI 10.1136/ard.2006.052092
   Hale S, 2006, CYTOKINE, V33, P231, DOI 10.1016/j.cyto.2005.12.012
   Hamuryudan V, 2002, ISR MED ASSOC J, V4, P928
   Heiligenhaus A, 2012, RHEUMATOL INT, V32, P1121, DOI 10.1007/s00296-011-2126-1
   Hogan AC, 2007, OPHTHALMOLOGY, V114, P1000, DOI 10.1016/j.ophtha.2007.01.026
   Holland GN, 2009, AM J OPHTHALMOL, V147, P667, DOI 10.1016/j.ajo.2008.11.009
   Hui MM, 2017, OCUL IMMUNOL INFLAMM, V25, P486, DOI 10.3109/09273948.2016.1139734
   Ibrahim MA, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.2.4
   Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0
   Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057
   Jabs DA, 2013, AM J OPHTHALMOL, V156, P228, DOI 10.1016/j.ajo.2013.03.027
   Jaffe GJ, 2015, ANN RHEUM DIS, V74, P849, DOI 10.1136/annrheumdis-2015-eular.2799
   Kacmaz RO, 2010, OPHTHALMOLOGY, V117, P576, DOI 10.1016/j.ophtha.2009.08.010
   Kane Sunanda V, 2011, Gastroenterol Hepatol (N Y), V7, P544
   Kaplan-Messas A, 2003, OCUL IMMUNOL INFLAMM, V11, P131, DOI 10.1076/ocii.11.2.131.15919
   Karim R, 2013, CLIN OPHTHALMOL, V7, P1109, DOI 10.2147/OPTH.S40268
   Kawaguchi T, 2014, JPN J OPHTHALMOL, V58, P75, DOI 10.1007/s10384-013-0283-3
   Kempen JH, 2015, OPHTHALMOLOGY, V122, P1976, DOI 10.1016/j.ophtha.2015.06.043
   Kesen MR, 2008, AM J OPHTHALMOL, V146, P819, DOI 10.1016/j.ajo.2008.05.043
   Khan IJ, 2013, BRIT J OPHTHALMOL, V97, P1118, DOI 10.1136/bjophthalmol-2012-302130
   Kim SJ, 2007, OCUL IMMUNOL INFLAMM, V15, P381, DOI 10.1080/09273940701624312
   Kotaniemi K, 2011, CLIN OPHTHALMOL, V5, P1425, DOI 10.2147/OPTH.S23646
   Kotter I, 2003, BRIT J OPHTHALMOL, V87, P423, DOI 10.1136/bjo.87.4.423
   Krause L, 2008, J RHEUMATOL, V35, P896
   Ledingham J, 2017, RHEUMATOLOGY, V56, P865, DOI 10.1093/rheumatology/kew479
   Lee RWJ, 2012, OPHTHALMOLOGY, V119, P1223, DOI 10.1016/j.ophtha.2011.12.030
   Lerman MA, 2015, AM J OPHTHALMOL, V160, P193, DOI 10.1016/j.ajo.2015.04.016
   Lescrauwaet B, 2015, VALUE HEALTH, V18, pA426, DOI 10.1016/j.jval.2015.09.586
   Letko E, 2015, OPHTHALMOLOGY, V122, P939, DOI 10.1016/j.ophtha.2014.12.033
   Levy-Clarke G, 2014, OPHTHALMOLOGY, V121, P785, DOI 10.1016/j.ophtha.2013.09.048
   Lightman S, 2015, ANN RHEUM DIS, V74, P1138, DOI 10.1136/annrheumdis-2014-205571
   Lim LL, 2007, ARTHRITIS RHEUM, V56, P3248, DOI 10.1002/art.22918
   Mackensen F, 2012, ACTA OPHTHALMOL, V90, DOI [10.1111/j.1755-3768.2012.2276.x/full, DOI 10.1111/J.1755-3768.2012.2276.X/FULL]
   Mackensen F, 2013, AM J OPHTHALMOL, V156, P478, DOI 10.1016/j.ajo.2013.05.002
   Magli A, 2013, GRAEF ARCH CLIN EXP, V251, P1601, DOI 10.1007/s00417-013-2275-x
   Markomichelakis N, 2011, RHEUMATOLOGY, V50, P593, DOI 10.1093/rheumatology/keq366
   Mili-Boussen Ilhem, 2015, Tunis Med, V93, P158
   Mocko P, 2017, CLIN DRUG INVEST, V37, P25, DOI 10.1007/s40261-016-0459-y
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Murphy CC, 2005, ARCH OPHTHALMOL-CHIC, V123, P634, DOI 10.1001/archopht.123.5.634
   Nakabayashi A, 2013, ARTHRITIS RHEUM-US, V65, pS1119
   Nussenblatt RB, 2005, OPHTHALMOLOGY, V112, P764, DOI 10.1016/j.ophtha.2004.12.034
   Onal S, 2011, ARCH OPHTHALMOL-CHIC, V129, P288, DOI 10.1001/archophthalmol.2011.3
   Pacheco PA, 2008, OCUL IMMUNOL INFLAMM, V16, P161, DOI 10.1080/09273940802204519
   Palmer Deborah, 2010, Br J Nurs, V19, P477
   Pan J, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0409-1
   Papagiannuli E, 2016, OCUL IMMUNOL INFLAMM, V26, P1, DOI DOI 10.1007/S12105-013-0506-4
   Pasadhika S, 2009, AM J OPHTHALMOL, V148, P500, DOI 10.1016/j.ajo.2009.05.008
   Patel SS, 2014, OPHTHALMOLOGY, V121, P596, DOI 10.1016/j.ophtha.2013.09.009
   Pato E, 2017, RHEUMATOL INT, V37, P647, DOI 10.1007/s00296-016-3593-1
   Pato E, 2011, SEMIN ARTHRITIS RHEU, V40, P314, DOI 10.1016/j.semarthrit.2010.05.008
   Pion B, 2013, Bull Soc Belge Ophtalmol, P55
   Pujari SS, 2010, OPHTHALMOLOGY, V117, P356, DOI 10.1016/j.ophtha.2009.06.060
   Nguyen QD, 2016, OPHTHALMOLOGY, V123, P2413, DOI 10.1016/j.ophtha.2016.07.029
   Nguyen QD, 2016, LANCET, V388, P1183, DOI 10.1016/S0140-6736(16)31339-3
   Ramanan AV, 2017, NEW ENGL J MED, V376, P1637, DOI 10.1056/NEJMoa1614160
   Ramanan AV, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-14
   Rathinam SR, 2014, OPHTHALMOLOGY, V121, P1863, DOI 10.1016/j.ophtha.2014.04.023
   Robinson PC, 2016, GENES IMMUN, V17, P46, DOI 10.1038/gene.2015.49
   Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332
   ROTHOVA A, 1992, BRIT J OPHTHALMOL, V76, P137, DOI 10.1136/bjo.76.3.137
   Rudwaleit M, 2009, ANN RHEUM DIS, V68, P696, DOI 10.1136/ard.2008.092585
   Saadoun D, 2010, ARTHRIT CARE RES, V62, P1733, DOI 10.1002/acr.20308
   Sakai T, 2013, BRIT J OPHTHALMOL, V97, P338, DOI 10.1136/bjophthalmol-2012-302515
   Samson CM, 2001, OPHTHALMOLOGY, V108, P1134, DOI 10.1016/S0161-6420(01)00576-0
   Sen ES, 2012, RHEUMATOLOGY, V51, P2199, DOI 10.1093/rheumatology/kes212
   Shakoor A, 2014, OCUL IMMUNOL INFLAMM, V22, P96, DOI 10.3109/09273948.2013.812222
   Shen E, 2016, AM J OPHTHALMOL, V168, P279, DOI 10.1016/j.ajo.2016.06.004
   Sikic J, 2001, COLLEGIUM ANTROPOL, V25, P71
   Simonini G, 2008, RHEUMATOLOGY, V47, P1510, DOI 10.1093/rheumatology/ken298
   Simonini G, 2015, SEMIN ARTHRITIS RHEU, V45, P238, DOI 10.1016/j.semarthrit.2015.05.006
   Simonini G, 2014, SEMIN ARTHRITIS RHEU, V44, P39, DOI 10.1016/j.semarthrit.2014.03.001
   Simonini G, 2014, ARTHRIT CARE RES, V66, P1073, DOI 10.1002/acr.22214
   Simonini G, 2013, RHEUMATOLOGY, V52, P825, DOI 10.1093/rheumatology/kes186
   Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783
   Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715
   Sobaci G, 2010, OPHTHALMOLOGY, V117, P1430, DOI 10.1016/j.ophtha.2009.11.022
   Stolwijk C, 2015, ANN RHEUM DIS, V74, P65, DOI 10.1136/annrheumdis-2013-203582
   Suelves AM, 2013, OPHTHALMOLOGY, V120, P1201, DOI 10.1016/j.ophtha.2013.01.031
   Suhler EB, 2005, ARCH OPHTHALMOL-CHIC, V123, P903, DOI 10.1001/archopht.123.7.903
   SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844
   Tabbara KF, 2008, AM J OPHTHALMOL, V146, P845, DOI 10.1016/j.ajo.2008.09.010
   Takeuchi M, 2014, OPHTHALMOLOGY, V121, P1877, DOI 10.1016/j.ophtha.2014.04.042
   Taylor SRJ, 2012, OCUL IMMUNOL INFLAMM, V20, P171, DOI 10.3109/09273948.2012.658467
   Taylor SRJ, 2009, OPHTHALMOLOGY, V116, P797, DOI 10.1016/j.ophtha.2008.10.033
   Teoh SC, 2008, AM J OPHTHALMOL, V146, P752, DOI 10.1016/j.ajo.2008.03.004
   Thorne JE, 2005, OPHTHALMOLOGY, V112, P1472, DOI 10.1016/j.ophtha.2005.02.020
   Thorne JE, 2007, AM J OPHTHALMOL, V143, P840, DOI 10.1016/j.ajo.2007.01.033
   Thorne JE, 2016, JAMA OPHTHALMOL, V134, P1237, DOI 10.1001/jamaophthalmol.2016.3229
   Tomkins-Netzer O, 2014, OPHTHALMOLOGY, V121, P2387, DOI 10.1016/j.ophtha.2014.07.007
   Toupin-April K, 2015, J RHEUMATOL, V42, P2442, DOI 10.3899/jrheum.141205
   Tranos P, 2006, BRIT J OPHTHALMOL, V90, P1107, DOI 10.1136/bjo.2006.092965
   Tugal-Tutkun I, 2004, AM J OPHTHALMOL, V138, P373, DOI 10.1016/j.ajo.2004.03.022
   Tugal-Tutkun I, 2003, AM J OPHTHALMOL, V136, P1114, DOI 10.1016/S0002-9394(03)00791-8
   Tugal-Tutkun I, 2006, GRAEF ARCH CLIN EXP, V244, P1692, DOI 10.1007/s00417-006-0346-y
   Tynjala P, 2008, RHEUMATOLOGY, V47, P339, DOI 10.1093/rheumatology/kem356
   van Denderen JC, 2014, J RHEUMATOL, V41, P1843, DOI 10.3899/jrheum.131289
   van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770
   Vigil EM, 2015, J OPHTHALMIC INFLAMM, V5, DOI 10.1186/s12348-015-0044-1
   Wakefield D, 2017, AUTOIMMUN REV, V16, P213, DOI 10.1016/j.autrev.2017.01.003
   Ward MM, 2016, ARTHRITIS RHEUMATOL, V68, P282, DOI 10.1002/art.39298
   Whallett AJ, 1999, QJM-MON J ASSOC PHYS, V92, P727, DOI 10.1093/qjmed/92.12.727
   Yamada Y, 2011, BRIT J OPHTHALMOL, V95, P205, DOI 10.1136/bjo.2009.168856
   Yamada Y, 2010, BRIT J OPHTHALMOL, V94, P284, DOI 10.1136/bjo.2009.158840
   Yang PZ, 2007, OPHTHALMOLOGY, V114, P606, DOI 10.1016/j.ophtha.2006.07.040
   Yates WB, 2015, OPHTHALMOLOGY, V122, P265, DOI 10.1016/j.ophtha.2014.08.024
   Yu EN, 2005, OCUL IMMUNOL INFLAMM, V13, P353, DOI 10.1080/09273940590951061
   Yu T, 2015, INVEST OPHTH VIS SCI, V56, P6864, DOI 10.1167/iovs.15-16705
NR 175
TC 47
Z9 47
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD MAY
PY 2018
VL 125
IS 5
BP 757
EP 773
DI 10.1016/j.ophtha.2017.11.017
PG 17
WC Ophthalmology
SC Ophthalmology
GA GD5PL
UT WOS:000430558800029
PM 29310963
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU Marquezan, MC
   Ventura, CV
   Sheffield, JS
   Golden, WC
   Omiadze, R
   Belfort, R
   May, W
AF Marquezan, Maria Carolina
   Ventura, Camila V.
   Sheffield, Jeanne S.
   Golden, William Christopher
   Omiadze, Revaz
   Belfort, Rubens, Jr.
   May, William
TI Ocular effects of Zika virus-a review
SO SURVEY OF OPHTHALMOLOGY
LA English
DT Review
DE Zika virus; ocular findings; congenital Zika syndrome; epidemic
ID GUILLAIN-BARRE-SYNDROME; BIRTH-DEFECTS; INFECTION; INFANTS;
   TRANSMISSION; OUTBREAK; DISEASE; BRAZIL; MANIFESTATIONS; ANTIBODIES
AB Zika virus was considered an innocent pathogen while restricted to the African and Asian population; however, after reaching the Americas in March 2015, it became a global threat. Despite usually causing mild or no symptoms in infected adults, Zika virus displays a different behavior toward fetuses. When infected during gestation, fetuses have their immature neural cells killed by the virus and consequently have devastating findings at birth. In the past year the drastic effects of Zika virus infection in newborns include neurological, ophthalmological, audiological, and skeletal abnormalities. These findings represent a new entity called congenital Zika syndrome. We summarize the ocular findings of congenital Zika Syndrome, as well as the current understanding of the illness, systemic manifestations, laboratory investigation, differential diagnosis, prophylaxis, and treatment for this disorder. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Marquezan, Maria Carolina; Ventura, Camila V.; Belfort, Rubens, Jr.] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Marquezan, Maria Carolina; Ventura, Camila V.; Belfort, Rubens, Jr.] Vis Inst, Sao Paulo, SP, Brazil.
   [Marquezan, Maria Carolina; Omiadze, Revaz; May, William] Johns Hopkins Univ Hosp, Wilmer Ophthalmol Inst, Baltimore, MD 21287 USA.
   [Ventura, Camila V.] Altino Ventura Fdn FAV, Recife, PE, Brazil.
   [Sheffield, Jeanne S.] Johns Hopkins Med, Dept Gynecol & Obstet, Baltimore, MD USA.
   [Golden, William Christopher] Johns Hopkins Med, Dept Pediat, Baltimore, MD USA.
RP Marquezan, MC (corresponding author), Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.; Marquezan, MC (corresponding author), Vis Inst, Sao Paulo, SP, Brazil.; Marquezan, MC (corresponding author), Johns Hopkins Univ Hosp, Wilmer Ophthalmol Inst, Baltimore, MD 21287 USA.
EM mcmarquezan@gmail.com
RI Ventura, Camila V/N-2654-2018
OI Ventura, Camila V/0000-0002-2927-4684; Golden,
   William/0000-0002-4834-6778
CR Aggarwal A, 2013, J NEUROSCI RURAL PRA, V4, P288, DOI 10.4103/0976-3147.118781
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   [Anonymous], 2016, PREGN WOM AN LAB EV
   [Anonymous], 2016, 5 M EM COMM INT HLTH
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, TRANSM RISKS
   Centers for Disease Control and Prevention, AB ZIK
   Centers for Disease Control and Prevention, 2016, OUTC COMPL PREGN US
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US 2015
   Centers for Disease Control and Prevention, TREATM
   Centers for Disease Control and Prevention, SYMPT TEST TREATM
   Centers for Disease Control and Prevention (CDC), ZIK VIR PREV
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cuturilo G, 2008, BIRTH DEFECTS RES A, V82, P166, DOI 10.1002/bdra.20441
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira Dias JR, 2017, RETIN CASES BRIEF RE
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dimantas Maria Angélica Pavão, 2003, Arq. Bras. Oftalmol., V66, P235, DOI 10.1590/S0004-27492003000200023
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   El-Ruby M, 2007, GENET COUNSEL, V18, P217
   Fernandez DG, 2016, OCUL IMMUNOL INFLAMM, P1, DOI DOI 10.3109/09273948.2015.1132741
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Goyal R, 2008, EYE, V22, P273, DOI 10.1038/sj.eye.6702958
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jonas JB, 2003, EUR J OPHTHALMOL, V13, P209
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Rosa RFM, 2015, SAO PAULO MED J, V133, P377, DOI 10.1590/1516-3180.2013.7930003
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-35
   Man BL, 2014, BMJ CASE REP, V2014
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mulvihill AO, 2007, BRIT J OPHTHALMOL, V91, P613, DOI 10.1136/bjo.2006.105569
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   O'Hara MF, 2002, TERATOLOGY, V65, P131, DOI 10.1002/tera.10028
   OLSHAN AF, 1989, INT J EPIDEMIOL, V18, P891, DOI 10.1093/ije/18.4.891
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Rasool N, 2016, JAMA OPHTHALMOL, V134, P1200, DOI 10.1001/jamaophthalmol.2016.2398
   Lyra PPR, 2016, AJP REP, V6, pE299, DOI 10.1055/s-0036-1587323
   Roze B, 2016, EUROSURVEILLANCE, V21, P1
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scripsema Nicole K, 2015, Retin Cases Brief Rep, V9, P352, DOI 10.1097/ICB.0000000000000232
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsay CH, 1996, J CHILD NEUROL, V11, P25, DOI 10.1177/088307389601100106
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, 2017, SIT REP
   Wong CW, 2017, RETIN CASES BRIEF RE
   World Health Organization, 2016, REG ZIK EP UPD AM
   World Health Organization. Programmes, 2016, 1 ZIK EM COMM
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 97
TC 7
Z9 7
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0039-6257
EI 1879-3304
J9 SURV OPHTHALMOL
JI Surv. Ophthalmol.
PD MAR-APR
PY 2018
VL 63
IS 2
BP 166
EP 173
DI 10.1016/j.survophthal.2017.06.001
PG 8
WC Ophthalmology
SC Ophthalmology
GA FX4EN
UT WOS:000426025600003
PM 28623165
DA 2020-12-01
ER

PT J
AU Salomao, SR
   Berezovsky, A
   Furtado, JM
   Fernandes, AG
   Munoz, S
   Cavascan, NN
   Cypel, MC
   Cunha, CC
   Vasconcelos, GC
   Mitsuhiro, MRKH
   Sacai, PY
   Campos, M
   Morales, PHA
   Cohen, MJ
   Cohen, JM
   Watanabe, SES
   Belfort, R
AF Salomao, Solange R.
   Berezovsky, Adriana
   Furtado, Joao M.
   Fernandes, Arthur G.
   Munoz, Sergio
   Cavascan, Nivea N.
   Cypel, Marcela C.
   Cunha, Cristina C.
   Vasconcelos, Galton C.
   Mitsuhiro, Marcia R. K. H.
   Sacai, Paula Y.
   Campos, Mauro
   Morales, Paulo H. A.
   Cohen, Marcos J.
   Cohen, Jacob M.
   Watanabe, Sung E. S.
   Belfort, Rubens, Jr.
TI Vision Status in Older Adults: The Brazilian Amazon Region Eye Survey
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CORRECTABLE VISUAL IMPAIRMENT; POPULATION; BLINDNESS; PREVALENCE;
   MAGNITUDE; ACUITY
AB Older adults living in remote areas with limited access to health services are at higher risk to develop visual impairment and blindness. We conducted a population-based survey to determine the vision status in subjects 45 years of age and older from urban and rural areas of Parintins city, Brazilian Amazon Region. Participants underwent ophthalmic examination, including uncorrected (UCVA), presenting (PVA) and best-corrected visual acuity (BCVA). Vision status was described as lines of visual acuity (VA) impairment and lines of VA improvement from UCVA to BCVA and from PVA to BCVA in the better-seeing eye. A total of 2384 subjects were enumerated, 2041 (85.6%) were examined, with reliable VA measurements obtained from 2025 participants. Vision status in lines of VA impairment was (mean +/- standard deviation): 3.44 +/- 3.53 for UCVA, 2.85 +/- 3.52 for PVA and 1.50 +/- 3.51 for BCVA. Female gender, older age and lower education were associated with >= 6 lines of UCVA impairment. Lines of improvement >= 3 was found in 626 (30.9%) participants and associated with female gender and rural residency. In conclusion, a third of participants could have at least three lines of VA improvement with proper refraction. Strategies to improve access to eye care and affordable glasses are needed.
C1 [Salomao, Solange R.; Berezovsky, Adriana; Furtado, Joao M.; Fernandes, Arthur G.; Cavascan, Nivea N.; Cypel, Marcela C.; Vasconcelos, Galton C.; Mitsuhiro, Marcia R. K. H.; Sacai, Paula Y.; Campos, Mauro; Morales, Paulo H. A.; Watanabe, Sung E. S.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Sao Paulo, SP, Brazil.
   [Furtado, Joao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Ribeirao Preto, SP, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
   [Cunha, Cristina C.] Univ Fed UFPA, Fac Med, Belem, PA, Brazil.
   [Vasconcelos, Galton C.] Univ Fed Minas Gerais, Fac Med, Dept Oftalmol & Otorrinolaringol, Belo Horizonte, MG, Brazil.
   [Cohen, Marcos J.; Cohen, Jacob M.] Univ Fed Amazonas UFAM, Fac Med, Dept Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
RP Salomao, SR (corresponding author), Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Sao Paulo, SP, Brazil.
EM ssalomao@unifesp.br
RI Sacai, Paula Y/B-6525-2014; Berezovsky, Adriana/F-2341-2013; Ferraz,
   Nivea/AAC-2439-2020; de Queiroz Campos, Mauro Silveira/H-7609-2017
OI Berezovsky, Adriana/0000-0001-6350-8221; Ferraz,
   Nivea/0000-0001-7568-6199; de Queiroz Campos, Mauro
   Silveira/0000-0002-9448-8742; Furtado, Joao M./0000-0003-2490-5747;
   Fernandes, Arthur Gustavo/0000-0002-7525-1838
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras [402120/2012-4];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   BrasilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/16397-7]; SightFirst Program - Lions Club International Foundation
   [1758]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras (Grant # 402120/2012-4
   to SRS, SM and JMF; Research Scholarships to SRS and RBJ); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo, Brasil
   (Grant # 2013/16397-7 to SRS); SightFirst Program - Lions Club
   International Foundation (Grant # 1758 to SRS). The authors thank Dr.
   Leon Ellwein for his comments and suggestions in the manuscript
   structure and writing.
CR Foran S, 2002, AM J OPHTHALMOL, V134, P712, DOI 10.1016/S0002-9394(02)01673-2
   KLEIN R, 1991, OPHTHALMOLOGY, V98, P1310
   Kuang TM, 2007, INVEST OPHTH VIS SCI, V48, P1032, DOI 10.1167/iovs.06-0616
   Munoz B, 2002, INVEST OPHTH VIS SCI, V43, P608
   Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210
   Salomao SR, 2008, OPHTHAL EPIDEMIOL, V15, P167, DOI 10.1080/09286580701843812
   Salomao SR, 2017, OPHTHAL EPIDEMIOL, V24, P257, DOI 10.1080/09286586.2016.1276199
   Stata Corporation, 2015, STATA SE STAT SOFTW
   Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025
   Sunness JS, 2010, OPHTHALMOLOGY, V117, P1442, DOI 10.1016/j.ophtha.2009.11.017
   WHO, 2003, CONS DEV STAND CHAR
   World Health Organization, 2016, ICD 10 INT STAT CLAS
   Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023
NR 13
TC 3
Z9 3
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 17
PY 2018
VL 8
AR 886
DI 10.1038/s41598-018-19338-6
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS9DR
UT WOS:000422716900020
PM 29343840
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Belfort, R
AF Belfort, Rubens, Jr.
TI 80 years of Arquivos Brasileiros de Oftalmologia (ABO)
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Editorial Material
C1 [Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Belfort, Rubens, Jr.] Vis Inst IPEPO, Sao Paulo, Brazil.
   [Belfort, Rubens, Jr.] Natl Acad Med, Washington, DC 20001 USA.
   [Belfort, Rubens, Jr.] Brazilian Acad Sci, Rio De Janeiro, RJ, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.; Belfort, R (corresponding author), Vis Inst IPEPO, Sao Paulo, Brazil.; Belfort, R (corresponding author), Natl Acad Med, Washington, DC 20001 USA.; Belfort, R (corresponding author), Brazilian Acad Sci, Rio De Janeiro, RJ, Brazil.
EM prof.belfort@clinicabelfort.com.br
NR 0
TC 1
Z9 1
U1 0
U2 1
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JAN-FEB
PY 2018
VL 81
IS 1
BP VII
EP VIII
DI 10.5935/0004-2749.20180002
PG 2
WC Ophthalmology
SC Ophthalmology
GA FZ2IL
UT WOS:000427401000002
PM 29538603
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Damasceno, JC
   Isenberg, J
   Lopes, LR
   Hime, B
   Fernandes, BF
   Lowen, M
   Camargo, LMA
   Belfort, RN
AF Damasceno, Jessica Carolinne
   Isenberg, Jordan
   Lopes, Laise Rondon
   Hime, Bernardo
   Fernandes, Bruno F.
   Lowen, Marcia
   Aranha Camargo, Luis Marcelo
   Belfort, Rubens N.
TI Largest case series of Latin American eyelid tumors over 13-Years from a
   single center in Sao Paulo, Brazil
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Eyelid neoplasms; Basal cell carcinoma; Squamous cell carcinoma;
   Melanoma; Brazil
ID BASAL-CELL CARCINOMA; NONMELANOMA SKIN-CANCER; RISK; EXPOSURE; LESIONS
AB Purpose: Malignant lesions of the eyelid are the most common eye cancers. Although rarely lethal, late diagnosis can lead to serious visual morbidity. Definitive diagnosis of neoplastic lesions is pathological. Indications and types of eyelid lesions in a single high-volume ophthalmic reference center in Sao Paulo, Brazil, were analyzed. Methods: The surgical pathological reports of patients who underwent eye removal procedures between January 2000 and December 2012 were retrieved from the electronic database of the Ophthalmology Department and retrospectively reviewed. Data regarding the final anatomopathological diagnosis, sex, and age were analyzed via the chi(2) test with Yates' correction. Results: Of the 1,113 eyelid tumors resected over the 13-year study period, 324 (29%) lesions were malignant. The most prevalent lesions were basal cell, squamous cell, and sebaceous gland carcinomas. The median ages of patients (females, n=165, 51%; males, n=159, 49%) with a diagnosis of basal cell, squamous cell, and sebaceous gland carcinomas were 65, 75, and 70 years, respectively. Conclusion: This is the largest retrospective cohort analysis of eyelid tumors in a Latin American population. These findings are in agreement with those from large centers in other countries and regions.
C1 [Damasceno, Jessica Carolinne] Fac Sao Lucas, Dept Med, Porto Velho, RO, Brazil.
   [Isenberg, Jordan] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada.
   [Lopes, Laise Rondon] Univ Fed Rondonia, Dept Med, Porto Velho, RO, Brazil.
   [Hime, Bernardo] Univ Cidade Sao Paulo, Fac Med, Sao Paulo, SP, Brazil.
   [Fernandes, Bruno F.] McGill Univ, Henry C Witelson Ocular Pathol Lab, Fac Med, Montreal, PQ, Canada.
   [Lowen, Marcia; Belfort, Rubens N.] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Ocular Oncol Serv, Sao Paulo, SP, Brazil.
   [Aranha Camargo, Luis Marcelo] Univ Sao Paulo, Inst Ciencias Biomed, Monte Negro, RO, Brazil.
RP Isenberg, J (corresponding author), Hop Maisoneuve Rosemont, 5415 Blvd Assompt, Montreal, PQ H1T 2M4, Canada.
EM jordan.isenberg@umontreal.ca
RI CAMARGO, LMA/B-4156-2009; Fernandes, Bruno F./ABA-3567-2020; Belfort,
   Rubens N./D-3579-2015
OI CAMARGO, LMA/0000-0001-9486-6195; Fernandes, Bruno
   F./0000-0002-5385-3571; Belfort, Rubens N./0000-0003-1775-7328;
   Isenberg, Jordan/0000-0002-7217-788X
CR Bernardini FP, 2006, CURR OPIN OPHTHALMOL, V17, P480, DOI 10.1097/01.icu.0000243022.20499.90
   Christenson LJ, 2005, JAMA-J AM MED ASSOC, V294, P681, DOI 10.1001/jama.294.6.681
   Cook BE, 1999, OPHTHALMOLOGY, V106, P746, DOI 10.1016/S0161-6420(99)90161-6
   Dean AG, OPENEPI OPEN SOURCE
   Donaldson MJ, 2002, BRIT J OPHTHALMOL, V86, P1161, DOI 10.1136/bjo.86.10.1161
   Efron PA, 2008, J PEDIATR SURG, V43, P2277, DOI 10.1016/j.jpedsurg.2008.08.035
   Ferreira FR, 2013, AN BRAS DERMATOL, V88, P726, DOI 10.1590/abd1806-4841.20132145
   Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016
   Jabs DA, 2007, OPHTHALMOLOGY, V114, P780, DOI 10.1016/j.ophtha.2006.11.008
   Jaso J, 2011, ARCH PATHOL LAB MED, V135, P511, DOI 10.1043/2009-0527-RS.1
   Kersten RC, 1997, OPHTHALMOLOGY, V104, P479, DOI 10.1016/S0161-6420(97)30288-7
   Lear JT, 1997, POSTGRAD MED J, V73, P538, DOI 10.1136/pgmj.73.863.538
   Lee SB, 1999, BRIT J OPHTHALMOL, V83, P595, DOI 10.1136/bjo.83.5.595
   Lim JL, 2005, J INVEST DERMATOL, V124, P505, DOI 10.1111/j.0022-202X.2005.23618.x
   Lin HY, 2006, OPHTHALMOLOGY, V113, P2101, DOI 10.1016/j.ophtha.2006.06.001
   Margo CE, 1998, ARCH OPHTHALMOL-CHIC, V116, P195
   Myers M, 2001, Optometry, V72, P705
   Popim RC, 2008, CIENC SAUDE COLETIVA, V13, P1331, DOI 10.1590/S1413-81232008000400030
   Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P47, DOI 10.1111/j.1365-2133.2007.08273.x
   Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19
   SHULER JD, 1989, ARCH OPHTHALMOL-CHIC, V107, P858, DOI 10.1001/archopht.1989.01070010880035
   Soares LH, 2001, ARQ BRAS OFTALMOL, V64, P287
   Staples M, 1998, INT J CANCER, V78, P144, DOI 10.1002/(SICI)1097-0215(19981005)78:2<144::AID-IJC3>3.0.CO;2-Z
NR 23
TC 1
Z9 1
U1 1
U2 2
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JAN-FEB
PY 2018
VL 81
IS 1
BP 7
EP 11
DI 10.5935/0004-2749.20180004
PG 5
WC Ophthalmology
SC Ophthalmology
GA FZ2IL
UT WOS:000427401000004
PM 29538586
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Souza, CE
   Nascimento, H
   Lima, A
   Muccioli, C
   Belfort, R
AF Souza, Carlos E.
   Nascimento, Heloisa
   Lima, Acacio
   Muccioli, Cristina
   Belfort, Rubens, Jr.
TI Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated
   with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Article
DE Dexamethasone; intravitreal injections; ocular toxoplasmosis;
   sulfamethoxazole/trimethoprim; toxoplasmosis
ID CLINDAMYCIN; TRIMETHOPRIM/SULFAMETHOXAZOLE; RETINOCHOROIDITIS;
   PHARMACOKINETICS; MANAGEMENT
AB Purpose: To evaluate intravitreal injections of sulfamethoxazole/trimethoprim in association with dexamethasone for treating toxoplasmic retinochoroiditis.
   Methods: Thirteen patients with active, recurrent ocular focal toxoplasmic retinochoroiditis and visual acuity worse than 20/63 in the affected eye were included. Ocular toxoplasmosis was diagnosed according to the classic clinical findings. The primary end point was the change in the final best-corrected visual acuity (BCVA).
   Results: The intraocular inflammation decreased within 2 weeks after injection in all eyes and resolved in 8 (62%) eyes with only one injection after 30 days; the remaining eyes received two injections. In all eyes, the retinitis was inactive and no patient had decreased early treatment diabetic retinopathy study lines of BCVA at the final examination.
   Conclusion: The combination of intravitreal trimethoprim/sulfamethoxazole and dexamethasone might be an alternative treatment strategy in patients with toxoplasmic retinochoroiditis.
C1 [Souza, Carlos E.; Nascimento, Heloisa; Lima, Acacio; Muccioli, Cristina; Belfort, Rubens, Jr.] Sao Paulo Fed Univ, Dept Ophthalmol, 1040 Doutor Diogo de Faria St, BR-04037003 Sao Paulo, SP, Brazil.
RP Souza, CE (corresponding author), Sao Paulo Fed Univ, Dept Ophthalmol, 1040 Doutor Diogo de Faria St, BR-04037003 Sao Paulo, SP, Brazil.
EM edusouzaa@gmail.com
RI Nascimento, Heloisa/P-8869-2017; de Souza Lima Filho, Acacio
   Alves/C-7189-2012
OI Nascimento, Heloisa/0000-0003-0315-1317; Alves de Souza Lima Filho,
   Acacio/0000-0003-1802-9592
CR Arikan G, 2011, INT J OPHTHALMOL-CHI, V4, P402, DOI 10.3980/j.issn.2222-3959.2011.04.16
   Belfort RJ, 2013, RETINA, V2, P1494
   Choudhury H, 2015, OSLI RETINA, V46, P137, DOI 10.3928/23258160-20150101-27
   FISCELLA R, 1988, OPHTHALMIC SURG LAS, V19, P44
   Harrell M, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/273506
   Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040
   Holland GN, 2002, AM J OPHTHALMOL, V134, P102, DOI 10.1016/S0002-9394(02)01526-X
   Hollands H, 2007, CAN J OPHTHALMOL, V42, P807, DOI 10.3129/i07-172
   Iaccheri B, 2008, CLIN THER, V30, P2069, DOI 10.1016/j.clinthera.2008.10.021
   Lasave AF, 2010, OPHTHALMOLOGY, V117, P1831, DOI 10.1016/j.ophtha.2010.01.028
   Maia M, 2007, BRIT J OPHTHALMOL, V91, P1122, DOI 10.1136/bjo.2007.115386
   Martinez CE, 1998, INT OPHTHALMOL, V22, P85, DOI 10.1023/A:1006129422690
   Radhika M, 2014, J OPHTHALMIC INFLAMM, V4, DOI 10.1186/s12348-014-0022-z
   REEVES DS, 1979, INFECTION, V7, pS330, DOI 10.1007/BF01639009
   Rey JA, 2008, LIPPINCOTTS ILLUSTRA
   Soheilian M, 2005, OPHTHALMOLOGY, V112, P1876, DOI 10.1016/j.ophtha.2005.05.025
   Soheilian M, 2011, OPHTHALMOLOGY, V118, P134, DOI 10.1016/j.ophtha.2010.04.020
   Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027
   Zamora YF, 2015, ARQ BRAS OFTALMOL, V78, P216, DOI 10.5935/0004-2749.20150056
NR 19
TC 8
Z9 8
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PY 2018
VL 26
IS 7
BP 1041
EP 1044
DI 10.1080/09273948.2017.1307420
PG 4
WC Ophthalmology
SC Ophthalmology
GA HD3QL
UT WOS:000452433400008
PM 28448726
DA 2020-12-01
ER

PT J
AU Cunningham, ET
   Khairallah, M
   Rathinam, SR
   Belfort, R
   Zierhut, M
AF Cunningham, Emmett T., Jr.
   Khairallah, Moncef
   Rathinam, Sivakumar R.
   Belfort, Rubens, Jr.
   Zierhut, Manfred
TI Mosquito-Borne Uveitis
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Editorial Material
ID VIRUS-INFECTION; ZIKA VIRUS; MANIFESTATIONS
C1 [Cunningham, Emmett T., Jr.] Calif Pacific Med Ctr, Dept Ophthalmol, San Francisco, CA USA.
   [Cunningham, Emmett T., Jr.] Stanford Univ, Dept Ophthalmol, Sch Med, Stanford, CA 94305 USA.
   [Cunningham, Emmett T., Jr.] UCSF Sch Med, Francis I Proctor Fdn, San Francisco, CA USA.
   [Khairallah, Moncef] Univ Monastir, Fattouma Bourguiba Univ Hosp, Dept Ophthalmol, Fac Med, Monastir, Tunisia.
   [Rathinam, Sivakumar R.] Aravind Eye Hosp, Uvea Dept, Madurai, Tamil Nadu, India.
   [Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Zierhut, Manfred] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany.
RP Cunningham, ET (corresponding author), West Coast Retina Med Grp, 1445 Bush St, San Francisco, CA 94109 USA.
EM emmett_cunningham@yahoo.com
FU Pacific Vision Foundation; San Francisco Retina Foundation
FX Supported in part by The Pacific Vision Foundation (ETC) and The San
   Francisco Retina Foundation (ETC).
CR Agrawal R, 2018, OCUL IMMUNOL INFLAMM, V26, P654, DOI 10.1080/09273948.2017.1294184
   Akanda M, 2018, OCUL IMMUNOL INFLAMM, V26, P671, DOI 10.1080/09273948.2017.1351571
   Al-Hazmi A, 2005, OPHTHALMOLOGY, V112, P313, DOI 10.1016/j.ophtha.2004.09.018
   Bakri Sophie J, 2004, Curr Opin Ophthalmol, V15, P537, DOI 10.1097/01.icu.0000143687.45232.f1
   Cunningham ET, 2017, OCUL IMMUNOL INFLAMM, V25, P737, DOI 10.1080/09273948.2017.1415077
   de Andrade Gabriel Costa, 2017, Int J Retina Vitreous, V3, P4, DOI 10.1186/s40942-016-0057-4
   Rocha VFD, 2018, OCUL IMMUNOL INFLAMM, V26, P677, DOI 10.1080/09273948.2017.1358378
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Garg S, 2005, SURV OPHTHALMOL, V50, P3, DOI 10.1016/j.survophthal.2004.10.001
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   Joob B, 2018, OCUL IMMUNOL INFLAMM, V26, P683, DOI 10.1080/09273948.2017.1311927
   Khairallah M, 2013, CURR OPIN OPHTHALMOL, V24, P574, DOI 10.1097/ICU.0b013e3283654e09
   Khairallah M, 2013, OPHTHALMIC RES, V49, P66, DOI 10.1159/000344009
   Khairallah Moncef, 2010, International Ophthalmology, V30, P465, DOI 10.1007/s10792-009-9319-6
   Lima LH, 2018, OCUL IMMUNOL INFLAMM, V26, P660, DOI 10.1080/09273948.2017.1285036
   Lin J, 2018, OCUL IMMUNOL INFLAMM, V26, P680, DOI 10.1080/09273948.2016.1263340
   Marquezan MC, 2018, SURV OPHTHALMOL, V63, P166, DOI 10.1016/j.survophthal.2017.06.001
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P451, DOI 10.1016/j.tmaid.2016.05.008
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Ng CWK, 2018, OCUL IMMUNOL INFLAMM, V26, P666, DOI 10.1080/09273948.2016.1254804
   Oo HH, 2018, OCUL IMMUNOL INFLAMM, V26, P684, DOI 10.1080/09273948.2017.1328246
   Padhi TR, 2017, SURV OPHTHALMOL, V62, P161, DOI 10.1016/j.survophthal.2016.09.005
   Singh Mandeep S, 2018, Am J Ophthalmol Case Rep, V10, P6, DOI 10.1016/j.ajoc.2018.01.023
   Ventura CV, 2018, PROG RETIN EYE RES
   White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0
   Yip VCH, 2012, OPHTHALMOL THER, V1, DOI 10.1007/s40123-012-0002-z
NR 27
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PY 2018
VL 26
IS 5
BP 651
EP 653
DI 10.1080/09273948.2018.1485402
PG 3
WC Ophthalmology
SC Ophthalmology
GA GL7DG
UT WOS:000437355500001
PM 29969369
OA Bronze
DA 2020-12-01
ER

PT J
AU Lima, LH
   Vianello, S
   Pimentel, S
   de Andrade, G
   Zett, C
   Muller, L
   Farah, ME
   Belfort, R
AF Lima, Luiz H.
   Vianello, Silvana
   Pimentel, Sergio
   de Andrade, Gabriel Costa
   Zett, Claudio
   Muller, Leo
   Farah, Michel E.
   Belfort, Rubens, Jr.
TI Dengue Fever Presenting as Purtscher-like Retinopathy
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Article
DE Cotton-wool spots; dengue fever; Purtscher-like retinopathy; retinal
   hemorrhages; spectral-domain optical coherence tomography
ID ACUTE MACULAR NEURORETINOPATHY; OPTICAL COHERENCE TOMOGRAPHY; OCULAR
   MANIFESTATIONS; CASE SERIES; PATHOGENESIS; HEMORRHAGE; DISEASE
AB Purpose: To report the fundus manifestations and spectral-domain optical coherence tomographic (SD-OCT) features of dengue fever presenting as Purtscher-like retinopathy.Methods: Retrospective review of two cases of dengue fever.Results: Color fundus photograph revealed the presence of cotton-wool spots in a Purtscher-like configuration in the posterior pole of all study eyes. SD-OCT demonstrated increased reflectivity signal in the inner retinal layers, and after a variable follow-up period, there was complete disappearance of cotton-wool spots and persistence of the hyperreflectivity signal.Conclusion: We report two unique cases of dengue fever associated with retinal lesions in a configuration of Purtscher-like retinopathy.
C1 [Lima, Luiz H.; Vianello, Silvana; de Andrade, Gabriel Costa; Zett, Claudio; Muller, Leo; Farah, Michel E.; Belfort, Rubens, Jr.] Fed Univ Sao Paulo UNIFESP, Dept Ophthalmol, Sao Paulo, Brazil.
   [Pimentel, Sergio] Univ Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Zett, Claudio] Pontificia Univ Catolica Valparaiso, Dept Ophthalmol, Valparaiso, Chile.
RP Lima, LH (corresponding author), Fed Univ Sao Paulo UNIFESP, Rua Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
EM luizlima9@gmail.com
RI Farah, Michel Eid E/F-3285-2012; Lima, Luiz H/V-4940-2017; Andrade,
   Gabriel/AAV-3155-2020
OI Farah, Michel Eid E/0000-0001-5951-0193; Lima, Luiz
   H/0000-0001-7304-909X; Andrade, Gabriel/0000-0002-5881-8126
CR Agrawal A, 2006, SURV OPHTHALMOL, V51, P129, DOI 10.1016/j.survophthal.2005.12.003
   Agrawal A, 2007, BRIT J OPHTHALMOL, V91, P1456, DOI 10.1136/bjo.2007.117408
   Alasil T, 2010, OPHTHAL SURG LAS IM, P1
   Australian Cancer Network Management of Metastatic Prostate Cancer Working Party, 2010, CLIN PRACTICE GUIDEL
   Bacsal KE, 2007, ARCH OPHTHALMOL-CHIC, V125, P501, DOI 10.1001/archopht.125.4.501
   BEHRENSBAUMANN W, 1992, GRAEF ARCH CLIN EXP, V230, P286, DOI 10.1007/BF00176306
   Gil P, 2015, EUR J OPHTHALMOL, V25, pE112, DOI 10.5301/ejo.5000623
   Goldhardt R, 2016, OCUL IMMUNOL INFLAMM, V22, P1
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Kozak I, 2006, AM J OPHTHALMOL, V141, P748, DOI 10.1016/j.ajo.2005.10.048
   Kozak I, 2007, OPHTHALMOLOGY, V114, P537, DOI 10.1016/j.ophtha.2006.06.054
   KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457
   Kurane I, 1992, Semin Immunol, V4, P121
   Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946
   Li ML, 2015, JAMA OPHTHALMOL, V133, P1329, DOI 10.1001/jamaophthalmol.2015.2687
   Lim WK, 2004, OPHTHALMOLOGY, V111, P2057, DOI 10.1016/j.ophtha.2004.03.038
   Loh BK, 2008, OPHTHALMOLOGICA, V222, P317, DOI 10.1159/000144074
   Miguel AIM, 2013, EYE, V27, P1, DOI 10.1038/eye.2012.222
   Munk MR, 2016, BRIT J OPHTHALMOL, V100, P389, DOI 10.1136/bjophthalmol-2015-306845
   Nainiwal S, 2005, EYE, V19, P1012, DOI 10.1038/sj.eye.6701704
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Rothman AL, 1999, VIROLOGY, P2571
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   Siqueira RC, 2004, OCUL IMMUNOL INFLAMM, V12, P323, DOI 10.1080/092739490500345
   SPITZNAS M, 1978, KLIN MONATSBL AUGENH, V172, P105
   TSAI TF, 2000, MANDELL DOUGLAS BENN, P1714
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Viola F, 2013, EUR J OPHTHALMOL, V23, P601, DOI 10.5301/ejo.5000290
   WALKER DH, 2003, MANUAL CLIN MICROBIO, P1005
   Wang AG, 1998, JPN J OPHTHALMOL, V42, P318, DOI 10.1016/S0021-5155(98)00015-X
NR 30
TC 1
Z9 1
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PY 2018
VL 26
IS 5
BP 660
EP 665
DI 10.1080/09273948.2017.1285036
PG 6
WC Ophthalmology
SC Ophthalmology
GA GL7DG
UT WOS:000437355500003
PM 28323496
DA 2020-12-01
ER

PT J
AU Nascimento, H
   Sousa, JM
   Fernandez, DG
   Salomao, GHA
   Sato, EH
   Muccioli, C
   Belfort, R
AF Nascimento, Heloisa
   Sousa, Jacqueline M.
   Fernandez, Delia Gonzalez
   Salomao, Gustavo H. A.
   Sato, Elcio H.
   Muccioli, Cristina
   Belfort, Rubens, Jr.
TI Blau-Jabs Syndrome in a Tertiary Ophthalmologic Center
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID GRANULOMATOUS ARTHRITIS; UVEITIS; MANIFESTATIONS; MUTATION; DISEASES;
   RASH
AB In a prospective case series of patients with Blau-Jabs syndrome (BJS) conducted in the Ophthalmology Department/Federal University of Sao Paulo, seven patients math clinical and ophthalmologic manifestations of the disease and a positive genetic test result for the presence of a mutation in the CARD15/NOD2 gene were followed for a minimal period of 1 year. All patients had uveitis, five had nummular corneal subepithelial opacities, and four had multifocal choroiditis. Oral prednisolone was administered to all patients; inflammation was controlled in six patients with at least one immunosuppressive drug. Infliximab (Remicade; Janssen Pharmaceuticals, Beerse, Belgium) and etanercept (Enbrel; Amgen, Thousand Oaks, CA) were used to treat two cases refractory to the antiinflammatory drugs. A subconjunctival dexamethasone implant (Ozurdex; Allergan, Irvine, CA) and a periocular injection of triamcinolone were used in one case to achieve inflammation control. Six patients achieved a visual acuity of 20/25 or better. The authors conclude that periocular treatment with steroid injections might be effective adjuvant therapy to control ocular inflammation.
C1 [Nascimento, Heloisa; Sousa, Jacqueline M.; Fernandez, Delia Gonzalez; Salomao, Gustavo H. A.; Sato, Elcio H.; Muccioli, Cristina; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, UNIFESP Escola Paulista Med Brazil, Dept Ophthalmol, Sao Paulo, Brazil.
RP Nascimento, H (corresponding author), Rua Botucatu 821-1o Andar, BR-04023062 Sao Paulo, SP, Brazil.
EM helomn@gmail.com
RI Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317
CR Alonso D, 2003, J AM ACAD DERMATOL, V49, P299, DOI 10.1067/S0190-9622(02)61772-4
   Becker Mara L, 2005, Curr Rheumatol Rep, V7, P427, DOI 10.1007/s11926-005-0046-3
   BLAU EB, 1985, J PEDIATR-US, V107, P689, DOI 10.1016/S0022-3476(85)80394-2
   Borzutzky A, 2010, CLIN IMMUNOL, V134, P251, DOI 10.1016/j.clim.2009.05.005
   Caso F, 2015, RMD OPEN, V20, P1
   Caso F, 2014, AUTOIMMUN REV, V13, P1220, DOI 10.1016/j.autrev.2014.08.010
   Glass Donald A 2nd, 2009, Dermatol Online J, V15, P5
   Gungor SG, 2013, OCUL IMMUNOL INFLAMM, V21, P1, DOI 10.3109/09273948.2012.719259
   JABS DA, 1985, AM J MED, V78, P801, DOI 10.1016/0002-9343(85)90286-4
   Kurokawa T, 2003, OPHTHALMOLOGY, V110, P2040, DOI 10.1016/S0161-6420(03)00717-6
   Latkany PA, 2002, AM J OPHTHALMOL, V134, P897, DOI 10.1016/S0002-9394(02)01709-9
   Martin J, 2011, QJM-INT J MED, V104, P997, DOI 10.1093/qjmed/hcq188
   PASTORES GM, 1990, J PEDIATR-US, V117, P403, DOI 10.1016/S0022-3476(05)81080-7
   Punzi L, 2011, BEST PRACT RES CL RH, V25, P703, DOI 10.1016/j.berh.2011.10.017
   Raiji VR, 2011, J AAPOS, V15, P205, DOI 10.1016/j.jaapos.2011.02.004
   Rose CD, 2011, CURR OPIN RHEUMATOL, V23, P411, DOI 10.1097/BOR.0b013e328349c430
   Simonini G, 2013, ARTHRITIS RHEUM-US, V65, P513, DOI 10.1002/art.37776
   Wouters CH, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-33
   Yasui K, 2010, ARTHRITIS RHEUM-US, V62, P250, DOI 10.1002/art.25035
   Zarranz-Ventura J, 2008, AN SIST SANIT NAVAR, V31, P155, DOI 10.4321/s1137-66272008000600014
NR 20
TC 0
Z9 0
U1 0
U2 3
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD JAN
PY 2018
VL 49
IS 1
BP 70
EP 75
DI 10.3928/23258160-20171215-12
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA FS7PP
UT WOS:000419990200012
PM 29304271
DA 2020-12-01
ER

PT J
AU Freitas, BD
   Zin, A
   Ko, A
   Maia, M
   Ventura, CV
   Belfort, R
AF Freitas, Bruno de Paula
   Zin, Andrea
   Ko, Albert
   Maia, Mauricio
   Ventura, Camila V.
   Belfort, Rubens, Jr.
TI Anterior-Segment Ocular Findings and Microphthalmia in Congenital Zika
   Syndrome
SO OPHTHALMOLOGY
LA English
DT Editorial Material
ID VIRUS
C1 [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [Freitas, Bruno de Paula; Maia, Mauricio; Ventura, Camila V.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.
   [Freitas, Bruno de Paula; Maia, Mauricio; Ventura, Camila V.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,1st Floor, BR-04023062 Sao Paulo, Brazil.
   [Zin, Andrea] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Clin Res Unit, Rio De Janeiro, Brazil.
   [Ko, Albert] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ventura, Camila V.] Altino Ventura Fdn, Recife, PE, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,1st Floor, BR-04023062 Sao Paulo, Brazil.
EM prof.belfort@clinicabelfort.com.br
RI Maia, Mauricio/I-5892-2015; Ko, Albert Icksang/P-2343-2015; Ventura,
   Camila V/N-2654-2018
OI Maia, Mauricio/0000-0002-7034-8091; Ko, Albert
   Icksang/0000-0001-9023-2339; Ventura, Camila V/0000-0002-2927-4684
CR Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 5
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD DEC
PY 2017
VL 124
IS 12
BP 1876
EP 1878
PG 3
WC Ophthalmology
SC Ophthalmology
GA FM9JZ
UT WOS:000415586000031
PM 28676282
DA 2020-12-01
ER

PT J
AU Freitas, BD
   Ventura, CV
   Maia, M
   Belfort, R
AF Freitas, Bruno de Paula
   Ventura, Camila V.
   Maia, Mauricio
   Belfort, Rubens, Jr.
TI Zika virus and the eye
SO CURRENT OPINION IN OPHTHALMOLOGY
LA English
DT Review
DE congenital Zika syndrome; ocular findings; Zika virus
ID INFECTION; INFANTS; BRAZIL; CLINICIAN
AB Purpose of review
   The aim of this study was to review the ocular findings related to the Zika virus (ZIKV) based on the main studies published to date, describe the patterns of the lesions and risk factors, and identify the public health implications and scientific importance of this emerging disease.
   Recent findings
   In most studies, the ZIKV seems related to congenital ocular lesions and most mothers reported mild symptoms during the first pregnancy trimester. Five fundus patterns were seen most often: macular chorioretinal atrophy, chorioretinal atrophy elsewhere, focal pigmentary changes in the macular region, optic nerve abnormalities and combined types. A few studies have suggested that the ZIKV might damage the anterior segment of these babies' eyes. Few reports have described the ocular complications seen in adults during the acute infection, including conjunctivitis, iridocyclitis and chorioretinitis.
   Summary
   Infants with congenital Zika syndrome might have vision-threatening fundus abnormalities. Although the full spectrum of ocular lesions caused by the ZIKV infection is not yet determined, a distinctive new disease has been observed. Recognition of these lesions by ophthalmologists can help ensure appropriate etiologic evaluation and clinical investigation to define the range of anomalies in an affected infant and determine essential follow-up and ongoing care.
C1 [Freitas, Bruno de Paula; Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Paulista Med Sch, Dept Ophthalmol, Sao Paulo, Brazil.
   [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [Ventura, Camila V.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
RP Freitas, BD (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,1st Floor, BR-04023062 Sao Paulo, SP, Brazil.
EM brunodepaulafreitas@hotmail.com
RI Ventura, Camila V/N-2654-2018; Maia, Mauricio/I-5892-2015
OI Ventura, Camila V/0000-0002-2927-4684; Maia,
   Mauricio/0000-0002-7034-8091
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira Dias JR, 2017, RETIN CASES BRIEF RE
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas B de Paula, 2016, JAMA OPHTHALMOL
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 25
TC 17
Z9 17
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-8738
EI 1531-7021
J9 CURR OPIN OPHTHALMOL
JI Curr. Opin. Ophthalmol.
PD NOV
PY 2017
VL 28
IS 6
BP 595
EP 599
DI 10.1097/ICU.0000000000000420
PG 5
WC Ophthalmology
SC Ophthalmology
GA FQ3GP
UT WOS:000418245600008
PM 28795959
DA 2020-12-01
ER

PT J
AU Aleman, TS
   Ventura, CV
   Cavalcanti, MM
   Serrano, LW
   Traband, A
   Nti, AA
   Gois, AL
   Bravo-Filho, V
   Martins, TT
   Nichols, CW
   Maia, M
   Belfort, R
AF Aleman, Tomas S.
   Ventura, Camila V.
   Cavalcanti, Milena M.
   Serrano, Leona W.
   Traband, Anastasia
   Nti, Akosua A.
   Gois, Adriana L.
   Bravo-Filho, Vasco
   Martins, Thayze T.
   Nichols, Charles W.
   Maia, Mauricio
   Belfort, Rubens
TI Quantitative Assessment of Microstructural Changes of the Retina in
   Infants With Congenital Zika Syndrome
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID OPTICAL COHERENCE TOMOGRAPHY; HUMAN FOVEAL DEVELOPMENT; VIRUS-INFECTION;
   NEURAL PROGENITORS; OCULAR FINDINGS; BRAZIL; BRAIN; MACULOPATHY;
   MUTATIONS; ORGANOIDS
AB IMPORTANCE A better pathophysiologic understanding of the neurodevelopmental abnormalities observed in neonates exposed in utero to Zika virus (ZIKV) is needed to develop treatments. The retina as an extension of the diencephalon accessible to in vivo microcopy with spectral-domain optical coherence tomography (SD-OCT) can provide an insight into the pathophysiology of congenital Zika syndrome (CZS).
   OBJECTIVE To quantify the microstructural changes of the retina in CZS and compare these changes with those of cobalamin C (cblC) deficiency, a disease with potential retinal maldevelopment.
   DESIGN, SETTING, AND PARTICIPANTS This case series included 8 infants with CZS and 8 individuals with cblC deficiency. All patients underwent ophthalmologic evaluation at 2 university teaching hospitals and SD-OCT imaging in at least 1 eye. Patients with cblC deficiency were homozygous or compound heterozygotes for mutations in the methylmalonic aciduria and homocystinuria type C (MMACHC) gene. Data were collected from January 1 to March 17, 2016, for patients with CZS and from May 4, 2015, to April 23, 2016, for patients with cblC deficiency.
   MAIN OUTCOMES AND MEASURES The SD-OCT cross-sections were segmented using automatic segmentation algorithms embedded in the SD-OCT systems. Each retinal layer thickness was measured at critical eccentricities using the position of the signal peaks and troughs on longitudinal reflectivity profiles.
   RESULTS Eight infants with CZS (5 girls and 3 boys; age range, 3-5 months) and 8 patients with cblC deficiency (3 girls and 5 boys; age range, 4 months to 15 years) were included in the analysis. All 8 patients with CZS had foveal abnormalities in the analyzed eyes (8 eyes), including discontinuities of the ellipsoid zone, thinning of the central retina with increased backscatter, and severe structural disorganization, with 3 eyes showing macular pseudocolobomas. Pericentral retina with normal lamination showed a thinned (< 30% of normal thickness) ganglion cell layer (GCL) that colocalized in 7 of 8 eyes with a normal photoreceptor layer. The inner nuclear layer was normal or had borderline thinning. The central retinal degeneration was similar to that of cblC deficiency.
   CONCLUSIONS AND RELEVANCE Congenital Zika syndrome showed a central retinal degeneration with severe GCL loss, borderline inner nuclear layer thinning, and less prominent photoreceptor loss. The findings provide the first, to date, in vivo evidence in humans for possible retinal maldevelopment with a predilection for retinal GCL loss in CZS, consistent with a murine model of the disease and suggestive of in utero depletion of this neuronal population as a consequence of Zika virus infection.
C1 [Aleman, Tomas S.; Serrano, Leona W.; Traband, Anastasia; Nti, Akosua A.; Nichols, Charles W.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Ctr Adv Med,Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Ventura, Camila V.; Gois, Adriana L.; Bravo-Filho, Vasco; Martins, Thayze T.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Gois, Adriana L.; Bravo-Filho, Vasco; Martins, Thayze T.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens] Univ Fed Sao Paulo, Dept Ophthalmol, Paulista Med Sch, Sao Paulo, Brazil.
   [Cavalcanti, Milena M.] Altino Ventura Fdn, Rehabil Ctr Menina Olhos, Recife, PE, Brazil.
RP Aleman, TS (corresponding author), Univ Penn, Dept Ophthalmol, Scheie Eye Inst, Perelman Ctr Adv Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM aleman@mail.med.upenn.edu
RI Filho, Vasco/N-6993-2018; Maia, Mauricio/I-5892-2015; Ventura, Camila
   V/N-2654-2018
OI Filho, Vasco/0000-0003-4460-3236; Maia, Mauricio/0000-0002-7034-8091;
   Ventura, Camila V/0000-0002-2927-4684; Gois, Adriana/0000-0001-5542-1097
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NEI-K12EY015398-10,
   R01-EY025287]; Hope for Vision; Foundation Fighting Blindness;
   Pennsylvania Lions Sight Conservation; National Council for Scientific
   and Technological Development of BrazilNational Council for Scientific
   and Technological Development (CNPq)
FX This study was supported by grants NEI-K12EY015398-10 and R01-EY025287
   from the National Institutes of Health, Hope for Vision, the Foundation
   Fighting Blindness, the Pennsylvania Lions Sight Conservation, and the
   National Council for Scientific and Technological Development of Brazil.
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Bonafede L, 2015, INVEST OPHTH VIS SCI, V56, P7875, DOI 10.1167/iovs.15-17857
   Cideciyan AV, 2013, HUM GENE THER, V24, P993, DOI 10.1089/hum.2013.153
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007
   Dubis AM, 2012, ARCH OPHTHALMOL-CHIC, V130, P1291, DOI 10.1001/archophthalmol.2012.2270
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Hendrickson A, 2006, EXP EYE RES, V83, P920, DOI 10.1016/j.exer.2006.04.017
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Huang YJ, 1998, INVEST OPHTH VIS SCI, V39, P2405
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1307
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Maldonado RS, 2011, OPHTHALMOLOGY, V118, P2315, DOI 10.1016/j.ophtha.2011.05.028
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Provis JM, 2013, PROG RETIN EYE RES, V35, P63, DOI 10.1016/j.preteyeres.2013.01.005
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wong Chee Wai, 2019, Retin Cases Brief Rep, V13, P171, DOI 10.1097/ICB.0000000000000552
   World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 47
TC 17
Z9 17
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD OCT
PY 2017
VL 135
IS 10
BP 1069
EP 1076
DI 10.1001/jamaophthalmol.2017.3292
PG 8
WC Ophthalmology
SC Ophthalmology
GA FJ6LL
UT WOS:000412869200016
PM 28880978
OA Green Published
DA 2020-12-01
ER

PT J
AU Neto, HO
   Regatieri, CV
   Nobrega, MJ
   Muccioli, C
   Casella, AM
   Andrade, RE
   Maia, M
   Kniggendorf, V
   Ferreira, M
   Branco, AC
   Belfort, R
AF Neto, Hermelino O.
   Regatieri, Caio V.
   Nobrega, Mario J.
   Muccioli, Cristina
   Casella, Antonio M.
   Andrade, Rafael E.
   Maia, Mauricio
   Kniggendorf, Vinicius
   Ferreira, Magno
   Branco, Andre C.
   Belfort, Rubens, Jr.
TI Multicenter, Randomized Clinical Trial to Assess the Effectiveness of
   Intravitreal Injections of Bevacizumab, Triamcinolone, or Their
   Combination in the Treatment of Diabetic Macular Edema
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID INTRAOCULAR-PRESSURE; RISK-FACTORS; RANIBIZUMAB; ACETONIDE; RETINOPATHY;
   AFLIBERCEPT; EFFICACY; VEGF
AB BACKGROUND AND OBJECTIVE: To evaluate the efficacy of combined bevacizumab-triamcinolone intravitreal injection in the treatment of diabetic macular edema (DME) compared to monotherapy.
   PATIENTS AND METHODS: At eight clinical sites, 111 patients with DME were randomly assigned to receive an intravitreal injection of bevacizumab (Avastin; Genentech, South San Francisco, CA), triamcinolone (Ophthalmos Pharmaceutical Industry, Sao Paulo-SP, Brazil), or their combination. The primary outcome was visual acuity (VA) at 6 months' follow-up.
   RESULTS: The average number of injections was 3.2 in the bevacizumab group, 2.4 in the combined group, and 2.1 in the triamcinolone group. All groups presented with improvements in VA (P < .001); however, no differences between groups were observed (P =.436). Mean reduction in central retinal thickness was statistically different only between the triamcinolone and bevacizumab groups (P < .015).
   CONCLUSION: Mono-or combination therapy was effective for DME treatment. No synergistic effects were observed; however, triamcinolone alone or a drug combination may reduce the number of injections required when compared to bevacizumab alone.
C1 [Neto, Hermelino O.; Regatieri, Caio V.; Muccioli, Cristina; Maia, Mauricio; Kniggendorf, Vinicius; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,1o Andar, BR-04023062 Sao Paulo, SP, Brazil.
   [Neto, Hermelino O.] Feira Santana Eye Hosp, CLIHON, Salvador, Brazil.
   [Maia, Mauricio] Brazilian Inst Fight Blindness Assis & Presidente, Dept Ophthalmol, Sao Paulo, Brazil.
   [Nobrega, Mario J.] Sadalla Amin Gahnem Eye Hosp, Joinville, SC, Brazil.
   [Casella, Antonio M.] Univ Estadual Londrina, Dept Ophthalmol, Londrina, Parana, Brazil.
   [Andrade, Rafael E.] Beira Rio Eye Hosp, Itabuna, Bahia, Brazil.
   [Ferreira, Magno] Univ Fed Uberlandia, Uberlandia, MG, Brazil.
   [Branco, Andre C.] Univ Fed Bahia, Salvador, Brazil.
RP Regatieri, CV (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,1o Andar, BR-04023062 Sao Paulo, SP, Brazil.
EM caiore@gmail.com
RI Maia, Mauricio/I-5892-2015; Regatieri, Caio/G-8152-2014
OI Maia, Mauricio/0000-0002-7034-8091; Regatieri, Caio/0000-0003-1511-8696
FU Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP)
FX This work was supported in part by Sao Paulo Research Foundation.
CR Abu El-Asrar AM, 2012, MIDDLE EAST AFR J OP, V19, P70, DOI 10.4103/0974-9233.92118
   Alasil T, 2010, OPHTHALMOLOGY, V117, P2379, DOI 10.1016/j.ophtha.2010.03.051
   Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463
   Aref AA, 2015, JAMA OPHTHALMOL, V133, P1022, DOI 10.1001/jamaophthalmol.2015.1823
   Bakri SJ, 2005, EYE, V19, P686, DOI 10.1038/sj.eye.6701602
   Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017
   Behl T, 2015, PHARMACOL RES, V99, P137, DOI 10.1016/j.phrs.2015.05.013
   Boyer DS, 2014, OPHTHALMOLOGY, V121, P1904, DOI 10.1016/j.ophtha.2014.04.024
   Chae JB, 2012, EYE, V26, P479, DOI 10.1038/eye.2011.310
   Edelman JL, 2005, EXP EYE RES, V80, P249, DOI 10.1016/j.exer.2004.09.013
   Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022
   Gavin JR, 1999, DIABETES CARE, V22, pS5
   Im L, 2008, J GLAUCOMA, V17, P128, DOI 10.1097/IJG.0b013e31814b9948
   Inoue M, 2004, AM J OPHTHALMOL, V138, P1046, DOI 10.1016/j.ajo.2004.05.028
   Ip MS, 2008, OPHTHALMOLOGY, V115, P1447, DOI 10.1016/j.ophtha.2008.06.015
   Kamppeter BA, 2008, OPHTHALMOLOGY, V115, P1372, DOI 10.1016/j.ophtha.2008.01.019
   Kook D, 2008, RETINA-J RET VIT DIS, V28, P1053, DOI 10.1097/IAE.0b013e318176de48
   Korobelnik JF, 2014, OPHTHALMOLOGY, V121, P2247, DOI 10.1016/j.ophtha.2014.05.006
   Lam DSC, 2009, RETINA-J RET VIT DIS, V29, P292, DOI 10.1097/IAE.0b013e31819a2d61
   Lang GE, 2012, OPHTHALMOLOGICA, V227, P21, DOI 10.1159/000337156
   Marey HM, 2011, CLIN OPHTHALMOL, V5, P1011, DOI 10.2147/OPTH.S22103
   Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493
   Michaelides M., 2010, OPHTHALMOLOGY, V117
   Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031
   Otani T, 2010, RETINA-J RET VIT DIS, V30, P774, DOI 10.1097/IAE.0b013e3181c2e0d6
   PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015
   Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039
   Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016
   Rangasamy S, 2012, MIDDLE EAST AFR J OP, V19, P52, DOI 10.4103/0974-9233.92116
   Romero-Aroca P, 2013, WORLD J DIABETES, V4, P165, DOI 10.4239/wjd.v4.i5.165
   Vasconcelos-Santos DV, 2008, RETINA-J RET VIT DIS, V28, P573, DOI 10.1097/IAE.0b013e31816079e8
   Wells JA, 2016, OPHTHALMOLOGY, V123, P1351, DOI 10.1016/j.ophtha.2016.02.022
   Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264
   Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909
NR 34
TC 9
Z9 10
U1 0
U2 2
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD SEP
PY 2017
VL 48
IS 9
BP 734
EP 740
DI 10.3928/23258160-20170829-08
PG 7
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA FN5TY
UT WOS:000416072300007
PM 28902334
DA 2020-12-01
ER

PT J
AU Zin, AA
   Tsui, I
   Rossetto, J
   Vasconcelos, Z
   Adachi, K
   Valderramos, S
   Halai, UA
   Pone, MVD
   Pone, SM
   Silveira, JCB
   Aibe, MS
   da Costa, ACC
   Zin, OA
   Belfort, R
   Brasil, P
   Nielsen-Saines, K
   Moreira, MEL
AF Zin, Andrea A.
   Tsui, Irena
   Rossetto, Julia
   Vasconcelos, Zilton
   Adachi, Kristina
   Valderramos, Stephanie
   Halai, Umme-Aiman
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Barros Silveira Filho, Joel Carlos
   Aibe, Mitsue S.
   da Costa, Ana Carolina C.
   Zin, Olivia A.
   Belfort, Rubens, Jr.
   Brasil, Patricia
   Nielsen-Saines, Karin
   Lopes Moreira, Maria Elisabeth
TI Screening Criteria for Ophthalmic Manifestations of Congenital Zika
   Virus Infection
SO JAMA PEDIATRICS
LA English
DT Article
ID INFANTS; VIREMIA
AB IMPORTANCE Current guidelines recommend screening eye examinations for infants with microcephaly or laboratory-confirmed Zika virus infection but not for all infants potentially exposed to Zika virus in utero.
   OBJECTIVE To evaluate eye findings in a cohort of infants whose mothers had polymerase chain reaction-confirmed Zika virus infection during pregnancy.
   DESIGN, SETTING, AND PARTICIPANTS In this descriptive case series performed from January 2 through October 30, 2016, infants were examined from birth to 1 year of age by a multidisciplinary medical team, including a pediatric ophthalmologist, from Fernandes Figueira Institute, a Ministry of Health referral center for high-risk pregnancies and infectious diseases in children in Rio de Janeiro, Brazil.
   PARTICIPANTS Mother-infant pairs from Rio de Janeiro, Brazil, who presented with suspected Zika virus infection during pregnancy were referred to our institution and had serum, urine, amniotic fluid, or placenta samples tested by real-time polymerase chain reaction for Zika virus.
   MAIN OUTCOMES AND MEASURES Description of eye findings, presence of microcephaly or other central nervous system abnormalities, and timing of infection in infants with confirmed Zika virus during pregnancy. Eye abnormalities were correlated with central nervous system findings, microcephaly, and the timing of maternal infection.
   RESULTS Of the 112 with polymerase chain reaction-confirmed Zika virus infection in maternal specimens, 24 infants (21.4%) examined had eye abnormalities (median age at first eye examination, 31 days; range, 0-305 days). Ten infants (41.7%) with eye abnormalities did not have microcephaly, and 8 (33.3%) did not have any central nervous system findings. Fourteen infants with eye abnormalities (58.3%) were born to women infected in the first trimester, 8 (33.3%) in the second trimester, and 2 (8.3%) in the third trimester. Optic nerve and retinal abnormalities were the most frequent findings. Eye abnormalities were statistically associated with microcephaly (odds ratio [OR], 19.1; 95% CI, 6.0-61.0), other central nervous system abnormalities (OR, 4.3; 95% CI, 1.6-11.2), arthrogryposis (OR, 29.0; 95% CI, 3.3-255.8), and maternal trimester of infection (first trimester OR, 5.1; 95% CI, 1.9-13.2; second trimester OR, 0.5; 95% CI, 0.2-1.2; and third trimester OR, 0.3; 95% CI, 0.1-1.2).
   CONCLUSIONS AND RELEVANCE Eye abnormalitiesmay be the only initial finding in congenital Zika virus infection. All infants with potential maternal Zika virus exposure at any time during pregnancy should undergo screening eye examinations regardless of the presence or absence of central nervous system abnormalities.
C1 [Zin, Andrea A.; Rossetto, Julia; Vasconcelos, Zilton; da Costa, Ana Carolina C.; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Dept Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
   [Tsui, Irena; Halai, Umme-Aiman] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA.
   [Rossetto, Julia; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Oftalmol, Sao Paulo, Brazil.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA.
   [Valderramos, Stephanie] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
   [da Silva Pone, Marcos Vinicius; Pone, Sheila Moura; Aibe, Mitsue S.] Fundacao Oswaldo Cruz, Dept Doencas Infecciosas, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Dept Oftalmol, Rio De Janeiro, Brazil.
   [Zin, Olivia A.] Hosp Fed Servidores Estado, Dept Oftalmol, Rio De Janeiro, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Lab Doencas Febris Agudas, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Dept Pesquisa Clin, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM andreazin@iff.fiocruz.br
RI Gaw, Stephanie/K-4592-2019; da Silva Pone, Marcos Vinicius/N-1285-2019;
   Vasconcelos, Zilton/AAD-5784-2019
OI Gaw, Stephanie/0000-0003-0891-6964; Vasconcelos,
   Zilton/0000-0002-2193-2224; Moura Pone, Sheila/0000-0002-6246-8915; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI AI28697]; National Eye InstituteUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318-01];
   Research to Prevent Blindness grantResearch to Prevent Blindness (RPB);
   Thrasher Research Fund [20164370]; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R21EY028318, R21EY028318] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI129534, R21AI129534] Funding Source:
   NIH RePORTER
FX This study was supported by grant 441098/2016-9 from the Brazilian
   National Council for Scientific and Technological Development, grant AI
   AI28697 from the National Institute of Allergy and Infectious Diseases,
   and grant R21EY028318-01 from the National Eye Institute. Dr Tsui was
   supported in part by an unrestricted Research to Prevent Blindness grant
   given to the Stein Eye Institute. Dr Adachi was supported in part by
   grant 20164370 from the Thrasher Research Fund.
CR [Anonymous], 2016, MMWR MORB MORTA 0819
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maa AY, 2017, TELEMED E-HEALTH, V23, P42, DOI 10.1089/tmj.2016.0039
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Pasquel Francisco J, 2015, J Diabetes Sci Technol, V10, P301, DOI 10.1177/1932296815624109
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasool N, 2016, JAMA OPHTHALMOL, V134, P1200, DOI 10.1001/jamaophthalmol.2016.2398
   Sadler T. W., 2015, LANGMANS MED EMBRYOL
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vasconcelos-Santos DV, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1313
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1219, DOI 10.1001/jamaophthalmol.2016.3623
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vinekar A, 2015, SEMIN FETAL NEONAT M, V20, P335, DOI 10.1016/j.siny.2015.05.002
NR 26
TC 37
Z9 38
U1 0
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD SEP
PY 2017
VL 171
IS 9
BP 847
EP 854
DI 10.1001/jamapediatrics.2017.1474
PG 8
WC Pediatrics
SC Pediatrics
GA FG3XL
UT WOS:000410140700011
PM 28715527
OA Green Published
DA 2020-12-01
ER

PT J
AU Salomao, SR
   Furtado, JM
   Berezovsky, A
   Cavascan, NN
   Ferraz, AN
   Cohen, JM
   Munoz, S
   Belfort, R
AF Salomao, Solange R.
   Furtado, Joao Marcello
   Berezovsky, Adriana
   Cavascan, Nivea N.
   Ferraz, Alberto N.
   Cohen, Jacob M.
   Munoz, Sergio
   Belfort, Rubens, Jr.
TI The Brazilian Amazon Region Eye Survey: Design and Methods
SO OPHTHALMIC EPIDEMIOLOGY
LA English
DT Article
DE Adults; baseline characteristics; blindness; Brazilian Amazon;
   methodology; population-based study; visual impairment
ID CATARACT-SURGERY; VISUAL IMPAIRMENT; BLINDNESS; PREVALENCE; COUNTY;
   CHINA
AB Purpose: To describe the study design, operational strategies, procedures, and baseline characteristics of the Brazilian Amazon Region Eye Survey (BARES), a population-based survey of the prevalence and causes of distance and near visual impairment and blindness in older adults residing in the city of Parintins.
   Methods: Cluster sampling, based on geographically defined census sectors, was used for cross-sectional random sampling of persons 45 years and older from urban and rural areas. Subjects were enumerated through a door-to-door survey and invited for measurement of uncorrected, presenting and best-corrected visual acuity and an ocular examination.
   Results: Of 9931 residents (5878 urban and 4053 rural), 2384 individuals (1410 urban and 974 rural) were eligible and 2041 (1180 urban and 861 rural) had a clinical examination (response rate 85.6%). The majority of participants were female (1041, 51.0%); the average age was 59.9 +/- 11.1 years (60.2 +/- 11.2 years for urban and 59.4 +/- 11.1 years for rural); 1360 (66.6%) had primary schooling or less (58.1% in urban and 78.4% in rural) and 57.8% were resident in urban areas. The age distribution between sexes was similar (p = 0.178). Both sex and age distributions of the sample were comparable to that of the Brazilian Amazon Region population.
   Conclusions: The BARES cohort will provide information about the prevalence and causes of near and distance vision in this underprivileged and remote population in Brazil.
C1 [Salomao, Solange R.; Furtado, Joao Marcello; Berezovsky, Adriana; Cavascan, Nivea N.; Ferraz, Alberto N.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Oftalmol & Ciencias Visuais, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Furtado, Joao Marcello] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Ribeirao Preto, SP, Brazil.
   [Cohen, Jacob M.] Univ Fed Amazonas, Div Oftalmol, Dept Cirurgia, Fac Med, Manaus, AM, Brazil.
   [Cohen, Jacob M.] Inst Olhos Manaus, Manaus, AM, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
RP Salomao, SR (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Oftalmol & Ciencias Visuais, Escola Paulista Med, R Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
EM ssalomao@unifesp.br
RI Ferraz, Nivea/AAC-2439-2020; Berezovsky, Adriana/F-2341-2013
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221; Furtado, Joao M./0000-0003-2490-5747
FU Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico, CNPq,
   Brasilia, Brasil, Science Without Borders grant [402120/2012-4]; Lions
   Club International Foundation, Sight First Grant [SF1758/UND]; Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/16397-7]
FX Financial support for this study was received from: Conselho Nacional de
   Pesquisa e Desenvolvimento Tecnologico, CNPq, Brasilia, Brasil, Science
   Without Borders grant #402120/2012-4 to SRS (Visiting Professor
   Scholarship to SM, post-doctoral scholarship to JMF), research
   scholarship to SRS and RBJ; Lions Club International Foundation, Sight
   First Grant #SF1758/UND to SRS; Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) Research Grant #2013/16397-7 to SRS.
CR Fraxe TJP, 2009, CIENCIA CULTURA, V61, P30
   Furtado JM, 2014, INVEST OPHTHALMOL VI, V55
   Arieta CEL, 2009, OPHTHAL EPIDEMIOL, V16, P58, DOI 10.1080/09286580802575032
   Li SZ, 1999, OPHTHALMOLOGY, V106, P1602, DOI 10.1016/S0161-6420(99)90459-1
   Michon JJ, 2002, BRIT J OPHTHALMOL, V86, P133, DOI 10.1136/bjo.86.2.133
   Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539
   Penna G, 2009, EMERG INFECT DIS, V15, P626, DOI 10.3201/eid1504.081329
   Pokharel GP, 1998, BRIT J OPHTHALMOL, V82, P600, DOI 10.1136/bjo.82.6.600
   Salomao SR, 2008, OPHTHAL EPIDEMIOL, V15, P167, DOI 10.1080/09286580701843812
   Schellini SA, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-8
   Stata Corporation, 2015, STAT SE STAT SOFTW R
   Zhao JL, 1998, AM J OPHTHALMOL, V126, P506, DOI 10.1016/S0002-9394(98)00275-X
NR 12
TC 6
Z9 6
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0928-6586
EI 1744-5086
J9 OPHTHAL EPIDEMIOL
JI Ophthalmic Epidemiol.
PD AUG
PY 2017
VL 24
IS 4
BP 257
EP 264
DI 10.1080/09286586.2016.1276199
PG 8
WC Ophthalmology
SC Ophthalmology
GA FA4FT
UT WOS:000405399900008
PM 28296523
DA 2020-12-01
ER

PT J
AU Hime, B
   Isenberg, J
   Rocha, G
   Lowen, M
   Morales, M
   Fernandes, BF
   Belfort, RN
AF Hime, Bernardo
   Isenberg, Jordan
   Rocha, Gustavo
   Lowen, Marcia
   Morales, Melina
   Fernandes, Bruno Franco
   Belfort, Rubens N.
TI Indications for eye removal over a 13-year period at an ophthalmology
   referral center in Sao Paulo, Brazil
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Eye enucleation; Eye evisceration; Retinoblastoma; Melanoma; Brazil
ID ORBITAL EXENTERATION; CARE CENTER; RETINOBLASTOMA; ENUCLEATION; INDIA;
   EXPERIENCE; TUMORS
AB Purpose: To analyze the indications and types of eye removal at Latin America's highest-volume ophthalmic reference center in Sao Paulo, Brazil.
   Methods: A retrospective analysis was conducted of surgical pathological reports in the electronic database of the Ophthalmology Department of the Universidade Federal de Sao Paulo Hospital of patients who underwent eye-removal procedures between January 2000 and December 2012.
   Results: A total of 412 cases met the inclusion criteria for this study. The most common indications for eye removal were ocular melanoma and retinoblastoma, representing 35.4% and 31.1% of the total cases, respectively. Other frequent indications included endophthalmitis (6.3%), nonspecific inflammation (4.1%), squamous cell carcinoma (3.6%), panophthalmitis (3.4%), and phthisis bulbi (1.2%). The remaining indications accounted for 14.8% of all cases, with each accounting for <1% of the total cases. Enucleation was the most common eye-removal procedure seen in our study.
   Conclusions: The two most common indications for eye removal were ocular melanoma and retinoblastoma. Alternative treatment options are effective in limiting the need for eye removal but are constrained by our public center's socioeconomic context.
C1 [Hime, Bernardo; Rocha, Gustavo] Univ Cidade Sao Paulo, Fac Med, Sao Paulo, SP, Brazil.
   [Isenberg, Jordan] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada.
   [Lowen, Marcia] Univ Fed Sao Paulo, Dept Pathol, Sao Paulo, SP, Brazil.
   [Morales, Melina; Belfort, Rubens N.] Univ Fed Sao Paulo, Ocular Oncol Serv, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Fernandes, Bruno Franco] McGill Univ, Henry C Witelson Ocular Pathol Lab, Montreal, PQ, Canada.
RP Isenberg, J (corresponding author), Hop Maison Neuve Rosemont, Dept Ophthalmol, 5415 Boul Assompt, Montreal, PQ H1T 2M4, Canada.
EM jordan.isenberg@umontreal.ca
RI Fernandes, Bruno F./ABA-3567-2020; Belfort, Rubens N./D-3579-2015
OI Fernandes, Bruno F./0000-0002-5385-3571; Belfort, Rubens
   N./0000-0003-1775-7328; Isenberg, Jordan/0000-0002-7217-788X
CR Balmer A, 2006, ONCOGENE, V25, P5341, DOI 10.1038/sj.onc.1209622
   Ben Simon GJ, 2005, AM J OPHTHALMOL, V139, P482, DOI 10.1016/j.ajo.2004.10.003
   Bonavolonta G, 2013, OPHTHAL PLAST RECONS, V29, P79, DOI 10.1097/IOP.0b013e31827a7622
   Bonanomi MTBC, 2009, CLINICS, V64, P427, DOI 10.1590/S1807-59322009000500010
   Cheng GY, 2008, EYE, V22, P1404, DOI 10.1038/sj.eye.6702919
   Geirsdottir A, 2014, ACTA OPHTHALMOL, V92, P121, DOI 10.1111/aos.12004
   Ho M, 2013, HONG KONG MED J, V19, P150
   Ibanga A, 2013, INT OPHTHALMOL, V33, P355, DOI 10.1007/s10792-012-9700-8
   Khandekar RB, 2014, SAUDI MED J, V35, P377
   Knezevic M, 2013, VOJNOSANIT PREGL, V70, P26, DOI 10.2298/VSP1301026K
   Leal-Leal C, 2004, BRIT J OPHTHALMOL, V88, P1074, DOI 10.1136/bjo.2003.035642
   Maheshwari R, 2010, ORBIT, V29, P35, DOI 10.3109/01676830903234020
   Pushker N, 2004, CLIN EXP OPHTHALMOL, V32, P51, DOI 10.1046/j.1442-9071.2004.00757.x
   Rahman I, 2005, BRIT J OPHTHALMOL, V89, P1335, DOI 10.1136/bjo.2004.062471
   Sahu S, 1998, PEDIATR HEMAT ONCOL, V15, P501, DOI 10.3109/08880019809018311
   Sirianni D, 2013, OPEN DENT J, V7, P140, DOI 10.2174/1874210601307010140
   Tsai YY, 2001, OPHTHALMIC SURG LAS, V32, P208
   Vemuganti GK, 2001, EYE, V15, P760, DOI 10.1038/eye.2001.245
   Wyse E, 2016, PEDIATR RADIOL, V46, P1223, DOI 10.1007/s00247-016-3554-6
   Zygulska-Mach H, 1994, Klin Oczna, V96, P21
NR 20
TC 0
Z9 0
U1 0
U2 2
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JUL-AUG
PY 2017
VL 80
IS 4
BP 220
EP 223
DI 10.5935/0004-2749.20170054
PG 4
WC Ophthalmology
SC Ophthalmology
GA FI2UI
UT WOS:000411799900004
PM 28954020
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Costa, DF
   Nascimento, H
   Sutili, A
   Nobrega, FAJ
   Fowler, F
   Nobrega, MJ
   Garrido, C
   Dias, JD
   Adan, CBD
   Rizzo, LV
   Silveira, C
   Belfort, R
   Commodaro, AG
AF Costa, Deise F.
   Nascimento, Heloisa
   Sutili, Aline
   Nobrega, Fernando A. J.
   Fowler, Flavio
   Nobrega, Mario Junqueira
   Garrido, Cristina
   Dias, Janaina de Oliveira
   Adan, Consuelo B. D.
   Rizzo, Luiz Vicente
   Silveira, Claudio
   Belfort, Rubens, Jr.
   Commodaro, Alessandra G.
TI Frequency of Toxoplasma gondii in the retina in eye banks in Brazil
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Eye bank; Brazil; Toxoplasma gondii; Real-time PCR
ID REAL-TIME PCR; OCULAR TOXOPLASMOSIS; SOUTHERN BRAZIL; INFECTION;
   RETINOCHOROIDITIS
AB Ocular toxoplasmosis is the main cause of posterior uveitis worldwide frequently leading to vision loss. In Brazil, the seroprevalence of Toxoplasma gondii infection ranges from 50 to 80% depending of the region studied. The frequency of toxoplasmic retinal scar may reach 18% of the adults in the South of Brazil. Our goal was to determine the frequency of T. gondii DNA in retinas from eye banks from different regions in Brazil. A total of 162 eyes were obtained from eye banks in Manaus (n = 60), Sao Paulo (n = 60), Chapeco (n = 26), and Joinville (n = 16). The retinas were macroscopically analyzed and collected for DNA extraction. Real-time PCR (qPCR) was performed using the T. gondii B1 marker. By qPCR, a higher frequency of T. gondii DNA in the retinas from the eye bank of Joinville (25%) was found when compared to Manaus (5%). The retinas from Sao Paulo and Chapeco were qPCR negative. Clinical examination determined the retina lesions to be compatible with toxoplasmosis in the following frequencies: Joinville (62.5%), Manaus (10%), Sao Paulo (6.7%), and Chapeco (15.4%).
C1 [Costa, Deise F.; Nascimento, Heloisa; Sutili, Aline; Fowler, Flavio; Belfort, Rubens, Jr.; Commodaro, Alessandra G.] Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
   [Costa, Deise F.; Nascimento, Heloisa; Sutili, Aline; Fowler, Flavio; Belfort, Rubens, Jr.; Commodaro, Alessandra G.] Vis Inst, Rua Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
   [Nobrega, Fernando A. J.; Nobrega, Mario Junqueira] Eye Bank Joinville, Joinville, SC, Brazil.
   [Garrido, Cristina] Eye Bank Manaus, Manaus, Amazonas, Brazil.
   [Dias, Janaina de Oliveira] Eye Bank Chapeco, Chapeco, SC, Brazil.
   [Adan, Consuelo B. D.] Eye Bank Sao Paulo, Sao Paulo, SP, Brazil.
   [Rizzo, Luiz Vicente] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
   [Silveira, Claudio] Clin Silveira, Erechim, RS, Brazil.
RP Commodaro, AG (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.; Commodaro, AG (corresponding author), Vis Inst, Rua Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
EM alecommodaro@gmail.com
RI Rizzo, Luiz Vicente/B-4458-2009; Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317; Fialho da Costa,
   Deise/0000-0002-1974-4451; Commodaro, Alessandra/0000-0002-7816-6508
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [400040/2014-0]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); CAPESCAPES
FX This work was supported by CNPq (AGC-grant 400040/2014-0), FAPESP, and
   CAPES. R.B.J. and L.V.R. are researchers of CNPq-Brazil.
CR Calderaro Adriana, 2006, Acta Biomed, V77, P75
   Cassaing S, 2006, J CLIN MICROBIOL, V44, P720, DOI 10.1128/JCM.44.3.720-724.2006
   Commodaro AG, 2016, EMERG INFECT DIS, V22, P691, DOI 10.3201/eid2204.141819
   Cordeiro CA, 2010, ARQ BRAS OFTALMOL, V73, P548, DOI 10.1590/S0004-27492010000600018
   Hierl T, 2004, J MED MICROBIOL, V53, P629, DOI 10.1099/jmm.0.45566-0
   Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025
   Montoya JG, 1996, CLIN INFECT DIS, V23, P277, DOI 10.1093/clinids/23.2.277
   Novais EA, 2014, BRIT J OPHTHALMOL, V98, P937, DOI 10.1136/bjophthalmol-2013-304184
   NUSSENBLATT RB, 1994, JAMA-J AM MED ASSOC, V271, P304, DOI 10.1001/jama.271.4.304
   SILVEIRA C, 1988, AM J OPHTHALMOL, V106, P362, DOI 10.1016/0002-9394(88)90382-0
   Silveira C, 2003, AM J OPHTHALMOL, V136, P370, DOI 10.1016/S0002-9394(03)00191-0
   Silveira C, 2001, AM J OPHTHALMOL, V131, P351, DOI 10.1016/S0002-9394(00)00830-8
   Sugita S, 2011, JPN J OPHTHALMOL, V55, P495, DOI 10.1007/s10384-011-0065-8
   Vallochi AL, 2005, AM J OPHTHALMOL, V139, P350, DOI 10.1016/j.ajo.2004.07.040
NR 14
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD JUL
PY 2017
VL 116
IS 7
BP 2031
EP 2033
DI 10.1007/s00436-017-5474-2
PG 3
WC Parasitology
SC Parasitology
GA EY4IH
UT WOS:000403940600031
PM 28508165
DA 2020-12-01
ER

PT J
AU Fernandez, DG
   Nascimento, H
   Nascimento, C
   Muccioli, C
   Belfort, R
AF Fernandez, Delia Gonzalez
   Nascimento, Heloisa
   Nascimento, Caio
   Muccioli, Cristina
   Belfort, Rubens, Jr.
TI Uveitis in SAo Paulo, Brazil: 1053 New Patients in 15 Months
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Article
DE Epidemiology; juvenile idiopathic arthritis-related uveitis; syphilis;
   toxoplasmosis; tuberculosis; uveitis; Vogt-Koyanagi-Harada disease
ID OCULAR TOXOPLASMOSIS; CLINICAL-FEATURES; TERTIARY CENTER; EPIDEMIOLOGY;
   INFLAMMATION; PREVALENCE; SYPHILIS; PATTERN
AB Purpose: To describe the clinical profile of uveitis and analyze changes over a 34-year period in the frequency of different entities and demographics, anatomic data, diagnoses, and systemic associations in SAo Paulo, Brazil.Methods: A total of 1053 consecutive patients who presented for the first time at the outpatient uveitis clinic were analyzed in a prospective, observational study, conducted between July 2012 and September 2013. Age, gender, clinical characteristics, visual acuity, and clinical and etiologic diagnoses in patients with and without human immunodeficiency virus (HIV) were studied.Results: Mean age was 39.8 17.8 years (56.8% female), with most between 41 and 64 years (41.79%); 10.9% of the patients were HIV-positive and 8.1% were legally blind (best-corrected visual acuity (BCVA): 20/400) at the first evaluation. The posterior, bilateral, and chronic forms of uveitis occurred most frequently and toxoplasmosis was the main cause (24.03%) but was less frequent than in 1980; the same was true for Fuchs heterochromic iridocyclitis. Syphilis, tuberculosis, Vogt-Koyanagi-Harada disease, and juvenile idiopathic arthritis-related uveitis had increased incidence rates.Conclusions: The current results can help determine the present epidemiology of uveitis and its changes over time in Brazil and increases essential information about the disease. Many uveitic entities are curable and visual damage can be prevented or limited if treated early and appropriately.
C1 [Fernandez, Delia Gonzalez; Nascimento, Heloisa; Nascimento, Caio; Muccioli, Cristina; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Sao Paulo Hosp, Dept Ophthalmol, Escola Paulista Med, Rua Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Sao Paulo Hosp, Dept Ophthalmol, Escola Paulista Med, Rua Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
EM clinbelf@uol.com.br
RI Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317
CR Acharya NR, 2013, JAMA OPHTHALMOL, V131, P1405, DOI 10.1001/jamaophthalmol.2013.4237
   Al Dhahri H, 2014, OCUL IMMUNOL INFLAMM, V24, P1
   Al-Shakarchi FI, 2014, MIDDLE EAST AFR J OP, V21, P291, DOI 10.4103/0974-9233.142263
   Barisani-Asenbauer T, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-57
   Belfort Jr R., 1978, ARQ BRAS OFTALMOL, V41, P196
   Chang JHM, 2002, OCUL IMMUNOL INFLAMM, V10, P263, DOI 10.1076/ocii.10.4.263.15592
   Chao JR, 2006, OPHTHALMOLOGY, V113, P2074, DOI 10.1016/j.ophtha.2006.05.048
   Chaves Fernandes L, 1996, REV BRAS OFTALMOL, V55, P9
   Chebil A, 2013, J FR OPHTALMOL, V36, P764, DOI 10.1016/j.jfo.2013.05.006
   Das D, 2009, INDIAN J OPHTHALMOL, V57, P144, DOI 10.4103/0301-4738.45506
   Davis JL, 2014, CURR OPIN OPHTHALMOL, V25, P513, DOI 10.1097/ICU.0000000000000099
   de Abreu M. T., 1980, ARQ BRAS OFTALMOL, V43, P10
   Freitas LL, 1992, THESIS
   Furtado JM, 2013, CLIN EXP OPHTHALMOL, V41, P82, DOI 10.1111/j.1442-9071.2012.02821.x
   Gehlen ML, 1999, ARQ BRAS OFTALMOL, V62, P622
   Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014
   Gupta V, 2007, SURV OPHTHALMOL, V52, P561, DOI 10.1016/j.survophthal.2007.08.015
   Hirata CE, 1988, ARQ BRAS OFTALMOL, V51, P15
   Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057
   Jakob E, 2009, J RHEUMATOL, V36, P127, DOI 10.3899/jrheum.080102
   Jones NP, 2015, OCUL IMMUNOL INFLAMM, V23, P118, DOI 10.3109/09273948.2013.855799
   Kazokoglu H, 2008, OPHTHAL EPIDEMIOL, V15, P285, DOI 10.1080/09286580802262821
   Keino H, 2009, CLIN EXP OPHTHALMOL, V37, P595, DOI 10.1111/j.1442-9071.2009.02102.x
   Khairallah M, 2007, EYE, V21, P33, DOI 10.1038/sj.eye.6702111
   Liberman P, 2014, OCUL IMMUNOL INFLAMM, V1, P1
   Belles VL, 2012, MED CLIN-BARCELONA, V138, P277, DOI 10.1016/j.medcli.2011.06.020
   Miserocchi E, 2013, EUR J OPHTHALMOL, V23, P705, DOI 10.5301/ejo.5000278
   Mowatt L, 2013, W INDIAN MED J, V62, P305, DOI 10.7727/wimj.2013.210
   Nizamuddin SHM, 2013, SAUDI MED J, V34, P379
   da Silva LMP, 2013, ARQ BRAS OFTALMOL, V76, P366, DOI 10.1590/S0004-27492013000600010
   Petersen E, 2012, OCUL IMMUNOL INFLAMM, V20, P68, DOI 10.3109/09273948.2012.661115
   Petrilli A. M. N., 1987, ARQUIVOS BRASILEIROS, V50, P203
   Rahimi Mansour, 2014, J Ophthalmic Vis Res, V9, P54
   Rao NA, 2013, INDIAN J OPHTHALMOL, V61, P253, DOI 10.4103/0301-4738.114090
   Silpa-Archa S, 2014, OCUL IMMUNOL INFLAMM, V11, P1
   Tran V T, 1994, Ocul Immunol Inflamm, V2, P169, DOI 10.3109/09273949409057073
   Xavier GA, 2013, REV INST MED TROP SP, V55, P25, DOI 10.1590/S0036-46652013000100005
   Yang PZ, 2005, CURR EYE RES, V30, P943, DOI 10.1080/02713680500263606
   Yawn BP, 2013, MAYO CLIN PROC, V88, P562, DOI 10.1016/j.mayocp.2013.03.014
NR 39
TC 12
Z9 15
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PD JUN
PY 2017
VL 25
IS 3
BP 382
EP 387
DI 10.3109/09273948.2015.1132741
PG 6
WC Ophthalmology
SC Ophthalmology
GA FA4CL
UT WOS:000405391300017
PM 26914347
DA 2020-12-01
ER

PT J
AU Berezovsky, A
   Higashi, M
   Fernandes, AG
   Morales, PH
   Furtado, JM
   Watanabe, S
   Vasconcelos, GC
   Cohen, MJ
   Cohen, JM
   Cypel, M
   Cunha, CC
   Cavascan, NN
   Sacai, P
   Munoz, S
   Belfort, R
   Salomao, SR
AF Berezovsky, Adriana
   Higashi, Marcia
   Fernandes, Arthur Gustavo
   Morales, Paulo Henrique
   Furtado, Joao M.
   Watanabe, Sung
   Vasconcelos, Galton Carvalho
   Cohen, Marcos Jacob
   Cohen, Jacob Moyses
   Cypel, Marcela
   Cunha, Cristina Coimbra
   Cavascan, Nivea Nunes
   Sacai, Paula
   Munoz, Sergio
   Belfort, Rubens
   Salomao, Solange Rios
TI Anterior Segment Digital Photography Accuracy in the Evaluation of
   Pterygium: The Brazilian Amazon Region Eye Survey (BARES)
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 07-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Berezovsky, Adriana; Higashi, Marcia; Fernandes, Arthur Gustavo; Morales, Paulo Henrique; Furtado, Joao M.; Watanabe, Sung; Vasconcelos, Galton Carvalho; Cohen, Marcos Jacob; Cypel, Marcela; Cunha, Cristina Coimbra; Cavascan, Nivea Nunes; Sacai, Paula; Belfort, Rubens; Salomao, Solange Rios] Univ Fed Sao Paulo, Dept Oftalmol & Ciencias Visuais, Sao Paulo, SP, Brazil.
   [Furtado, Joao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Ribeirao Preto, Brazil.
   [Vasconcelos, Galton Carvalho] Univ Fed Minas Gerais, Dept Oftalmol, Belo Horizonte, MG, Brazil.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Univ Fed Amazonas, Fac Med, Dept Cirurgia, Div Oftalmol, Manaus, AM, Brazil.
   [Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, AM, Brazil.
   [Cunha, Cristina Coimbra] Univ Fed Para, Fac Med, Residencia Med Oftalmol, Belem, PA, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
RI Ferraz, Nivea/AAC-2439-2020; Sacai, Paula Y/B-6525-2014; Berezovsky,
   Adriana/F-2341-2013
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras [402120/2012-4];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   BrasilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/16397-7]; Sight First Program - Lions Club International
   Foundation [1758]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras (Grant # 402120/2012-4
   to SRS, SM and JMF; Research Scholarships to SRS and RBJ); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo, Brasil
   (Grant # 2013/16397-7 to SRS); Sight First Program - Lions Club
   International Foundation (Grant # 1758 to SRS).
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 4800
PG 3
WC Ophthalmology
SC Ophthalmology
GA GF7VL
UT WOS:000432176304117
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Cunha, CC
   Berezovsky, A
   Fernandes, AG
   Cavascan, NN
   Sacai, P
   Cypel, M
   Watanabe, SE
   Furtado, JM
   Cohen, MJ
   Vasconcelos, GC
   Cohen, JM
   Campos, MSD
   Munoz, S
   Belfort, R
   Salomao, SR
AF Cunha, Cristina Coimbra
   Berezovsky, Adriana
   Fernandes, Arthur Gustavo
   Cavascan, Nivea Nunes
   Sacai, Paula
   Cypel, Marcela
   Watanabe, Sung Eun
   Furtado, Joao M.
   Cohen, Marcos Jacob
   Vasconcelos, Galton Carvalho
   Cohen, Jacob Moyses
   de Queiroz Campos, Mauro Silveira
   Munoz, Sergio
   Belfort, Rubens
   Salomao, Solange Rios
TI Vision Status and Impact of Refractive Correction on Near Visual Acuity
   in Older Adults from Parintins City: the Brazilian Amazon Region Eye
   Survey
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO) - Imaging in
   the Eye
CY MAY 06-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Cunha, Cristina Coimbra; Berezovsky, Adriana; Fernandes, Arthur Gustavo; Cavascan, Nivea Nunes; Sacai, Paula; Cypel, Marcela; Watanabe, Sung Eun; Furtado, Joao M.; Cohen, Marcos Jacob; Vasconcelos, Galton Carvalho; Cohen, Jacob Moyses; de Queiroz Campos, Mauro Silveira; Munoz, Sergio; Belfort, Rubens; Salomao, Solange Rios] Univ Fed Sao Paulo, UNIFESP, Belem, Para, Brazil.
   [Cunha, Cristina Coimbra] Univ Fed Para, Hosp Bettina Ferro de Souza, Oftalmol, Belem, Para, Brazil.
RI Ferraz, Nivea/AAC-2439-2020; Sacai, Paula Y/B-6525-2014; Berezovsky,
   Adriana/F-2341-2013; de Queiroz Campos, Mauro Silveira/H-7609-2017
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221; de Queiroz Campos, Mauro
   Silveira/0000-0002-9448-8742
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras [402120/2012-4];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   BrasilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/16397-7]; Sight First Program - Lions Club International
   Foundation [1758]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras (Grant # 402120/2012-4
   to SRS, SM and JMF; Research Scholarships to SRS and RBJ); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo, Brasil
   (Grant # 2013/16397-7 to SRS); Sight First Program - Lions Club
   International Foundation (Grant # 1758 to SRS).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 2382
PG 3
WC Ophthalmology
SC Ophthalmology
GA GF7TE
UT WOS:000432170306123
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU da Costa, DFD
   Fowler, FD
   Nascimento, H
   Toledo, AS
   Dias, JD
   Nobrega, MJ
   Garrido, CMB
   Nobrega, FAJ
   Rizzo, LV
   Silveira, C
   Commodaro, AG
   Belfort, R
AF da Fialho da Costa, Deise Fialho
   Fowler, Flavio de Avila
   Nascimento, Heloisa
   Toledo, Aline Sutili
   Dias, Janaina De Oliveira
   Nobrega, Mario J.
   Bittencourt Garrido, Cristina Maria
   Junqueira Nobrega, Fernando Amaral
   Rizzo, Luiz Vicente
   Silveira, Claudio
   Commodaro, Alessandra Goncalves
   Belfort, Rubens
TI Frequency of toxoplasmic retinal lesions in Eye Bank retinas
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 07-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [da Fialho da Costa, Deise Fialho; Fowler, Flavio de Avila; Nascimento, Heloisa; Toledo, Aline Sutili; Commodaro, Alessandra Goncalves; Belfort, Rubens] Univ Fed Sao Paulo, Dept Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Dias, Janaina De Oliveira] Hosp Reg Oeste, Banco Olhos Chapeco, Chapeco, SC, Brazil.
   [Nobrega, Mario J.; Junqueira Nobrega, Fernando Amaral] Banco Olhos Joinville, Joinville, SC, Brazil.
   [Bittencourt Garrido, Cristina Maria] Fundacao Hosp Adriano Jorge, Banco Olhos Amazonas, Manaus, Amazonas, Brazil.
   [Rizzo, Luiz Vicente] Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa, Sao Paulo, Brazil.
   [Silveira, Claudio] Clin Silveira, Erechim, RS, Brazil.
RI Rizzo, Luiz Vicente/B-4458-2009; Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 3889
PG 2
WC Ophthalmology
SC Ophthalmology
GA GF7VL
UT WOS:000432176302035
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Fernandes, AG
   Berezovsky, A
   Higashi, M
   Furtado, JM
   Watanabe, S
   Morales, PH
   Cohen, MJ
   Cohen, JM
   Cypel, M
   Cunha, CC
   Cavascan, NN
   Sacai, P
   Vasconcelos, GC
   Munoz, S
   Belfort, R
   Salomao, SR
AF Fernandes, Arthur Gustavo
   Berezovsky, Adriana
   Higashi, Marcia
   Furtado, Joao M.
   Watanabe, Sung
   Morales, Paulo Henrique
   Cohen, Marcos Jacob
   Cohen, Jacob Moyses
   Cypel, Marcela
   Cunha, Cristina Coimbra
   Cavascan, Nivea Nunes
   Sacai, Paula
   Vasconcelos, Galton Carvalho
   Munoz, Sergio
   Belfort, Rubens
   Salomao, Solange Rios
TI Prevalence and contribution of pterygium in visual impairment and
   blindness in older adults: the Brazilian Amazon Region Eye Survey
   (BARES)
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO) - Imaging in
   the Eye
CY MAY 06-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Fernandes, Arthur Gustavo; Berezovsky, Adriana; Higashi, Marcia; Furtado, Joao M.; Watanabe, Sung; Morales, Paulo Henrique; Cypel, Marcela; Cunha, Cristina Coimbra; Cavascan, Nivea Nunes; Sacai, Paula; Vasconcelos, Galton Carvalho; Belfort, Rubens; Salomao, Solange Rios] Univ Fed Sao Paulo, Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Univ Fed Amazonas, Dept Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cunha, Cristina Coimbra] Univ Fed Para, Hosp Bettina Ferro de Souza, Belem, Para, Brazil.
   [Vasconcelos, Galton Carvalho] Univ Fed Minas Gerais, Oftalmol & Otorrinolaringol, Belo Horizonte, MG, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
RI Ferraz, Nivea/AAC-2439-2020; Sacai, Paula Y/B-6525-2014; Berezovsky,
   Adriana/F-2341-2013
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras [402120/2012-4];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   BrasilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/16397-7]; Sight First Program - Lions Club International
   Foundation [1758]
FX Support Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPq, Brasilia, Brasil, Programa Ciencia sem Fronteiras (Grant #
   402120/2012-4 to SRS, SM and JMF; Research Scholarships to SRS and RBJ);
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   Brasil (Grant # 2013/16397-7 to SRS); Sight First Program - Lions Club
   International Foundation (Grant # 1758 to SRS).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 2199
PG 3
WC Ophthalmology
SC Ophthalmology
GA GF7TE
UT WOS:000432170305327
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Fiorot, C
   Coblentz, J
   Discepola, G
   Cohen, S
   Belfort, R
   Burnier, MN
AF Fiorot, Claudia
   Coblentz, Jacqueline
   Discepola, Gerardo
   Cohen, Sabrina
   Belfort, Rubens
   Burnier, Miguel N.
TI Kaposi's sarcoma of the conjunctiva and orbit
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 07-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Fiorot, Claudia; Coblentz, Jacqueline; Discepola, Gerardo; Cohen, Sabrina; Belfort, Rubens; Burnier, Miguel N.] McGill Univ, Westmount, PQ, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 3357
PG 2
WC Ophthalmology
SC Ophthalmology
GA GF7VL
UT WOS:000432176300350
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Salomao, SR
   Fernandes, AG
   Berezovsky, A
   Higashi, M
   Furtado, JM
   Watanabe, S
   Vasconcelos, GC
   Cohen, MJ
   Cohen, JM
   Cypel, M
   Cunha, CC
   Cavascan, NN
   Sacai, P
   Morales, PH
   Munoz, S
   Belfort, R
AF Salomao, Solange Rios
   Fernandes, Arthur Gustavo
   Berezovsky, Adriana
   Higashi, Marcia
   Furtado, Joao M.
   Watanabe, Sung
   Vasconcelos, Galton Carvalho
   Cohen, Marcos Jacob
   Cohen, Jacob Moyses
   Cypel, Marcela
   Cunha, Cristina Coimbra
   Cavascan, Nivea Nunes
   Sacai, Paula
   Morales, Paulo Henrique
   Munoz, Sergio
   Belfort, Rubens
TI Influence of Pterygium on Refractive Status in Older Adults: The
   Brazilian Amazon Region Eye Survey (BARES)
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 07-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Salomao, Solange Rios; Fernandes, Arthur Gustavo; Berezovsky, Adriana; Higashi, Marcia; Furtado, Joao M.; Watanabe, Sung; Vasconcelos, Galton Carvalho; Cohen, Marcos Jacob; Cypel, Marcela; Cunha, Cristina Coimbra; Cavascan, Nivea Nunes; Sacai, Paula; Morales, Paulo Henrique; Belfort, Rubens] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Sao Paulo, SP, Brazil.
   [Furtado, Joao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Oftalmol Otorrinolaringol & Cirurgia Cabeca & Pes, Ribeirao Preto, SP, Brazil.
   [Vasconcelos, Galton Carvalho] Univ Fed Minas Gerais, Fac Med, Oftalmol & Otorrinolaringol, Belo Horizonte, MG, Brazil.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Univ Fed Amazonas, Fac Med, Dept Cirurgia, Div Oftalmol, Manaus, AM, Brazil.
   [Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, AM, Brazil.
   [Cunha, Cristina Coimbra] Univ Fed Para, Fac Med, Residencia Med Oftalmol, Belem, PA, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
RI Sacai, Paula Y/B-6525-2014; Berezovsky, Adriana/F-2341-2013; Ferraz,
   Nivea/AAC-2439-2020
OI Berezovsky, Adriana/0000-0001-6350-8221; Ferraz,
   Nivea/0000-0001-7568-6199
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras [402120/2012-4];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   BrasilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/16397-7]; Sight First Program - Lions Club International
   Foundation [1758]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras (Grant # 402120/2012-4
   to SRS, SM and JMF; Research Scholarships to SRS and RBJ); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo, Brasil
   (Grant # 2013/16397-7 to SRS); Sight First Program - Lions Club
   International Foundation (Grant # 1758 to SRS).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 4799
PG 3
WC Ophthalmology
SC Ophthalmology
GA GF7VL
UT WOS:000432176304116
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Vasconcelos, GC
   Berezovsky, A
   Cavascan, NN
   Sacai, P
   Fernandes, AG
   Cypel, M
   Watanabe, S
   Cohen, MJ
   Cunha, CC
   Furtado, JM
   Cohen, JM
   Belfort, R
   Munoz, S
   Salomao, SR
AF Vasconcelos, Galton Carvalho
   Berezovsky, Adriana
   Cavascan, Nivea Nunes
   Sacai, Paula
   Fernandes, Arthur Gustavo
   Cypel, Marcela
   Watanabe, Sung
   Cohen, Marcos Jacob
   Cunha, Cristina Coimbra
   Furtado, Joao M.
   Cohen, Jacob Moyses
   Belfort, Rubens
   Munoz, Sergio
   Salomao, Solange Rios
TI Vision Status and Impact of Refractive Correction on Distance Visual
   Acuity in Older Adults from Parintins City: The Brazilian Amazon Region
   Eye Survey
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO) - Imaging in
   the Eye
CY MAY 06-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Vasconcelos, Galton Carvalho] Univ Fed Minas Gerais, Ophthalmol, Belo Horizonte, MG, Brazil.
   [Berezovsky, Adriana; Cavascan, Nivea Nunes; Sacai, Paula; Fernandes, Arthur Gustavo; Cypel, Marcela; Watanabe, Sung; Belfort, Rubens; Salomao, Solange Rios] Univ Fed Sao Paulo, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Sao Paulo, SP, Brazil.
   [Cohen, Marcos Jacob; Cunha, Cristina Coimbra; Cohen, Jacob Moyses] Univ Fed Amazonas, Fac Med, Div Oftalmol, Dept Cirurgia, Manaus, Amazonas, Brazil.
   [Furtado, Joao M.] Univ Sao Paulo, Dept Oftalmol, Ribeirao Preto, SP, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
RI Ferraz, Nivea/AAC-2439-2020; Sacai, Paula Y/B-6525-2014; Berezovsky,
   Adriana/F-2341-2013
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras [402120/2012-4];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   BrasilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/16397-7]; Sight First Program - Lions Club International
   Foundation [1758]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras (Grant # 402120/2012-4
   to SRS, SM and JMF; Research Scholarships to SRS and RBJ); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo, Brasil
   (Grant # 2013/16397-7 to SRS); Sight First Program - Lions Club
   International Foundation (Grant # 1758 to SRS).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 2383
PG 3
WC Ophthalmology
SC Ophthalmology
GA GF7TE
UT WOS:000432170306124
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Watanabe, SE
   Higashi, M
   Cypel, M
   Fernandes, AG
   Berezovsky, A
   Cohen, MJ
   Furtado, JM
   Morales, PH
   Cunha, CC
   Cohen, JM
   Cavascan, NN
   Sacai, P
   Vasconcelos, GC
   Munoz, S
   Belfort, R
   Salomao, SR
AF Watanabe, Sung Eun
   Higashi, Marcia
   Cypel, Marcela
   Fernandes, Arthur Gustavo
   Berezovsky, Adriana
   Cohen, Marcos Jacob
   Furtado, Joao M.
   Morales, Paulo Henrique
   Cunha, Cristina Coimbra
   Cohen, Jacob Moyses
   Cavascan, Nivea Nunes
   Sacai, Paula
   Vasconcelos, Galton Carvalho
   Munoz, Sergio
   Belfort, Rubens
   Salomao, Solange Rios
TI Post Cataract Surgery Complications and its Contribution to Visual
   Impairment/Blindness: The Brazilian Amazon Region Eye Survey (BARES)
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO) - Imaging in
   the Eye
CY MAY 06-11, 2017
CL Baltimore, MD
SP Assoc Res Vis & Ophthalmol
C1 [Watanabe, Sung Eun; Higashi, Marcia; Cypel, Marcela; Fernandes, Arthur Gustavo; Berezovsky, Adriana; Cohen, Marcos Jacob; Furtado, Joao M.; Morales, Paulo Henrique; Cunha, Cristina Coimbra; Cavascan, Nivea Nunes; Sacai, Paula; Vasconcelos, Galton Carvalho; Belfort, Rubens; Salomao, Solange Rios] Univ Fed Sao Paulo, Dept Oftalmol & Ciencias Visuais, Sao Paulo, SP, Brazil.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Univ Fed Amazonas, Fac Med, Dept Cirurgia, Div Oftalmol, Manaus, AM, Brazil.
   [Furtado, Joao M.] Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Ribeirao Preto, SP, Brazil.
   [Cunha, Cristina Coimbra] Univ Fed Para, Fac Med, Residencia Med Oftalmol, Belem, Para, Brazil.
   [Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, AM, Brazil.
   [Vasconcelos, Galton Carvalho] Univ Fed Minas Gerais, Dept Oftalmol, Belo Horizonte, MG, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
RI Ferraz, Nivea/AAC-2439-2020; Sacai, Paula Y/B-6525-2014; Berezovsky,
   Adriana/F-2341-2013
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil; Programa Ciencia sem Fronteiras [402120/2012-4];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   BrasilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/16397-7]; Sight First Program - Lions Club International
   Foundation [1758]
FX Support Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPq, Brasilia, Brasil, Programa Ciencia sem Fronteiras (Grant #
   402120/2012-4 to SRS, SM and JMF; Research Scholarships to SRS and RBJ);
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   Brasil (Grant # 2013/16397-7 to SRS); Sight First Program - Lions Club
   International Foundation (Grant # 1758 to SRS).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2017
VL 58
IS 8
MA 776
PG 4
WC Ophthalmology
SC Ophthalmology
GA GF7TE
UT WOS:000432170302007
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Hwang, TJ
   Karanjia, R
   Moraes, MN
   Gale, J
   Tran, JS
   Chu, ER
   Salomao, SR
   Berezovsky, A
   Belfort, R
   Moraes, MN
   Sadun, F
   DeNegri, AM
   La Morgia, C
   Barboni, P
   Ramos, CDF
   Chicani, CF
   Quiros, PA
   Carelli, V
   Sadun, AA
AF Hwang, Tiffany Jean
   Karanjia, Rustum
   Moraes-Filho, Milton Nunes
   Gale, Jesse
   Tran, Jeffrey Show
   Chu, Edward R.
   Salomao, Solange R.
   Berezovsky, Adriana
   Belfort, Rubens, Jr.
   Moraes, Milton Nunes
   Sadun, Federico
   DeNegri, Anna Maria
   La Morgia, Chiara
   Barboni, Piero
   Ramos, Carolina do V. F.
   Chicani, Carlos Filipe
   Quiros, Peter A.
   Carelli, Valerio
   Sadun, Alfredo A.
TI Natural History of Conversion of Leber's Hereditary Optic Neuropathy A
   Prospective Case Series
SO OPHTHALMOLOGY
LA English
DT Article
AB Purpose: To illustrate the natural history of Leber's hereditary optic neuropathy (LHON).
   Design: Prospective observational case series.
   Participants: The Soave-Brazil pedigree of m. 11778G>A/ND4 mitochondrial DNA LHON mutation.
   Methods: A prospectively acquired database of the Soave-Brazil pedigree was reviewed. Data from 285 individuals were included in the database over a 15-year period. The pedigree was reviewed for unaffected mutation carriers who converted to affected status, 6 patients with LHON were identified. The medical records were reviewed 1 year preconversion to 1 year postconversion for visual acuity (logarithm of the minimum angle of resolution [logMAR]), Humphrey Visual Field (HVF) mean deviation (MD), and retinal nerve fiber layer (RNFL) thickness, as measured by Cirrus (Carl Zeiss, Oberkochen, Germany) optic coherence tomography (OCT). The RNFL thickness values were normalized for age. Visual acuity, HVF, and processed RNFL data from each of the 12 eyes were then sorted into 2-month time periods relative to the date of conversion, within which they were averaged.
   Main Outcome Measures: The main outcome measures were visual acuity, HVF MD, and RNFL thickness.
   Results: Decreased visual acuity preceded conversion by up to 2 months and then declined up to 8 months postconversion. Decrease in HVF MD occurred at least 4 months preceding conversion, after which values decreased until plateau at 6 to 8 months. Average RNFL thickness was above normal baseline thickness in all 4 quadrants as measured by OCT at the time of conversion. Increase in RNFL thickness preceded conversion as early as 4 to 6 months, peaked at conversion, and decreased until individual plateaus. The temporal quadrant was first to be involved, then the inferior and superior quadrants, and the nasal quadrant showed the latest and least changes.
   Conclusions: Subclinical changes preceded the date of conversion and may reflect the complicated nature of identifying the date of conversion in LHON. Early increases in RNFL preceding conversion suggest that structural changes precede clinically significant vision loss. Asynchronous quadrant involvement supports a previously published mathematical model. The natural history of LHON is not a subacute process, as previously believed, but progresses more slowly, taking up to 8 months to plateau. (C) 2017 by the American Academy of Ophthalmology.
C1 [Hwang, Tiffany Jean; Karanjia, Rustum; Tran, Jeffrey Show; Chu, Edward R.; Chicani, Carlos Filipe; Quiros, Peter A.; Sadun, Alfredo A.] Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA USA.
   [Karanjia, Rustum; Quiros, Peter A.; Sadun, Alfredo A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Doheny Eye Ctr, Los Angeles, CA USA.
   [Karanjia, Rustum] Univ Ottawa, Ottawa Eye Inst, Ottawa, ON, Canada.
   [Karanjia, Rustum] Ottawa Hlth Res Inst, Ottawa, ON, Canada.
   [Moraes-Filho, Milton Nunes; Moraes, Milton Nunes] Inst Olhos Colatina, Colatina, ES, Brazil.
   [Gale, Jesse] Univ Otago, Surg & Anaesthesia, Wellington, New Zealand.
   [Salomao, Solange R.; Berezovsky, Adriana; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Hosp Sao Paulo, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Belfort, Rubens, Jr.] Inst Paulista Visao, Sao Paulo, Brazil.
   [Sadun, Federico] Osped Parodi Delfino, Dept Ophthalmol, Rome, Italy.
   [DeNegri, Anna Maria] Azienda Osped San Camillo Forlanini, Rome, Italy.
   [La Morgia, Chiara; Carelli, Valerio] Bellaria Hosp, IRCCS, Inst Neurol Sci Bologna, Bologna, Italy.
   [La Morgia, Chiara; Carelli, Valerio] Univ Bologna, Neurol Unit, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy.
   [Barboni, Piero] Studio Oculist Azeglio, Bologna, Italy.
   [Ramos, Carolina do V. F.] Hosp Fed Lagoa, Rio De Janeiro, Brazil.
RP Sadun, AA (corresponding author), Doheny UCLA, 800 Fairmount Ave,Suite 215, Pasadena, CA 91105 USA.
EM sadun@jsei.ucla.edu
RI Berezovsky, Adriana/F-2341-2013; sadun, federico/AAF-6588-2019; Gale,
   Jesse/AAB-7406-2019; Barboni, Piero/AAA-9936-2020; Chicani,
   Carlos/AAZ-9580-2020
OI Berezovsky, Adriana/0000-0001-6350-8221; Gale,
   Jesse/0000-0002-6616-445X; Barboni, Piero/0000-0002-0118-4177; 
FU Edison Pharmaceuticals; Stealth Biotechnology; AbbVieAbbott
   Laboratories; AllerganAllergan; NovartisNovartis; AlconNovartis;
   Ophthalmos
FX A.A.S.: Board member - IFOND; Consultant - Edison Pharmaceuticals,
   Stealth BioTherapeutics; Expert testimony in many different cases;
   Grants/grants pending - Edison Pharmaceuticals; Royalties - publishers
   for textbooks he has served as editor or written, including Ryan's
   Retina by Ryan SJ, Schachat AP, Wilkinson CP, Hinton DR, Sadda SR,
   Wiedemann P, eds. (Elsevier) and Ophthalmology by Yanoff M, and Duker
   JS, eds. (Saunders).; Support provided to C.L.M., V.C., and A.A.S. by
   Edison Pharmaceuticals; R.K. and A.A.S. by Stealth Biotechnology; R.B.
   by AbbVie, Allergan, Novartis, Alcon, Ophthalmos.
CR Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V., 2002, MITOCHONDRIAL DISORD, P115
   Giordano C, 2016, BRAIN, V139, DOI 10.1093/brain/awv217
   Karanjia R, 2016, NEURO-OPHTHALMOLOGY, V40, P219, DOI 10.1080/01658107.2016.1209221
   NIKOSKELAINEN E, 1983, ARCH OPHTHALMOL-CHIC, V101, P1059, DOI 10.1001/archopht.1983.01040020061011
   Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504
   Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452
   Pisano A, 2015, HUM MOL GENET, V24, P6921, DOI 10.1093/hmg/ddv396
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sadun AA, 2013, CLIN EXP OPHTHALMOL, V41, P702, DOI 10.1111/ceo.12086
   Sadun Alfredo A, 2002, Trans Am Ophthalmol Soc, V100, P169
   Savini G, 2006, ARCH OPHTHALMOL-CHIC, V124, P1111, DOI 10.1001/archopht.124.8.1111
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
NR 14
TC 20
Z9 21
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD JUN
PY 2017
VL 124
IS 6
BP 843
EP 850
DI 10.1016/j.ophtha.2017.01.002
PG 8
WC Ophthalmology
SC Ophthalmology
GA EW3MW
UT WOS:000402402800021
PM 28196731
DA 2020-12-01
ER

PT J
AU Cypel, MC
   Salomao, SR
   Dantas, PEC
   Lottenberg, CL
   Kasahara, N
   Ramos, LR
   Belfort, R
AF Cypel, Marcela Colussi
   Salomao, Solange Rios
   Correa Dantas, Paulo Elias
   Lottenberg, Claudio Luiz
   Kasahara, Niro
   Ramos, Luiz Roberto
   Belfort, Rubens, Jr.
TI Vision status, ophthalmic assessment, and quality of life in the very
   old
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Aging; Vision disorders/diagnosis; Geriatric assessment; Blindness;
   Vision, low; Quality of life; Surveys and questionnaires; Aged; Aged, 80
   and over
ID VISUAL FUNCTION QUESTIONNAIRE; CATARACT-SURGERY; SAO-PAULO; EYE;
   IMPAIRMENT; PREVALENCE; POPULATION; BLINDNESS; AGE; DISORDERS
AB Purpose: To determine the vision status, ophthalmic findings, and quality of life among the very elderly.
   Methods: This was a cross-sectional observational study of individuals aged 80 years and above. A comprehensive ophthalmic exam was performed with mea-surement of both the presenting (PVA) and best-corrected visual acuity. The Quality of Life Short Form-36 (SF-36) and the Visual Function Questionnaire (VFQ-25) were also administered.
   Results: A total of 150 non-institutionalized participants were assigned to three age groups: 80-89 years (n = 70), 90-99 years (n = 50), and 100 years and older (n= 30). PVA and best-corrected visual acuity were normal (>= 20/30) in 20 (13.3%) and 37 participants (24.7%), respectively. Regarding PVA, mild visual impairment (<20/30 to >= 20/60) was found in in 53 (35.4%), moderate visual impairment (<20/60 to >= 20/200) in 50 (33.3%), severe visual impairment (<20/200 to >= 20/400) in 8 (5.3%), and blindness (<20/400) in 19 (12.7%) participants. Regarding best-corrected visual acuity, mild, moderate, and severe visual impairments were present in 55 (36.7%), 38 (25.3%), and 5 (3.3%) participants, respectively, and blindness was present in 15 (10%). The main causes of visual impairment/blindness were cataract (43.8%), refractive errors (21.5%), age-related macular degeneration (17.7%), and myopic degeneration (3.8%). SF-36 scores were worse in those with low visual acuity, while VFQ-25 domain scores were poorer in those with vision impairment/blindness.
   Conclusion: Vision impairment and blindness was present in three-quarters of this sample, but it was notable that adequate correction with spectacles improved visual acuity. This reinforces the need for regular ophthalmic care in elderly patients to improve their quality of life by optimizing vision.
C1 [Cypel, Marcela Colussi; Salomao, Solange Rios; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, EPM, Dept Ophthalmol & Visual Sci, UNIFESP, Sao Paulo, SP, Brazil.
   [Correa Dantas, Paulo Elias; Kasahara, Niro] Santa Casa Sao Paulo, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Lottenberg, Claudio Luiz] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.
   [Ramos, Luiz Roberto] Univ Fed Sao Paulo, UNIFESP, Dept Med Prevent, Sao Paulo, SP, Brazil.
RP Cypel, MC (corresponding author), Rua Simao Alvares 1-015, BR-05417030 Sao Paulo, SP, Brazil.
EM macypel@gmail.com
RI Ramos, Luiz R/E-5343-2012; DANTAS, PAULO ELIAS CORREA/AAO-8315-2020;
   Ramos, Luiz/AAF-3871-2020; Kasahara, Niro/P-4631-2019
OI DANTAS, PAULO ELIAS CORREA/0000-0002-4363-9301; Ramos,
   Luiz/0000-0003-3143-8315; Kasahara, Niro/0000-0003-4101-0304
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) at
   Departamento de Oftalmologia, Escola Paulista de Medicina, Universidade
   Federal de Sao Paulo, Sao Paulo, SP, Brasil
FX This study was supported by CAPES (Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior) for doctoral fellowship (MCC) at Departamento
   de Oftalmologia, Escola Paulista de Medicina, Universidade Federal de
   Sao Paulo, Sao Paulo, SP, Brasil. SRS and RBJ are research scholars from
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brasilia, Brasil).
CR Araujo A, 2008, ARQ BRAS OFTALMOL, V71, P246, DOI 10.1590/S0004-27492008000200021
   Attebo K, 1996, OPHTHALMOLOGY, V103, P357
   Bergman B, 2004, ACTA OPHTHALMOL SCAN, V82, P166, DOI 10.1111/j.1600-0420.2004.00182.x
   Bledowski P, 2011, EXP GERONTOL, V46, P1003, DOI 10.1016/j.exger.2011.09.006
   Brasil. Ministerio da Saude, 2007, RED INT INF SAUD RIP
   Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010
   Chia EM, 2006, ANN ACAD MED SINGAP, V35, P461
   Cypel Marcela C., 2004, International Ophthalmology, V25, P267, DOI 10.1007/s10792-005-0077-9
   Cypel Marcela Colussi, 2006, Arq. Bras. Oftalmol., V69, P665, DOI 10.1590/S0004-27492006000500008
   Cypel MC, 2008, OFTALMOGERIATRIA
   Dev MK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-345
   EDERER F, 1973, ARCH OPHTHALMOL-CHIC, V89, P1
   Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570
   Geirsdottir A, 2007, AM J OPHTHALMOL, V143, P889, DOI 10.1016/j.ajo.2006.11.057
   Glynn RJ, 2012, OPHTHAL EPIDEMIOL, V19, P159, DOI 10.3109/09286586.2012.674614
   Hennis AJ, 2009, OPHTHALMOLOGY, V116, P1461, DOI 10.1016/j.ophtha.2009.02.017
   Hsu WM, 2004, OPHTHALMOLOGY, V111, P62, DOI 10.1016/j.ophtha.2003.05.011
   Instituto Brasileiro de Geografia e Estatistica, 2013, TAB COMPL POP SUA PR
   Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653
   Leibowitz H M, 1980, Surv Ophthalmol, V24, P335
   Lima MG, 2009, CAD SAUDE PUBLICA, V25, P2159, DOI 10.1590/S0102-311X2009001000007
   Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050
   McGwin G, 2010, CURR EYE RES, V35, P451, DOI 10.3109/02713681003664931
   Owen Christopher G, 2006, BMC Ophthalmol, V6, P24, DOI 10.1186/1471-2415-6-24
   Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210
   Salomao SR, 2008, OPHTHAL EPIDEMIOL, V15, P167, DOI 10.1080/09286580701843812
   Simao LM, 2008, ARQ BRAS OFTALMOL, V71, P540, DOI 10.1590/S0004-27492008000400014
   Veras RP, 2012, CAD SAUDE PUBLICA, V28, P1834, DOI 10.1590/S0102-311X2012001000003
   WHO, 2013, AG LIF COURS
   Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023
NR 30
TC 5
Z9 5
U1 0
U2 4
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD MAY-JUN
PY 2017
VL 80
IS 3
BP 159
EP 164
DI 10.5935/0004-2749.20170039
PG 6
WC Ophthalmology
SC Ophthalmology
GA FE5LX
UT WOS:000408254100005
PM 28832732
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Karanjia, R
   Berezovsky, A
   Sacai, PY
   Cavascan, NN
   Liu, HY
   Nazarali, S
   Moraes, MN
   Anderson, K
   Tran, JS
   Watanabe, SE
   Moraes, MN
   Sadun, F
   DeNegri, AM
   Barboni, P
   Ramos, CDF
   La Morgia, C
   Carelli, V
   Belfort, R
   Coupland, SG
   Salomao, SR
   Sadun, AA
AF Karanjia, Rustum
   Berezovsky, Adriana
   Sacai, Paula Yuri
   Cavascan, Nivea Nunes
   Liu, Henry Yuheng
   Nazarali, Samir
   Moraes-Filho, Milton Nunes
   Anderson, Kirsten
   Tran, Jeffrey Show
   Watanabe, Sung EunSong
   Moraes, Milton Nunes
   Sadun, Federico
   DeNegri, Anna Maria
   Barboni, Piero
   Ferreira Ramos, Carolina do Val
   La Morgia, Chiara
   Carelli, Valerio
   Belfort, Rubens, Jr.
   Coupland, Stuart Glenn
   Salomao, Solange Rios
   Sadun, Alfredo A.
TI The Photopic Negative Response: An Objective Measure of Retinal Ganglion
   Cell Function in Patients With Leber's Hereditary Optic Neuropathy
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
DE LHON; PhNR; ERG
AB PURPOSE. The photopic negative response (PhNR) is a slow negative component of a flash photopic full-field ERG that has been shown to be specific for retinal ganglion cell (RGC) activity. Direct evaluation of RGC function is desirable in patients with Leber's hereditary optic neuropathy (LHON) in which the loss of central acuity can make it difficult to monitor patients with standard metrics. The purpose of this study was to evaluate the use of PhNR as an objective noninvasive clinical metric in LHON.
   METHODS. Full-field photopic ERG recordings were collected in subjects with the mt.11778G>A/ND4 LHON mutation using a red on blue stimulus. The PhNR was identified using a computer-based automated detection system, and data were manually examined to remove movement artifacts.
   RESULTS. The PhNR amplitude was compared between controls (n = 13), carriers (n = 17), and affected (n = 6). Mean PhNR amplitude decreased significantly across groups (P < 0.0001). Post hoc Tukey's test revealed a significant decrease in PhNR amplitude between carriers and controls (P < 0.05) and between carriers and affected (P < 0.01).
   CONCLUSIONS. We are able to demonstrate that the PhNR amplitude is significantly decreased in patients affected by LHON compared to carriers in a well-described pedigree. Surprisingly, there was also a decrease in PhNR in carriers, suggesting potential subclinical RGC dysfunction in some carriers. This is important in patients affected with LHON who typically have a dense central scotoma. The PhNR may be a useful objective outcome measure for future clinical trials.
C1 [Karanjia, Rustum; Anderson, Kirsten; Tran, Jeffrey Show; Sadun, Alfredo A.] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA.
   [Karanjia, Rustum; Anderson, Kirsten; Sadun, Alfredo A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Doheny Eye Ctr, Los Angeles, CA 90095 USA.
   [Karanjia, Rustum; Liu, Henry Yuheng; Nazarali, Samir; Coupland, Stuart Glenn] Univ Ottawa, Ottawa Eye Inst, Ottawa, ON, Canada.
   [Karanjia, Rustum; Coupland, Stuart Glenn] Ottawa Hosp Res Inst, Ottawa, ON, Canada.
   [Berezovsky, Adriana; Sacai, Paula Yuri; Cavascan, Nivea Nunes; Watanabe, Sung EunSong; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Sao Paulo, SP, Brazil.
   [Moraes-Filho, Milton Nunes; Moraes, Milton Nunes] Inst Olhos Colatina, Colatina, ES, Brazil.
   [Sadun, Federico] Osped Parodi Delfino, Dept Ophthalmol, Rome, Italy.
   [DeNegri, Anna Maria] Azienda Osped San Camillo Forlanini, Rome, Italy.
   [Barboni, Piero] Studio Oculist Azeglio, Bologna, Italy.
   [Ferreira Ramos, Carolina do Val] Hosp Fed Lagoa, Rio De Janeiro, Brazil.
   [La Morgia, Chiara; Carelli, Valerio] Bellaria Hosp, Inst Neurol Sci Bologna, IRCCS, Bologna, Italy.
   [La Morgia, Chiara; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Unit Neurol, Bologna, Italy.
RP Karanjia, R (corresponding author), Suite 215,800 Fairmount, Pasadena, CA 91105 USA.
EM Karanjia@jsei.ucla.edu
RI Barboni, Piero/AAA-9936-2020; Berezovsky, Adriana/F-2341-2013; sadun,
   federico/AAF-6588-2019; Sacai, Paula Y/B-6525-2014; Ferraz,
   Nivea/AAC-2439-2020
OI Barboni, Piero/0000-0002-0118-4177; Berezovsky,
   Adriana/0000-0001-6350-8221; Ferraz, Nivea/0000-0001-7568-6199; Tran,
   Jeffrey/0000-0002-5239-959X
FU Stealth BioTherapeutics; International Foundation for Optic Nerve
   Disease (IFOND)
FX Supported in part by an unrestricted research grant from Stealth
   BioTherapeutics, and grant funding from the International Foundation for
   Optic Nerve Disease (IFOND).
CR Abed E, 2015, INVEST OPHTH VIS SCI, V56, P2469, DOI 10.1167/iovs.14-16235
   Balducci N, 2016, BRIT J OPHTHALMOL, V100, P1232, DOI 10.1136/bjophthalmol-2015-307326
   CARELLI V, 2016, BRAIN 3, V139, DOI DOI 10.1093/BRAIN/AWV339
   Chen HL, 2006, DOC OPHTHALMOL, V113, P53, DOI 10.1007/s10633-006-9015-z
   Colotto A, 2000, INVEST OPHTH VIS SCI, V41, P2205
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Gotoh Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P341, DOI 10.1001/archopht.122.3.341
   Guy J, 2014, INVEST OPHTH VIS SCI, V55, P841, DOI 10.1167/iovs.13-13365
   Hwang TJ, 2017, OPHTHALMOLOGY, V124, P843, DOI 10.1016/j.ophtha.2017.01.002
   Kaneko M, 2015, CURR EYE RES, V40, P77, DOI 10.3109/02713683.2014.915575
   Kim Hoon Dong, 2010, Korean J Ophthalmol, V24, P89, DOI 10.3341/kjo.2010.24.2.89
   Machida S, 2004, AM J OPHTHALMOL, V137, P938, DOI 10.1016/j.ajo.2003.10.023
   Machida S, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/397178
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1086/346066
   Meyerson C, 2015, CLIN OPHTHALMOL, V9, P1165, DOI 10.2147/OPTH.S62021
   Moss HE, 2015, INVEST OPHTH VIS SCI, V56, P3709, DOI 10.1167/iovs.15-16586
   Nakamura H, 2011, EYE, V25, P358, DOI 10.1038/eye.2010.205
   Preiser D, 2013, INVEST OPHTH VIS SCI, V54, P1182, DOI 10.1167/iovs.12-11201
   Sacai PY, 2010, DOC OPHTHALMOL, V121, P147, DOI 10.1007/s10633-010-9241-2
   Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223
   Sadun AA, 2000, T AM OPHTHAL SOC, V98, P232
   Sadun Alfredo A, 2002, Trans Am Ophthalmol Soc, V100, P169
   Tamada K, 2009, JPN J OPHTHALMOL, V53, P608, DOI 10.1007/s10384-009-0731-2
   Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514
   Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124
   Wilsey L, 2017, DOC OPHTHALMOL, V134, P111, DOI 10.1007/s10633-017-9578-x
   Yan Y, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-36
   Ziccardi L, 2013, INVEST OPHTH VIS SCI, V54, P6893, DOI 10.1167/iovs.13-12894
NR 28
TC 6
Z9 6
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD MAY
PY 2017
VL 58
IS 6
SI SI
BP 300
EP 306
DI 10.1167/iovs.17-21773
PG 7
WC Ophthalmology
SC Ophthalmology
GA VI3AO
UT WOS:000468834100017
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Martins, MD
   Kiefer, K
   Kanecadan, LAA
   Garcia, PN
   Belfort, RN
   Allemann, N
AF Martins, Maira de Franca
   Kiefer, Kelcia
   Andrade Kanecadan, Liliane Almeida
   Garcia, Patricia Novita
   Belfort, Rubens N.
   Allemann, Norma
TI Comparisons of choroidal nevus measurements obtained using 10-and 20-MHz
   ultrasound and spectral domain optical coherence tomography
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Choroidal neoplasms/ultrasonography; Nevus, pigmented/pathology;
   Tomography, optical coherence; Ultrasonography
ID TRANSFORMATION; POPULATION; MELANOMAS; TUMORS
AB Purpose: To compare measurements of lesions clinically diagnosed as choroidal nevi using spectral domain optical coherence tomography (SD-OCT) and 10- and 20-MHz ultrasound (US).
   Methods: This prospective study, which was conducted between May 2011 and December 2011, evaluated eyes diagnosed with choroidal nevus via photographic documentation using 10- or 20-MHz A- and B-mode US (experienced examiner using both the transpalpebral technique and direct contact) or SD-OCT in the enhanced depth imaging mode (performed by a different examiner blinded to the US results). Anteroposterior (AP) and transverse (T) US sections corresponded to sections adjusted perpendicularly on SD-OCT.
   Results: We evaluated 14 eyes from 12 patients (six males, mean patient age=64.5 years) diagnosed with choroidal nevus. The choroidal nevi of all samples had a melanocytic profile. Moreover, eight nevi were located at the equator, five nevi were located in the posterior pole (peripapillary in one sample), and one nevus shifted from the equator to the periphery. On SD-OCT, the maximum measurable dimension was 9 mm. The lesions in the posterior pole were easier to evaluate, and image acquisition of lesions located more peripherally was possible depending on patient cooperation. The accurate assessment of height was difficult. Baseline dimensions on 10- and 20-MHz US were larger than those determined via OCT. No significant differences in height were observed between US and SD-OCT. All parameters were statistically similar between 10- and 20-MHz US measurements.
   Conclusions: No significant difference in the AP and T diameters was observed between 10- and 20-MHz US measurements; however, these measurements (AP and T) were significantly higher than those obtained using OCT. No significant differences in height were observed among the techniques adopted.
C1 [Andrade Kanecadan, Liliane Almeida; Garcia, Patricia Novita; Belfort, Rubens N.; Allemann, Norma] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, SP, Brazil.
RP Allemann, N (corresponding author), Rua Olimpiadas 134-51, BR-04551000 Sao Paulo, SP, Brazil.
EM norma.allemann@pobox.com
RI Allemann, Norma/K-5451-2013
OI Allemann, Norma/0000-0001-5432-4287
CR Basdekidou C, 2011, CASE REP OPHTHALM, V2, P185, DOI 10.1159/000329539
   Branchini L, 2012, OPHTHALMOLOGY, V119, P119, DOI 10.1016/j.ophtha.2011.07.002
   Espinoza G, 2004, AM J OPHTHALMOL, V137, P90, DOI 10.1016/S0002-9394(03)00868-7
   Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029
   Johnna MS, 2006, RETINA, P699
   Kaiserman I, 2006, BRIT J OPHTHALMOL, V90, P994, DOI 10.1136/bjo.2006.090738
   Maruko I, 2011, RETINA-J RET VIT DIS, V31, P510, DOI 10.1097/IAE.0b013e3181eef053
   Mendes MH, 2009, REV BRAS OFTALMOL, V68, P291, DOI 10.1590/S0034-72802009000500007
   Muscat S, 2004, BRIT J OPHTHALMOL, V88, P120, DOI 10.1136/bjo.88.1.120
   Say EAT, 2012, J OPHTHALMOL, V2012
   Shields CL, 2008, RETINA-J RET VIT DIS, V28, P1035, DOI 10.1097/IAE.0b013e318181b94b
   Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P981, DOI 10.1001/archophthalmol.2009.151
   Singh AD, 2005, OPHTHALMOLOGY, V112, P1784, DOI 10.1016/j.ophtha.2005.06.011
   Singh AD, 2010, BRIT J OPHTHALMOL, V94, P474, DOI 10.1136/bjo.2009.162636
   Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010
   Sumich P, 1998, ARCH OPHTHALMOL-CHIC, V116, P645, DOI 10.1001/archopht.116.5.645
   Thiagalingam S, 2004, ARCH OPHTHALMOL-CHIC, V122, P89, DOI 10.1001/archopht.122.1.89
   Torres VLL, 2011, AM J OPHTHALMOL, V151, P586, DOI 10.1016/j.ajo.2010.09.028
NR 18
TC 2
Z9 3
U1 0
U2 0
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD MAR-APR
PY 2017
VL 80
IS 2
BP 78
EP 83
DI 10.5935/0004-2749.20170020
PG 6
WC Ophthalmology
SC Ophthalmology
GA EX5AR
UT WOS:000403248600004
PM 28591278
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Roberti, NC
   Dias, JRD
   Novais, EA
   Regatieri, CS
   Belfort, R
AF Roberti, Nathalia Corbelli
   de Oliveira Dias, Joao Rafael
   Novais, Eduardo Amorim
   Regatieri, Caio Saito
   Belfort, Rubens, Jr.
TI Large colloid drusen analyzed with structural en face optical coherence
   tomography
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Retinal drusen; Tomography, optical coherence/methods; Fluorescein
   angiography; Indocyanine green
ID ONSET; COLOR
AB Drusen are extracellular deposits between the basal lamina of the retinal pigment epithelium (RPE) and the inner collagenous layer of Bruch's membrane. Large colloid drusen (LCD) are located below the RPE and are characterized by multiple, large, dome-shaped RPE detachments, with marked attenuation of the ellipsoid zone overlaying the drusen. This report presents the structural en face optical coherence tomography (OCT) findings of LCD and relates them to findings from fluorescein and indocyanine green angiography. We describe the case of a 55-year-old woman who presented with the chief complaint of a 5-year history of progressively worsening vision. Her best-corrected visual acuities were 20/40 and 20/400 in the right eye and the left eye, respectively. Fundus examination showed large bilateral, symmetrical, sub-retinal, yellowish lesions compatible with LCD. We describe the structural en face OCT characteristics and angiographic findings from this patient.
C1 [Roberti, Nathalia Corbelli] Hosp Brigadeiro, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [de Oliveira Dias, Joao Rafael; Novais, Eduardo Amorim; Regatieri, Caio Saito; Belfort, Rubens, Jr.] Univ Fed Sao Paulo UNIFESP, Dept Ophthalmol & Visual Sci, EPM, Sao Paulo, SP, Brazil.
RP Roberti, NC (corresponding author), Av Brigadeiro Luis Antonio 2-651, BR-01401901 Sao Paulo, SP, Brazil.
EM nathaliaroberti@yahoo.com.br
CR Boon CJF, 2013, PROG RETIN EYE RES, V37, P90, DOI 10.1016/j.preteyeres.2013.08.003
   Gregori G, 2014, INVEST OPHTH VIS SCI, V55, P7662, DOI 10.1167/iovs.14-15273
   Guigui B, 2013, RETINA-J RET VIT DIS, V33, P1346, DOI 10.1097/IAE.0b013e318283127d
   Guigui B, 2011, BRIT J OPHTHALMOL, V95, P238, DOI 10.1136/bjo.2009.178400
   Khan KN, 2016, PROG RETIN EYE RES, V53, P70, DOI 10.1016/j.preteyeres.2016.04.008
   Kozak I, 2014, SAUDI J OPHTHALMOL, V28, P117, DOI 10.1016/j.sjopt.2014.02.005
   Lamory B, 2011, INVEST OPHTH VIS SCI, V52, P4469
   Querques G, 2012, ACTA OPHTHALMOL, V90, pE327, DOI 10.1111/j.1755-3768.2011.02228.x
   Russell SR, 2004, AM J OPHTHALMOL, V137, P924, DOI 10.1016/j.ajo.2003.12.043
   Wolff B, 2013, ISRN OPHTHALMOL
NR 10
TC 2
Z9 2
U1 0
U2 1
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD MAR-APR
PY 2017
VL 80
IS 2
BP 122
EP 124
DI 10.5935/0004-2749.20170029
PG 3
WC Ophthalmology
SC Ophthalmology
GA EX5AR
UT WOS:000403248600013
PM 28591287
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Freitas, BDP
   Ko, AI
   Khouri, R
   Mayoral, M
   Henriques, DF
   Maia, M
   Belfort, R
AF Freitas, Bruno De Paula
   Ko, Albert I.
   Khouri, Ricardo
   Mayoral, Monica
   Henriques, Daniele Freitas
   Maia, Mauricio
   Belfort, Rubens, Jr.
TI Glaucoma and Congenital Zika Syndrome
SO OPHTHALMOLOGY
LA English
DT Editorial Material
ID VIRUS-INFECTION
C1 [Freitas, Bruno De Paula; Mayoral, Monica] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [Freitas, Bruno De Paula; Maia, Mauricio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Paulista Med Sch, Vis Inst, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Ko, Albert I.; Khouri, Ricardo] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Henriques, Daniele Freitas] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Paulista Med Sch, Dept Ophthalmol, Rua Botucatu,821, BR-04023062 Sao Paulo, SP, Brazil.
EM prof.belfort@clinicabelfort.com.br
RI Ko, Albert Icksang/P-2343-2015; Maia, Mauricio/I-5892-2015; Khouri,
   Ricardo/M-3184-2018
OI Ko, Albert Icksang/0000-0001-9023-2339; Maia,
   Mauricio/0000-0002-7034-8091; Khouri, Ricardo/0000-0001-5664-4436
CR Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 5
TC 22
Z9 22
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD MAR
PY 2017
VL 124
IS 3
BP 407
EP 408
PG 2
WC Ophthalmology
SC Ophthalmology
GA EQ1SB
UT WOS:000397848800040
PM 27914834
DA 2020-12-01
ER

PT J
AU Benzekri, R
   Belfort, R
   Ventura, CV
   Freitas, BDP
   Maia, M
   Leite, M
   Labetoulle, M
   Rousseau, A
AF Benzekri, R.
   Belfort, R., Jr.
   Ventura, C. V.
   Freitas, B. de Paula
   Maia, M.
   Leite, M.
   Labetoulle, M.
   Rousseau, A.
TI Ocular manifestations of Zika virus: What we do and do not know
SO JOURNAL FRANCAIS D OPHTALMOLOGIE
LA French
DT Review
DE Zika; Virus; Microcephaly; Maculopathy; Uveitis; Conjunctivitis;
   Epidemics
ID INTERIM GUIDANCE; INFECTION; TRANSMISSION; BRAZIL; INFANTS;
   PATHOGENESIS; SPECIFICITY; MICRONESIA; EPIDEMIC; OUTBREAK
AB Zika virus (ZIKV) disease outbreak, which was declared by the end of 2015 inBrazil, has become the largest one to date. Being reported in the Americas and in certain islands of the Pacific, it has the potential to spread worldwide. Although ZIKV infections are mostly self-limiting and/or asymptomatic in the healthy adult, they are responsible for devastating congenital neurologic malformations ZIKV (mainly microcephaly) when contracted during the first months of pregnancy. Ocular manifestations during the acute adult infection include conjunctivitis and more rarely ocular inflammation. Congenital infection is associated with chorioretinal atrophy pigment mottling of the retina retinal vasculature abnormalities and optic nerve atrophy. Therefore, complete ophthalmological evaluation is recommended for suspected congenital infections. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Benzekri, R.; Leite, M.; Labetoulle, M.; Rousseau, A.] Univ Paris Sud, Hop Bicetre, Assistance Publ Hop Paris, Serv Ophtalmol,DHU Vis & Handicap, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.
   [Belfort, R., Jr.; Ventura, C. V.; Maia, M.] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Sao Paulo, Brazil.
   [Belfort, R., Jr.; Ventura, C. V.; Maia, M.] Vis Inst, Sao Paulo, Brazil.
   [Ventura, C. V.] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, C. V.] Pernambucos Eye Hosp HOPE, Dept Ophthalmol, Recife, PE, Brazil.
   [Freitas, B. de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [Labetoulle, M.; Rousseau, A.] Commissariat Energie Atom & Energies Alternat, Immunol Infect Virales & Malad Autoimmunes, UMR 1184, Fontenay Aux Roses, France.
RP Rousseau, A (corresponding author), Univ Paris Sud, Hop Bicetre, Assistance Publ Hop Paris, Serv Ophtalmol,DHU Vis & Handicap, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.; Rousseau, A (corresponding author), Commissariat Energie Atom & Energies Alternat, Immunol Infect Virales & Malad Autoimmunes, UMR 1184, Fontenay Aux Roses, France.
EM antoine.rousseau@aphp.fr
RI Maia, Mauricio/Z-1042-2019; Ventura, Camila V/N-2654-2018; Maia,
   Mauricio/I-5892-2015; Rousseau, Antoine/A-6667-2018
OI Maia, Mauricio/0000-0002-7034-8091; Ventura, Camila
   V/0000-0002-2927-4684; Maia, Mauricio/0000-0002-7034-8091; BENZEKRI,
   Reda/0000-0002-4599-9909
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Oliveira Dias JR, 2017, RETIN CASES BRIEF RE
   de Paula Freitas B, 2016, OPHTHALMOLOGY
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization (PAHO), 2016, ZIK VIR INF
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasool N, 2016, JAMA OPHTHALMOL, V134, P1200, DOI 10.1001/jamaophthalmol.2016.2398
   Rousseau A, 2015, J FR OPHTALMOL, V38, P758, DOI 10.1016/j.jfo.2015.06.002
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Ventura C. V, 2016, ARQ BRAS OFTALMOL, V79
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 2
Z9 2
U1 0
U2 4
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0181-5512
EI 1773-0597
J9 J FR OPHTALMOL
JI J. Fr. Ophthamol.
PD FEB
PY 2017
VL 40
IS 2
BP 138
EP 145
DI 10.1016/j.jfo.2017.01.002
PG 8
WC Ophthalmology
SC Ophthalmology
GA EO0VP
UT WOS:000396416800018
PM 28189347
DA 2020-12-01
ER

PT J
AU Belfort, RN
   Isenberg, J
   Fernandes, BF
   Di Cesare, S
   Belfort, R
   Burnier, MN
AF Belfort, Rubens N.
   Isenberg, Jordan
   Fernandes, Bruno F.
   Di Cesare, Sebastian
   Belfort, Rubens, Jr.
   Burnier, Miguel N., Jr.
TI Evaluating the presence of Toxoplasma gondii in peripheral blood of
   patients with diverse forms of uveitis
SO INTERNATIONAL OPHTHALMOLOGY
LA English
DT Article
DE PCR; Toxoplasma gondii; Uveitis
ID REAL-TIME PCR; OCULAR TOXOPLASMOSIS; CONGENITAL TOXOPLASMOSIS; CEREBRAL
   TOXOPLASMOSIS; QUANTITATIVE PCR; SOUTHERN BRAZIL; AMNIOTIC-FLUID;
   SAMPLES; DIAGNOSIS; INFECTION
AB The purpose of this study was to evaluate the presence of Toxoplasmosis gondii in samples of peripheral blood from patients with varying etiologies of uveitis. Whole blood from patients with different forms of uveitis was tested for the presence of T. gondii using real-time PCR targeting the well-characterized 529 bp fragment. Extracted DNA was both frozen. Thirty-one patients were included in the current study and grouped as follows: acute toxoplasmosis (n = 10); toxoplasmic retinal scars (n = 9); non-infectious etiologies of uveitis (n = 6); and IgG negative for toxoplasmosis (n = 6). In total, only two patients were shown to have circulating T. gondii in peripheral blood; both of these patients were IgG positive for toxoplasmosis, were receiving immunosuppressive therapy for autoimmune uveitis, and had no clinical features of toxoplasmosis. T. gondii was identified in peripheral blood of some immunosuppressed patients. No other patients, including those with acute toxoplasmosis, had circulating parasites in peripheral blood.
C1 [Belfort, Rubens N.; Isenberg, Jordan; Fernandes, Bruno F.; Di Cesare, Sebastian; Burnier, Miguel N., Jr.] McGill Univ, Henry C Witleson Ocular Pathol Lab, 3375 Univ,Room 216, Montreal, PQ, Canada.
   [Belfort, Rubens N.; Belfort, Rubens, Jr.; Burnier, Miguel N., Jr.] Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol & Visual Sci, Rua Botucatu 821, Sao Paulo, SP, Brazil.
RP Isenberg, J (corresponding author), McGill Univ, Henry C Witleson Ocular Pathol Lab, 3375 Univ,Room 216, Montreal, PQ, Canada.
EM rubens@belfort.med.br; chaughten@gmail.com
RI Fernandes, Bruno F./ABA-3567-2020
OI Fernandes, Bruno F./0000-0002-5385-3571; Burnier,
   Miguel/0000-0002-2335-7470; Isenberg, Jordan/0000-0002-7217-788X
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (Brazil)CAPES
FX Partial results presented at the ARVO 2008/9, Fort Lauderdale, FL USA
   and the World Ophthalmology Congress 2008, Hong Kong, SAR-PRC. This work
   was funded in part by a grant from Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (Brazil).
CR Belfort-Neto R, 2007, AN ACAD BRAS CIENC, V79, P111, DOI 10.1590/S0001-37652007000100013
   Bin Dajem SM, 2012, ANN SAUDI MED, V32, P507, DOI 10.5144/0256-4947.2012.14.7.1200
   Bourdin C, 2014, J CLIN MICROBIOL, V52, P3987, DOI 10.1128/JCM.01793-14
   Centers for Disease Control, 2016, TOX LAB ID PAR DIS P
   Colombo FA, 2005, J CLIN MICROBIOL, V43, P5044, DOI 10.1128/JCM.43.10.5044-5047.2005
   Dao A, 2001, INT J PARASITOL, V31, P63, DOI 10.1016/S0020-7519(00)00151-X
   Dumetre A, 2003, FEMS MICROBIOL REV, V27, P651, DOI 10.1016/S0168-6445(03)00071-8
   Fekkar A, 2008, J CLIN MICROBIOL, V46, P1965, DOI 10.1128/JCM.01900-07
   Hill DE, 2006, VET PARASITOL, V141, P9, DOI 10.1016/j.vetpar.2006.05.008
   HOHLFELD P, 1994, NEW ENGL J MED, V331, P695, DOI 10.1056/NEJM199409153311102
   Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8
   Kompalic-Cristo A, 2007, PARASITOL RES, V101, P619, DOI 10.1007/s00436-007-0524-9
   Mahalakshmi B, 2006, OCUL IMMUNOL INFLAMM, V14, P105, DOI 10.1080/09273940500545692
   Mesquita RT, 2010, J MED MICROBIOL, V59, P641, DOI 10.1099/jmm.0.016261-0
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Montoya JG, 2002, J INFECT DIS, V185, pS73, DOI 10.1086/338827
   SILVEIRA C, 1988, AM J OPHTHALMOL, V106, P362, DOI 10.1016/0002-9394(88)90382-0
   Silveira C, 2001, AM J OPHTHALMOL, V131, P351, DOI 10.1016/S0002-9394(00)00830-8
   Smith Justine R, 2002, Curr Opin Ophthalmol, V13, P387, DOI 10.1097/00055735-200212000-00008
   Soheilian M, 2004, OCUL IMMUNOL INFLAMM, V12, P297, DOI 10.1080/092739490500174
   Switaj K, 2006, J CLIN MICROBIOL, V44, P4262, DOI 10.1128/JCM.01786-06
   Thalib L, 2005, BJOG-INT J OBSTET GY, V112, P567, DOI 10.1111/j.1471-0528.2005.00486.x
   Vallochi AL, 2005, AM J OPHTHALMOL, V139, P350, DOI 10.1016/j.ajo.2004.07.040
   Yang WL, 2009, APPL ENVIRON MICROB, V75, P3477, DOI 10.1128/AEM.00285-09
NR 24
TC 0
Z9 0
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0165-5701
EI 1573-2630
J9 INT OPHTHALMOL
JI Int. Ophthalmol.
PD FEB
PY 2017
VL 37
IS 1
BP 19
EP 23
DI 10.1007/s10792-016-0221-8
PG 5
WC Ophthalmology
SC Ophthalmology
GA EK8FR
UT WOS:000394159800004
PM 26975400
DA 2020-12-01
ER

PT J
AU Lima, LH
   de Andrade, GC
   Vianello, S
   Zett, C
   Farah, ME
   Belfort, R
AF Lima, Luiz H.
   de Andrade, Gabriel Costa
   Vianello, Silvana
   Zett, Claudio
   Farah, Michel E.
   Belfort, Rubens, Jr.
TI Multimodal imaging analyses of hyperreflective dot-like lesions in acute
   syphilitic posterior placoid chorioretinopathy
SO JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION
LA English
DT Article
DE Acute syphilitic posterior placoid chorioretinitis; En-face optical
   coherence tomography; Spectral-domain optical coherence tomography;
   Syphilis; Outer retinal abnormalities
ID OPTICAL COHERENCE TOMOGRAPHY
AB Background: Retrospective review of one acute syphilitic posterior placoid chorioretinitis (ASPPC) case with serological evidence of syphilis who had ocular signs and symptoms not attributable to other diseases. Enface and spectral-domain optical coherence tomographySD-OCT were analyzed at the time of presentation and at 1-month visit following initiation of treatment. The study patient underwent standard treatment for neurosyphilis.
   Results: Ophthalmic examination and imaging studies were consistent with the diagnosis of ASPPC. The patient age was 33 year-old and the baseline visual acuity was 20/400 and 20/80 in the right and left eyes, respectively. At presentation, SD-OCT scans showed disruption and loss of the ellipsoid zone (EZ), small nodular elevations on retinal pigment epithelium (RPE) and punctate hyperreflectivity in the choroid. Enface OCT at the level of RPE and EZ demonstrated multiple hyperreflective dot-like lesions simmetrically distributed within the macular area. These dot-like lesions corresponded to the small nodular elevations on RPE and to disruption/loss of EZ observed with SD-OCT. One month after neurosyphilis therapy, the visual acuity improved and the outer retinal changes partially reversed in both eyes.
   Conclusions: We report the outer retinal findings and its correlation using both en-face and SD-OCT in a patient with ASPPC. En-face OCT imaging provides a more precise outer retinal layers analyses allowing a better understanding of the ASPPC pathophysiology.
C1 [Lima, Luiz H.; de Andrade, Gabriel Costa; Vianello, Silvana; Zett, Claudio; Farah, Michel E.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Lima, Luiz H.] Fed Univ Sao Paulo UNIFESP, Rua Botucatu,821,Vila Clementino, BR-04023062 Sao Paulo, SP, Brazil.
RP Lima, LH (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.; Lima, LH (corresponding author), Fed Univ Sao Paulo UNIFESP, Rua Botucatu,821,Vila Clementino, BR-04023062 Sao Paulo, SP, Brazil.
EM luizlima9@gmail.com
RI Lima, Luiz H/V-4940-2017; Farah, Michel Eid E/F-3285-2012; Andrade,
   Gabriel/AAV-3155-2020
OI Lima, Luiz H/0000-0001-7304-909X; Farah, Michel Eid
   E/0000-0001-5951-0193; Andrade, Gabriel/0000-0002-5881-8126
CR Armstrong BK, 2014, OSLI RETINA, V45, P606, DOI 10.3928/23258160-20141008-02
   Benhamou N, 2003, AM J OPHTHALMOL, V135, P362, DOI 10.1016/S0002-9394(02)01946-3
   Brito P, 2011, CASE REP OPHTHALM, V2, P39, DOI 10.1159/000324086
   Burkholder BM, 2014, J OPHTHALMIC INFLAMM, V4, DOI 10.1186/1869-5760-4-2
   Centers for Disease Control and Prevention, 2010, SEX TRANSM DIS SYPH
   Chao JR, 2006, OPHTHALMOLOGY, V113, P2074, DOI 10.1016/j.ophtha.2006.05.048
   DESOUZA EC, 1988, AM J OPHTHALMOL, V105, P271, DOI 10.1016/0002-9394(88)90009-8
   Eandi CM, 2012, RETINA-J RET VIT DIS, V32, P1915, DOI 10.1097/IAE.0b013e31825f3851
   Fenton KA, 2004, SEX TRANSM INFECT, V80, P255, DOI 10.1136/sti.2004.009415
   GASS JDM, 1990, OPHTHALMOLOGY, V97, P1288
   Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173
   Joseph A, 2007, EYE, V21, P1114, DOI 10.1038/sj.eye.6702504
   Kiss Szilard, 2005, Semin Ophthalmol, V20, P161, DOI 10.1080/08820530500232092
   Meira-Freitas D, 2009, ARQ BRAS OFTALMOL, V72, P832, DOI 10.1590/S0004-27492009000600019
   MORGAN CM, 1984, RETINA-J RET VIT DIS, V4, P225, DOI 10.1097/00006982-198400440-00003
   Parc CE, 2007, SEX TRANSM DIS, V34, P553, DOI 10.1097/01.olq.0000253385.49373.1a
   Pichi F, 2014, RETINA-J RET VIT DIS, V34, P373, DOI 10.1097/IAE.0b013e3182993f11
   Sridhar J, 2016, OPHTHALMOLOGY, V123, P557, DOI 10.1016/j.ophtha.2016.01.001
   World Health Organization Department of Reproductive Health and Research, 2011, METH RES US WHO GEN
   YOUNG H, 1979, BRIT J HOSP MED, V22, P292
   Zamani M, 2003, AM J OPHTHALMOL, V135, P891, DOI 10.1016/S0002-9394(02)02160-8
NR 21
TC 8
Z9 8
U1 0
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1869-5760
J9 J OPHTHALMIC INFLAMM
JI J. Ophthalmic Inflamm. Infect.
PD JAN 12
PY 2017
VL 7
AR 1
DI 10.1186/s12348-016-0119-7
PG 6
WC Ophthalmology
SC Ophthalmology
GA EH4TV
UT WOS:000391764400001
PM 28083861
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Campos, M
   Beer, S
   Nakano, EM
   Muccioli, C
   Belfort, R
   Chamon, W
AF Campos, Mauro
   Beer, Sandra
   Nakano, Eliane Mayumi
   Muccioli, Cristina
   Belfort, Rubens, Jr.
   Chamon, Wallace
TI Complete depigmentation of a small aperture corneal inlay implanted for
   compensation of presbyopia
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Corneal transplantation; Corneal stroma; Presbiopia/surgery; Polyvinyls;
   Visual acuity; Case report
ID OUTCOMES
AB We describe a case of late-onset remarkable depigmentation of a small aperture corneal inlay implanted for presbyopia compensation. The patient was a participant in a clinical trial designed to evaluate the safety and efficacy of the AcuFocus (TM) ACU-10R160, which is a 10 mu m-thick polyimide film tinted with an organic dye. Inlay implantation occurred under mechanical microkeratome Lasik flaps set for a depth of 120 mu m. The patient returned to the clinic 11 years after surgery and reported loss of near-vision acuity. Clinical examination showed the complete absence of pigments in the device and the total loss of the initial effect on near vision, despite normal distance vision. Manifest refraction remained stable during the follow-up period. Scheimpflug images characterized the loss of the small aperture effect on incoming light. Confocal analysis revealed small hyper-reflective round images on the endothelium and no signs of inflammation.
C1 [Campos, Mauro; Beer, Sandra; Nakano, Eliane Mayumi; Muccioli, Cristina; Belfort, Rubens, Jr.; Chamon, Wallace] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Chamon, Wallace] UIC, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL USA.
RP Campos, M (corresponding author), Rua Monsanto 166, BR-05412030 Sao Paulo, SP, Brazil.
EM mcampos@pobox.com
RI Chamon, Wallace/A-5400-2010; de Queiroz Campos, Mauro
   Silveira/H-7609-2017
OI Chamon, Wallace/0000-0002-2528-0526; de Queiroz Campos, Mauro
   Silveira/0000-0002-9448-8742
CR Dexl AK, 2015, J CATARACT REFR SURG, V41, P566, DOI 10.1016/j.jcrs.2014.05.051
   European Commission, 2015, OP CARB BLACK NAN
   Food and Drug Administration. Department of Health & Human Services, 2015, KAMRA INL DEV REG GU
   Holden BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1731, DOI 10.1001/archopht.126.12.1731
   Kanno M, 2002, J BIOMED MATER RES, V60, P53, DOI 10.1002/jbm.1280
   Limnopoulou AN, 2013, J REFRACT SURG, V29, P12, DOI 10.3928/1081597X-20121210-01
   McDonnell PJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P1577, DOI 10.1001/archopht.121.11.1577
   MILLER D, 2003, Patent No. 6554424
   NOLTE T, 1993, EXP TOXICOL PATHOL, V45, P135, DOI 10.1016/S0940-2993(11)80489-6
   Waring GO, 2011, J REFRACT SURG, V27, P842, DOI 10.3928/1081597X-20111005-04
   Yilmaz OF, 2011, J CATARACT REFR SURG, V37, P1275, DOI 10.1016/j.jcrs.2011.01.027
   Ziemer Ophthalmology. The presbyopia solution, 2012, ZIEM OPHTH PRESB SOL
NR 12
TC 1
Z9 1
U1 0
U2 2
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JAN-FEB
PY 2017
VL 80
IS 1
BP 52
EP 56
DI 10.5935/0004-2749.20170014
PG 5
WC Ophthalmology
SC Ophthalmology
GA EQ3MV
UT WOS:000397977900014
PM 28380104
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Roizenblatt, M
   Fares, N
   Nascimento, H
   Novais, EA
   Muccioli, C
   Belfort, R
AF Roizenblatt, Marina
   Fares, Nikoly
   Nascimento, Heloisa
   Novais, Eduardo A.
   Muccioli, Cristina
   Belfort, Rubens, Jr.
TI Asymptomatic Progression of Ocular Behcet's Disease
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID INDOCYANINE GREEN; MANIFESTATIONS; INFLAMMATION; FLUORESCEIN; UVEITIS
AB BACKGROUND AND OBJECTIVE: To emphasize the importance of auxiliary exams to detect progression of ocular Behcet's disease (BD) in asymptomatic patients.
   PATIENTS AND METHODS: This was a retrospective review of the clinical records of a consecutive series of patients with BD and asymptomatic visual deterioration, imaged on fundus photograph (FP), visual field (VF), fluorescein angiography (FA), and optical coherence tomography (OCT).
   RESULTS: Patients presented with no clinical findings or with mild inflammation on ophthalmic examination. However, during follow-up, VF examination indicated a progressive enlargement of previously visualized scotomas. On FA, the authors detected leakage and ischemia. On OCT, there was macular anatomical disruption, and the FP showed areas of atrophic retina.
   CONCLUSION: In patients with ocular BD, the visual acuity deterioration may be asymptomatic and progressive. This should justify the importance of early and sequential ancillary exams in the management of BD patients to detect subclinical ocular involvement.
C1 [Roizenblatt, Marina; Fares, Nikoly; Nascimento, Heloisa] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Novais, Eduardo A.; Muccioli, Cristina; Belfort, Rubens, Jr.] Inst Visao, Sao Paulo, Brazil.
RP Roizenblatt, M (corresponding author), Univ Fed Sao Paulo, Dept Oftalmol, Secretaria Adm, Rua Botucatu 862,1st Floor, BR-04023062 Sao Paulo, SP, Brazil.
EM maroizenb@gmail.com
RI Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317
CR Alibaz-Oner F, 2014, CLIN RHEUMATOL, V33, P277, DOI 10.1007/s10067-013-2382-4
   Alli N, 2009, AM J CLIN DERMATOL, V10, P411, DOI 10.2165/11310880-000000000-00000
   Atmaca LS, 2003, BRIT J OPHTHALMOL, V87, P1466, DOI 10.1136/bjo.87.12.1466
   BARRA C, 1991, JPN J OPHTHALMOL, V35, P339
   Cingu AK, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/398054
   Fernandez DG, 2016, OCUL IMMUNOL INFLAMM, P1, DOI DOI 10.3109/09273948.2015.1132741
   Gedik S, 2005, OCUL IMMUNOL INFLAMM, V13, P51, DOI 10.1080/09273940490518757
   Gerber S, 1996, NEURORADIOLOGY, V38, P761, DOI 10.1007/s002340050343
   Hatemi G, 2014, CLIN EXP RHEUMATOL, V32, pS112
   Hatemi G, 2013, RHEUM DIS CLIN N AM, V39, P245, DOI 10.1016/j.rdc.2013.02.010
   Kacmaz RO, 2008, AM J OPHTHALMOL, V146, P828, DOI 10.1016/j.ajo.2008.06.019
   Oray M, 2015, AM J OPHTHALMOL, V159, P475, DOI 10.1016/j.ajo.2014.11.029
   Saadoun D, 2010, REV MED INTERNE, V31, P545, DOI 10.1016/j.revmed.2009.04.014
   SILMAN AJ, 1990, LANCET, V335, P1078
   Tugal-Tutkun I, 2008, GRAEF ARCH CLIN EXP, V246, P1169, DOI 10.1007/s00417-008-0823-6
   Wallace GR, 2014, P NATL ACAD SCI USA, V111, P8706, DOI 10.1073/pnas.1407307111
   Yuksel H, 2014, ARQ BRAS OFTALMOL, V77, P219, DOI 10.5935/0004-2749.20140056
   Zouboulis CC, 2003, ADV EXP MED BIOL, V528, P7
   Zouboulis CC, 2003, MED MICROBIOL IMMUN, V192, P149, DOI 10.1007/s00430-002-0167-5
NR 19
TC 1
Z9 1
U1 0
U2 2
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD JAN
PY 2017
VL 48
IS 1
BP 18
EP 25
DI 10.3928/23258160-20161219-03
PG 8
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA EO1OH
UT WOS:000396467300003
PM 28060390
DA 2020-12-01
ER

PT J
AU Ventura, CV
   Ventura, LO
   Bravo, V
   Martins, TT
   Berrocal, AM
   Gois, AL
   Dias, JRD
   Araujo, L
   Escariao, P
   van der Linden, V
   Belfort, R
   Maia, M
AF Ventura, Camila V.
   Ventura, Liana O.
   Bravo-Filho, Vasco
   Martins, Thayze T.
   Berrocal, Audina M.
   Gois, Adriana L.
   de Oliveira Dias, Joao Rafael
   Araujo, Leandro
   Escariao, Paulo
   van der Linden, Vanessa
   Belfort, Rubens, Jr.
   Maia, Mauricio
TI Optical Coherence Tomography of Retinal Lesions in Infants With
   Congenital Zika Syndrome
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID VIRUS; OUTBREAK
AB IMPORTANCE Zika virus (ZIKV) can cause severe changes in the retina and choroid that may result in marked visual impairment in infants with congenital Zika syndrome (CZS), the term created for a variety of anomalies associated with intrauterine ZIKV infection.
   OBJECTIVE To evaluate the affected retinal layers in infants with CZS and associated retinal abnormalities using optical coherence tomography (OCT).
   DESIGN, SETTING, AND PARTICIPANTS This cross-sectional, consecutive case series included 8 infants (age range, 3.0-5.1 months) with CZS. Optical coherence tomographic images were obtained in the affected eyes of 7 infants with CZS who had undergone previous ophthalmologic examinations on March 17, 2016, and in 1 infant on January 1, 2016. An IgM antibody-capture enzyme-linked immunosorbent assay for ZIKV was performed on the cerebrospinal fluid samples of 7 of the 8 infants (88%), and other congenital infections were ruled out.
   MAIN OUTCOMES AND MEASURES Observation of retinal and choroidal findings in the OCT images.
   RESULTS Among the 8 infants included in the study (3 male; 5 female; mean [SD] age at examination, 4.1 [0.7] months), 7 who underwent cerebrospinal fluid analysis for ZIKV had positive findings for IgM antibodies. Eleven of the 16 eyes (69%) of the 8 infants had retinal alterations and OCT imaging was performed in 9 (82%) of them. Optical coherence tomography was also performed in 1 unaffected eye. The main OCT findings in the affected eyes included discontinuation of the ellipsoid zone and hyperreflectivity underlying the retinal pigment epithelium in 9 eyes (100%), retinal thinning in 8 eyes (89%), choroidal thinning in 7 eyes (78%), and colobomatouslike excavation involving the neurosensory retina, retinal pigment epithelium, and choroid in 4 eyes (44%).
   CONCLUSIONS AND RELEVANCE Zika virus can cause severe damage to the retina, including the internal and external layers, and the choroid. The colobomatouslike finding seen in the OCT images relate to the excavated chorioretinal scar observed clinically.
C1 [Ventura, Camila V.; Ventura, Liana O.; Bravo-Filho, Vasco; Martins, Thayze T.; Gois, Adriana L.; Araujo, Leandro; Escariao, Paulo] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.; Bravo-Filho, Vasco; Martins, Thayze T.; Gois, Adriana L.; Araujo, Leandro; Escariao, Paulo] Pernambuco Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; de Oliveira Dias, Joao Rafael; Belfort, Rubens, Jr.; Maia, Mauricio] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Rua Botucatu 831, BR-04023062 Sao Paulo, SP, Brazil.
   [Ventura, Camila V.; Berrocal, Audina M.; de Oliveira Dias, Joao Rafael] Bascom Palmer Eye Inst, Miami, FL 33136 USA.
   [van der Linden, Vanessa] Barao de Lucena Hosp, Dept Pediat Neurol, Recife, PE, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Rua Botucatu 831, BR-04023062 Sao Paulo, SP, Brazil.
EM clinbelf@uol.com.br
RI Filho, Vasco/N-6993-2018; Maia, Mauricio/I-5892-2015; Ventura, Liana
   Vieira O/N-6151-2018; Ventura, Camila V/N-2654-2018; Escariao,
   Paulo/N-3349-2018
OI Filho, Vasco/0000-0003-4460-3236; Maia, Mauricio/0000-0002-7034-8091;
   Ventura, Liana Vieira O/0000-0001-6529-6883; Ventura, Camila
   V/0000-0002-2927-4684; Escariao, Paulo/0000-0003-3710-9475; Gois,
   Adriana/0000-0001-5542-1097; Martins, Thayze/0000-0002-8082-2623
CR Brasil Ministerio da Saude, INF EP NO 32 MON CAS
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garg S, 2009, RETINA-J RET VIT DIS, V29, P631, DOI 10.1097/IAE.0b013e318198d8de
   Goldenberg D, 2013, GRAEF ARCH CLIN EXP, V251, P2037, DOI 10.1007/s00417-013-2334-3
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Oh Joo Youn, 2007, Korean J Ophthalmol, V21, P175, DOI 10.3341/kjo.2007.21.3.175
   Optovue, RTVUE 100 OPT COH TO
   Optovue, AV OPT COH TOM BROCH
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217
   Sun Lisa L, 2012, Digit J Ophthalmol, V18, P1, DOI 10.5693/djo.02.2012.04.001
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Trevino R, 2014, OPTOMETRY VISION SCI, V91, pS71, DOI 10.1097/OPX.0000000000000181
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villegas VM, 2014, OSLI RETINA, V45, P222, DOI 10.3928/23258160-20140410-01
   World Health Organization, 2015, EP AL NEUR SYNDR CON
   General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14, DOI 10.1001/jama.2013.281053
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 25
TC 27
Z9 27
U1 0
U2 36
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD DEC 1
PY 2016
VL 134
IS 12
BP 1420
EP 1427
DI 10.1001/jamaophthalmol.2016.4283
PG 9
WC Ophthalmology
SC Ophthalmology
GA EF8SR
UT WOS:000390600300020
PM 27832267
DA 2020-12-01
ER

PT J
AU de Mello, PC
   Brasil, OFM
   Vidoris, A
   Morales, MC
   Belfort, RN
AF de Mello, Patricia Correa
   Moura Brasil, Oswaldo Ferreira
   Vidoris, Andre
   Morales, Melina Correia
   Belfort, Rubens N.
TI Iris metastases from systemic cancer: a report of three cases
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Iris neoplasms; Iris metastasis; Case reports
ID CARCINOMA; MELANOMA; TUMORS; ORBIT; EYE
AB Ocular metastasis is relatively uncommon, with a reported incidence of approximately 8%, according to the results of autopsy evaluation. The majority of ocular metastases are located within the choroid, while metastatic tumors affecting the iris are rare. Metastatic tumors may manifest as stromal nodules or ill-defined iris thickening, or they may present with nonspecific features such as pain, iridocyclitis, and hyphema. Here, we describe three patients with iris metastasis and discuss the diagnostic challenges and unusual findings associated with these cases.
C1 [de Mello, Patricia Correa] Hosp Fed Serv Estado Rio de Janeiro, Serv Oftalmol, Rio De Janeiro, RJ, Brazil.
   [de Mello, Patricia Correa; Moura Brasil, Oswaldo Ferreira] Inst Brasileiro Oftalmol IBOL, Setor Retina & Vitreo, Rio De Janeiro, RJ, Brazil.
   [de Mello, Patricia Correa; Vidoris, Andre; Morales, Melina Correia; Belfort, Rubens N.] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med EPM, Setor Tumores, Dept Oftalmol & Ciencias Visuais, Sao Paulo, SP, Brazil.
RP de Mello, PC (corresponding author), Praia Botafogo 206, BR-22250040 Rio De Janeiro, RJ, Brazil.
EM paticma@gmail.com
RI Belfort, Rubens N./D-3579-2015
OI Belfort, Rubens N./0000-0003-1775-7328
CR BLOCH RS, 1971, ARCH OPHTHALMOL-CHIC, V85, P673
   FERRY AP, 1975, ARCH OPHTHALMOL-CHIC, V93, P472, DOI 10.1001/archopht.1975.01010020488002
   FERRY AP, 1974, ARCH OPHTHALMOL-CHIC, V92, P276, DOI 10.1001/archopht.1974.01010010286003
   Giuliari GP, 2011, AM J OPHTHALMOL, V151, P579, DOI 10.1016/j.ajo.2010.09.024
   Ho K, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-40
   Hood CT, 2011, OPHTHALMOLOGY, V118, P221, DOI 10.1016/j.ophtha.2010.09.018
   Shields CL, 2006, OPHTHALMOLOGY, V113, P2080, DOI 10.1016/j.ophtha.2006.05.042
   Shields CL, 2015, CORNEA, V34, P42, DOI 10.1097/ICO.0000000000000285
   Shields CL, 2012, OPHTHALMOLOGY, V119, P407, DOI 10.1016/j.ophtha.2011.07.059
   Shields CL, 1997, OPHTHALMOLOGY, V104, P1265, DOI 10.1016/S0161-6420(97)30148-1
NR 10
TC 2
Z9 2
U1 0
U2 0
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD NOV-DEC
PY 2016
VL 79
IS 6
BP 407
EP 410
DI 10.5935/0004-2749.20160115
PG 4
WC Ophthalmology
SC Ophthalmology
GA EJ2EH
UT WOS:000393022300015
PM 28076572
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Peres, MB
   Kato, RT
   Kniggendorf, VF
   Cole, ED
   Onal, S
   Torres, E
   Louzada, R
   Belfort, R
   Duker, JS
   Novais, EA
   Regatieri, CV
AF Peres, Murilo Bertazzo
   Kato, Renata Tiemi
   Kniggendorf, Vinicius F.
   Cole, Emily D.
   Onal, Sumru
   Torres, Elmar
   Louzada, Ricardo
   Belfort, Rubens, Jr.
   Duker, Jay S.
   Novais, Eduardo A.
   Regatieri, Caio V.
TI Comparison of Optical Coherence Tomography Angiography and Fluorescein
   Angiography for the Identification of Retinal Vascular Changes in Eyes
   With Diabetic Macular Edema
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID ACUTE MIDDLE MACULOPATHY; FOVEAL AVASCULAR ZONE; CHOROIDAL
   NEOVASCULARIZATION; VEIN OCCLUSION; RETINOPATHY; MICROCIRCULATION;
   MICROANEURYSMS; PROGRESSION; ISCHEMIA; IMAGES
AB BACKGROUND AND OBJECTIVE: To compare the visualization of microaneurysms (MA) and the foveal avascular zone (FAZ) area using optical coherence tomography angiography (OCTA) versus fluorescein angiography (FA) in patients with diabetic macular edema (DME).
   PATIENTS AND METHODS: Patients were prospectively recruited for same-day imaging on spectral-domain OCTA and FA. OCTA images were automatically segmented into superficial (sOCTA) and deep (dOCTA) capillary plexuses. The number of visible MAs and the FAZ area were compared between the two imaging modalities.
   RESULTS: Nineteen eyes of 10 patients were included. There was a statistically significant difference between MA counts for FA, sOCTA, and dOCTA (P = .002), and median MA counts were 14.5 (range: 2-43), 9.75 (range: 0-37.5), and 22.5 (range: 5.5-46.5), respectively. dOCTA showed significantly more MAs than sOCTA (P < .001). Although not significant statistically, dOCTA revealed more MAs than FA (P = .06). There was a statistically significant difference between FAZ area for FA, sOCTA, and dOCTA (P = .046), and median FAZ areas were 0.444 (range: 0.1-0.689), 0.224 (range: 0.335-0.806), and 0.345 (range: 0.106-0.881), respectively. FA showed a significantly larger FAZ area than sOCTA (P = .04).
   CONCLUSIONS: Deep plexus OCTA can better identify microaneurysms compared to either sOCTA or FA. The FAZ area appears larger on FA in contrast to OCTA of both plexuses.
C1 [Peres, Murilo Bertazzo; Kato, Renata Tiemi; Kniggendorf, Vinicius F.; Torres, Elmar; Belfort, Rubens, Jr.; Novais, Eduardo A.; Regatieri, Caio V.] Univ Fed Sao Paulo UNIFESP, Sch Med EPM, Dept Ophthalmol, Sao Paulo, Brazil.
   [Belfort, Rubens, Jr.; Novais, Eduardo A.] Inst Visao, Sao Paulo, Brazil.
   [Cole, Emily D.; Onal, Sumru; Louzada, Ricardo; Duker, Jay S.; Novais, Eduardo A.; Regatieri, Caio V.] Tufts Med Ctr, New England Eye Ctr, Boston, MA USA.
   [Louzada, Ricardo] Univ Fed Goias, Goiania, Go, Brazil.
RP Regatieri, CV (corresponding author), Univ Fed Sao Paulo, Dept Oftalmol, Secretaria Adm, Rua Botucatu 821,1o Andar, BR-04023062 Sao Paulo, Brazil.
EM caiore@gmail.com
RI Regatieri, Caio/G-8152-2014; Onal, Sumru/N-8296-2014
OI Regatieri, Caio/0000-0003-1511-8696; Onal, Sumru/0000-0002-4036-922X
FU CAPES Foundation, Ministry of Education of Brazil, Brasilia, DF,
   BrazilCAPES
FX Support for Dr. Novais' and Dr. Louzada's research was provided by CAPES
   Foundation, Ministry of Education of Brazil, Brasilia, DF, Brazil. The
   remaining authors report no relevant financial disclosures.
CR An L, 2008, OPT EXPRESS, V16, P11438, DOI 10.1364/OE.16.011438
   AREND O, 1995, ARCH OPHTHALMOL-CHIC, V113, P610, DOI 10.1001/archopht.1995.01100050078034
   Baumal CR, 2015, JAMA OPHTHALMOL, V133, P1087, DOI 10.1001/jamaophthalmol.2015.1946
   CARSKI TR, 1978, JAMA-J AM MED ASSOC, V240, P635
   Chung EJ, 2008, RETINA-J RET VIT DIS, V28, P957, DOI 10.1097/IAE.0b013e3181754209
   Cole ED, 2016, CLIN EXP OPHTHALMOL, V44, P289, DOI 10.1111/ceo.12711
   de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5
   de Carlo TE, 2015, OPHTHALMOLOGY, V122, P1228, DOI 10.1016/j.ophtha.2015.01.029
   Di G, 2016, GRAEF ARCH CLIN EXP, V254, P873, DOI 10.1007/s00417-015-3143-7
   Ha SO, 2014, INTERN EMERG MED, V9, P325, DOI 10.1007/s11739-013-1019-6
   Haritoglou C, 2014, RETINA-J RET VIT DIS, V34, P157, DOI 10.1097/IAE.0b013e318295f6de
   Horii T, 2010, AM J OPHTHALMOL, V150, P840, DOI 10.1016/j.ajo.2010.06.015
   Hwang TS, 2016, JAMA OPHTHALMOL, V134, P367, DOI 10.1001/jamaophthalmol.2015.5658
   Hwang TS, 2015, RETINA, V35, P2371
   Ishibazawa A, 2015, AM J OPHTHALMOL, V160, P35, DOI 10.1016/j.ajo.2015.04.021
   Jalli PYI, 1997, RETINA-J RET VIT DIS, V17, P211, DOI 10.1097/00006982-199705000-00007
   Jonathan E, 2011, J BIOPHOTONICS, V4, P583, DOI 10.1002/jbio.201000103
   Kuehlewein L, 2015, AM J OPHTHALMOL, V160, P739, DOI 10.1016/j.ajo.2015.06.030
   Lee DH, 2013, INVEST OPHTH VIS SCI, V54, P1080, DOI 10.1167/iovs.12-10503
   Matsunaga DR, 2015, OSLI RETINA, V46, P796, DOI 10.3928/23258160-20150909-03
   Mendis KR, 2010, INVEST OPHTH VIS SCI, V51, P5864, DOI 10.1167/iovs.10-5333
   Moore J, 1999, J ANAT, V194, P89, DOI 10.1046/j.1469-7580.1999.19410089.x
   Musa F, 2006, ACTA OPHTHALMOL SCAN, V84, P740, DOI 10.1111/j.1600-0420.2006.00728.x
   Nunes S, 2009, OPHTHALMOLOGICA, V223, P292, DOI 10.1159/000213639
   PARODI MB, 1995, INT OPHTHALMOL, V19, P25, DOI 10.1007/BF00156415
   Rahimy E, 2014, AM J OPHTHALMOL, V158, P372, DOI 10.1016/j.ajo.2014.04.024
   Retinopathy Diabetic, 2014, CLIN GUIDE ANGIO OCT
   Sakata K, 2006, OPHTHALMOLOGY, V113, P1385, DOI 10.1016/j.ophtha.2006.04.023
   Sarraf D, 2013, JAMA OPHTHALMOL, V131, P1275, DOI 10.1001/jamaophthalmol.2013.4056
   Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616
   STITT AW, 1995, BRIT J OPHTHALMOL, V79, P362, DOI 10.1136/bjo.79.4.362
   Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5
   Yu SQ, 2015, AM J OPHTHALMOL, V159, P53, DOI 10.1016/j.ajo.2014.09.027
NR 33
TC 10
Z9 11
U1 0
U2 1
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD NOV
PY 2016
VL 47
IS 11
BP 1013
EP 1019
DI 10.3928/23258160-20161031-05
PG 7
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA EJ3HY
UT WOS:000393104400005
PM 27842196
DA 2020-12-01
ER

PT J
AU Dias, JRD
   Freitas, BD
   Belfort, R
AF de Oliveira Dias, Joao Rafael
   Freitas, Bruno de Paula
   Belfort, Rubens, Jr.
TI Similarities in the Retinal Appearance of Patients With Zika Virus
   Compared With Cobalamin C Deficiency Reply
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [de Oliveira Dias, Joao Rafael; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 821,First Floor, BR-04023062 Sao Paulo, Brazil.
   [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 821,First Floor, BR-04023062 Sao Paulo, Brazil.
EM prof.belfort@clinicabelfort.com.br
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD OCT 1
PY 2016
VL 134
IS 10
BP 1201
EP 1201
DI 10.1001/jamaophthalmol.2016.2404
PG 1
WC Ophthalmology
SC Ophthalmology
GA EA3FO
UT WOS:000386486900036
PM 27490445
DA 2020-12-01
ER

PT J
AU Berezovsky, A
   Watanabe, SES
   Munoz, S
   Furtado, JM
   Cohen, MJ
   Morales, PH
   Cypel, M
   Cohen, JM
   Belfort, R
   Salomao, SR
AF Berezovsky, Adriana
   Song Watanabe, Sung Eun
   Munoz, Sergio
   Furtado, Joao M.
   Cohen, Marcos Jacob
   Morales, Paulo Henrique
   Cypel, Marcela
   Cohen, Jacob Moyses
   Belfort, Rubens
   Salomao, Solange Rios
TI Prevalence and Outcomes of Cataract Surgery: the Brazilian Amazon Region
   Eye Survey (BARES)
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-05, 2016
CL Seattle, WA
SP Assoc Res Vis & Ophthalmol
C1 [Berezovsky, Adriana; Song Watanabe, Sung Eun; Furtado, Joao M.; Morales, Paulo Henrique; Cypel, Marcela; Belfort, Rubens; Salomao, Solange Rios] Univ Fed Sao Paulo, Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
   [Furtado, Joao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Oftalmol Otorrinolaringol & Cirurgia Cabeca & Pes, Ribeirao Preto, Brazil.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Univ Fed Amazonas, Dept Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
RI Berezovsky, Adriana/F-2341-2013
OI Berezovsky, Adriana/0000-0001-6350-8221
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil [402120/2012-4]; Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo, FAPESP, Sao Paulo, BrasilFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/16397-7]; Sight First
   Program - Lions Club International Foundation [1758]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras (Grant # 402120/2012-4
   to SRS, SM and JMF; Research Scholarships to SRS and RBJ); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo, Brasil
   (Grant # 2013/16397-7 to SRS); Sight First Program - Lions Club
   International Foundation (Grant # 1758 to SRS).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD SEP
PY 2016
VL 57
IS 12
MA 1997
PG 3
WC Ophthalmology
SC Ophthalmology
GA EK8LA
UT WOS:000394174004322
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Furtado, JM
   Cavascan, NN
   Munoz, S
   Berezovsky, A
   Cohen, MJ
   Vasconcelos, GC
   Cohen, JM
   Watanabe, SES
   Belfort, R
   Salomao, SR
AF Furtado, Joao M.
   Cavascan, Nivea Nunes
   Munoz, Sergio
   Berezovsky, Adriana
   Cohen, Marcos Jacob
   Vasconcelos, Galton Carvalho
   Cohen, Jacob Moyses
   Song Watanabe, Sung Eun
   Belfort, Rubens
   Salomao, Solange Rios
TI PREVALENCE AND CAUSES OF DISTANCE VISION IMPAIRMENT AND BLINDNESS IN
   OLDER ADULTS IN URBAN AND RURAL AREAS OF PARINTINS: THE BRAZILIAN AMAZON
   REGION EYE SURVEY
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-05, 2016
CL Seattle, WA
SP Assoc Res Vis & Ophthalmol
C1 [Furtado, Joao M.; Cavascan, Nivea Nunes; Berezovsky, Adriana; Cohen, Marcos Jacob; Vasconcelos, Galton Carvalho; Song Watanabe, Sung Eun; Belfort, Rubens; Salomao, Solange Rios] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Furtado, Joao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Ribeirao Preto, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Vasconcelos, Galton Carvalho] Univ Fed Minas Gerais, Fac Med, Dept Oftalmol, Belo Horizonte, MG, Brazil.
   [Cohen, Jacob Moyses] Univ Fed Amazonas, Fac Med, Dept Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
RI Ferraz, Nivea/AAC-2439-2020; Berezovsky, Adriana/F-2341-2013
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221
FU Conselho Nacional de Desenvolvimento Cientfico e Tecnologico - CNPq,
   Brasilia, Brasil [402120/2012-4]; Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo, FAPESP, Sao Paulo, BrasilFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/16397-7]; Sight First
   Program - Lions Club International Foundation [1758]
FX Support Conselho Nacional de Desenvolvimento Cientfico e Tecnologico -
   CNPq, Brasilia, Brasil, Programa Ciencia sem Fronteiras (Grant #
   402120/2012-4 to SRS, SM and JMF; Research Scholarships to SRS and RBJ);
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   Brasil (Grant # 2013/16397-7 to SRS); Sight First Program - Lions Club
   International Foundation (Grant #1758 to SRS).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD SEP
PY 2016
VL 57
IS 12
MA 1569
PG 3
WC Ophthalmology
SC Ophthalmology
GA EK8LA
UT WOS:000394174003391
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Salomao, SR
   Munoz, S
   Furtado, JM
   Ferraz, AN
   Berezovsky, A
   Cavascan, NN
   Sacai, PY
   Mitsuhiro, MRKH
   Cohen, JM
   Belfort, R
AF Salomao, Solange Rios
   Munoz, Sergio
   Furtado, Joao M.
   Ferraz, Alberto Nunes, Jr.
   Berezovsky, Adriana
   Cavascan, Nivea Nunes
   Sacai, Paula Y.
   Kimie Higashi Mitsuhiro, Marcia Regina
   Cohen, Jacob Moyses
   Belfort, Rubens
TI Study Design and Methods for a Population-based Study on the Prevalence
   and Causes of Distance and Near Vision Impairment and Blindness in
   Parintins City: The Brazilian Amazon Region Eye Survey (BARES)
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-05, 2016
CL Seattle, WA
SP Assoc Res Vis & Ophthalmol
C1 [Salomao, Solange Rios; Furtado, Joao M.; Ferraz, Alberto Nunes, Jr.; Berezovsky, Adriana; Cavascan, Nivea Nunes; Sacai, Paula Y.; Kimie Higashi Mitsuhiro, Marcia Regina; Belfort, Rubens] Univ Fed Sao Paulo, Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
   [Furtado, Joao M.] Fac Med Ribeirao Preto USP, Oftalmol Otorrinolaringol & Cirurgia Cabeca & Pes, Ribeirao Preto, Brazil.
   [Cohen, Jacob Moyses] Univ Fed Amazonas, Dept Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
   [Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
RI Ferraz, Nivea/AAC-2439-2020; Sacai, Paula Y/B-6525-2014; Berezovsky,
   Adriana/F-2341-2013
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil [402120/2012-4]; Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo, FAPESP, Sao Paulo, BrasilFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/16397-7]; Sight First
   Program - Lions Club International Foundation [1758]
FX Support Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPq, Brasilia, Brasil, Programa Ciencia sem Fronteiras (Grant #
   402120/2012-4 to SRS, SM and JMF; Research Scholarships to SRS and RBJ);
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   Brasil (Grant # 2013/16397-7 to SRS); Sight First Program - Lions Club
   International Foundation (Grant # 1758 to SRS).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD SEP
PY 2016
VL 57
IS 12
MA 1570
PG 3
WC Ophthalmology
SC Ophthalmology
GA EK8LA
UT WOS:000394174003392
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Apinyawasisuk, S
   Ganti, A
   Karanjia, R
   Chu, ER
   Wagschal, T
   Belfort, R
   de Moraes, MN
   Salomao, SR
   Miller, G
   Sadun, AA
AF Apinyawasisuk, Supanut
   Ganti, Amitha
   Karanjia, Rustum
   Chu, Edward R.
   Wagschal, Tana
   Belfort, Rubens
   de Moraes-Filho, Milton N.
   Salomao, Solange Rios
   Miller, Guy
   Sadun, Alfredo A.
TI EPI-743 (Quinone) therapy for Leber's Hereditary Optic Neuropathy: the
   Brazil experience
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-05, 2016
CL Seattle, WA
SP Assoc Res Vis & Ophthalmol
C1 [Apinyawasisuk, Supanut; Karanjia, Rustum; Sadun, Alfredo A.] Doheny Eye Inst, Ophthalmol, 1355 San Pablo St, Los Angeles, CA 90033 USA.
   [Ganti, Amitha; Chu, Edward R.] Univ Southern Calif, Ophthalmol, Los Angeles, CA USA.
   [Wagschal, Tana] Univ Iowa, Visual Field Reading Ctr, Coralville, IA USA.
   [Belfort, Rubens; de Moraes-Filho, Milton N.; Salomao, Solange Rios] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
   [de Moraes-Filho, Milton N.] Ctr Univ Espirito Santo, Colatina, Brazil.
   [Miller, Guy] Edison Pharmaceut, Mountain View, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD SEP
PY 2016
VL 57
IS 12
MA 5084
PG 2
WC Ophthalmology
SC Ophthalmology
GA EK8YI
UT WOS:000394210205350
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Karanjia, R
   Berezovsky, A
   Sacai, PY
   de Moraes, MN
   Cavascan, NN
   Salomao, SR
   Watanabe, SES
   Belfort, R
   Carelli, V
   Coupland, SG
   Sadun, AA
AF Karanjia, Rustum
   Berezovsky, Adriana
   Sacai, Paula Y.
   de Moraes-Filho, Milton N.
   Cavascan, Nivea Nunes
   Salomao, Solange Rios
   Watanabe, Sung Eun Song
   Belfort, Rubens
   Carelli, Vallerio
   Coupland, Stuart G.
   Sadun, Alfredo A.
TI The photopic negative response: an objective measure of retinal ganglion
   cell in patients with Leber's Hereditary Optic Neuropathy
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-05, 2016
CL Seattle, WA
SP Assoc Res Vis & Ophthalmol
C1 [Karanjia, Rustum; Coupland, Stuart G.] Univ Ottawa, OUHSC, Ophthalmol, Ottawa, ON, Canada.
   [Karanjia, Rustum; Sadun, Alfredo A.] Univ Calif Los Angeles, Ophthalmol, Los Angeles, CA USA.
   [Berezovsky, Adriana; Sacai, Paula Y.; de Moraes-Filho, Milton N.; Cavascan, Nivea Nunes; Salomao, Solange Rios; Watanabe, Sung Eun Song; Belfort, Rubens] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Carelli, Vallerio] Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Bologna, Italy.
RI Ferraz, Nivea/AAC-2439-2020; Salomao, Solange R/G-9500-2012; Berezovsky,
   Adriana/F-2341-2013; Sacai, Paula Y/B-6525-2014
OI Ferraz, Nivea/0000-0001-7568-6199; Salomao, Solange
   R/0000-0002-3436-5599; Berezovsky, Adriana/0000-0001-6350-8221; 
FU Stealth Biotechnology
FX Unrestricted Grant support Stealth Biotechnology
CR Sadun Alfredo A, 2002, Trans Am Ophthalmol Soc, V100, P169
NR 1
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD SEP
PY 2016
VL 57
IS 12
PG 3
WC Ophthalmology
SC Ophthalmology
GA EK8YM
UT WOS:000394210605325
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Vasconcelos, GC
   Cavascan, NN
   Berezovsky, A
   Cunha, CC
   Munoz, S
   Furtado, LM
   Cohen, JM
   Cohen, MJ
   Belfort, R
   Salomao, SR
AF Vasconcelos, Galton C.
   Cavascan, Nivea Nunes
   Berezovsky, Adriana
   Cunha, Cristina Coimbra
   Munoz, Sergio
   Furtado, Loao M.
   Cohen, Jlacob Moyses
   Cohen, Marcos Jacob
   Belfort, Rubens
   Salomao, Solange Rios
TI Spectacle Coverage in Older Adults from Parintins: The Brazilian Amazon
   Region Eye Survey (BARES)
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 01-05, 2016
CL Seattle, WA
SP Assoc Res Vis & Ophthalmol
C1 [Vasconcelos, Galton C.] Univ Fed Minas Gerais, Oftalmol & Otorrinolaringol, Belo Horizonte, MG, Brazil.
   [Vasconcelos, Galton C.; Cavascan, Nivea Nunes; Berezovsky, Adriana; Cunha, Cristina Coimbra; Belfort, Rubens; Salomao, Solange Rios] Univ Fed Sao Paulo, Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
   [Furtado, Loao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Ribeirao Preto, SP, Brazil.
   [Cohen, Jlacob Moyses] Univ Fed Amazonas, Fac Med, Dept Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
   [Cohen, Marcos Jacob] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
RI Berezovsky, Adriana/F-2341-2013; Ferraz, Nivea/AAC-2439-2020; Salomao,
   Solange R/G-9500-2012
OI Berezovsky, Adriana/0000-0001-6350-8221; Ferraz,
   Nivea/0000-0001-7568-6199; Salomao, Solange R/0000-0002-3436-5599
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras [402120/2012-4];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo,
   BrasilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/16397-7]; Sight First Program - Lions Club International
   Foundation [1758]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq,
   Brasilia, Brasil, Programa Ciencia sem Fronteiras (Grant # 402120/2012-4
   to SRS, SM and JMF; Research Scholarships to SRS and RBJ); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, Sao Paulo, Brasil
   (Grant # 2013/16397-7 to SRS); Sight First Program - Lions Club
   International Foundation (Grant # 1758 to SRS).
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD SEP
PY 2016
VL 57
IS 12
MA 3973
PG 3
WC Ophthalmology
SC Ophthalmology
GA EK8YI
UT WOS:000394210203253
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Novais, EA
   Roisman, L
   de Oliveira, PRC
   Louzada, RN
   Cole, ED
   Lane, M
   Bonini, M
   Romano, A
   Dias, JRD
   Regatieri, CV
   Chow, D
   Belfort, R
   Rosenfeld, P
   Waheed, NK
   Ferrara, D
   Duker, JS
AF Novais, Eduardo A.
   Roisman, Luiz
   de Oliveira, Paulo Ricardo Chaves
   Louzada, Ricardo N.
   Cole, Emily D.
   Lane, Mark
   Bonini Filho, Marco
   Romano, Andre
   de Oliveira Dias, Joao Rafael
   Regatieri, Caio V.
   Chow, David
   Belfort, Rubens, Jr.
   Rosenfeld, Philip
   Waheed, Nadia K.
   Ferrara, Daniela
   Duker, Jay S.
TI Optical Coherence Tomography Angiography of Chorioretinal Diseases
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID ACUTE MIDDLE MACULOPATHY; CENTRAL SEROUS CHORIORETINOPATHY; INDOCYANINE
   GREEN ANGIOGRAPHY; FOVEAL AVASCULAR ZONE; RETINAL VEIN OCCLUSION;
   POLYPOIDAL CHOROIDAL VASCULOPATHY; IDIOPATHIC MACULAR TELANGIECTASIA;
   DEEP CAPILLARY ISCHEMIA; FLUORESCEIN-ANGIOGRAPHY; OCT ANGIOGRAPHY
AB Fluorescein angiography (FA) and indocyanine green angiography (ICGA) have been the gold standard for the evaluation of retinal and choroidal vasculature in the last three decades and have revolutionized the diagnosis of retinal and choroidal vascular diseases. The advantage of these imaging modalities lies in their ability to document retinal and choroidal vasculature through the dynamic assessment of contrast transit over time in the intravascular and extravascular spaces. However, disadvantages include the absence of depth resolution, blurring of details by contrast leakage, and the inability to selectively evaluate different levels of the retinal and choroidal microvasculature. In addition, these angiographic methods require intravenous dye, which may cause adverse reactions such as nausea, vomiting, and rarely, anaphylaxis.
   Optical coherence tomography angiography (OCTA) is a noninvasive imaging technique that, in contrast to dye-based angiography, is faster and depth-resolved, allowing in some cases for more precise evaluation of the vascular plexuses of the retina and choroid. The method has been demonstrated in the assessment of various vascular diseases such as venous occlusions, diabetic retinopathy, macular neovascularization, and others. Limitations of this imaging modality include a small registered field of view and the inability to visualize leakage and dye transit over time. It is also subject to a variety of artifacts, including those generated by blinking and eye movement during image acquisition. However, more than an alternative for FA and ICGA, OCTA is bringing new insights to our understanding of retinal and choroidal vascular structure and is changing fundamental paradigms in the clinical management of pathologic conditions.
C1 [Novais, Eduardo A.; Roisman, Luiz; Romano, Andre; de Oliveira Dias, Joao Rafael; Regatieri, Caio V.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Escola Paulista Med, Sao Paulo, Brazil.
   [Novais, Eduardo A.; Louzada, Ricardo N.; Cole, Emily D.; Lane, Mark; Regatieri, Caio V.; Waheed, Nadia K.; Ferrara, Daniela; Duker, Jay S.] Tufts Med Ctr, New England Eye Ctr, 800 Washington St, Boston, MA 02111 USA.
   [Roisman, Luiz; Romano, Andre; de Oliveira Dias, Joao Rafael; Rosenfeld, Philip] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.
   [de Oliveira, Paulo Ricardo Chaves; Chow, David] Toronto Retina Inst, Toronto, ON, Canada.
   [Louzada, Ricardo N.] Univ Fed Goias, Goiania, Go, Brazil.
   [Lane, Mark] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England.
   [Bonini Filho, Marco] Inst Olhos Tres Lagoas, Tres Lagoas, MS, Brazil.
   [Bonini Filho, Marco] CDO, Tres Lagoas, MS, Brazil.
RP Duker, JS (corresponding author), Tufts Med Ctr, New England Eye Ctr, 800 Washington St, Boston, MA 02111 USA.
EM jduker@tuftsmedicalcenter.org
RI roisman, luiz/AAD-3822-2019; Regatieri, Caio/G-8152-2014
OI Regatieri, Caio/0000-0003-1511-8696
FU Macula Vision Research Foundation; Massachusetts Lions Club; CAPES
   FoundationCAPES; Ministry of Education of Brazil, Brasilia, DF, Brazil;
   Carl Zeiss Meditec; OptoVue
FX Supported in part by a grant from the Macula Vision Research Foundation
   and the Massachusetts Lions Club.; Drs. Novais, Roisman, and Louzada are
   researchers supported by CAPES Foundation, Ministry of Education of
   Brazil, Brasilia, DF, Brazil. Dr. Duker is a consultant for and receives
   research support from Carl Zeiss Meditec and OptoVue. Dr. Ferrara is an
   employee at Genentech and has Roche stock/stock options. Dr. Rosenfeld
   has received research funding and speaker fees from Carl Zeiss Meditec.
   Dr. Waheed has received research support and speaker fees from Carl
   Zeiss Meditec and Optovue. The remaining authors report no relevant
   financial disclosures.
CR Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4
   CARSKI TR, 1978, JAMA-J AM MED ASSOC, V240, P635
   Chen XJ, 2015, AM J OPHTHALMOL, V160, P26, DOI 10.1016/j.ajo.2015.04.004
   Christenbury JG, 2015, OSLI RETINA, V46, P579, DOI 10.3928/23258160-20150521-11
   Coscas G, 2015, OPHTHALMIC RES, V54, P57, DOI 10.1159/000433547
   de Carlo TE, 2016, OSLI RETINA, V47, P108, DOI 10.3928/23258160-20160126-02
   de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5
   de Carlo TE, 2015, OPHTHALMOLOGY, V122, P1228, DOI 10.1016/j.ophtha.2015.01.029
   Di G, 2016, GRAEF ARCH CLIN EXP, V254, P873, DOI 10.1007/s00417-015-3143-7
   Do DV, 2013, CURR OPIN OPHTHALMOL, V24, P244, DOI 10.1097/ICU.0b013e32835fd7dd
   Ferrara D, 2014, OPHTHALMOLOGY, V121, P719, DOI 10.1016/j.ophtha.2013.10.014
   Fingler J, 2007, OPT EXPRESS, V15, P12636, DOI 10.1364/OE.15.012636
   Freiberg FJ, 2016, GRAEF ARCH CLIN EXP, V254, P1051, DOI 10.1007/s00417-015-3148-2
   Huang YP, 2015, BIOMED OPT EXPRESS, V6, P1195, DOI 10.1364/BOE.6.001195
   Hwang TS, 2016, JAMA OPHTHALMOL, V134, P367, DOI 10.1001/jamaophthalmol.2015.5658
   Hwang TS, 2015, RETINA-J RET VIT DIS, V35, P2371, DOI 10.1097/IAE.0000000000000716
   Iida T, 1999, RETINA-J RET VIT DIS, V19, P508, DOI 10.1097/00006982-199911000-00005
   Ishibazawa A, 2015, AM J OPHTHALMOL, V160, P35, DOI 10.1016/j.ajo.2015.04.021
   Jia YL, 2014, OPHTHALMOLOGY, V121, P1435, DOI 10.1016/j.ophtha.2014.01.034
   Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710
   Kashani AH, 2015, RETINA-J RET VIT DIS, V35, P2323, DOI 10.1097/IAE.0000000000000811
   Khan MA, 2015, OSLI RETINA, V46, P972, DOI 10.3928/23258160-20151008-12
   Kim DY, 2011, BIOMED OPT EXPRESS, V2, P1504, DOI 10.1364/BOE.2.001504
   Kotsolis AI, 2010, BRIT J OPHTHALMOL, V94, P1506, DOI 10.1136/bjo.2009.159913
   Kuehlewein L, 2015, RETINA-J RET VIT DIS, V35, P2229, DOI 10.1097/IAE.0000000000000835
   Kuehlewein L, 2015, AM J OPHTHALMOL, V160, P739, DOI 10.1016/j.ajo.2015.06.030
   Kuehlewein L, 2015, INVEST OPHTH VIS SCI, V56, P3984, DOI 10.1167/iovs.15-16510
   Kuehlewein L, 2015, OSLI RETINA, V46, P249, DOI 10.3928/23258160-20150213-19
   Leitgeb RA, 2014, PROG RETIN EYE RES, V41, P26, DOI 10.1016/j.preteyeres.2014.03.004
   Lumbroso B., 2015, CLIN GUIDE ANGIO OCT
   Matsunaga D, 2014, OSLI RETINA, V45, P510, DOI 10.3928/23258160-20141118-04
   Mendis KR, 2010, INVEST OPHTH VIS SCI, V51, P5864, DOI 10.1167/iovs.10-5333
   Musa F, 2006, ACTA OPHTHALMOL SCAN, V84, P740, DOI 10.1111/j.1600-0420.2006.00728.x
   Naftalin CM, 2015, INT J STD AIDS, V26, P803, DOI 10.1177/0956462414553826
   Nemiroff J, 2016, AM J OPHTHALMOL, V162, P121, DOI 10.1016/j.ajo.2015.10.026
   Nishiyama Y, 2001, Jpn J Ophthalmol, V45, P116, DOI 10.1016/S0021-5155(00)00309-9
   Novais EA, 2016, AM J OPHTHALMOL, V164, P80, DOI 10.1016/j.ajo.2016.01.011
   PARODI MB, 1995, INT OPHTHALMOL, V19, P25, DOI 10.1007/BF00156415
   Paunescu LA, 2006, OPHTHALMOLOGY, V113, P48, DOI 10.1016/j.ophtha.2005.08.016
   Pecen PE, 2015, JAMA OPHTHALMOL, V133, P1478, DOI 10.1001/jamaophthalmol.2015.4100
   Prunte C, 1996, AM J OPHTHALMOL, V121, P26
   Quaranta-El Maftouhi M, 2015, AM J OPHTHALMOL, V160, P581, DOI 10.1016/j.ajo.2015.06.016
   Rahimy E, 2014, AM J OPHTHALMOL, V158, P372, DOI 10.1016/j.ajo.2014.04.024
   Roisman L, 2016, OPHTHALMOLOGY, V123, P1309, DOI 10.1016/j.ophtha.2016.01.044
   Ruminski D, 2015, BIOMED OPT EXPRESS, V6, P2738, DOI 10.1364/BOE.6.002738
   Saito M, 2008, RETINA-J RET VIT DIS, V28, P459, DOI 10.1097/IAE.0b013e318156db60
   Sarraf D, 2013, JAMA OPHTHALMOL, V131, P1275, DOI 10.1001/jamaophthalmol.2013.4056
   SNODDERLY DM, 1992, J NEUROSCI, V12, P1169
   Soheilian M, 2007, OPHTHAL SURG LAS IM, V38, P167, DOI 10.3928/15428877-20070301-16
   Spaide RF, 2015, AM J OPHTHALMOL, V160, P6, DOI 10.1016/j.ajo.2015.04.012
   Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616
   Stanga PE, 2003, OPHTHALMOLOGY, V110, P15, DOI 10.1016/S0161-6420(02)01563-4
   Surguch V, 2007, GRAEF ARCH CLIN EXP, V245, P783, DOI 10.1007/s00417-006-0432-1
   Takase N, 2015, RETINA-J RET VIT DIS, V35, P2377, DOI 10.1097/IAE.0000000000000849
   Teussink MM, 2015, INVEST OPHTH VIS SCI, V56, P5229, DOI 10.1167/iovs.15-17140
   Thorell MR, 2014, OSLI RETINA, V45, P369, DOI 10.3928/23258160-20140909-06
   Ueno C, 2012, RETINA-J RET VIT DIS, V32, P2006, DOI 10.1097/IAE.0b013e31825c1c31
   White BR, 2003, OPT EXPRESS, V11, P3490, DOI 10.1364/OE.11.003490
   Yang F, 2014, DRUG DES DEV THER, V8, P1789, DOI 10.2147/DDDT.S62530
   Yannuzzi LA, 2006, ARCH OPHTHALMOL-CHIC, V124, P450, DOI 10.1001/archopht.124.4.450
   Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003
   Yi J, 2014, BIOMED OPT EXPRESS, V5, P3603, DOI 10.1364/BOE.5.003603
   Yu SQ, 2015, AM J OPHTHALMOL, V159, P53, DOI 10.1016/j.ajo.2014.09.027
   Zeimer M, 2015, RETINA-J RET VIT DIS, V35, P2307, DOI 10.1097/IAE.0000000000000868
   Zhang QQ, 2015, RETINA-J RET VIT DIS, V35, P2285, DOI 10.1097/IAE.0000000000000840
   Zhang QQ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.6.066008
NR 66
TC 7
Z9 8
U1 0
U2 4
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD SEP
PY 2016
VL 47
IS 9
BP 848
EP 861
DI 10.3928/23258160-20160901-09
PG 14
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA EJ3HM
UT WOS:000393103200009
PM 27631482
DA 2020-12-01
ER

PT J
AU Miranda, AF
   de Andrade, GC
   Novais, EA
   Maia, A
   Nascimento, H
   Muccioli, C
   Belfort, R
AF Miranda, Ana F.
   de Andrade, Gabriel Costa
   Novais, Eduardo A.
   Maia, Andre
   Nascimento, Heloisa
   Muccioli, Cristina
   Belfort, Rubens, Jr.
TI OUTCOMES AFTER PARS PLANA VITRECTOMY FOR EPIRETINAL MEMBRANES ASSOCIATED
   WITH TOXOPLASMOSIS
SO RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
LA English
DT Article
DE epiretinal membrane; ocular toxoplasmosis; ocular surgery; pars plana
   vitrectomy; toxoplasmic retinochoroiditis
ID OCULAR TOXOPLASMOSIS; GLOBAL REASSESSMENT; MEMORIAL-LECTURE;
   RETINOCHOROIDITIS; DISEASE
AB Purpose:To evaluate outcomes and complications of pars plana vitrectomy in patients with epiretinal membrane secondary to toxoplasmic retinochoroiditis.Methods:Retrospective evaluation of the records of 14 patients who underwent pars plana vitrectomy for epiretinal membrane secondary to toxoplasmic retinochoroiditis. The best-corrected visual acuity, intraoperative and postoperative complications, and macular optical coherence tomography were analysed. All patients received postoperative prophylactic treatment with trimethoprim/sulfamethoxazole.Results:Fourteen patients, 5 men and 9 women, were included. Mean follow-up period after surgery was 6.07 2.64 months. Preoperative mean best-corrected visual acuity was 20/200, and postoperative mean best-corrected visual acuity was 20/60. There were no intraoperative complications. Three patients developed posterior capsule opacification, and one patient developed cataract.Conclusion:Pars plana vitrectomy is a safe and effective procedure in patients with epiretinal membrane secondary to toxoplasmic retinochoroiditis, improving both visual acuity and anatomical result on macular optical coherence tomography. The most frequent postoperative complications were posterior capsule opacification and cataract. No recurrences of the disease were recorded.
C1 [Miranda, Ana F.; de Andrade, Gabriel Costa; Novais, Eduardo A.; Maia, Andre; Nascimento, Heloisa; Muccioli, Cristina; Belfort, Rubens, Jr.] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med EPM, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
   [Miranda, Ana F.] Hosp Garcia de Orta, Almada, Portugal.
   [de Andrade, Gabriel Costa; Maia, Andre] Retina Clin, Sao Paulo, Brazil.
RP Miranda, AF (corresponding author), Rua Botucatu 820, BR-04023062 Sao Paulo, Brazil.
EM anafbmiranda@gmail.com
RI Andrade, Gabriel/AAV-3155-2020; Nascimento, Heloisa/P-8869-2017
OI Andrade, Gabriel/0000-0002-5881-8126; Nascimento,
   Heloisa/0000-0003-0315-1317
CR Adan A, 2009, EUR J OPHTHALMOL, V19, P1039
   Arana B, 2014, INT OPHTHALMOL, V34, P141, DOI 10.1007/s10792-013-9754-2
   Bosch-Driessen LH, 2002, OPHTHALMOLOGY, V109, P41, DOI 10.1016/S0161-6420(01)00845-4
   Dev S, 1999, OPHTHALMOLOGY, V106, P1086, DOI 10.1016/S0161-6420(99)90247-6
   Eugenio Faria E, 2011, ACTA OPHTHALMOL, V89, pe538
   Faridi A, 2015, RETINA-J RET VIT DIS, V35, P358, DOI 10.1097/IAE.0000000000000279
   Hazar Leyla, 2013, Retin Cases Brief Rep, V7, P368, DOI 10.1097/ICB.0b013e3182964fa5
   Heringer GC, 2014, BRIT J OPHTHALMOL, V98, P1218, DOI 10.1136/bjophthalmol-2013-304259
   Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032
   Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040
   Kiryu J, 2003, JPN J OPHTHALMOL, V47, P479, DOI 10.1016/S0021-5155(03)00128-X
   Klein R, 1994, Trans Am Ophthalmol Soc, V92, P403
   Papadopoulou DN, 2011, EUR J OPHTHALMOL, V21, P83, DOI 10.5301/EJO.2010.2075
   Rodriguez A, 2015, EUR J OPHTHALMOL, V25, P159, DOI 10.5301/ejo.5000508
NR 14
TC 1
Z9 1
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0275-004X
EI 1539-2864
J9 RETINA-J RET VIT DIS
JI Retin.-J. Retin. Vitr. Dis.
PD SEP
PY 2016
VL 36
IS 9
BP 1713
EP 1717
DI 10.1097/IAE.0000000000000973
PG 5
WC Ophthalmology
SC Ophthalmology
GA DW9KZ
UT WOS:000383979500017
PM 26982340
DA 2020-12-01
ER

PT J
AU Sen, HN
   Belfort, R
   Chan, CC
   Lee, RWJ
   Rosenbaum, JT
   Holland, GN
AF Sen, H. Nida
   Belfort, Rubens, Jr.
   Chan, Chi-Chao
   Lee, Richard W. J.
   Rosenbaum, James T.
   Holland, Gary N.
TI ROBERT B. NUSSENBLATT, MD, MPH (1948-2016): EXTRAORDINARY
   CLINICIAN-SCIENTIST AND EDUCATOR OBITUARY
SO AMERICAN JOURNAL OF OPHTHALMOLOGY
LA English
DT Biographical-Item
RI Lee, Richard/A-3116-2017
OI Lee, Richard/0000-0002-9480-6843
NR 0
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9394
EI 1879-1891
J9 AM J OPHTHALMOL
JI Am. J. Ophthalmol.
PD SEP
PY 2016
VL 169
BP 300
EP 302
DI 10.1016/j.ajo.2016.06.024
PG 3
WC Ophthalmology
SC Ophthalmology
GA DW4UA
UT WOS:000383637300045
OA Bronze
DA 2020-12-01
ER

PT J
AU Belfort, R
   Freitas, BD
   Dias, JRD
AF Belfort, Rubens, Jr.
   Freitas, Bruno de Paula
   de Oliveira Dias, Joao Rafael
TI Zika Virus, Microcephaly, and Ocular Findings Reply
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [Belfort, Rubens, Jr.; de Oliveira Dias, Joao Rafael] Univ Fed Sao Paulo, Dept Ophthalmol, Vis Inst, Paulista Med Sch, Rua Botucatu,821,First Floor, BR-04023062 Sao Paulo, Brazil.
   [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Vis Inst, Paulista Med Sch, Rua Botucatu,821,First Floor, BR-04023062 Sao Paulo, Brazil.
EM prof.belfort@clinicabelfort.com.br
CR Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
NR 2
TC 2
Z9 2
U1 0
U2 32
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2016
VL 134
IS 8
BP 946
EP 947
DI 10.1001/jamaophthalmol.2016.1305
PG 2
WC Ophthalmology
SC Ophthalmology
GA DT1AD
UT WOS:000381213200026
PM 27253365
DA 2020-12-01
ER

PT J
AU Ventura, CV
   Maia, M
   Travassos, SB
   Martins, TT
   Patriota, F
   Nunes, ME
   Agra, C
   Torres, VL
   van der Linden, V
   Ramos, RC
   Rocha, MAW
   Silva, PS
   Ventura, LO
   Belfort, R
AF Ventura, Camila V.
   Maia, Mauricio
   Travassos, Simone B.
   Martins, Thayze T.
   Patriota, Felipe
   Nunes, Marcos Eugenio
   Agra, Cristiana
   Torres, Virginia L.
   van der Linden, Vanessa
   Ramos, Regina C.
   Rocha, Maria Angela W.
   Silva, Paula S.
   Ventura, Liana O.
   Belfort, Rubens, Jr.
TI Risk Factors Associated With the Ophthalmoscopic Findings Identified in
   Infants With Presumed Zika Virus Congenital Infection
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID TRANSMISSION; CHILD
AB IMPORTANCE The Zika virus (ZIKV) might cause microcephaly and ophthalmoscopic findings in infants of mothers infected during pregnancy.
   OBJECTIVE To assess and identify possible risk factors for ophthalmoscopic findings in infants born with microcephaly and a presumed clinical diagnosis of ZIKV intrauterine infection.
   DESIGN, SETTING, AND PARTICIPANTS We conducted a cross-sectional study at the Altino Ventura Foundation in Recife, Brazil, that included 40 infants with microcephaly born in Pernambuco state, Brazil, between May and December 2015. Toxoplasmosis, rubella, cytomegalovirus, syphilis, and human immunodeficiency virus were ruled out in all of them. Testing of cerebrospinal fluid for ZIKV using IgM antibody-capture enzyme-linked immunosorbent assay was performed in 24 of 40 infants (60.0%). The infants and mothers underwent ocular examinations. The infants were divided into 2 groups, those with and without ophthalmoscopic alterations, for comparison.
   MAIN OUTCOMES AND MEASURES Identification of risk factors for ophthalmoscopic findings in infants born with microcephaly and ZIKV intrauterine infection.
   RESULTS Among the 40 infants, the mean (SD) age was 2.2 (1.2) months (range, 0.1-7.3 months). Of the 24 infants tested, 100% had positive results for ZIKV infection: 14 of 22 infants (63.6%) from the group with ophthalmoscopic findings and 10 of 18 infants (55.6%) from the group without ophthalmoscopic findings. The major symptoms reported in both groups were rash by 26 mothers (65.0%), fever by 9 mothers (22.5%), headache by 9 mothers (22.5%), and arthralgia by 8 mothers (20.0%). No mothers reported conjunctivitis or other ocular symptoms during pregnancy or presented signs of uveitis at the time of examination. Thirty-seven eyes (46.3%) of 22 infants (55.0%) had ophthalmoscopic alterations. Ten mothers (71.4%) of infants with ocular findings reported symptoms during the first trimester (frequency, 0.48; 95% CI, 0.02-0.67; P = .04). A difference was also observed between the groups of infants with and without ocular findings regarding the cephalic perimeter: mean (SD) of 28.8 (1.7) and 30.3 (1.5), respectively (frequency, -1.50; 95% CI, -2.56 to -0.51; P = .004).
   CONCLUSIONS AND RELEVANCE Ocular involvement in infants with presumed ZIKV congenital infection were more often seen in infants with smaller cephalic diameter at birth and in infants whose mothers reported symptoms during the first trimester.
C1 [Ventura, Camila V.; Travassos, Simone B.; Martins, Thayze T.; Patriota, Felipe; Nunes, Marcos Eugenio; Torres, Virginia L.; Ventura, Liana O.] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila V.; Travassos, Simone B.; Martins, Thayze T.; Patriota, Felipe; Nunes, Marcos Eugenio; Agra, Cristiana; Torres, Virginia L.; Ventura, Liana O.] Pernambucos Eye Hosp HOPE, Recife, PE, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Sao Paulo, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens, Jr.] Vis Inst, Sao Paulo, Brazil.
   [van der Linden, Vanessa] Barao de Lucena Hosp, Recife, PE, Brazil.
   [Ramos, Regina C.; Rocha, Maria Angela W.; Silva, Paula S.] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
RP Belfort, R (corresponding author), Escola Paulista Med, Dept Oftalmol, Rua Botucatu 831, BR-04023062 Sao Paulo, Brazil.
EM clinbelf@uol.com.br
RI Ventura, Camila V/N-2654-2018; Torres, Virginia/N-6951-2018; Ventura,
   Liana Vieira O/N-6151-2018; Maia, Mauricio/I-5892-2015
OI Ventura, Camila V/0000-0002-2927-4684; Torres,
   Virginia/0000-0002-3744-0961; Ventura, Liana Vieira
   O/0000-0001-6529-6883; Maia, Mauricio/0000-0002-7034-8091; Martins,
   Thayze/0000-0002-8082-2623; AGRA, CRISTIANA/0000-0002-4400-7744
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil Ministerio da Saude, PROT VIG RESP OC MIC
   Brasil - Ministerio da Saude, SAUD CONF 1 113 CAS
   Centers for Disease Control and Prevention, TRAV HLTH NOT
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8
   European Centre for Disease Prevention and Control, MICR BRAZ POT LINK Z
   Freitas B de Paula, 2016, JAMA OPHTHALMOL
   Kaur Savleen, 2013, Oman J Ophthalmol, V6, P77, DOI 10.4103/0974-620X.116622
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, N ENGL J MED
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura CV, 2014, ARQ BRAS OFTALMOL, V77, P300, DOI 10.5935/0004-2749.20140076
   World Health Organization, WHO DIR GEN SUMM OUT
   World Health Organization (WHO), EP AL NEUR SYNDR CON
   General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14, DOI 10.1001/jama.2013.281053
NR 26
TC 87
Z9 87
U1 0
U2 81
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2016
VL 134
IS 8
BP 912
EP 918
DI 10.1001/jamaophthalmol.2016.1784
PG 7
WC Ophthalmology
SC Ophthalmology
GA DT1AD
UT WOS:000381213200015
PM 27228275
OA Bronze
DA 2020-12-01
ER

PT J
AU Ventura, CV
   Maia, M
   Ventura, BV
   Linden, VVD
   Araojo, EB
   Ramos, RC
   Rocha, MAW
   Carvalho, DCG
   Belfort, R
   Ventura, LO
AF Ventura, Camila V.
   Maia, Mauricio
   Ventura, Bruna V.
   Linden, Vanessa V. D.
   Araojo, Eveline B.
   Ramos, Regina C.
   Rocha, Maria Angela W.
   Carvalho, Durce C. G.
   Belfort, Rubens, Jr.
   Ventura, Liana O.
TI Response letter: Serological evidence confirms the presumed diagnosis of
   Zika virus congenital infection in infants with microcephaly and ocular
   findings
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Letter
C1 [Ventura, Camila V.; Ventura, Bruna V.; Araojo, Eveline B.; Ventura, Liana O.] FAV, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Bruna V.; Araojo, Eveline B.; Ventura, Liana O.] Hosp Olhos HOPE, Recife, PE, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Ventura, Bruna V.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo UNIFESP, EPM, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Maia, Mauricio; Belfort, Rubens, Jr.] Inst Visiao, Sao Paulo, SP, Brazil.
   [Linden, Vanessa V. D.] Hosp Barao de Lucena, Recife, PE, Brazil.
   [Ramos, Regina C.; Rocha, Maria Angela W.; Carvalho, Durce C. G.] HUOC, Recife, PE, Brazil.
RP Belfort, R (corresponding author), Escola Paulista Med, Dept Oftalmol, Rua Botucatu 831, BR-04023062 Sao Paulo, SP, Brazil.
EM clinbelf@uol.com.br
RI Maia, Mauricio/I-5892-2015; Ventura, Bruna/N-2724-2018; Ventura, Liana
   Vieira/N-6151-2018
OI Maia, Mauricio/0000-0002-7034-8091; Ventura, Bruna/0000-0003-4333-3932;
   Ventura, Liana Vieira/0000-0001-6529-6883
CR Cugola F. R., 2016, NATURE
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura CV, 2016, JAMA IN PRESS
   Yakob L., 2016, LANCET GLOB HLTH
NR 5
TC 0
Z9 0
U1 0
U2 2
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JUL-AUG
PY 2016
VL 79
IS 4
BP 280
EP 280
PG 1
WC Ophthalmology
SC Ophthalmology
GA DX4EN
UT WOS:000384334100025
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Ventura, CV
   Maia, M
   Dias, N
   Ventura, LO
   Belfort, R
AF Ventura, Camila V.
   Maia, Mauricio
   Dias, Natalia
   Ventura, Liana O.
   Belfort, Rubens, Jr.
TI Zika: neurological and ocular findings in infant without microcephaly
SO LANCET
LA English
DT Letter
ID VIRUS
C1 [Ventura, Camila V.; Dias, Natalia; Ventura, Liana O.] Altino Ventura Fdn, Recife, PE, Brazil.
   [Maia, Mauricio; Belfort, Rubens, Jr.] HOPE Eye Hosp, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Sao Paulo, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] Vis Inst, Sao Paulo, Brazil.
RP Belfort, R (corresponding author), HOPE Eye Hosp, Recife, PE, Brazil.
EM clinbelf@uol.com.br
RI Ventura, Camila V/N-2654-2018; Ventura, Liana Vieira O/N-6151-2018;
   Maia, Mauricio/I-5892-2015
OI Ventura, Camila V/0000-0002-2927-4684; Ventura, Liana Vieira
   O/0000-0001-6529-6883; Maia, Mauricio/0000-0002-7034-8091
CR Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Organization W. H., 2016, WHO DIR GEN SUMM OUT
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, 2015, EP AL NEUR SYNDR CON
NR 5
TC 75
Z9 75
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 18
PY 2016
VL 387
IS 10037
BP 2502
EP 2502
DI 10.1016/S0140-6736(16)30776-0
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO7FG
UT WOS:000377947200018
PM 27287830
OA Bronze
DA 2020-12-01
ER

PT J
AU Freitas, BD
   Dias, JRD
   Prazeres, J
   Sacramento, GA
   Ko, AI
   Maia, M
   Belfort, R
AF Freitas, Bruno de Paula
   de Oliveira Dias, Joao Rafael
   Prazeres, Juliana
   Sacramento, Gielson Almeida
   Ko, Albert Icksang
   Maia, Mauricio
   Belfort, Rubens, Jr.
TI Ocular Findings in Infants With Microcephaly Associated With Presumed
   Zika Virus Congenital Infection in Salvador, Brazil
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID FRENCH-POLYNESIA; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION;
   DECEMBER 2013; DENGUE; PREGNANCY; OUTBREAK; OUTCOMES; FEVER
AB IMPORTANCE The Zika virus (ZIKV) has rapidly reached epidemic proportions, especially in northeastern Brazil, and has rapidly spread to other parts of the Americas. A recent increase in the prevalence of microcephaly in newborn infants and vision-threatening findings in these infants is likely associated with the rapid spread of ZIKV.
   OBJECTIVE To evaluate the ocular findings in infants with microcephaly associated with presumed intrauterine ZIKV infection in Salvador, Bahia, Brazil.
   DESIGN, SETTING, AND PARTICIPANTS Case series at a tertiary hospital. Twenty-nine infants with microcephaly (defined by a cephalic circumference of <= 32 cm) with a presumed diagnosis of congenital ZIKV were recruited through an active search and referrals from other hospitals and health unities. The study was conducted between December 1 and December 21, 2015.
   INTERVENTIONS All infants and mothers underwent systemic and ophthalmic examinations from December 1 through December 21, 2015, in the Roberto Santos General Hospital, Salvador, Brazil. Anterior segment and retinal, choroidal, and optic nerve abnormalities were documented using a wide-field digital imaging system. The differential diagnosis included toxoplasmosis, rubella, cytomegalovirus, herpes simplex virus, syphilis, and human immunodeficiency virus, which were ruled out through serologic and clinical examinations.
   MAIN OUTCOMES AND MEASURES Ocular abnormalities associated with ZIKV.
   RESULTS Twenty-three of 29 mothers (79.3%) reported suspected ZIKV infection signs and symptoms during pregnancy, 18 in the first trimester, 4 in the second trimester, and 1 in the third trimester. Of the 29 infants (58 eyes) examined (18 [62.1%] female), ocular abnormalities were present in 17 eyes (29.3%) of 10 children (34.5%). Bilateral findings were found in 7 of 10 patients presenting with ocular lesions, the most common of which were focal pigment mottling of the retina and chorioretinal atrophy in 11 of the 17 eyes with abnormalities (64.7%), followed by optic nerve abnormalities in 8 eyes (47.1%), bilateral iris coloboma in 1 patient (2 eyes [11.8%]), and lens subluxation in 1 eye (5.9%).
   CONCLUSIONS AND RELEVANCE Congenital infection due to presumed ZIKV exposure is associated with vision-threatening findings, which include bilateral macular and perimacular lesions as well as optic nerve abnormalities in most cases.
C1 [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [de Oliveira Dias, Joao Rafael; Prazeres, Juliana; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 822, BR-04023062 Sao Paulo, Brazil.
   [Sacramento, Gielson Almeida; Ko, Albert Icksang] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert Icksang] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 822, BR-04023062 Sao Paulo, Brazil.
EM clinbelf@uol.com.br
RI Maia, Mauricio/I-5892-2015; Ko, Albert Icksang/P-2343-2015; de Oliveira
   Dias, Joao/J-6735-2016
OI Maia, Mauricio/0000-0002-7034-8091; Ko, Albert
   Icksang/0000-0001-9023-2339; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Federal University of Sao Paulo (Paulista Medical School);
   Vision Institute (IPEPO); FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R01TW009504, R01TW009504,
   R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207] Funding Source: NIH
   RePORTER
FX Hospital Geral Roberto Santos provided the site and materials for
   ophthalmologic examination. Federal University of Sao Paulo (Paulista
   Medical School), Vision Institute (IPEPO), and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) provided funds for
   travel expenses as well as the materials necessary for the ocular
   examinations.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, MON CAS MICR BRAS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kelly JC, 2016, MEDSCAPE
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministerio da Saude, MICR 3174 CAS SAO IN
   Ministerio da Saude, NOT MED PER CEF DIAG
   Ministerio da Saude, MIN SAUD CONF REL EN
   Ministerio da Saude Secretaria de Vigilancia em Saude, PROT VIG RESP OC MIC
   Ministerio de Saude (MS), 2015, B EPIDEMIOL, V46, P1
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Stewart RD, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/351872
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization (WHO), EP AL NEUR SYNDR CON
   General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14, DOI 10.1001/jama.2013.281053
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 35
TC 136
Z9 140
U1 0
U2 97
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD MAY
PY 2016
VL 134
IS 5
BP 529
EP 535
DI 10.1001/jamaophthalmol.2016.0267
PG 7
WC Ophthalmology
SC Ophthalmology
GA DL7CB
UT WOS:000375796100014
PM 26865554
OA Green Published, Green Accepted, Bronze
DA 2020-12-01
ER

PT J
AU Commodaro, AG
   Chiasson, M
   Sundar, N
   Rizzo, LV
   Belfort, R
   Grigg, ME
AF Commodaro, Alessandra G.
   Chiasson, Melissa
   Sundar, Natarajan
   Rizzo, Luiz Vicente
   Belfort, Rubens, Jr.
   Grigg, Michael E.
TI Elevated Toxoplasma gondii Infection Rates for Retinas from Eye Banks,
   Southern Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID OCULAR TOXOPLASMOSIS; STRAINS
AB We found significantly higher incidence of Toxoplasma gondii DNA in eye bank specimens from Joinville in southern Brazil (13/15, 87%) than in Sao Paulo (3/42, 7%; p = 2.1 x 10E-8). PCR DNA sequence analysis was more sensitive at locus NTS2 than at locus 131; a high frequency of mixed co-infections was detected.
C1 [Commodaro, Alessandra G.; Chiasson, Melissa; Sundar, Natarajan; Grigg, Michael E.] NIH, Bldg 10, Bethesda, MD 20892 USA.
   [Commodaro, Alessandra G.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Rizzo, Luiz Vicente] Hosp Albert Einstein, Sao Paulo, Brazil.
RP Grigg, ME (corresponding author), NIAID, Parasit Dis Lab, 4 Ctr Dr,Rm B1-06, Bethesda, MD 20892 USA.
EM griggm@niaid.nih.gov
RI Rizzo, Luiz Vicente/B-4458-2009
OI Commodaro, Alessandra/0000-0002-7816-6508; Chiasson,
   Melissa/0000-0002-1880-3181
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID); Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [237252/2012]; FundaCao de Amparo a
   Perquisa do Estado de Sao Paulo; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [ZIAAI001017, ZIAAI001017,
   ZIAAI001017, ZIAAI001017, ZIAAI001017, ZIAAI001017, ZIAAI001017,
   ZIAAI001017, ZIAAI001017, ZIAAI001017, ZIAAI001017] Funding Source: NIH
   RePORTER
FX This work was supported in part by the National Institute of Allergy and
   Infectious Diseases, National Institutes of Health (to M.E.G.), Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (grant no.
   237252/2012), FundaCao de Amparo a Perquisa do Estado de Sao Paulo, and
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. R.B.J. and
   L.V.R. are researchers at Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico Brazil. M.E.G. is a scholar at the Canadian
   Institute for Advanced Research Integrated Microbial Biodiversity
   Program.
CR Aspinall TV, 2003, INT J PARASITOL, V33, P97, DOI 10.1016/S0020-7519(02)00230-8
   Fernandes GCVR, 2009, EPIDEMIOL INFECT, V137, P1809, DOI 10.1017/S0950268809002799
   Ferreira AIC, 2014, EPIDEMIOL INFECT, V142, P142, DOI 10.1017/S0950268813000526
   GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5
   Gouveia Enéias Bezerra, 2004, Arq. Bras. Oftalmol., V67, P139, DOI 10.1590/S0004-27492004000100025
   Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800
   Grigg ME, 2001, J CLIN MICROBIOL, V39, P398, DOI 10.1128/JCM.39.1.398-400.2001
   Guimaraes A. C. S., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P479, DOI 10.1590/S0036-46651993000600001
   Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040
   LUFT BJ, 1993, NEW ENGL J MED, V329, P995, DOI 10.1056/NEJM199309303291403
   McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258
   Pan ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045147
   Shobab L, 2013, J INFECT DIS, V208, P1520, DOI 10.1093/infdis/jit313
   Silveira C, 2001, AM J OPHTHALMOL, V131, P351, DOI 10.1016/S0002-9394(00)00830-8
   Vallochi AL, 2005, AM J OPHTHALMOL, V139, P350, DOI 10.1016/j.ajo.2004.07.040
NR 15
TC 8
Z9 8
U1 0
U2 7
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2016
VL 22
IS 4
BP 691
EP 693
DI 10.3201/eid2204.141819
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DH3LM
UT WOS:000372688500015
PM 26982526
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Carelli, V
   d'Adamo, P
   Valentino, ML
   La Morgia, C
   Ross-Cisneros, FN
   Caporali, L
   Maresca, A
   Polosa, PL
   Barboni, P
   De Negri, A
   Sadun, F
   Karanjia, R
   Salomao, SR
   Berezovsky, A
   Chicani, F
   Moraes, M
   Moraes, M
   Belfort, R
   Sadun, AA
AF Carelli, Valerio
   d'Adamo, Pio
   Valentino, Maria Lucia
   La Morgia, Chiara
   Ross-Cisneros, Fred N.
   Caporali, Leonardo
   Maresca, Alessandra
   Polosa, Paola Loguercio
   Barboni, Piero
   De Negri, Annamaria
   Sadun, Federico
   Karanjia, Rustum
   Salomao, Solange R.
   Berezovsky, Adriana
   Chicani, Filipe
   Moraes, Milton
   Moraes Filho, Milton
   Belfort, Rubens, Jr.
   Sadun, Alfredo A.
TI Parsing the differences in affected with LHON: genetic versus
   environmental triggers of disease conversion
SO BRAIN
LA English
DT Letter
ID HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL DYSFUNCTION; DNA; EXPRESSION;
   MUTATIONS; EXPOSURE; ALCOHOL; ONSET
C1 [Carelli, Valerio; Valentino, Maria Lucia; La Morgia, Chiara; Caporali, Leonardo; Maresca, Alessandra] Bellaria Hosp, IRCCS Ist Sci Neurol Bologna, Bologna, Italy.
   [Carelli, Valerio; Valentino, Maria Lucia; La Morgia, Chiara; Maresca, Alessandra] Univ Bologna, Neurol Unit, Dept Biomed & NeuroMotor Sci DIBINEM, Bologna, Italy.
   [d'Adamo, Pio] Univ Trieste, Med Genet, Dept Reprod Sci, Dev & Publ Hlth, Trieste, Italy.
   [d'Adamo, Pio] IRCCS Burlo Garofolo Children Hosp, Trieste, Italy.
   [Ross-Cisneros, Fred N.; Sadun, Alfredo A.] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA.
   [Polosa, Paola Loguercio] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.
   [Barboni, Piero] IRCCS Ist Sci San Raffaele, Milan, Italy.
   [De Negri, Annamaria] Azienda San Camillo Forlanini, Rome, Italy.
   [Sadun, Federico] Osped San Giovanni Evangelista, Tivoli, Italy.
   [Karanjia, Rustum; Sadun, Alfredo A.] Univ Calif Los Angeles, Dept Ophthalmol, David Geffen Sch Med, Los Angeles, CA USA.
   [Salomao, Solange R.; Berezovsky, Adriana; Chicani, Filipe; Belfort, Rubens, Jr.] Fed Univ Sao Paulo UNIFESP, Dept Ophthalmol, Sao Paulo, Brazil.
   [Moraes, Milton; Moraes Filho, Milton] Inst Olhos Colatina, Colatina, Brazil.
RP Carelli, V (corresponding author), Univ Bologna, Neurogenet Lab, Bellaria Hosp, IRCCS Inst Neurol Sci Bologna,Dept Biomed & Neuro, Via Altura 3, I-40139 Bologna, Italy.; Sadun, AA (corresponding author), UCLA, Doheny Eye Ctr, 800 Fairmount Ave, Pasadena, CA 91105 USA.
EM valerio.carelli@unibo.it; alfredo.sadun@gmail.com
RI Berezovsky, Adriana/F-2341-2013; Salomao, Solange R/G-9500-2012;
   Maresca, Alessandra/J-7393-2016; Caporali, Leonardo/J-7398-2016;
   d'Adamo, Adamo Pio/G-4064-2011; La Morgia, Chiara/H-6765-2012; Barboni,
   Piero/AAA-9936-2020; sadun, federico/AAF-6588-2019
OI Berezovsky, Adriana/0000-0001-6350-8221; Salomao, Solange
   R/0000-0002-3436-5599; Maresca, Alessandra/0000-0002-8959-8832;
   Caporali, Leonardo/0000-0002-0666-4380; d'Adamo, Adamo
   Pio/0000-0001-9367-4909; Barboni, Piero/0000-0002-0118-4177; 
FU NEI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [EY03040] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040] Funding Source: NIH RePORTER
CR Amaral-Fernandes MS, 2011, MOL VIS, V17, P3175
   Barboni P, 2006, INVEST OPHTH VIS SCI, V47, P5303, DOI 10.1167/iovs.06-0520
   Bianco A, 2016, BRAIN, V139, DOI 10.1093/brain/awv216
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2
   Carelli V, 2007, ENVIRON HEALTH PERSP, V115, P113, DOI 10.1289/ehp.9245
   Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180
   CULLOM ME, 1993, ARCH OPHTHALMOL-CHIC, V111, P1482, DOI 10.1001/archopht.1993.01090110048021
   Dimitriadis K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0158-9
   Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Giordano L, 2015, CELL DEATH IN PRESS
   Giraudet S, 2011, BRIT J OPHTHALMOL, V95, P887, DOI 10.1136/bjo.2009.161539
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155
   Luca CC, 2004, MITOCHONDRION, V4, P31, DOI 10.1016/j.mito.2004.05.002
   Mackey DA, 2003, EYE, V17, P312, DOI 10.1038/sj.eye.6700362
   Miro O, 1999, CARCINOGENESIS, V20, P1331, DOI 10.1093/carcin/20.7.1331
   Newman NJ, 2009, BRAIN, V132, P2306, DOI 10.1093/brain/awp195
   Rua EDO, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0105-z
   Sadun A, 1998, Trans Am Ophthalmol Soc, V96, P881
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sanchez RN, 2006, J NEURO-OPHTHALMOL, V26, P268, DOI 10.1097/01.wno.0000249320.27110.ab
   Seo JH, 2010, CLIN EXP OPHTHALMOL, V38, P363, DOI 10.1111/j.1442-9071.2010.02240.x
   Shah VA, 2008, SURV OPHTHALMOL, V53, P403, DOI 10.1016/j.survophthal.2008.04.003
   Yu-Wai-Man P, 2008, J NEURO-OPHTHALMOL, V28, P155, DOI 10.1097/WNO.0b013e3181772db4
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
NR 31
TC 7
Z9 7
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD MAR 1
PY 2016
VL 139
AR e17
DI 10.1093/brain/awv339
PN 3
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DF9PX
UT WOS:000371694600003
PM 26657166
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Ventura, CV
   Maia, M
   Bravo-Filho, V
   Gois, AL
   Belfort, R
AF Ventura, Camila V.
   Maia, Mauricio
   Bravo-Filho, Vasco
   Gois, Adriana L.
   Belfort, Rubens, Jr.
TI Zika virus in Brazil and macular atrophy in a child with microcephaly
SO LANCET
LA English
DT Letter
C1 [Ventura, Camila V.; Bravo-Filho, Vasco; Gois, Adriana L.] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Bravo-Filho, Vasco; Gois, Adriana L.] HOPE Eye Hosp, Recife, PE, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
EM clinbelf@uol.com.br
RI Maia, Mauricio/I-5892-2015; Ventura, Camila V/N-2654-2018; Filho,
   Vasco/N-6993-2018
OI Maia, Mauricio/0000-0002-7034-8091; Ventura, Camila
   V/0000-0002-2927-4684; Filho, Vasco/0000-0003-4460-3236; Gois,
   Adriana/0000-0001-5542-1097
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Brazil Ministry of Health, MICR MIN HLTH REL EP
   Brazil Ministry of Health, MIN SAUD CONF REL EN
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   World Health Organization (WHO), EP AL NEUR SYNDR CON
NR 5
TC 324
Z9 337
U1 0
U2 187
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JAN 16
PY 2016
VL 387
IS 10015
BP 228
EP 228
DI 10.1016/S0140-6736(16)00006-4
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DA9LQ
UT WOS:000368130700028
PM 26775125
OA Bronze
DA 2020-12-01
ER

PT J
AU Ventura, C
   Maia, M
   Martins, T
   Patriota, F
   Agra, C
   Ventura, L
   Belfort, R
AF Ventura, Camila
   Maia, Mauricio
   Martins, Thayze
   Patriota, Felipe
   Agra, Cristiana
   Ventura, Liana
   Belfort, Rubens, Jr.
TI Variables Related to the Ophthalmoscopic Findings Identified in Infants
   with Presumed Zika Virus Congenital Infection
SO OPHTHALMOLOGICA
LA English
DT Meeting Abstract
RI Maia, Mauricio/I-5892-2015
OI Maia, Mauricio/0000-0002-7034-8091
NR 0
TC 0
Z9 0
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3755
EI 1423-0267
J9 OPHTHALMOLOGICA
JI Ophthalmologica
PY 2016
VL 236
SU 1
MA 69
BP 33
EP 33
PG 1
WC Ophthalmology
SC Ophthalmology
GA DX3HO
UT WOS:000384264400070
DA 2020-12-01
ER

PT J
AU Vianna, LMM
   Li, HD
   Holiman, JD
   Stoeger, C
   Belfort, R
   Jun, AS
AF Monteiro Vianna, Lucas Monferrari
   Li, Hao-Dong
   Holiman, Jeffrey D.
   Stoeger, Christopher
   Belfort, Rubens, Jr.
   Jun, Albert S.
TI Characterization of cryopreserved primary human corneal endothelial
   cells cultured in human serum-supplemented media
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Cryopreservation; Cornea; Endothelium; Corneal; Cell culture techniques;
   Culture media
ID PROLIFERATIVE CAPACITY; TRANSPLANTATION
AB Purpose: To compare cryopreserved human corneal endothelial cells (HCECs) grown in human serum-supplemented media (HS-SM) with cryopreserved HCECs grown in fetal bovine serum-supplemented media (FBS-SM).
   Methods: Three pairs of human corneas from donors aged 8, 28, and 31 years were obtained from the eye bank. From each pair, one cornea was used to start a HCEC culture using HS-SM; the other cornea was grown in FBS-SM. On reaching confluence, the six cell populations were frozen using 10% dimethyl sulfoxide-containing medium. Thawed cells grown in HS-SM were compared with those grown in FBS-SM with respect to morphology, growth curves, immunohistochemistry, real time-reverse transcriptase polymerase chain reaction (RT-PCR) for endothelial cell markers, and detachment time.
   Results: No difference in morphology was observed for cells grown in the two media before or after cryopreservation. By growth curves, cell counts after thawing were similar in both media, with a slight trend toward higher cell counts in FBS-SM. Cells grown in both the media demonstrated a similar expression of endothelial cell markers when assessed by immunohistochemistry, although HCEC marker gene expression was higher in cells grown in HS-SM than in those grown in FBS-SM as assessed by RT-PCR. With FBS-SM, there was a tendency of longer detachment time and lower cell passages.
   Conclusions: HS-SM was similar to FBS-SM for cryopreservation of cultured HCECs as assessed by analysis of cell morphology, proliferation, and protein expression, although marker gene expression was higher in cells grown in HS-SM than in those grown in FBS-SM. Detachment time was longer with FBS-SM and in lower passages.
C1 [Monteiro Vianna, Lucas Monferrari; Li, Hao-Dong; Jun, Albert S.] Johns Hopkins Univ, Wilmer Eye Inst, Cornea & Anterior Segment Serv, Baltimore, MD 21218 USA.
   [Monteiro Vianna, Lucas Monferrari; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Escola Paulista Med, Ophhtalmol & Vis Sci Dept, Sao Paulo, SP, Brazil.
   [Monteiro Vianna, Lucas Monferrari] Univ Estado Rio De Janeiro, Hosp Univ Pedro Ernesto, Dept Ophthalmol, Rio De Janeiro, RJ, Brazil.
   [Holiman, Jeffrey D.; Stoeger, Christopher] Lions VisionGift, Portland, OR USA.
   [Monteiro Vianna, Lucas Monferrari] Rua Botucatu 821, BR-04023900 Sao Paulo, SP, Brazil.
RP Vianna, LMM (corresponding author), Rua Botucatu 821, BR-04023900 Sao Paulo, SP, Brazil.
EM lucasmmvianna@yahoo.com.br
FU Brazilian government CAPES Foundation; State University of Rio de
   Janeiro
FX The authors acknowledge the Brazilian government CAPES Foundation and
   State University of Rio de Janeiro for supporting Dr. Vianna's research
   fellowship, Norman Barker, MS, for assistance with the figures, and
   Lions VisionGift (Portland, OR) and the Alabama Eye Bank (Birmingham,
   AL) for providing corneas.
CR BONANNO JA, 1992, INVEST OPHTH VIS SCI, V33, P3058
   Brunette I, 2001, CORNEA, V20, P590, DOI 10.1097/00003226-200108000-00007
   Dapena I, 2009, CURR OPIN OPHTHALMOL, V20, P299, DOI 10.1097/ICU.0b013e32832b8d18
   Engelmann K, 2004, EXP EYE RES, V78, P573, DOI 10.1016/S0014-4835(03)00209-4
   Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014
   Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4
   Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298
   Koizumi N, 2012, EXP EYE RES, V95, P60, DOI 10.1016/j.exer.2011.10.014
   Mimura T, 2007, CURR EYE RES, V32, P617, DOI 10.1080/02713680701530589
   Okumura N, 2014, CORNEA, V33, pS37, DOI 10.1097/ICO.0000000000000229
   Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01
   Ple-Plakon PA, 2014, CURR OPIN OPHTHALMOL, V25, P300, DOI 10.1097/ICU.0000000000000080
   Proulx S, 2012, EXP EYE RES, V95, P68, DOI 10.1016/j.exer.2011.06.013
   STOCKER FW, 1958, AM J OPHTHALMOL, V46, P294, DOI 10.1016/0002-9394(58)90811-0
   Suh LH, 2007, INVEST OPHTH VIS SCI, V48, P3056, DOI 10.1167/iovs.06-0771
   Vianna LM, 2014, BR J OPHTHALMOL, P1
   Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814
NR 17
TC 4
Z9 4
U1 0
U2 9
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JAN-FEB
PY 2016
VL 79
IS 1
BP 37
EP 41
DI 10.5935/0004-2749.20160011
PG 5
WC Ophthalmology
SC Ophthalmology
GA DD1BS
UT WOS:000369656700011
PM 26840165
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Ventura, CV
   Maia, M
   Ventura, BV
   Van Der Linden, V
   Araujo, EB
   Ramos, RC
   Rocha, MAW
   Carvalho, MDCG
   Belfort, R
   Ventura, LO
AF Ventura, Camila V.
   Maia, Mauricio
   Ventura, Bruna V.
   Van Der Linden, Vanessa
   Araujo, Eveline B.
   Ramos, Regina C.
   Rocha, Maria Angela W.
   Carvalho, Maria Durce C. G.
   Belfort, Rubens, Jr.
   Ventura, Liana O.
TI Ophthalmological findings in infants with microcephaly and presumable
   intra-uterus Zika virus infection
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Microcephaly; Zika virus; Ocular findings; Vertical transmission; Retina
AB Purpose: In 2015, a twenty-fold increase in the prevalence of microcephaly in Brazil was reported, and the Ministry of Health associated this abnormal prevalence with the maternal-fetal Zika virus (ZIKV) transmission.
   Methods: We assessed the ophthalmological findings of ten mothers and their infants that had been clinically diagnosed with ZIKV-related microcephaly and presented ocular abnormalities, born from May to December 2015.
   Results: Seven mothers (70.0%) referred symptoms during pregnancy (malaise, rash and arthralgia), of which six (85.7%) were in the first trimester. At the time of exam, no ophthalmological abnormalities were identified in the mothers and they did not report ocular symptoms during pregnancy. Serology was negative in all infants for Toxoplasmosis, Rubella, Cytomegalovirus, Syphilis and Human Immunodeficiency Viruses. Ocular findings included macular alterations (gross pigment mottling and/or chorioretinal atrophy) in fifteen eyes (75.0%), and optic nerve abnormalities (hypoplasia with double-ring sign, pallor, and/or increased cup-to-disk ratio) in nine eyes (45.0%).
   Conclusions: Patients presented normal anterior segment and important macular and optic nerve abnormalities. Further studies will assess the visual significance of these alterations.
C1 [Ventura, Camila V.; Ventura, Bruna V.; Araujo, Eveline B.; Ventura, Liana O.] FAV, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Bruna V.; Araujo, Eveline B.; Ventura, Liana O.] Hosp Olhos Pernambuco HOPE, Recife, PE, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Ventura, Bruna V.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo UNIFESP, EPM, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Van Der Linden, Vanessa] Hosp Barao de Lucena, Recife, PE, Brazil.
   [Ramos, Regina C.; Rocha, Maria Angela W.; Carvalho, Maria Durce C. G.] HUOC, Recife, PE, Brazil.
RP Belfort, R (corresponding author), Escola Paulista Med, Dept Oftalmol, Rua Botucatu 831, BR-04023062 Sao Paulo, SP, Brazil.
EM clinbelf@uol.com.br
RI Ventura, Camila V/N-2654-2018; Ventura, Bruna/N-2724-2018; Maia,
   Mauricio/I-5892-2015; Ventura, Liana Vieira O/N-6151-2018
OI Ventura, Camila V/0000-0002-2927-4684; Ventura,
   Bruna/0000-0003-4333-3932; Maia, Mauricio/0000-0002-7034-8091; Ventura,
   Liana Vieira O/0000-0001-6529-6883
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BRASIL. Ministerio do Planejamento Orcamento e Gestao. Instituto Brasileiro de Geografia e Estatistica (IBGE), 2015, PROT VIG RESP OC MIC, P1
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias (COES), 2015, INF EP SEM EP, V47
   GORDON RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P785
   Kaur Savleen, 2013, Oman J Ophthalmol, V6, P77, DOI 10.4103/0974-620X.116622
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Ventura CV, 2015, LANCET
NR 9
TC 167
Z9 175
U1 2
U2 171
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JAN-FEB
PY 2016
VL 79
IS 1
BP 1
EP 3
DI 10.5935/0004-2749.20160002
PG 3
WC Ophthalmology
SC Ophthalmology
GA DD1BS
UT WOS:000369656700002
PM 26840156
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Valim, V
   Trevisani, VFM
   de Sousa, JM
   Vilela, V
   Belfort, R
AF Valim, Valeria
   Moca Trevisani, Virginia Fernandes
   de Sousa, Jacqueline Martins
   Vilela, Vernica Silva
   Belfort, Rubens, Jr.
TI Current Approach to Dry Eye Disease
SO CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
LA English
DT Review
DE Dry eye disease; Sjogren's syndrome; Cornea; Ocular surface
ID PRIMARY SJOGRENS-SYNDROME; AUTOLOGOUS SERUM EYEDROPS; QUALITY-OF-LIFE;
   KERATOCONJUNCTIVITIS SICCA; OCULAR SURFACE; DOUBLE-BLIND; ARTIFICIAL
   TEARS; ROSE-BENGAL; SODIUM HYALURONATE; STAINING CHARACTERISTICS
AB Dry eye disease (DED) is a multifactorial disease of the tears and ocular surface that causes tear film instability with potential damage to the ocular surface. The prevalence of dry eye in the world population ranges from 6 to 34 %. It is more common in those aged over 50, and affects mainly women. Since the introduction of the Schirmer's test in 1903, other tests have been developed to evaluate dry eye, such as biomicroscopy, the tear film breakup time (BUT), vital dyes (lissamine green and rose bengal), fluorescein, leaf fern test, corneal sensitivity test, conjunctiva impression cytology, optical coherence tomography (OCT), and tear osmolarity measurement. Although there is no gold standard, it is advisable to combine at least two tests. Strategies for treating DED have recently been modified and include patient education, tear substitute, corticosteroids, secretagogues, fatty acids, immunomodulators, occlusion of lacrimal puncta surgery and, tarsorrhaphy. Biological therapy and new topical immunomodulators such as tacrolimus, tofacitinib and IL-1 receptor inhibitor are being tested. In this review, the evaluation tests for dry eye are compared and the main studies on treatment are presented, with emphasis on studies in patients with Sjogren's syndrome. The authors propose an approach for the management of dry eye.
C1 [Valim, Valeria] Univ Fed Espirito Santo, Ctr Referencia Doencas Reumat, Serv Reumatol, Hosp Univ Cassiano Antonio de Moraes, BR-29040091 Vitoria, ES, Brazil.
   [Moca Trevisani, Virginia Fernandes] Univ Fed Sao Paulo, Disciplina Med Urgencia & Med Baseada Evidencias, BR-04023062 Sao Paulo, SP, Brazil.
   [Moca Trevisani, Virginia Fernandes] Univ Santo Amaro, Sao Paulo, SP, Brazil.
   [de Sousa, Jacqueline Martins; Belfort, Rubens, Jr.] Escola Paulista Med, Dept Oftalmol & Ciencias Visuais, BR-04023062 Sao Paulo, SP, Brazil.
   [Vilela, Vernica Silva] Univ Estado Rio de Janeiro, Disciplina Reumatol, BR-20551900 Rio De Janeiro, RJ, Brazil.
   [Valim, Valeria; Moca Trevisani, Virginia Fernandes; Vilela, Vernica Silva] Brazilian Soc Rheumatol, Sci Comm Sjogrens Syndrome, BR-01402000 Sao Paulo, SP, Brazil.
RP Valim, V (corresponding author), Brazilian Soc Rheumatol, Sci Comm Sjogrens Syndrome, Av Brigadeiro Luis Antonio 2466, BR-01402000 Sao Paulo, SP, Brazil.
EM val.valim@gmail.com
RI Trevisani, Virginia FM/B-4423-2015; trevisani, Virginia Fernandes
   Moca/I-1137-2013; Trevisani, Virginia/AAI-5225-2020
OI Trevisani, Virginia FM/0000-0001-8881-9106; trevisani, Virginia
   Fernandes Moca/0000-0002-7180-6285; Trevisani,
   Virginia/0000-0002-7180-6285
CR Adatia FA, 2004, CAN J OPHTHALMOL, V39, P767, DOI 10.1016/S0008-4182(04)80071-1
   Adler S, 2013, ARTHRIT CARE RES, V65, P1862, DOI 10.1002/acr.22052
   Alves M, 2013, OCUL SURF, V11, P181, DOI 10.1016/j.jtos.2013.02.002
   Aragona P, 2002, BRIT J OPHTHALMOL, V86, P181, DOI 10.1136/bjo.86.2.181
   Aragona P, 2005, INVEST OPHTH VIS SCI, V46, P4474, DOI 10.1167/iovs.04-1394
   Aragona P, 2013, EUR J OPHTHALMOL, V23, P368, DOI 10.5301/ejo.5000229
   Baudouin C, 2014, BRIT J OPHTHALMOL, V98, P1168, DOI 10.1136/bjophthalmol-2013-304619
   Begley C, 2013, INVEST OPHTH VIS SCI, V54, P2645, DOI 10.1167/iovs.12-11299
   Behrens A, 2006, CORNEA, V25, P900, DOI 10.1097/01.ico.0000214802.40313.fa
   Bourcier T, 2005, INVEST OPHTH VIS SCI, V46, P2341, DOI 10.1167/iovs.04-1426
   Bowman SJ, 2003, J RHEUMATOL, V30, P1259
   Brignole F, 2005, GRAEF ARCH CLIN EXP, V243, P531, DOI 10.1007/s00417-004-1040-6
   Bron AJ, 2014, OCUL SURF, V12, pS1, DOI 10.1016/j.jtos.2014.02.002
   Caffery B, 2010, INVEST OPHTH VIS SCI, V51, P2381, DOI 10.1167/iovs.09-4188
   Carubbi F, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4359
   COCHET P, 1961, Bull Soc Ophtalmol Fr, V6, P541
   Barboza MNC, 2008, ARQ BRAS OFTALMOL, V71, P547, DOI 10.1590/S0004-27492008000400015
   Cosar CB, 2001, CORNEA, V20, P787, DOI 10.1097/00003226-200111000-00002
   Dart J, 1997, BRIT J OPHTHALMOL, V81, P930, DOI 10.1136/bjo.81.11.930
   Davies JB, 2008, CURR OPIN RHEUMATOL, V19, P178
   de Monchy I, 2011, INVEST OPHTH VIS SCI, V52, P5167, DOI 10.1167/iovs.10-6671
   Devauchelle-Pensec V, 2010, ARTHRITIS RHEUM-US, V62, P2262, DOI 10.1002/art.27509
   Farrell J, 2003, OPHTHAL PHYSL OPT, V23, P1, DOI 10.1046/j.1475-1313.2003.00081.x
   FEENSTRA RPG, 1992, OPHTHALMOLOGY, V99, P605
   Felberg Sergio, 2006, Arq. Bras. Oftalmol., V69, P959, DOI 10.1590/S0004-27492006000600032
   Fenner BJ, 2013, INVEST OPHTH VIS SCI, V54, P8013, DOI 10.1167/iovs.13-12802
   Fife RS, 2002, ARCH INTERN MED, V162, P1293, DOI 10.1001/archinte.162.11.1293
   Fonseca EC, 2010, ARQ BRAS OFTALMOL, V73, P197, DOI 10.1590/S0004-27492010000200021
   Foulks GN, 2014, AM J OPHTHALMOL, V157, P1122, DOI 10.1016/j.ajo.2014.03.002
   FOX PC, 1993, CLIN EXP RHEUMATOL, V11, P149
   Fox R, 2012, WOLTERS KLUWER HLTH, V7, P210
   FOX RI, 1984, ARTHRITIS RHEUM, V27, P459, DOI 10.1002/art.1780270415
   FOX RI, 1992, RHEUM DIS CLIN N AM, V18, P517
   FOX RI, 1994, INT OPHTHALMOL CLIN, V34, P71, DOI 10.1097/00004397-199403410-00008
   FOX RI, 1988, AM J MED, V85, P62, DOI 10.1016/0002-9343(88)90365-8
   Galor A, 2014, OPHTHALMOLOGY, V121, P972, DOI 10.1016/j.ophtha.2013.11.036
   GUNDUZ K, 1994, ACTA OPHTHALMOL, V72, P438
   Hamrah P, 2011, EYE, V25, P1429, DOI 10.1038/eye.2011.184
   Hohenstein-Blaul NVU, 2013, EXP EYE RES, V117, P126, DOI 10.1016/j.exer.2013.07.015
   Huang JF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.017
   Kanellopoulos AJ, 2014, AM J OPHTHALMOL, V157, P63, DOI 10.1016/j.ajo.2013.08.025
   Kassan SS, 2004, ARCH INTERN MED, V164, P1275, DOI 10.1001/archinte.164.12.1275
   Kheirkhah A, 2011, EYE, V25, P871, DOI 10.1038/eye.2011.75
   KLAASSENBROEKEMA N, 1992, NETH J MED, V40, P113
   Knezovic I, 2011, COLLEGIUM ANTROPOL, V35, P1105
   Koffler BH, 2006, OCUL SURF, V4, P188, DOI 10.1016/S1542-0124(12)70165-9
   Kojima T, 2005, AM J OPHTHALMOL, V139, P242, DOI 10.1016/j.ajo.2004.08.040
   KRUIZE AA, 1993, ANN RHEUM DIS, V52, P360, DOI 10.1136/ard.52.5.360
   Lee GA, 2008, CLIN EXP OPHTHALMOL, V36, P119, DOI 10.1111/j.1442-9071.2008.01680.x
   Lee JH, 2014, YONSEI MED J, V55, P203, DOI 10.3349/ymj.2014.55.1.203
   Lee JH, 2011, CORNEA, V30, P175, DOI 10.1097/ICO.0b013e3181e9adcc
   Lee MS, 2011, ACTA OPHTHALMOL, V89, P101, DOI 10.1111/j.1755-3768.2009.01855.x
   Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003
   Lemp MA, 1982, INT OPHTHALMOL CLIN, V13, P97
   Lemp MA, 2007, OCUL SURF, V5, P75
   Lemp MA, 2012, CORNEA, V31, P472, DOI 10.1097/ICO.0b013e318225415a
   Leung KCM, 2008, CLIN RHEUMATOL, V27, P429, DOI 10.1007/s10067-007-0723-x
   Liu L, 2005, GRAEF ARCH CLIN EXP, V243, P706, DOI 10.1007/s00417-004-1106-5
   Manning FJ, 1995, OPHTHALMOLOGY, V102, P1953, DOI 10.1016/S0161-6420(95)30769-5
   MANTHORPE R, 1984, RHEUMATOL INT, V4, P165, DOI 10.1007/BF00541208
   Mariette X, 2004, ARTHRITIS RHEUM, V50, P1270, DOI 10.1002/art.20146
   Mariette X, 2015, ANN RHEUM DIS, V74, P526, DOI 10.1136/annrheumdis-2013-203991
   MCDONNELL PJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P1423
   Meijer JM, 2010, ARTHRITIS RHEUM-US, V62, P960, DOI 10.1002/art.27314
   Meiners PM, 2014, ANN RHEUM DIS, V73, P1393, DOI 10.1136/annrheumdis-2013-204653
   Oden NL, 1998, ADV EXP MED BIOL, V438, P807
   Okanobo A, 2012, AM J OPHTHALMOL, V154, P63, DOI 10.1016/j.ajo.2012.01.034
   Ono M, 2004, AM J OPHTHALMOL, V138, P6, DOI 10.1016/j.ajo.2004.02.010
   OXHOLM P, 1986, SCAND J RHEUMATOL, V15, P103, DOI 10.3109/03009748609102073
   Papas AS, 2004, JCR-J CLIN RHEUMATOL, V10, P169, DOI 10.1097/01.rhu.0000135553.08057.21
   Paulsen AJ, 2014, AM J OPHTHALMOL, V157, P799, DOI 10.1016/j.ajo.2013.12.023
   Petrone D, 2002, ARTHRITIS RHEUM, V46, P748, DOI 10.1002/art.510
   Pinheiro Jr. Manuel Neuzimar, 2007, Arq. Bras. Oftalmol., V70, P649, DOI 10.1590/S0004-27492007000400016
   Poon AC, 2001, BRIT J OPHTHALMOL, V85, P1188, DOI 10.1136/bjo.85.10.1188
   Qiu WQ, 2013, RHEUMATOL INT, V33, P2543, DOI 10.1007/s00296-013-2769-1
   Quinto GG, 2008, ARQ BRAS OFTALMOL, V71, P47, DOI 10.1590/S0004-27492008000700010
   Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014
   Rolando M, 2009, J OCUL PHARMACOL TH, V25, P271, DOI 10.1089/jop.2008.0026
   Rosenberg GJ, 2000, PLAST RECONSTR SURG, V106, P721, DOI 10.1097/00006534-200009030-00034
   Salib GM, 2006, J CATARACT REFR SURG, V32, P772, DOI 10.1016/j.jcrs.2005.10.034
   Sall K, 2000, OPHTHALMOLOGY, V107, P631, DOI 10.1016/S0161-6420(99)00176-1
   Sall Ken N, 2006, Eye Contact Lens, V32, P21, DOI 10.1097/01.icl.0000170599.57728.29
   Sankar V, 2004, ARTHRITIS RHEUM-US, V50, P2240, DOI 10.1002/art.20299
   Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103
   Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615
   Schirmer O, 1903, ALBRECH GRAEFES ARCH, V56, P197, DOI 10.1007/BF01946264
   Smith JA, 2007, OCUL SURF, V5, P93
   TABBARA KF, 1982, OPHTHALMOLOGY, V89, P712
   Tananuvat N, 2001, CORNEA, V20, P802, DOI 10.1097/00003226-200111000-00005
   Theander E, 2002, SCAND J RHEUMATOL, V31, P72, DOI 10.1080/03009740252937577
   Utine CA, 2011, CURR EYE RES, V36, P683, DOI 10.3109/02713683.2011.571357
   van Landingham SW, 2014, BRIT J OPHTHALMOL, V98, P639, DOI 10.1136/bjophthalmol-2013-303518
   Versura P, 2007, EYE, V21, P229, DOI 10.1038/sj.eye.6702204
   VITALI C, 1994, ANN RHEUM DIS, V53, P637, DOI 10.1136/ard.53.10.637
   Waszczykowska A, 2013, ARCH MED SCI, V9, P1107, DOI 10.5114/aoms.2013.39217
   Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013
   Yavuz B, 2012, SCI WORLD J, DOI 10.1100/2012/194848
   Yavuz S, 2011, RHEUMATOL INT, V31, P1045, DOI 10.1007/s00296-010-1415-4
   Zeev MSB, 2014, CLIN OPHTHALMOL, V8, P581, DOI 10.2147/OPTH.S45444
NR 99
TC 30
Z9 30
U1 1
U2 40
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1080-0549
EI 1559-0267
J9 CLIN REV ALLERG IMMU
JI Clin. Rev. Allergy Immunol.
PD DEC
PY 2015
VL 49
IS 3
BP 288
EP 297
DI 10.1007/s12016-014-8438-7
PG 10
WC Allergy; Immunology
SC Allergy; Immunology
GA CX0WZ
UT WOS:000365419400004
PM 25081064
DA 2020-12-01
ER

PT J
AU Nascimento, H
   Yasuta, MK
   Marquezan, MC
   Salomao, GHA
   Gonzalez, D
   Francesconi, C
   Muccioli, C
   Belfort, R
AF Nascimento, Heloisa
   Yasuta, Mariana Kaori
   Marquezan, Maria Carolina
   Araujo Salomao, Gustavo Henrique
   Gonzalez, Delia
   Francesconi, Claudia
   Muccioli, Cristina
   Belfort, Rubens, Jr.
TI Uveitic band keratopathy: child and adult
SO JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION
LA English
DT Article
ID PHOTOTHERAPEUTIC KERATECTOMY
AB Background: Calcified band keratopathy is a chronic degenerative disease characterized by the deposition of gray to white opacity in superficial layers of the cornea that typically develops over months or years. It is associated with a variety of conditions, including chronic uveitis.
   Purpose: The objective of this study is to assess visual acuity and corneal changes in patients with band keratopathy secondary to uveitis who underwent phototherapeutic keratectomy (PTK).
   Setting: The place where this study was performed was in the Department of Ophthalmology and Visual Sciences, Federal University of Sao Paulo.
   Design: This is a retrospective study.
   Methods: Patients with uveitic band keratopathy were submitted to PTK. The PTK was performed using Allegreto Wave EX500, with the ablation area of 6 mm.
   Results: Twelve patients (13 eyes) diagnosed with band keratopathy secondary to chronic uveitis were analyzed. Of the 12 patients, 8 patients were female (66 %), aged 22 years (7-53 years). From the 12 patients (13 eyes) evaluated in this study, only one patient (one eye) did not have visual improvement, due to epithelial deposits 2 weeks after PTK, and all the others benefited with the procedure. In the children group, all eyes had visual improvement, and quantitatively speaking, the children had a more significant improvement than adults.
   Conclusions: PTK is a safe and effective procedure even for children. However, the improvement in visual acuity was restricted due to other ocular changes secondary to uveitis, such as cataract and retinal changes, or even the corneal irregularity.
C1 [Nascimento, Heloisa; Yasuta, Mariana Kaori; Marquezan, Maria Carolina; Araujo Salomao, Gustavo Henrique; Gonzalez, Delia; Francesconi, Claudia; Muccioli, Cristina; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
RP Nascimento, H (corresponding author), Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
EM helomn@gmail.com
RI Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317
CR Galor A, 2008, CLIN OPHTHALMOL, V2, P645
   Jhanji V, 2011, CURR OPIN OPHTHALMOL, V22, P283, DOI 10.1097/ICU.0b013e3283477d36
   Kollias AN, 2007, J REFRACT SURG, V23, P703
   Moisseiev E, 2013, J CATARACT REFR SURG, V39, P292, DOI 10.1016/j.jcrs.2012.12.020
   Rathi VM, 2012, INDIAN J OPHTHALMOL, V60, P5, DOI 10.4103/0301-4738.91335
   Rathi VM, 2010, CORNEA, V29, P1109, DOI 10.1097/ICO.0b013e3181d14288
   Stewart OG, 2003, EYE, V17, P233, DOI 10.1038/sj.eye.6700327
NR 7
TC 5
Z9 6
U1 0
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1869-5760
J9 J OPHTHALMIC INFLAMM
JI J. Ophthalmic Inflamm. Infect.
PD NOV 21
PY 2015
VL 5
AR 35
DI 10.1186/s12348-015-0062-z
PG 4
WC Ophthalmology
SC Ophthalmology
GA DQ5FF
UT WOS:000379229700002
PM 26590046
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU dos Santos, FF
   Nascimento, H
   Muccioli, C
   da Costa, DF
   Rizzo, LV
   Commodaro, AG
   Belfort, R
AF dos Santos, Fabio Felipe
   Nascimento, Heloisa
   Muccioli, Cristina
   da Costa, Deise Fialho
   Rizzo, Luiz Vicente
   Commodaro, Alessandra Goncalves
   Belfort, Rubens, Jr.
TI Detection of Toxoplasma gondii DNA in peripheral blood and aqueous humor
   of patients with Toxoplasmic active focal necrotizing retinochoroiditis
   using real-time PCR
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Toxoplasmosis, ocular/diagnosis; Toxoplasma; Blood/parasitology;
   Choroiditis; Real-time polymerase techniques/methods; Aqueous humor
ID POLYMERASE-CHAIN-REACTION; OCULAR TOXOPLASMOSIS; DIAGNOSIS; UVEITIS;
   SAMPLES; ASSAYS; INFECTION; RETINITIS; BRAZIL
AB Purpose: To evaluate the ability of real-time quantitative PCR (qPCR) for detecting Toxoplasma gondii DNA in the peripheral blood and aqueous humor of patients with toxoplasmic active focal necrotizing retinochoroiditis.
   Methods: Fifty-five patients with infectious uveitis seen from 2009 to 2013 at the Department of Ophthalmology and Visual Sciences of the Federal University of Sao Paulo were enrolled in this study. Forty-three patients had toxoplasmic active focal necrotizing retinochoroiditis, and the remaining 12 had non-toxoplasmic infectious uveitis and served as controls. qPCR analysis for T. gondii DNA was performed on the patients' peripheral blood and aqueous humor samples.
   Results: The qPCR was positive for T. gondii DNA in 37.21% (16/43) of the aqueous humor samples and 2.33% (1/43) of the peripheral blood samples; further, 16.27% (7/43) of the patients had positive results in both their blood and aqueous humor samples.
   Conclusion: qPCR was able to detect T. gondii DNA in patients with toxoplasmic active focal necrotizing retinochoroiditis in the blood as well as the aqueous humor and can help with the diagnosis of the disease.
C1 [dos Santos, Fabio Felipe; Nascimento, Heloisa; Muccioli, Cristina; da Costa, Deise Fialho; Commodaro, Alessandra Goncalves; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Escola Paulista Med, Inst Visao, Sao Paulo, SP, Brazil.
   [dos Santos, Fabio Felipe; Nascimento, Heloisa; Muccioli, Cristina; da Costa, Deise Fialho; Commodaro, Alessandra Goncalves; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Rizzo, Luiz Vicente] Hosp Albert Einstein, Sao Paulo, SP, Brazil.
RP Commodaro, AG (corresponding author), Rua Botucatu 822, BR-04023062 Sao Paulo, SP, Brazil.
EM alecommodaro@gmail.com
RI Rizzo, Luiz Vicente/B-4458-2009; Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317; Commodaro,
   Alessandra/0000-0002-7816-6508; dos Santos, Fabio/0000-0001-7456-742X;
   Fialho da Costa, Deise/0000-0002-1974-4451
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [473179/2011-3]; instituto da visao; CAPESCAPES
FX This work was supported by grants from FAPESP, CNPq-473179/2011-3,
   instituto da visao and CAPES.
CR AOUIZERATE F, 1993, BRIT J OPHTHALMOL, V77, P107, DOI 10.1136/bjo.77.2.107
   Bou G, 1999, J CLIN MICROBIOL, V37, P3465, DOI 10.1128/JCM.37.11.3465-3468.1999
   Bourdin C, 2014, J CLIN MICROBIOL, V52, P3987, DOI 10.1128/JCM.01793-14
   Cantos G A, 2000, Rev Assoc Med Bras (1992), V46, P335, DOI 10.1590/S0104-42302000000400033
   Cordeiro CA, 2010, ARQ BRAS OFTALMOL, V73, P548, DOI 10.1590/S0004-27492010000600018
   Danise A, 1997, CLIN INFECT DIS, V24, P1100, DOI 10.1086/513625
   de-la-Torre A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002541
   dos Santos FF, 2011, ARQ BRAS OFTALMOL, V74, P258, DOI 10.1590/S0004-27492011000400006
   Fekkar A, 2008, J CLIN MICROBIOL, V46, P1965, DOI 10.1128/JCM.01900-07
   Garcia J L, 1999, Rev Soc Bras Med Trop, V32, P671, DOI 10.1590/S0037-86821999000600009
   Hierl T, 2004, J MED MICROBIOL, V53, P629, DOI 10.1099/jmm.0.45566-0
   Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025
   Kompalic-Cristo Alicia, 2005, J. Bras. Patol. Med. Lab., V41, P229, DOI 10.1590/S1676-24442005000400003
   Costa JGL, 2013, J CLIN MICROBIOL, V51, P2766, DOI 10.1128/JCM.00982-13
   Lee SE, 2012, KOREAN J PARASITOL, V50, P229, DOI 10.3347/kjp.2012.50.3.229
   London Nikolas J S, 2010, Int Ophthalmol Clin, V50, P1, DOI 10.1097/IIO.0b013e3181d2cc6b
   Bispo PJM, 2011, INVEST OPHTH VIS SCI, V52, P873, DOI 10.1167/iovs.10-5712
   Matos Kimble, 2007, Arq. Bras. Oftalmol., V70, P109, DOI 10.1590/S0004-27492007000100020
   Novais EA, 2014, BRIT J OPHTHALMOL, V98, P937, DOI 10.1136/bjophthalmol-2013-304184
   Oahalou A, 2014, RETINA-J RET VIT DIS, V34, P108, DOI 10.1097/IAE.0b013e31828e6985
   Park YH, 2013, KOREAN J PARASITOL, V51, P393, DOI 10.3347/kjp.2013.51.4.393
   Silveira C, 2001, AM J OPHTHALMOL, V131, P351, DOI 10.1016/S0002-9394(00)00830-8
   Silveira C, 2011, BRIT J OPHTHALMOL, V95, P396, DOI 10.1136/bjo.2008.148205
   Sugita S, 2013, OPHTHALMOLOGY, V120, P1761, DOI 10.1016/j.ophtha.2013.02.020
NR 24
TC 6
Z9 7
U1 0
U2 7
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD NOV-DEC
PY 2015
VL 78
IS 6
BP 356
EP 358
DI 10.5935/0004-2749.20150094
PG 3
WC Ophthalmology
SC Ophthalmology
GA CZ4TH
UT WOS:000367095100007
PM 26677037
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Elias, FTS
   da Silva, EN
   Belfort, R
   Silva, MT
   Atallah, AN
AF Silva Elias, Flavia Tavares
   da Silva, Everton Nunes
   Belfort, Rubens, Jr.
   Silva, Marcus Tolentino
   Atallah, Alvaro Nagib
TI Treatment Options for Age-Related Macular Degeneration: A Budget Impact
   Analysis from the Perspective of the Brazilian Public Health System
SO PLOS ONE
LA English
DT Article
ID BEVACIZUMAB; RANIBIZUMAB; DISEASES; AVASTIN; PEOPLE; RISK; EYE
AB Background
   Age-related macular degeneration (AMD) is a disease that causes reduced visual acuity and blindness. The new treatment options for AMD are not provided by the Brazilian public health system.
   Objective
   To conduct a budget impact analysis of three scenarios for the introduction of AMD treatments: all the medications (verteporfin, ranibizumab, and bevacizumab-the reference scenario), ranibizumab alone, and bevacizumab alone.
   Methods
   The basic assumption was that the Brazilian public health system would treat the entire target population with AMD aged >70 years between 2008 and 2011. The size of the population of interest was estimated from official population projections and the prevalence of the disease was obtained from a systematic review. Medication prices were estimated by weighting their market values with correction factors to take account of the public procurement policy. The possibility of aliquoting bevacizumab was also considered. A panel of experts was consulted to estimate the market share of the different medications for the reference scenario. The incremental costs of the ranibizumab-alone and bevacizumab-alone scenarios compared to the reference scenario were calculated. Univariate sensitivity analyses were run to check the robustness of the model.
   Results
   In four years, the Brazilian public health system would have treated 1,136,349 individuals with AMD. The annual costs of treating one patient would have been US$476.65 for bevacizumab, US$11,469.39 for ranibizumab, and US$4,376.28 for verteporfin. The incremental cost of the ranibizumab-alone scenario would have been US$1,878,318,056.00 in four years, while the incremental cost for the bevacizumab-alone scenario would have been a reduction of US$4,978,326,359.00 (i.e., a cost saving) in the same period. The bevacizumab-alone option was found to represent a cost saving across sensitivity analyses.
   Conclusion
   The introduction of bevacizumab for the treatment of AMD is recommended for the Brazilian Public Health System.
C1 [Silva Elias, Flavia Tavares] Fundacao Oswaldo Cruz, Brasilia, DF, Brazil.
   [da Silva, Everton Nunes] Univ Brasilia, Brasilia, DF, Brazil.
   [Belfort, Rubens, Jr.; Atallah, Alvaro Nagib] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil.
   [Silva, Marcus Tolentino] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
RP Elias, FTS (corresponding author), Fundacao Oswaldo Cruz, Brasilia, DF, Brazil.
EM flavia.tselias@gmail.com
RI Silva, Marcus Tolentino/J-1791-2014; Atallah, Alvaro N/K-7182-2013
OI Silva, Marcus Tolentino/0000-0002-7186-9075; Silva,
   Everton/0000-0001-8747-4185
CR American Academy of Ophthalmology, 2008, PREF PRACT PATT AG R
   Andriolo RB, 2009, SAO PAULO MED J, V127, P84, DOI 10.1590/S1516-31802009000200006
   Antoniak Katarzyna, 2008, Klin Oczna, V110, P211
   Bakri SJ, 2006, RETINA-J RET VIT DIS, V26, P519, DOI 10.1097/01.iae.0000225354.92444.7a
   BRAZIL, 2012, BANC PREC SAUD BPS N, V2009, P2010
   BRAZIL, 2008, BRATS B BRAS AV TECN, V6
   BRAZIL. Ministerio da Saude. Secretaria de Atencao a Saude, 2012, MIN SAUD SECR AT SAU
   Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015
   Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31
   Ferreira-Da-Silva AL, 2012, CAD SAUDE PUBLICA, V28, P1223, DOI 10.1590/S0102-311X2012000700002
   Fraser-Bell S, 2005, AM J OPHTHALMOL, V139, P30, DOI 10.1016/j.ajo.2004.08.029
   Gonzalez S, 2012, AM J OPHTHALMOL, V153, P196, DOI 10.1016/j.ajo.2011.11.023
   Gupta OP, 2010, OPHTHALMOLOGY, V117, P2134, DOI 10.1016/j.ophtha.2010.02.032
   Hutton D, 2014, HEALTH AFFAIR, V33, P931, DOI 10.1377/hlthaff.2013.0832
   Ivers RQ, 1998, J AM GERIATR SOC, V46, P58
   Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417
   Klein BEK, 2001, AM J EPIDEMIOL, V154, P207, DOI 10.1093/aje/154.3.207
   KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659
   Kodjikian L, 2013, OPHTHALMOLOGY, V120, P2300, DOI 10.1016/j.ophtha.2013.06.020
   Leske MC, 2006, OPHTHALMOLOGY, V113, P29, DOI 10.1016/j.ophtha.2005.08.012
   Malta DC, 2011, EPIDEMIOL SERV SAUDE, V20, P425, DOI 10.5123/S1679-49742011000400002
   Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053
   Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673
   Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x
   Moja L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011230.pub2
   National Institute for Health and Care Excellence, 2008, TECHN APPR GUID, V155
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   World Health Organization, 2003, PRIOR EYE DIS
   WORMALD R, 2003, COCHRANE DB SYST REV
   Zimmermann I, 2012, VALUE HEALTH, V15, pA569, DOI 10.1016/j.jval.2012.08.2052
NR 30
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 12
PY 2015
VL 10
IS 10
AR e0139556
DI 10.1371/journal.pone.0139556
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CT6YZ
UT WOS:000362961100011
PM 26457416
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Novais, EA
   Badaro, E
   Allemann, N
   Morales, MSA
   Rodrigues, EB
   Lima, RD
   Regatieri, CVS
   Belfort, R
AF Novais, Eduardo Amorim
   Badaro, Emmerson
   Allemann, Norma
   Avila Morales, Maira Saad
   Rodrigues, Eduardo Buechele
   Lima, Rodrigo de Souza
   Saito Regatieri, Caio Vinicius
   Belfort, Rubens, Jr.
TI Correlation Between Choroidal Thickness and Ciliary Artery Blood Flow
   Velocity in Normal Subjects
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID OPTICAL COHERENCE TOMOGRAPHY; NITRIC-OXIDE; PHOTODYNAMIC THERAPY; EYES;
   REPRODUCIBILITY; CIRCULATION; GLAUCOMA
AB BACKGROUND AND OBJECTIVE: To study the correlation between the choroidal thickness (CT) measured by spectral-domain optical coherence tomography (SD-OCT) and retrobulbar blood flow measured by color Doppler flowmetry (CD) in normal subjects.
   PATIENTS AND METHODS: Healthy subjects underwent enhanced-depth imaging SD-OCT and CD using a linear 6 MHz to 18 MHz transducer. The maximal peak systolic velocity and resistance index (RI) were obtained for the ophthalmic artery (OA), short posterior ciliary artery (SPCA), and central retinal artery (CRA) and correlated with the subfoveal CT measured by SD-OCT.
   RESULTS: Twenty-seven eyes of 27 healthy patients were enrolled (mean age: 40.6 +/- 12.4 years; range: 27-68 years). An inverse proportional relationship (P=.0496) was identified between the RI of the SPCA (mean, 0.6117 +/- 0.07911) and the subfoveal CT (319.9 mu m +/- 83.79 mu m) but not between the RI and the OA (mean: 0.7019 mu m +/- 0.07317 mu m) or the CRA (mean: 0.68843 mu m +/- 0.08994 mu m).
   CONCLUSION: The results of this study suggested there is an inverse proportional relationship between the RI of the SPCA and the subfoveal CT. The data also suggested a correlation between a decrease in the CT and increased RI in the retrobulbar arteries. Therefore, lower choroidal blood flow may explain the thinner CT in normal subjects.
C1 [Novais, Eduardo Amorim; Badaro, Emmerson; Allemann, Norma; Avila Morales, Maira Saad; Rodrigues, Eduardo Buechele; Lima, Rodrigo de Souza; Saito Regatieri, Caio Vinicius; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Saito Regatieri, Caio Vinicius] Tufts Med Sch, Dept Ophthalmol, Boston, MA USA.
RP Regatieri, CVS (corresponding author), Univ Fed Sao Paulo, Dept Oftalmol, Secretaria Adm, Rua Botucatu 821,1o Andar, BR-04023062 Sao Paulo, Brazil.
EM caiore@gmail.com
RI Allemann, Norma/K-5451-2013; Regatieri, Caio/G-8152-2014
OI Allemann, Norma/0000-0001-5432-4287; Regatieri,
   Caio/0000-0003-1511-8696; Buchele Rodrigues, Eduardo/0000-0002-4224-0921
FU CNPq (EAN)National Council for Scientific and Technological Development
   (CNPq) [479648/2012-3]; CAPES foundationCAPES
FX Supported in part by CNPq (EAN - grant number 479648/2012-3) and the
   CAPES foundation.
CR Boker T, 1993, Ger J Ophthalmol, V2, P10
   Branchini L, 2012, OPHTHALMOLOGY, V119, P119, DOI 10.1016/j.ophtha.2011.07.002
   Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066
   Cao JT, 1998, ARCH OPHTHALMOL-CHIC, V116, P589, DOI 10.1001/archopht.116.5.589
   CHEN JC, 1992, INVEST OPHTH VIS SCI, V33, P334
   Falsini B, 2011, INVEST OPHTH VIS SCI, V52, P1064, DOI 10.1167/iovs.10-5964
   FRIEDMAN E, 1995, OPHTHALMOLOGY, V102, P640, DOI 10.1016/S0161-6420(95)30974-8
   Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029
   Gemenetzi M, 2010, EYE, V24, P1743, DOI 10.1038/eye.2010.130
   Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042
   Grunwald JE, 1998, INVEST OPHTH VIS SCI, V39, P385
   Grunwald JE, 2005, INVEST OPHTH VIS SCI, V46, P1033, DOI 10.1167/iovs.04-1050
   HAEFLIGER IO, 1992, INVEST OPHTH VIS SCI, V33, P2340
   Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83
   Inoue R, 2010, AM J OPHTHALMOL, V149, P441, DOI 10.1016/j.ajo.2009.10.011
   Lin P, 2012, INVEST OPHTH VIS SCI, V53, P1874, DOI 10.1167/iovs.11-9290
   Lockhart CJ, 2006, CLIN SCI, V111, P47, DOI 10.1042/cs20050365
   Lutty G, 1999, MOL VIS, V5
   Ramos MHMC, 2011, ARQ BRAS OFTALMOL, V74, P361, DOI 10.1590/S0004-27492011000500011
   Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008
   Maruko I, 2011, AM J OPHTHALMOL, V151, P594, DOI 10.1016/j.ajo.2010.10.030
   Maruko I, 2011, RETINA-J RET VIT DIS, V31, P510, DOI 10.1097/IAE.0b013e3181eef053
   Nagaoka T, 2004, BRIT J OPHTHALMOL, V88, P1060, DOI 10.1136/bjo.2003.035345
   PAULEIKHOFF D, 1990, AM J OPHTHALMOL, V109, P211, DOI 10.1016/S0002-9394(14)75989-6
   Pemp B, 2008, CAN J OPHTHALMOL, V43, P295, DOI 10.3129/i08-049
   Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P865, DOI 10.1097/IAE.0b013e318251a3a8
   Ryan SJ, 2013, RETINA
   Schmidl D, 2010, CLIN PHARMACOL THER, V87, P87, DOI 10.1038/clpt.2009.186
   Shin JW, 2012, OPHTHALMOLOGY, V119, P1017, DOI 10.1016/j.ophtha.2011.10.029
   Shiraki Kunihiko, 1999, International Ophthalmology, V23, P105, DOI 10.1023/A:1026571327117
   Sogawa K, 2012, AM J OPHTHALMOL, V153, P1129, DOI 10.1016/j.ajo.2011.11.005
   Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032
   Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010
   Stalmans I, 2011, ACTA OPHTHALMOL, V89, pe609, DOI 10.1111/j.1755-3768.2011.02178.x
   Toda N, 2007, PROG RETIN EYE RES, V26, P205, DOI 10.1016/j.preteyeres.2007.01.004
   Torres VLL, 2011, AM J OPHTHALMOL, V151, P586, DOI 10.1016/j.ajo.2010.09.028
   Vance SK, 2011, RETINA-J RET VIT DIS, V31, P332, DOI 10.1097/IAE.0b013e3181eef0ae
   Yamashita T, 2012, INVEST OPHTH VIS SCI, V53, P1102, DOI 10.1167/iovs.11-8836
NR 38
TC 11
Z9 11
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD OCT
PY 2015
VL 46
IS 9
BP 920
EP 924
DI 10.3928/23258160-20151008-04
PG 5
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA DP9UF
UT WOS:000378842200004
PM 26469231
DA 2020-12-01
ER

PT J
AU Marquezan, MC
   Nascimento, H
   Vieira, LA
   Serapiao, M
   Ghanem, RC
   Belfort, R
   Freitas, D
AF Marquezan, Maria Carolina
   Nascimento, Heloisa
   Vieira, Luis Antonio
   Serapiao, Myrna
   Ghanem, Ramon Coral
   Belfort, Rubens, Jr.
   Freitas, Denise
TI Effect of Topical Tacrolimus in the Treatment of Thygeson's Superficial
   Punctate Keratitis
SO AMERICAN JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID SEVERE ALLERGIC CONJUNCTIVITIS; VERSUS-HOST-DISEASE; VERNAL
   KERATOCONJUNCTIVITIS; EYE DROPS; ATOPIC KERATOCONJUNCTIVITIS; PAPILLARY
   CONJUNCTIVITIS; CALCINEURIN INHIBITORS; OPHTHALMIC SUSPENSION;
   INFLAMMATORY DISEASES; 0.03-PERCENT OINTMENT
AB PURPOSE: To evaluate topical tacrolimus ointment for treating Thygeson's superficial punctate keratitis (Thygeson SPK).
   DESIGN: Retrospective interventional case series.
   METHODS: SETTING: Institutional practice. PATIENT POPULATION: The medical records of 14 patients (9 women; age range, 9-65 years) with Thygeson SPK were reviewed retrospectively. Diagnosis was based on the history and clinical examination. INTERVENTION: Patients were treated with tacrolimus 0.03% eye ointment instilled into the lower fornix twice daily for the first 2 weeks, followed by nocturnal application. The clinical signs and symptoms were assessed after 1 month of treatment. The drug was tapered with disease improvement. MAIN OUTCOME MEASURE(S): Treatment efficacy and side effects.
   RESULTS: All patients had bilateral disease (average duration, 6 years). All patients, except 2 who used the medication irregularly, had improved visual acuity (VA), symptoms, and signs as long as the medication was applied. Before treatment 28.57% of patients had VA between 20/30 and 20/50, with improvement after treatment to 20/25 or 20/20. Attempts to withdraw the medication resulted in recurrent disease, and, therefore, treatment was not curative during the study period. No significant local medication side effects were reported.
   CONCLUSION: Tacrolimus eye ointment 0.03% was effective for controlling Thygeson SPK for a long period with good patient tolerance and no noticeable local or systemic side effects. During the average 6-year follow-up, treatment was not curative. Randomized studies are difficult to conduct because of the disease rarity. (C) 2015 by Elsevier Inc. All rights reserved.
C1 [Marquezan, Maria Carolina; Nascimento, Heloisa; Vieira, Luis Antonio; Serapiao, Myrna; Ghanem, Ramon Coral; Belfort, Rubens, Jr.; Freitas, Denise] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sa Paulo Hosp, BR-04023062 Sao Paulo, SP, Brazil.
RP Freitas, D (corresponding author), Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Rua Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
EM dfreitas@uol.com.br
RI Freitas, Denise/G-9374-2015; Nascimento, Heloisa/P-8869-2017; Freitas,
   Denise/N-8197-2019
OI Freitas, Denise/0000-0002-3389-6021; Nascimento,
   Heloisa/0000-0003-0315-1317; Freitas, Denise/0000-0002-3389-6021
CR ABBOTT RL, 1979, AM J OPHTHALMOL, V87, P296, DOI 10.1016/0002-9394(79)90066-7
   Abeysiri P, 2010, OPHTHALMOL EYE DIS, V2, P5
   Attas-Fox L, 2008, CURR EYE RES, V33, P545, DOI 10.1080/02713680802149115
   del Castillo JMB, 1997, DOC OPHTHALMOL, V93, P193, DOI 10.1007/BF02569059
   Diao HX, 2012, ADV THER, V29, P645, DOI 10.1007/s12325-012-0031-y
   Ebihara N, 2012, ALLERGOL INT, V61, P275, DOI 10.2332/allergolint.11-OA-0349
   Fintelmann RE, 2012, CORNEA, V31, P1446, DOI 10.1097/ICO.0b013e31823f777f
   Fukushima A, 2014, BRIT J OPHTHALMOL, V98, P1023, DOI 10.1136/bjophthalmol-2013-304453
   Ghanem RC, 2014, CORNEA, V33, P1210, DOI 10.1097/ICO.0000000000000247
   Hall VC, 2003, ARCH DERMATOL, V139, P1083, DOI 10.1001/archderm.139.8.1083
   Hasanreisoglu Murat, 2008, Cases J, V1, P415, DOI 10.1186/1757-1626-1-415
   HOOKS MA, 1994, ANN PHARMACOTHER, V28, P501, DOI 10.1177/106002809402800414
   Joseph MA, 2005, CORNEA, V24, P417, DOI 10.1097/01.ico.0000151507.49565.6e
   Jung JW, 2015, AM J OPHTHALMOL, V159, P519, DOI 10.1016/j.ajo.2014.11.035
   Kheirkhah A, 2011, EYE, V25, P871, DOI 10.1038/eye.2011.75
   Kymionis GD, 2008, CORNEA, V27, P228, DOI 10.1097/ICO.0b013e318159afbb
   Kymionis GD, 2013, CORNEA, V32, P1499, DOI 10.1097/ICO.0b013e318295e6b9
   Kymionis GD, 2012, CORNEA, V31, P950, DOI 10.1097/ICO.0b013e318243f69d
   Labcharoenwongs P, 2012, ASIAN PAC J ALLERGY, V30, P177
   Lee YJ, 2013, AM J OPHTHALMOL, V155, P804, DOI 10.1016/j.ajo.2012.12.009
   Michel JL, 2006, ANN DERMATOL VENER, V133, P161, DOI 10.1016/S0151-9638(06)70869-9
   Miyazaki D, 2008, OPHTHALMOLOGY, V115, P988, DOI 10.1016/j.ophtha.2007.07.025
   Moscovici BK, 2012, CORNEA, V31, P945, DOI 10.1097/ICO.0b013e31823f8c9b
   Muller GG, 2014, EYE CONTACT LENS, V40, P79, DOI 10.1097/ICL.0000000000000001
   Nagra PK, 2004, OPHTHALMOLOGY, V111, P34, DOI 10.1016/j.ophtha.2003.05.002
   Ohashi Y, 2010, J OCUL PHARMACOL TH, V26, P165, DOI 10.1089/jop.2009.0087
   Garcia DP, 2011, CORNEA, V30, P462, DOI 10.1097/ICO.0b013e3181d83875
   PLEYER U, 1993, INVEST OPHTH VIS SCI, V34, P2737
   Reinhard T, 2002, KLIN MONATSBL AUGENH, V219, P125, DOI 10.1055/s-2002-26727
   Reinhard T, 1999, GRAEF ARCH CLIN EXP, V237, P109, DOI 10.1007/s004170050204
   Reinhard T, 1996, KLIN MONATSBL AUGENH, V209, P224, DOI 10.1055/s-2008-1035307
   Sanz-Marco E, 2013, J OCUL PHARMACOL TH, V29, P776, DOI 10.1089/jop.2012.0265
   Siegfried EC, 2013, AM J CLIN DERMATOL, V14, P163, DOI 10.1007/s40257-013-0020-1
   Tam PMK, 2010, BONE MARROW TRANSPL, V45, P957, DOI 10.1038/bmt.2009.249
   THYGESON P, 1966, AM J OPHTHALMOL, V61, P1344, DOI 10.1016/0002-9394(66)90265-0
   Tzu JH, 2012, CORNEA, V31, P649, DOI 10.1097/ICO.0b013e31822481c2
   Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027
   Virtanen HM, 2006, ACTA OPHTHALMOL SCAN, V84, P693, DOI 10.1111/j.1600-0420.2006.00699.x
   Wakamatsu TH, 2011, MOL VIS, V17, P932
   Wyrsch S, 2009, KLIN MONATSBL AUGENH, V226, P234, DOI 10.1055/s-0028-1109328
NR 40
TC 1
Z9 1
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9394
EI 1879-1891
J9 AM J OPHTHALMOL
JI Am. J. Ophthalmol.
PD OCT
PY 2015
VL 160
IS 4
BP 663
EP 668
DI 10.1016/j.ajo.2015.06.019
PG 6
WC Ophthalmology
SC Ophthalmology
GA CR7BR
UT WOS:000361503400006
PM 26133248
DA 2020-12-01
ER

PT J
AU Paiva, R
   Nascimento, H
   Salomao, G
   Freitas, L
   Muccioli, C
   Belfort, R
AF Paiva, Roberta
   Nascimento, Heloisa
   Salomao, Gustavo
   Freitas, Lincoln
   Muccioli, Cristina
   Belfort, Rubens, Jr.
TI Epilens membrane simulating cataract in children with uveitis: a report
   of three cases
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Epilens membrane Uveitis; Cataract; Phacoemulsification; Child;
   Sympathetic ophthalmia
AB Here we present the cases of three female children, of whom two were aged 6 years and one was aged 11 years. Two of the three children had bilateral uveitis and suspected cataract and Vogt-Koyanagi-Harada (VKH) disease. The third one had uveitis and suspected cataract in one eye and sympathetic ophthalmia (SO), and had undergone penetrating keratoplasty in the fellow eye following a trauma. After controlling the inflammation, we planned to perform phacoemulsification without intraocular lens implantation. However, intraoperatively, after removing the epilens membranes, the lenses appeared clear, and therefore phacoemulsification was not performed. During follow-up, the patients did not develop cataract, and visual acuity levels ranged from 20/30 to 20/100. Fundoscopy revealed VKH disease and SO. Ophthalmologists should not always assume that patients with uveitis have cataract; a transparent lens may exist behind the epilens membrane, allowing a less aggressive therapeutic approach.
C1 [Paiva, Roberta] Clovis Paiva Eye Inst, Recife, PE, Brazil.
   [Nascimento, Heloisa; Freitas, Lincoln; Muccioli, Cristina; Belfort, Rubens, Jr.] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Salomao, Gustavo] Fac Med ABC, Dept Ophthalmol, Sao Paulo, SP, Brazil.
RP Paiva, R (corresponding author), Rua Dom Bosco 855, BR-50070070 Recife, PE, Brazil.
EM betapaiva@hotmail.com
RI Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317
CR Agrawal R, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/548453
   Baheti U, 2012, SAUDI J OPHTHALMOL, V26, P55, DOI 10.1016/j.sjopt.2011.10.003
   Elgohary MA, 2007, BRIT J OPHTHALMOL, V91, P916, DOI 10.1136/bjo.2006.109660
   Foster Charles Stephen, 2003, Curr Opin Ophthalmol, V14, P1
   Murthy SI, 2013, INDIAN J OPHTHALMOL, V61, P284, DOI 10.4103/0301-4738.114103
   Wentworth Bailey A, 2014, F1000Prime Rep, V6, P41, DOI 10.12703/P6-41
NR 6
TC 2
Z9 2
U1 0
U2 2
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD SEP-OCT
PY 2015
VL 78
IS 5
BP 326
EP 327
DI 10.5935/0004-2749.20150086
PG 2
WC Ophthalmology
SC Ophthalmology
GA CT8SO
UT WOS:000363087000015
PM 26466236
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Damasceno, RW
   Avgitidou, G
   Belfort, R
   Dantas, PEC
   Holbach, LM
   Heindl, LM
AF Damasceno, Renato Wendell
   Avgitidou, Georgia
   Belfort, Rubens, Jr.
   Correa Dantas, Paulo Elias
   Holbach, Leonard M.
   Heindl, Ludwig M.
TI Eyelid aging: pathophysiology and clinical management
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Review
DE Aging; Eyelid; Eyelid diseases; Ectropion; Entropion; Extracellular
   matrix; Elastin; Matrix metalloproteinases
ID ISCHEMIA-REPERFUSION INJURY; INVOLUTIONAL ENTROPION; MATRIX
   METALLOPROTEINASES; ELASTIC FIBERS; RISK-FACTORS; ECTROPION; SKIN; AGE;
   HISTOPATHOLOGY; INVOLVEMENT
AB Life expectancy is increasing in most countries. With increasing age, many individuals may develop involutional ophthalmic diseases, such as eyelid aging. Dermatochalasis, ptosis, ectropion, and entropion are common disorders in middle-aged and older adults. This review outlines the pathophysiology and clinical management of these involutional eyelid disorders. Recently, a decrease in elastic fibers with ultrastructural abnormalities and an overexpression of elastin-degrading enzymes have been demonstrated in involutional ectropion and entropion. This may be the consequence of local ischemia, inflammation, and/or chronic mechanical stress. Eyelid aging with progressive loss of tone and laxity may affect the ocular surface and adnexal tissues, resulting in different clinical symptoms and signs. Surgical management depends on the appropriate correction of the underlying anatomical defect.
C1 [Damasceno, Renato Wendell] Univ Estadual Ciencias Saude Alagoas, Maceio, AL, Brazil.
   [Damasceno, Renato Wendell] Ctr Reabilitacao Visual, BR-57050080 Maceio, AL, Brazil.
   [Avgitidou, Georgia; Heindl, Ludwig M.] Univ Cologne, Dept Ophthalmol, D-50931 Cologne, Germany.
   [Belfort, Rubens, Jr.] Univ Fed Sao Paulo UNIFESP, Dept Ophthalmol, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Correa Dantas, Paulo Elias] Santa Casa Misericordia Sao Paulo, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Holbach, Leonard M.] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany.
RP Damasceno, RW (corresponding author), Ctr Reabilitacao Visual, Rua Dr Albino Magalhaes 135, BR-57050080 Maceio, AL, Brazil.
EM renatowendell@hotmail.com
RI DANTAS, PAULO ELIAS CORREA/AAO-8315-2020; Damasceno, Renato/S-2291-2019
OI DANTAS, PAULO ELIAS CORREA/0000-0002-4363-9301; 
CR Alfonso-Jaume MA, 2006, AM J PHYSIOL-HEART C, V291, pH1838, DOI 10.1152/ajpheart.00026.2006
   [Anonymous], 2009, WORLD HLTH STAT 2009
   Barnes JA, 2006, OPHTHALMOLOGY, V113, P92, DOI 10.1016/j.ophtha.2005.06.039
   Bashour M, 2000, OPHTHAL PLAST RECONS, V16, P131, DOI 10.1097/00002341-200003000-00008
   Baumann L, 2007, J PATHOL, V211, P241, DOI 10.1002/path.2098
   Cheung PY, 2000, CIRCULATION, V101, P1833, DOI 10.1161/01.CIR.101.15.1833
   COLLIN JRO, 1978, ARCH OPHTHALMOL-CHIC, V96, P1058, DOI 10.1001/archopht.1978.03910050578018
   Cruz A. A., 1998, BLEFAROPTOSES RETRAC
   Damasceno RW, 2011, ORBIT, V30, P132, DOI 10.3109/01676830.2011.569049
   Damasceno RW, 2011, OPHTHAL PLAST RECONS, V27, P317, DOI 10.1097/IOP.0b013e3182115229
   Damasceno RW, 2011, OPHTHAL PLAST RECONS, V27, P321, DOI 10.1097/IOP.0b013e31821637e4
   Danks JJ, 1998, OPHTHALMOLOGY, V105, P2065, DOI 10.1016/S0161-6420(98)91126-5
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Diridollou S, 2007, INT J DERMATOL, V46, P11, DOI 10.1111/j.1365-4632.2007.03455.x
   Finsterer J, 2003, AESTHET PLAST SURG, V27, P193, DOI 10.1007/s00266-003-0127-5
   Ghomrasseni S, 2002, AM J DERMATOPATH, V24, P118, DOI 10.1097/00000372-200204000-00003
   Guinot C, 2002, ARCH DERMATOL, V138, P1454, DOI 10.1001/archderm.138.11.1454
   Heimmel MR, 2009, OPHTHAL PLAST RECONS, V25, P7, DOI 10.1097/IOP.0b013e31819128fd
   Heindl LM, 2008, APPL PATHOLOGY OPHTH, P30
   Hintschich Christoph, 2008, Dev Ophthalmol, V41, P85, DOI 10.1159/000131075
   IMAYAMA S, 1989, AM J PATHOL, V134, P1019
   Jacobs LC, 2014, JAMA DERMATOL, V150, P836, DOI 10.1001/jamadermatol.2014.27
   Kase S, 2014, OPHTHAL PLAST RECONS, V30, P290, DOI 10.1097/IOP.0000000000000090
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Kocaoglu FA, 2009, CAN J OPHTHALMOL, V44, P677, DOI 10.3129/i09-152
   Liesegang TJ, 2007, ORBIT EYELIDS LACRIM, P236
   Lim JM, 2013, ORBIT, V32, P231, DOI 10.3109/01676830.2013.788673
   Lindsey M, 2001, CIRCULATION, V103, P2181
   Marshall JA, 2006, OPHTHAL PLAST RECONS, V22, P192, DOI 10.1097/01.iop.0000217561.41150.68
   Matayoshi S, 2006, SUPERFICIE OCULAR CO, P347
   Mitchell P, 2001, CLIN EXP OPHTHALMOL, V29, P108, DOI 10.1046/j.1442-9071.2001.00412.x
   Montes GS, 1996, CELL BIOL INT, V20, P15, DOI 10.1006/cbir.1996.0004
   Nagi KS, 2011, OPHTHALMOLOGY, V118, P1205, DOI 10.1016/j.ophtha.2010.10.013
   NETLAND PA, 1994, OPHTHALMOLOGY, V101, P174
   Patroi I, 2003, J AM ACAD DERMATOL, V48, P846, DOI 10.1067/mjd.2003.452
   Prajapati RT, 2000, WOUND REPAIR REGEN, V8, P238, DOI 10.1046/j.1524-475x.2000.00238.x
   Rawlings A. V., 2006, International Journal of Cosmetic Science, V28, P79, DOI 10.1111/j.1467-2494.2006.00302.x
   Scheepers MA, 2010, OPHTHALMOLOGY, V117, P352, DOI 10.1016/j.ophtha.2009.06.056
   Schlotzer-Schrehardt U, 2005, OPHTHALMOLOGY, V112, P694, DOI 10.1016/j.ophtha.2004.11.031
   SISLER H A, 1976, Annals of Ophthalmology, V8, P319
   Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007
   STEFANYSZYN MA, 1985, OPHTHALMOLOGY, V92, P120
   Swartz MA, 2001, P NATL ACAD SCI USA, V98, P6180, DOI 10.1073/pnas.111133298
   TYERS AG, 1984, ORBIT, V3, P75, DOI 10.3109/01676838409023101
   TYERS AG, 1982, J ROY SOC MED, V75, P900
   Uitto J, 1997, NEW ENGL J MED, V337, P1463, DOI 10.1056/NEJM199711133372011
   Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302
   배정범, 2013, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V54, P1165
NR 48
TC 17
Z9 19
U1 1
U2 7
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD SEP-OCT
PY 2015
VL 78
IS 5
BP 328
EP 331
DI 10.5935/0004-2749.20150087
PG 4
WC Ophthalmology
SC Ophthalmology
GA CT8SO
UT WOS:000363087000016
PM 26466237
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Mitsuhiro, MH
   Berezovsky, A
   Belfort, R
   Ellwein, LB
   Salomao, SR
AF Mitsuhiro, Marcia H.
   Berezovsky, Adriana
   Belfort, Rubens, Jr.
   Ellwein, Leon B.
   Salomao, Solange R.
TI Uptake, Barriers and Outcomes in the Follow-up of Patients Referred for
   Free-of-Cost Cataract Surgery in the Sao Paulo Eye Study
SO OPHTHALMIC EPIDEMIOLOGY
LA English
DT Article
DE Barriers; cataract; cataract surgery; outcomes; uptake
ID SELF-REPORTED BARRIERS; SURGICAL COVERAGE; VISUAL IMPAIRMENT;
   POPULATION; PREVALENCE; BLINDNESS; NIGERIA; BRAZIL; SERVICES; INDIA
AB Purpose: To determine uptake, barriers and outcomes in the follow-up of patients referred for free-of-charge, expedited cataract surgery in the Sao Paulo Eye Study (SPES).
   Methods: SPES was a population-based study of urban, low-middle income residents aged >= 50 years. Presenting visual acuity (PVA), best-corrected visual acuity, refraction, and slit-lamp examination were performed in 3677 participants. For subjects with cataract as a principal cause of best-corrected visual acuity <= 20/40, surgery was offered free of charge. Two years after the baseline study, surgery uptake, barriers to surgery, and visual outcomes were analyzed.
   Results: Among 210 (5.71%) participants who had a cataract surgery indication at baseline, 164 (78.1%) were successfully contacted and 55 (33.5%) reported being operated on for cataract, with 51 agreeing to be re-examined. In a multiple logistic regression model, age, sex, schooling, previous cataract surgery, and PVA at baseline were not significantly associated with surgery uptake. Co-existing health conditions (20.4%), fear of surgery (12.2%) and fear of losing eyesight (11.6%) were the most frequent barriers to cataract surgery adherence. Among the 69 eyes operated on in the interval between baseline and follow-up, PVA >= 20/63 was observed in 50 (72.6%, 95% confidence interval, CI, 62.2-82.3%), PVA <20/63-20/200 in 11 (15.8%, 95% CI 8.9-22.9%) and PVA <20/200 in 8 (11.6%, 95% CI 5.3-17.9%).
   Conclusions: Quality of surgery is an increasing determinant of uptake rates. Although free-of-charge and expedited cataract surgery was offered, surgical outcomes might have influenced the low uptake. Aside from cataract surgery campaigns, improvement of surgeon skills, accurate biometry, treatment of ocular comorbidities, postoperative follow-up and eye-care education are needed.
C1 [Mitsuhiro, Marcia H.; Berezovsky, Adriana; Belfort, Rubens, Jr.; Salomao, Solange R.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Oftalmol, BR-04023062 Sao Paulo, SP, Brazil.
   [Ellwein, Leon B.] NEI, Bethesda, MD 20892 USA.
RP Salomao, SR (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Oftalmol, Rua Botucatu 821, BR-04023062 Sao Paulo, SP, Brazil.
EM ssalomao@unifesp.br
RI Salomao, Solange R/G-9500-2012; Berezovsky, Adriana/F-2341-2013
OI Salomao, Solange R/0000-0002-3436-5599; Berezovsky,
   Adriana/0000-0001-6350-8221
FU Coordenadoria de Apoio a Pessoal de Nivel Superior (CAPES, Brasilia,
   Brasil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq, Brasilia, Brasil); World Health Organization (WHO), Geneva,
   Switzerland (under the National Institutes of Health, Bethesda,
   Maryland) [NEI-EY-2103]
FX Financial support was received from: Coordenadoria de Apoio a Pessoal de
   Nivel Superior (CAPES, Brasilia, Brasil) post-doctoral scholarship to
   MHM; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq, Brasilia, Brasil) research scholarships to AB, RB and SRS; and
   World Health Organization (WHO), Geneva, Switzerland (under the National
   Institutes of Health, Bethesda, Maryland contract no. NEI-EY-2103).
CR Caligaris LSA, 2011, REV PANAM SALUD PUBL, V29, P428, DOI 10.1590/S1020-49892011000600008
   Abubakar T, 2012, OPHTHAL EPIDEMIOL, V19, P58, DOI 10.3109/09286586.2011.643271
   Athanasiov PA, 2008, CLIN EXP OPHTHALMOL, V36, P521, DOI 10.1111/j.1442-9071.2008.01829.x
   Athanasiov PA, 2009, CLIN EXP OPHTHALMOL, V37, P780, DOI 10.1111/j.1442-9071.2009.02152.x
   Chandrashekhar TS, 2007, PUBLIC HEALTH, V121, P130, DOI 10.1016/j.puhe.2006.07.027
   Chibuga E, 2008, EYE, V22, P830, DOI 10.1038/sj.eye.6702736
   de Senne FMB, 2002, ACTA OPHTHALMOL SCAN, V80, P262, DOI 10.1034/j.1600-0420.2002.800306.x
   Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002
   Gyasi Me, 2007, Ghana Med J, V41, P167
   Hashemi H, 2012, OPHTHAL EPIDEMIOL, V19, P242, DOI 10.3109/09286586.2012.691600
   JOSE NK, 1990, INT OPHTHALMOL, V14, P155, DOI 10.1007/BF00158313
   Kara-Jose N, 1999, Rev Panam Salud Publica, V6, P242, DOI 10.1590/S1020-49891999000900003
   Lavanya R, 2009, BRIT J OPHTHALMOL, V93, P299, DOI 10.1136/bjo.2008.148650
   Lundstrom M, 2001, J CATARACT REFR SURG, V27, P1176, DOI 10.1016/S0886-3350(01)00772-6
   Lundstrom M, 2013, J CATARACT REFR SURG, V39, P673, DOI 10.1016/j.jcrs.2012.11.026
   Melese M, 2004, TROP MED INT HEALTH, V9, P426, DOI 10.1111/j.1365-3156.2004.01205.x
   Monestam E, 1999, J CATARACT REFR SURG, V25, P1127, DOI 10.1016/S0886-3350(99)00135-2
   Mpyet C, 2005, BRIT J OPHTHALMOL, V89, P936, DOI 10.1136/bjo.2004.062455
   Nangia V, 2011, J CATARACT REFR SURG, V37, P1932, DOI 10.1016/j.jcrs.2011.08.020
   Nkumbe Henry, 2008, Community Eye Health, V21, P26
   Odugbo OP, 2012, MIDDLE EAST AFR J OP, V19, P282, DOI 10.4103/0974-9233.97925
   Rabiu MM, 2001, BRIT J OPHTHALMOL, V85, P776, DOI 10.1136/bjo.85.7.776
   Salomao SR, 2008, OPHTHAL EPIDEMIOL, V15, P167, DOI 10.1080/09286580701843812
   Saw SM, 2002, J CATARACT REFR SURG, V28, P445, DOI 10.1016/S0886-3350(01)01016-1
   Schellini SA, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-8
   Shrestha MK, 2004, BRIT J OPHTHALMOL, V88, P319, DOI 10.1136/bjo.2003.026260
   Syed A, 2013, DISABIL REHABIL, V35, P1660, DOI 10.3109/09638288.2012.748843
   Thapa SS, 2011, CLIN EXP OPHTHALMOL, V39, P851, DOI 10.1111/j.1442-9071.2011.02576.x
   Walia Tony, 2008, Community Eye Health, V21, P58
   Zhang MZ, 2011, OPHTHAL EPIDEMIOL, V18, P179, DOI 10.3109/09286586.2011.580884
NR 30
TC 6
Z9 6
U1 0
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0928-6586
EI 1744-5086
J9 OPHTHAL EPIDEMIOL
JI Ophthalmic Epidemiol.
PD AUG
PY 2015
VL 22
IS 4
SI SI
BP 253
EP 259
DI 10.3109/09286586.2014.966849
PG 7
WC Ophthalmology
SC Ophthalmology
GA CP4VH
UT WOS:000359880200004
PM 25310584
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Zamora, YF
   Arantes, T
   Reis, FA
   Garcia, CR
   Saraceno, JJF
   Belfort, R
   Muccioli, C
AF Zamora, Yuslay Fernandez
   Arantes, Tiago
   Reis, Frederico Augusto
   Garcia, Claudio Renato
   Ferreira Saraceno, Janana Jamile
   Belfort, Rubens, Jr.
   Muccioli, Cristina
TI Local treatment of toxoplasmic retinochoroiditis with intravitreal
   clindamycin and dexamethasone
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Chorioretinitis/drug therapy; Toxoplasmosis, ocular; Intravitreal
   injections; Clindamycin/administration and dosage;
   Dexamethasone/administration and dosage
ID OCULAR TOXOPLASMOSIS; GLOBAL REASSESSMENT; MEMORIAL-LECTURE; THERAPY;
   MANAGEMENT; UPDATE; SYSTEM; TRIAL
AB Purpose: To report the clinical outcomes of local treatment of toxoplasmic retino-choroiditis (TRC) with intravitreal injections of clindamycin and dexamethasone.
   Methods: Study population: 16 eyes (16 patients) with active TRC sparing the macula and juxtapapillary area treated with intravitreal injections of clindamycin (1 mg) and dexamethasone (1 mg) without concomitant systemic antitoxoplasmic or anti-inflammatory therapy. Measured parameters: Best-corrected visual acuity (BCVA) was measured by an Early Treatment Diabetic Retinopathy Study (ETDRS) chart. BCVA and clinical characteristics of retinochoroiditis were assessed at baseline and at 1, 3, 6, and 12 months. Primary outcome measures: Resolution of retinochoroiditis and changes in BCVA.
   Results: Control of TRC was achieved in all cases with a mean interval of 2.48 +/- 1.03 weeks (2-6 weeks). A single injection of intravitreal clindamycin and dexamethasone was performed in 12 patients, and four patients required two intravitreal injections, during the follow-up period. Fourteen eyes (87.5%) improved >= 2 ETDRS lines of BCVA, of two or more Early Treatment Diabetic Retinopathy Study lines, BCVA remained stable in two eyes (12.5%), and no patient had decreased BCVA at the end of the follow-up period. No ocular or systemic adverse events were observed.
   Conclusion: Local treatment with intravitreal injections of clindamycin and dexamethasone without concomitant systemic therapy was associated with resolution of TRC in patients without macular or juxtapapillary involvement. Intravitreal clindamycin and dexamethasone may represent a viable treatment option in patients with allergies or inadequate responses to oral medications.
C1 [Zamora, Yuslay Fernandez; Arantes, Tiago; Reis, Frederico Augusto; Garcia, Claudio Renato; Ferreira Saraceno, Janana Jamile; Belfort, Rubens, Jr.; Muccioli, Cristina] Univ Fed Sao Paulo UNIFESP, EPM, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
RP Zamora, YF (corresponding author), Rua Botucatu,822 10 Andar, Sao Paulo, Brazil.
EM yuslay82@gmail.com
RI Arantes, Tiago EF/I-3093-2013; garcia, claudio/AAB-9313-2020
OI Arantes, Tiago EF/0000-0002-8122-3446; 
CR Arevalo J Fernando, 2010, Int Ophthalmol Clin, V50, P57, DOI 10.1097/IIO.0b013e3181d26bf4
   Baharivand N, 2013, INT OPHTHALMOL, V33, P39, DOI 10.1007/s10792-012-9634-1
   Bosch-Driessen LH, 2002, AM J OPHTHALMOL, V134, P34, DOI 10.1016/S0002-9394(02)01537-4
   Chan CKM, 2010, OPHTHAL SURG LAS IM, V41, P26, DOI 10.3928/15428877-20091230-05
   Commodaro AG, 2009, MEM I OSWALDO CRUZ, V104, P345, DOI 10.1590/S0074-02762009000200030
   Ehmann D, 2010, CAN J OPHTHALMOL, V45, P36, DOI 10.3129/i09-243
   GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5
   Haller JA, 2010, OPHTHALMOLOGY, V117, P1134, DOI 10.1016/j.ophtha.2010.03.032
   Haller JA, 2010, ARCH OPHTHALMOL-CHIC, V128, P289, DOI 10.1001/archophthalmol.2010.21
   Holladay JT, 1997, J REFRACT SURG, V13, P388
   HOLLAND GN, 1989, ARCH OPHTHALMOL-CHIC, V107, P1759, DOI 10.1001/archopht.1989.01070020841024
   Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032
   Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040
   Holland GN, 2002, AM J OPHTHALMOL, V134, P102, DOI 10.1016/S0002-9394(02)01526-X
   Iaccheri B, 2008, CLIN THER, V30, P2069, DOI 10.1016/j.clinthera.2008.10.021
   Kim P, 2002, CLIN EXP OPHTHALMOL, V30, P147, DOI 10.1046/j.1442-6404.2002.00502.x
   Kishore K, 2001, OPHTHALMIC SURG LAS, V32, P183
   Lasave AF, 2010, OPHTHALMOLOGY, V117, P1831, DOI 10.1016/j.ophtha.2010.01.028
   Martinez CE, 1998, INT OPHTHALMOL, V22, P85, DOI 10.1023/A:1006129422690
   RAO VS, 1989, INT OPHTHALMOL, V13, P181, DOI 10.1007/BF02028207
   ROTHOVA A, 1993, AM J OPHTHALMOL, V115, P517, DOI 10.1016/S0002-9394(14)74456-3
   SILVEIRA C, 1988, AM J OPHTHALMOL, V106, P362, DOI 10.1016/0002-9394(88)90382-0
   Sobrin L, 2007, RETINA-J RET VIT DIS, V27, P952, DOI 10.1097/IAE.0b013e31804b3f0d
   Soheilian Masoud, 2001, International Ophthalmology, V24, P323, DOI 10.1023/B:INTE.0000006768.66170.c1
   Soheilian M, 2011, OPHTHALMOLOGY, V118, P134, DOI 10.1016/j.ophtha.2010.04.020
   Stanford MR, 2003, OPHTHALMOLOGY, V110, P926, DOI 10.1016/S0161-6420(03)00083-6
   Wong Roger, 2009, International Ophthalmology, V29, P195, DOI 10.1007/s10792-008-9192-8
NR 27
TC 7
Z9 7
U1 1
U2 1
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JUL-AUG
PY 2015
VL 78
IS 4
BP 216
EP 219
DI 10.5935/0004-2749.20150056
PG 4
WC Ophthalmology
SC Ophthalmology
GA CR7QV
UT WOS:000361546500004
PM 26375334
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Casaroli-Marano, RP
   Sousa-Martins, D
   Martinez-Conesa, EM
   Badaro, E
   Nunes, RP
   Lima, AA
   Rodrigues, EB
   Belfort, R
   Maia, M
AF Casaroli-Marano, Ricardo P.
   Sousa-Martins, Diogo
   Martinez-Conesa, Eva M.
   Badaro, Emmerson
   Nunes, Renata Portella
   Lima-Filho, Acacio A. S.
   Rodrigues, Eduardo B.
   Belfort, Rubens, Jr.
   Maia, Mauricio
TI Dye Solutions Based on Lutein and Zeaxanthin: In Vitro and In Vivo
   Analysis of Ocular Toxicity Profiles
SO CURRENT EYE RESEARCH
LA English
DT Article
DE ARPE-19; chromovitrectomy; in vitro validation assays; lutein; retinal
   pigment epithelium; zeaxanthin
ID INTERNAL LIMITING MEMBRANE; BRILLIANT BLUE-G; MACULAR PIGMENT;
   INDOCYANINE GREEN; VITAL DYES; CHROMOVITRECTOMY; CAROTENOIDS;
   SUPPLEMENTATION; DEGENERATION; MONOLAYER
AB Purpose: To study the safety profile of Lutein/Zeaxanthin(L/Z)-based natural dye solutions in in vitro and in vivo models.
   Material and methods: In vitro cytotoxicity and cellular growth experiments were carried out on ARPE-19 and human corneal epithelial (HCE) cell lines using different L/Z-based dye solutions, either alone or in association with brilliant blue (BB) or trypan blue (TB). Light and transmission electron microscopy studies were performed seven days after intravitreal injection of dye solutions in rabbits. Electroretinogram (ERG) recordings were taken at baseline and before histopathology.
   Results: In vitro cytotoxicity assays demonstrated that the different L/Z-based solutions (from 0.3 to 2%), either alone or in association with BB (0.025%) or TB (0.04%), did not significantly alter mitochondrial activity (<= 15%) in the cell lines tested. In addition, in vitro cell growth was inhibited by up to 60% depending on the dye solution, and in direct proportion to the concentration assayed. There was no evidence of structural alterations in the neurosensory retina, retinal pigment epithelium (RPE), or choriocapillaris-choroidal complex. b-Wave ERG records showed no significant differences (+/- 15.2%) in comparison with baseline.
   Conclusions: L/Z-based dye solutions demonstrated a safe profile in in vitro and in vivo models, and may be a useful tool for staining intraocular structures.
C1 [Casaroli-Marano, Ricardo P.; Sousa-Martins, Diogo; Badaro, Emmerson; Nunes, Renata Portella; Lima-Filho, Acacio A. S.; Rodrigues, Eduardo B.; Belfort, Rubens, Jr.; Maia, Mauricio] Univ Fed Sao Paulo, Inst Visao IPEPO, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
   [Casaroli-Marano, Ricardo P.] Univ Barcelona, Sch Med, Dept Surg, Barcelona, Spain.
   [Casaroli-Marano, Ricardo P.] Univ Barcelona, Cell Tec UB, Barcelona, Spain.
   [Martinez-Conesa, Eva M.] Hosp Clin Barcelona, Transplant Serv Fdn, E-08028 Barcelona, Spain.
RP Casaroli-Marano, RP (corresponding author), Hosp Clin Barcelona, Inst Clin Oftalmol, Calle Sabino de Arana 1, E-08028 Barcelona, Spain.
EM rcasaroli@ub.edu
RI Sousa-Martins, Diogo/B-1554-2019; Maia, Mauricio/I-5892-2015; de Souza
   Lima Filho, Acacio Alves/C-7189-2012; Casaroli-Marano, Ricardo
   Pedro/D-4535-2014
OI Sousa-Martins, Diogo/0000-0002-2285-3990; Maia,
   Mauricio/0000-0002-7034-8091; Casaroli-Marano, Ricardo
   Pedro/0000-0003-1812-9323; Buchele Rodrigues,
   Eduardo/0000-0002-4224-0921; Alves de Souza Lima Filho,
   Acacio/0000-0003-1802-9592
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo,
   Brazil)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPq (Conselho Nacional de Pesquisa, Brazil)National Council for
   Scientific and Technological Development (CNPq); FIS (Fondo de
   Investigacion Sanitaria del Instituto de Salud Carlos III, Spain)
   [PI09/0992]
FX This study was supported by grants from the FAPESP (Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo, Brazil), CNPq (Conselho Nacional de
   Pesquisa, Brazil) and FIS (PI09/0992; Fondo de Investigacion Sanitaria
   del Instituto de Salud Carlos III, Spain). The authors declare no
   competing interests.
CR Ahmed SS, 2005, SURV OPHTHALMOL, V50, P183, DOI 10.1016/j.survophthal.2004.12.009
   Aleman TS, 2001, INVEST OPHTH VIS SCI, V42, P1873
   Baszkin A, 2006, ADV COLLOID INTERFAC, V128, P111, DOI 10.1016/j.cis.2006.11.008
   Beatty S, 1999, BRIT J OPHTHALMOL, V83, P867, DOI 10.1136/bjo.83.7.867
   Bone RA, 2001, INVEST OPHTH VIS SCI, V42, P235
   Caseli L, 2013, COLLOID SURFACE B, V107, P124, DOI 10.1016/j.colsurfb.2013.01.076
   Chew EY, 2012, OPHTHALMOLOGY, V119, P2282, DOI 10.1016/j.ophtha.2012.05.027
   Da Mata AP, 2004, OPHTHALMOLOGY, V111, P2246, DOI 10.1016/j.ophtha.2004.05.037
   Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007
   Enaida Hiroshi, 2008, Dev Ophthalmol, V42, P115, DOI 10.1159/000138989
   Falsini B, 2003, OPHTHALMOLOGY, V110, P51, DOI 10.1016/S0161-6420(02)01547-6
   Farah ME, 2010, RETINAL PHARMACOTHER, P331
   Farah ME, 2009, AM J OPHTHALMOL, V148, P332, DOI 10.1016/j.ajo.2009.04.003
   Gale CR, 2001, OPHTHALMOLOGY, V108, P1992, DOI 10.1016/S0161-6420(01)00833-8
   GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3
   Landrum JT, 1997, EXP EYE RES, V65, P57, DOI 10.1006/exer.1997.0309
   Lo HM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-18
   Maia M, 2004, RETINA-J RET VIT DIS, V24, P157, DOI 10.1097/00006982-200402000-00024
   Maia M, 2004, RETINA-J RET VIT DIS, V24, P69, DOI 10.1097/00006982-200402000-00011
   Maia M, 2007, CURR EYE RES, V32, P309, DOI 10.1080/02713680701199377
   Maia M, 2014, RETINA-J RET VIT DIS, V34, P262, DOI 10.1097/IAE.0b013e3182a0b7f4
   MARESPERLMAN JA, 1995, ARCH OPHTHALMOL-CHIC, V113, P1518, DOI 10.1001/archopht.1995.01100120048007
   Margrain TH, 2004, PROG RETIN EYE RES, V23, P523, DOI 10.1016/j.preteyeres.2004.05.001
   Nolan JM, 2006, CURR EYE RES, V31, P199, DOI 10.1080/02713680500514677
   Pavinatto FJ, 2010, BIOMACROMOLECULES, V11, P1897, DOI 10.1021/bm1004838
   Rodrigues EB, 2007, CURR OPIN OPHTHALMOL, V18, P179, DOI 10.1097/ICU.0b013e32811080b5
   Rodrigues EB, 2010, AM J OPHTHALMOL, V149, P265, DOI 10.1016/j.ajo.2009.08.020
   Rodrigues EB, 2009, SURV OPHTHALMOL, V54, P576, DOI 10.1016/j.survophthal.2009.04.011
   Rodrigues Eduardo B, 2008, Dev Ophthalmol, V42, P29, DOI 10.1159/000138911
   Rodrigues EB, 2009, RETINA-J RET VIT DIS, V29, P497, DOI 10.1097/IAE.0b013e318196b1ad
   Seddon JM, 1994, EYE DIS CASE CONTROL, V272, P1413, DOI DOI 10.1001/JAMA.272.18.1413)
   SNODDERLY DM, 1991, INVEST OPHTH VIS SCI, V32, P268
   Sommerburg O, 1998, BRIT J OPHTHALMOL, V82, P907, DOI 10.1136/bjo.82.8.907
   Sousa-Martins D, 2012, RETINA-J RET VIT DIS, V32, P1328, DOI 10.1097/IAE.0b013e318239e2b6
   Steel DHW, 2011, OPHTHALMOLOGICA, V226, P27, DOI 10.1159/000328207
   Sujak A, 1999, ARCH BIOCHEM BIOPHYS, V371, P301, DOI 10.1006/abbi.1999.1437
   Toropainen E, 2001, INVEST OPHTH VIS SCI, V42, P2942
   Yemelyanov AY, 2001, EXP EYE RES, V72, P381, DOI 10.1006/exer.2000.0965
   Yuen D, 2009, AM J OPHTHALMOL, V147, P251, DOI 10.1016/j.ajo.2008.08.031
NR 39
TC 7
Z9 8
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0271-3683
EI 1460-2202
J9 CURR EYE RES
JI Curr. Eye Res.
PD JUL
PY 2015
VL 40
IS 7
BP 707
EP 718
DI 10.3109/02713683.2014.952831
PG 12
WC Ophthalmology
SC Ophthalmology
GA CP4NC
UT WOS:000359858000007
PM 25153042
DA 2020-12-01
ER

PT J
AU Berezovsky, A
   Cavascan, NN
   Furtado, JM
   Munoz, S
   Cohen, MJ
   Watanabe, SES
   Ferraz, AN
   Cohen, JM
   Belfort, R
   Salomao, SR
AF Berezovsky, Adriana
   Cavascan, Nivea Nunes
   Furtado, Joao M.
   Munoz, Sergio
   Cohen, Marcos Jacob
   Watanabe, Sung Eun Song
   Ferraz, Alberto Nunes
   Cohen, Jacob Moyses
   Belfort, Rubens, Jr.
   Salomao, Solange Rios
TI Interobserver Agreement of Anterior Chamber Angle Measurements with
   Optical Coherence Tomography in Older Adults from Urban Areas of
   Parintins, Brazilian Amazon Region
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Berezovsky, Adriana; Cavascan, Nivea Nunes; Furtado, Joao M.; Watanabe, Sung Eun Song; Ferraz, Alberto Nunes; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo, Dept Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Furtado, Joao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, BR-14049 Ribeirao Preto, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cohen, Jacob Moyses] Univ Fed Amazonas, Setor Oftalmol, Dept Cirurgia, Manaus, Amazonas, Brazil.
RI Furtado, Joao/D-4436-2012; Salomao, Solange R/G-9500-2012; Ferraz,
   Nivea/AAC-2439-2020; Berezovsky, Adriana/F-2341-2013
OI Salomao, Solange R/0000-0002-3436-5599; Ferraz,
   Nivea/0000-0001-7568-6199; Berezovsky, Adriana/0000-0001-6350-8221
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 4981
PG 3
WC Ophthalmology
SC Ophthalmology
GA CT5ZY
UT WOS:000362891104338
DA 2020-12-01
ER

PT J
AU Furtado, JM
   Berezovsky, A
   Cavascan, NN
   Munoz, S
   Cohen, MJ
   Cunha, C
   Mitsuhiro, MRKH
   Cohen, JM
   Belfort, R
   Salomao, SR
AF Furtado, Joao M.
   Berezovsky, Adriana
   Cavascan, Nivea Nunes
   Munoz, Sergio
   Cohen, Marcos Jacob
   Cunha, Cristina
   Kimie Higashi Mitsuhiro, Marcia Regina
   Cohen, Jacob Moyses
   Belfort, Rubens, Jr.
   Salomao, Solange Rios
TI Anterior Segment Optical Coherence Tomography in Healthy Older Adults
   from Parintins City: The Brazilian Amazon Region Eye Survey
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Furtado, Joao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, BR-14049 Ribeirao Preto, Brazil.
   [Furtado, Joao M.; Berezovsky, Adriana; Cavascan, Nivea Nunes; Cunha, Cristina; Kimie Higashi Mitsuhiro, Marcia Regina; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cohen, Jacob Moyses] Univ Fed Amazonas, Dept Cirurgia, Setor Oftalmol, Manaus, Amazonas, Brazil.
RI Furtado, Joao/D-4436-2012; Ferraz, Nivea/AAC-2439-2020; Salomao, Solange
   R/G-9500-2012; Berezovsky, Adriana/F-2341-2013
OI Ferraz, Nivea/0000-0001-7568-6199; Salomao, Solange
   R/0000-0002-3436-5599; Berezovsky, Adriana/0000-0001-6350-8221
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 6206
PG 3
WC Ophthalmology
SC Ophthalmology
GA CT5ZY
UT WOS:000362891107274
DA 2020-12-01
ER

PT J
AU Mitsuhiro, MRKH
   Munoz, S
   Berezovsky, A
   Cunha, C
   Furtado, JM
   Vasconcelos, G
   Cohen, MJ
   Cohen, JM
   Belfort, R
   Salomao, SR
AF Mitsuhiro, Marcia Regina Kimie Higashi
   Munoz, Sergio
   Berezovsky, Adriana
   Cunha, Cristina
   Furtado, Joao M.
   Vasconcelos, Galton
   Cohen, Marcos Jacob
   Cohen, Jacob Moyses
   Belfort, Rubens, Jr.
   Salomao, Solange Rios
TI Characterization of Pterygium as Primary Cause of Visual
   Impairment/Blindness in Older Adults from Urban Areas of Parintins: The
   Brazilian Amazon Region Eye Survey
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Mitsuhiro, Marcia Regina Kimie Higashi; Berezovsky, Adriana; Cunha, Cristina; Furtado, Joao M.; Vasconcelos, Galton; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
   [Furtado, Joao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Oftalmol Otorrinolaringol & Cirurgia Cabeca & Pes, Ribeirao Preto, Brazil.
   [Cohen, Marcos Jacob] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cohen, Jacob Moyses] Univ Fed Amazonas, Fac Med, Dept Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
RI Furtado, Joao/D-4436-2012; Salomao, Solange R/G-9500-2012; Berezovsky,
   Adriana/F-2341-2013
OI Salomao, Solange R/0000-0002-3436-5599; Berezovsky,
   Adriana/0000-0001-6350-8221
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 6205
PG 3
WC Ophthalmology
SC Ophthalmology
GA CT5ZY
UT WOS:000362891107273
DA 2020-12-01
ER

PT J
AU Sacai, PY
   Cavascan, NN
   Watanabe, SES
   Cypel, M
   Munoz, S
   Cohen, MJ
   Cohen, JM
   Berezovsky, A
   Belfort, R
   Salomao, SR
AF Sacai, Paula Y.
   Cavascan, Nivea Nunes
   Song Watanabe, Sung Eun
   Cypel, Marcela
   Munoz, Sergio
   Cohen, Marcos Jacob
   Cohen, Jacob Moyses
   Berezovsky, Adriana
   Belfort, Rubens, Jr.
   Salomao, Solange Rios
TI Ganglion Cell Complex Assessed by Spectral-Domain Optical Coherence
   Tomography in Normal Older Adults from the City of Parintins, Brazilian
   Amazon Region
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Sacai, Paula Y.; Cavascan, Nivea Nunes; Song Watanabe, Sung Eun; Cypel, Marcela; Berezovsky, Adriana; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo, Dept Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
   [Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cohen, Jacob Moyses] Univ Fed Amazonas, Setor Oftalmol, Dept Cirurgia, Manaus, Amazonas, Brazil.
RI Ferraz, Nivea/AAC-2439-2020; Sacai, Paula Y/B-6525-2014; Berezovsky,
   Adriana/F-2341-2013; Salomao, Solange R/G-9500-2012
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221; Salomao, Solange R/0000-0002-3436-5599
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 4537
PG 3
WC Ophthalmology
SC Ophthalmology
GA CT5ZY
UT WOS:000362891103318
DA 2020-12-01
ER

PT J
AU Bachmann, BO
   Sousa, SH
   Matthaei, M
   Cursiefen, C
   Siebelmann, SE
   Cunha, CSE
   Sousa-Martins, D
   Lima, A
   Belfort, R
   Maia, M
AF Bachmann, Bjoern O.
   Sousa, Sara Homem
   Matthaei, Mario
   Cursiefen, Claus
   Siebelmann, Sebastian E.
   Sa e Cunha, Claudia
   Sousa-Martins, Diogo
   Lima, Acacio
   Belfort, Rubens
   Maia, Mauricio
TI Trypan Blue free DMEK: Use of Brilliant Blue combined with Lutein /
   Zeaxanthin for staining of Descemet's membrane during DMEK surgery
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Bachmann, Bjoern O.; Matthaei, Mario; Cursiefen, Claus; Siebelmann, Sebastian E.] Universityhosp Cologne, Ophthalmol, Cologne, Germany.
   [Sousa, Sara Homem; Sa e Cunha, Claudia; Sousa-Martins, Diogo] Kemin Pharma, Barcarena, Portugal.
   [Sousa-Martins, Diogo; Lima, Acacio; Belfort, Rubens; Maia, Mauricio] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
RI Maia, Mauricio/I-5892-2015; de Souza Lima Filho, Acacio
   Alves/C-7189-2012; Cursiefen, Claus/ABE-5284-2020
OI Maia, Mauricio/0000-0002-7034-8091; Alves de Souza Lima Filho,
   Acacio/0000-0003-1802-9592
NR 0
TC 2
Z9 2
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 1589
PG 3
WC Ophthalmology
SC Ophthalmology
GA CT5WQ
UT WOS:000362882204050
DA 2020-12-01
ER

PT J
AU Cabral, T
   Polido, J
   Okuda, EA
   Oshima, A
   Serracarbassa, P
   Belfort, R
   Regatieri, C
AF Cabral, Thiago
   Polido, Julia
   Okuda, Erika Araki
   Oshima, Akiyoshi
   Serracarbassa, Pedro
   Belfort, Rubens, Jr.
   Regatieri, Caio
TI VEGF dosage curve in the aqueous humor after bevacizumab intravitreal
   injection in patients with neovascular AMD
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Cabral, Thiago; Polido, Julia; Belfort, Rubens, Jr.; Regatieri, Caio] UNIFESP, Vitoria, Brazil.
   [Cabral, Thiago; Polido, Julia; Okuda, Erika Araki; Oshima, Akiyoshi; Serracarbassa, Pedro] HSPE IAMSPE, Ophthalmol, Sao Paulo, Brazil.
RI Regatieri, Caio/G-8152-2014; Cabral, Thiago/AAD-4857-2019
OI Regatieri, Caio/0000-0003-1511-8696; Cabral, Thiago/0000-0002-1201-8772
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 1513
PG 3
WC Ophthalmology
SC Ophthalmology
GA CT5WQ
UT WOS:000362882203403
DA 2020-12-01
ER

PT J
AU Cavascan, NN
   Watanabe, SES
   Cypel, M
   Sacai, PY
   Berezovsky, A
   Cohen, MJ
   Cohen, JM
   Munoz, S
   Belfort, R
   Salomao, SR
AF Cavascan, Nivea Nunes
   Song Watanabe, Sung Eun
   Cypel, Marcela
   Sacai, Paula Y.
   Berezovsky, Adriana
   Cohen, Marcos Jacob
   Cohen, Jacob Moyses
   Munoz, Sergio
   Belfort, Rubens, Jr.
   Salomao, Solange Rios
TI Optic nerve head and retinal nerve fiber layer OCT values in a
   population-based sample of healthy older adults from urban areas of
   Parintins, Brazilian Amazon Region
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Cavascan, Nivea Nunes; Song Watanabe, Sung Eun; Cypel, Marcela; Sacai, Paula Y.; Berezovsky, Adriana; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo, Dept Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cohen, Jacob Moyses] Univ Fed Amazonas, Dept Cirurgia, Setor Oftalmol, Manaus, Amazonas, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
RI Ferraz, Nivea/AAC-2439-2020; Berezovsky, Adriana/F-2341-2013; Salomao,
   Solange R/G-9500-2012; Sacai, Paula Y/B-6525-2014
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221; Salomao, Solange R/0000-0002-3436-5599; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 591
PG 3
WC Ophthalmology
SC Ophthalmology
GA CT5WQ
UT WOS:000362882201349
DA 2020-12-01
ER

PT J
AU Salomao, SR
   Munoz, S
   Furtado, JM
   Berezovsky, A
   Cohen, MJ
   Cavascan, NN
   Morales, PHA
   Watanabe, SES
   Cohen, JM
   Belfort, R
AF Salomao, Solange Rios
   Munoz, Sergio
   Furtado, Joao M.
   Berezovsky, Adriana
   Cohen, Marcos Jacob
   Cavascan, Nivea Nunes
   Avila Morales, Paulo Henrique
   Song Watanabe, Sung Eun
   Cohen, Jacob Moyses
   Belfort, Rubens, Jr.
TI Prevalence and Causes of Visual Impairment and Blindness in Older Adults
   from Urban Areas of Parintins City: The Brazilian Amazon Region Eye
   Survey
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Salomao, Solange Rios; Furtado, Joao M.; Berezovsky, Adriana; Cavascan, Nivea Nunes; Avila Morales, Paulo Henrique; Song Watanabe, Sung Eun; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Oftalmol, Sao Paulo, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
   [Furtado, Joao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Otorrinolaringol & Cirurgia Cabeca & Pescoco, Oftalmol, Ribeirao Preto, Brazil.
   [Cohen, Marcos Jacob; Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cohen, Jacob Moyses] Univ Fed Amazonas, Dept Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
RI Salomao, Solange R/G-9500-2012; Berezovsky, Adriana/F-2341-2013; Ferraz,
   Nivea/AAC-2439-2020; Furtado, Joao/D-4436-2012
OI Salomao, Solange R/0000-0002-3436-5599; Berezovsky,
   Adriana/0000-0001-6350-8221; Ferraz, Nivea/0000-0001-7568-6199; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 2105
PG 3
WC Ophthalmology
SC Ophthalmology
GA CT5WQ
UT WOS:000362882205108
DA 2020-12-01
ER

PT J
AU Watanabe, SES
   Sacai, PY
   Cavascan, NN
   Cypel, M
   Munoz, S
   Morales, PHA
   Cohen, JM
   Berezovsky, A
   Belfort, R
   Salomao, SR
AF Song Watanabe, Sung Eun
   Sacai, Paula Y.
   Cavascan, Nivea Nunes
   Cypel, Marcela
   Munoz, Sergio
   Avila Morales, Paulo Henrique
   Cohen, Jacob Moyses
   Berezovsky, Adriana
   Belfort, Rubens, Jr.
   Salomao, Solange Rios
TI MACULAR THICKNESS MEASURED BY OPTICAL COHERENCE TOMOGRAPHY IN HEALTHY
   OLDER ADULTS FROM THE CITY OF PARINTINS, BRAZILIAN AMAZON REGION
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Song Watanabe, Sung Eun; Sacai, Paula Y.; Cavascan, Nivea Nunes; Cypel, Marcela; Avila Morales, Paulo Henrique; Berezovsky, Adriana; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
   [Cohen, Jacob Moyses] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cohen, Jacob Moyses] Univ Fed Amazonas, Dept Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
RI Sacai, Paula Y/B-6525-2014; Salomao, Solange R/G-9500-2012; Ferraz,
   Nivea/AAC-2439-2020; Berezovsky, Adriana/F-2341-2013
OI Salomao, Solange R/0000-0002-3436-5599; Ferraz,
   Nivea/0000-0001-7568-6199; Berezovsky, Adriana/0000-0001-6350-8221
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 593
PG 3
WC Ophthalmology
SC Ophthalmology
GA CT5WQ
UT WOS:000362882201351
DA 2020-12-01
ER

PT J
AU Vianna, L
   Li, HD
   Holiman, JD
   Stoeger, C
   Belfort, R
   Jun, AS
AF Vianna, Lucas
   Li, Hao Dong
   Holiman, Jeffrey D.
   Stoeger, Chris
   Belfort, Rubens
   Jun, Albert S.
TI Characterization of cryopreserved primary human corneal endothelial
   cells cultured in human serum supplemented media
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY MAY 03-07, 2015
CL Denver, CO
SP Assoc Res Vis & Ophthalmol
C1 [Vianna, Lucas; Li, Hao Dong; Jun, Albert S.] Johns Hopkins Univ, Ophthalmol, Baltimore, MD USA.
   [Vianna, Lucas; Belfort, Rubens] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
   [Vianna, Lucas] Univ Estado Rio De Janeiro, Sao Paulo, Brazil.
   [Holiman, Jeffrey D.; Stoeger, Chris] Lions VisionGift, Portland, OR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2015
VL 56
IS 7
MA 1160
PG 2
WC Ophthalmology
SC Ophthalmology
GA CT5WQ
UT WOS:000362882203069
DA 2020-12-01
ER

PT J
AU Cunningham, ET
   Belfort, R
   Muccioli, C
   Arevalo, JF
   Zierhut, M
AF Cunningham, Emmett T., Jr.
   Belfort, Rubens, Jr.
   Muccioli, Cristina
   Arevalo, J. Fernando
   Zierhut, Manfred
TI Ocular Toxoplasmosis
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Editorial Material
ID INTRAVITREAL CLINDAMYCIN; GLOBAL REASSESSMENT; MEMORIAL-LECTURE;
   RETINOCHOROIDITIS; EPIDEMIOLOGY; MANIFESTATIONS; DEXAMETHASONE;
   RECURRENCES; RISK; PATHOPHYSIOLOGY
C1 [Cunningham, Emmett T., Jr.] Calif Pacific Med Ctr, Dept Ophthalmol, San Francisco, CA USA.
   [Cunningham, Emmett T., Jr.] Stanford Univ, Sch Med, Dept Ophthalmol, Stanford, CA 94305 USA.
   [Cunningham, Emmett T., Jr.] Univ Calif San Francisco, Francis I Proctor Fdn, Sch Med, San Francisco, CA 94143 USA.
   [Belfort, Rubens, Jr.; Muccioli, Cristina] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo Hosp, Sao Paulo, Brazil.
   [Arevalo, J. Fernando] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia.
   [Arevalo, J. Fernando] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.
   [Zierhut, Manfred] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany.
RP Cunningham, ET (corresponding author), West Coast Retina Med Grp, 1445 Bush St, San Francisco, CA 94109 USA.
EM emmett_cunningham@yahoo.com
CR Baharivand N, 2013, INT OPHTHALMOL, V33, P39, DOI 10.1007/s10792-012-9634-1
   Bonfioli Adriana A, 2005, Semin Ophthalmol, V20, P129, DOI 10.1080/08820530500231961
   Bosch-Driessen LH, 2002, OPHTHALMOLOGY, V109, P41, DOI 10.1016/S0161-6420(01)00845-4
   Braakenburg AMD, 2014, AM J OPHTHALMOL, V157, P767, DOI 10.1016/j.ajo.2014.01.004
   Butler NJ, 2013, CLIN EXP OPHTHALMOL, V41, P95, DOI 10.1111/j.1442-9071.2012.02838.x
   Commodaro AG, 2009, MEM I OSWALDO CRUZ, V104, P345, DOI 10.1590/S0074-02762009000200030
   Cunningham ET, 2011, ARCH OPHTHALMOL-CHIC, V129, P1507, DOI 10.1001/archophthalmol.2011.331
   Delair E, 2011, OCUL IMMUNOL INFLAMM, V19, P91, DOI 10.3109/09273948.2011.564068
   Felix JPF, 2014, AM J OPHTHALMOL, V157, P762, DOI 10.1016/j.ajo.2013.12.022
   Furtado JM, 2013, CLIN EXP OPHTHALMOL, V41, P82, DOI 10.1111/j.1442-9071.2012.02821.x
   Garweg JG, 2013, OCUL IMMUNOL INFLAMM, V21, P300, DOI 10.3109/09273948.2013.779724
   Garweg JG, 2011, OCUL IMMUNOL INFLAMM, V19, P255, DOI 10.3109/09273948.2011.595872
   Harrell M, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/273506
   Heringer GC, 2014, BRIT J OPHTHALMOL, V98, P1218, DOI 10.1136/bjophthalmol-2013-304259
   Holland GN, 2008, AM J OPHTHALMOL, V145, P1007, DOI 10.1016/j.ajo.2008.01.023
   Holland GN, 2009, MEM I OSWALDO CRUZ, V104, P351, DOI 10.1590/S0074-02762009000200031
   Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032
   Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040
   Hovakimyan Anna, 2002, Ophthalmol Clin North Am, V15, P327, DOI 10.1016/S0896-1549(02)00030-5
   Kijlstra A, 2014, OCUL IMMUNOL INFLAMM, V22, P138, DOI 10.3109/09273948.2013.823214
   Kim SJ, 2013, OPHTHALMOLOGY, V120, P371, DOI 10.1016/j.ophtha.2012.07.061
   Kishore K, 2001, OPHTHALMIC SURG LAS, V32, P183
   Lasave AF, 2010, OPHTHALMOLOGY, V117, P1831, DOI 10.1016/j.ophtha.2010.01.028
   Maenz M, 2014, PROG RETIN EYE RES, V39, P77, DOI 10.1016/j.preteyeres.2013.12.005
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   ONIKI S, 1983, JPN J OPHTHALMOL, V27, P166
   Petersen E, 2012, OCUL IMMUNOL INFLAMM, V20, P68, DOI 10.3109/09273948.2012.661115
   Pleyer U, 2014, OPHTHALMIC RES, V52, P116, DOI 10.1159/000363141
   Reich M., 2014, OCUL IMMUNOL INFLAMM, V16, P1
   Reich M, 2015, RETINA-J RET VIT DIS, V35, P809, DOI 10.1097/IAE.0000000000000361
   Silveira C, 2002, AM J OPHTHALMOL, V134, P41, DOI 10.1016/S0002-9394(02)01527-1
   Silveira C, 2014, OCUL IMMUNOL INFLAMM, V17, P1
   Smith Justine R, 2002, Curr Opin Ophthalmol, V13, P387, DOI 10.1097/00055735-200212000-00008
   Sobrin L, 2007, RETINA-J RET VIT DIS, V27, P952, DOI 10.1097/IAE.0b013e31804b3f0d
   Soheilian M, 2011, OPHTHALMOLOGY, V118, P134, DOI 10.1016/j.ophtha.2010.04.020
   Taravati P, 2013, CURR OPHTHALMOL REP, V1
   Vasconcelos-Santos DV, 2012, CURR OPIN OPHTHALMOL, V23, P543, DOI 10.1097/ICU.0b013e328358bae5
   Yusuf IH, 2014, OCUL IMMUNOL INFLAMM
   Zamora YF, 2015, ARQ BRAS OFTALMOL, V78, P216, DOI 10.5935/0004-2749.20150056
NR 39
TC 1
Z9 1
U1 0
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PD JUN
PY 2015
VL 23
IS 3
BP 191
EP 193
DI 10.3109/09273948.2015.1051360
PG 3
WC Ophthalmology
SC Ophthalmology
GA CK9BZ
UT WOS:000356536700001
PM 26066570
DA 2020-12-01
ER

PT J
AU Silveira, C
   Muccioli, C
   Nussenblatt, R
   Belfort, R
AF Silveira, Claudio
   Muccioli, Cristina
   Nussenblatt, Robert
   Belfort, Rubens, Jr.
TI The Effect of Long-term Intermittent Trimethoprim/Sulfamethoxazole
   Treatment on Recurrences of Toxoplasmic Retinochoroiditis: 10 Years of
   Follow-up
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Editorial Material
C1 [Silveira, Claudio] Clin Silveira, Erechim, RS, Brazil.
   [Muccioli, Cristina; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Ophthalmol, Sao Paulo, Brazil.
   [Nussenblatt, Robert] NEI, Immunol Lab, Bethesda, MD 20892 USA.
   [Nussenblatt, Robert] NIH, Ctr Human Immunol, Bethesda, MD 20892 USA.
RP Belfort, R (corresponding author), R Botucatu 821, BR-04023062 Sao Paulo, Brazil.
FU Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA Funding Source:
   Medline
CR Commodaro AG, 2009, MEM I OSWALDO CRUZ, V104, P345, DOI 10.1590/S0074-02762009000200030
   Holland GN, 1996, OCULAR INFECT IMMUNI, P1083
   Silveira C, 2002, AM J OPHTHALMOL, V134, P41, DOI 10.1016/S0002-9394(02)01527-1
NR 3
TC 13
Z9 14
U1 0
U2 1
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PD JUN
PY 2015
VL 23
IS 3
BP 246
EP 247
DI 10.3109/09273948.2014.964422
PG 2
WC Ophthalmology
SC Ophthalmology
GA CK9BZ
UT WOS:000356536700009
PM 25325434
OA Bronze
DA 2020-12-01
ER

PT J
AU Arantes, TEF
   Silveira, C
   Holland, GN
   Muccioli, C
   Yu, F
   Jones, JL
   Goldhardt, R
   Lewis, KG
   Belfort, R
AF Arantes, Tiago E. F.
   Silveira, Claudio
   Holland, Gary N.
   Muccioli, Cristina
   Yu, Fei
   Jones, Jeffrey L.
   Goldhardt, Raquel
   Lewis, Kevan G.
   Belfort, Rubens, Jr.
TI Ocular Involvement Following Postnatally Acquired Toxoplasma gondii
   Infection in Southern Brazil: A 28-Year Experience
SO AMERICAN JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID UNITED-STATES; RETINOCHOROIDITIS; OUTBREAK; DIAGNOSIS; PATTERNS; DECADE;
   IGM
AB PURPOSE: To determine the incidence of, and risk factors for, ocular involvement among people known to have postnatally acquired Toxoplasma gondii infection in a region of southern Brazil where there is a high prevalence of endemic disease.
   DESIGN: Retrospective longitudinal cohort study.
   METHODS: Records of 302 patients with serologic evidence of recent T gondii infection (a positive anti-T gondii IgM antibody test) from Erechim, Rio Grande do Sul state, Brazil (1974-2002) were analyzed. The incidence of ocular involvement was calculated in terms of person-years (PY) of follow-up. Risk factors for ocular involvement were analyzed using log-rank and Fisher exact tests.
   RESULTS: At initial ocular examination (baseline), 30 patients (9.9%) had intraocular inflammation only (anterior chamber cells and flare, vitreous inflammatory reactions, retinal whitening), without clinically apparent necrotizing retinochoroiditis. At baseline, men were more likely to have ocular involvement (P =.043) and antiparasitic treatment was associated with less ocular involvement (P =.015). Follow-up examinations were performed on 255 patients (median follow-up, 13.7 months [range 0.4-261.9 months]). Among those without ocular involvement at baseline, the incidence of necrotizing retinochoroiditis was 6.4/100 PY. Patients >40 years of age at first IgM test had a greater risk of incident necrotizing retinochoroiditis (hazard ratio = 4.47, 95% CI = 1.67-11.93, P =.003) than younger patients. The incidence of recurrent necrotizing retinochoroiditis was 10.5/100 PY.
   CONCLUSION: Isolated intraocular inflammatory reactions can be an initial manifestation of T gondii infection, with necrotizing retinochoroiditis occurring months or years later. Male sex and older age are risk factors for toxoplasmic retinochoroiditis. Antitoxoplasmic treatment may protect against early ocular involvement. (C) 2015 by Elsevier Inc. All rights reserved.
C1 [Arantes, Tiago E. F.; Holland, Gary N.; Yu, Fei; Goldhardt, Raquel; Lewis, Kevan G.] Univ Calif Los Angeles, Jules Stein Eye Inst, David Geffen Sch Med, Ocular Inflammatory Dis Ctr, Los Angeles, CA 90095 USA.
   [Arantes, Tiago E. F.; Holland, Gary N.; Yu, Fei; Goldhardt, Raquel; Lewis, Kevan G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA.
   [Silveira, Claudio] Clin Silveira, Erechim, RS, Brazil.
   [Arantes, Tiago E. F.; Silveira, Claudio; Muccioli, Cristina; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Jones, Jeffrey L.] US Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA.
RP Holland, GN (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, 100 Stein Plaza, Los Angeles, CA 90095 USA.
EM uveitis@jsei.ucla.edu
RI Arantes, Tiago EF/I-3093-2013
OI Arantes, Tiago EF/0000-0002-8122-3446
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (CNPq/FAPESP), Sao Paulo,
   Brazil; Research to Prevent Blindness (RPB), Inc, New York, New
   YorkResearch to Prevent Blindness (RPB); Skirball Foundation, New York,
   New York; Centers for Disease Control and PreventionUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA; RPB Physician-Scientist Award
FX Funding: Supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico and the Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (CNPq/FAPESP), Sao Paulo, Brazil (Drs Silveira, Muccioli,
   Belfort); Research to Prevent Blindness (RPB), Inc, New York, New York
   (Dr Holland), the Skirball Foundation, New York, New York (Dr Holland),
   and the Centers for Disease Control and Prevention (Dr Jones). Dr
   Holland is recipient of an RPB Physician-Scientist Award. Funding
   entities had no rote in the reporting of study data and the
   interpretation of the data. All authors attest that they meet the
   current ICMJE requirements to qualify as authors.
CR Balasundaram MB, 2010, ARCH OPHTHALMOL-CHIC, V128, P28, DOI 10.1001/archophthalmol.2009.354
   Bosch-Driessen LEH, 2002, OPHTHALMOLOGY, V109, P869, DOI 10.1016/S0161-6420(02)00990-9
   Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3
   Burnett AJ, 1998, OPHTHALMOLOGY, V105, P1032, DOI 10.1016/S0161-6420(98)96004-3
   de Moura L, 2006, EMERG INFECT DIS, V12, P326, DOI 10.3201/eid1202.041115
   DELBONO V, 1989, J CLIN MICROBIOL, V27, P2133, DOI 10.1128/JCM.27.9.2133-2135.1989
   Dodds EM, 2008, AM J OPHTHALMOL, V146, P856, DOI 10.1016/j.ajo.2008.09.006
   Dubey JP, 2004, J PARASITOL, V90, P721, DOI 10.1645/GE-382R
   Gilbert RE, 2000, BRIT J OPHTHALMOL, V84, P224, DOI 10.1136/bjo.84.2.224
   GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5
   Gomez-Marin JE, 2000, MEM I OSWALDO CRUZ, V95, P89, DOI 10.1590/S0074-02762000000100014
   Gras L, 2004, EPIDEMIOL INFECT, V132, P541, DOI 10.1017/S0950268803001948
   Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800
   Holland GN, 2008, AM J OPHTHALMOL, V145, P1007, DOI 10.1016/j.ajo.2008.01.023
   Holland GN, 2010, ARCH OPHTHALMOL-CHIC, V128, P126, DOI 10.1001/archophthalmol.2008.538
   Holland GN, 2009, MEM I OSWALDO CRUZ, V104, P351, DOI 10.1590/S0074-02762009000200031
   Holland GN, 1999, AM J OPHTHALMOL, V128, P413, DOI 10.1016/S0002-9394(99)00300-1
   Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040
   Jabs DA, 2005, AM J OPHTHALMOL, V139, P900, DOI 10.1016/j.ajo.2004.12.009
   Johnson MW, 1997, OPHTHALMOLOGY, V104, P48, DOI 10.1016/S0161-6420(97)30362-5
   Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405
   Jones JL, 2015, CLIN INFECT DIS, V60, P271, DOI 10.1093/cid/ciu793
   Jones JL, 2009, CLIN INFECT DIS, V49, P878, DOI 10.1086/605433
   Jones JL, 2006, EMERG INFECT DIS, V12, P582
   Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025
   Labalette P, 2002, AM J OPHTHALMOL, V133, P506, DOI 10.1016/S0002-9394(02)01324-7
   McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Neves ES, 2009, MEM I OSWALDO CRUZ, V104, P393, DOI 10.1590/S0074-02762009000200039
   Silva CSP, 2008, BRAZ J INFECT DIS, V12, P438, DOI 10.1590/S1413-86702008000500016
   Phan L, 2008, OPHTHALMOLOGY, V115, P553, DOI 10.1016/j.ophtha.2007.06.022
   Shobab L, 2013, J INFECT DIS, V208, P1520, DOI 10.1093/infdis/jit313
   Shwab EK, 2014, PARASITOLOGY, V141, P453, DOI 10.1017/S0031182013001844
   SILVEIRA C, 1988, AM J OPHTHALMOL, V106, P362, DOI 10.1016/0002-9394(88)90382-0
   Silveira C, 2002, AM J OPHTHALMOL, V134, P41, DOI 10.1016/S0002-9394(02)01527-1
   Silveira C, 2001, AM J OPHTHALMOL, V131, P351, DOI 10.1016/S0002-9394(00)00830-8
   Silveira C., 2002, TOXOPLASMOSE DUVIDAS, V1st, P53
   Silveira C, 2015, AM J OPHTHALMOL, V159, P1013, DOI 10.1016/j.ajo.2015.02.017
   Silveira C, 2011, BRIT J OPHTHALMOL, V95, P396, DOI 10.1136/bjo.2008.148205
   Vaudaux JD, 2010, J INFECT DIS, V202, P1226, DOI 10.1086/656397
   WELCH PC, 1980, J INFECT DIS, V142, P256, DOI 10.1093/infdis/142.2.256
NR 41
TC 25
Z9 26
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9394
EI 1879-1891
J9 AM J OPHTHALMOL
JI Am. J. Ophthalmol.
PD JUN
PY 2015
VL 159
IS 6
BP 1002
EP 1012
DI 10.1016/j.ajo.2015.02.015
PG 11
WC Ophthalmology
SC Ophthalmology
GA CI9DL
UT WOS:000355070500002
PM 25743338
DA 2020-12-01
ER

PT J
AU Silveira, C
   Muccioli, C
   Holland, GN
   Jones, JL
   Yu, F
   de Paulo, A
   Belfort, R
AF Silveira, Claudio
   Muccioli, Cristina
   Holland, Gary N.
   Jones, Jeffrey L.
   Yu, Fei
   de Paulo, Adam
   Belfort, Rubens, Jr.
TI Ocular Involvement Following an Epidemic of Toxoplasma gondii Infection
   in Santa Isabel do Ivai, Brazil
SO AMERICAN JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID OUTBREAK
AB PURPOSE: To investigate ocular involvement (prevalence, incidence, lesion characteristics) following postnatally. acquired infection with an "atypical" genotype of Toxoplasma gondii during a well-characterized 2001 outbreak in Santa Isabel do Ivai, Brazil, attributed to a contaminated municipal reservoir.
   DESIGN: Prospective longitudinal cohort study.
   METHODS: We performed ophthalmic examinations on 290 of 454 individuals with serologic evidence of T gondii infection during the epidemic (positive IgM antibody tests). Prevalence of ophthalmic findings (intraocular inflammatory reactions [including transient, isolated retinal whitening without clinically apparent retinal necrosis] and necrotizing retinochoroiditis) at initial examination (baseline) and incidence of new findings during 10.5 months of follow-up were calculated. Cumulative risks of ophthalmic events were determined (Kaplan-Meier technique). "
   RESULTS: Ocular involvement was present in 33 of 288 IgM individuals (11.5%) at baseline, including 17 with focal retinal whitening only and 13 with necrotizing retinochoroiditis. Incidence of new ocular involvement was estimated to be 1.73 events per 100 person-months (PM); cumulative risk at 10.5 months was 30.1%. Incident necrotizing retinochoroiditis was more common among those with focal retinal whitening at baseline (6.7/100 PM) than among those with no ocular involvement at baseline (1.11/100 PM; hazard ratio 6.07 [1.94-19.01]; P <.0001).
   CONCLUSIONS: Waterborne infection with an atypical genotype of T gondii is associated with substantial risk of ocular involvement. Lesions may continue to develop during the first year after infection. The increased risk of late necrotizing retinochoroiditis associated with isolated focal retinal whitening at presentation suggests the early presence of parasites in the retina, despite initial lack of observable retinal necrosis. (C) 2015 by Elsevier Inc. All rights reserved.
C1 [Silveira, Claudio; Muccioli, Cristina; de Paulo, Adam; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Silveira, Claudio] Clin Silveira, Erechim, RS, Brazil.
   [Holland, Gary N.; Yu, Fei] Univ Calif Los Angeles, Jules Stein Eye Inst, David Geffen Sch Med, Ocular Inflammatory Dis Ctr, Los Angeles, CA 90095 USA.
   [Holland, Gary N.; Yu, Fei] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA.
   [Jones, Jeffrey L.] US Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA.
RP Holland, GN (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, 100 Stein Plaza, Los Angeles, CA 90095 USA.
EM uveitis@jsei.ucla.edu
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (CNPq/FAPESP), Sao Paulo,
   Brazil; Research to Prevent Blindness (RPB), Inc, New York, New
   YorkResearch to Prevent Blindness (RPB); Skirball Foundation, New York,
   New York; Centers for Disease Control and Prevention, Atlanta,
   GeorgiaUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA; RPB Physician-Scientist Award
FX Funding: Supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico and the Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (CNPq/FAPESP), Sao Paulo, Brazil (Drs Silveira, Muccioli,
   Belfort); Research to Prevent Blindness (RPB), Inc, New York, New York
   (Dr Holland); the Skirball Foundation, New York, New York (Dr Holland);
   and the Centers for Disease Control and Prevention, Atlanta, Georgia (Dr
   Jones). Dr Holland is recipient of an RPB Physician-Scientist Award.
   Funding entities had no role in the reporting of study data and the
   interpretation of the data. All authors attest that they meet the
   current ICMJE requirements to qualify as authors.
CR AKSTEIN RB, 1982, OPHTHALMOLOGY, V89, P1299, DOI 10.1016/S0161-6420(82)34629-1
   Arantes TE, 2015, AM J OPHTHALMOL
   Balasundaram MB, 2010, ARCH OPHTHALMOL-CHIC, V128, P28, DOI 10.1001/archophthalmol.2009.354
   BENENSON MW, 1982, NEW ENGL J MED, V307, P666, DOI 10.1056/NEJM198209093071107
   Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1
   Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3
   Burnett AJ, 1998, OPHTHALMOLOGY, V105, P1032, DOI 10.1016/S0161-6420(98)96004-3
   de Moura L, 2006, EMERG INFECT DIS, V12, P326, DOI 10.3201/eid1202.041115
   Dodds EM, 2008, AM J OPHTHALMOL, V146, P856, DOI 10.1016/j.ajo.2008.09.006
   Dubey JP, 2002, INT J PARASITOL, V32, P99, DOI 10.1016/S0020-7519(01)00364-2
   GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5
   Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800
   Holland GN, 2008, AM J OPHTHALMOL, V145, P1007, DOI 10.1016/j.ajo.2008.01.023
   Holland GN, 2010, ARCH OPHTHALMOL-CHIC, V128, P126, DOI 10.1001/archophthalmol.2008.538
   Holland GN, 1999, AM J OPHTHALMOL, V128, P413, DOI 10.1016/S0002-9394(99)00300-1
   Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032
   Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040
   Jabs DA, 2005, AM J OPHTHALMOL, V139, P900, DOI 10.1016/j.ajo.2004.12.009
   Jones JL, 2010, AM J TROP MED HYG, V82, P464, DOI 10.4269/ajtmh.2010.09-0664
   Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025
   PERKINS ES, 1973, BRIT J OPHTHALMOL, V57, P1, DOI 10.1136/bjo.57.1.1
   Silveira C, 2002, AM J OPHTHALMOL, V134, P41, DOI 10.1016/S0002-9394(02)01527-1
   Silveira C, 2001, AM J OPHTHALMOL, V131, P351, DOI 10.1016/S0002-9394(00)00830-8
   Silveira C, 2011, BRIT J OPHTHALMOL, V95, P396, DOI 10.1136/bjo.2008.148205
   STAGNO S, 1980, PEDIATRICS, V65, P706
   TEUTSCH SM, 1979, NEW ENGL J MED, V300, P695, DOI 10.1056/NEJM197903293001302
   Vaudaux JD, 2010, J INFECT DIS, V202, P1226, DOI 10.1086/656397
   WELCH PC, 1980, J INFECT DIS, V142, P256, DOI 10.1093/infdis/142.2.256
NR 28
TC 23
Z9 23
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9394
EI 1879-1891
J9 AM J OPHTHALMOL
JI Am. J. Ophthalmol.
PD JUN
PY 2015
VL 159
IS 6
BP 1013
EP 1021
DI 10.1016/j.ajo.2015.02.017
PG 9
WC Ophthalmology
SC Ophthalmology
GA CI9DL
UT WOS:000355070500003
PM 25743340
DA 2020-12-01
ER

PT J
AU de Melo, MB
   Mandal, AK
   Tavares, IM
   Ali, MH
   Kabra, M
   de Vasconcellos, JPC
   Senthil, S
   Sallum, JMF
   Kaur, I
   Betinjane, AJ
   Moura, CR
   Paula, JS
   Costa, KA
   Sarfarazi, M
   Della Paolera, M
   Finzi, S
   Ferraz, VEF
   Costa, VP
   Belfort, R
   Chakrabarti, S
AF de Melo, Monica Barbosa
   Mandal, Anil K.
   Tavares, Ivan M.
   Ali, Mohammed Hasnat
   Kabra, Meha
   Cabral de Vasconcellos, Jose Paulo
   Senthil, Sirisha
   Sallum, Juliana M. F.
   Kaur, Inderjeet
   Betinjane, Alberto J.
   Moura, Christiane R.
   Paula, Jayter S.
   Costa, Karita A.
   Sarfarazi, Mansoor
   Della Paolera, Mauricio
   Finzi, Simone
   Ferraz, Victor E. F.
   Costa, Vital P.
   Belfort, Rubens, Jr.
   Chakrabarti, Subhabrata
TI Genotype-Phenotype Correlations in CYP1B1-Associated Primary Congenital
   Glaucoma Patients Representing Two Large Cohorts from India and Brazil
SO PLOS ONE
LA English
DT Article
ID CYTOCHROME P4501B1 CYP1B1; MOLECULAR-GENETICS; JAPANESE PATIENTS;
   UNITED-STATES; LTBP2 GENE; MUTATIONS; POPULATION; FAMILIES; LOCUS;
   BUPHTHALMOS
AB Background
   Primary congenital glaucoma (PCG), occurs due to the developmental defects in the trabecular meshwork and anterior chamber angle in children. PCG exhibits genetic heterogeneity and the CYP1B1 gene has been widely implicated worldwide. Despite the diverse mutation spectra, the clinical implications of these mutations are yet unclear. The present study attempted to delineate the clinical profile of PCG in the background of CYP1B1 mutations from a large cohort of 901 subjects from India (n=601) and Brazil (n=300).
   Methods
   Genotype-phenotype correlations was undertaken on clinically well characterized PCG cases from India (n=301) and Brazil (n=150) to assess the contributions of CYP1B1 mutation on a set of demographic and clinical parameters. The demographic (gender, and history of consanguinity) and quantitative clinical (presenting intraocular pressure [IOP] and corneal diameter [CD]) parameters were considered as binary and continuous variables, respectively, for PCG patients in the background of the overall mutation spectra and also with respect to the prevalent mutations in India (R368H) and Brazil (4340delG). All these variables were fitted in a multivariate logistic regression model using the Akaike Information Criterion (AIC) to estimate the adjusted odds ratio (OR) using the R software (version 2.14.1).
   Results
   The overall mutation spectrum were similar across the Indian and Brazilian PCG cases, despite significantly higher number of homozygous mutations in the former (p=0.024) and compound heterozygous mutations in the later (p=0.012). A wide allelic heterogeneity was observed and only 6 mutations were infrequently shared between these two populations. The adjusted ORs for the binary (demographic) and continuous (clinical) variables did not indicate any susceptibility to the observed mutations (p>0.05).
   Conclusions
   The present study demonstrated a lack of genotype-phenotype correlation of the demographic and clinical traits to CYP1B1 mutations in PCG at presentation. However, the susceptibility of these mutations to the long-term progression of these traits are yet to be deciphered.
C1 [de Melo, Monica Barbosa] Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Campinas, SP, Brazil.
   [Mandal, Anil K.; Senthil, Sirisha] LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, Andhra Pradesh, India.
   [Tavares, Ivan M.; Sallum, Juliana M. F.; Moura, Christiane R.; Costa, Karita A.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Ali, Mohammed Hasnat] LV Prasad Eye Inst, Ctr Clin Epidemiol & Biostat, Hyderabad, Andhra Pradesh, India.
   [Kabra, Meha; Kaur, Inderjeet; Chakrabarti, Subhabrata] LV Prasad Eye Inst, Kallam Anji Reddy Mol Genet Lab, Hyderabad, Andhra Pradesh, India.
   [Cabral de Vasconcellos, Jose Paulo; Costa, Vital P.] Univ Estadual Campinas, Fac Med Sci, Dept Ophthalmol, Campinas, SP, Brazil.
   [Betinjane, Alberto J.; Finzi, Simone] Univ Sao Paulo, Sch Med, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Paula, Jayter S.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Ophthalmol, BR-14049 Ribeirao Preto, SP, Brazil.
   [Sarfarazi, Mansoor] Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, Farmington, CT USA.
   [Della Paolera, Mauricio] Irmandade Santa Casa de Misericordia Sao Paulo, Sch Med Sci, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Ferraz, Victor E. F.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP, Brazil.
RP Chakrabarti, S (corresponding author), LV Prasad Eye Inst, Kallam Anji Reddy Mol Genet Lab, Hyderabad, Andhra Pradesh, India.
EM subho@lvpei.org
RI de Moura, Christiane R Rolim/P-2489-2015; Ferraz, Victor/A-8774-2013;
   Tavares, Ivan Maynart/F-6766-2010; Sallum, Juliana Maria
   Ferraz/AAL-4000-2020; PAULA, JAYTER S/D-1249-2013; Mandal,
   Anil/AAY-4809-2020
OI de Moura, Christiane R Rolim/0000-0002-0636-8100; Ferraz,
   Victor/0000-0003-0337-4588; Tavares, Ivan Maynart/0000-0003-2220-7603;
   PAULA, JAYTER S/0000-0002-8111-3810; Sallum, Juliana/0000-0002-7206-4447
FU Department of Science and Technology, Government of IndiaDepartment of
   Science & Technology (India) [DST/INT/BRAZIL/RPO-01/2008]; Brazilian
   Academy of Sciences-CNPq, Government of Brazil [EU475687/20094]
FX Funding: This study was supported through a bilateral Indo-Brazil grant
   from the Department of Science and Technology
   (DST/INT/BRAZIL/RPO-01/2008) to SC, Government of India and Brazilian
   Academy of Sciences-CNPq (Grant EU475687/20094), Government of Brazil to
   RB. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abu-Amero KK, 2011, MOL VIS, V17, P2911
   Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199
   Al-Haddad C, 2014, OPHTHALMIC GENET, V18, P1
   Alfadhli S, 2006, AM J OPHTHALMOL, V141, P512, DOI 10.1016/j.ajo.2005.11.001
   Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017
   Anderson D R, 1981, Trans Am Ophthalmol Soc, V79, P458
   Bagiyeva S, 2007, MOL VIS, V13, P1458
   Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725
   Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367
   Belmouden A, 2002, CLIN GENET, V62, P334, DOI 10.1034/j.1399-0004.2002.620415.x
   Campos-Mollo E, 2009, MOL VIS, V15, P417
   Chakrabarti S, 2006, INVEST OPHTH VIS SCI, V47, P43, DOI 10.1167/iovs.05-0912
   Chakrabarti S, 2010, HUM MOL GENET, V19, P4083, DOI 10.1093/hmg/ddq309
   Chavarria-Soley G, 2006, MOL VIS, V12, P523
   Chen YH, 2008, ARCH OPHTHALMOL-CHIC, V126, P1443, DOI 10.1001/archopht.126.10.1443
   Chitsazian F, 2007, J MOL DIAGN, V9, P382, DOI 10.2353/jmoldx.2007.060157
   Choudhary D, 2009, XENOBIOTICA, V39, P606, DOI 10.1080/00498250903000198
   Colomb E, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9197
   Dandona L, 1998, ARCH OPHTHALMOL-CHIC, V116, P545, DOI 10.1001/archopht.116.4.514
   Della Paolera M, 2010, J GLAUCOMA, V19, P176, DOI 10.1097/IJG.0b013e3181a98bae
   Dimasi DP, 2007, CLIN GENET, V72, P255, DOI 10.1111/j.1399-0004.2007.00864.x
   El-Ashry MF, 2007, J GLAUCOMA, V16, P104, DOI 10.1097/01.ijg.0000212288.00917.e1
   Firasat S, 2008, MOL VIS, V14, P1659
   FRANCOIS J, 1980, OPHTHALMOLOGICA, V181, P61, DOI 10.1159/000309028
   Geyer O, 2011, AM J OPHTHALMOL, V151, P263, DOI 10.1016/j.ajo.2010.08.038
   Hollander David A, 2006, Trans Am Ophthalmol Soc, V104, P183
   Hollander DA, 2006, AM J OPHTHALMOL, V142, P993, DOI 10.1016/j.ajo.2006.07.054
   Khan AO, 2011, CURR OPIN OPHTHALMOL, V22, P347, DOI 10.1097/ICU.0b013e32834922d2
   Lim SH, 2013, AM J OPHTHALMOL, V155, P508, DOI 10.1016/j.ajo.2012.09.012
   Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007
   Mandal AK, 2006, PEDIAT GLAUCOMAS, P119
   Mashima Y, 2001, INVEST OPHTH VIS SCI, V42, P2211
   Milla E, 2013, MOL VIS, V19, P1707
   Mohanty K, 2013, MOL VIS, V19, P78
   Moore DB, 2013, SURV OPHTHALMOL, V58, P278, DOI 10.1016/j.survophthal.2012.11.003
   Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338
   Ohtake Y, 2003, BRIT J OPHTHALMOL, V87, P302, DOI 10.1136/bjo.87.3.302
   Ou Y, 2012, DEV OPHTHALMOL, V50, P157, DOI 10.1159/000334798
   Panicker SG, 2004, INVEST OPHTH VIS SCI, V45, P1149, DOI 10.1167/iovs.03-0404
   Plasilova M, 1999, J MED GENET, V36, P290
   Reddy ABM, 2004, MOL VIS, V10, P696
   Sarfarazi M, 2000, EYE, V14, P422, DOI 10.1038/eye.2000.126
   SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888
   Sarfarazi Mansoor, 2003, Ophthalmol Clin North Am, V16, P543, DOI 10.1016/S0896-1549(03)00062-2
   Sena DF, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010777
   Sharafieh R, 2013, OPHTHALMIC GENET, V34, P14, DOI 10.3109/13816810.2012.716486
   Sheikh SA, 2014, MOL VIS, V20, P991
   Sitorus R, 2003, J Med Genet, V40, pe9, DOI 10.1136/jmg.40.1.e9
   Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641
   STOILOV I, 2002, INVEST OPHTH VIS SCI, V43, P3015
   Stoilov IR, 2002, INVEST OPHTH VIS SCI, V43, P1820
   Suh W, 2012, BRIT J OPHTHALMOL, V96, P1372, DOI 10.1136/bjophthalmol-2012-301517
   Vasilou V, 2008, ANN REV PHARM TOXICO, V48, P131
NR 53
TC 8
Z9 8
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 15
PY 2015
VL 10
IS 5
AR e0127147
DI 10.1371/journal.pone.0127147
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CI7AU
UT WOS:000354916100131
PM 25978063
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Afonso, VCC
   Nascimento, H
   Belfort, RM
   Sato, EI
   Muccioli, C
   Belfort, R
AF Costa Afonso, Vivian Cristina
   Nascimento, Heloisa
   Belfort, Rubens M.
   Sato, Emilia Inoue
   Muccioli, Cristina
   Belfort, Rubens, Jr.
TI Visual loss resulting from immunosuppressive therapy in patients with
   syphilitic uveitis
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Syphilis; Uveitis/drug therapy; Immunosuppressive agents/therapeutic
   use; Immunosuppressive agents/adverse effects; Vision
   disorders/etiology; Case reports
AB Permanent visual loss can be caused by improper use of immunosuppressive therapy in cases of uveitis without differential diagnosis of syphilitic uveitis. We present four cases of syphilitic uveitis that were incorrectly diagnosed as being secondary to rheumatic diseases and were subsequently treated with immunosuppressive therapy, leading to permanent visual loss. These cases highlight the importance of ruling out syphilis in the differential diagnosis of inflammatory ocular diseases before starting use of immunosuppressive therapy.
C1 [Costa Afonso, Vivian Cristina; Nascimento, Heloisa; Belfort, Rubens M.; Muccioli, Cristina; Belfort, Rubens, Jr.] Univ Fed Sao Paulo UNIFESP, EPM, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Sato, Emilia Inoue] Univ Fed Sao Paulo UNIFESP, EPM, Dept Rheumatol, Sao Paulo, SP, Brazil.
RP Afonso, VCC (corresponding author), Rua Botucatu 823, BR-04123000 Sao Paulo, SP, Brazil.
EM vivian_cris@yahoo.com.br
RI Sato, Emilia Inoue/A-4446-2013; Nascimento, Heloisa/P-8869-2017
OI Sato, Emilia Inoue/0000-0001-8540-014X; Nascimento,
   Heloisa/0000-0003-0315-1317
CR Aldave AJ, 2001, CURR OPIN OPHTHALMOL, V12, P433, DOI 10.1097/00055735-200112000-00008
   Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1
   Asahina A, 2012, J DERMATOL, V39, P199, DOI 10.1111/j.1346-8138.2011.01243.x
   Avelleira João Carlos Regazzi, 2006, An. Bras. Dermatol., V81, P111, DOI 10.1590/S0365-05962006000200002
   Bories-Haffner C, 2010, JOINT BONE SPINE, V77, P364, DOI 10.1016/j.jbspin.2010.02.023
   Diaz-Lagares C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3397
   Gaudio PA, 2006, CURR OPIN OPHTHALMOL, V17, P562, DOI 10.1097/ICU.0b013e328010a9b5
   Lima BR, 2013, EXPERT OPIN DRUG MET, V9, P875, DOI 10.1517/17425255.2013.783818
   Martel JN, 2012, OCUL IMMUNOL INFLAMM, V20, P18, DOI 10.3109/09273948.2011.633205
   Solebo AL, 2007, OPHTHALMOLOGY, V114, P1593, DOI 10.1016/j.ophtha.2007.04.017
NR 10
TC 2
Z9 3
U1 0
U2 0
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD MAY-JUN
PY 2015
VL 78
IS 3
BP 185
EP 186
DI 10.5935/0004-2749.20150047
PG 2
WC Ophthalmology
SC Ophthalmology
GA CN9MD
UT WOS:000358772000012
PM 26222110
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Rossetto, JD
   Nascimento, H
   Fernandes, DDPG
   Belfort, R
   Muccioli, C
AF Rossetto, Julia Dutra
   Nascimento, Heloisa
   Paola Gonzalez Fernandes, Delia Diana
   Belfort, Rubens, Jr.
   Muccioli, Cristina
TI Treatment of cystoid macular edema secondary to chronic non-infectious
   intermediate uveitis with an intraocular dexamethasone implant
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Macular edema/etiology; Uveitis/complications; Tomography; optical
   coherence; Dexamethasone/therapeutic use; Visual acuity
ID INTRAVITREAL TRIAMCINOLONE
AB Purpose: To evaluate the use of a slow-release dexamethasone 0.7-mg intravitreal implant for cystoid macular edema (CME) secondary to intermediate uveitis and refractory to systemic steroids.
   Methods: A retrospective study of the best-corrected visual acuity (BCVA), intraocular inflammation, intraocular pressure (IOP), fundus photography, optical coherence tomography (OCT), inflammation, and adverse reactions of five patients (women, mean age of 35 years) with cystoid macular edema treated with a dexamethasone implant. Patients were evaluated in seven visits until the 150th day after the implant.
   Results: Four patients had bilateral pars planitis and one had bilateral intermediate uveitis associated with juvenile idiopathic arthritis. Six dexamethasone devices were implanted, under topical anesthesia (one each in six eyes, five patients). The mean follow-up time was 5 months. The best-corrected visual acuity improved in all eyes that received an implant, with five having improvements of two or more lines. Optical coherence tomography showed thinning of the macula in all eyes treated, and we saw a correlation between the best-corrected visual acuity and retinal thinning. No serious adverse events occurred and no significant increase in intraocular pressure was observed.
   Conclusions: Slow-release dexamethasone intravitreal implants can effectively treat CME secondary to intermediate uveitis and refractory to systemic steroids.
C1 [Rossetto, Julia Dutra; Nascimento, Heloisa; Paola Gonzalez Fernandes, Delia Diana; Belfort, Rubens, Jr.; Muccioli, Cristina] Univ Fed Sao Paulo UNIFESP, EPM, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
RP Rossetto, JD (corresponding author), Rua Botucatu 821, BR-04023062 Sao Paulo, Brazil.
EM julia_rossetto@hotmail.com
RI Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317
CR Andrade RE, 2004, AM J OPHTHALMOL, V137, P572, DOI 10.1016/j.ajo.2003.08.035
   Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275
   Goldstein DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P1478, DOI 10.1001/archopht.125.11.ecs70063
   Haller JA, 2008, ARCH OPHTHALMOL-CHIC, V128, P289
   Haller JA, 2010, OPHTHALMOLOGY, V117, P1134, DOI 10.1016/j.ophtha.2010.03.032
   Kempen JH, 2010, AM J OPHTHALMOL, V149, P550, DOI 10.1016/j.ajo.2009.11.019
   Kempen John H, 2009, BMJ, V339, pb2480, DOI 10.1136/bmj.b2480
   Lowder C, 2011, ARCH OPHTHALMOL-CHIC, V129, P545, DOI 10.1001/archophthalmol.2010.339
   Nascimento H, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-7
   van Kooij B, 2006, OCUL IMMUNOL INFLAMM, V14, P73, DOI 10.1080/09273940500545684
   Williams GA, 2009, AM J OPHTHALMOL, V147, P1048, DOI 10.1016/j.ajo.2008.12.033
NR 11
TC 2
Z9 2
U1 0
U2 0
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD MAY-JUN
PY 2015
VL 78
IS 3
BP 190
EP 193
DI 10.5935/0004-2749.20150049
PG 4
WC Ophthalmology
SC Ophthalmology
GA CN9MD
UT WOS:000358772000014
PM 26222112
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Vianna, LMM
   Stoeger, CG
   Galloway, JD
   Terry, M
   Cope, L
   Belfort, R
   Jun, AS
AF Vianna, Lucas M. M.
   Stoeger, Christopher G.
   Galloway, Joshua D.
   Terry, Mark
   Cope, Leslie
   Belfort, Rubens, Jr.
   Jun, Albert S.
TI Risk Factors for Eye Bank Preparation Failure of Descemet Membrane
   Endothelial Keratoplasty Tissue
SO AMERICAN JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID DMEK GRAFTS; CELL-LOSS
AB PURPOSE: To assess the results of a single eye bank preparing a high volume of Descemet membrane endothelial keratoplasty (DMEK) tissues using multiple technicians to provide an overview of the experience and to identify possible risk factors for DMEK preparation failure.
   DESIGN: Cross-sectional study.
   METHODS: SETTING: Lions Vision Gift and Wilmer Eye Institute at Johns Hopkins Hospital. STUDY POPULATION: All 563 corneal tissues processed by technicians at Lions Vision Gift for DMEK between October 2011 and May 2014 inclusive. OBSERVATION PROCEDURES: Tissues were divided into 2 groups: DMEK preparation success and DMEK preparation failure. MAIN OUTCOME MEASURES: We compared donor characteristics, including past medical history.
   RESULTS: The overall tissue preparation failure rate was 5.2%. Univariate analysis showed diabetes mellitus (P = .000028) and its duration (P = .023), hypertension (P = .021), and hyperlipidemia or obesity (P = .0004) were more common in the failure group. Multivariate analysis showed diabetes mellitus (P = .0001) and hyperlipidemia or obesity (P = .0142) were more common in the failure group. Elimination of tissues from donors either with diabetes or with hyperlipidemia or obesity reduced the failure rate from 5.2% to 2.2%. Trends toward lower failure rates occurring with increased technician experience also were found.
   CONCLUSIONS: Our work showed that tissues from donors with diabetes mellitus (especially with longer disease duration) and hyperlipidemia or obesity were associated with higher failure rates in DMEK preparation. Elimination of tissues from donors either with diabetes mellitus or with hyperlipidemia or obesity reduced the failure rate. In addition, our data may provide useful initial guidelines and benchmark values for eye;banks seeking to establish and maintain DMEK programs. (C) 2015 by Elsevier Inc. All rights reserved.
C1 [Vianna, Lucas M. M.; Jun, Albert S.] Johns Hopkins Med Sch, Wilmer Eye Inst, Cornea & Anterior Segment Serv, Baltimore, MD 21231 USA.
   [Stoeger, Christopher G.; Galloway, Joshua D.; Terry, Mark] Lions VisionGift, Portland, OR USA.
   [Terry, Mark] Devers Eye Inst, Corneal Serv, Portland, OR USA.
   [Cope, Leslie] Johns Hopkins Univ, Oncol Ctr Biostat Bioinformat, Baltimore, MD USA.
   [Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol, Sao Paulo, Brazil.
RP Jun, AS (corresponding author), Johns Hopkins Med Sch, Wilmer Eye Inst, Cornea & Anterior Segment Serv, 400 North Broadway,Wilmer Smith Bldg 5011, Baltimore, MD 21231 USA.
EM aljun@jhmi.edu
FU Moria (Doylestown, Pennsylvania, USA); National Institutes of Health
   (Bethesda, Maryland, USA)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS) [EY019874]; J. Willard and
   Alice S. Marriott Foundation, Bethesda, Maryland, USA; Brazilian
   government CAPES Foundation (Brasilia, DF, Brazil); State University of
   Rio de Janeiro (Rio de Janeiro, RJ, Brazil); NATIONAL CANCER
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973, P30CA006973, P30CA006973, P30CA006973,
   P30CA006973, P30CA006973] Funding Source: NIH RePORTER; NATIONAL EYE
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R01EY019874, R01EY019874, R01EY019874, R01EY019874, R01EY019874]
   Funding Source: NIH RePORTER
FX ALL AUTHORS HAVE COMPLETED AND SUBMITTED THE ICMJE FORM FOR DISCLOSURE
   OF POTENTIAL CONFLICTS OF INTEREST and the following were reported. Dr
   Terry has received grants from Moria (Doylestown, Pennsylvania, USA) and
   Bausch and Lomb Surgical (Rochester, New York, USA) for educational
   breakfast meetings and royalties from Bausch and Lomb Surgical for
   instruments he designed. Dr Jun has received research grants from the
   National Institutes of Health (Bethesda, Maryland, USA, number EY019874)
   paid to his institution for unrelated work. Supported by the J. Willard
   and Alice S. Marriott Foundation, Bethesda, Maryland, USA; Edward
   Colburn; Richard Dianich; Barbara Freeman; Mary Finegan; Stanley
   Friedler, MD; Herbert Kasoff; Diane Kemker; James Lamson; Jean Mattison;
   Florenz Ourisman; Lee Silverman; and Norman Tunkel, PhD (all to A.S.J.);
   the Brazilian government CAPES Foundation (Brasilia, DF, Brazil
   [L.M.M.V.]); and the State University of Rio de Janeiro (Rio de Janeiro,
   RJ, Brazil [L.M.M.V.] Involved in Design of study (L.M.M.V., A.S.J.);
   Conduct of study (L.M.M.V., A.S.J.); Data collection (L.M.M.V., C.G.S.,
   J.D.G., M.T., A.S.J.); Data management (L.M.M.V., C.G.S., J.D.G., M.T.,
   L.C., A.S.J.); Data analysis (L.M.M.V., C.G.S., J.D.G., M.T., L.C.,
   A.S.J.): Data interpretation (L.M.M.V., C.G.S., J.D.G., M.T., L.C.,
   R.B., A.S.J.); Preparation of manuscript (L.M.M.V., A.S.J.); Review of
   manuscript (L.M.M.V., C.O.S., J.D.G., M.T., L.C., R.B., A.S.J.); and
   Final approval of manuscript (L.M.M.V., C.G.S., J.D.G., M.T., L.C.,
   R.B., A.S.J.).
CR Akimoto Y, 2008, EXP DIABETES RES, DOI 10.1155/2008/818341
   Bahar I, 2009, CORNEA, V28, P485, DOI 10.1097/ICO.0b013e3181901df4
   BARCHIESI BJ, 1992, SURV OPHTHALMOL, V36, P324
   Boynton GE, 2014, CURR OPIN OPHTHALMOL, V25, P319, DOI 10.1097/ICU.0000000000000060
   Dapena I, 2009, CURR OPIN OPHTHALMOL, V20, P299, DOI 10.1097/ICU.0b013e32832b8d18
   Gaens KHJ, 2013, CURR OPIN LIPIDOL, V24, P4, DOI 10.1097/MOL.0b013e32835aea13
   Gorovoy IR, 2014, CORNEA, V33, P683, DOI 10.1097/ICO.0000000000000135
   Greiner MA, 2014, CORNEA, V33, P1129, DOI 10.1097/ICO.0000000000000262
   Guerra FP, 2011, OPHTHALMOLOGY, V118, P2368, DOI 10.1016/j.ophtha.2011.06.002
   Guerra FP, 2011, CORNEA, V30, P1382, DOI 10.1097/ICO.0b013e31821ddd25
   Heinzelmann S, 2014, CORNEA, V33, P644, DOI 10.1097/ICO.0000000000000106
   Jardine GJ, 2014, CURR EYE RES, V39, P894, DOI 10.3109/02713683.2014.887120
   Kelliher C, 2009, CORNEA, V28, P966, DOI 10.1097/ICO.0b013e31819c4fcf
   Krabcova I, 2013, CELL TISSUE BANK, V14, P325, DOI 10.1007/s10561-012-9327-z
   Latour G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048388
   Melles GRJ, 2008, AM J OPHTHALMOL, V145, P222, DOI 10.1016/j.ajo.2007.09.021
   Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34
   Price MO, 2009, OPHTHALMOLOGY, V116, P2361, DOI 10.1016/j.ophtha.2009.07.010
   SADY C, 1995, BIOCHEM BIOPH RES CO, V214, P793, DOI 10.1006/bbrc.1995.2356
   Schlotzer-Schrehardt U, 2013, OPHTHALMOLOGY, V120, P1769, DOI 10.1016/j.ophtha.2013.06.038
   Tenkman LR, 2014, CORNEA, V33, P319, DOI 10.1097/ICO.0000000000000045
   Terry MA, 2012, CORNEA, V31, P469, DOI 10.1097/ICO.0b013e31823f8ee2
   Tourtas T, 2012, AM J OPHTHALMOL, V153, P1082, DOI 10.1016/j.ajo.2011.12.012
NR 23
TC 32
Z9 32
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9394
EI 1879-1891
J9 AM J OPHTHALMOL
JI Am. J. Ophthalmol.
PD MAY
PY 2015
VL 159
IS 5
BP 829
EP 834
DI 10.1016/j.ajo.2015.01.030
PG 6
WC Ophthalmology
SC Ophthalmology
GA CG5VW
UT WOS:000353365000002
PM 25640409
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Sousa-Martins, D
   Caseli, L
   Figueiredo, MC
   Cunha, CSE
   Mota-Filipe, H
   Souza-Lima, A
   Belfort, R
   Rodrigues, E
   Maia, M
AF Sousa-Martins, Diogo
   Caseli, Luciano
   Figueiredo, Mafalda C.
   Sa e Cunha, Claudia
   Mota-Filipe, Helder
   Souza-Lima, Acacio
   Belfort, Rubens, Jr.
   Rodrigues, Eduardo
   Maia, Mauricio
TI Comparing the Mode of Action of Intraocular Lutein-Based Dyes With
   Synthetic Dyes
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
DE lutein-based dyes; synthetic dyes; intraocular membranes; Langmuir films
ID INTRAVITREAL TRIAMCINOLONE ACETONIDE; PIGMENT EPITHELIAL-CELLS;
   BRILLIANT BLUE; CATARACT-SURGERY; MACULAR PIGMENT; TRYPAN BLUE; VITAL
   DYES; ACUTE ENDOPHTHALMITIS; OPTICAL-DENSITY; ZEAXANTHIN
AB PURPOSE. To investigate and compare the mechanism by which lutein-based and synthetic intraocular dyes interact with their target membranes during ophthalmic surgeries.
   METHODS. Surrogate membrane models were used in order to simulate the different intraocular membranes: internal limiting membrane (ILM), vitreous, anterior capsule (AC), and epiretinal membrane (ERM). Different lutein-based dyes, such as Phacodyne, Retidyne, Retidyne Plus, and Vitreodyne were tested, as well as Trypan Blue (TB), Indocyanine Green (ICG), Brilliant Blue (BB), and Triamcinolone Acetonide (TA). The interactions between the film components occurring at the air-water interface were investigated with surface pressure-area isotherms and polarization modulation infrared reflection-absorption spectroscopy (PM-IRRAS).
   RESULTS. With the exception of TA and ICG, none of the tested dyes revealed toxicity to the analyzed membranes. The interaction of TA with the vitreous model affected deeply the biointerface structure of the model. A significant condensation of the monolayer is noted when ICG contacted with ILM by the isotherms or even a solubilization of part of the monolayer toward the aqueous subphase. Retidyne Plus may provide the fluidization of the membrane, but maintains intact the structure of proteins present in the model.
   CONCLUSIONS. The present study demonstrates for the first time that lutein-based dyes interact through a physical mechanism of action with membrane models of structures present in human eye. On the other hand, the chemical interaction of synthetic dyes TA and ICG resulted in an alteration of the membrane models.
C1 [Sousa-Martins, Diogo; Figueiredo, Mafalda C.; Sa e Cunha, Claudia; Mota-Filipe, Helder] Univ Lisbon, Coll Pharm, Dept Social Pharm, P-1649003 Lisbon, Portugal.
   [Sousa-Martins, Diogo; Souza-Lima, Acacio; Belfort, Rubens, Jr.; Rodrigues, Eduardo; Maia, Mauricio] Fed Univ Sao Paulo Unifesp, Escola Paulista Med, Dept Ophthalmol, Sao Paulo, Brazil.
   [Caseli, Luciano] Fed Univ Sao Paulo Unifesp, Dept Earth & Exacts Sci, Sao Paulo, Brazil.
RP Sousa-Martins, D (corresponding author), Univ Lisbon, Coll Pharm, Dept Social Pharm, Ave Prof Gama Pinto, P-1649003 Lisbon, Portugal.
EM dsousamartins@gmail.com
RI Maia, Mauricio/Z-1042-2019; Maia, Mauricio/I-5892-2015; de Souza Lima
   Filho, Acacio Alves/C-7189-2012; Mota-Filipe, Helder/M-6199-2019;
   Caseli, Luciano/D-9533-2012; Sousa-Martins, Diogo/B-1554-2019;
   Mota-Filipe, Helder/M-6298-2013
OI Maia, Mauricio/0000-0002-7034-8091; Maia, Mauricio/0000-0002-7034-8091;
   Mota-Filipe, Helder/0000-0003-3045-2553; Sousa-Martins,
   Diogo/0000-0002-2285-3990; Mota-Filipe, Helder/0000-0003-3045-2553;
   Caseli, Luciano/0000-0002-1177-8454; Alves de Souza Lima Filho,
   Acacio/0000-0003-1802-9592
CR Ahmed SS, 2005, SURV OPHTHALMOL, V50, P183, DOI 10.1016/j.survophthal.2004.12.009
   Ando F, 2004, GRAEF ARCH CLIN EXP, V242, P995, DOI 10.1007/s00417-004-0864-4
   Badaro E, 2014, GRAEF ARCH CLIN EXP, V252, P1071, DOI 10.1007/s00417-013-2539-5
   Baszkin A, 2006, ADV COLLOID INTERFAC, V128, P111, DOI 10.1016/j.cis.2006.11.008
   Beatty S, 2004, ARCH BIOCHEM BIOPHYS, V430, P70, DOI 10.1016/j.abb.2004.03.015
   Bone RA, 2001, INVEST OPHTH VIS SCI, V42, P235
   Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X
   Casaroli-Marano RP, 2014, CURR EYE RES, P1
   Caseli L, 2013, COLLOID SURFACE B, V107, P124, DOI 10.1016/j.colsurfb.2013.01.076
   Cekic O, 2005, AM J OPHTHALMOL, V139, P993, DOI 10.1016/j.ajo.2005.01.022
   Dynarowicz-Latka P, 2001, ADV COLLOID INTERFAC, V91, P221, DOI 10.1016/S0001-8686(99)00034-2
   Farah Michel E, 2008, Dev Ophthalmol, V42, P91, DOI 10.1159/000138980
   FULLER D, 1978, AM J OPHTHALMOL, V85, P519, DOI 10.1016/S0002-9394(14)75250-X
   Furlani BA, 2014, J OCUL PHARMACOL TH, V30, P559, DOI 10.1089/jop.2013.0171
   Jacobs DS, 2006, OPHTHALMOLOGY, V113, P707, DOI 10.1016/j.ophtha.2006.01.024
   Jin Y, 2005, EXP EYE RES, V81, P395, DOI 10.1016/j.exer.2005.02.010
   Jonas JB, 2003, BRIT J OPHTHALMOL, V87, P24, DOI 10.1136/bjo.87.1.24
   Jonas JB, 2005, EUR J OPHTHALMOL, V15, P462
   Junghans A, 2001, ARCH BIOCHEM BIOPHYS, V391, P160, DOI 10.1006/abbi.2001.2411
   Kadonosono K, 2003, GRAEF ARCH CLIN EXP, V241, P284, DOI 10.1007/s00417-003-0636-6
   Krishnan V, 2011, CURR OPIN COLLOID IN, V16, P459, DOI 10.1016/j.cocis.2011.08.005
   Luke C, 2005, BRIT J OPHTHALMOL, V89, P1188, DOI 10.1136/bjo.2004.062794
   Maia M, 2009, BRIT J OPHTHALMOL, V93, P1687, DOI 10.1136/bjo.2008.151597
   Maia M, 2014, RETINA-J RET VIT DIS, V34, P262, DOI 10.1097/IAE.0b013e3182a0b7f4
   Marticorena J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/928123
   Vianna LMM, 2014, ARQ BRAS OFTALMOL, V77, P173, DOI 10.5935/0004-2749.20140044
   Morales MC, 2010, INVEST OPHTH VIS SCI, V51, P6018, DOI 10.1167/iovs.09-4916
   Moshfeghi DM, 2003, AM J OPHTHALMOL, V136, P791, DOI 10.1016/S0002-9394(03)00483-5
   Narayanan R, 2005, INVEST OPHTH VIS SCI, V46, P304, DOI 10.1167/iovs.04-0703
   Narayanan R, 2005, CURR EYE RES, V30, P471, DOI 10.1080/02713680590959312
   Nelson ML, 2003, RETINA-J RET VIT DIS, V23, P686, DOI 10.1097/00006982-200310000-00014
   Nolan JM, 2006, CURR EYE RES, V31, P199, DOI 10.1080/02713680500514677
   Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101
   Pavinatto FJ, 2010, BIOMACROMOLECULES, V11, P1897, DOI 10.1021/bm1004838
   Peyman GA, 2000, RETINA-J RET VIT DIS, V20, P554, DOI 10.1097/00006982-200005000-00024
   Rodrigues EB, 2007, RETINA-J RET VIT DIS, V27, P958, DOI 10.1097/01.iae.0000253051.01194.ab
   Rodrigues EB, 2007, CURR OPIN OPHTHALMOL, V18, P179, DOI 10.1097/ICU.0b013e32811080b5
   Rodrigues EB, 2009, SURV OPHTHALMOL, V54, P576, DOI 10.1016/j.survophthal.2009.04.011
   Sakamoto T, 2004, AM J OPHTHALMOL, V138, P137, DOI 10.1016/j.ajo.2004.02.072
   Sasaki M, 2009, INVEST OPHTH VIS SCI, V50, P1433, DOI 10.1167/iovs.08-2493
   SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413
   Smithen LM, 2004, AM J OPHTHALMOL, V138, P740, DOI 10.1016/j.ajo.2004.06.067
   Sousa-Martins D, 2012, RETINA-J RET VIT DIS, V32, P1328, DOI 10.1097/IAE.0b013e318239e2b6
   Sujak A, 1999, ARCH BIOCHEM BIOPHYS, V371, P301, DOI 10.1006/abbi.1999.1437
   Sundelin SP, 2001, FREE RADICAL BIO MED, V31, P217, DOI 10.1016/S0891-5849(01)00573-1
   Veckeneer M, 2001, GRAEF ARCH CLIN EXP, V239, P698, DOI 10.1007/s004170100341
   Woo TTY, 2013, GRAEF ARCH CLIN EXP, V251, P41, DOI 10.1007/s00417-012-2128-z
   Yuen D, 2009, AM J OPHTHALMOL, V147, P251, DOI 10.1016/j.ajo.2008.08.031
NR 48
TC 2
Z9 2
U1 0
U2 6
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD MAR
PY 2015
VL 56
IS 3
BP 1993
EP 2000
DI 10.1167/iovs.14-16187
PG 8
WC Ophthalmology
SC Ophthalmology
GA CE9BF
UT WOS:000352137600074
PM 25698703
DA 2020-12-01
ER

PT J
AU Vianna, LMM
   Kallay, L
   Toyono, T
   Belfort, R
   Holiman, JD
   Jun, AS
AF Vianna, Lucas Monferrari Monteiro
   Kallay, Laura
   Toyono, Tetsuya
   Belfort, Rubens, Jr.
   Holiman, Jeffrey D.
   Jun, Albert S.
TI Use of human serum for human corneal endothelial cell culture
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID FETAL BOVINE SERUM; PROLIFERATIVE CAPACITY; TRANSPLANTATION;
   ALTERNATIVES; KERATOPLASTY
AB Background/aims To study human corneal endothelial cells (HCECs) cultured in vitro with human serum (HS) supplemented media (HS-SM) compared with HCEC cultured in fetal bovine serum (FBS) supplemented media (FBS-SM).
   Methods One cornea from a donor aged 21 years and a pair of corneas from a 16 year-old donor were obtained from the eye bank and used to create two different cell populations. At the first passage, the cell populations were equally divided and seeded in two different wells containing FBS-SM or HS-SM. In subsequent passages, HS-SM was compared with FBS-SM by morphology, growth curves, immunohistochemistry and real-time reverse-transcriptase PCR for endothelial cell markers.
   Results No difference in morphology could be seen in P2, P5 or in any other passages for cells grown in the two media. By growth curves, cell counts were similar in FBS-SM and HS-SM from days 1 to 5, with a trend towards higher cell counts in HS-SM at day 7. Cells grown in FBS-SM and HS-SM media showed similar expression of endothelial cell markers when assessed by immunohistochemistry and real-time reverse-transcriptase PCR.
   Conclusions HS-SM was similar to FBS-SM for HCEC culture when assessed by cell morphology, proliferation and protein/gene expression.
C1 [Vianna, Lucas Monferrari Monteiro; Kallay, Laura; Toyono, Tetsuya; Jun, Albert S.] Johns Hopkins Sch Med, Dept Ophthalmol, Cornea & Anterior Segment Serv, Wilmer Eye Inst, Baltimore, MD 21231 USA.
   [Vianna, Lucas Monferrari Monteiro; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol, Sao Paulo, Brazil.
   [Vianna, Lucas Monferrari Monteiro] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Holiman, Jeffrey D.] Lions VisionGift, Portland, OR USA.
RP Jun, AS (corresponding author), Johns Hopkins Sch Med, Dept Ophthalmol, Cornea & Anterior Segment Serv, Wilmer Eye Inst, 400 N Broadway,Smith Bldg 5011, Baltimore, MD 21231 USA.
EM aljun@jhmi.edu
FU J Willard and Alice S Marriott Foundation; National Eye InstituteUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [EY001765]; Brazilian
   Government CAPES Foundation; State University of Rio de Janeiro;
   NATIONAL EYE INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765, P30EY001765, P30EY001765, P30EY001765,
   P30EY001765, P30EY001765] Funding Source: NIH RePORTER
FX Grants from the J Willard and Alice S Marriott Foundation, Edward
   Colburn, Lorraine Collins, Richard Dianich, Mary Finegan, Barbara and
   Peter Freeman, Stanley Friedler, MD, Ida Jeffries, Herbert Kasoff, Diane
   Kemker, Jean Mattison, Florenz Ourisman, Lee Silverman, Norman Tunkel,
   PhD (all to ASJ), National Eye Institute EY001765 to Wilmer Microscopy
   Core Facility, and the Brazilian Government CAPES Foundation and the
   State University of Rio de Janeiro to LMMV.
CR Ang LPK, 2005, BRIT J OPHTHALMOL, V89, P748, DOI 10.1136/bjo.2004.055046
   Bednarz J, 2001, BRIT J OPHTHALMOL, V85, P1416, DOI 10.1136/bjo.85.12.1416
   Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139
   BONANNO JA, 1992, INVEST OPHTH VIS SCI, V33, P3058
   Cheong YK, 2013, INVEST OPHTH VIS SCI, V54, P4538, DOI 10.1167/iovs.13-11754
   Dapena I, 2009, CURR OPIN OPHTHALMOL, V20, P299, DOI 10.1097/ICU.0b013e32832b8d18
   Engelmann K, 2004, EXP EYE RES, V78, P573, DOI 10.1016/S0014-4835(03)00209-4
   Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014
   Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4
   Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298
   Koizumi N, 2012, EXP EYE RES, V95, P60, DOI 10.1016/j.exer.2011.10.014
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Mimura T, 2007, CURR EYE RES, V32, P617, DOI 10.1080/02713680701530589
   Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310
   Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01
   Ple-Plakon PA, 2014, CURR OPIN OPHTHALMOL, V25, P300, DOI 10.1097/ICU.0000000000000080
   Proulx S, 2012, EXP EYE RES, V95, P68, DOI 10.1016/j.exer.2011.06.013
   SCHULTZ G, 1992, CORNEA, V11, P20, DOI 10.1097/00003226-199201000-00003
   STOCKER FW, 1958, AM J OPHTHALMOL, V46, P294, DOI 10.1016/0002-9394(58)90811-0
   Suh LH, 2007, INVEST OPHTH VIS SCI, V48, P3056, DOI 10.1167/iovs.06-0771
   Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723
   Thanos S, 2013, CELL TRANSPLANT, V22, P477, DOI 10.3727/096368912X657459
   Witzeneder K, 2013, TRANSFUS MED HEMOTH, V40, P417, DOI 10.1159/000356236
   Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814
NR 24
TC 7
Z9 7
U1 0
U2 8
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
EI 1468-2079
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD FEB
PY 2015
VL 99
IS 2
BP 267
EP 271
DI 10.1136/bjophthalmol-2014-306034
PG 5
WC Ophthalmology
SC Ophthalmology
GA AZ5UG
UT WOS:000348285500026
PM 25452555
DA 2020-12-01
ER

PT J
AU Boyer, DS
   Yoon, YH
   Belfort, R
   Bandello, F
   Maturi, RK
   Augustin, AJ
   Li, XY
   Cui, H
   Hashad, Y
   Whitcup, SM
AF Boyer, David S.
   Yoon, Young Hee
   Belfort, Rubens, Jr.
   Bandello, Francesco
   Maturi, Raj K.
   Augustin, Albert J.
   Li, Xiao-Yan
   Cui, Harry
   Hashad, Yehia
   Whitcup, Scott M.
CA Ozurdex MEAD Study Grp
TI Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone
   Intravitreal Implant in Patients with Diabetic Macular Edema
SO OPHTHALMOLOGY
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; TRABECULAR MESHWORK; VASCULAR LEAKAGE;
   RANIBIZUMAB; TRIAMCINOLONE; LEUKOSTASIS; LASER
AB Purpose: To evaluate the safety and efficacy of dexamethasone intravitreal implant (Ozurdex, DEX implant) 0.7 and 0.35 mg in the treatment of patients with diabetic macular edema (DME).
   Design: Two randomized, multicenter, masked, sham-controlled, phase III clinical trials with identical protocols were conducted. Data were pooled for analysis.
   Participants: Patients (n = 1048) with DME, best-corrected visual acuity (BCVA) of 20/50 to 20/200 Snellen equivalent, and central retinal thickness (CRT) of >= 300 mu m by optical coherence tomography.
   Methods: Patients were randomized in a 1:1:1 ratio to study treatment with DEX implant 0.7 mg, DEX implant 0.35 mg, or sham procedure and followed for 3 years (or 39 months for patients treated at month 36) at <= 40 scheduled visits. Patients who met retreatment eligibility criteria could be retreated no more often than every 6 months.
   Main Outcome Measures: The predefined primary efficacy endpoint for the United States Food and Drug Administration was achievement of >= 15-letter improvement in BCVA from baseline at study end. Safety measures included adverse events and intraocular pressure (IOP).
   Results: Mean number of treatments received over 3 years was 4.1, 4.4, and 3.3 with DEX implant 0.7 mg, DEX implant 0.35 mg, and sham, respectively. The percentage of patients with >= 15-letter improvement in BCVA from baseline at study end was greater with DEX implant 0.7 mg (22.2%) and DEX implant 0.35 mg (18.4%) than sham (12.0%; P <= 0.018). Mean average reduction in CRT from baseline was greater with DEX implant 0.7 mg (-111.6 mu m) and DEX implant 0.35 mg (-107.9 mu m) than sham (-41.9 mu m; P < 0.001). Rates of cataract-related adverse events in phakic eyes were 67.9%, 64.1%, and 20.4% in the DEX implant 0.7 mg, DEX implant 0.35 mg, and sham groups, respectively. Increases in IOP were usually controlled with medication or no therapy; only 2 patients (0.6%) in the DEX implant 0.7 mg group and 1 (0.3%) in the DEX implant 0.35 mg group required trabeculectomy.
   Conclusions: The DEX implant 0.7 mg and 0.35 mg met the primary efficacy endpoint for improvement in BCVA. The safety profile was acceptable and consistent with previous reports. (C) 2014 by the American Academy of Ophthalmology.
C1 [Boyer, David S.] Retina Vitreous Associates Med Grp, Los Angeles, CA 90017 USA.
   [Yoon, Young Hee] Univ Ulsan, Asan Med Ctr, Seoul, South Korea.
   [Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.
   [Bandello, Francesco] Univ Vita Salute, Hosp San Raffaele, Milan, Italy.
   [Maturi, Raj K.] Midwest Eye Inst, Indianapolis, IN USA.
   [Augustin, Albert J.] Staedt Klinikum Karlsruhe, Dept Ophthalmol, Karlsruhe, Germany.
   [Li, Xiao-Yan; Cui, Harry; Hashad, Yehia; Whitcup, Scott M.] Allergan Pharmaceut Inc, Irvine, CA USA.
RP Boyer, DS (corresponding author), Retina Vitreous Associates Med Grp, 1127 Wilshire Blvd,Suite 1620, Los Angeles, CA 90017 USA.
EM vitdoc@aol.com
RI Xu, Qingguo/C-1962-2014; bandello, francesco/AAH-2405-2019; Chong,
   Victor/Q-6565-2018; Studnicka, Jan/K-2875-2017
OI Xu, Qingguo/0000-0003-3191-0771; bandello,
   francesco/0000-0003-3238-9682; Chong, Victor/0000-0002-7693-522X;
   Augustin, Prof. Dr. Albert J./0000-0003-1591-0536; Sandner,
   Dirk/0000-0002-9375-5204; Kaiser, Peter/0000-0001-5126-045X; Studnicka,
   Jan/0000-0002-9911-4379; newsom, Richard/0000-0002-2221-0653
FU Allergan, Inc.Allergan
FX Sponsored by Allergan, Inc. The sponsor participated in the design of
   the study, data management, data analysis, interpretation of the data,
   and preparation, review, and approval of the manuscript.
CR Aiello LP, 2010, OPHTHALMOLOGY, V117, P946, DOI 10.1016/j.ophtha.2009.10.002
   Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013
   Antcliff R J, 1999, Semin Ophthalmol, V14, P223, DOI 10.3109/08820539909069541
   Antonetti DA, 2002, J NEUROCHEM, V80, P667, DOI 10.1046/j.0022-3042.2001.00740.x
   Bhagat N, 2009, SURV OPHTHALMOL, V54, P1, DOI 10.1016/j.survophthal.2008.10.001
   Bhisitkul RB, 2013, OPHTHALMOLOGY, V120, P1057, DOI 10.1016/j.ophtha.2012.11.011
   Boyer DS, 2011, RETINA-J RET VIT DIS, V31, P915, DOI 10.1097/IAE.0b013e318206d18c
   Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034
   Campochiaro PA, 2012, OPHTHALMOLOGY, V119, P2125, DOI 10.1016/j.ophtha.2012.04.030
   Chang-Lin JE, 2011, INVEST OPHTH VIS SCI, V52, P80, DOI 10.1167/iovs.10-5285
   Edelman JL, 2010, OPHTHALMOLOGICA, V224, P25, DOI 10.1159/000315158
   Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033
   Funatsu H, 2009, OPHTHALMOLOGY, V116, P73, DOI 10.1016/j.ophtha.2008.09.037
   Gillies MC, 2006, OPHTHALMOLOGY, V113, P1533, DOI 10.1016/j.ophtha.2006.02.065
   Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419
   Haller JA, 2010, OPHTHALMOLOGY, V117, P1134, DOI 10.1016/j.ophtha.2010.03.032
   Haller JA, 2010, ARCH OPHTHALMOL-CHIC, V128, P289, DOI 10.1001/archophthalmol.2010.21
   Ip MS, 2008, OPHTHALMOLOGY, V115, P1447, DOI 10.1016/j.ophtha.2008.06.015
   Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552
   Kiddee W, 2013, SURV OPHTHALMOL, V58, P291, DOI 10.1016/j.survophthal.2012.08.003
   Lazic R, 2014, RETINA-J RET VIT DIS, V34, P719, DOI 10.1097/IAE.0b013e3182a48958
   Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031
   Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836
   Nehme A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-58
   Pacella E, 2013, CLIN OPHTHALMOL, V7, P1423, DOI 10.2147/OPTH.S48364
   PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015
   Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039
   Tamura H, 2005, INVEST OPHTH VIS SCI, V46, P1440, DOI 10.1167/iovs.04-0905
   Thakur A, 2011, ARCH OPHTHALMOL-CHIC, V129, P914, DOI 10.1001/archophthalmol.2011.39
   Wang K, 2008, BIOL PHARM BULL, V31, P1541, DOI 10.1248/bpb.31.1541
   Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909
NR 31
TC 469
Z9 479
U1 2
U2 41
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD OCT
PY 2014
VL 121
IS 10
BP 1904
EP 1914
DI 10.1016/j.ophtha.2014.04.024
PG 11
WC Ophthalmology
SC Ophthalmology
GA AQ3ME
UT WOS:000342697300019
PM 24907062
OA Other Gold, Green Published
DA 2020-12-01
ER

PT J
AU Furlani, BA
   Barroso, L
   Sousa-Martins, D
   Maia, M
   Moraes, MN
   Badaro, E
   Portella, R
   Lima, AA
   Rodrigues, EB
   Belfort, R
AF Furlani, Bruno Albuquerque
   Barroso, Leticia
   Sousa-Martins, Diogo
   Maia, Mauricio
   Moraes-Filho, Milton Nunes
   Badaro, Emerson
   Portella, Renata
   Lima-Filho, Acacio Alves
   Rodrigues, Eduardo Buchelle
   Belfort, Rubens, Jr.
TI Lutein and Zeaxanthin Toxicity With and Without Brilliant Blue in
   Rabbits
SO JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
LA English
DT Article
ID INTERNAL LIMITING MEMBRANE; INTRAVITREAL INDOCYANINE GREEN;
   RETINAL-PIGMENT EPITHELIUM; MACULAR HOLE SURGERY; SELECTIVELY STAINS;
   TRYPAN BLUE; RAT RETINA; VITAL DYES; IN-VITRO; CAROTENOIDS
AB Purpose: To evaluate the safety profile of solutions containing lutein and zeaxanthin alone or associated with brilliant blue (BB).
   Methods: Twenty-eight New Zealand rabbits were used to evaluate 4 concentrations of the various dye solutions: 0.5% lutein/zeaxanthin; 0.5% lutein/zeaxanthin associated with 0.0125% BB; 0.3% lutein/zeaxanthin associated with 0.025% BB; and 0.25% lutein/zeaxanthin associated with 0.05% BB. The pHs of the dye solutions ranged from 6.5 to 7.2 and the osmolarities from 280 to 320 mOsm/mL. Each rabbit had 0.1mL of one of the dyeing solutions injected into the vitreous cavity of the right eye, while balanced salt solution (BSS) was injected into the left eye as the control. Scotopic electroretinography responses were recorded in all eyes at different time points. The animals were sacrificed at 1 and 7 days after injection; the eyes were analyzed by light and transmission electron microscopy.
   Results: No significant (P > 0.05) differences were seen in the a- and b-wave amplitudes among groups at any given point in time. Light and electron microscopy findings showed no significant abnormalities either, and were similar to the histological findings after intravitreal BSS injection.
   Conclusions: Lutein and zeaxanthin alone or in association with BB showed a good safety profile in this experimental model.
C1 [Furlani, Bruno Albuquerque; Barroso, Leticia; Sousa-Martins, Diogo; Maia, Mauricio; Moraes-Filho, Milton Nunes; Badaro, Emerson; Portella, Renata; Lima-Filho, Acacio Alves; Rodrigues, Eduardo Buchelle; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, BR-06023062 Sao Paulo, Brazil.
RP Maia, M (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Vitreoretinal Surg Unit, 822 Botucatu St, BR-06023062 Sao Paulo, Brazil.
EM retina@femanet.com.br
RI Maia, Mauricio/Z-1042-2019; Maia, Mauricio/I-5892-2015; Rodrigues,
   Eduardo Buchele/C-6852-2015; de Souza Lima Filho, Acacio
   Alves/C-7189-2012; Sousa-Martins, Diogo/B-1554-2019
OI Maia, Mauricio/0000-0002-7034-8091; Maia, Mauricio/0000-0002-7034-8091;
   Sousa-Martins, Diogo/0000-0002-2285-3990; Alves de Souza Lima Filho,
   Acacio/0000-0003-1802-9592; Buchele Rodrigues,
   Eduardo/0000-0002-4224-0921
CR Ahmed SS, 2005, SURV OPHTHALMOL, V50, P183, DOI 10.1016/j.survophthal.2004.12.009
   Bone RA, 2001, INVEST OPHTH VIS SCI, V42, P235
   Creuzot-Garcher C, 2010, RETINA-J RET VIT DIS, V30, P1294, DOI 10.1097/IAE.0b013e3181d205aa
   Enaida H, 2006, RETINA-J RET VIT DIS, V26, P623, DOI 10.1097/00006982-200607000-00006
   Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007
   Enaida Hiroshi, 2008, Dev Ophthalmol, V42, P115, DOI 10.1159/000138989
   Falsini B, 2003, OPHTHALMOLOGY, V110, P51, DOI 10.1016/S0161-6420(02)01547-6
   Farah ME, 2009, AM J OPHTHALMOL, V148, P332, DOI 10.1016/j.ajo.2009.04.003
   Gale CR, 2001, OPHTHALMOLOGY, V108, P1992, DOI 10.1016/S0161-6420(01)00833-8
   Gandorfer A, 2001, AM J OPHTHALMOL, V131, P387, DOI 10.1016/S0002-9394(00)00924-7
   Haritoglou C, 2003, GRAEF ARCH CLIN EXP, V241, P958, DOI 10.1007/s00417-003-0737-2
   Haritoglou C, 2002, AM J OPHTHALMOL, V134, P836, DOI 10.1016/S0002-9394(02)01816-0
   Ho JD, 2003, ARCH OPHTHALMOL-CHIC, V121, P1423, DOI 10.1001/archopht.121.10.1423
   Iriyama A, 2004, INVEST OPHTH VIS SCI, V45, P943, DOI 10.1167/iovs.03-1026
   Maia M, 2004, RETINA-J RET VIT DIS, V24, P69, DOI 10.1097/00006982-200402000-00011
   Maia M, 2004, RETINA-J RET VIT DIS, V24, P80, DOI 10.1097/00006982-200402000-00012
   MARESPERLMAN JA, 1995, ARCH OPHTHALMOL-CHIC, V113, P1518, DOI 10.1001/archopht.1995.01100120048007
   Narayanan R, 2005, CURR EYE RES, V30, P471, DOI 10.1080/02713680590959312
   Nolan JM, 2006, CURR EYE RES, V31, P199, DOI 10.1080/02713680500514677
   Penha FM, 2008, J OCUL PHARMACOL TH, V24, P52, DOI 10.1089/jop.2007.0047
   Penha FM, 2007, OPHTHALMOLOGY, V114, P899, DOI 10.1016/j.ophtha.2006.09.028
   Remy M, 2008, BRIT J OPHTHALMOL, V92, P1142, DOI 10.1136/bjo.2008.138164
   Rezai KA, 2004, AM J OPHTHALMOL, V137, P931, DOI 10.1016/j.ajo.2003.11.016
   Rodrigues EB, 2005, OPHTHALMOLOGICA, V219, P251, DOI 10.1159/000086107
   Rodrigues EB, 2009, SURV OPHTHALMOL, V54, P576, DOI 10.1016/j.survophthal.2009.04.011
   Rodrigues Eduardo B, 2008, Dev Ophthalmol, V42, P29, DOI 10.1159/000138911
   Rodrigues EB, 2009, RETINA-J RET VIT DIS, V29, P497, DOI 10.1097/IAE.0b013e318196b1ad
   SNODDERLY DM, 1991, INVEST OPHTH VIS SCI, V32, P268
   Sommerburg O, 1998, BRIT J OPHTHALMOL, V82, P907, DOI 10.1136/bjo.82.8.907
   Sousa-Martins D, 2012, RETINA-J RET VIT DIS, V32, P1328, DOI 10.1097/IAE.0b013e318239e2b6
   Tokuda K, 2009, RETINA-J RET VIT DIS, V29, P371, DOI 10.1097/IAE.0b013e318195cb00
   Wu WC, 2005, PHOTOCHEM PHOTOBIOL, V81, P537, DOI 10.1562/2004-09-03-RA-302.1
   Yemelyanov AY, 2001, EXP EYE RES, V72, P381, DOI 10.1006/exer.2000.0965
   Yuen D, 2009, AM J OPHTHALMOL, V147, P251, DOI 10.1016/j.ajo.2008.08.031
NR 34
TC 7
Z9 7
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1080-7683
EI 1557-7732
J9 J OCUL PHARMACOL TH
JI J. Ocular Pharmacol. Ther.
PD SEP
PY 2014
VL 30
IS 7
BP 559
EP 566
DI 10.1089/jop.2013.0171
PG 8
WC Ophthalmology; Pharmacology & Pharmacy
SC Ophthalmology; Pharmacology & Pharmacy
GA AP0FR
UT WOS:000341737200007
PM 24901374
DA 2020-12-01
ER

PT J
AU Belfort, R
   Boyer, DS
   Yoon, YH
   Bandello, F
   Maturi, RK
   Augustin, AJ
   Li, XY
   Cui, H
   Hashad, Y
   Whitcup, SM
AF Belfort, Rubens, Jr.
   Boyer, David S.
   Yoon, Young Hee
   Bandello, Francesco
   Maturi, Raj K.
   Augustin, Albert J.
   Li, Xiao-Yan
   Cui, Harry
   Hashad, Yehia
   Whitcup, Scott M.
CA Ozurdex MEAD Study Grp
TI Three-year, Randomized, Sham-controlled, Phase III Study of
   Dexamethasone Intravitreal Implant in Patients with Diabetic Macular
   Edema
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 499 diabetic retinopathy; 487 corticosteroids; 505 edema
C1 [Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
   [Boyer, David S.] Retina Vitreous Associates Med Grp, Los Angeles, CA USA.
   [Yoon, Young Hee] Univ Ulsan, Asan Med Ctr, Seoul, South Korea.
   [Bandello, Francesco] Univ Vita Salute, Hosp San Raffaele, Milan, Italy.
   [Maturi, Raj K.] Midwest Eye Inst, Indianapolis, IN USA.
   [Augustin, Albert J.] Staedt Klinikum Karlsruhe, Ophthalmol, Karlsruhe, Germany.
   [Li, Xiao-Yan; Cui, Harry; Hashad, Yehia; Whitcup, Scott M.] Allergan Pharmaceut Inc, Irvine, CA USA.
RI bandello, francesco/AAH-2405-2019
OI bandello, francesco/0000-0003-3238-9682
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 1706
PG 4
WC Ophthalmology
SC Ophthalmology
GA VC2FS
UT WOS:000433199704084
DA 2020-12-01
ER

PT J
AU Berezovsky, A
   Munoz, S
   Sacai, PY
   Cavascan, NN
   Furtado, JM
   Morales, PH
   Cohen, MJ
   Cohen, JM
   Belfort, R
   Salomao, SR
AF Berezovsky, Adriana
   Munoz, Sergio
   Sacai, Paula Y.
   Cavascan, Nivea Nunes
   Furtado, Joao M.
   Morales, Paulo H.
   Cohen, Marcos J.
   Cohen, Jacob M.
   Belfort, Rubens, Jr.
   Salomao, Solange Rios
TI Self-Reported Visual Function and Related Quality of Life in Middle-Aged
   and Older Adults from an Urban Census District of Parintins, Brazilian
   Amazon Region
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 669 quality of life; 464 clinical (human) or epidemiologic studies: risk
   factor assessment; 754 visual acuity
C1 [Berezovsky, Adriana; Sacai, Paula Y.; Cavascan, Nivea Nunes; Furtado, Joao M.; Morales, Paulo H.; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo, Dept Oftalmol, Sao Paulo, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
   [Furtado, Joao M.] Univ Sao Paulo, Oftalmol Otorrinolaringol & Cirurgia Cabeca & Pes, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Cohen, Marcos J.; Cohen, Jacob M.] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cohen, Jacob M.] Univ Fed Amazonas, Fac Med, Cirurgia, Div Oftalmol, Manaus, Amazonas, Brazil.
RI Berezovsky, Adriana/F-2341-2013; Sacai, Paula Y/B-6525-2014; Ferraz,
   Nivea/AAC-2439-2020
OI Berezovsky, Adriana/0000-0001-6350-8221; Ferraz,
   Nivea/0000-0001-7568-6199
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 184
PG 3
WC Ophthalmology
SC Ophthalmology
GA VC2FS
UT WOS:000433199700174
DA 2020-12-01
ER

PT J
AU Chu, ER
   Ross-Cisneros, FN
   Pham, AH
   Gale, J
   Moraes, M
   Salomao, SR
   Berezovsky, A
   Carelli, V
   Belfort, R
   Sadun, AA
AF Chu, Edward Rickie
   Ross-Cisneros, Fred N.
   Anh Hoang Pham
   Gale, Jesse
   Moraes, Milton
   Salomao, Solange Rios
   Berezovsky, Adriana
   Carelli, Valerio
   Belfort, Rubens, Jr.
   Sadun, Alfredo A.
TI The mt11778/ND4 mutation, in Leber's hereditary optic neuropathy, is
   associated with less degeneration in the peripheral nerve compared to
   the mt3460/ND1 mutation
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 613 neuro-ophthalmology: optic nerve; 600 mitochondria; 531 ganglion
   cells
C1 [Chu, Edward Rickie; Ross-Cisneros, Fred N.; Anh Hoang Pham; Gale, Jesse; Sadun, Alfredo A.] Univ Southern Calif, Keck Sch Med, Ophthalmol, Los Angeles, CA USA.
   [Moraes, Milton] Ctr Univ Espirito Santo, Colatina, Brazil.
   [Moraes, Milton; Salomao, Solange Rios; Berezovsky, Adriana; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
   [Carelli, Valerio] Univ Bologna, Neurol Sci, Bologna, Italy.
   [Carelli, Valerio] Univ Bologna, Biomed & NeuroMotor Sci, Bologna, Italy.
RI Berezovsky, Adriana/F-2341-2013; Gale, Jesse/AAB-7406-2019
OI Berezovsky, Adriana/0000-0001-6350-8221; Gale, Jesse/0000-0002-6616-445X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 6208
PG 3
WC Ophthalmology
SC Ophthalmology
GA VC2FU
UT WOS:000433205505229
DA 2020-12-01
ER

PT J
AU Vidoris, AAC
   Maia, A
   Belfort, R
   Lowen, M
   Fernandes, B
   Salas, R
   Costa, M
AF Coazza Vidoris, Andre Aexis
   Maia, Andre
   Belfort, Rubens, Jr.
   Lowen, Marcia
   Fernandes, Bruno
   Salas, Rafaello
   Costa, Marcio
TI Endoresection Surgery for Intra Ocular Choroidal Tumors. Short Term
   Results
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 452 choroid; 589 melanoma; 762 vitreoretinal surgery
C1 [Coazza Vidoris, Andre Aexis; Maia, Andre; Belfort, Rubens, Jr.; Lowen, Marcia; Fernandes, Bruno; Salas, Rafaello; Costa, Marcio] Univ Fed Sao Paulo, Ocular Oncol, Sao Paulo, Brazil.
   [Fernandes, Bruno] McGill Univ, Montreal, PQ, Canada.
RI Fernandes, Bruno F./ABA-3567-2020
OI Fernandes, Bruno F./0000-0002-5385-3571
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 5096
PG 4
WC Ophthalmology
SC Ophthalmology
GA VC2FU
UT WOS:000433205502255
DA 2020-12-01
ER

PT J
AU Coelho, MD
   Morales, PH
   Salomao, SR
   da Silva, IRL
   Jardel, M
   Mileo, MG
   Belfort, R
   Aranha, LM
AF Coelho, Mariana de Andrade
   Morales, Paulo H.
   Salomao, Solange Rios
   Lins da Silva, Igor Rodrigo
   Jardel, Mesquita
   Mileo, Mahler Giordani
   Belfort, Rubens, Jr.
   Aranha, Luis Marcelo
CA Telemed Amazon
TI Telemedicine as a useful tool for referrals to eye care services in a
   remote city of the Brazilian Amazon
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 465 clinical (human) or epidemiologic studies:
   systems/equipment/techniques; 460 clinical (human) or epidemiologic
   studies: health care delivery/economics/manpower; 550 imaging/image
   analysis: clinical
C1 [Coelho, Mariana de Andrade; Morales, Paulo H.; Salomao, Solange Rios; Lins da Silva, Igor Rodrigo; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Jardel, Mesquita; Mileo, Mahler Giordani; Aranha, Luis Marcelo] Montenegro ICB5 USP, Inst Biomed Res, Montenegro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 5882
PG 3
WC Ophthalmology
SC Ophthalmology
GA VC2FU
UT WOS:000433205504259
DA 2020-12-01
ER

PT J
AU Commodaro, A
   Muccioli, C
   Silveira, C
   Rizzo, LV
   Belfort, R
   Grigg, M
AF Commodaro, Alessandra
   Muccioli, Cristina
   Silveira, Claudio
   Rizzo, Luiz V.
   Belfort, Rubens, Jr.
   Grigg, Michael
TI Toxoplasma gondii serotype associated with patients experiencing severe
   ocular toxoplasmosis in Brazil
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 734 toxoplasmosis; 539 genetics
C1 [Commodaro, Alessandra; Grigg, Michael] NIAID, NIH, Bethesda, MD 20892 USA.
   [Muccioli, Cristina; Silveira, Claudio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Ophthalmolgy, Sao Paulo, Brazil.
   [Rizzo, Luiz V.] Hosp Albert Einstein, Sao Paulo, Brazil.
RI Rizzo, Luiz Vicente/B-4458-2009
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 2841
PG 2
WC Ophthalmology
SC Ophthalmology
GA VC2FT
UT WOS:000433203501416
DA 2020-12-01
ER

PT J
AU Frousiakis, SE
   Karanjia, R
   Ganti, AK
   Pouw, A
   Moraes, M
   Salomao, SR
   Belfort, R
   Quiros, PA
   Chicani, F
   Sadun, AA
AF Frousiakis, Starleen Elizabeth
   Karanjia, Rustum
   Ganti, Amitha K.
   Pouw, Andrew
   Moraes, Milton
   Salomao, Solange Rios
   Belfort, Rubens, Jr.
   Quiros, Peter A.
   Chicani, Filipe
   Sadun, Alfredo A.
TI Cardiac Conduction in Leber's Hereditary Optic Neuropathy
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 531 ganglion cells; 600 mitochondria; 613 neuro-ophthalmology: optic
   nerve
C1 [Frousiakis, Starleen Elizabeth; Karanjia, Rustum; Ganti, Amitha K.; Pouw, Andrew; Quiros, Peter A.; Sadun, Alfredo A.] Univ Southern Calif, Ophthalmol, Los Angeles, CA USA.
   [Moraes, Milton] Ctr Univ Espirito Santo, Colatina, Brazil.
   [Moraes, Milton; Salomao, Solange Rios; Belfort, Rubens, Jr.; Chicani, Filipe] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 6205
PG 3
WC Ophthalmology
SC Ophthalmology
GA VC2FU
UT WOS:000433205505226
DA 2020-12-01
ER

PT J
AU Furtado, JM
   Munoz, S
   Berezovsky, A
   Cohen, MJ
   Cohen, JM
   Morales, PH
   Cavascan, NN
   Watanabe, SES
   Belfort, R
   Salomao, SR
AF Furtado, Joao M.
   Munoz, Sergio
   Berezovsky, Adriana
   Cohen, Marcos J.
   Cohen, Jacob M.
   Morales, Paulo H.
   Cavascan, Nivea Nunes
   Song Watanabe, Sung Eun
   Belfort, Rubens, Jr.
   Salomao, Solange Rios
TI PREVALENCE AND CAUSES OF VISION IMPAIRMENT AND BLINDNESS IN OLDER ADULTS
   IN AN URBAN CENSUS SECTOR OF PARINTINS, BRAZILIAN AMAZON REGION
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 463 clinical (human) or epidemiologic studies: prevalence/incidence
C1 [Furtado, Joao M.; Berezovsky, Adriana; Morales, Paulo H.; Cavascan, Nivea Nunes; Song Watanabe, Sung Eun; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo, Dept Oftalmol & Ciencias Visuais, Escola Paulista Med, Sao Paulo, Brazil.
   [Furtado, Joao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol Otorrinolaringol & Cirurgia Cabeca, Ribeirao Preto, Brazil.
   [Munoz, Sergio] Univ La Frontera, Dept Salud Publ, Temuco, Chile.
   [Cohen, Marcos J.; Cohen, Jacob M.] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cohen, Marcos J.; Cohen, Jacob M.] Univ Fed Amazonas UFAM, Dept Cirurgia, Fac Med, Setor Oftalmol, Manaus, Amazonas, Brazil.
RI Berezovsky, Adriana/F-2341-2013; Ferraz, Nivea/AAC-2439-2020
OI Berezovsky, Adriana/0000-0001-6350-8221; Ferraz,
   Nivea/0000-0001-7568-6199
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 6079
PG 4
WC Ophthalmology
SC Ophthalmology
GA VC2FU
UT WOS:000433205505100
DA 2020-12-01
ER

PT J
AU Ganti, AK
   Chu, ER
   Karanjia, R
   Tran, J
   Belfort, R
   Moraes, M
   Berezovsky, A
   Sadun, AA
   Miller, G
   Chicani, F
AF Ganti, Amitha K.
   Chu, Edward Rickie
   Karanjia, Rustum
   Tran, Jeffery
   Belfort, Rubens, Jr.
   Moraes, Milton
   Berezovsky, Adriana
   Sadun, Alfredo A.
   Miller, Guy
   Chicani, Filipe
TI EPI-743 May Improve Visual Acuity in LHON: Data from a Brazilian Cohort
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 613 neuro-ophthalmology: optic nerve; 642 perimetry; 600 mitochondria
C1 [Ganti, Amitha K.; Chu, Edward Rickie; Karanjia, Rustum; Tran, Jeffery; Sadun, Alfredo A.] Univ Southern Calif, Ophthalmol, Los Angeles, CA USA.
   [Belfort, Rubens, Jr.; Moraes, Milton; Berezovsky, Adriana; Chicani, Filipe] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
   [Moraes, Milton] Ctr Univ Espirito Santo, Colatina, Brazil.
   [Miller, Guy] Edison Pharmaceut, Mountain View, CA USA.
RI Berezovsky, Adriana/F-2341-2013
OI Berezovsky, Adriana/0000-0001-6350-8221
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 6201
PG 3
WC Ophthalmology
SC Ophthalmology
GA VC2FU
UT WOS:000433205505222
DA 2020-12-01
ER

PT J
AU da Silva, MCM
   Nascimento, HM
   Vieira, L
   Serapiao, M
   Belfort, R
   de Freitas, D
AF Marquezan da Silva, Maria Carolina
   Nascimento, Heloisa M.
   Vieira, Luiz
   Serapiao, Myrna
   Belfort, Rubens, Jr.
   de Freitas, Denise
TI Topical Tacrolimus in Thygeson Superficial Punctate Keratitis.
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 573 keratitis; 482 cornea: epithelium
C1 [Marquezan da Silva, Maria Carolina; Nascimento, Heloisa M.; Vieira, Luiz; Serapiao, Myrna; Belfort, Rubens, Jr.; de Freitas, Denise] Univ Fed Sao Paulo, Sao Paulo, Brazil.
RI Freitas, Denise/N-8197-2019; Nascimento, Heloisa/P-8869-2017
OI Freitas, Denise/0000-0002-3389-6021; Nascimento,
   Heloisa/0000-0003-0315-1317
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 6290
PG 3
WC Ophthalmology
SC Ophthalmology
GA VC2FU
UT WOS:000433205505311
DA 2020-12-01
ER

PT J
AU Novais, E
   Badaro, E
   Allemann, N
   Rodrigues, E
   Lima, R
   Regatieri, C
   Belfort, R
AF Novais, Eduardo
   Badaro, Emmerson
   Allemann, Norma
   Rodrigues, Eduardo
   Lima, Rodrigo
   Regatieri, Caio
   Belfort, Rubens, Jr.
TI Correlation between choroidal thickness and choroidal blood flow in
   normal subjects
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 452 choroid; 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO,
   ultrasound)
C1 [Novais, Eduardo; Badaro, Emmerson; Allemann, Norma; Rodrigues, Eduardo; Lima, Rodrigo; Regatieri, Caio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
RI Regatieri, Caio/G-8152-2014; Allemann, Norma/K-5451-2013
OI Regatieri, Caio/0000-0003-1511-8696; Allemann, Norma/0000-0001-5432-4287
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 639
PG 3
WC Ophthalmology
SC Ophthalmology
GA VC2FS
UT WOS:000433199701189
DA 2020-12-01
ER

PT J
AU Salomao, SR
   Munoz, S
   Furtado, JM
   Sacai, PY
   Cohen, MJ
   Cohen, JM
   Mitsuhiro, MRKH
   Arruda, SB
   Belfort, R
   Berezovsky, A
AF Salomao, Solange Rios
   Munoz, Sergio
   Furtado, Joao M.
   Sacai, Paula Y.
   Cohen, Marcos J.
   Cohen, Jacob M.
   Kimie Higashi Mitsuhiro, Marcia Regina
   Arruda, Sigrid B.
   Belfort, Rubens, Jr.
   Berezovsky, Adriana
TI PREVALENCE OF NEAR VISION IMPAIRMENT IN MIDDLE-AGED AND OLDER ADULTS IN
   AN URBAN CENSUS SECTOR OF PARINTINS, BRAZILIAN AMAZON REGION
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 653 presbyopia; 463 clinical (human) or epidemiologic studies:
   prevalence/incidence; 754 visual acuity
C1 [Salomao, Solange Rios; Furtado, Joao M.; Sacai, Paula Y.; Kimie Higashi Mitsuhiro, Marcia Regina; Belfort, Rubens, Jr.; Berezovsky, Adriana] Univ Fed Sao Paulo, Dept Oftalmol, Sao Paulo, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
   [Furtado, Joao M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Oftalmol Otorrinolaringol & Cirurgia Cabeca & Pes, Ribeirao Preto, Brazil.
   [Cohen, Marcos J.; Cohen, Jacob M.; Arruda, Sigrid B.] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cohen, Jacob M.] Univ Fed Amazonas, Fac Med, Div Oftalmol, Cirurgia, Manaus, Amazonas, Brazil.
RI Berezovsky, Adriana/F-2341-2013; Sacai, Paula Y/B-6525-2014
OI Berezovsky, Adriana/0000-0001-6350-8221; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 6087
PG 3
WC Ophthalmology
SC Ophthalmology
GA VC2FU
UT WOS:000433205505108
DA 2020-12-01
ER

PT J
AU Santos, FF
   Commodaro, A
   Nascimento, HM
   Furtado, JM
   Muccioli, C
   Rizzo, LV
   Belfort, R
AF Santos, Fabio Felipe
   Commodaro, Alessandra
   Nascimento, Heloisa M.
   Furtado, Joao M.
   Muccioli, Cristina
   Rizzo, Luiz V.
   Belfort, Rubens, Jr.
TI Real-time PCR in the diagnosis of infectious posterior uveitis by
   toxoplasmosis
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 746 uveitis-clinical/animal model; 467 clinical laboratory testing; 427
   aqueous
C1 [Santos, Fabio Felipe; Commodaro, Alessandra; Nascimento, Heloisa M.; Furtado, Joao M.; Muccioli, Cristina; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Ophtalmol & Visual Sci, Sao Paulo, Brazil.
   [Rizzo, Luiz V.] Albert Einstein Hosp, Sao Paulo, Brazil.
RI Rizzo, Luiz Vicente/B-4458-2009; Nascimento, Heloisa/P-8869-2017
OI Nascimento, Heloisa/0000-0003-0315-1317
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 5284
PG 2
WC Ophthalmology
SC Ophthalmology
GA VC2FU
UT WOS:000433205503058
DA 2020-12-01
ER

PT J
AU Watanabe, SES
   Munoz, S
   Berezovsky, A
   Furtado, JM
   Cohen, MJ
   Cohen, JM
   Mitsuhiro, MRKH
   Sa, AG
   Belfort, R
   Salomao, SR
AF Song Watanabe, Sung Eun
   Munoz, Sergio
   Berezovsky, Adriana
   Furtado, Joao M.
   Cohen, Marcos J.
   Cohen, Jacob M.
   Kimie Higashi Mitsuhiro, Marcia Regina
   Sa, Alex G.
   Belfort, Rubens, Jr.
   Salomao, Solange Rios
TI PREVALENCE AND OUTCOMES OF CATARACT SURGERY IN AN URBAN CENSUS SECTOR OF
   PARINTINS, BRAZILIAN AMAZON REGION
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 445 cataract; 462 clinical (human) or epidemiologic studies:
   outcomes/complications; 463 clinical (human) or epidemiologic studies:
   prevalence/incidence
C1 [Song Watanabe, Sung Eun; Berezovsky, Adriana; Furtado, Joao M.; Kimie Higashi Mitsuhiro, Marcia Regina; Belfort, Rubens, Jr.; Salomao, Solange Rios] Univ Fed Sao Paulo, Oftalmol & Ciencias Visuais, Sao Paulo, Brazil.
   [Munoz, Sergio] Univ La Frontera, Salud Publ, Temuco, Chile.
   [Furtado, Joao M.] Fac Med Ribeirao Preto, Oftalmol Otorrinolaringol & Cirurgia Cabeca & Pes, Ribeirao Preto, Brazil.
   [Cohen, Marcos J.; Cohen, Jacob M.; Sa, Alex G.] Inst Olhos Manaus, Manaus, Amazonas, Brazil.
   [Cohen, Jacob M.] Univ Fed Amazonas, Cirurgia, Manaus, Amazonas, Brazil.
RI Berezovsky, Adriana/F-2341-2013
OI Berezovsky, Adriana/0000-0001-6350-8221
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 1572
PG 3
WC Ophthalmology
SC Ophthalmology
GA VC2FS
UT WOS:000433199703301
DA 2020-12-01
ER

PT J
AU Yoon, YH
   Boyer, DS
   Belfort, R
   Bandello, F
   Maturi, RK
   Augustin, AJ
   Li, XY
   Cui, H
   Hashad, Y
   Whitcup, SM
AF Yoon, Young Hee
   Boyer, David S.
   Belfort, Rubens, Jr.
   Bandello, Francesco
   Maturi, Raj K.
   Augustin, Albert J.
   Li, Xiao-Yan
   Cui, Harry
   Hashad, Yehia
   Whitcup, Scott M.
CA Ozurdex MEAD Study Grp
TI Long-term Efficacy and Safety of Dexamethasone Intravitreal Implant in
   Phakic and Pseudophakic Eyes with Diabetic Macular Edema
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 499 diabetic retinopathy; 487 corticosteroids; 505 edema
C1 [Yoon, Young Hee] Univ Ulsan, Coll Med, Asan Med Ctr, Ophthalmol, Seoul, South Korea.
   [Boyer, David S.] Retina Vitreous Associates Med Grp, Los Angeles, CA USA.
   [Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.
   [Bandello, Francesco] Univ Vita Salute, Hosp San Raffaele, Milan, Italy.
   [Maturi, Raj K.] Midwest Eye Inst, Indianapolis, IN USA.
   [Augustin, Albert J.] Staedt Klinikum Karlsruhe, Ophthalmol, Karlsruhe, Germany.
   [Li, Xiao-Yan; Cui, Harry; Hashad, Yehia; Whitcup, Scott M.] Allergan Pharmaceut Inc, Irvine, CA USA.
RI bandello, francesco/AAH-2405-2019
OI bandello, francesco/0000-0003-3238-9682
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2014
VL 55
IS 13
MA 1779
PG 5
WC Ophthalmology
SC Ophthalmology
GA VC2FS
UT WOS:000433199704157
DA 2020-12-01
ER

PT J
AU Giordano, C
   Iommarini, L
   Giordano, L
   Maresca, A
   Pisano, A
   Valentino, ML
   Caporali, L
   Liguori, R
   Deceglie, S
   Roberti, M
   Fanelli, F
   Fracasso, F
   Ross-Cisneros, FN
   D'Adamo, P
   Hudson, G
   Pyle, A
   Yu-Wai-Man, P
   Chinnery, PF
   Zeviani, M
   Salomao, SR
   Berezovsky, A
   Belfort, R
   Ventura, DF
   Moraes, M
   Moraes, M
   Barboni, P
   Sadun, F
   De Negri, A
   Sadun, AA
   Tancredi, A
   Mancini, M
   d'Amati, G
   Polosa, PL
   Cantatore, P
   Carelli, V
AF Giordano, Carla
   Iommarini, Luisa
   Giordano, Luca
   Maresca, Alessandra
   Pisano, Annalinda
   Valentino, Maria Lucia
   Caporali, Leonardo
   Liguori, Rocco
   Deceglie, Stefania
   Roberti, Marina
   Fanelli, Francesca
   Fracasso, Flavio
   Ross-Cisneros, Fred N.
   D'Adamo, Pio
   Hudson, Gavin
   Pyle, Angela
   Yu-Wai-Man, Patrick
   Chinnery, Patrick F.
   Zeviani, Massimo
   Salomao, Solange R.
   Berezovsky, Adriana
   Belfort, Rubens, Jr.
   Ventura, Dora Fix
   Moraes, Milton
   Moraes Filho, Milton
   Barboni, Piero
   Sadun, Federico
   De Negri, Annamaria
   Sadun, Alfredo A.
   Tancredi, Andrea
   Mancini, Massimiliano
   d'Amati, Giulia
   Polosa, Paola Loguercio
   Cantatore, Palmiro
   Carelli, Valerio
TI Efficient mitochondrial biogenesis drives incomplete penetrance in
   Leber's hereditary optic neuropathy
SO BRAIN
LA English
DT Article
DE LHON penetrance; mitochondrial biogenesis; mtDNA copy number
ID LARGE BRAZILIAN PEDIGREE; COMPLEX-I; DNA; PHENOTYPE; MUTATION; CELLS;
   NERVE; LHON; INVOLVEMENT; DYSFUNCTION
AB Leber's hereditary optic neuropathy is a maternally inherited blinding disease caused as a result of homoplasmic point mutations in complex I subunit genes of mitochondrial DNA. It is characterized by incomplete penetrance, as only some mutation carriers become affected. Thus, the mitochondrial DNA mutation is necessary but not sufficient to cause optic neuropathy. Environmental triggers and genetic modifying factors have been considered to explain its variable penetrance. We measured the mitochondrial DNA copy number and mitochondrial mass indicators in blood cells from affected and carrier individuals, screening three large pedigrees and 39 independently collected smaller families with Leber's hereditary optic neuropathy, as well as muscle biopsies and cells isolated by laser capturing from post-mortem specimens of retina and optic nerves, the latter being the disease targets. We show that unaffected mutation carriers have a significantly higher mitochondrial DNA copy number and mitochondrial mass compared with their affected relatives and control individuals. Comparative studies of fibroblasts from affected, carriers and controls, under different paradigms of metabolic demand, show that carriers display the highest capacity for activating mitochondrial biogenesis. Therefore we postulate that the increased mitochondrial biogenesis in carriers may overcome some of the pathogenic effect of mitochondrial DNA mutations. Screening of a few selected genetic variants in candidate genes involved in mitochondrial biogenesis failed to reveal any significant association. Our study provides a valuable mechanism to explain variability of penetrance in Leber's hereditary optic neuropathy and clues for high throughput genetic screening to identify the nuclear modifying gene(s), opening an avenue to develop predictive genetic tests on disease risk and therapeutic strategies.
C1 [Giordano, Carla; Pisano, Annalinda; Mancini, Massimiliano; d'Amati, Giulia] Univ Rome, Dept Radiol Oncol & Pathol, Rome, Italy.
   [Iommarini, Luisa; Maresca, Alessandra; Valentino, Maria Lucia; Caporali, Leonardo; Liguori, Rocco; Carelli, Valerio] Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Bologna, Italy.
   [Giordano, Luca; Deceglie, Stefania; Roberti, Marina; Fanelli, Francesca; Fracasso, Flavio; Polosa, Paola Loguercio; Cantatore, Palmiro] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.
   [Maresca, Alessandra; Valentino, Maria Lucia; Caporali, Leonardo; Liguori, Rocco; Carelli, Valerio] Bellaria Hosp, IRCCS Ist Sci Neurol Bologna, I-40139 Bologna, Italy.
   [Ross-Cisneros, Fred N.; Sadun, Alfredo A.] USC, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA USA.
   [Ross-Cisneros, Fred N.; Sadun, Alfredo A.] USC, Keck Sch Med, Dept Neurosurg, Los Angeles, CA USA.
   [D'Adamo, Pio] Univ Trieste, Dept Reprod Sci Dev & Publ Hlth, Trieste, Italy.
   [D'Adamo, Pio] Univ Trieste, IRCCS Burlo Garofolo Children Hosp, Trieste, Italy.
   [Hudson, Gavin; Pyle, Angela; Yu-Wai-Man, Patrick; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Zeviani, Massimo] Fdn Ist Neurol Carlo Besta IRCCS, Unit Mol Neurogenet, Milan, Italy.
   [Zeviani, Massimo] MRC Mitochondrial Biol Unit, Cambridge, England.
   [Salomao, Solange R.; Berezovsky, Adriana; Belfort, Rubens, Jr.; Moraes, Milton; Moraes Filho, Milton] Fed Univ Sao Paulo UNIFESP, Dept Ophthalmol, Sao Paulo, Brazil.
   [Ventura, Dora Fix] Univ Sao Paulo, Inst Psychol, Dept Expt Psychol, Sao Paulo, Brazil.
   [Barboni, Piero] Studio Oculist dAzeglio, Bologna, Italy.
   [Sadun, Alfredo A.] Osped San Giovanni Evangelista, Tivoli, Italy.
   [De Negri, Annamaria] Azienda Osped San Camillo Forlanini, Rome, Italy.
   [Tancredi, Andrea] Univ Rome, Dipartimento Metodi & Modelli Econ Finanza & Terr, Rome, Italy.
   [Mancini, Massimiliano] Univ Rome, Dept Mol Med, Rome, Italy.
RP Giordano, C (corresponding author), Policlin Umberto 1, Dept Radiol Oncol & Pathol, Viale Regina Elena 324, I-00161 Rome, Italy.
EM carla.giordano@uniroma1.it; valerio.carelli@unibo.it
RI Salomao, Solange R/G-9500-2012; Zeviani, Massimo/K-2891-2014; Barboni,
   Piero/AAA-9936-2020; sadun, federico/AAF-6588-2019; Liguori,
   Rocco/AAB-7860-2020; Maresca, Alessandra/J-7393-2016; d'Amati,
   Giulia/F-1251-2011; Iommarini, Luisa/J-2328-2018; Ventura, Dora
   F/B-9071-2012; Fanelli, Francesca/O-1734-2015; Giordano,
   Carla/L-5657-2015; Berezovsky, Adriana/F-2341-2013; d'Adamo, Adamo
   Pio/G-4064-2011; Caporali, Leonardo/J-7398-2016; Hudson,
   Gavin/E-7117-2017
OI Salomao, Solange R/0000-0002-3436-5599; Barboni,
   Piero/0000-0002-0118-4177; Maresca, Alessandra/0000-0002-8959-8832;
   d'Amati, Giulia/0000-0002-6959-691X; Iommarini,
   Luisa/0000-0002-6804-7302; Ventura, Dora F/0000-0002-7616-4031; Fanelli,
   Francesca/0000-0003-3559-3689; Giordano, Carla/0000-0002-3716-4303;
   Berezovsky, Adriana/0000-0001-6350-8221; d'Adamo, Adamo
   Pio/0000-0001-9367-4909; Caporali, Leonardo/0000-0002-0666-4380;
   Liguori, Rocco/0000-0002-1815-1013; VALENTINO, MARIA
   LUCIA/0000-0001-5323-0115; Giordano, Luca/0000-0001-6315-7361; Zeviani,
   Massimo/0000-0002-9067-5508; CARELLI, VALERIO/0000-0003-4923-6404
FU TelethonFondazione Telethon [GGP06233, GGP11182, GPP10005]; Associazione
   Serena Talarico per i giovani nel mondo and Fondazione Giuseppe
   Tomasello O.N.L.U.S.; Mitocon Onlus; Research to Prevent
   BlindnessResearch to Prevent Blindness (RPB); International Foundation
   for Optic Nerve Diseases (IFOND); Struggling Within Leber's; Poincenot
   Family; Eierman Foundation; National Eye InstituteUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [EY03040]; Medical Research
   CouncilMedical Research Council UK (MRC) [G1002570, MC_UP_1002/1,
   MR/K000608/1, G0701386] Funding Source: researchfish; Fight for Sight
   [1479/80] Funding Source: researchfish; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040, P30EY003040,
   P30EY003040, P30EY003040, P30EY003040, P30EY003040] Funding Source: NIH
   RePORTER
FX This work was supported by Telethon Grants GGP06233 (to G.d.A., P.M. and
   V.C.), GGP11182 (to V. C. and P. M.), and GPP10005 (to M.Z. and V.C.),
   as well as by Associazione Serena Talarico per i giovani nel mondo and
   Fondazione Giuseppe Tomasello O.N.L.U.S. (to C. G.), Mitocon Onlus
   (grant to C.G. and V.C.), Research to Prevent Blindness, the
   International Foundation for Optic Nerve Diseases (IFOND), Struggling
   Within Leber's, The Poincenot Family, the Eierman Foundation, and a
   National Eye Institute grant EY03040 (F.N.R.-C and A.A.S.).
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Andrews RM, 1999, BRIT J OPHTHALMOL, V83, P231, DOI 10.1136/bjo.83.2.231
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026
   Barron MJ, 2004, BRIT J OPHTHALMOL, V88, P286, DOI 10.1136/bjo.2003.027664
   BENDALL KE, 1995, AM J HUM GENET, V57, P248
   Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197
   Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002
   Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P
   Cossarizza A, 2003, ANTIVIR THER, V8, P315
   Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101
   Curran JE, 2010, HUM GENET, V127, P183, DOI 10.1007/s00439-009-0756-0
   DiMauro S, 2003, NEW ENGL J MED, V356, P809
   Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537
   Giordano C, 2011, METHODS MOL BIOL, V755, P223, DOI 10.1007/978-1-61779-163-5_18
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gomez-Duran A, 2012, BBA-MOL BASIS DIS, V1822, P1216, DOI 10.1016/j.bbadis.2012.04.014
   Gonzalez-Halphen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.107
   Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573
   Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963
   Howell N, 1998, AM J HUM GENET, V63, P1220, DOI 10.1086/302049
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Iommarini L, 2012, NEUROLOGY, V79, P1517, DOI 10.1212/WNL.0b013e31826d5f72
   Ji YL, 2010, MOL VIS, V16, P416
   Korsten A, 2010, BBA-BIOENERGETICS, V1797, P197, DOI 10.1016/j.bbabio.2009.10.003
   La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155
   LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Mackey DA, 2003, EYE, V17, P312, DOI 10.1038/sj.eye.6700362
   Martinelli P, 2010, BBA-BIOENERGETICS, V1797, P1, DOI 10.1016/j.bbabio.2009.07.013
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Moreno-Loshuertos R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001379
   Newman N. J., 2005, WALSH HOYTS CLIN NEU, P465
   Nishioka T, 2004, J HUM GENET, V49, P701, DOI 10.1007/s10038-004-0209-5
   Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452
   Phasukkijwatana N, 2010, HUM GENET, V128, P39, DOI 10.1007/s00439-010-0821-8
   Ramos CDF, 2009, INVEST OPHTH VIS SCI, V50, P1666, DOI 10.1167/iovs.08-2695
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   Sadun AA, 2000, T AM OPHTHAL SOC, V98, P232
   Sadun Alfredo A, 2006, Trans Am Ophthalmol Soc, V104, P51
   Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010
   Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012
   Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474
   Toompuu M, 1999, HUM MOL GENET, V8, P2275, DOI 10.1093/hmg/8.12.2275
   Ventura DF, 2005, INVEST OPHTH VIS SCI, V46, P4809, DOI 10.1167/iovs.05-0455
   VERGANI L, 1995, BIOCHEM BIOPH RES CO, V210, P880, DOI 10.1006/bbrc.1995.1740
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Yen MY, 2002, BRIT J OPHTHALMOL, V86, P1027, DOI 10.1136/bjo.86.9.1027
   Yen MY, 1996, BRIT J OPHTHALMOL, V80, P78, DOI 10.1136/bjo.80.1.78
   Zhang AM, 2010, HUM GENET, V128, P465, DOI 10.1007/s00439-010-0875-7
NR 63
TC 88
Z9 97
U1 0
U2 29
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD FEB
PY 2014
VL 137
BP 335
EP 353
DI 10.1093/brain/awt343
PN 2
PG 19
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AA7QB
UT WOS:000331290900007
PM 24369379
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU Fernandes, BF
   Nikolitch, K
   Coates, J
   Novais, G
   Odashiro, A
   Odashiro, PP
   Belfort, RN
   Burnier, MN
AF Fernandes, Bruno F.
   Nikolitch, Katerina
   Coates, James
   Novais, Gustavo
   Odashiro, Alexandre
   Odashiro, Patricia P.
   Belfort, Rubens N.
   Burnier, Miguel N., Jr.
TI Local chemotherapeutic agents for the treatment of ocular malignancies
SO SURVEY OF OPHTHALMOLOGY
LA English
DT Review
DE mytomicin; carboplatin; interferon; PAM; melanoma; retinoblastoma;
   carcinoma; conjunctiva; PAM; CIN
ID TOPICAL MITOMYCIN-C; SURFACE SQUAMOUS NEOPLASIA; PRIMARY ACQUIRED
   MELANOSIS; CONJUNCTIVAL INTRAEPITHELIAL NEOPLASIA; TRANSGENIC MURINE
   RETINOBLASTOMA; CORNEAL EPITHELIAL DYSPLASIA; PRIMARY INTRAOCULAR
   LYMPHOMA; OPHTHALMIC DRUG-DELIVERY; CENTRAL-NERVOUS-SYSTEM; HIGH-DOSE
   CHEMOTHERAPY
AB We critically analyze available peer-reviewed literature, including clinical trials and case reports, on local ocular cancer treatments. Recent innovations in many areas of ocular oncology have introduced promising new therapies, but, for the most part, the optimal treatment of ocular malignancies remains elusive. (C) 2014 Elsevier Inc. All rights reserved.
C1 McGill Univ, Ctr Hlth, Dept Ophthalmol & Pathol, Montreal, PQ, Canada.
   Henry C Witelson Ocular Pathol Lab, Montreal, PQ, Canada.
RP Fernandes, BF (corresponding author), 3775 Univ St,Room 216, Montreal, PQ H3A 2B4, Canada.
EM bruno.mtl@gmail.com
RI Fernandes, Bruno F./ABA-3567-2020
OI Fernandes, Bruno F./0000-0002-5385-3571; Coates,
   James/0000-0002-4908-0975; Burnier, Miguel/0000-0002-2335-7470
CR Abraham LM, 2007, DRUGS, V67, P237, DOI 10.2165/00003495-200767020-00005
   Abraham LM, 2006, DRUGS, V66, P321, DOI 10.2165/00003495-200666030-00005
   Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014
   Abramson DH, 2012, BRIT J OPHTHALMOL, V96, P499, DOI 10.1136/bjophthalmol-2011-300498
   Abramson DH, 2010, OPHTHALMOLOGY, V117, P1623, DOI 10.1016/j.ophtha.2009.12.030
   Abramson DH, 2010, BRIT J OPHTHALMOL, V94, P396, DOI 10.1136/bjo.2009.174268
   Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2
   Abramson DH, 2005, ARCH OPHTHALMOL-CHIC, V123, P128, DOI 10.1001/archopht.123.1.128-b
   AHFS, 2009, CARB 4 AHFS DET MON
   Ahmed T, 2005, LEUKEMIA LYMPHOMA, V46, P405, DOI 10.1080/10428190400019826
   Aldave AJ, 2007, BRIT J OPHTHALMOL, V91, P1087, DOI 10.1136/bjo.2006.107482
   Alvarado JA, 2008, AM J OPHTHALMOL, V146, P276, DOI 10.1016/j.ajo.2008.04.008
   Anandajeya Wendy V., 2009, International Ophthalmology, V29, P285, DOI 10.1007/s10792-008-9225-3
   Ballalai PL, 2009, OPHTHAL PLAST RECONS, V25, P296, DOI 10.1097/IOP.0b013e3181ac4c39
   BARON S, 1991, JAMA-J AM MED ASSOC, V266, P1375, DOI 10.1001/jama.266.10.1375
   Basti S, 2003, CORNEA, V22, P687, DOI 10.1097/00003226-200310000-00015
   Beleznay KM, 2009, CURR ONCOL, V16, P81
   BLEYER WA, 1977, CANCER TREAT REV, V4, P87, DOI 10.1016/S0305-7372(77)80007-8
   BLUMENKRANZ MS, 1982, AM J OPHTHALMOL, V94, P458, DOI 10.1016/0002-9394(82)90239-2
   Boehm MD, 2004, OPHTHALMOLOGY, V111, P1755, DOI 10.1016/j.ophtha.2004.01.034
   Boutrid H, 2008, INVEST OPHTH VIS SCI, V49, P2799, DOI 10.1167/iovs.08-1751
   Chalasani R, 2006, CLIN EXP OPHTHALMOL, V34, P708, DOI 10.1111/j.1442-9071.2006.01356.x
   Chan Chi-Chao, 2004, Cancer Control, V11, P285
   Chang SW, 2004, J CATARACT REFR SURG, V30, P1742, DOI 10.1016/j.jcrs.2003.12.044
   Chen C, 2004, BRIT J OPHTHALMOL, V88, P17, DOI 10.1136/bjo.88.1.17
   Chen HC, 2004, CORNEA, V23, P726, DOI 10.1097/01.ico.0000126320.36014.d1
   Chen JY, 2007, CLIN EXP OPHTHALMOL, V35, P865, DOI 10.1111/j.1442-9071.2007.01640.x
   Daniell M, 2002, CLIN EXP OPHTHALMOL, V30, P94, DOI 10.1046/j.1442-6404.2002.00497.x
   de Benito-Llopis L, 2012, AM J OPHTHALMOL, V153, P17, DOI 10.1016/j.ajo.2011.05.034
   de Salamanca AE, 2006, INVEST OPHTH VIS SCI, V47, P1416, DOI 10.1167/iovs.05-0495
   de Smet MD, 1999, BRIT J OPHTHALMOL, V83, P448, DOI 10.1136/bjo.83.4.448
   DEKEIZER RJW, 1986, DOC OPHTHALMOL, V64, P31, DOI 10.1007/BF00166683
   DERICK RJ, 1991, ARCH OPHTHALMOL-CHIC, V109, P1635, DOI 10.1001/archopht.1991.01080120013002
   Di Pascuale MA, 2004, CORNEA, V23, P89, DOI 10.1097/00003226-200401000-00016
   Edelhauser HF, 2010, INVEST OPHTH VIS SCI, V51, P5403, DOI 10.1167/iovs.10-5392
   Eljarrat-Binstock E, 2007, CURR EYE RES, V32, P639, DOI 10.1080/02713680701528674
   ERICSON L, 1964, ACTA OPHTHALMOL, V42, P721
   Esquenazi S, 2005, BRIT J OPHTHALMOL, V89, P1221, DOI 10.1136/bjo.2004.063339
   Finger PT, 2008, AM J OPHTHALMOL, V145, P124, DOI 10.1016/j.ajo.2007.08.027
   FINGER PT, 1993, BRIT J OPHTHALMOL, V77, P751, DOI 10.1136/bjo.77.11.751
   Finger PT, 1998, BRIT J OPHTHALMOL, V82, P476, DOI 10.1136/bjo.82.5.476
   Fishburne BC, 1997, ARCH OPHTHALMOL-CHIC, V115, P1152, DOI 10.1001/archopht.1997.01100160322009
   Fotoohi AK, 2008, LEUKEMIA LYMPHOMA, V49, P410, DOI 10.1080/10428190701824569
   Fram Robert J., 1992, Current Opinion in Oncology, V4, P1073, DOI 10.1097/00001622-199212000-00012
   Frenkel S, 2008, BRIT J OPHTHALMOL, V92, P383, DOI 10.1136/bjo.2007.127928
   Frucht-Pery J, 2002, OPHTHALMOLOGY, V109, P548, DOI 10.1016/S0161-6420(01)00967-8
   Fujioka Miyuki, 2006, Nippon Ganka Gakkai Zasshi, V110, P51
   Fujita T, 1997, J DRUG TARGET, V4, P289, DOI 10.3109/10611869708995844
   Galm U, 2005, CHEM REV, V105, P739, DOI 10.1021/cr030117g
   Galor A, 2010, BRIT J OPHTHALMOL, V94, P551, DOI 10.1136/bjo.2008.153197
   Garcia RA, 2007, OPHTHAL SURG LAS IM, V38, P276, DOI 10.3928/15428877-20070701-02
   Gaudana R, 2009, PHARM RES-DORDR, V26, P1197, DOI 10.1007/s11095-008-9694-0
   Gebhardt DOE, 1998, AM J OPHTHALMOL, V125, P416, DOI 10.1016/S0002-9394(99)80165-2
   Gilheeney SW, 2010, PEDIATR BLOOD CANCER, V54, P591, DOI 10.1002/pbc.22347
   Go RS, 1999, J CLIN ONCOL, V17, P409, DOI 10.1200/JCO.1999.17.1.409
   Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5
   Goldberg S, 2007, OPHTHALMOLOGY, V114, P1236, DOI 10.1016/j.ophtha.2007.03.040
   Gordinier ME, 2002, INT J GYNECOL CANCER, V12, P710, DOI 10.1046/j.1525-1438.2002.01138.x
   Gulsen D, 2004, INVEST OPHTH VIS SCI, V45, P2342, DOI 10.1167/iovs.03-0959
   Gupta A, 2010, BRIT J OPHTHALMOL, V94, P555, DOI 10.1136/bjo.2009.168294
   Han A, 2010, J DRUGS DERMATOL, V9, P864
   Harbour JW, 1996, INVEST OPHTH VIS SCI, V37, P1892
   Hayden BC, 2004, INVEST OPHTH VIS SCI, V45, P3644, DOI 10.1167/iovs.04-0228
   Hayden BH, 2000, ARCH OPHTHALMOL-CHIC, V118, P1549
   Hayden B, 2006, INVEST OPHTH VIS SCI, V47, P3717, DOI 10.1167/iovs.06-0365
   Henson JW, 1999, J CLIN ONCOL, V17, P1329
   Herold TR, 2010, GRAEF ARCH CLIN EXP, V248, P111, DOI 10.1007/s00417-009-1189-0
   Hirst LW, 2007, OPHTHALMOLOGY, V114, P976, DOI 10.1016/j.ophtha.2006.09.026
   Holcombe DJ, 2006, AM J OPHTHALMOL, V142, P568, DOI 10.1016/j.ajo.2006.05.058
   Honavar SG, 2009, BRIT J OPHTHALMOL, V93, P848, DOI 10.1136/bjo.2008.154427
   Hu FR, 1998, AM J OPHTHALMOL, V125, P118, DOI 10.1016/S0002-9394(99)80252-9
   Hu T, 2007, J PHARMACEUT BIOMED, V43, P263, DOI 10.1016/j.jpba.2006.06.032
   Huerva V, 2006, CORNEA, V25, P1220, DOI 10.1097/01.ico.0000240088.38631.46
   Huerva V, 2007, J OCUL PHARMACOL TH, V23, P143, DOI 10.1089/jop.2006.0114
   Hung S, 2009, BMJ CASE REPORTS
   JAMPEL HD, 1992, OPHTHALMOLOGY, V99, P1471
   Jockovich ME, 2007, INVEST OPHTH VIS SCI, V48, P5371, DOI 10.1167/iovs.07-0708
   Kaneko A, 2003, JPN J CLIN ONCOL, V33, P601, DOI 10.1093/jjco/hyg113
   Kang Derwent Jennifer J, 2008, Trans Am Ophthalmol Soc, V106, P206
   Kang SG, 2001, CURR EYE RES, V22, P174, DOI 10.1076/ceyr.22.3.174.5513
   Karp CL, 2010, OPHTHALMOLOGY, V117, P2241, DOI 10.1016/j.ophtha.2010.03.052
   Karp CL, 2001, OPHTHALMOLOGY, V108, P1093, DOI 10.1016/S0161-6420(01)00577-2
   Kemp EG, 2002, BRIT J OPHTHALMOL, V86, P31, DOI 10.1136/bjo.86.1.31
   KHAW PT, 1992, ARCH OPHTHALMOL-CHIC, V110, P1150, DOI 10.1001/archopht.1992.01080200130040
   Kim ES, 2009, PHARM RES-DORDR, V26, P1155, DOI 10.1007/s11095-009-9835-0
   Kim Eunah, 2009, Korean J Ophthalmol, V23, P210, DOI 10.3341/kjo.2009.23.3.210
   Kirath H, 2007, J AAPOS, V11, P404, DOI 10.1016/j.jaapos.2006.11.005
   Kobayashi A, 2002, JPN J OPHTHALMOL, V46, P215, DOI 10.1016/S0021-5155(01)00494-4
   Kumar GS, 1997, BIOCHEMISTRY-US, V36, P14128, DOI 10.1021/bi971394i
   Kurli M, 2005, GRAEF ARCH CLIN EXP, V243, P1108, DOI 10.1007/s00417-004-1080-y
   LEE GA, 1995, SURV OPHTHALMOL, V39, P429, DOI 10.1016/S0039-6257(05)80054-2
   Lin P, 2009, AM J OPHTHALMOL, V148, P192, DOI 10.1016/j.ajo.2009.04.004
   Lokich J, 1998, ANN ONCOL, V9, P13, DOI 10.1023/A:1008215213739
   Lokich J, 2001, CANCER INVEST, V19, P756, DOI 10.1081/CNV-100106152
   Low S, 2008, J AAPOS, V12, P166, DOI 10.1016/j.jaapos.2007.09.012
   Ma'luf RN, 2010, OPHTHAL PLAST RECONS, V26, P214, DOI 10.1097/IOP.0b013e3181b9e73e
   Martin NE, 2008, J OCUL PHARMACOL TH, V24, P433, DOI 10.1089/jop.2007.0110
   MASKIN SL, 1994, ARCH OPHTHALMOL-CHIC, V112, P1145, DOI 10.1001/archopht.1994.01090210029007
   Mason WP, 1998, J NEURO-ONCOL, V37, P135, DOI 10.1023/A:1005980206723
   Maury G, 2009, ANN DERMATOL VENER, V136, P508, DOI 10.1016/j.annder.2009.04.011
   Midena E, 2000, BRIT J OPHTHALMOL, V84, P268, DOI 10.1136/bjo.84.3.268
   Midena E, 1997, ARCH OPHTHALMOL-CHIC, V115, P1600, DOI 10.1001/archopht.1997.01100160770023
   Mulvihill A, 2003, ARCH OPHTHALMOL-CHIC, V121, P1120, DOI 10.1001/archopht.121.8.1120
   Munier FL, 2012, BRIT J OPHTHALMOL, V96, P1084, DOI 10.1136/bjophthalmol-2011-301016
   Murray TG, 1996, ARCH OPHTHALMOL-CHIC, V114, P1385, DOI 10.1001/archopht.1996.01100140585010
   Murray TG, 1997, INVEST OPHTH VIS SCI, V38, P2516
   Murray TG, 1997, ARCH OPHTHALMOL-CHIC, V115, P1286, DOI 10.1001/archopht.1997.01100160456013
   MUSSER SM, 1992, CHEM RES TOXICOL, V5, P95, DOI 10.1021/tx00025a016
   Musto P, 2007, EXPERT OPIN INV DRUG, V16, P1467, DOI 10.1517/13543784.16.9.1467
   Nagarwal RC, 2009, J CONTROL RELEASE, V136, P2, DOI 10.1016/j.jconrel.2008.12.018
   Nair A, 2008, J BIOMED NANOTECHNOL, V4, P410, DOI 10.1166/jbn.2008.004
   National Toxicology Program, 2011, Rep Carcinog, V12, P406
   Nemet AY, 2006, CLIN EXP OPHTHALMOL, V34, P375, DOI 10.1111/j.1442-9071.2006.01226.x
   Netto MV, 2006, J REFRACT SURG, V22, P562
   Ngoy D, 1998, J FR OPHTALMOL, V21, P96
   OBRIEN JM, 1990, ARCH OPHTHALMOL-CHIC, V108, P1145, DOI 10.1001/archopht.1990.01070100101043
   OCCLESTON NL, 1994, INVEST OPHTH VIS SCI, V35, P3681
   Ohshima K, 2009, JPN J OPHTHALMOL, V53, P186, DOI 10.1007/s10384-008-0636-5
   OPHIR A, 1991, EXP EYE RES, V53, P799, DOI 10.1016/0014-4835(91)90116-V
   Paczos TA, 2010, INT J GYNECOL PATHOL, V29, P193, DOI 10.1097/PGP.0b013e3181b6a7d7
   Panda A, 2008, AM J OPHTHALMOL, V145, P635, DOI 10.1016/j.ajo.2007.12.004
   Pardue MT, 2004, RETINA-J RET VIT DIS, V24, P776, DOI 10.1097/00006982-200410000-00015
   Paz MM, 2009, CHEM RES TOXICOL, V22, P1663, DOI 10.1021/tx9002758
   Pe'er J, 2005, AM J OPHTHALMOL, V139, P229, DOI 10.1016/j.ajo.2004.08.065
   Peterson EC, 2011, J NEUROSURG, V114, P1603, DOI 10.3171/2011.1.JNS10466
   PHILLIPS RM, 1988, CANCER CHEMOTH PHARM, V21, P168
   Pikkel J, 2001, CORNEA, V20, P168, DOI 10.1097/00003226-200103000-00011
   Poothullil Antony M, 2006, Semin Ophthalmol, V21, P161, DOI 10.1080/08820530500351694
   PRADHAN SN, 1961, CANCER RES, V21, P984
   Rajan MS, 2006, J CATARACT REFR SURG, V32, P1741, DOI 10.1016/j.jcrs.2006.05.014
   Rodriguez-Ares T, 2003, CORNEA, V22, P114, DOI 10.1097/00003226-200303000-00006
   Rodriguez-Galindo C, 2008, PEDIATRICS, V122, pE763, DOI 10.1542/peds.2008-0518
   ROOTMAN J, 1985, CANCER TREAT REP, V69, P119
   Rudkin Adam K, 2009, Can J Ophthalmol, V44, pe41, DOI 10.3129/i09-125
   Rudkin AK, 2009, CLIN EXP OPHTHALMOL, V37, P352, DOI 10.1111/j.1442-9071.2009.02048.x
   Russell HC, 2010, BRIT J OPHTHALMOL, V94, P1316, DOI 10.1136/bjo.2009.176099
   SAMUELS BL, 1995, J CLIN ONCOL, V13, P1786, DOI 10.1200/JCO.1995.13.7.1786
   Sandor V, 1998, J CLIN ONCOL, V16, P3000, DOI 10.1200/JCO.1998.16.9.3000
   Schechter BA, 2002, CORNEA, V21, P6, DOI 10.1097/00003226-200201000-00003
   Schechter BA, 2008, OPHTHALMOLOGY, V115, P1291, DOI 10.1016/j.ophtha.2007.10.039
   Schmack I, 2006, AM J OPHTHALMOL, V142, P310, DOI 10.1016/j.ajo.2006.02.044
   Schouten-van Meeteren AYN, 2001, CANCER, V92, P2933, DOI 10.1002/1097-0142(20011201)92:11<2933::AID-CNCR10071>3.0.CO;2-G
   Sen HN, 2008, OCUL IMMUNOL INFLAMM, V16, P29, DOI 10.1080/09273940801899764
   Sepulveda R, BR J OPHTHALMOL, V94, P532
   SEREGARD S, 1995, BRIT J OPHTHALMOL, V79, P194, DOI 10.1136/bjo.79.2.194
   Seregard S, 2012, BRIT J OPHTHALMOL, V96, P473, DOI 10.1136/bjophthalmol-2012-301528
   Sharma TK, 2007, EYE, V21, P780, DOI 10.1038/sj.eye.6702327
   Shields C L, 2000, Trans Am Ophthalmol Soc, V98, P471
   Shields CL, 2010, CLIN EXP OPHTHALMOL, V38, P638, DOI 10.1111/j.1442-9071.2010.02297.x
   Shields CL, 2002, AM J OPHTHALMOL, V133, P601, DOI 10.1016/S0002-9394(02)01400-9
   Shields CL, 2005, ARCH OPHTHALMOL-CHIC, V123, P109, DOI 10.1001/archopht.123.1.109
   Shields CL, 2004, SURV OPHTHALMOL, V49, P3, DOI 10.1016/j.survophthal.2003.10.008
   Shields CL, 2002, BRIT J OPHTHALMOL, V86, P244, DOI 10.1136/bjo.86.2.244
   Shields JA, 1997, ARCH OPHTHALMOL-CHIC, V115, P808, DOI 10.1001/archopht.1997.01100150810025
   Shimoda Y, 2008, GRAEF ARCH CLIN EXP, V246, P501, DOI 10.1007/s00417-007-0685-3
   Siganos CS, 2002, CORNEA, V21, P12, DOI 10.1097/00003226-200201000-00004
   Simpson AE, 2002, ARCH OPHTHALMOL-CHIC, V120, P1069
   Smith JR, 2002, OPHTHALMOLOGY, V109, P1709, DOI 10.1016/S0161-6420(02)01125-9
   SMITH M, 1989, CORNEA, V8, P58
   Smith SJ, 2012, BRIT J OPHTHALMOL, V96, P1073, DOI 10.1136/bjophthalmol-2011-300829
   Snodgrass RG, 2010, J BIOL CHEM, V285, P19068, DOI 10.1074/jbc.M109.040477
   Soussain C, 1996, LEUKEMIA LYMPHOMA, V23, P339, DOI 10.3109/10428199609054837
   Stone DU, 2005, CORNEA, V24, P297, DOI 10.1097/01.ico.0000138834.42489.ba
   Sturges A, 2008, OPHTHALMOLOGY, V115, P1297, DOI 10.1016/j.ophtha.2008.01.006
   Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013
   Torabifard H, 2012, J MOL MODEL, V18, P3563, DOI 10.1007/s00894-012-1354-y
   U. S. Department of Health, 1978, US DEP HLTH ED WELF, V168
   Ueda Mitsuyuki, 1994, Nippon Ganka Gakkai Zasshi, V98, P352
   Ueda Mitsuyuki, 1995, Nippon Ganka Gakkai Zasshi, V99, P1230
   Ullah N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027093
   Vajzovic LM, 2011, CLIN OPHTHALMOL, V5, P171, DOI 10.2147/OPTH.S12665
   Valezi VG, 2009, ARQ BRAS OFTALMOL, V72, P169, DOI 10.1590/S0004-27492009000200007
   van Maanen MJ, 1999, CANCER RES, V59, P4720
   Van Quill KR, 2005, OPHTHALMOLOGY, V112, P1151, DOI 10.1016/j.ophtha.2004.11.060
   VanderWalde A, 2012, BIOL BLOOD MARROW TR, V18, P1273, DOI 10.1016/j.bbmt.2012.01.021
   Vann RR, 1999, OPHTHALMOLOGY, V106, P91, DOI 10.1016/S0161-6420(99)90009-X
   Velez G, 2001, ARCH OPHTHALMOL-CHIC, V119, P1518
   Velez G, 1999, BRIT J OPHTHALMOL, V83, P1225, DOI 10.1136/bjo.83.11.1225
   VERWEIJ J, 1990, Anti-Cancer Drugs, V1, P5, DOI 10.1097/00001813-199010000-00002
   Walling J, 2006, INVEST NEW DRUG, V24, P37, DOI 10.1007/s10637-005-4541-1
   Wang JK, 2006, JPN J OPHTHALMOL, V50, P474, DOI 10.1007/s10384-005-0327-4
   Williams SK, 2010, EXPERT OPIN PHARMACO, V11, P947, DOI 10.1517/14656561003657145
   Wilson MW, 1997, AM J OPHTHALMOL, V124, P303, DOI 10.1016/S0002-9394(14)70822-0
   Wu KY, 2008, MOL VIS, V14, P1705
   Wu KY, 1999, J OCUL PHARMACOL TH, V15, P401, DOI 10.1089/jop.1999.15.401
   Yamamoto N, 2002, OPHTHALMOLOGY, V109, P249, DOI 10.1016/S0161-6420(01)00926-5
   Yamane Takashi, 2004, Int J Clin Oncol, V9, P69, DOI 10.1007/s10147-004-0392-6
   YEATTS RP, 1995, OPHTHALMOLOGY, V102, P1338, DOI 10.1016/S0161-6420(95)30866-4
   Zaki AA, 2009, CORNEA, V28, P986, DOI 10.1097/ICO.0b013e3181a0a23d
   ZLIOBA A, 1988, ANN OPHTHALMOL, V20, P71
NR 190
TC 11
Z9 12
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0039-6257
EI 1879-3304
J9 SURV OPHTHALMOL
JI Surv. Ophthalmol.
PD JAN-FEB
PY 2014
VL 59
IS 1
BP 97
EP 114
DI 10.1016/j.survophthal.2013.01.003
PG 18
WC Ophthalmology
SC Ophthalmology
GA 275DL
UT WOS:000328656400007
PM 24112549
DA 2020-12-01
ER

PT J
AU Dare, A
   Cardillo, J
   Jorge, R
   Belfort, R
   Farah, M
AF Dare, Alessandro
   Cardillo, Jose
   Jorge, Rodrigo
   Belfort, Rubens
   Farah, Michel
CA Pan-Amer Collaborative Retina
TI Reduced Energy Macular Laser Phototherapy for the Treatment of Diabetic
   Macular Edema
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 499 diabetic retinopathy; 505 edema; 578 laser
C1 [Dare, Alessandro] CBEO, Ophthalmol, Ribeirao Preto, Brazil.
   [Dare, Alessandro] Consultores Retina & Vitreo, Retina, Ribeirao Preto, Brazil.
   [Cardillo, Jose; Belfort, Rubens; Farah, Michel] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
   [Cardillo, Jose; Jorge, Rodrigo] Univ Sao Paulo, Ophthalmol, Ribeirao Preto, Brazil.
RI Farah, Michel Eid E/F-3285-2012
OI Farah, Michel Eid E/0000-0001-5951-0193
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2013
VL 54
IS 15
MA 2375
PG 2
WC Ophthalmology
SC Ophthalmology
GA VD1WC
UT WOS:000436232705267
DA 2020-12-01
ER

PT J
AU Romano, A
   Belfort, R
AF Romano, Andre
   Belfort, Rubens
TI En-face optical coherence tomography of ocular toxoplasmosis
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound); 550
   imaging/image analysis: clinical; 704 retinochoroiditis
C1 [Romano, Andre; Belfort, Rubens] UNIFESP, Paulista Sch Med, Ophthalmol, Americana, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2013
VL 54
IS 15
MA 3609
PG 2
WC Ophthalmology
SC Ophthalmology
GA VD1WC
UT WOS:000436232708166
DA 2020-12-01
ER

PT J
AU Salomao, S
   Cavascan, N
   Berezovsky, A
   Mitsuhiro, M
   Sacai, P
   Araujo, A
   Morales, PH
   Watanabe, S
   Belfort, R
   Ellwein, L
AF Salomao, Solange
   Cavascan, Nivea
   Berezovsky, Adriana
   Mitsuhiro, Marcia
   Sacai, Paula
   Araujo-Filho, Arnaud
   Morales, Paulo Henrique
   Watanabe, Sung
   Belfort, Rubens
   Ellwein, Leon
TI Assessment of Disability Weights Associated with Visual Acuity
   Impairment in Patients from a University Hospital in Brazil
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE 465 clinical (human) or epidemiologic studies:
   systems/equipment/techniques; 584 low vision; 754 visual acuity
C1 [Salomao, Solange; Cavascan, Nivea; Berezovsky, Adriana; Mitsuhiro, Marcia; Sacai, Paula; Araujo-Filho, Arnaud; Morales, Paulo Henrique; Watanabe, Sung; Belfort, Rubens] Univ Fed Sao Paulo, Dept Oftalmol, Sao Paulo, Brazil.
   [Ellwein, Leon] NEI, Bethesda, MD 20892 USA.
RI Ferraz, Nivea/AAC-2439-2020; Berezovsky, Adriana/F-2341-2013; Sacai,
   Paula Y/B-6525-2014
OI Ferraz, Nivea/0000-0001-7568-6199; Berezovsky,
   Adriana/0000-0001-6350-8221; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2013
VL 54
IS 15
MA 5315
PG 3
WC Ophthalmology
SC Ophthalmology
GA VD1WD
UT WOS:000436232902405
DA 2020-12-01
ER

PT J
AU Commodaro, AG
   Bombardieri, CR
   Peron, JPS
   Saito, KC
   Guedes, PM
   Hamassaki, DE
   Belfort, RN
   Rizzo, LV
   Belfort, R
   de Camargo, MM
AF Commodaro, Alessandra Goncalves
   Bombardieri, Cintia Raquel
   Schatzmann Peron, Jean Pierre
   Saito, Kelly Cristina
   Guedes, Pedro Mancini
   Hamassaki, Dania E.
   Belfort, Rubens N.
   Rizzo, Luiz Vicente
   Belfort, Rubens, Jr.
   de Camargo, Maristela Martins
TI p38 alpha MAP Kinase Controls IL-17 Synthesis in Vogt-Koyanagi-Harada
   Syndrome and Experimental Autoimmune Uveitis
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; CD4(+) T-CELLS; MULTIPLE-SCLEROSIS; EFFECTOR
   RESPONSE; TH17 CELLS; IFN-GAMMA; DISEASE; UVEORETINITIS; MICE;
   DIFFERENTIATION
AB PURPOSE. Interleukin (IL)-17, which is responsible for the initial influx of leukocytes into the target tissue, was recently described as the main cytokine involved in autoimmune diseases. Vogt-Koyanagi-Harada (VKH) syndrome is a significant cause of noninfectious blindness in the world. Herein the authors aimed at unraveling the involvement of IL-17 in VKH and in experimental autoimmune uveitis, focusing on the signaling pathways involved in IL-17 synthesis.
   METHODS. Mice were immunized with 161-180 peptide and pertussis toxin. Draining lymph node cells, harvested 21 days after immunization, were cultured in the presence or absence of p38 alpha mitogen-activated protein kinase (MAPK) inhibitor (SB203580) and assayed for cytokine production and quantification of CD4(+)IL-17(+) cells. Mice received intraocular injections of SB203580, and disease severity was evaluated by histologic examination of the enucleated eyes at day 21. CD4(+) lymphocytes from MSK-1/2-deficient mice, human CD4(+) cells silenced with MSK1 siRNA, or peripheral blood mononuclear cells (PBMCs) from VKH patients were cultured in the presence or absence of p38 alpha MAPK inhibitor and then assayed for IL-17, IFN-gamma, and IL-4 production.
   RESULTS. The inhibition of p38 alpha MAPK fully blocked the synthesis of IL-17 by PBMCs from VKH patients and lymphocytes from EAU mice. The absence of the msk1/2 gene resulted in failure to produce IL-17 by murine and human lymphocytes. Interestingly, intraocular injections of SB203580 in EAU mice did not suppress development of the disease.
   CONCLUSIONS. These data show that p38 alpha MAPK-MSK1/2 is involved in the control of IL-17 synthesis by CD4(+) T cells and that inhibition of p38 alpha MAPK in vitro suppresses IL-17 synthesis but that inhibition of this kinase in vivo did not protect from EAU. (Invest Ophthalmol Vis Sci. 2010;51:3567-3574) DOI: 10.1167/iovs.09-4393
C1 [Bombardieri, Cintia Raquel; Schatzmann Peron, Jean Pierre; Guedes, Pedro Mancini; Rizzo, Luiz Vicente; de Camargo, Maristela Martins] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil.
   [Commodaro, Alessandra Goncalves; Belfort, Rubens N.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.
   [Saito, Kelly Cristina; Hamassaki, Dania E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508900 Sao Paulo, Brazil.
   [Rizzo, Luiz Vicente] Albert Einstein Jewish Inst Educ & Res, Sao Paulo, Brazil.
RP de Camargo, MM (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Av Prof Lineu Prestes 1730, BR-05508900 Sao Paulo, Brazil.
EM mmcamar@usp.br
RI Xu, Qingguo/C-1962-2014; Rizzo, Luiz Vicente/B-4458-2009; Belfort,
   Rubens/E-2252-2012; Peron, Jean Pierre S/F-9248-2012; Hamassaki, Dania
   E/C-4455-2012; Camargo, Maristela/G-8584-2011
OI Xu, Qingguo/0000-0003-3191-0771; Belfort, Rubens/0000-0002-8422-3898;
   Hamassaki, Dania E/0000-0002-4351-6002; Camargo,
   Maristela/0000-0003-2815-125X; Saito, Kelly/0000-0001-6397-6754;
   Commodaro, Alessandra/0000-0002-7816-6508
FU Sao Paulo State Science Council [01/02584-2]; CAPESP (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior)CAPES [PNPD 0188085]
FX Supported by a Sao Paulo State Science Council Young Investigators Award
   (01/02584-2 to MMDC) and by CAPESP (Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior) Grant PNPD 0188085 (JPSP).
CR Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859
   Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585
   Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644
   Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453
   Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797
   Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x
   CASPI RR, 1988, J IMMUNOL, V140, P1490
   Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010
   Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652
   Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015
   Damico Francisco Max, 2005, Semin Ophthalmol, V20, P183, DOI 10.1080/08820530500232126
   Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095
   Dominguez C, 2005, CURR OPIN DRUG DISC, V8, P421
   Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035
   Kawanokuchi J, 2008, J NEUROIMMUNOL, V194, P54, DOI 10.1016/j.jneuroim.2007.11.006
   Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487
   LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0
   Liu L, 2008, BRIT J OPHTHALMOL, V92, P557, DOI 10.1136/bjo.2007.128769
   Liu XL, 2009, CLIN IMMUNOL, V131, P333, DOI 10.1016/j.clim.2008.12.007
   Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070
   Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500
   Locke NR, 2009, J IMMUNOL, V183, P975, DOI 10.4049/jimmunol.0803749
   Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258
   Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206
   Medicherla S, 2006, J PHARMACOL EXP THER, V318, P99, DOI 10.1124/jpet.105.097857
   MOCHIZUKI M, 1985, INVEST OPHTH VIS SCI, V26, P1
   Peng Y, 2007, INVEST OPHTH VIS SCI, V48, P4153, DOI 10.1167/iovs.07-0251
   PETRILLI BR, 1987, UVEITE, P19
   Rao NA, 1997, EYE, V11, P213, DOI 10.1038/eye.1997.54
   Read R W, 2000, Curr Opin Ophthalmol, V11, P437, DOI 10.1097/00055735-200012000-00009
   Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4
   Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817
   Rizzo LV, 1996, J IMMUNOL, V156, P1654
   Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114
   Staschke KA, 2009, J IMMUNOL, V183, P568, DOI 10.4049/jimmunol.0802361
   Sugita S, 2006, INVEST OPHTH VIS SCI, V47, P2547, DOI 10.1167/iovs.05-1547
   Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543
   Ward KW, 2001, XENOBIOTICA, V31, P783, DOI 10.1080/00498250110065621
   Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002
   Yang K, 2009, BRIT J OPHTHALMOL, V93, P249, DOI 10.1136/bjo.2008.142489
   Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135
   Yoshimura T, 2009, RHEUMATOLOGY, V48, P347, DOI 10.1093/rheumatology/ken489
   Zhang R, 2009, CURR EYE RES, V34, P297, DOI 10.1080/02713680902741696
   Zheng XF, 2010, J CELL PHYSIOL, V222, P95, DOI 10.1002/jcp.21926
NR 44
TC 21
Z9 21
U1 0
U2 5
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2010
VL 51
IS 7
BP 3567
EP 3574
DI 10.1167/iovs.09-4393
PG 8
WC Ophthalmology
SC Ophthalmology
GA 614HX
UT WOS:000279047500034
PM 20164464
OA Green Published
DA 2020-12-01
ER

PT J
AU Belfort, RN
   Belfort, R
   Isenberg, J
   Fernandes, BF
   Romano, A
   Burnier, MN
AF Belfort, R. N.
   Belfort, R., Jr.
   Isenberg, J.
   Fernandes, B. F.
   Romano, A.
   Burnier, M. N.
TI Evaluating the Presence of Toxoplasma Gondii in Peripheral Blood of
   Patients With Uveitis
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE toxoplasmosis; microbial pathogenesis: clinical studies; inflammation
C1 [Belfort, R. N.; Romano, A.] Univ Fed Sao Paulo, Vis Inst, Oftalmol, Sao Paulo, Brazil.
   [Belfort, R., Jr.] Univ Fed Sao Paulo, Ophthalmol, Sao Paulo, Brazil.
   [Isenberg, J.] McGill Univ, Pathol, Montreal, PQ, Canada.
   [Fernandes, B. F.] McGill Univ, Ocular Pathol, Montreal, PQ, Canada.
   [Burnier, M. N.] McGill Univ, Ophthalmol, Montreal, PQ, Canada.
RI Fernandes, Bruno F./ABA-3567-2020
OI Fernandes, Bruno F./0000-0002-5385-3571
FU CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
FX Support CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2010
VL 51
IS 13
MA 5868
PG 2
WC Ophthalmology
SC Ophthalmology
GA VF2UT
UT WOS:000442393605444
DA 2020-12-01
ER

PT J
AU Isenberg, J
   Belfort, RN
   Fernandes, BF
   Belfort, R
   Burnier, MN
   Ndao, M
AF Isenberg, J.
   Belfort, R. N.
   Fernandes, B. F.
   Belfort, R., Jr.
   Burnier, M. N., Jr.
   Ndao, M.
TI Eight Novel Serum Biomarkers for Ocular Toxoplasmosis by Mass
   Spectroscopy
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
DE toxoplasmosis; uveitis-clinical/animal model; proteomics
C1 [Isenberg, J.; Fernandes, B. F.; Burnier, M. N., Jr.] McGill Univ, Ocular Pathol, Montreal, PQ, Canada.
   [Belfort, R. N.; Belfort, R., Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Vis Inst, Sao Paulo, Brazil.
   [Ndao, M.] McGill Univ, Ctr Host Parasite Interact, Montreal, PQ, Canada.
RI Fernandes, Bruno F./ABA-3567-2020
OI Fernandes, Bruno F./0000-0002-5385-3571
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2010
VL 51
IS 13
MA 2905
PG 3
WC Ophthalmology
SC Ophthalmology
GA VF2UF
UT WOS:000442387306116
DA 2020-12-01
ER

PT J
AU Commodaro, AG
   Belfort, RN
   Rizzo, LV
   Muccioli, C
   Silveira, C
   Burnier, MN
   Belfort, R
AF Commodaro, Alessandra G.
   Belfort, Rubens N.
   Rizzo, Luiz Vicente
   Muccioli, Cristina
   Silveira, Claudio
   Burnier, Miguel N., Jr.
   Belfort, Rubens, Jr.
TI Ocular toxoplasmosis - an update and review of the literature
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article; Proceedings Paper
CT Meeting on Toxoplasma Centennial Congress from Discovery to Public
   Health Management
CY SEP, 2008
CL Buzios, BRAZIL
DE ocular toxoplasmosis; diagnosis; treatment and ocular lesions
ID POLYMERASE-CHAIN-REACTION; FUCHS HETEROCHROMIC IRIDOCYCLITIS; REAL-TIME
   PCR; CONGENITAL TOXOPLASMOSIS; GONDII INFECTION; INTRAVITREAL
   CLINDAMYCIN; EYE MANIFESTATIONS; POSTERIOR UVEITIS; SOUTHERN BRAZIL;
   RETINOCHOROIDITIS
AB Ocular toxoplasmosis is the most common cause of posterior uveitis worldwide. The infection can be acquired congenitally or postnatally and ocular lesions may present during or years after the acute infection occur. Current treatment controls ocular infection and inflammation, but does not prevent recurrences. We present a review and update on ocular toxoplasmosis and address misconceptions still found in the current medical literature.
C1 [Commodaro, Alessandra G.; Belfort, Rubens N.; Muccioli, Cristina; Burnier, Miguel N., Jr.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Inst Visao, BR-04038000 Sao Paulo, Brazil.
   [Belfort, Rubens N.; Burnier, Miguel N., Jr.] McGill Univ, Henry C Witelson Ocular Pathol Lab, Montreal, PQ, Canada.
   [Rizzo, Luiz Vicente] Albert Einstein Jewish Inst Educ & Res, Sao Paulo, Brazil.
   [Silveira, Claudio] Clin Silveira, Erechim, RS, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Inst Visao, Rua Botucatu 820, BR-04038000 Sao Paulo, Brazil.
EM clinbelf@uol.com.br
RI Rizzo, Luiz Vicente/B-4458-2009; Belfort, Rubens/E-2252-2012; Muccioli,
   Cristina/C-3419-2013
OI Belfort, Rubens/0000-0002-8422-3898; Burnier,
   Miguel/0000-0002-2335-7470; Commodaro, Alessandra/0000-0002-7816-6508
CR Abreu M. T., 1987, UVEITES, P211
   Aggio FB, 2006, EYE, V20, P1080, DOI 10.1038/sj.eye.6702113
   Antoniazzi E., 2008, Parassitologia (Rome), V50, P35
   BELFORT RN, 2008, ACTA OPHTHA IN PRESS
   Belfort-Neto R, 2007, AN ACAD BRAS CIENC, V79, P111, DOI 10.1590/S0001-37652007000100013
   Bonfioli Adriana A, 2005, Semin Ophthalmol, V20, P129, DOI 10.1080/08820530500231961
   Bosch-Driessen LEH, 2002, OPHTHALMOLOGY, V109, P869, DOI 10.1016/S0161-6420(02)00990-9
   Bosch-Driessen LH, 2000, OPHTHALMOLOGY, V107, P36, DOI 10.1016/S0161-6420(99)00013-5
   BREZIN AP, 1990, AM J OPHTHALMOL, V110, P599, DOI 10.1016/S0002-9394(14)77055-2
   Calderaro Adriana, 2006, Acta Biomed, V77, P75
   COLIN J, 1989, J FR OPHTALMOL, V12, P161
   de Moura L, 2006, EMERG INFECT DIS, V12, P326, DOI 10.3201/eid1202.041115
   DEABREU MT, 1982, AM J OPHTHALMOL, V93, P739, DOI 10.1016/0002-9394(82)90470-6
   Dubey JP, 2006, J PARASITOL, V92, P36, DOI 10.1645/GE-655R.1
   Dworkin LL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1534, DOI 10.1001/archopht.120.11.1534
   Eckert GU, 2007, EYE, V21, P746, DOI 10.1038/sj.eye.6702319
   Fekkar A, 2008, J CLIN MICROBIOL, V46, P1965, DOI 10.1128/JCM.01900-07
   Ganesh SK, 2004, OCUL IMMUNOL INFLAMM, V12, P75, DOI 10.1076/ocii.12.1.75.28065
   Garweg JG, 2005, PARASITE IMMUNOL, V27, P61, DOI 10.1111/j.1365-3024.2005.00747.x
   Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800
   Holland G.N., 1996, OCULAR INFECT IMMUNI, P1183
   Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032
   HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561
   Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997
   Jones JL, 2006, EMERG INFECT DIS, V12, P582
   Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025
   Kishore K, 2001, OPHTHALMIC SURG LAS, V32, P183
   Kodjikian L, 2006, GRAEF ARCH CLIN EXP, V244, P14, DOI 10.1007/s00417-005-1164-3
   LAHEY E, 1993, BRIT J OPHTHALMOL, V77, P455, DOI 10.1136/bjo.77.7.455
   Lin MH, 2000, J CLIN MICROBIOL, V38, P4121, DOI 10.1128/JCM.38.11.4121-4125.2000
   Mahalakshmi B, 2006, OCUL IMMUNOL INFLAMM, V14, P105, DOI 10.1080/09273940500545692
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Mets MB, 1997, AM J OPHTHALMOL, V123, P1, DOI 10.1016/S0002-9394(14)70986-9
   MITCHEL EO, 1992, OPHTHALMOLOGY, V99, P920, DOI 10.1016/S0161-6420(92)31873-1
   Montoya JG, 1996, CLIN INFECT DIS, V23, P277, DOI 10.1093/clinids/23.2.277
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Montoya JG, 1999, OPHTHALMOLOGY, V106, P1554, DOI 10.1016/S0161-6420(99)90453-0
   Montoya JG, 2008, CLIN INFECT DIS, V47, P554, DOI 10.1086/590149
   Morhun PJ, 1996, RETINA-J RET VIT DIS, V16, P383, DOI 10.1097/00006982-199616050-00003
   Nowakowska D, 2006, J CLIN MICROBIOL, V44, P1382, DOI 10.1128/JCM.44.4.1382-1389.2006
   NUSSENBLATT RB, 1994, JAMA-J AM MED ASSOC, V271, P304, DOI 10.1001/jama.271.4.304
   Ongkosuwito JV, 1999, AM J OPHTHALMOL, V128, P407, DOI 10.1016/S0002-9394(99)00266-4
   Pleyer U, 2007, OPHTHALMOLOGE, V104, P603, DOI 10.1007/s00347-007-1535-8
   RAO NA, 1977, ARCH OPHTHALMOL-CHIC, V95, P273, DOI 10.1001/archopht.1977.04450020074012
   ROTHOVA A, 1989, INT OPHTHALMOL, V13, P415, DOI 10.1007/BF02306491
   ROTHOVA A, 1993, AM J OPHTHALMOL, V115, P517, DOI 10.1016/S0002-9394(14)74456-3
   Rothova A, 2008, OPHTHALMOLOGY, V115, P306, DOI 10.1016/j.ophtha.2007.05.014
   Rothova Aniki, 2003, Curr Opin Ophthalmol, V14, P384, DOI 10.1097/00055735-200312000-00011
   SCHWAB IR, 1991, AM J OPHTHALMOL, V111, P356, DOI 10.1016/S0002-9394(14)72322-0
   SILVEIRA C, 1988, AM J OPHTHALMOL, V106, P362, DOI 10.1016/0002-9394(88)90382-0
   Silveira C, 2003, AM J OPHTHALMOL, V136, P370, DOI 10.1016/S0002-9394(03)00191-0
   Silveira C, 2002, AM J OPHTHALMOL, V134, P41, DOI 10.1016/S0002-9394(02)01527-1
   Silveira C, 2001, AM J OPHTHALMOL, V131, P351, DOI 10.1016/S0002-9394(00)00830-8
   Smith Justine R, 2002, Curr Opin Ophthalmol, V13, P387, DOI 10.1097/00055735-200212000-00008
   Sobrin L, 2007, RETINA-J RET VIT DIS, V27, P952, DOI 10.1097/IAE.0b013e31804b3f0d
   Soheilian M, 2005, OPHTHALMOLOGY, V112, P1876, DOI 10.1016/j.ophtha.2005.05.025
   Soheilian M, 2004, OCUL IMMUNOL INFLAMM, V12, P297, DOI 10.1080/092739490500174
   Tan HK, 2007, AM J OPHTHALMOL, V144, P648, DOI 10.1016/j.ajo.2007.07.013
   Vallet-Regi M, 2008, J BIOMED NANOTECHNOL, V4, P1, DOI 10.1166/jbn.2008.002
   Vallochi AL, 2005, AM J OPHTHALMOL, V139, P350, DOI 10.1016/j.ajo.2004.07.040
   Wallon M, 2004, PEDIATRICS, V113, P1567, DOI 10.1542/peds.113.6.1567
NR 61
TC 74
Z9 81
U1 0
U2 9
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAR
PY 2009
VL 104
IS 2
BP 345
EP 350
DI 10.1590/S0074-02762009000200030
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 458UT
UT WOS:000267051500030
PM 19430662
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Belfort, R
AF Belfort, Rubens, Jr.
TI Contact Lenses, Ophthalmology
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Editorial Material
C1 Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD NOV-DEC
PY 2008
VL 71
IS 6
SU S
BP 7
EP 8
PG 2
WC Ophthalmology
SC Ophthalmology
GA V28GZ
UT WOS:000208670600002
PM 19274402
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Lavinsky, D
   Belfort, RN
   Navajas, E
   Torres, V
   Martins, MC
   Belfort, R
AF Lavinsky, Daniel
   Belfort, Rubens N.
   Navajas, Eduardo
   Torres, Virginia
   Martins, Maria Cristina
   Belfort, Rubens, Jr.
TI Fundus autofluorescence of choroidal nevus and melanoma
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID ORANGE PIGMENT
AB Background: To describe autofluorescence patterns of choroidal melanocytic lesions using the Heidelberg Retinal Angiograph 2 system (HRA2).
   Methods: 20 patients with choroidal melanocytic lesions in the ocular fundus underwent ophthalmologic examination, fundus photography, autofluorescence and optical coherence tomography (OCT). Pathologic examination was performed on one enucleated eye with a large choroidal melanoma.
   Results: 15 patients had choroidal nevi and 5 had malignant choroidal melanoma ( 1 small, 1 medium and 3 large tumours). Choroidal nevi did not show any characteristic autofluorescence pattern, although secondary retinal pigment epithelium (RPE) changes, such as drusen and pigment epithelium detachment, appeared faintly hyperautofluorescent in 2 patients. Only the small malignant choroidal melanomas had prominent orange pigmentation, although all melanomas had an intense confluent hyperautofluorescent signal over the lesions. Pathology of one large malignant melanoma revealed lipofuscin underlying RPE.
   Conclusion: Most nevi did not have characteristic hyperautofluorescent features, but choroidal melanomas seemed to have a pattern of confluent hyperautofluorescence. Therefore, autofluorescence may be a useful non-invasive tool to assess lipofuscin in pigmented choroidal lesions, which may contribute to the diagnosis of malignancy. This hypothesis, however, remains to be confirmed in large prospective studies.
C1 Univ Fed Sao Paulo, Escola Paulista Med, Vis Inst, Sao Paulo, Brazil.
RP Lavinsky, D (corresponding author), 820,Vila Clementino, BR-04023062 Sao Paulo, Brazil.
EM lavinsky@via-rs.net
RI Lavinsky, Daniel/E-9524-2013; Torres, Virginia/N-6951-2018; Belfort,
   Rubens/E-2252-2012
OI Torres, Virginia/0000-0002-3744-0961; Belfort,
   Rubens/0000-0002-8422-3898
CR AUGSBURGER JJ, 1989, BRIT J OPHTHALMOL, V73, P911, DOI 10.1136/bjo.73.11.911
   DAMATO BE, 1990, EYE, V4, P382, DOI 10.1038/eye.1990.51
   Delori FC, 2004, ARCH BIOCHEM BIOPHYS, V430, P156, DOI 10.1016/j.abb.2004.05.016
   FONT RL, 1974, ARCH OPHTHALMOL-CHIC, V91, P359, DOI 10.1001/archopht.1974.03900060371004
   Holz FG, 1999, GRAEF ARCH CLIN EXP, V237, P145, DOI 10.1007/s004170050209
   Karadimas P, 2005, AM J OPHTHALMOL, V140, P1163, DOI 10.1016/j.ajo.2005.07.037
   Keilhauer CN, 2006, INVEST OPHTH VIS SCI, V47, P3556, DOI 10.1167/iovs.06-0122
   Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192
   LOHMANN W, 1995, OPHTHALMOLOGICA, V209, P7, DOI 10.1159/000310565
   Lois N, 1999, BRIT J OPHTHALMOL, V83, P276, DOI 10.1136/bjo.83.3.276
   Margo Curtis E, 2004, Cancer Control, V11, P304
   Shields CL, 2000, ARCH OPHTHALMOL-CHIC, V118, P360, DOI 10.1001/archopht.118.3.360
   Singh AD, 2006, OPHTHALMOLOGY, V113, P1032, DOI 10.1016/j.ophtha.2006.01.053
   SMITH LT, 1973, AM J OPHTHALMOL, V76, P212, DOI 10.1016/0002-9394(73)90162-1
   VONRUCKMANN A, 1995, BRIT J OPHTHALMOL, V79, P407, DOI 10.1136/bjo.79.5.407
NR 15
TC 31
Z9 35
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
EI 1468-2079
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD OCT
PY 2007
VL 91
IS 10
BP 1299
EP 1302
DI 10.1136/bjo.2007.116665
PG 4
WC Ophthalmology
SC Ophthalmology
GA 214AH
UT WOS:000249707900017
PM 17431017
OA Green Published
DA 2020-12-01
ER

PT J
AU Maia, M
   Farah, ME
   Belfort, RN
   Penha, FM
   Lima, CAS
   Aggio, FB
   Belfort, R
AF Maia, Mauricio
   Farah, Michel Eid
   Belfort, Rubens N.
   Penha, Fernando Marcondes
   Lima, Cio A. S. Filho
   Aggio, Fabio Bom
   Belfort, Rubens, Jr.
TI Effects of intravitreal triamcinolone acetonide injection with and
   without preservative
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
C1 Univ Fed Sao Paulo, Dept Ophthalmol, Vis Inst, BR-04023062 Sao Paulo, Brazil.
RP Maia, M (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Vis Inst, Rua Botucatu 822, BR-04023062 Sao Paulo, Brazil.
EM maiaretina@uol.com.br
RI Maia, Mauricio/Z-1042-2019; Penha, Fernando M/G-1784-2012; Belfort,
   Rubens/E-2252-2012; de Souza Lima Filho, Acacio Alves/C-7189-2012; Maia,
   Mauricio/I-5892-2015; Farah, Michel Eid E/F-3285-2012
OI Maia, Mauricio/0000-0002-7034-8091; Belfort, Rubens/0000-0002-8422-3898;
   Maia, Mauricio/0000-0002-7034-8091; Farah, Michel Eid
   E/0000-0001-5951-0193; Alves de Souza Lima Filho,
   Acacio/0000-0003-1802-9592
NR 0
TC 47
Z9 49
U1 0
U2 0
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD SEP
PY 2007
VL 91
IS 9
BP 1122
EP 1124
DI 10.1136/bjo.2007.115386
PG 3
WC Ophthalmology
SC Ophthalmology
GA 202EN
UT WOS:000248884900011
PM 17383993
OA Green Published
DA 2020-12-01
ER

EF